<!DOCTYPE html> <html class=js style lang=en><!--
 Page saved with SingleFile 
 url: https://www.nature.com/articles/s41418-022-01015-x 
 saved date: Tue May 31 2022 13:37:51 GMT+0200 (Mitteleuropäische Sommerzeit)
--><meta charset=utf-8>
<title>Immune response in COVID-19: what is next? | Cell Death &amp; Differentiation</title>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=applicable-device content=pc,mobile>
<meta name=viewport content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<style>@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){html{box-sizing:border-box;font-family:sans-serif;font-size:100%;height:100%;line-height:1.15;overflow-y:scroll}body{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.76;min-height:100%}article,aside,header,main,section{display:block}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}svg:not(:root){overflow:hidden}button{font-size:100%;line-height:1.15}button{overflow:visible}button{text-transform:none}button{-webkit-appearance:button}button{border-radius:0;cursor:pointer}button,h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{letter-spacing:-.0390625rem}h2{letter-spacing:-.0117156rem}h2{font-size:1.5rem;line-height:1.6rem}h2{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-weight:700}h3{font-size:1.25rem}h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-weight:700;letter-spacing:-.0117156rem;line-height:1.4rem}body,button,div,h1,h2,h3{margin:0;padding:0}p{padding:0}body{font-size:1.125rem}p{margin:0 0 28px}ol,ul{margin-bottom:28px;margin-top:0}p:empty{display:none}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}.c-article-author-list__show-more{margin-right:4px}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-header__menu--global .c-header__item svg{display:none}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-breadcrumbs>li{display:inline}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}.c-skip-link:link{color:#fff}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}.c-breadcrumbs__chevron{fill:#888;margin:4px 4px 0}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:8px 0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__row--flush{padding:0}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin-right:24px}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;line-height:1.4;list-style:none;margin:0 -8px;padding:0}.c-header__menu--global{font-weight:400;justify-content:flex-end}@media only screen and (min-width:540px){.c-header__menu--global .c-header__item svg{display:block}}.c-header__menu--journal{font-size:.875rem}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}@media only screen and (max-width:1023px){.c-header__menu--tools{display:none}}.c-header__item{display:flex}@media only screen and (min-width:540px){.c-header__item:not(:first-child){margin-left:8px}}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}@media only screen and (max-width:767px){.c-header__item--nature-research{display:none}}.c-header__row--flush .c-header__item{padding-bottom:8px;padding-top:8px}.c-header__link{align-items:center;color:inherit;display:flex;padding:8px;white-space:nowrap}.c-header__link>svg{margin-left:2px;transition-duration:.2s}@media only screen and (min-width:540px){.c-header__link>svg{margin-left:4px}}.c-header__show-text{display:none}@media only screen and (min-width:540px){.c-header__show-text{display:inline}.c-header__item--dropdown-menu{position:relative}}.u-button svg{fill:currentcolor}.u-button{align-items:center;border-radius:2px;cursor:pointer;font-family:sans-serif;font-size:1rem;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:768px){.u-show-at-md{display:block;visibility:visible}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-ma-0{margin:0}.u-mt-32{margin-top:32px}.u-mr-2{margin-right:2px}.u-mb-16{margin-bottom:16px}.u-mb-32{margin-bottom:32px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.u-lazy-ad-wrapper{background-color:#ccc;display:none;min-height:137px}@media only screen and (min-width:768px){.u-lazy-ad-wrapper{display:block}}}</style>
<style media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;height:100%;overflow-y:scroll;font-size:100%;box-sizing:border-box}body{min-height:100%;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;line-height:1.76;color:#222}article,aside,figcaption,figure,footer,header,main,section{display:block}figure{margin:0}a,sup{vertical-align:baseline}a{background-color:transparent;-webkit-text-decoration-skip:objects;color:#069;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word;text-decoration:underline;text-decoration-thickness:.0625rem;text-underline-offset:.08em}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative}sup{top:-.5em}img{border:0;max-width:100%;height:auto;vertical-align:middle}svg:not(:root){overflow:hidden}button{line-height:1.15}button{overflow:visible}button{text-transform:none}button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}.c-article-box__controls button:focus,.c-article-box__controls button:hover,.c-pan-zoom-controls button:focus,.c-pan-zoom-controls button:hover,a:focus,a:hover{text-decoration:underline}button{cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;border-radius:0}abbr[title]{text-decoration:none}b:focus,dd:focus,div:focus,dl:focus,dt:focus,em:focus,h1:focus,h2:focus,h3:focus,h4:focus,h5:focus,i:focus,li:focus,ol:focus,p:focus,span:focus,strong:focus,ul:focus{outline:0}h1{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}h1{letter-spacing:min(max(-.011715625rem,4vw),-.0390625rem)}h2{letter-spacing:-.011715625rem}h2{font-size:min(max(1.25rem,3.5vw),1.5rem);line-height:min(max(1.4rem,3.5vw),1.6rem)}h2{font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}h3{font-size:min(max(1.125rem,3vw),1.25rem)}h3{letter-spacing:-.011715625rem;line-height:1.4rem}[contenteditable]:focus,[tabindex="0"]:focus,a:focus,button:focus,input:focus,select:focus{outline:3px solid #fece3e;will-change:transform}body,button,div,h1,h2,h3{margin:0;padding:0}p{padding:0}a:hover{-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:active,button:active{outline:0}nav ol{list-style-image:none}body{font-size:1.125rem}p{margin:0 0 28px}ol,ul{margin-top:0;margin-bottom:28px}p:empty{display:none}.article-page{background:#fff}.composite-layer{transform:translateZ(0)}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1rem;line-height:1.3;display:flex;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{font-size:1rem;display:inline;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}.c-article-author-list__show-more{margin-right:4px}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-metrics-bar{display:flex;flex-wrap:wrap;line-height:1.3;font-size:1rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-author-affiliation__list,.c-article-author-information__list,.c-article-references{list-style:none;padding:0}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px;margin:0}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{padding-top:8px;margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__pill-button{padding:8px 16px 8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:.875rem;line-height:1.4;font-weight:700;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-decoration:none;display:inline-block}.c-article__pill-button:hover{background-color:#069;color:#fff;text-decoration:none}.c-article__pill-button:focus{outline:0;box-shadow:0 0 0 3px #fece3e;text-decoration:none}.c-article__pill-button:active,.c-article__pill-button:hover{box-shadow:0 0 0 0}.c-article__pill-button svg{width:auto;height:100%}.c-article__sub-heading{font-size:1.125rem;font-weight:400;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-style:normal;line-height:1.3;color:#222;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article-references__item{display:flex;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item::before{content:attr(data-counter);font-size:1.5rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__item::before{font-size:1.125rem;line-height:inherit}}.c-article-references__item>p.c-article-references__text{flex:1;padding-left:8px}.c-article-references__text{margin-bottom:8px}.c-article-references__links{display:flex;flex-basis:100%;justify-content:flex-end;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links>a{padding-left:8px}.c-article-references__links>a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-references__download svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-author-information__list{margin-top:0;margin-bottom:24px}.c-article-author-information__item{margin-bottom:16px}.c-article-author-information__subtitle{font-weight:700}.c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-author-affiliation__authors-list{padding:0;list-style:none;margin-bottom:16px;margin-top:0}.c-article-subject-list{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;list-style:none;display:flex;flex-wrap:wrap;padding:0;margin:0 0 24px}.c-article-subject-list__subject{background-color:#dae5ea;border-radius:20px;padding:4px 10px;font-weight:700;margin-right:15px;margin-bottom:16px;flex:0 1 auto}.c-bibliographic-information{display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1rem;display:block}.c-bibliographic-information__column:first-child{width:81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:flex;justify-content:flex-start;flex-wrap:wrap}.c-bibliographic-information__list-item{flex:0 0 33%;box-sizing:border-box;padding-right:8px;margin-bottom:16px;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{flex:0 0 100%}}.c-bibliographic-information__list-item p{margin-bottom:0}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;margin-bottom:8px}.c-bibliographic-information__download-citation{margin-bottom:24px}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-share-box__description{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:8px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem;margin-bottom:24px}.c-article-share-box__button{background:#fff;border:1px solid #069;box-sizing:content-box;color:#069;font-size:1rem;line-height:1.5;margin-bottom:8px;padding:8px 20px;text-align:center}@supports ((-webkit-backdrop-filter:blur(10px)) or (backdrop-filter:blur(10px))){.c-context-bar--sticky:after{background:linear-gradient(to top,rgba(255,255,255,.75) 50%,#fff);-webkit-backdrop-filter:blur(10px);backdrop-filter:blur(10px)}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0;min-height:200px}.c-reading-companion__tabs{font-size:1rem;list-style:none;display:flex;flex-direction:row;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{color:#069;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1.5;overflow:hidden;white-space:nowrap;text-overflow:ellipsis}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;color:#222}.c-header__menu--global .c-header__item svg{display:none}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-section__figure{border:2px solid #d5d5d5;padding:20px 10px;max-width:100%;margin-bottom:24px;clear:both}.c-article-section__figure-caption{margin-bottom:8px;display:block;word-break:break-word}.c-article-section__figure-content{margin-bottom:16px}.c-article-section__figure-item{max-width:100%}.c-article-section__figure-link{max-width:100%;display:block;margin:0 0 16px;padding:0}.c-article-section__figure-item img{display:block;margin:0 auto}.c-article-section__figure-description{font-size:1rem}.c-article-section__figure-description>*{margin-bottom:0}.c-article-table{border:2px solid #d5d5d5;clear:both;padding:20px 10px;margin-bottom:24px}.c-article-table__figcaption{line-height:1.4;margin-bottom:16px;word-break:break-word}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1;padding:13px 24px!important}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:.875rem}}a:hover{text-decoration:underline;text-decoration-thickness:.3875rem;text-underline-offset:.08em}p{word-wrap:break-word;overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{display:none;background-color:#ccc}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 4px + 90px)}@media only screen and (min-width:768px){.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{display:none;background-color:transparent;padding:0}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 4px + 250px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad__label{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-ad__label{font-size:.875rem;font-weight:400;margin-bottom:4px;color:#333;line-height:1.5}.c-breadcrumbs>li{display:inline}.c-meta{list-style:none;padding:0;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:.875rem;color:inherit;line-height:1.4}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;padding-right:4px;margin-right:4px}.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;position:absolute}.c-skip-link{background:#069;color:#fff;font-size:.875rem;text-align:center;padding:8px;inset:0;bottom:auto;z-index:9999;transform:translateY(-100%)}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#fff}.c-skip-link:focus{transform:translateY(0)}.c-breadcrumbs{list-style:none;margin:0;padding:0;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;color:#000}.c-breadcrumbs__link,.c-breadcrumbs__link:hover,.c-breadcrumbs__link:visited{color:#666}.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0;aspect-ratio:var(--card--image-aspect-ratio, 16/9)}}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{width:100%;height:100%;transform:unset;-o-object-fit:cover;object-fit:cover}}.c-corporate-footer{background-color:#222;border-top:none;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;padding-top:16px;padding-bottom:24px}.c-corporate-footer__legal{color:#a2a2a2;font-size:.813rem;margin-bottom:0;padding-top:4px}.c-menu{list-style:none;margin:0;padding:0;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;display:flex;line-height:1.3}.c-menu__item:not(:last-child){margin-right:16px}.c-menu__link{display:inline-block}.c-menu__link:active,.c-menu__link:visited{color:inherit}.c-menu__link:hover{text-decoration:underline}.c-menu--inherit .c-menu__link,.c-menu--inherit .c-menu__link:hover,.c-menu--inherit .c-menu__link:visited{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;margin-bottom:16px;line-height:1.4}.c-header__row{position:relative;padding:8px 0}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__row--flush{padding:0}.c-header__split{display:flex;align-items:center;justify-content:space-between}.c-header__logo-container{flex:1 1 0;margin-right:24px;line-height:0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header__menu{list-style:none;padding:0;display:flex;align-items:center;flex-wrap:wrap;flex:0 1 auto;font-weight:700;line-height:1.4;margin:0 -8px}.c-header__menu--global{font-weight:400;justify-content:flex-end}@media only screen and (min-width:540px){.c-header__menu--global .c-header__item svg{display:block}}.c-header__menu--journal{font-size:.875rem}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}@media only screen and (max-width:1023px){.c-header__menu--tools{display:none}}.c-header__item{display:flex}@media only screen and (min-width:540px){.c-header__item:not(:first-child){margin-left:8px}}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}@media only screen and (max-width:767px){.c-header__item--nature-research{display:none}}.c-header__row--flush .c-header__item{padding-top:8px;padding-bottom:8px}.c-header__link{color:inherit;padding:8px;display:flex;align-items:center;white-space:nowrap}.c-header-expander a,.c-header-expander a.hover,.c-header-expander a.visited,.c-header-expander a:hover,.c-header-expander a:visited,.c-header__link.hover,.c-header__link.visited,.c-header__link:hover,.c-header__link:visited{color:inherit}.c-header__link ::first-letter{text-transform:capitalize}.c-header__link>svg{margin-left:2px;transition-duration:.2s}@media only screen and (min-width:540px){.c-header__link>svg{margin-left:4px}}.c-header__show-text{display:none}@media only screen and (min-width:540px){.c-header__show-text{display:inline}}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}.c-footer a,.c-footer a:hover,.c-footer a:visited{color:inherit}.c-footer{background-color:#2f2f2f;color:#d5d5d5;line-height:1.4;padding:24px 0;font-size:.875rem}.c-footer a{vertical-align:middle}.c-footer__header{margin-bottom:24px;padding-bottom:24px;border-bottom:1px solid #555}@media only screen and (min-width:768px){.c-footer__header{display:flex;align-items:center}}@media only screen and (max-width:767px){.c-footer__header>:not(:last-child){margin-bottom:16px}}@media only screen and (min-width:768px){.c-footer__logo{flex:1}}.c-footer__list{list-style:none;margin:0;padding:0}.c-footer__grid{display:flex;flex-wrap:wrap}@supports (display:grid){.c-footer__grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(250px,1fr));grid-column-gap:16px;grid-row-gap:32px}}.c-footer__group{flex:1 1 50%;max-width:50%;padding-right:16px;margin-bottom:16px}@media only screen and (min-width:1024px){.c-footer__group{flex-basis:25%;max-width:25%}}@supports (display:grid){.c-footer__group{padding-right:0;max-width:none;margin-bottom:0}}.c-footer__heading{color:#eee;margin-bottom:16px;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-footer__item:not(:last-child){margin-bottom:4px}.u-button svg{fill:currentColor}.u-button{text-decoration:none}.u-button{align-items:center;cursor:pointer;margin:0;position:relative;font-family:sans-serif;font-size:1rem;line-height:1.3;padding:8px;transition:.25s ease,color .25s ease,border-color .25s ease;border-radius:2px}.u-button,.u-button:visited{color:#069}.u-button,.u-button:hover{border:1px solid #069}.u-button:focus{border:1px solid #069}.u-button:focus,.u-button:hover{color:#fff;background-color:#069;background-image:none}.u-button--primary{color:#fff;background-color:#069;background-image:none}.u-button--primary:visited{color:#fff}.u-button--primary,.u-button--primary:hover{border:1px solid #069}.u-button--primary:focus{border:1px solid #069}.u-button--primary:focus,.u-button--primary:hover{color:#069;background-color:#fff;background-image:none}.u-button--disabled,.u-button:disabled{color:#222;background-color:transparent;background-image:none;border:1px solid #eee;opacity:.7;cursor:default}.u-button--disabled svg,.u-button:disabled svg{fill:currentColor}.u-button--disabled:visited,.u-button:disabled:visited{color:#222}.u-button--disabled:hover,.u-button:disabled:hover{border:1px solid #eee;text-decoration:none}.u-button--disabled:focus,.u-button:disabled:focus{border:1px solid #eee;text-decoration:none}.u-button--disabled:focus,.u-button--disabled:hover,.u-button:disabled:focus,.u-button:disabled:hover{color:#222;background-color:transparent;background-image:none}.u-button--full-width{display:flex;width:100%}.u-hide{display:none;visibility:hidden}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:768px){.u-show-at-md{display:block;visibility:visible}}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-float-left{float:left}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-style-none{list-style-type:none}.u-list-reset{list-style:none;margin:0;padding:0}.u-custom-list-number{float:left;width:3em;padding-right:.5em;margin-left:-3.5em;text-align:right}.u-text-right{text-align:right}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-inline{display:inline}.u-display-flex{display:flex;width:100%}.u-flex-wrap{flex-wrap:wrap}.u-justify-content-space-between{justify-content:space-between}.u-flex-shrink{flex:0 1 auto}.u-ma-0{margin:0}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-2{margin-right:2px}.u-mr-32{margin-right:32px}.u-mb-16{margin-bottom:16px}.u-mb-32{margin-bottom:32px}html *,html ::after,html ::before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-footer a,.c-header__link{text-decoration:inherit}.c-footer a:hover,.c-header__link:hover,.c-site-messages .c-site-messages__close:hover,.nature-briefing-banner__checkbox-label a:hover{text-decoration:underline}.grade-c-hide{display:block}.u-lazy-ad-wrapper{min-height:137px;display:none;background-color:#ccc}@media only screen and (min-width:768px){.u-lazy-ad-wrapper{display:block}}</style>
<noscript>
                    <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-c2e8e04715.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
                </noscript>
<meta name=msapplication-TileColor content=#000000>
<meta name=msapplication-config content=/static/browserconfig.xml>
<meta name=theme-color content=#000000>
<meta name=application-name content=Nature>
<meta name=robots content=noarchive>
<meta name=access content=Yes>
<link rel=search href=http://www.nature.com/search>
<link rel=search href=http://www.nature.com/opensearch/opensearch.xml type=application/opensearchdescription+xml title=nature.com>
<link rel=search href=http://www.nature.com/opensearch/request type=application/sru+xml title=nature.com>
<script type=application/ld+json>{"mainEntity":{"headline":"Immune response in COVID-19: what is next?","description":"The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. \n              \n                \n                  \n                \n              \n            ","datePublished":"2022-05-17","dateModified":"2022-05-17","pageStart":"1","pageEnd":"16","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41418-022-01015-x","keywords":"Antimicrobial responses,Infectious diseases,Life Sciences,general,Biochemistry,Cell Biology,Stem Cells,Apoptosis,Cell Cycle Analysis","image":"https://static-content.springer.com/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Figa_HTML.png","isPartOf":{"name":"Cell Death & Differentiation","issn":["1476-5403","1350-9047"],"@type":["Periodical"]},"publisher":{"name":"Nature Publishing Group UK","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Li, Qing","url":"http://orcid.org/0000-0003-1990-5857","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wang, Ying","url":"http://orcid.org/0000-0002-2571-9367","affiliation":[{"name":"Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences","address":{"name":"CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sun, Qiang","affiliation":[{"name":"Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences","address":{"name":"Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Knopf, Jasmin","url":"http://orcid.org/0000-0003-2922-9370","affiliation":[{"name":"Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen","address":{"name":"Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen","address":{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Herrmann, Martin","url":"http://orcid.org/0000-0002-0258-2484","affiliation":[{"name":"Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen","address":{"name":"Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen","address":{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Lin, Liangyu","url":"http://orcid.org/0000-0003-4312-8955","affiliation":[{"name":"Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences","address":{"name":"CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Jiang, Jingting","url":"http://orcid.org/0000-0002-3128-9762","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Shao, Changshun","url":"http://orcid.org/0000-0003-2618-9342","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Li, Peishan","url":"http://orcid.org/0000-0002-6881-396X","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"He, Xiaozhou","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hua, Fei","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Niu, Zubiao","affiliation":[{"name":"Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences","address":{"name":"Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ma, Chaobing","affiliation":[{"name":"Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences","address":{"name":"Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Zhu, Yichao","affiliation":[{"name":"Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences","address":{"name":"Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ippolito, Giuseppe","affiliation":[{"name":"Ministry of Health","address":{"name":"Ministry of Health, Rome, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Piacentini, Mauro","affiliation":[{"name":"TOR, University of Rome Tor Vergata","address":{"name":"Department of Biology, TOR, University of Rome Tor Vergata, Rome, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Estaquier, Jerome","url":"http://orcid.org/0000-0002-9432-8044","affiliation":[{"name":"INSERM-U1124, Université Paris","address":{"name":"INSERM-U1124, Université Paris, Paris, France","@type":"PostalAddress"},"@type":"Organization"},{"name":"CHU de Québec - Université Laval Research Center","address":{"name":"CHU de Québec - Université Laval Research Center, Québec City, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Melino, Sonia","affiliation":[{"name":"TOR, University of Rome Tor Vergata","address":{"name":"Department of Biology, TOR, University of Rome Tor Vergata, Rome, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Weiss, Felix Daniel","url":"http://orcid.org/0000-0003-0228-5081","affiliation":[{"name":"University Hospital Bonn, University of Bonn","address":{"name":"Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Andreano, Emanuele","url":"http://orcid.org/0000-0003-0088-5788","affiliation":[{"name":"Research and Development Center, GlaxoSmithKline (GSK)","address":{"name":"Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Latz, Eicke","url":"http://orcid.org/0000-0003-1488-5666","affiliation":[{"name":"University Hospital Bonn, University of Bonn","address":{"name":"Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)","address":{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Schultze, Joachim L.","url":"http://orcid.org/0000-0003-2812-9853","affiliation":[{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)","address":{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"Genomics & Immunoregulation, LIMES-Institute, University of Bonn","address":{"name":"Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rappuoli, Rino","affiliation":[{"name":"Research and Development Center, GlaxoSmithKline (GSK)","address":{"name":"Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mantovani, Alberto","url":"http://orcid.org/0000-0001-5578-236X","affiliation":[{"name":"Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele","address":{"name":"Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, Milan, Italy","@type":"PostalAddress"},"@type":"Organization"},{"name":"IRCCS Humanitas Clinical Research Hospital","address":{"name":"IRCCS Humanitas Clinical Research Hospital, Milan, Italy","@type":"PostalAddress"},"@type":"Organization"},{"name":"William Harvey Research Institute, Queen Mary University","address":{"name":"William Harvey Research Institute, Queen Mary University, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mak, Tak Wah","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, 610 University Avenue","address":{"name":"Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Canada","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Hong Kong, Hong Kong","address":{"name":"Department of Pathology, University of Hong Kong, Hong Kong, Pok Fu Lam, Hong Kong","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Melino, Gerry","url":"http://orcid.org/0000-0001-9428-5972","affiliation":[{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)","address":{"name":"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany","@type":"PostalAddress"},"@type":"Organization"},{"name":"TOR, University of Rome Tor Vergata","address":{"name":"Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy","@type":"PostalAddress"},"@type":"Organization"}],"email":"melino@uniroma2.it","@type":"Person"},{"name":"Shi, Yufang","url":"http://orcid.org/0000-0001-8964-319X","affiliation":[{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College","address":{"name":"The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China","@type":"PostalAddress"},"@type":"Organization"},{"name":"Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences","address":{"name":"CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"},{"name":"TOR, University of Rome Tor Vergata","address":{"name":"Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy","@type":"PostalAddress"},"@type":"Organization"}],"email":"yufangshi@sibs.ac.cn","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>
<link rel=canonical href=https://www.nature.com/articles/s41418-022-01015-x>
<meta name=journal_id content=41418>
<meta name=dc.title content="Immune response in COVID-19: what is next?">
<meta name=dc.source content="Cell Death &amp; Differentiation 2022">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="Nature Publishing Group">
<meta name=dc.date content=2022-05-17>
<meta name=dc.type content=ReviewPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2022 The Author(s)">
<meta name=dc.rights content="2022 The Author(s)">
<meta name=dc.rightsAgent content=journalpermissions@springernature.com>
<meta name=dc.description content="The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.">
<meta name=prism.issn content=1476-5403>
<meta name=prism.publicationName content="Cell Death &amp; Differentiation">
<meta name=prism.publicationDate content=2022-05-17>
<meta name=prism.section content=ReviewPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=16>
<meta name=prism.copyright content="2022 The Author(s)">
<meta name=prism.rightsAgent content=journalpermissions@springernature.com>
<meta name=prism.url content=https://www.nature.com/articles/s41418-022-01015-x>
<meta name=prism.doi content=doi:10.1038/s41418-022-01015-x>
<meta name=citation_pdf_url content=https://www.nature.com/articles/s41418-022-01015-x.pdf>
<meta name=citation_fulltext_html_url content=https://www.nature.com/articles/s41418-022-01015-x>
<meta name=citation_journal_title content="Cell Death &amp; Differentiation">
<meta name=citation_journal_abbrev content="Cell Death Differ">
<meta name=citation_publisher content="Nature Publishing Group">
<meta name=citation_issn content=1476-5403>
<meta name=citation_title content="Immune response in COVID-19: what is next?">
<meta name=citation_online_date content=2022/05/17>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=16>
<meta name=citation_article_type content="Review Article">
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1038/s41418-022-01015-x>
<meta name=DOI content=10.1038/s41418-022-01015-x>
<meta name=citation_doi content=10.1038/s41418-022-01015-x>
<meta name=citation_springer_api_url content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41418-022-01015-x&amp;api_key=">
<meta name=description content="The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.">
<meta name=dc.creator content="Li, Qing">
<meta name=dc.creator content="Wang, Ying">
<meta name=dc.creator content="Sun, Qiang">
<meta name=dc.creator content="Knopf, Jasmin">
<meta name=dc.creator content="Herrmann, Martin">
<meta name=dc.creator content="Lin, Liangyu">
<meta name=dc.creator content="Jiang, Jingting">
<meta name=dc.creator content="Shao, Changshun">
<meta name=dc.creator content="Li, Peishan">
<meta name=dc.creator content="He, Xiaozhou">
<meta name=dc.creator content="Hua, Fei">
<meta name=dc.creator content="Niu, Zubiao">
<meta name=dc.creator content="Ma, Chaobing">
<meta name=dc.creator content="Zhu, Yichao">
<meta name=dc.creator content="Ippolito, Giuseppe">
<meta name=dc.creator content="Piacentini, Mauro">
<meta name=dc.creator content="Estaquier, Jerome">
<meta name=dc.creator content="Melino, Sonia">
<meta name=dc.creator content="Weiss, Felix Daniel">
<meta name=dc.creator content="Andreano, Emanuele">
<meta name=dc.creator content="Latz, Eicke">
<meta name=dc.creator content="Schultze, Joachim L.">
<meta name=dc.creator content="Rappuoli, Rino">
<meta name=dc.creator content="Mantovani, Alberto">
<meta name=dc.creator content="Mak, Tak Wah">
<meta name=dc.creator content="Melino, Gerry">
<meta name=dc.creator content="Shi, Yufang">
<meta name=dc.subject content="Antimicrobial responses">
<meta name=dc.subject content="Infectious diseases">
<meta name=citation_reference content="citation_journal_title=Cell Death Dis; citation_title=COVID-19 infection: the China and Italy perspectives; citation_author=J Chen, H Lu, G Melino, S Boccia, M Piacentini, W Ricciardi; citation_volume=11; citation_publication_date=2020; citation_pages=438; citation_doi=10.1038/s41419-020-2603-0; citation_id=CR1">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Patients with COVID-19: in the dark-NETs of neutrophils; citation_author=M Ackermann, HJ Anders, R Bilyy, GL Bowlin, C Daniel, R Lorenzo; citation_volume=28; citation_publication_date=2021; citation_pages=3125-39; citation_doi=10.1038/s41418-021-00805-z; citation_id=CR2">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis; citation_author=AG Goubet, A Dubuisson, A Geraud, FX Danlos, S Terrisse, CAC Silva; citation_volume=28; citation_publication_date=2021; citation_pages=3297-315; citation_doi=10.1038/s41418-021-00817-9; citation_id=CR3">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=An aberrant STAT pathway is central to COVID-19; citation_author=T Matsuyama, SP Kubli, SK Yoshinaga, K Pfeffer, TW Mak; citation_volume=27; citation_publication_date=2020; citation_pages=3209-25; citation_doi=10.1038/s41418-020-00633-7; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19; citation_author=T Matsuyama, SK Yoshinaga, K Shibue, TW Mak; citation_volume=28; citation_publication_date=2021; citation_pages=3199-213; citation_doi=10.1038/s41418-021-00892-y; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=Biol Direct; citation_title=Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?; citation_author=A Verkhratsky, Q Li, S Melino, G Melino, Y Shi; citation_volume=15; citation_publication_date=2020; citation_doi=10.1186/s13062-020-00282-3; citation_id=CR6">
<meta name=citation_reference content="citation_journal_title=JAMA.; citation_title=The potential future of the COVID-19 pandemic: will SARS-CoV-2 become a recurrent seasonal infection?; citation_author=CJL Murray, P Piot; citation_volume=325; citation_publication_date=2021; citation_pages=1249-50; citation_doi=10.1001/jama.2021.2828; citation_id=CR7">
<meta name=citation_reference content="citation_journal_title=Cell Death Disco; citation_title=New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion; citation_author=S Buonvino, S Melino; citation_volume=6; citation_publication_date=2020; citation_pages=134; citation_doi=10.1038/s41420-020-00372-1; citation_id=CR8">
<meta name=citation_reference content='Colson P, Fournier PE, Delerce J, Million M, Bedotto M, Houhamdi L, et al. Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France. J Med Virol. 2022. Online ahead of print.'>
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Covid-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: where we stand and challenges ahead; citation_author=G Forni, A Mantovani; citation_volume=28; citation_publication_date=2021; citation_pages=626-39; citation_doi=10.1038/s41418-020-00720-9; citation_id=CR10">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence; citation_author=L Lin, Y Wang, Q Li, M Hu, Y Shi; citation_volume=29; citation_publication_date=2022; citation_pages=263-5; citation_doi=10.1038/s41418-021-00909-6; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=COVID-19 infection: the perspectives on immune responses; citation_author=Y Shi, Y Wang, C Shao, J Huang, J Gan, X Huang; citation_volume=27; citation_publication_date=2020; citation_pages=1451-4; citation_doi=10.1038/s41418-020-0530-3; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=Cell Death Dis; citation_title=Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia; citation_author=A Mauriello, M Scimeca, I Amelio, R Massoud, A Novelli, F Lorenzo; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41419-021-04058-z; citation_id=CR13">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=After the pandemic: perspectives on the future trajectory of COVID-19; citation_author=A Telenti, A Arvin, L Corey, D Corti, MS Diamond, A Garcia-Sastre; citation_volume=596; citation_publication_date=2021; citation_pages=495-504; citation_doi=10.1038/s41586-021-03792-w; citation_id=CR14">
<meta name=citation_reference content="citation_journal_title=Psychol Neuropsychiatr Vieil; citation_title=Symptoms of COVID-19 among older adults: a systematic review of biomedical literature. Geriatr; citation_author=G Sacco, O Briere, M Asfar, O Guerin, G Berrut, C Annweiler; citation_volume=18; citation_publication_date=2020; citation_pages=135-9; citation_id=CR15">
<meta name=citation_reference content="citation_journal_title=Glob Health; citation_title=Sex differences in COVID-19 case fatality: do we know enough? Lancet; citation_author=N Dehingia, A Raj; citation_volume=9; citation_publication_date=2021; citation_pages=e14-e5.; citation_id=CR16">
<meta name=citation_reference content="citation_journal_title=Trop Dis Travel Med Vaccines; citation_title=COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations; citation_author=GT Flaherty, P Hession, CH Liew, BCW Lim, TK Leong, V Lim; citation_volume=6; citation_publication_date=2020; citation_pages=16; citation_doi=10.1186/s40794-020-00118-y; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=Lancet.; citation_title=Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic; citation_author=SSA Karim, QA Karim; citation_volume=398; citation_publication_date=2021; citation_pages=2126-8; citation_doi=10.1016/S0140-6736(21)02758-6; citation_id=CR18">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Omicron’s feeble attack on the lungs could make it less dangerous; citation_author=M Kozlov; citation_volume=601; citation_publication_date=2022; citation_pages=177; citation_doi=10.1038/d41586-022-00007-8; citation_id=CR19">
<meta name=citation_reference content="citation_journal_title=Lancet.; citation_title=Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study; citation_author=N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome; citation_volume=399; citation_publication_date=2022; citation_pages=437-46; citation_doi=10.1016/S0140-6736(22)00017-4; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Lessons from the host defences of bats, a unique viral reservoir; citation_author=AT Irving, M Ahn, G Goh, DE Anderson, LF Wang; citation_volume=589; citation_publication_date=2021; citation_pages=363-70; citation_doi=10.1038/s41586-020-03128-0; citation_id=CR21">
<meta name=citation_reference content="citation_journal_title=Lancet Respir Med; citation_title=Omicron variant and booster COVID-19 vaccines; citation_author=TK Burki; citation_volume=10; citation_publication_date=2022; citation_pages=e17; citation_doi=10.1016/S2213-2600(21)00559-2; citation_id=CR22">
<meta name=citation_reference content="Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022. Online ahead of print.">
<meta name=citation_reference content="citation_journal_title=J Infect Dis; citation_title=SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a spanish hospital after 3 months of follow-up; citation_author=G Moncunill, A Mayor, R Santano, A Jimenez, M Vidal, M Tortajada; citation_volume=223; citation_publication_date=2021; citation_pages=62-71; citation_doi=10.1093/infdis/jiaa696; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Front Immunol; citation_title=ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19; citation_author=D Zipeto, JDF Palmeira, GA Arganaraz, ER Arganaraz; citation_volume=11; citation_publication_date=2020; citation_pages=576745; citation_doi=10.3389/fimmu.2020.576745; citation_id=CR25">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Scientists deliberately gave people COVID - here’s what they learnt; citation_author=E Callaway; citation_volume=602; citation_publication_date=2022; citation_pages=191-2; citation_doi=10.1038/d41586-022-00319-9; citation_id=CR26">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=Severe COVID-19 is marked by a dysregulated myeloid cell compartment; citation_author=J Schulte-Schrepping, N Reusch, D Paclik, K Bassler, S Schlickeiser, B Zhang; citation_volume=182; citation_publication_date=2020; citation_pages=1419-40 e23; citation_doi=10.1016/j.cell.2020.08.001; citation_id=CR27">
<meta name=citation_reference content="Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570.">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Genomewide association study of severe Covid-19 with respiratory failure; citation_author=D Ellinghaus, F Degenhardt, L Bujanda, M Buti, A Albillos, P Invernizzi; citation_volume=383; citation_publication_date=2020; citation_pages=1522-34; citation_doi=10.1056/NEJMoa2020283; citation_id=CR29">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets; citation_author=TM Delorey, CGK Ziegler, G Heimberg, R Normand, Y Yang, A Segerstolpe; citation_volume=595; citation_publication_date=2021; citation_pages=107-13.; citation_doi=10.1038/s41586-021-03570-8; citation_id=CR30">
<meta name=citation_reference content="citation_journal_title=Cell; citation_title=COVID-19 and the human innate immune system; citation_author=JL Schultze, AC Aschenbrenner; citation_volume=184; citation_publication_date=2021; citation_pages=1671-92; citation_doi=10.1016/j.cell.2021.02.029; citation_id=CR31">
<meta name=citation_reference content="Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M, et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight. 2021;6:e150542.">
<meta name=citation_reference content="citation_journal_title=JAMA.; citation_title=Presence of genetic variants among young men with severe COVID-19; citation_author=CI Made, A Simons, J Schuurs-Hoeijmakers, G Heuvel, T Mantere, S Kersten; citation_volume=324; citation_publication_date=2020; citation_pages=663-73; citation_doi=10.1001/jama.2020.13719; citation_id=CR33">
<meta name=citation_reference content="citation_journal_title=Immunity.; citation_title=SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2; citation_author=Q Lu, J Liu, S Zhao, MF Gomez Castro, M Laurent-Rolle, J Dong; citation_volume=54; citation_publication_date=2021; citation_pages=1304-19 e9; citation_doi=10.1016/j.immuni.2021.05.006; citation_id=CR34">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies; citation_author=FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni, J Noack, YJ Park; citation_volume=598; citation_publication_date=2021; citation_pages=342-7; citation_doi=10.1038/s41586-021-03925-1; citation_id=CR35">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules; citation_author=M Stravalaci, I Pagani, EM Paraboschi, M Pedotti, A Doni, F Scavello; citation_volume=23; citation_publication_date=2022; citation_pages=275-86; citation_doi=10.1038/s41590-021-01114-w; citation_id=CR36">
<meta name=citation_reference content="Chiodo F, Bruijns S, Rodriguez E, Eveline Li RJ, Molinaro A, Silipo A, et al. Novel ACE2-independent carbohydrate-binding of SARS-CoV-2 spike protein to host lectins and lung microbiota. Preprint at 
                https://www.biorxiv.org/content/10.1101/2020.05.13.092478v1
                
              . 2020.">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics; citation_author=C Muus, MD Luecken, G Eraslan, L Sikkema, A Waghray, G Heimberg; citation_volume=27; citation_publication_date=2021; citation_pages=546-59; citation_doi=10.1038/s41591-020-01227-z; citation_id=CR38">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia; citation_author=RA Grant, L Morales-Nebreda, NS Markov, S Swaminathan, M Querrey, ER Guzman; citation_volume=590; citation_publication_date=2021; citation_pages=635-41; citation_doi=10.1038/s41586-020-03148-w; citation_id=CR39">
<meta name=citation_reference content="citation_journal_title=Trends Immunol; citation_title=Metabolic alterations in aging macrophages: ingredients for inflammaging?; citation_author=AA Beek, J Bossche, PG Mastroberardino, MPJ Winther, PJM Leenen; citation_volume=40; citation_publication_date=2019; citation_pages=113-27; citation_doi=10.1016/j.it.2018.12.007; citation_id=CR40">
<meta name=citation_reference content="citation_journal_title=Annu Rev Pathol; citation_title=Diversity, mechanisms, and significance of macrophage plasticity; citation_author=M Locati, G Curtale, A Mantovani; citation_volume=15; citation_publication_date=2020; citation_pages=123-47; citation_doi=10.1146/annurev-pathmechdis-012418-012718; citation_id=CR41">
<meta name=citation_reference content="citation_journal_title=Immunity.; citation_title=Transcriptome-based network analysis reveals a spectrum model of human macrophage activation; citation_author=J Xue, SV Schmidt, J Sander, A Draffehn, W Krebs, I Quester; citation_volume=40; citation_publication_date=2014; citation_pages=274-88; citation_doi=10.1016/j.immuni.2014.01.006; citation_id=CR42">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Trained innate immunity, epigenetics, and Covid-19; citation_author=A Mantovani, MG Netea; citation_volume=383; citation_publication_date=2020; citation_pages=1078-80; citation_doi=10.1056/NEJMcibr2011679; citation_id=CR43">
<meta name=citation_reference content="citation_journal_title=JAMA Netw Open; citation_title=COVID-19 infection among women in iran exposed vs unexposed to children who received attenuated poliovirus used in oral polio vaccine; citation_author=F Habibzadeh, MM Sajadi, K Chumakov, M Yadollahie, S Kottilil, A Simi; citation_volume=4; citation_publication_date=2021; citation_pages=e2135044; citation_doi=10.1001/jamanetworkopen.2021.35044; citation_id=CR44">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis; citation_author=D Wendisch, O Dietrich, T Mari, S Stillfried, IL Ibarra, M Mittermaier; citation_volume=184; citation_publication_date=2021; citation_pages=6243-61 e27; citation_doi=10.1016/j.cell.2021.11.033; citation_id=CR45">
<meta name=citation_reference content="citation_journal_title=Immunity.; citation_title=Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19; citation_author=B Kramer, R Knoll, L Bonaguro, M ToVinh, J Raabe, R Astaburuaga-Garcia; citation_volume=54; citation_publication_date=2021; citation_pages=2650-69 e14; citation_doi=10.1016/j.immuni.2021.09.002; citation_id=CR46">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells; citation_author=M Witkowski, C Tizian, M Ferreira-Gomes, D Niemeyer, TC Jones, F Heinrich; citation_volume=600; citation_publication_date=2021; citation_pages=295-301; citation_doi=10.1038/s41586-021-04142-6; citation_id=CR47">
<meta name=citation_reference content="citation_journal_title=Immunity.; citation_title=Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19; citation_author=JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase; citation_volume=53; citation_publication_date=2020; citation_pages=1296-314 e9; citation_doi=10.1016/j.immuni.2020.11.017; citation_id=CR48">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=Complement activation induces excessive T cell cytotoxicity in severe COVID-19; citation_author=P Georg, R Astaburuaga-Garcia, L Bonaguro, S Brumhard, L Michalick, LJ Lippert; citation_volume=185; citation_publication_date=2022; citation_pages=493-512 e25; citation_doi=10.1016/j.cell.2021.12.040; citation_id=CR49">
<meta name=citation_reference content="citation_journal_title=Annu Rev Immunol; citation_title=An integrated view of humoral innate immunity: pentraxins as a paradigm; citation_author=B Bottazzi, A Doni, C Garlanda, A Mantovani; citation_volume=28; citation_publication_date=2010; citation_pages=157-83; citation_doi=10.1146/annurev-immunol-030409-101305; citation_id=CR50">
<meta name=citation_reference content="citation_journal_title=Physiol Rev; citation_title=PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer; citation_author=C Garlanda, B Bottazzi, E Magrini, A Inforzato, A Mantovani; citation_volume=98; citation_publication_date=2018; citation_pages=623-39; citation_doi=10.1152/physrev.00016.2017; citation_id=CR51">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19; citation_author=E Brunetta, M Folci, B Bottazzi, M Santis, G Gritti, A Protti; citation_volume=22; citation_publication_date=2021; citation_pages=19-24; citation_doi=10.1038/s41590-020-00832-x; citation_id=CR52">
<meta name=citation_reference content="citation_journal_title=Leukemia.; citation_title=Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19; citation_author=G Gritti, F Raimondi, B Bottazzi, D Ripamonti, I Riva, F Landi; citation_volume=35; citation_publication_date=2021; citation_pages=2710-4; citation_doi=10.1038/s41375-021-01299-x; citation_id=CR53">
<meta name=citation_reference content="citation_journal_title=Nat Commun; citation_title=SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care; citation_author=C Gutmann, K Takov, SA Burnap, B Singh, H Ali, K Theofilatos; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-23494-1; citation_id=CR54">
<meta name=citation_reference content="Hansen FC, Nadeem A, Browning KL, Campana M, Schmidtchen A, van der Plas MJA. Differential internalization of thrombin-derived host defense peptides into monocytes and macrophages. J Innate Immun. 2021:1–15.">
<meta name=citation_reference content="citation_journal_title=J Infect; citation_title=Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department; citation_author=A Schirinzi, F Pesce, R Laterza, MG D’Alise, R Lovero, A Fontana; citation_volume=82; citation_publication_date=2021; citation_pages=84-123; citation_doi=10.1016/j.jinf.2020.10.027; citation_id=CR56">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection; citation_author=C Phetsouphanh, DR Darley, DB Wilson, A Howe, CML Munier, SK Patel; citation_volume=23; citation_publication_date=2022; citation_pages=210-6; citation_doi=10.1038/s41590-021-01113-x; citation_id=CR57">
<meta name=citation_reference content="citation_journal_title=Nat Rev Immunol; citation_title=Complement as a target in COVID-19?; citation_author=AM Risitano, DC Mastellos, M Huber-Lang, D Yancopoulou, C Garlanda, F Ciceri; citation_volume=20; citation_publication_date=2020; citation_pages=343-4; citation_doi=10.1038/s41577-020-0320-7; citation_id=CR58">
<meta name=citation_reference content="citation_journal_title=Clin Immunol; citation_title=Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy; citation_author=DC Mastellos, BGP Pires da Silva, BAL Fonseca, NP Fonseca, M Auxiliadora-Martins, S Mastaglio; citation_volume=220; citation_publication_date=2020; citation_pages=108598; citation_doi=10.1016/j.clim.2020.108598; citation_id=CR59">
<meta name=citation_reference content="citation_journal_title=Clin Immunol; citation_title=The first case of COVID-19 treated with the complement C3 inhibitor AMY-101; citation_author=S Mastaglio, A Ruggeri, AM Risitano, P Angelillo, D Yancopoulou, DC Mastellos; citation_volume=215; citation_publication_date=2020; citation_pages=108450; citation_doi=10.1016/j.clim.2020.108450; citation_id=CR60">
<meta name=citation_reference content="citation_journal_title=Immunobiology.; citation_title=Endothelial injury and thrombotic microangiopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab; citation_author=A Rambaldi, G Gritti, MC Mico, M Frigeni, G Borleri, A Salvi; citation_volume=225; citation_publication_date=2020; citation_pages=152001; citation_doi=10.1016/j.imbio.2020.152001; citation_id=CR61">
<meta name=citation_reference content="citation_journal_title=Genet Mol Biol.; citation_title=MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19; citation_author=V Bumiller-Bini, C Freitas Oliveira-Tore, TM Carvalho, GC Kretzschmar, LB Goncalves, NM Alencar; citation_volume=44; citation_publication_date=2021; citation_pages=e20200199; citation_doi=10.1590/1678-4685-gmb-2020-0199; citation_id=CR62">
<meta name=citation_reference content="Flude BM, Nannetti G, Mitchell P, Compton N, Richards C, Heurich M, et al. Targeting the complement serine protease MASP-2 as a therapeutic strategy for coronavirus infections. Viruses. 2021;13:312.">
<meta name=citation_reference content="Junqueira C, Crespo A, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq. 2021.">
<meta name=citation_reference content="Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022. Online ahead of print.">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Longitudinal analyses reveal immunological misfiring in severe COVID-19; citation_author=C Lucas, P Wong, J Klein, TBR Castro, J Silva, M Sundaram; citation_volume=584; citation_publication_date=2020; citation_pages=463-9; citation_doi=10.1038/s41586-020-2588-y; citation_id=CR66">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines; citation_author=M Zheng, R Karki, EP Williams, D Yang, E Fitzpatrick, P Vogel; citation_volume=22; citation_publication_date=2021; citation_pages=829-38; citation_doi=10.1038/s41590-021-00937-x; citation_id=CR67">
<meta name=citation_reference content="Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707.">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19); citation_author=C Agrati, A Sacchi, V Bordoni, E Cimini, S Notari, G Grassi; citation_volume=27; citation_publication_date=2020; citation_pages=3196-207; citation_doi=10.1038/s41418-020-0572-6; citation_id=CR69">
<meta name=citation_reference content="citation_journal_title=Front Immunol; citation_title=Aggregated NETs sequester and detoxify extracellular histones; citation_author=J Knopf, M Leppkes, G Schett, M Herrmann, LE Muñoz; citation_volume=10; citation_publication_date=2019; citation_pages=2176; citation_doi=10.3389/fimmu.2019.02176; citation_id=CR70">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines; citation_author=C Schauer, C Janko, LE Munoz, Y Zhao, D Kienhöfer, B Frey; citation_volume=20; citation_publication_date=2014; citation_pages=511-7; citation_doi=10.1038/nm.3547; citation_id=CR71">
<meta name=citation_reference content="citation_journal_title=EBioMedicine.; citation_title=Vascular occlusion by neutrophil extracellular traps in COVID-19; citation_author=M Leppkes, J Knopf, E Naschberger, A Lindemann, J Singh, I Herrmann; citation_volume=58; citation_publication_date=2020; citation_pages=102925; citation_doi=10.1016/j.ebiom.2020.102925; citation_id=CR72">
<meta name=citation_reference content="Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, et al. Neutrophil extracellular trap-driven occlusive diseases. Cells. 2021;10:2201.">
<meta name=citation_reference content="Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI insight. 2020;5:e138999.">
<meta name=citation_reference content="citation_journal_title=Sci Rep; citation_title=The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19); citation_author=A Arcanjo, J Logullo, CCB Menezes, TC Souza Carvalho Giangiarulo, MC Reis, GMM Castro; citation_volume=10; citation_publication_date=2020; citation_doi=10.1038/s41598-020-76781-0; citation_id=CR75">
<meta name=citation_reference content="citation_journal_title=Blood.; citation_title=Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome; citation_author=EA Middleton, XY He, F Denorme, RA Campbell, D Ng, SP Salvatore; citation_volume=136; citation_publication_date=2020; citation_pages=1169-79; citation_doi=10.1182/blood.2020007008; citation_id=CR76">
<meta name=citation_reference content="Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129.">
<meta name=citation_reference content="citation_journal_title=J Infect Dis; citation_title=Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019; citation_author=E Petito, E Falcinelli, U Paliani, E Cesari, G Vaudo, M Sebastiano; citation_volume=223; citation_publication_date=2021; citation_pages=933-44; citation_doi=10.1093/infdis/jiaa756; citation_id=CR78">
<meta name=citation_reference content="citation_journal_title=J Clin Invest; citation_title=Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis; citation_author=P Skendros, A Mitsios, A Chrysanthopoulou, DC Mastellos, S Metallidis, P Rafailidis; citation_volume=130; citation_publication_date=2020; citation_pages=6151-7; citation_doi=10.1172/JCI141374; citation_id=CR79">
<meta name=citation_reference content="Bilyy R, Bila G, Vishchur O, Vovk V, Herrmann M. Neutrophils as main players of immune response towards nondegradable nanoparticles. Nanomaterials. 2020;10:1273.">
<meta name=citation_reference content="citation_journal_title=Res Pract thrombosis Haemost; citation_title=Using heparin molecules to manage COVID-2019; citation_author=J Liu, J Li, K Arnold, R Pawlinski, NS Key; citation_volume=4; citation_publication_date=2020; citation_pages=518-23; citation_doi=10.1002/rth2.12353; citation_id=CR81">
<meta name=citation_reference content="citation_journal_title=Mol Med; citation_title=Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series; citation_author=AG Weber, AS Chau, M Egeblad, BJ Barnes, T Janowitz; citation_volume=26; citation_publication_date=2020; citation_pages=91; citation_doi=10.1186/s10020-020-00215-w; citation_id=CR82">
<meta name=citation_reference content="citation_journal_title=Trials.; citation_title=Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial; citation_author=JP Desilles, C Gregoire, C Cossec, J Lambert, O Mophawe, MR Losser; citation_volume=21; citation_publication_date=2020; citation_doi=10.1186/s13063-020-04488-8; citation_id=CR83">
<meta name=citation_reference content="Adrover JM, Carrau L, Daßler-Plenker J, Bram Y, Chandar V, Houghton S, et al. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection. JCI insight. 2022;7:e157342.">
<meta name=citation_reference content="Elliott W, Jr., Guda MR, Asuthkar S, Teluguakula N, Prasad DVR, Tsung AJ, et al. PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis. Biomedicines. 2021;9:1867.">
<meta name=citation_reference content="citation_journal_title=Nat Rev Immunol; citation_title=Interferon-inducible effector mechanisms in cell-autonomous immunity; citation_author=JD MacMicking; citation_volume=12; citation_publication_date=2012; citation_pages=367-82; citation_doi=10.1038/nri3210; citation_id=CR86">
<meta name=citation_reference content="citation_journal_title=Annu Rev Microbiol; citation_title=Detection of microbial infections through innate immune sensing of nucleic acids; citation_author=X Tan, L Sun, J Chen, ZJ Chen; citation_volume=72; citation_publication_date=2018; citation_pages=447-78; citation_doi=10.1146/annurev-micro-102215-095605; citation_id=CR87">
<meta name=citation_reference content="citation_journal_title=Front Microbiol; citation_title=The interplay between coronavirus and type I IFN response; citation_author=W Xue, C Ding, K Qian, Y Liao; citation_volume=12; citation_publication_date=2021; citation_pages=805472; citation_doi=10.3389/fmicb.2021.805472; citation_id=CR88">
<meta name=citation_reference content="citation_journal_title=Nat Commun; citation_title=Activation and evasion of type I interferon responses by SARS-CoV-2; citation_author=X Lei, X Dong, R Ma, W Wang, X Xiao, Z Tian; citation_volume=11; citation_publication_date=2020; citation_doi=10.1038/s41467-020-17665-9; citation_id=CR89">
<meta name=citation_reference content="citation_journal_title=Nat Rev Immunol; citation_title=The type I interferon response in COVID-19: implications for treatment; citation_author=JS Lee, EC Shin; citation_volume=20; citation_publication_date=2020; citation_pages=585-6; citation_doi=10.1038/s41577-020-00429-3; citation_id=CR90">
<meta name=citation_reference content="Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL, et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9002.">
<meta name=citation_reference content="Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol. 2021;6.">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=A STING in the tail for SARS-CoV-2; citation_author=NJ Bernard; citation_volume=22; citation_publication_date=2021; citation_pages=800; citation_doi=10.1038/s41590-021-00971-9; citation_id=CR93">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response; citation_author=Y Zhao, L Sui, P Wu, W Wang, Z Wang, Y Yu; citation_volume=6; citation_publication_date=2021; citation_pages=331; citation_doi=10.1038/s41392-021-00742-w; citation_id=CR94">
<meta name=citation_reference content="citation_journal_title=Biol Direct; citation_title=Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection; citation_author=H Ren, C Ma, H Peng, B Zhang, L Zhou, Y Su; citation_volume=16; citation_publication_date=2021; citation_doi=10.1186/s13062-021-00305-7; citation_id=CR95">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection; citation_author=Z Zhou, X Zhang, X Lei, X Xiao, T Jiao, R Ma; citation_volume=6; citation_publication_date=2021; citation_pages=382; citation_doi=10.1038/s41392-021-00800-3; citation_id=CR96">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins; citation_author=Y Rui, J Su, S Shen, Y Hu, D Huang, W Zheng; citation_volume=6; citation_publication_date=2021; citation_pages=123; citation_doi=10.1038/s41392-021-00515-5; citation_id=CR97">
<meta name=citation_reference content="citation_journal_title=Br Dent J; citation_title=Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2; citation_author=DW Denning, A Kilcoyne, C Ucer; citation_volume=229; citation_publication_date=2020; citation_pages=521-4; citation_doi=10.1038/s41415-020-2228-9; citation_id=CR98">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=Antibody responses to SARS-CoV-2 in patients with COVID-19; citation_author=QX Long, BZ Liu, HJ Deng, GC Wu, K Deng, YK Chen; citation_volume=26; citation_publication_date=2020; citation_pages=845-8; citation_doi=10.1038/s41591-020-0897-1; citation_id=CR99">
<meta name=citation_reference content="citation_journal_title=Sci Rep; citation_title=Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan; citation_author=Y Nakano, M Kurano, Y Morita, T Shimura, R Yokoyama, C Qian; citation_volume=11; citation_publication_date=2021; citation_doi=10.1038/s41598-021-82428-5; citation_id=CR100">
<meta name=citation_reference content="citation_journal_title=Sci Rep; citation_title=Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients; citation_author=AD Moura, HHM Costa, VA Correa, SLAK de, JAL Lindoso, E Gaspari; citation_volume=11; citation_publication_date=2021; citation_doi=10.1038/s41598-021-95045-z; citation_id=CR101">
<meta name=citation_reference content="Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claer L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13:eabd2223.">
<meta name=citation_reference content="citation_journal_title=Cell Mol Immunol; citation_title=Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients; citation_author=HY Zheng, M Zhang, CX Yang, N Zhang, XC Wang, XP Yang; citation_volume=17; citation_publication_date=2020; citation_pages=541-3; citation_doi=10.1038/s41423-020-0401-3; citation_id=CR103">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity; citation_author=C Rydyznski Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf; citation_volume=183; citation_publication_date=2020; citation_pages=996-1012 e19; citation_doi=10.1016/j.cell.2020.09.038; citation_id=CR104">
<meta name=citation_reference content="Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5:e140329.">
<meta name=citation_reference content="citation_journal_title=Cell Host Microbe; citation_title=Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2; citation_author=SCA Nielsen, F Yang, KJL Jackson, RA Hoh, K Roltgen, GH Jean; citation_volume=28; citation_publication_date=2020; citation_pages=516-25 e5; citation_doi=10.1016/j.chom.2020.09.002; citation_id=CR106">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=Delayed production of neutralizing antibodies correlates with fatal COVID-19; citation_author=C Lucas, J Klein, ME Sundaram, F Liu, P Wong, J Silva; citation_volume=27; citation_publication_date=2021; citation_pages=1178-86; citation_doi=10.1038/s41591-021-01355-0; citation_id=CR107">
<meta name=citation_reference content="citation_journal_title=Nat Commun; citation_title=Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19; citation_author=K Li, B Huang, M Wu, A Zhong, L Li, Y Cai; citation_volume=11; citation_publication_date=2020; citation_doi=10.1038/s41467-020-19943-y; citation_id=CR108">
<meta name=citation_reference content="citation_journal_title=Cell; citation_title=Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19; citation_author=N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, VS Mahajan; citation_volume=183; citation_publication_date=2020; citation_pages=143-57 e13; citation_doi=10.1016/j.cell.2020.08.025; citation_id=CR109">
<meta name=citation_reference content="citation_journal_title=Nat Commun; citation_title=Organ-specific genome diversity of replication-competent SARS-CoV-2; citation_author=J Cleemput, W Snippenberg, L Lambrechts, A Dendooven, V D’Onofrio, L Couck; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-26884-7; citation_id=CR110">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients; citation_author=S Baize, EM Leroy, MC Georges-Courbot, M Capron, J Lansoud-Soukate, P Debre; citation_volume=5; citation_publication_date=1999; citation_pages=423-6; citation_doi=10.1038/7422; citation_id=CR111">
<meta name=citation_reference content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections; citation_author=J Estaquier, T Idziorek, F Bels, F Barre-Sinoussi, B Hurtrel, AM Aubertin; citation_volume=91; citation_publication_date=1994; citation_pages=9431-5; citation_doi=10.1073/pnas.91.20.9431; citation_id=CR112">
<meta name=citation_reference content="citation_journal_title=Aids.; citation_title=Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS; citation_author=V Monceaux, J Estaquier, M Février, MC Cumont, Y Rivière, AM Aubertin; citation_volume=17; citation_publication_date=2003; citation_pages=1585-96; citation_doi=10.1097/00002030-200307250-00002; citation_id=CR113">
<meta name=citation_reference content="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print.">
<meta name=citation_reference content="citation_journal_title=Nat Commun; citation_title=Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions; citation_author=D Butler, C Mozsary, C Meydan, J Foox, J Rosiene, A Shaiber; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-21361-7; citation_id=CR115">
<meta name=citation_reference content="citation_journal_title=ACS Cent Sci.; citation_title=CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2; citation_author=W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao; citation_volume=7; citation_publication_date=2021; citation_pages=1156-65; citation_doi=10.1021/acscentsci.0c01537; citation_id=CR116">
<meta name=citation_reference content="citation_journal_title=Nat Med.; citation_title=An inflammatory cytokine signature predicts COVID-19 severity and survival; citation_author=DM Valle, S Kim-Schulze, HH Huang, ND Beckmann, S Nirenberg, B Wang; citation_volume=26; citation_publication_date=2020; citation_pages=1636-43; citation_doi=10.1038/s41591-020-1051-9; citation_id=CR117">
<meta name=citation_reference content="citation_journal_title=JAMA J Am Med Assoc; citation_title=Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review; citation_author=WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott; citation_volume=324; citation_publication_date=2020; citation_pages=782-93; citation_doi=10.1001/jama.2020.12839; citation_id=CR118">
<meta name=citation_reference content="citation_journal_title=iScience; citation_title=SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and furin proteases; citation_author=L Zhou, Z Niu, X Jiang, Z Zhang, Y Zheng, Z Wang; citation_volume=23; citation_publication_date=2020; citation_pages=101744; citation_doi=10.1016/j.isci.2020.101744; citation_id=CR119">
<meta name=citation_reference content="citation_journal_title=Br J Haematol; citation_title=Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients; citation_author=S Bellesi, E Metafuni, S Hohaus, E Maiolo, F Marchionni, S D’Innocenzo; citation_volume=191; citation_publication_date=2020; citation_pages=207-11; citation_doi=10.1111/bjh.17034; citation_id=CR120">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes; citation_author=R Karki, BR Sharma, S Tuladhar, EP Williams, L Zalduondo, P Samir; citation_volume=184; citation_publication_date=2021; citation_pages=149-68.e17; citation_doi=10.1016/j.cell.2020.11.025; citation_id=CR121">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination; citation_author=Z Zhang, Y Zheng, Z Niu, B Zhang, C Wang, X Yao; citation_volume=28; citation_publication_date=2021; citation_pages=2765-77; citation_doi=10.1038/s41418-021-00782-3; citation_id=CR122">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma; citation_author=H Huang, M He, Y Zhang, B Zhang, Z Niu, Y Zheng; citation_volume=5; citation_publication_date=2020; citation_pages=246-8; citation_doi=10.1038/s41392-020-00346-w; citation_id=CR123">
<meta name=citation_reference content="citation_journal_title=Cell Disco; citation_title=Cell-in-cell structure mediates in-cell killing suppressed by CD44; citation_author=Y Su, H Huang, T Luo, Y Zheng, J Fan, H Ren; citation_volume=8; citation_publication_date=2022; citation_pages=35; citation_doi=10.1038/s41421-022-00387-1; citation_id=CR124">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=p53-dependent elimination of aneuploid mitotic offspring by entosis; citation_author=J Liang, Z Niu, B Zhang, X Yu, Y Zheng, C Wang; citation_volume=28; citation_publication_date=2021; citation_pages=799-813; citation_doi=10.1038/s41418-020-00645-3; citation_id=CR125">
<meta name=citation_reference content="citation_journal_title=Cell Res; citation_title=Competition between human cells by entosis; citation_author=Q Sun, T Luo, Y Ren, O Florey, S Shirasawa, T Sasazuki; citation_volume=24; citation_publication_date=2014; citation_pages=1299-310; citation_doi=10.1038/cr.2014.138; citation_id=CR126">
<meta name=citation_reference content="citation_journal_title=Natl Sci Open.; citation_title=Cell-in-cell: an emerging player in COVID-19 and immune disorders; citation_author=Q Sun, W Chen; citation_volume=1; citation_publication_date=2022; citation_pages=20220001; citation_doi=10.1360/nso/20220001; citation_id=CR127">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia; citation_author=L Braga, H Ali, I Secco, E Chiavacci, G Neves, D Goldhill; citation_volume=594; citation_publication_date=2021; citation_pages=88-93; citation_doi=10.1038/s41586-021-03491-6; citation_id=CR128">
<meta name=citation_reference content="citation_journal_title=Mil Med Res; citation_title=Cell fusion in the pathogenesis of COVID-19; citation_author=Y Zheng, LL Zhou, Y Su, Q Sun; citation_volume=8; citation_publication_date=2021; citation_pages=68; citation_id=CR129">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ.; citation_title=Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes; citation_author=L Lin, Q Li, Y Wang, Y Shi; citation_volume=28; citation_publication_date=2021; citation_pages=2019-21; citation_doi=10.1038/s41418-021-00795-y; citation_id=CR130">
<meta name=citation_reference content="citation_journal_title=Cell Disco; citation_title=Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells; citation_author=H Ma, Z Zhu, H Lin, S Wang, P Zhang, Y Li; citation_volume=7; citation_publication_date=2021; citation_pages=73; citation_doi=10.1038/s41421-021-00310-0; citation_id=CR131">
<meta name=citation_reference content="Meng B, Ferreira IATM, Abdullahi A, Saito A, Kimura I, Yamasoba D, et al. SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion. Preprint at 
                https://www.biorxiv.org/content/10.1101/2021.12.17.473248v2
                
              . 2021.">
<meta name=citation_reference content="Willett BJ, Grove J, MacLean OA, Wilkie C, Logan N, Lorenzo GD, et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. Preprint at 
                https://www.medrxiv.org/content/10.1101/2022.01.03.21268111v1
                
              . 2022.">
<meta name=citation_reference content="Peacock TP, Brown JC, Zhou J, Thakur N, Newman J, Kugathasan R, et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. Preprint at 
                https://www.biorxiv.org/content/10.1101/2021.12.31.474653v1
                
              . 2021.">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells; citation_author=SE Hamilton, MC Wolkers, SP Schoenberger, SC Jameson; citation_volume=7; citation_publication_date=2006; citation_pages=475-81; citation_doi=10.1038/ni1326; citation_id=CR135">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death; citation_author=EM Janssen, NM Droin, EE Lemmens, MJ Pinkoski, SJ Bensinger, BD Ehst; citation_volume=434; citation_publication_date=2005; citation_pages=88-93; citation_doi=10.1038/nature03337; citation_id=CR136">
<meta name=citation_reference content="citation_journal_title=J Clin Invest; citation_title=Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent; citation_author=A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci; citation_volume=130; citation_publication_date=2020; citation_pages=4694-703; citation_doi=10.1172/JCI138554; citation_id=CR137">
<meta name=citation_reference content="citation_journal_title=J Clin Invest; citation_title=The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques; citation_author=M Laforge, R Silvestre, V Rodrigues, J Garibal, L Campillo-Gimenez, S Mouhamad; citation_volume=128; citation_publication_date=2018; citation_pages=1627-40; citation_doi=10.1172/JCI95127; citation_id=CR138">
<meta name=citation_reference content="Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 2022. Online ahead of print.">
<meta name=citation_reference content="citation_journal_title=Brain Behav Immun; citation_title=Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology; citation_author=Y Shi, S Devadas, KM Greeneltch, D Yin, R Allan Mufson, JN Zhou; citation_volume=17; citation_publication_date=2003; citation_pages=S18-26; citation_doi=10.1016/S0889-1591(02)00062-4; citation_id=CR140">
<meta name=citation_reference content="citation_journal_title=Ann Intern Med; citation_title=The pathophysiologic roles of interleukin-6 in human disease; citation_author=DA Papanicolaou, RL Wilder, SC Manolagas, GP Chrousos; citation_volume=128; citation_publication_date=1998; citation_pages=127-37; citation_doi=10.7326/0003-4819-128-2-199801150-00009; citation_id=CR141">
<meta name=citation_reference content="citation_journal_title=Neuroimmunomodulation.; citation_title=Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice; citation_author=M Hong, J Zheng, ZY Ding, JH Chen, L Yu, Y Niu; citation_volume=20; citation_publication_date=2013; citation_pages=39-50; citation_doi=10.1159/000343100; citation_id=CR142">
<meta name=citation_reference content="citation_journal_title=Front Immunol; citation_title=Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity; citation_author=S Westfall, F Caracci, M Estill, T Frolinger, L Shen, GM Pasinetti; citation_volume=12; citation_publication_date=2021; citation_pages=670500; citation_doi=10.3389/fimmu.2021.670500; citation_id=CR143">
<meta name=citation_reference content="citation_journal_title=J Exp Med; citation_title=Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression; citation_author=D Yin, D Tuthill, RA Mufson, Y Shi; citation_volume=191; citation_publication_date=2000; citation_pages=1423-8; citation_doi=10.1084/jem.191.8.1423; citation_id=CR144">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=The advent and rise of monoclonal antibodies; citation_author=K Rajewsky; citation_volume=575; citation_publication_date=2019; citation_pages=47-9; citation_doi=10.1038/d41586-019-02840-w; citation_id=CR145">
<meta name=citation_reference content="citation_journal_title=Pediatrics.; citation_title=Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection; citation_author=; citation_volume=134; citation_publication_date=2014; citation_pages=415-20; citation_doi=10.1542/peds.2014-1665; citation_id=CR146">
<meta name=citation_reference content="citation_journal_title=Nat Med; citation_title=An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus; citation_author=E Traggiai, S Becker, K Subbarao, L Kolesnikova, Y Uematsu, MR Gismondo; citation_volume=10; citation_publication_date=2004; citation_pages=871-5; citation_doi=10.1038/nm1080; citation_id=CR147">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Recent progress in broadly neutralizing antibodies to HIV; citation_author=D Sok, DR Burton; citation_volume=19; citation_publication_date=2018; citation_pages=1179-88; citation_doi=10.1038/s41590-018-0235-7; citation_id=CR148">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike; citation_author=L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang; citation_volume=584; citation_publication_date=2020; citation_pages=450-6; citation_doi=10.1038/s41586-020-2571-7; citation_id=CR149">
<meta name=citation_reference content="citation_journal_title=J Biomed Sci; citation_title=Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection; citation_author=YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke; citation_volume=29; citation_publication_date=2022; citation_pages=1; citation_doi=10.1186/s12929-021-00784-w; citation_id=CR150">
<meta name=citation_reference content="citation_journal_title=Nature.; citation_title=Antibody evasion properties of SARS-CoV-2 Omicron sublineages; citation_author=S Iketani, L Liu, Y Guo, L Liu, JF Chan, Y Huang; citation_volume=604; citation_publication_date=2022; citation_pages=553-6; citation_doi=10.1038/s41586-022-04594-4; citation_id=CR151">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Immunology in China: the past, present and future; citation_author=X Cao; citation_volume=9; citation_publication_date=2008; citation_pages=339-42; citation_doi=10.1038/ni0408-339; citation_id=CR152">
<meta name=citation_reference content="citation_journal_title=Lancet Microbe; citation_title=WHO international standard for SARS-CoV-2 antibodies to determine markers of protection; citation_author=F Zhu, T Althaus, CW Tan, A Costantini, WN Chia, N Vinh Chau; citation_volume=3; citation_publication_date=2022; citation_pages=e81-e2; citation_doi=10.1016/S2666-5247(21)00307-4; citation_id=CR153">
<meta name=citation_reference content="citation_journal_title=Proc Bayl Univ Med Cent; citation_title=Edward Jenner and the history of smallpox and vaccination; citation_author=S Riedel; citation_volume=18; citation_publication_date=2005; citation_pages=21-5; citation_doi=10.1080/08998280.2005.11928028; citation_id=CR154">
<meta name=citation_reference content="citation_journal_title=Nature; citation_title=SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls; citation_author=N Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia; citation_volume=584; citation_publication_date=2020; citation_pages=457-62; citation_doi=10.1038/s41586-020-2550-z; citation_id=CR155">
<meta name=citation_reference content="citation_journal_title=Nat Immunol; citation_title=Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses; citation_author=JA Tomalka, MS Suthar, SG Deeks, RP Sekaly; citation_volume=23; citation_publication_date=2022; citation_pages=360-70; citation_doi=10.1038/s41590-022-01130-4; citation_id=CR156">
<meta name=citation_reference content="citation_journal_title=Nat Hum Behav; citation_title=Evolution of resistance to COVID-19 vaccination with dynamic social distancing; citation_author=G Lobinska, A Pauzner, A Traulsen, Y Pilpel, MA Nowak; citation_volume=6; citation_publication_date=2022; citation_pages=193-206; citation_doi=10.1038/s41562-021-01281-8; citation_id=CR157">
<meta name=citation_reference content="citation_journal_title=Science; citation_title=Where did ‘weird’ Omicron come from?; citation_author=K Kupferschmidt; citation_volume=374; citation_publication_date=2021; citation_pages=1179; citation_doi=10.1126/science.acx9738; citation_id=CR158">
<meta name=citation_reference content="citation_journal_title=Science.; citation_title=Where did 'weird' Omicron come from?; citation_author=K Kupferschmidt; citation_volume=374; citation_publication_date=2021; citation_pages=1179; citation_doi=10.1126/science.acx9738; citation_id=CR159">
<meta name=citation_reference content="citation_journal_title=J Mol Cell Biol; citation_title=The virological impacts of SARS-CoV-2 D614G mutation; citation_author=C Wang, Y Zheng, Z Niu, X Jiang, Q Sun; citation_volume=13; citation_publication_date=2021; citation_pages=712-20; citation_doi=10.1093/jmcb/mjab045; citation_id=CR160">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity; citation_author=X Jiang, Z Zhang, C Wang, H Ren, L Gao, H Peng; citation_volume=5; citation_publication_date=2020; citation_pages=268-71; citation_doi=10.1038/s41392-020-00392-4; citation_id=CR161">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape; citation_author=Q Li, J Nie, J Wu, L Zhang, R Ding, H Wang; citation_volume=14; citation_publication_date=2021; citation_pages=2362-71 e9; citation_doi=10.1016/j.cell.2021.02.042; citation_id=CR162">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding; citation_author=Z Niu, Z Zhang, X Gao, P Du, J Lu, B Yan; citation_volume=6; citation_publication_date=2021; citation_pages=284; citation_doi=10.1038/s41392-021-00704-2; citation_id=CR163">
<meta name=citation_reference content="citation_journal_title=Cell Death Differ; citation_title=SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse; citation_author=H Huang, Y Zhu, Z Niu, L Zhou, Q Sun; citation_volume=28; citation_publication_date=2021; citation_pages=2840-2; citation_doi=10.1038/s41418-021-00846-4; citation_id=CR164">
<meta name=citation_reference content="citation_journal_title=Emerg Microbes Infect; citation_title=Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong; citation_author=KH Kok, SC Wong, WM Chan, L Wen, AW Chu, JD Ip; citation_volume=11; citation_publication_date=2022; citation_pages=689-98; citation_doi=10.1080/22221751.2022.2040922; citation_id=CR165">
<meta name=citation_reference content="citation_journal_title=Signal Transduct Target Ther; citation_title=Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters; citation_author=YN Zhang, ZR Zhang, HQ Zhang, N Li, QY Zhang, XD Li; citation_volume=7; citation_publication_date=2022; citation_pages=62; citation_doi=10.1038/s41392-022-00930-2; citation_id=CR166">
<meta name=citation_reference content="citation_journal_title=EBioMedicine.; citation_title=Emerging SARS-CoV-2 variants expand species tropism to murines; citation_author=H Shuai, JF Chan, TT Yuen, C Yoon, JC Hu, L Wen; citation_volume=73; citation_publication_date=2021; citation_pages=103643; citation_doi=10.1016/j.ebiom.2021.103643; citation_id=CR167">
<meta name=citation_reference content="citation_journal_title=Cell.; citation_title=Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2; citation_author=P Han, L Li, S Liu, Q Wang, D Zhang, Z Xu; citation_volume=185; citation_publication_date=2022; citation_pages=630-40 e10; citation_doi=10.1016/j.cell.2022.01.001; citation_id=CR168">
<meta name=citation_reference content="citation_journal_title=Nature Communications.; citation_title=Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant; citation_author=F Zuo, H Abolhassani, L Du, A Piralla, F Bertoglio, L de Campos-Mata; citation_volume=13; citation_publication_date=2022; citation_pages=2670; citation_doi=10.1038/s41467-022-30340-5; citation_id=CR169">
<meta name=citation_reference content="citation_journal_title=China CDC Wkly; citation_title=GISAID’s role in pandemic response; citation_author=S Khare, C Gurry, L Freitas, MB Schultz, G Bach, A Diallo; citation_volume=3; citation_publication_date=2021; citation_pages=1049-51; citation_doi=10.46234/ccdcw2021.255; citation_id=CR170">
<meta name=citation_reference content="citation_journal_title=Cell Rep; citation_title=Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies; citation_author=CA Jette, AA Cohen, PNP Gnanapragasam, F Muecksch, YE Lee, KE Huey-Tubman; citation_volume=37; citation_publication_date=2021; citation_pages=110188; citation_doi=10.1016/j.celrep.2021.110188; citation_id=CR171">
<meta name=citation_reference content="citation_journal_title=Immunity.; citation_title=Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations; citation_author=F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, Z Wang; citation_volume=54; citation_publication_date=2021; citation_pages=1853-68 e7; citation_doi=10.1016/j.immuni.2021.07.008; citation_id=CR172">
<meta name=citation_reference content="Rino R, Emanuele A, Ida P, Silvia M, Lorena D, Giulio P et al. Anatomy of Omicron neutralizing antibodies in COVID-19 mRNA vaccinees. PREPRINT (Version 1) available at Research Square. 2022. 
                https://doi.org/10.21203/rs.3.rs-1330153/v1
                
              .">
<meta name=citation_reference content="Latif AA, Mullen JL, Alkuzweny M, Tsueng G, Cano M, Haag E, the Center for Viral Systems Biology, et al. Lineage comparison. outbreak.info. 
                https://outbreak.info/compare-lineages
                
              . Accessed 13 April 2022.">
<meta name=citation_author content="Li, Qing">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="Wang, Ying">
<meta name=citation_author_institution content="CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China">
<meta name=citation_author content="Sun, Qiang">
<meta name=citation_author_institution content="Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China">
<meta name=citation_author content="Knopf, Jasmin">
<meta name=citation_author_institution content="Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany">
<meta name=citation_author_institution content="Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany">
<meta name=citation_author content="Herrmann, Martin">
<meta name=citation_author_institution content="Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany">
<meta name=citation_author_institution content="Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany">
<meta name=citation_author content="Lin, Liangyu">
<meta name=citation_author_institution content="CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China">
<meta name=citation_author content="Jiang, Jingting">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="Shao, Changshun">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="Li, Peishan">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="He, Xiaozhou">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="Hua, Fei">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author content="Niu, Zubiao">
<meta name=citation_author_institution content="Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China">
<meta name=citation_author content="Ma, Chaobing">
<meta name=citation_author_institution content="Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China">
<meta name=citation_author content="Zhu, Yichao">
<meta name=citation_author_institution content="Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, Beijing, China">
<meta name=citation_author content="Ippolito, Giuseppe">
<meta name=citation_author_institution content="Ministry of Health, Rome, Italy">
<meta name=citation_author content="Piacentini, Mauro">
<meta name=citation_author_institution content="Department of Biology, TOR, University of Rome Tor Vergata, Rome, Italy">
<meta name=citation_author content="Estaquier, Jerome">
<meta name=citation_author_institution content="INSERM-U1124, Université Paris, Paris, France">
<meta name=citation_author_institution content="CHU de Québec - Université Laval Research Center, Québec City, Canada">
<meta name=citation_author content="Melino, Sonia">
<meta name=citation_author_institution content="Department of Biology, TOR, University of Rome Tor Vergata, Rome, Italy">
<meta name=citation_author content="Weiss, Felix Daniel">
<meta name=citation_author_institution content="Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Andreano, Emanuele">
<meta name=citation_author_institution content="Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy">
<meta name=citation_author content="Latz, Eicke">
<meta name=citation_author_institution content="Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany">
<meta name=citation_author_institution content="Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany">
<meta name=citation_author content="Schultze, Joachim L.">
<meta name=citation_author_institution content="Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany">
<meta name=citation_author_institution content="Genomics &amp; Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany">
<meta name=citation_author content="Rappuoli, Rino">
<meta name=citation_author_institution content="Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy">
<meta name=citation_author content="Mantovani, Alberto">
<meta name=citation_author_institution content="Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, Milan, Italy">
<meta name=citation_author_institution content="IRCCS Humanitas Clinical Research Hospital, Milan, Italy">
<meta name=citation_author_institution content="William Harvey Research Institute, Queen Mary University, London, UK">
<meta name=citation_author content="Mak, Tak Wah">
<meta name=citation_author_institution content="Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Canada">
<meta name=citation_author_institution content="Department of Pathology, University of Hong Kong, Hong Kong, Pok Fu Lam, Hong Kong">
<meta name=citation_author content="Melino, Gerry">
<meta name=citation_author_institution content="Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany">
<meta name=citation_author_institution content="Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy">
<meta name=citation_author content="Shi, Yufang">
<meta name=citation_author_institution content="The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China">
<meta name=citation_author_institution content="CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China">
<meta name=citation_author_institution content="Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy">
<meta name=access_endpoint content=https://www.nature.com/platform/readcube-access>
<meta name=twitter:site content=@cddpress>
<meta name=twitter:card content=summary_large_image>
<meta name=twitter:image:alt content="Content cover image">
<meta name=twitter:title content="Immune response in COVID-19: what is next?">
<meta name=twitter:description content="Cell Death &amp; Differentiation - Immune response in COVID-19: what is next?">
<meta name=twitter:image content=https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Figa_HTML.png>
<meta property=og:url content=https://www.nature.com/articles/s41418-022-01015-x>
<meta property=og:type content=article>
<meta property=og:site_name content=Nature>
<meta property=og:title content="Immune response in COVID-19: what is next? - Cell Death &amp; Differentiation">
<meta property=og:image content=https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Figa_HTML.png>
<meta http-equiv=origin-trial content="AzoawhTRDevLR66Y6MROu167EDncFPBvcKOaQispTo9ouEt5LvcBjnRFqiAByRT+2cDHG1Yj4dXwpLeIhc98/gIAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A6+nc62kbJgC46ypOwRsNW6RkDn2x7tgRh0wp7jb3DtFF7oEhu1hhm4rdZHZ6zXvnKZLlYcBlQUImC4d3kKihAcAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A/9La288e7MDEU2ifusFnMg1C2Ij6uoa/Z/ylwJIXSsWfK37oESIPbxbt4IU86OGqDEPnNVruUiMjfKo65H/CQwAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta itemprop=position content=1 class=sf-hidden><meta itemprop=position content=2 class=sf-hidden><meta itemprop=position content=3 class=sf-hidden><meta itemprop=position content=4 class=sf-hidden><meta itemprop=publisher content="Springer Nature" class=sf-hidden><link rel=icon type=image/png sizes=32x32 href="data:image/png;base64,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"><style>.sf-hidden{display:none!important}</style><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"></head>
<body class=article-page>
<noscript class=sf-hidden><iframe src="https://collect.nature.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<div class="position-relative cleared z-index-50 background-white" data-test=top-containers>
 <a class=c-skip-link href=#content>Skip to main content</a>
<div class="c-grade-c-banner u-hide sf-hidden">
 
</div>
 
 <div class=u-lazy-ad-wrapper>
 
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 <aside class="c-ad c-ad--728x90">
 <div class=c-ad__inner data-container-type=banner-advert>
 <p class=c-ad__label>Advertisement</p>
 
 
 
 <div id=div-gpt-ad-top-1 class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type=top data-pa11y-ignore data-gpt data-gpt-unitpath=/285/cdd.nature.com/article data-gpt-sizes=728x90 data-gpt-targeting="type=article;pos=top;artid=s41418-022-01015-x;doi=10.1038/s41418-022-01015-x;subjmeta=2499,250,255,631;kwrd=Antimicrobial+responses,Infectious+diseases" data-google-query-id=COjqiJjTifgCFRO83godxgsP4A>
 
 <div id=google_ads_iframe_/270604982/nature/cdd/articles_0__container__ style="border:0pt none"></div></div>
 
 
 </div>
 </aside>
 </div>
 <header class=c-header id=header data-header data-track-component=nature-150-split-header style=border-color:#184877>
 <div class="c-header__row c-header__row--flush">
 <div class=c-header__container>
 <div class=c-header__split>
 
 
 <div class=c-header__logo-container>
 
 <a href=https://www.nature.com/cdd data-track=click data-track-action=home data-track-label=image>
 <picture class=c-header__logo>
 
 <img src="data:image/svg+xml;base64,<svg height="32" viewBox="0 0 112 32" width="112" xmlns="http://www.w3.org/2000/svg"><g><path d="m7.52313725 15.0337255c1.4054902 0 3.13725495-.4078431 3.70823525-.5458824l.0815687-.0188235.0313725-.0815686c.3262745-.7843137.7654902-2.3654902 1.0290196-3.3945098l.0439216-.1694118-.8219608-.2007843-.0627451.1254902c-.4768627 1.0039216-.9662745 1.8321569-1.60627449 2.3968627-.64.5647059-1.41176471.8909804-2.51607843.8909804-1.46196079 0-2.66666667-.6211764-3.52-1.7066666s-1.34901961-2.64784317-1.34901961-4.53647062c0-1.53725491.39529412-2.97411765 1.19215686-4.00941177.79686275-1.03529412 1.98901961-1.69411765 3.65176471-1.69411765 1.01647059 0 1.7945098.20078432 2.39686274.66509804.59607842.45803922 1.03529412 1.19843138 1.31137252 2.31529412l.0376471.15058824.1568627-.02509804.6776471-.10666667-.0188235-.16313725c-.1192157-1.19843138-.2070589-2.07058824-.3639216-3.18117647l-.012549-.11294118-.1129412-.02509804c-.2635294-.05647059-.7152941-.18196078-1.305098-.29490196-.59607847-.11294118-1.33647063-.20705882-2.20235298-.20705882-2.23372549 0-4.16.72784313-5.52784314 1.9890196-1.36784313 1.26117647-2.17098039 3.05568628-2.17098039 5.15764706 0 1.63137255.53960785 3.32549021 1.7254902 4.61803921 1.17333333 1.2862745 3.00549019 2.1647059 5.54666666 2.1647059z"/><path d="m14.1803922 13.6533333c.7090196.8094118 1.7505882 1.3301961 3.0368627 1.3239777.3262745 0 .8407843-.1067228 1.4431373-.4078992.5960784-.3011765 1.2674509-.7968628 1.8760784-1.574902l.0815686-.1066667-.5270588-.64-.1317647.1254902c-.3764706.3576471-.7215686.5960785-1.0603922.7466667-.3388235.1505882-.677647.2133333-1.0478431.2133333h-.0313726c-.665098 0-1.3803921-.2572549-1.932549-.8470588-.5270588-.5647059-.9160784-1.4556863-.947451-2.74823528 1.1921569-.04392157 2.3717647-.10666667 3.3066667-.16941177.4894118-.03137255.9160784-.06901961 1.2360784-.09411765.32-.03137255.5333334-.05019607.6337255-.0690196.1003922-.02509804.1945098-.05019608.269804-.08784314.1192156-.0627451.2196078-.16941177.2635294-.30117647.0439215-.1254902.0564706-.26980392.0564706-.43921569 0-.81568627-.3576471-1.60627451-.9286275-2.20235294-.5709804-.58980392-1.3741176-.98509804-2.265098-.98509804h-.0188236c-1.0541176 0-2.1835294.60235294-3.0180392 1.51215686-.9223529 1.00392157-1.3866666 2.31529412-1.3866666 3.67058822 0 1.1670588.382745 2.2650981 1.0917647 3.0807843zm2.8047058-7.21568624h.0188236c.5458823 0 .9662745.22588235 1.2611764.57098039.294902.34509804.4580393.81568628.4580393 1.29882353v.01882353c0 .0627451-.0062746.11294118-.0125491.13803922-.0188235.04392156-.0188235.05019607-.050196.0690196-.0313726.01882353-.1066667.03764706-.2321569.03764706-1.0792157.01882353-2.2023529.05019608-3.3066667.05019608-.0062745 0-.012549 0-.025098 0 .1317647-.7027451.4015686-1.24235294.7278431-1.60627451.3513726-.3827451.7717647-.5772549 1.1607843-.5772549z"/><path d="m25.5247059 13.9545098-.1568628-.012549c-.3137255-.0250981-.5584313-.0627451-.7341176-.1129412-.1317647-.0376471-.2258824-.0815686-.294902-.1380392-.1003921-.0815686-.1631372-.1819608-.2007843-.3701961-.0439216-.1882353-.0564706-.4580392-.0564706-.8219608v-12.4988235l-.2321568.08156863c-.6650981.24470588-1.8760785.5772549-2.8611765.69019608l-.1505882.01882353v.73411764l.1568627.01254902c.32.03137255.5647059.05647059.7403922.10039216.1317647.03137255.2196078.06901961.2823529.11294118.0439216.03137254.0752941.0690196.1066667.11921568.0439215.07529412.0752941.19450981.0941176.37019608.0188235.16941176.0250981.39529412.0250981.67764706v9.57490194c0 .32-.0125491.5709804-.0439216.7529412-.0250981.1380392-.0627451.2384314-.1066667.3137255-.0690196.1129412-.1631372.1819608-.3388235.2447059-.1819608.0627451-.4392157.1003921-.7905882.1317647l-.1568628.012549v.7843137h4.7247059v-.7780392z"/><path d="m30.4188235 13.9545098-.1568627-.012549c-.3137255-.0250981-.5584314-.0627451-.7341177-.1129412-.1317647-.0376471-.2258823-.0815686-.2949019-.1380392-.1003922-.0815686-.1631373-.1819608-.2070588-.3701961-.0439216-.1882353-.0564706-.4580392-.0564706-.8219608v-12.4988235l-.2321569.08156863c-.665098.24470588-1.8760784.5772549-2.8611765.69019608l-.1505882.01882353v.73411764l.1568627.01254902c.32.03137255.5647059.05647059.7403922.10039216.1317647.03137255.2196078.06901961.2823529.11294118.0439216.03137254.0752942.0690196.1066667.11921568.0439216.07529412.0752941.19450981.0941177.37019608.0188235.16941176.025098.39529412.025098.67764706v9.57490194c0 .32-.012549.5709804-.0439216.7529412-.025098.1380392-.0627451.2384314-.1066666.3137255-.0690197.1129412-.1631373.1819608-.3388236.2447059-.1756862.0627451-.4392157.1003921-.7905882.1317647l-.1568628.012549v.7843137h4.7247059z"/><path d="m45.4713725 13.0321569c1.549804-1.1796079 2.509804-3.0117647 2.509804-5.50901965 0-1.90117647-.6650981-3.40078431-1.7066667-4.41098039-.652549-.64-1.4807843-1.06666666-2.4407843-1.33647059-.96-.26980392-2.0454902-.37647058-3.2313726-.37647058h-5.7035294v.78431372l.1568628.01254902c.3827451.03137255.677647.06901961.8909804.1254902.1631372.04392157.2760784.10039215.357647.16941176.1254902.10039216.2007843.24470588.2509804.48941177.0501961.24470588.0627451.58980392.0627451 1.04784313v8.08156861c0 .4078432-.012549.7215686-.0501961.96-.0313725.1756863-.0752941.307451-.1317647.4078432-.0941176.1443137-.2196078.2384313-.4643137.3137254-.2447059.0752942-.5960784.1192157-1.0729412.1505883l-.1568627.012549v.7843137h4.6870588c2.3717647 0 4.4737255-.5270588 6.0423529-1.7066666zm-6.9145098-10.18352945c0-.1945098.0188236-.30745098.0376471-.35764706.0062745-.02509804.0188235-.03764706.025098-.03764706l.0313726-.01882353c.0439216-.01882353.1819608-.05647058.3952941-.07529411.2133333-.02509804.5082353-.03764706.8847059-.03764706 1.5811765 0 2.7545098.26352941 3.5827451.75921568.7717647.43921569 1.3239216 1.12313726 1.6941176 1.96392157.3701961.84078432.5458824 1.84470588.5458824 2.91137255 0 1.53098039-.4015686 2.98039217-1.2737255 4.03450977-.8721569 1.0541177-2.214902 1.7380393-4.1662745 1.7443138-.4141177 0-.7341177-.0250981-.972549-.0878432-.1819608-.0439215-.3137255-.1066666-.4078432-.1819608-.1443137-.1129411-.2384313-.2635294-.2949019-.4956862-.0564706-.2321569-.0815687-.5521569-.0815687-.947451z"/><path d="m50.252549 13.6533333c.7090196.8094118 1.7505883 1.3301961 3.0368628 1.3239777.3262745 0 .8407843-.1067228 1.4431372-.4078992.5960785-.3011765 1.267451-.7968628 1.8760785-1.574902l.0815686-.1066667-.5270588-.64-.1317648.1254902c-.3764705.3576471-.7215686.5960785-1.0603921.7466667s-.6776471.2133333-1.0478431.2133333h-.0313726c-.665098 0-1.3803922-.2572549-1.932549-.8470588-.5270588-.5647059-.9160784-1.4556863-.947451-2.74823528 1.1921569-.04392157 2.3717647-.10666667 3.3129412-.16941177.4894117-.03137255.9160784-.06901961 1.2360784-.09411765.32-.03137255.5333333-.05019607.6337255-.0690196.1003922-.02509804.1945098-.05019608.2698039-.08784314.1192157-.0627451.2196079-.16941177.2635294-.30117647.0439216-.1254902.0564706-.26980392.0564706-.43921569 0-.81568627-.357647-1.60627451-.9286274-2.20235294-.5709804-.58980392-1.3741177-.98509804-2.2650981-.98509804h-.0188235c-1.0541176 0-2.1835294.60235294-3.0180392 1.51215686-.922353 1.00392157-1.3867426 2.31529412-1.3867426 3.67058822-.0061986 1.1670588.3765465 2.2650981 1.0855661 3.0807843zm2.7984314-7.21568624h.0188235c.5458824 0 .9662745.22588235 1.2611765.57098039s.4580392.81568628.4580392 1.30509804v.01882353c0 .0627451-.0062745.11294118-.012549.13803922-.0188235.04392156-.0188235.05019607-.0501961.0690196-.0313725.01882353-.1066667.03764706-.2321569.03764706-1.0792156.01882353-2.2023529.05019608-3.3066666.05019608-.0062745 0-.012549 0-.0250981 0 .1317647-.7027451.4015687-1.24235294.7278432-1.60627451.357647-.38901961.7780392-.58352941 1.1607843-.58352941z"/><path d="m61.8478431 9.17960784c-.6588235.32-1.7129411.69019608-2.4784313.95999996-.6337255.2258824-1.1105883.5145098-1.4243138.8847059-.32.3701961-.4643137.8282353-.4643137 1.3552941 0 .6650981.2635294 1.3176471.7152941 1.8007844.4580392.4831372 1.1105883.8031372 1.8886275.8031372.1756863 0 .3639216-.0501961.5647059-.1317647.5333333-.2196078 1.1670588-.652549 1.7317647-1.0541176.0941176.2698039.2258823.5145098.4392157.7403921.1317647.1317647.3011764.2384314.4643137.32.1694117.0752941.3262745.1254902.4705882.1254902h.0439216l2.0329412-1.0729412-.3388236-.7843137-.1631372.0878431c-.2258824.1192157-.4831373.2133334-.7278432.2133334-.0690196 0-.1254902-.012549-.1756862-.0439216-.0752942-.0439216-.1505883-.1192157-.2133334-.2698039s-.1003921-.3764706-.1003921-.6839216v-4.31058821c0-.3827451-.0439216-.77803922-.1756863-1.1482353s-.3576471-.72156863-.7090196-1.00392157c-.4956863-.3890196-1.1607843-.58352941-1.7568628-.58352941h-.0188235l-.0188235.00627451c-1.1670588.26980392-2.5035294 1.02901961-3.0807843 1.43058824-.2007843.14431372-.3701961.28235294-.4956863.44549019-.1254902.16313726-.2007843.35137255-.2007843.55843138 0 .28862745.1505882.53333333.345098.69647058.1945098.16313726.4266667.26352942.6588236.26352942.1882353 0 .357647-.05019608.4831372-.15686275.1317647-.10039216.2133333-.25098039.2572549-.42039216.1380392-.57098039.332549-.97254902.5458824-1.20470588.2070588-.23215686.4956862-.39529412.8658823-.39529412.4705883 0 .8156863.16313726 1.0666667.47058824.2509804.31372549.4015686.79686274.4015686 1.45568627v.41411765c-.1066667.0627451-.2509804.14431373-.4329412.23215686zm.4329412 3.57647056c-.1882353.1882353-.4392157.3701961-.7027451.5082353-.2823529.1443138-.5835294.2321569-.8282353.2321569-.2698039 0-.5898039-.1192157-.8345098-.3513726-.2447059-.2321568-.4266666-.5772549-.4266666-1.0603921 0-.3388235.0878431-.5647059.2635294-.7654902.1756862-.2007843.4580392-.3764706.8345098-.5584314.2070588-.1003921.5835294-.2635294.9662745-.4329412.2635294-.1192156.5207843-.2321568.7278431-.33254898z"/><path d="m66.7294118 6.77019608v5.66588232c0 .8031373.1756862 1.4368628.5333333 1.882353.3576471.4392157.8972549.665098 1.5498039.6589507.2258824 0 .5145098-.0628723.8784314-.2448331l1.3929412-.6713725-.0062745.6713725h4.5678431v-.7780392l-.1568627-.012549c-.2886275-.0250981-.5082353-.0627451-.6650981-.1129412-.1192157-.0376471-.2070588-.0815686-.2635294-.1317647-.0941176-.0752941-.1505882-.1819608-.1945098-.3701961-.0376471-.1882353-.0564706-.4517647-.0564706-.8094117v-4.76862749c.4831373-.55215686 1.1796079-.86588236 1.907451-.8972549.3513725 0 .64.05019607.8721569.15058823.3513725.15058824.5960784.39529412.7592156.77176471.1694118.37647059.2509804.88470588.2447059 1.52470588v3.21882357c0 .3137254-.012549.5584313-.0439215.7403921-.0250981.1380392-.0564706.2384314-.1003922.3137255-.0627451.1066667-.1443137.1756863-.3137255.2384314-.1631373.0564706-.4015686.1003921-.7278431.1317647l-.1568628.012549v.7780392h4.5239216v-.7843137l-.1568628-.012549c-.2886274-.0250981-.5145098-.0564706-.6713725-.1066667-.1192157-.0376471-.2070588-.0815686-.2698039-.1317647-.0941177-.0752941-.1505883-.1819608-.1945098-.3701961-.0439216-.1882353-.0564706-.4580392-.0564706-.8156863v-3.68941172c0-1.11686274-.2760784-1.98274509-.7780392-2.56627451-.5019608-.58352941-1.2360785-.87843137-2.0768628-.87215686-.0313725 0-.0564706 0-.0878431 0-1.0415686.03764706-1.9890196.5772549-2.6917647 1.21098039v-6.58196078l-.2196079.06901961c-.7968627.24470588-1.945098.55843137-2.892549.69647059l-.1443137.01882353v.71529411l.1505882.01882353c.332549.04392157.5835294.07529412.7592157.11921569.1380392.03137255.2258824.06901961.2886275.11294117.0439215.03137255.0752941.06901961.1066666.11294118.0439216.06901961.0752941.18196079.0878432.35137255.0188235.16313726.025098.3827451.0188235.65882353v9.61254899c0 .32-.012549.5647059-.0439216.7529412-.025098.1380392-.0627451.2384314-.1066666.3137255-.0690196.1129412-.1568628.1819608-.3325491.2384314-.1694117.0564706-.4141176.1003921-.7466666.1317647l-.0501961.0062745-.3011765-.7215686-.1631372.0752941c-.269804.1317647-.6776471.3011764-1.1482353.3011764-.1192157 0-.2447059-.0188235-.3513726-.0627451-.1631372-.0690196-.32-.1882352-.4454902-.4517647-.1254902-.2572549-.2133333-.6588235-.2133333-1.2486274v-5.06980393h2.0015686l.0439216-.03137255c.2133333-.15058824.32-.39529412.32-.63372549 0-.14431373-.0439216-.29490196-.1380392-.41411765l-.0501961-.0627451h-2.1772549v-2.57254902l-.5396078-.0690196-1.3050981 1.52470588v1.11686274h-.8094117l-.7027451.69019608.1945098.45176471h1.3490196z"/><path d="m87.0964706 13.8164706c.665098.7027451 1.6627451 1.1921569 2.9615686 1.1921569.7780392 0 1.5058824-.2196079 2.2337255-.7090197.6901961-.4643137 1.3866667-1.1733333 2.1521569-2.1647058.3137255.370196.6211764.7843137.8784313 1.1545098.1505883.2133333.282353.4078431.3952942.5647058.1129411.1631373.2007843.2886275.2760784.3701961.0815686.0941177.2070588.1694118.3639216.2572549.4643137.2572549 1.2486274.5396079 1.970196.627451l.1003922.012549.2698039-.3701961-.0501961-.0941176c-.3011764-.5898039-.8784313-1.4305882-1.4807843-2.2462745-.5647059-.7592157-1.1545098-1.4870588-1.5686274-1.9576471.5458823-.77803918 1.0352941-1.56235291 1.5435294-2.30901957.3137255-.48313726.5333333-.80313726.8219608-1.01647059.2886274-.21333334.6713725-.35137255 1.3615686-.42666667l.1505882-.01882353v-.77803921h-.1694117-4.762353v.77803921l.1505883.01882353c.5145098.0627451.8721568.13176471 1.0666666.21960784.1003922.04392157.1505883.09411765.1882353.14431373.0313726.05019608.0501961.10666667.0501961.1945098 0 .16941177-.0752941.43921569-.2258824.81568628-.2384313.60235294-.5584313 1.18588235-.8658823 1.64392157-1.0980392-1.18588236-2.4031373-2.23372549-3.1435294-2.77960785.6149019-.3890196 1.0415686-.66509804 1.3866666-.91607843.2007844-.15058823.4266667-.39529412.614902-.71529412.1819608-.32.32-.71529411.32-1.16705882v-.01254902c0-.8345098-.3513725-1.56235294-.9098039-2.07058823-.5584314-.5082353-1.3301961-.80941177-2.1647059-.80941177-.8721569 0-1.7066667.37019608-2.3278431.96627451-.6211765.60235294-1.0290196 1.43686275-1.0352941 2.37803922v.00627451c0 .55215686.1568627 1.04784313.4454901 1.51215686.2572549.40784314.6211765.78431372 1.0792157 1.16705882-.7843137.49568628-1.5121568.98509804-2.0768627 1.58745098-.6086275.64627451-1.0039216 1.43686275-1.0039216 2.45960785v.0062745c0 .8658824.3388235 1.7819608 1.0039216 2.4847059zm2.6917647-11.13725491c.2572549-.29490196.5960784-.45176471.96-.45176471h.0188235c.4956863 0 .8596079.21960784 1.1168628.55843137s.4015686.80941177.4015686 1.28v.00627451c0 .52078432-.1192157.97254902-.3513726 1.36156863-.2133333.36392157-.5333333.67764706-.9474509.94117647-.4894118-.33882353-.8909804-.69019608-1.1670589-1.06039216-.2949019-.40156862-.4517647-.82196078-.4517647-1.33019607 0-.5709804.1694118-1.01019608.4203922-1.30509804zm.1192157 5.22666666c1.6188235 1.1482353 2.88 2.25254905 3.8901961 3.44470585-.4015687.5647059-.8658824 1.0666667-1.3803922 1.4305883-.5458824.3827451-1.1356863.6149019-1.7631373.6149019h-.0188235c-.5898039 0-1.2423529-.2133333-1.7380392-.652549-.4956863-.4329412-.8407843-1.0792157-.8470588-1.9827451 0-.5521568.1254902-1.04156861.4266666-1.51215685.2886275-.45803921.7466667-.8972549 1.4305883-1.3427451z"/><path d="m9.09803922 18.1647059c-.96-.2698039-2.0454902-.3764706-3.23137255-.3764706h-5.70352941v.7843137l.15686274.012549c.3827451.0313726.67764706.0690196.89098039.1254902.16313726.0439216.27607843.1003922.35764706.1694118.1254902.1003922.20078431.2447059.25098039.4894118.05019608.2509804.0627451.5960784.0627451 1.0541176v8.0815686c0 .4078432-.01254902.7215687-.05019608.96-.03137255.1756863-.07529411.307451-.1317647.4078432-.09411765.1443137-.21960785.2384313-.46431373.3137255-.24470588.0752941-.59607843.1192157-1.07294117.1505882l-.16313726.0062745v.7843137h4.68705882c2.38431373 0 4.48627451-.5270588 6.05490198-1.7066666 1.5498039-1.1796079 2.5098039-3.0117647 2.5098039-5.5090196 0-1.9011765-.665098-3.4007844-1.7066667-4.4109804-.6588235-.6337255-1.4870588-1.0666667-2.44705878-1.3364706zm-3.51372549 11.9592157c-.41411765 0-.73411765-.0250981-.97254902-.0878432-.18196079-.0439215-.31372549-.1066666-.40784314-.1819608-.14431373-.1129411-.23843137-.2635294-.29490196-.4956862-.05647059-.2321569-.08156863-.5521569-.08156863-.947451v-9.1670588c0-.1945098.01882353-.307451.03764706-.3576471.01254902-.025098.01882353-.037647.02509804-.037647l.02509804-.0250981c.04392157-.0188235.18196078-.0564706.39529412-.0752941.21333333-.025098.50823529-.0376471.88470588-.0376471 1.58117647 0 2.7545098.269804 3.5827451.7592157.7717647.4392157 1.32392158 1.1231373 1.69411768 1.9639216.370196.8407843.5458823 1.8447059.5458823 2.9113725 0 1.5309804-.4015686 2.9803922-1.27372547 4.0345098-.86588236 1.0603922-2.20862746 1.7443138-4.16 1.7443138z"/><path d="m17.8196078 30.2180392c-.1317647-.037647-.2258823-.0815686-.2949019-.1380392-.1003922-.0815686-.1568628-.1819608-.2007843-.3764706-.0439216-.1882353-.0564706-.4643137-.0564706-.8282353v-7.2156863l-.2384314.1003922c-.8721569.3764706-1.7756863.6211765-2.7356863.7968627l-.1380392.0250981v.6901961l.1443137.025098c.2886275.0501961.5082353.0941176.6650981.1443137.1192157.0376471.2007843.0815687.2509804.1254902.0439215.0376471.0752941.0752941.1003921.1254902.0439216.0815686.0690196.2007843.0878432.3701961.0188235.1694118.025098.3952941.025098.6776471v4.1411764c0 .3262745-.012549.5772549-.0439216.7592157-.025098.1380392-.0627451.2384314-.1066666.3137255-.0690196.1129412-.1631373.1819608-.3388236.2447059-.1756862.0627451-.4392156.1003921-.7843137.1317647l-.1568627.012549v.7780392h4.7184313v-.7780392l-.1568627-.012549c-.3262745-.025098-.5647059-.0627451-.7403922-.1129412z"/><path d="m16.32 17.1984314h-.0188235c-.6588236 0-1.2172549.5458823-1.2172549 1.2486274.0062745.6650981.5584313 1.2235294 1.2172549 1.2235294.345098 0 .652549-.1443137.8721568-.3639215.2196079-.2258824.3513726-.5270589.3513726-.8596079 0-.3513725-.1317647-.6588235-.3513726-.8847059-.2133333-.2321568-.5207843-.3639215-.8533333-.3639215z"/><path d="m31.0964706 18.5286275v.0062745h-.0062745z"/><path d="m29.8164706 22.4627451c0-.1254902-.0250981-.2447059-.0941177-.3576471l-.050196-.0815686h-2.2964706v-.627451c0-.025098 0-.050196 0-.0815686 0-.8219608.0564706-1.4870588.1380392-1.9827451s.2007843-.8282353.294902-.9662745c.1066666-.1631373.2258823-.2760784.357647-.3513726.1380392-.0752941.294902-.1129411.4831373-.1129411.6086274 0 1.2360784.2949019 1.5749019.64.1129412.1129411.2572549.1819608.4078432.1756862.1694117 0 .32-.0752941.4580392-.1882352.1505882-.1254902.307451-.3011765.3890196-.5019608.037647-.0941177.0627451-.2007843.0627451-.307451 0-.1694118-.0627451-.3388235-.1945098-.4894118-.3890196-.4329412-1.0352941-.7152941-1.7192157-.7592157h-.0188235-.0188236c-.8470588.1254902-1.7380392.5709804-2.5286274 1.3490196-.4141177-.4329411-1.1607843-.8470588-2.2337255-.8847058h-.012549-.012549c-1.0164706.1003921-1.8509804.4580392-2.6854902 1.1294117-1.1105883.8847059-1.4996079 1.8760785-1.6564706 2.3466667-.1505883.4517647-.2384314 1.0729412-.2384314 1.5247059v.0878431h-.8470588l-.6776471.6901961.1756863.4580392h1.3490196v5.7411765c0 .32-.012549.5647059-.0439216.7466666-.025098.1380393-.0564706.2384314-.1003921.307451-.0690196.1066667-.1505883.1756863-.32.2384314-.1631373.0564706-.4078432.1003922-.7341177.1317647l-.1505882.0188235v.7780392h4.5992157v-.7654901l-.1505883-.0188236c-.3074509-.0313725-.5396078-.0690196-.7152941-.1254902-.1317647-.037647-.2196078-.0815686-.2823529-.1380392-.0941177-.0815686-.1568628-.1819608-.1945098-.3701961-.0439216-.1882353-.0564706-.4517647-.0564706-.8156862v-5.7411765h3.4509804v5.7411765c0 .32-.012549.5647058-.0439216.7466666-.025098.1380392-.0564706.2384314-.1003921.3137255-.0627451.1066667-.1443138.1756863-.3011765.2321569-.1568628.0564706-.3890196.1003921-.6964706.1317647l-.1505882.0188235v.7780392h4.9380392v-.7529411l-.1568628-.0125491c-.4078431-.037647-.7152941-.0752941-.9474509-.1254902-.1694118-.037647-.294902-.0878431-.3827451-.1443137-.1317648-.0878431-.1945098-.1819608-.2447059-.3639216-.0501961-.1819607-.0627451-.4454902-.0627451-.8094117v-5.7411765h2.0329412l.037647-.0188235c.1317647-.0690196.2196079-.1819608.282353-.3011765.0564705-.1254902.0878431-.2635294.0878431-.3890196zm-7.7364706-.7215686v-.0564706c0-1.3803922.32-2.3341177.6023529-2.7796079.1192157-.1819607.282353-.3639215.5207844-.5019607.2321568-.1380393.5396078-.2384314.9474509-.2384314.4894118 0 .9035294.1380392 1.242353.345098.3011764.1819608.5396078.4141177.7215686.6462745-.2007843.3827451-.3011765.7027451-.3701961.8909804v.0062745.0062745c-.1192157.3890197-.2007843 1.0039216-.2007843 1.7066667v.2635294h-3.4509804z"/><path d="m36.3545098 22.7701961c-.5709804-.5898039-1.3741176-.9850981-2.265098-.9850981h-.0188236c-1.0541176 0-2.1835294.602353-3.0180392 1.5121569-.9223529 1.0039216-1.3866666 2.3152941-1.3866666 3.6705882 0 1.1670589.3827451 2.2650981 1.0917647 3.0807844.7090196.8094117 1.7505882 1.330196 3.0368627 1.3239776.3262745 0 .8407843-.1067227 1.4431373-.4078992.5960784-.3011765 1.2674509-.7968628 1.8760784-1.574902l.0815686-.1066666-.5270588-.64-.1317647.1254902c-.3764706.357647-.7215686.5960784-1.0603922.7466666-.3388235.1505883-.677647.2133334-1.0478431.2133334h-.0313726c-.665098 0-1.3803921-.257255-1.932549-.8470589-.5270588-.5647059-.9160784-1.4556862-.947451-2.7482353 1.1921569-.0439215 2.3717648-.1066666 3.3129412-.1694117.4894118-.0313726.9160785-.0690196 1.2360785-.0941177.32-.0313725.5333333-.0501961.6337254-.0690196.1003922-.025098.1945098-.0501961.269804-.0878431.1192157-.0627451.2196078-.1694118.2635294-.3011765.0439215-.1254902.0564706-.2698039.0564706-.4392157-.0062745-.8219608-.3576471-1.612549-.934902-2.2023529zm-2.7984314.0627451h.0188236c.5458823 0 .9662745.2258823 1.2611764.5709804.294902.345098.4580392.8156862.4580392 1.305098v.0188235c0 .0627451-.0062745.1129412-.012549.1380393-.0188235.0439215-.0188235.050196-.0501961.0690196-.0313725.0188235-.1066666.037647-.2321568.037647-1.0792157.0188235-2.2086275.0501961-3.3129412.0501961-.0062745 0-.012549 0-.0188235 0 .1317647-.7027451.4015686-1.2360784.7278431-1.6062745.3576471-.3890196.7780392-.5835294 1.1607843-.5835294z"/><path d="m44.0784314 22.1678431c-.2258824-.2196078-.5521569-.3827451-.9286275-.3827451-.2698039 0-.5333333.0815687-.7843137.2196079-.5960784.3262745-1.1294118.947451-1.5309804 1.587451v-1.9513726l-.2384314.1066667c-.9223529.4015686-1.8196078.652549-2.7607843.8094117l-.1443137.0250981v.6964706l.1505882.0188235c.294902.0376471.5207843.0752941.6839216.1192157.1192157.0313725.2007843.0752941.2572549.1192157.0439216.0313725.0752941.0690196.1003922.1254902.0439215.0815686.0752941.2007843.0878431.3764706.0188235.1756862.025098.3952941.025098.6839215v4.1850981c0 .32-.012549.5647058-.0439215.7529411-.0250981.1380393-.0627451.2384314-.1066667.3137255-.0690196.1129412-.1568627.1819608-.3388235.2384314-.1756863.0627451-.4329412.1003922-.7780392.1317647l-.1568628.012549v.7843138h5.0007843v-.7843138l-.1568627-.012549c-.3890196-.025098-.6901961-.0627451-.9098039-.1129412-.1631373-.037647-.282353-.0878431-.3701961-.1443137-.1254902-.0878431-.1882353-.1819608-.2384314-.3701961s-.0627451-.4580392-.0627451-.8156862v-3.5513726c.2196078-.5898039.4831373-1.0290196.7403922-1.3113725.2572549-.2886275.5082353-.4078432.677647-.4078432.1505883 0 .2635294.0313726.3827451.0878432.1192157.0564705.2384314.1505882.3764706.2823529.0941177.1003922.2321569.1568627.3764706.1568627.1066667 0 .2196078-.025098.332549-.0752941.4517647-.2070588.7278432-.6588235.7278432-1.1105882-.0062746-.294902-.1443138-.5835294-.3701961-.8031373z"/><path d="m50.9427451 22.7701961c-.5709804-.5898039-1.3741176-.9850981-2.265098-.9850981h-.0188236c-1.0541176 0-2.1835294.602353-3.0180392 1.5121569-.9223529 1.0039216-1.3866667 2.3152941-1.3866667 3.6705882 0 1.1670589.3827451 2.2650981 1.0917648 3.0807844.7090196.8094117 1.7505882 1.3239215 3.0368627 1.3239215.3262745 0 .8407843-.1066666 1.4431373-.4078431.5960784-.3011765 1.2674509-.7968628 1.8760784-1.574902l.0815686-.1066666-.5270588-.64-.1317647.1254902c-.3764706.357647-.7215686.5960784-1.0603922.7466666-.3388235.1505883-.677647.2133334-1.0478431.2133334h-.0313726c-.665098 0-1.3803921-.257255-1.932549-.8470589-.5270588-.5647059-.9160784-1.4556862-.947451-2.7482353 1.1921569-.0439215 2.3717647-.1066666 3.3066667-.1694117.4894118-.0313726.9160784-.0690196 1.2360784-.0941177.32-.0313725.5333334-.0501961.6337255-.0690196.1003922-.025098.1945098-.0501961.2698039-.0878431.1192157-.0627451.2196079-.1694118.2635295-.3011765.0439215-.1254902.0564705-.2698039.0564705-.4392157 0-.8219608-.357647-1.612549-.9286274-2.2023529zm-2.7984314.0627451h.0188236c.5458823 0 .9662745.2258823 1.2611764.5709804.294902.345098.4580392.8156862.4580392 1.305098v.0188235c0 .0627451-.0062745.1129412-.012549.1380393-.0188235.0439215-.0188235.050196-.0501961.0690196-.0313725.0188235-.1066666.037647-.2321568.037647-1.0792157.0188235-2.2086275.0501961-3.3129412.0501961-.0062745 0-.012549 0-.0188235 0 .1317647-.7027451.4015686-1.2360784.7278431-1.6062745.3576471-.3890196.7780392-.5835294 1.1607843-.5835294z"/><path d="m61.4839216 30.2305882c-.1129412-.0313725-.1882353-.0752941-.2447059-.1254902-.0815686-.0690196-.1380392-.1694117-.1756863-.3639215-.037647-.1945098-.0501961-.4643138-.0501961-.8345098v-4.1725491c0-.8721568-.2447058-1.612549-.7215686-2.1396078-.4768627-.5270588-1.1733333-.8156863-2.0203922-.8156863-.6211764 0-1.1482352.2509804-1.7254901.6086275-.4203922.2635294-.7968628.5145098-1.1231373.7403921v-1.4996078l-.2447059.1129412c-.8533333.3890196-1.7882353.6337255-2.7043137.8094117l-.1380392.0250981v.6839215l.1380392.0250981c.2823529.0564706.4956863.0941176.6462745.1505882.1129412.0376471.1945098.0752941.2447059.1254902.037647.0313726.0690196.0690196.0941176.1254902.0376471.0752941.0690196.1945098.0878432.3639216.0188235.1694117.025098.3890196.025098.6713725v4.172549c0 .32-.012549.5647059-.0501961.7529412-.0313725.1380392-.0690196.2384314-.1192157.3137255-.0752941.1129412-.1756862.1819608-.3639215.2447059-.1819608.0627451-.4454902.1003922-.7905883.1317647l-.1568627.012549v.7843137h4.6431372v-.7780392l-.1568627-.012549c-.2823529-.025098-.5019608-.0627451-.6588235-.1129412-.1192157-.037647-.2007843-.0815686-.2635294-.1317647-.0878432-.0752941-.1443138-.1819608-.1882353-.370196-.0376471-.1882353-.0501961-.4580393-.0501961-.8156863v-4.6807843c.5647059-.5207844 1.3552941-.9850981 2.0580392-.9788236.345098 0 .614902.0564706.8282353.1568628.32.1505882.5270588.3952941.665098.7341176.1380393.332549.1945098.7592157.1945098 1.2360785v3.4133333c0 .345098-.012549.614902-.0439215.8156863-.0250981.1505882-.0627451.2635294-.1066667.345098-.0690196.1192157-.1568627.1882353-.32.2509804-.1631372.0627451-.4015686.1003922-.7278431.1317647l-.1568628.012549v.7843137h4.467451v-.7780392l-.1505882-.012549c-.2760785-.037647-.4894118-.0690196-.64-.1129412z"/><path d="m67.4760784 29.6156863-.1631372.0752941c-.2698039.1317647-.6776471.3011765-1.1482353.3011765-.1192157 0-.2447059-.0188236-.3513726-.0627451-.1631372-.0690196-.32-.1882353-.4454902-.4517647-.1254902-.2572549-.2133333-.6588236-.2133333-1.2486275v-5.0698039h2.0015686l.0439216-.0313726c.2133333-.1505882.32-.3952941.32-.6337255 0-.1443137-.0439216-.2949019-.1380392-.4141176l-.0501961-.0627451h-2.1772549v-2.572549l-.5396078-.0690196-1.3050981 1.5247059v1.1168627h-.8094117l-.7027451.6901961.1945098.4517647h1.317647v5.6658823c0 .8031373.1756863 1.4368628.5333334 1.882353.357647.4392157.8972549.665098 1.5498039.6588235.2258823 0 .5145098-.0627451.8784313-.2447059l1.5184314-.7341176z"/><path d="m70.2807843 17.1984314c-.6588235 0-1.2172549.5458823-1.2172549 1.2486274.0062745.6650981.5584314 1.2235294 1.2172549 1.2235294.3450981 0 .652549-.1443137.8721569-.3639215.2196078-.2258824.3513725-.5270589.3513725-.8596079 0-.3513725-.1317647-.6588235-.3513725-.8847059-.2196079-.2258823-.5207843-.3639215-.8533334-.3639215z"/><path d="m71.7929412 30.2180392c-.1317647-.037647-.2258824-.0815686-.294902-.1380392-.1003921-.0815686-.1568627-.1819608-.2007843-.3764706-.0439216-.1882353-.0564706-.4643137-.0564706-.8282353v-7.2156863l-.2384314.1003922c-.8721568.3764706-1.7756862.6211765-2.7356862.7968627l-.1380392.0250981v.6901961l.1443137.025098c.2886274.0501961.5082353.0941176.665098.1443137.1192157.0376471.2007843.0815687.2509804.1254902.0439216.0376471.0752941.0752941.1003922.1254902.0439215.0815686.0690196.2007843.0878431.3701961s.025098.3952941.025098.6776471v4.1411764c0 .3262745-.012549.5772549-.0439215.7592157-.0250981.1380392-.0627451.2384314-.1066667.3137255-.0690196.1129412-.1631372.1819608-.3388235.2447059s-.4392157.1003921-.7843137.1317647l-.1568628.012549v.7780392h4.7184314v-.7780392l-.1568628-.012549c-.32-.025098-.5647058-.0627451-.7403921-.1129412z"/><path d="m80.8219608 29.6094118c-.2258824.1192157-.4831373.2133333-.7278432.2133333-.0690196 0-.1254901-.012549-.1756862-.0439216-.0752941-.0439215-.1505883-.1192157-.2133334-.2698039s-.1003921-.3764706-.1003921-.6839216v-4.3105882c0-.3827451-.0439216-.7780392-.1756863-1.1482353s-.3576471-.7215686-.7090196-1.0039216c-.4956863-.3890196-1.1607843-.5835294-1.7568627-.5835294h-.0188236l-.0188235.0062745c-1.1670588.269804-2.5035294 1.0290196-3.0807843 1.4305883-.2007843.1443137-.3701961.2823529-.4956863.4454902-.1254902.1631372-.2007843.3513725-.2007843.5584313 0 .2886275.1505882.5333334.345098.6964706.1945098.1631373.4266667.2635294.6588236.2635294.1882353 0 .357647-.050196.4831372-.1568627.1317647-.1003922.2133334-.2509804.2572549-.4203922.1380392-.5709804.332549-.972549.5458824-1.2047058.2070588-.2321569.4956862-.3952942.8658823-.3952942.4705883 0 .8156863.1631373 1.0666667.4705883.2509804.3137255.4015686.7968627.4015686 1.4556863v.4141176c-.1003921.0690196-.2509804.1505882-.4266666.2384314-.6588236.3137255-1.7129412.690196-2.4784314.96-.6337255.2258823-1.1105883.5145098-1.4243137.8847059-.32.370196-.4643138.8282352-.4643138 1.3552941 0 .665098.2635294 1.3113725.7152941 1.8007843.4580393.4831372 1.1105883.8031372 1.8886275.8031372.1756863 0 .3639216-.050196.5647059-.1317647.5333333-.2196078 1.1670588-.652549 1.7317647-1.0541176.0941176.2698039.2258823.5145098.4392157.7403921.1317647.1317647.3011764.2384314.4643137.32.1694118.0752942.3262745.1254902.4705882.1254902h.0439216l2.0329412-1.0729411-.3388236-.7843138zm-4.7435294-2.4533334c.2070588-.1003921.5898039-.2635294.9662745-.4329411.2635294-.1192157.5207843-.2321569.7278431-.3325491v2.7545098c-.1882353.1882353-.4392157.3701961-.7027451.5082353-.2823529.1443138-.5835294.2321569-.8282353.2321569-.2698039 0-.5898039-.1192157-.8345098-.3513726-.2447059-.2321568-.4266666-.5772549-.4266666-1.0603921 0-.3388235.0878431-.5647059.2635294-.7654902.1756862-.2007843.4517647-.3764706.8345098-.5521569z"/><path d="m86.0172549 29.6972549c-.2698039.1317647-.6776471.3011765-1.1482353.3011765-.1192157 0-.2447059-.0188236-.3513725-.0627451-.1631373-.0690196-.32-.1882353-.4454902-.4517647-.1254902-.2572549-.2133334-.6588236-.2133334-1.2486275v-5.0698039h2.0015687l.0439215-.0313726c.2133334-.1505882.32-.3952941.32-.6337254 0-.1443138-.0439215-.294902-.1380392-.4141177l-.0501961-.0627451h-2.1772549v-2.572549l-.5396078-.0690196-1.3050981 1.5247059v1.1168627h-.8094117l-.7027451.6901961.1945098.4517647h1.317647v5.6658823c0 .8031373.1756863 1.4368628.5333334 1.882353.357647.4392157.8972549.665098 1.5498039.6588235.2258824 0 .5145098-.0627451.8784314-.2447059l1.5247059-.7341176-.32-.7780392z"/><path d="m90.4972549 30.2180392c-.1317647-.037647-.2258824-.0815686-.294902-.1380392-.1003921-.0815686-.1568627-.1819608-.2007843-.3764706-.0439215-.1882353-.0564706-.4643137-.0564706-.8282353v-7.2156863l-.2384313.1003922c-.8721569.3764706-1.7756863.6211765-2.7356863.7968627l-.1380392.0250981v.6901961l.1443137.025098c.2886275.0501961.5082353.0941176.665098.1443137.1192157.0376471.2007844.0815687.2509804.1254902.0439216.0376471.0752942.0752941.1003922.1254902.0439216.0815686.0690196.2007843.0878431.3701961.0188236.1694118.0250981.3952941.0250981.6776471v4.1411764c0 .3262745-.0125491.5772549-.0439216.7592157-.025098.1380392-.0627451.2384314-.1066667.3137255-.0690196.1129412-.1631372.1819608-.3388235.2447059s-.4392157.1003921-.7843137.1317647l-.1568628.012549v.7780392h4.7184314v-.7780392l-.1568627-.012549c-.32-.025098-.5647059-.0627451-.7403922-.1129412z"/><path d="m89.0039216 17.1984314h-.0188236c-.6588235 0-1.2172549.5458823-1.2172549 1.2486274.0062745.6650981.5584314 1.2235294 1.2172549 1.2235294.3450981 0 .6525491-.1443137.8721569-.3639215.2196078-.2258824.3513726-.5270589.3513726-.8596079 0-.3513725-.1317648-.6588235-.3513726-.8847059-.2133333-.2321568-.5207843-.3639215-.8533333-.3639215z"/><path d="m96.1631373 21.785098h-.0188236c-.972549 0-2.1145098.3890196-3.0243137 1.2109804s-1.574902 2.0894118-1.574902 3.802353c0 1.1419608.4329412 2.2839215 1.229804 3.1435294.7905882.8596078 1.9513725 1.4305882 3.3756862 1.4305882 1.0603922 0 2.1960785-.4203921 3.0745098-1.2486274.878431-.8282353 1.487059-2.0705883 1.487059-3.6956863 0-1.28-.476863-2.4470588-1.2925492-3.2878431-.8031372-.8407844-1.945098-1.3552942-3.2564705-1.3552942zm1.8007843 7.8745098c-.1945098.2635295-.4266667.4454902-.6839216.5584314s-.5521569.1694118-.8658824.1694118c-.4203921 0-.7905882-.1066667-1.1231372-.307451-.4956863-.3011765-.8909804-.8156863-1.1670588-1.4996078-.2760785-.6839216-.4266667-1.5435295-.4266667-2.5035295 0-1.0729411.2447059-1.9074509.64-2.4658823s.934902-.8407843 1.574902-.8407843h.0188235c.4517647 0 .8345098.1129412 1.1607843.3137255.4956863.3011764.8721569.8156862 1.1294118 1.4745098.2572549.652549.3827451 1.4494117.3827451 2.2964706.0062745 1.3866666-.2509804 2.277647-.64 2.8047058z"/><path d="m111.071373 30.3372549c-.276079-.025098-.483138-.0564706-.633726-.1066667-.112941-.0313725-.188235-.0752941-.244706-.1254902-.081568-.0690196-.138039-.1694117-.175686-.3639215s-.050196-.4643138-.050196-.8345098v-4.1725491c0-.8721568-.244706-1.612549-.721569-2.1396078s-1.173333-.8156863-2.020392-.8156863c-.621176 0-1.148235.2509804-1.72549.6086275-.420392.2635294-.796863.5145098-1.123137.7403921v-1.4996078l-.244706.1129412c-.853334.3890196-1.788236.6337255-2.704314.8094117l-.138039.0250981v.6839215l.138039.0250981c.282353.0564706.495686.0941176.646274.1505882.112942.0376471.19451.0752941.244706.1254902.037647.0313726.06902.0690196.094118.1254902.037647.0752941.06902.1945098.087843.3639216.018824.1694117.025098.3890196.025098.6713725v4.172549c0 .32-.012549.5647059-.050196.7529412-.025098.1380392-.069019.2384314-.119216.3137255-.075294.1129412-.175686.1819608-.363921.2447059-.181961.0627451-.44549.1003922-.790588.1317647l-.156863.012549v.7843137h4.643137v-.7780392l-.156863-.012549c-.282353-.025098-.50196-.0627451-.658823-.1129412-.119216-.037647-.200784-.0815686-.26353-.1317647-.087843-.0752941-.144313-.1819608-.188235-.370196-.037647-.1882353-.050196-.4580393-.050196-.8156863v-4.6807843c.564706-.5207844 1.355294-.9850981 2.058039-.9788236.345098 0 .614902.0564706.828236.1568628.32.1505882.527058.3952941.665098.7341176.138039.332549.194509.7592157.194509 1.2360785v3.4133333c0 .345098-.012549.614902-.043921.8156863-.025098.1505882-.062745.2635294-.106667.345098-.069019.1192157-.156863.1882353-.32.2509804s-.401568.1003922-.727843.1317647l-.156863.012549v.7843137h4.467451v-.7780392z"/></g></svg>" alt="Cell Death &amp; Differentiation" srcset sizes>
 </picture>
 </a>
 
 </div>
 
 <ul class="c-header__menu c-header__menu--global">
 <li class="c-header__item c-header__item--nature-research">
 <a class=c-header__link href=https://www.nature.com/siteindex data-test=siteindex-link data-track=click data-track-action="open nature research index" data-track-label=link>
 <span>View all journals</span>
 </a>
 </li>
 <li class="c-header__item c-header__item--pipe">
 <a class=c-header__link href=https://www.nature.com/articles/s41418-022-01015-x data-header-expander data-test=search-link data-track=click data-track-action="open search tray" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>Search</span><svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg>
 </a><div id=search-menu class="c-header-expander c-header-expander--tray u-hide-print has-tethered u-js-hide sf-hidden" data-track-component=nature-150-split-header hidden>
 
</div>
 </li>
 <li class=c-header__item>
 <a href=https://www.nature.com/nams/svc/myaccount id=my-account class="c-header__link placeholder" data-test=login-link data-track=click data-track-action="my account" data-track-category=nature-150-split-header data-track-label=link style=display:none>
 <svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill=#333 fill-rule=evenodd></path></svg>
</a>
<a href="https://idp.nature.com/authorize/natureuser?client_id=grover&amp;redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41418-022-01015-x" id=login-button class="c-header__link placeholder" data-test=login-link data-track=click data-track-action=login data-track-category=nature-150-split-header data-track-label=link>
 <span>Login</span><svg role=img aria-hidden=true focusable=false height=22 width=22 viewBox="0 0 18 18" xmlns=http://www.w3.org/2000/svg><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill=#333 fill-rule=evenodd></path></svg>
</a>
 </li>
 </ul>
 </div>
 </div>
 </div>
 
 <div class=c-header__row>
 <div class=c-header__container data-test=navigation-row>
 <div class=c-header__split>
 <div class=c-header__split>
 <ul class="c-header__menu c-header__menu--journal">
 
 <li class="c-header__item c-header__item--dropdown-menu" data-test=explore-content-button>
 <a href=https://www.nature.com/articles/s41418-022-01015-x class="c-header__link c-header__link--chevron" data-header-expander data-test=menu-button--explore data-track=click data-track-action="open explore expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span><span class=c-header__show-text>Explore</span> content</span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=Explore-content data-test=Explore-content id=explore data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 
 <li class="c-header__item c-header__item--dropdown-menu">
 <a href=https://www.nature.com/articles/s41418-022-01015-x class="c-header__link c-header__link--chevron" data-header-expander data-test=menu-button--about-the-journal data-track=click data-track-action="open about the journal expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>About <span class=c-header__show-text>the journal</span></span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=About-the-journal id=about-the-journal data-test=about-the-journal data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 <li class="c-header__item c-header__item--dropdown-menu u-mr-2" data-test=publish-with-us-button>
 <a href=https://www.nature.com/articles/s41418-022-01015-x class="c-header__link c-header__link--chevron c-header__link--dropdown-menu" data-header-expander data-test=menu-button--publish data-track=click data-track-action="open publish with us expander" data-track-label=button role=button aria-haspopup=true aria-expanded=false>
 <span>Publish <span class=c-header__show-text>with us</span></span><svg role=img aria-hidden=true focusable=false height=16 viewBox="0 0 16 16" width=16 xmlns=http://www.w3.org/2000/svg><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
 </a><nav class="u-hide-print c-header-expander has-tethered u-js-hide sf-hidden" aria-labelledby=Publish-with-us-label id=publish-with-us data-test=publish-with-us data-track-component=nature-150-split-header hidden>
 
 </nav>
 </li>
 
 
 </ul>
 
 </div>
 <ul class="c-header__menu c-header__menu--tools">
 
 <li class=c-header__item>
 <a class=c-header__link href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=32" rel=nofollow data-track=click data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external>
 <span>Sign up for alerts</span><svg role=img aria-hidden=true focusable=false height=18 viewBox="0 0 18 18" width=18 xmlns=http://www.w3.org/2000/svg><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill=#222></path></svg>
 </a>
 </li>
 
 
 <li class="c-header__item c-header__item--pipe">
 <a class=c-header__link href=http://feeds.nature.com/cdd/rss/current data-track=click data-track-action="rss feed" data-track-label=link>
 <span>RSS feed</span>
 </a>
 </li>
 
 </ul>
 </div>
 </div>
 </div>
 
 </header>
 
 
 <nav class="u-mb-16 u-hide u-show-at-md" aria-label=breadcrumbs>
 <div class=u-container>
 <ol class=c-breadcrumbs itemscope itemtype=https://schema.org/BreadcrumbList>
 <li class=c-breadcrumbs__item id=breadcrumb0 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href=https://www.nature.com/ itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label=link:nature><span itemprop=name>nature</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb1 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href=https://www.nature.com/cdd itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label="link:cell death &amp; differentiation"><span itemprop=name>cell death &amp; differentiation</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb2 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem><a class=c-breadcrumbs__link href="https://www.nature.com/cdd/articles?type=review-article" itemprop=item data-track=click data-track-action=breadcrumb data-track-category=header data-track-label="link:review articles"><span itemprop=name>review articles</span></a>
 <svg class=c-breadcrumbs__chevron role=img aria-hidden=true focusable=false height=10 viewBox="0 0 10 10" width=10 xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=#666 fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </svg>
 <li class=c-breadcrumbs__item id=breadcrumb3 itemprop=itemListElement itemscope itemtype=https://schema.org/ListItem>
 <span itemprop=name>article</span></li>
 </ol>
 </div>
 </nav>
 
 
</div>
<div class="u-container u-mt-32 u-mb-32 u-clearfix" id=content data-component=article-container data-container-type=article>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 
 <div class="c-context-bar u-hide sf-hidden" data-test=context-bar data-context-bar aria-hidden=true>
 
 </div>
 
 <article lang=en>
 
 <div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile sf-hidden">
 
 </div>
 
 <div class=c-article-header>
 <header>
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Review Article</li>
 
 
 <li class=c-article-identifiers__item>
 <span class=c-article-identifiers__open data-test=open-access>Open Access</span>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2022-05-17>17 May 2022</time></a></li>
 </ul>
 <h1 class=c-article-title data-test=article-title data-article-title>Immune response in COVID-19: what is next?</h1>
 <ul class="c-article-author-list js-etal-collapsed js-no-scroll" data-etal=25 data-etal-small=3 data-test=authors-list data-component-authors-activator=authors-list><li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Qing-Li aria-label="Read more about Qing Li" data-author-popup=auth-Qing-Li>Qing Li</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup><sup class="u-js-hide sf-hidden">&nbsp;</sup>, <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Ying-Wang aria-label="Read more about Ying Wang" data-author-popup=auth-Ying-Wang>Ying Wang</a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup><sup class="u-js-hide sf-hidden">&nbsp;</sup>, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden">, <li class=c-article-author-list__show-more aria-label="Show all 27 authors for this article" title="Show all 27 authors for this article">…<li class="c-article-author-list__item js-author-etal js-smaller-author-etal sf-hidden"> &amp; <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Yufang-Shi aria-label="Read more about Yufang Shi" data-author-popup=auth-Yufang-Shi data-corresp-id=c2>Yufang Shi<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden">,,</sup>&nbsp;</ul><button aria-expanded=false class="c-button-author-list js-etal-show-more"><svg aria-hidden=true width=16 height=16 focusable=false class=u-icon><use href=#icon-plus></use></svg><span>Show authors</span></button>
 
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://www.nature.com/cdd><i data-test=journal-title>Cell Death &amp; Differentiation</i></a>
 (<span data-test=article-publication-year>2022</span>)<a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>1857 <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>19 <span class=c-article-metrics-bar__label>Altmetric</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://www.nature.com/articles/s41418-022-01015-x/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
 
 </header>
 
 
 
 
 
 
 </div>
 <div class=c-article-body>
 <section aria-labelledby=Abs1 data-title=Abstract data-gtm-vis-recent-on-screen-50443292_562=804 data-gtm-vis-first-on-screen-50443292_562=804 data-gtm-vis-total-visible-time-50443292_562=10000 data-gtm-vis-recent-on-screen-50443292_563=935 data-gtm-vis-first-on-screen-50443292_563=935 data-gtm-vis-total-visible-time-50443292_563=10000 data-gtm-vis-has-fired-50443292_562=1 data-gtm-vis-has-fired-50443292_563=1 lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><p>The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.</p>
 <figure><div class=c-article-section__figure data-test=figure data-container-section=figure><div class=c-article-section__figure-content><div class=c-article-section__figure-item><picture><img src="data:image/webp;base64,UklGRkAqAQBXRUJQVlA4IDQqAQAw7wKdASqtAvkCPjEWiUOiISETOdVoIAMEsbd+OZf0zx8ADMi+B8B/vP8B+7Hgrxn4u/Of379xf7t7yHGvaz6v+3fr7/B/Lt/C/7XVv7d/vv2e9Rfzr9o/4v+R/KX5w/7b/xf7X3K/0P/V/9T8//oC/U3/f/3v/LftD8WX/N/3Xuc/xH/P/4v7M//b5B/0L/C/9r/Hfvx/2Ppv/2f/b/4H7z/Ln+3f7T/r/6T/rfIF/Ov7t/0/z/+cH/l/+b3JP8t/2P+Z7hP9C/zn/s/P/5ev+x/6v9t/r///9If9b/3//k/2P+8//v+6+w3+hf3H/qftB/+P+L9AH/19rn+Af/D1AP/V7E/VD+of4P9dP7f/zvU/+hf1v+8/5n/Af37/h+wv4l8t/Tv7X/nP71/Yf+z/qvj9/of8J42PSf57/Uf579mP30+S/4n9Yvqv9n/yP+Q/tP/3/0v3O/f/8p/i/2M/tP7qez/x8/hf7j+0v93/az7BfxP+Of1f+3/sf/cP/v/qPsL+V/0n+d/03ft7L/p/9d/g/3M+AX1Q+Zf3v+3f4z/bf3D92PY0/hP8V+4v+C/9f/c+m/1X+5f47/D/uT/e//d+AP8f/m397/uX+N/3P91//3/K+//9B/xPGE++/6X/n/5z80fsB/lX9U/2P99/zf/n/zX///7P4sfxv+//wv+h/7/+j////v+Ln5n/dv97/iP9B/4f83////b+gv8m/on+h/u3+Y/6v+N////h+6v/4e4X9v//P+f/0gfrz/2f2n//5gZra6/rrW11/XWtSnQeNbEeZ0RKd0MfFZU96xzzP9bau3ipMSwVe/+IvG9/8ReN7/4i8b3yTVHaPuGBQ4VIrcfPtIEIp11slrxb47YK2vUQ0t11ra6/rrW11/XWtrr+utbXX8onDkS1aH7C6lqkEH1Mh4Xv1ZDypcgRYWEAK61tdf11ra6/rrW11/XWtrr+utPXquqDvk3FlaU8MEOBzAZ1zVSO5Y5MHtdC/s6wHm27yFE6fqKAeRhSIaFz6oDq3XqfPwHvL4C6pFPJZIP2vtMiM/RGvrni/4i8b3/xF43v/iLxvf/EaN1blvsTzdNerxYoaZM5JHrpKu4uOhiif9aEuC6zw+M0WD3lU4LSnse3G/2Ev5Q9TYr/FZJ8XkxpL6dxkxV9OQ8qYlgq9/8ReN7/4i8b3/xAiwjiPzbUiv+eQt9JufteWc3sTYGnJnTJCk+0MtazobzUQxaO64e1DbphWo+BNhPqWfBTf50rIXcd6NxVaXORS7Brr+utbXX9da2uv661PmlT1k/qw/x+xhyBh6cGHliaEzMEb/d6T803sG52lrEzzBD5IwwA+EJwb6ootSYkNJZb/TEWq+hhknNpbPahqmuv661tdf11ra6/kRvCUn9tpergU5+VRtwvtFaBLFdqmMhF+hzQMWeZv2tWiCNFdqRPYjrsMEZxS6RTRtrW11/XWtrr+urSLv6tdn47ZOkK4lBBHNl9rSc/lM8KixQ0N4ERfIsmW79zwDebVGycQtqfn/Kt4mAM2Ap2D1qa9rb6whfp330QRbsFXv/iLxvf+2OqwE7Lq5yNMT5ZzWAwmi4dSc1Sdt//59FQ0FN+C299JKg3SgfRb9kNJpB2xW61YcGyrr0tqDg/bs21R1skrBeOjiUYA22ToUe2GPqQ7vh4l/pFchi8Xvc0rVkSwVe/+IvGL0vc6iZllPdbJcH2xZEMUKVuDx1vNKtB7LXwMyNA0t0gTiqIvBpweO6NBpop4uu3+zZakOBN8L0G2eAB2JE1XNeHRd5K3WrIRtVAJo2w4PUxEfLtiv2oYU1+gFYPSG9l0KWtgq9/8RdtAsDGhq9VJ74ag9bCkeJAHeBhGEwoDAlVkPYHJuf6uY2kVphOPVjowhnrUpTc34Bk2J+5EmTjGW9C4scqOkNWvDUWC8K91Y1/uyubtUci1pQiH0PKCZJZgcs1DEtivGW9gaSUG3ALkdYKGByqM/La1tdf11L/RfZF+6ZGBDsLygJtGCDwmpoNOkyofdkCrEwtzSRKqupikAXqNtRfME6gHHuXNaCCJUSQn1g2AuG09IMCPO0hW8JB4x3/GMZtKG+Yj/G3uq5JB2aQc5asuwvuLjygppGPI9Zz5uzl+Ve/+IuNN6MAG3QQeBRxhzNmbxm3Fgk+4MBH4koAjJK9ta2AE/NgPF8qMBJ+JFTnHIRN0MhtwJYFwtXmKSaKFP+O7HHSC22PYilqRuezDZKk8NAZ4G+8JT/vBqgl2ndhGgR3fADsaItcmmq3fOwhBAXPFQyrEOdh8vfd75YdqppTNU3S4e9aLM65Nw7rGL4QPIGSZmgAHipMSdVmKh40c4A/80WUHxnbSkfX3U5egHiOf6x53TUvnsF78FAFZgH1ETlxA5VE1vfbRixcI1dWOcU7UpUTg84JcDWyrWv9jpQe5F1JszEccxfGnebo7mj7tx1xsXA61u+qOclkZhw5mw4UQ5UfDZ25ZcQGJSF8Fbwsu9li+ZPoYATLxvOjI/Gmd2+QLORbDBsTorrY4izLeqbT2Jto2Fro33jp2zx/dXtHK5s48F0YBuX5W6LUFgH3/gE59zIJSH1fY2G95/GLpqnkBjqT9S/ZkBrZ660IXlJuE7Kcmxi7dAdl5zQepOip/f/J5hwSf09Zewt82estrrphAmj/haAQi85MjkTbQXatktC7stN78k8f+XmltI8bUQOAeLJZIif6UlLP29F/8VLCGEJQvmBzSNdrSFx12ZRsgvggEjv0RlFGqiXuMvH/J2nWNyoQLrzgdYTXTCtanfmXLJwq1JxSVZ9aguQhkojrbd1zTomLrWd6Gx6fto+C2J4bAFcGSqVfqZXwSkx3PklHs741DcdlKPf6AIufXl13+SU+PSLrote5+dAc4O/CqYrmpEekBLIreDu+MH5ByzTtSzfb7NHI7Aia2tZv8PQ0x+6cb0oq298LILywI2KfkgidckLl/V8Pr2yuMVqPyJwmyqEXVYLmyO+fXVwz3Ce+t5xMQjG96/K3x5zzaON3nvq0IH7It+eLEHDri1qmXYMcZbv1DRLmupixWYKsHXrJGoEwhXUL4/ESZ+MocY3S3uwKh7rKx+rKqhjLu4eJOv2YIM04Ax7d/E17DZk6wB2SLX7gFSB2tVY0qUbwYPPniXzzR3cVwvdWYJxc0nJClmRk0zh6B8XkxeMLpeONH18mPCIE2X5vXGVfcsF3xU8S6qYx89peAaPRsOsxvGax8CWx4cPOWmKJAqJaXvvBc9sDuMFmpodinXKsbnVze8CdvPMWArbWLgalE/+UEua5KaIHrAbqvw2no4Ds4hJMPnaEK2qJYGL82n9456iCoh9+L0ur4oRSytpylBzyD0NlhIMjoQJ/frqyr6/gX9y7V86RvSBnmMeWKE8kv1UNx9uGeIWwOwZMpY8jw6EowmFotJu9ZrTlMzbN0YPRHSGwEqk4K8m9VhxLTxgx8OUMIeDTAU0NXq3Ba39vm+NTAoKDLoPl5v2skLvkuo7n3AFppPoNKFcb1OqkslWwFv4KCEUzJ4S6wt6IpL9OlukWmv0xBpWcT/6qbLQGXSHQt5FaYCFfm32xqy4whdyd8Ri1KB67GdOSu2CtwQUxCxkrns1dl7J8zK7YRIpIE1so47aI9VE/rTor4T7FSsERE/hel72zo3x5Cw9lvIovRSE/MOtlk/GuUf9RiN3in4X0+G82xMjMvuX+zRPU1oEVGwsWb+MhBU/PZvtR13Hepu6NwZSjzF/3zPRJyp15kQPiOE+/9z3TR7CZ342Kk41u4uO/1CAjXh9lneRf7KwCy9pGN8WkOTDo+ELTFWVcFd683hOkZY5N7uEJcKCJRhFfsqCNb4GrlfP/xBGIxAPkmW+pR1YuRuckNJuq9D6SCtX8u++bkXIhcL9qCJN99Om1BrFSLuBFf3/G/beaB1shegxc6LhR3LKz6raxCXxZaDyDMP6SJqbrxCgYMPXogge1Vd15uNaBYNhWmDg/tpR27UklQJz3R8kQVDEEKVGu2Abzo9ed6hw8oMYtN+zwIOS8KZrHgvQTVp2KWVLTY+V9RcbxWfpwhEog1u7DiUglS+JLaDwFGdPjkumVJOEF2fY0kaI+GkKxP2niuyJ1gppiOBzhR95IdVq+3qLahsi/70UvQjwT4FCZS12mxwJkbQYq1ZjuU06fl9RX2uIyOyPCpOg3mnkTcYaUcD+8syDve71EAFZPRjTAwOCTMa9zZe6OEYOdtJG1fJ/SgrnYTsd7suKtTDd1KZML/8mXwGO09Uz2fb8mi7sEFq+V0LHdhlktcyxtc6c917/KtL4XzctqtewYBG3lY1cHcvWHwX7+YNlxGqdEH1GVeaEYDBE2sgWAZ6q65jzf0uYzILP2Tk+LpZcaE/I24f1svo25vyitoMT5UdNJyFs8MJdayZQmu9dlS8syqCm3IQku/N49uNse9cV2aemf3jcPRLnNCZu/Ao4iB8CMO+jHz+3Oh0TWw7RXvkb3gY6T4ujGpkvlz/TXdRrAwHTSzCB+t5kAsmGrg//OY1pGiibAHjfIqzXMdfoK+hR506UWKEERNZVbj8QgGx+O5s9owh254OWlBbvH9rJGhGgGo69XeXMz1V5daTi+j05olvy1gwyNqG6id0sFtTjjevzyupQGT/DY0LrEigZZCUeT0eoE8hxYY6GMP6NiR4c/Gk8Wo2nT8PBTHA0TS6iupTlhuLbtBQQUpe+pVacD8XPXKPxftFmCLnEWeNZ6kQDVUvKkcFK9Gt8GDK3i5O9xnSQQ7FoVBZ3Vb6b/hDPugnkNx+YOe+x4m1WEGzsoeyrDnDWXgbjO1Gw18nC5jdLOPoV8T1jmB5+Uk7OE84NdORKGQY/jXFN3zlx04os208mQbfA8p9oN+/W11/KH4RtzCh76YnxltUQGbzFS6vXSc7vi/6akLxsF9hdT/rYECqUy/gOuE5HgindgYSZQC7vYbc8AK9sExoeKWmmDXF5eGLv79tmTU0VyrNbsap/28Su0WyZG383FMEJZRy8RRkQVG/poeaUPYw67EjsTqziABmITGOhEKl/XgKflPwU4lse0zv4543jjb5GrVkm9vhMGHCaIeM8Wzjrn6fJBH+9sgfLlaf0ucjOebAXXu6AirkmdQOq29DsGivvcNpIPrzVpymZS09udJxIT3DpZx7/nfXTUKAq9Hyh7JD0YTTsro7ZEsFTCVdxuk3fOZvcDXUVOILsRr6ALx100D6p2qnguux40lBvGWn5wlaVzl+hfwZFB19v7+9/LdtT1OXto8C0i31cioRlYr+HnLQzH2ulzorOZ76Pe1C3w3dfc39IA0OIm9Pb39V+dPbKlMDLlBKJNAwQTLlhQLrD8XBXqQCLaGln3U3zUYusngGMBW5KvZv1Qmuv5NZaZWLbhh3KFLUTr4vlRqhWVMuS0pAzjTpRUYUyHv761bA4zL8U4vO72KwtRsrwnlv9WaryTZVLdJ3zQmR1pNJl3wmsgi9bMk3gIFr30mlhdVVcH3lLt7CpRT0iyWthVD1UfilZP8zlqT9uCtpdEm0Emm30og4V/VAqyJAKIw2rkuhR6XyPWrXXxJACQf23f8116o0qbDs+MmZZ/R1PfT9pFj2lEdAIX+2UbHFsEKRd1wdz0O2AcBZYP1w0gOIPL7EaBvd0v/BeDGqmQo/9rj2di8rvuylOh/c3kbxjBP1gcddeNYL1SwcNT/0LHxnqfh5ROpkb5Fp8rN0L77XpSO+nA6SYKIKfa9YfLTZUZz6FeKP/yNNJO4a8F0mfYdgL9fODUlAkE8Opo7vp6of1NTVwvBukdaKcoUTdTLPj8s0/LRkRm8CXJKjqj+7Tb5+VlMsIqcSkLBo348u59TeUobTQ7ZSo0q30J0tUX23bAaisLRcyZE0bsbVwzL8SJC2shRuzuIk+Ghrn0dyooaZyeAr5Lh7aTvDYU9ZGZ3QwEOywM7DQGh2SvFwcvDz2HYlubtVqVZNT0u9hXSg2qo61S48DBDH7mEcDAdP3jyOOUL+l7amFPNFjgBsE8iUhWHE5GL+sGWRU7jIASWViSliIMvt5tp0h/czhPy6gyk8kPw+V5pUTi+SUb8F7D0VUU7u22kzl3x3ziwnmJyBprper6o2c/lnjm+EMD3xV4Dyo9A3Cupcgc8AkV8MTvZ7kADai2JFzzB1nqGvY+15U1lSDVfAODq9Q//wIHocZBTfqMUp1cw0+rXSBGf3SHRxb0e/XPwKoAJMSwVOuGphz2PdMmp31w8Q/0KdezAyQOC+CBjHUZSO6ujh1uvkvwDmbYu5PGad1p+NS/IQb9MVSDOQ7gB9jgbA+Rl7fdlO+ftMB5e+myn3zmk1u2TtwvBNbXX9aciST9V/g5yLymSLCvJptdXv9mzmTBrW4MPpUaS5tlRXqtKUGLGmp2STwPEmMVYUsFXMwNRZU8Aa7Tm7p3GwyQ+pQPsp95y1ZnOCZ9pHiYaRf11ranQojg1wRdKvfCJqt77fHiFjDn2xa2F0JVevh8c8Bv/iw0MrBpR4pj3fi+OVZFfUpwXev1UvBr6MWr7zfx3N/x/blpyfp4V9utk48dfUrSRgBk1X5z7MMV8O+bySMzK/v5/tSsF3a05Q2AekCPR3r+XqMH+PtC9psGqf69+80iXNRh7ekHBvSmV6MlUf239j3vrTqH/fppeDCfZmT73fB2mZ20mYtjJyN1iw+rVcuEV9D2qAuUZRacieuNEIx1h61p/jHdIWH84pvHoXHQoMTuBkEg2ZzpCBNfTMA1zUgbs3z4GYRIR3BxQZH8kDynGiSVC2Myj490XPOCWCeQixdKDEo4u2xnhQWopAFBhafxZr2n6n3TbN9vF2e7xHPZFfE7fg/X9yxJArOpU0wPDwm6kNwrQ+1NyCeqlcct1HPaOGjEnofYrbsn7f2vbEkuEysUwKt8IDV2ci3MReLg8tNvA9dkVkwCdAHTN+4+VY6TeoUD1cIXAjDkmVWCTZS2jVKgVpQ6XI6C1VM50U+TdkZy2I4tOImm1rChH9OY7DmzPf7LvFyfJy87HqgrAYwhvxRGS/vP5+bBGSh8YAZznmJTpqdmW/mz2uyPgBLxvCfvbcmB8S3N+HNR2lkIFa7hd2poOdEzwKP/juZOPJKrKecgKk+u7IE043v/iENMtZvplc6tendRp8NPHYanAlnt7ss5ggB3mF2ETDTxkzJcV8yQJu2VRw3KRkiqxAMJzqUGe9zzHK0qHzIj/ahSH7ujws4FfhRt8Mbfhjv9O8ycj0vulGpXDat8HAsmWhe94NVyLvZrZCzfUEAN+QLP4Wb80I2xD7FGMv8Nx4XXXKrM/8t3Becgg98fcKL33a/rrW10k4fyg9dVn6BwFbnPyPeSE5dxWevTNxgLaHoBC/Uyg2XAlcpzHehx6QcLZ5Kf9mHKPEGriTX0qZaXp8zNwTneCN9koKvBzZpFyZc+LGppYw3phSHquZlsDo0mMYNzK8ya5ZzUmVWCr3/wBEXURC2B3BKnadEu5Bjxf8OG+sIe7NHSIGR12tlSM6qzDCJ2Mra6Cdiz53oEF5XiphffyuMntUff5gJnz+BSeecwB1E3lAB96POkfFvN8e6JuQy0H/EXje/+Iv88rkt8m7LRXS5ebAQXc9tw1YyIq1T/jFohHqHIGay2sdvhTfsbn4/DxX1boNc0VAjUs426yDQCrj2/rqOG//mH56+nxLBQkVPwSewhGqfItQCZNHuAzWusW2Yv661tdf11rWEl2Gg9TOU3lxc5xHLh80bpHPAolg+gz7i6HXhgQi7J7PN5oL0jF7UWZ4Rx1ax8S9O960L1Q07eL4JKV4Qgydv+jJxj487//FovrvnHnnxEhoq0L+dQo984fDKkcReN7/4i8b3/xIcdjJV0cKZF8yb7NlyUPiTty1EB2bc4KiIgw4z3wfFOwK0Xl9AWZL2zUM3T12zpAR3aMFOd597jJYAT//MA4EL/iLxvf/EXje/+IvGXHJ4RpVicpjhHMnnL2cvGErXCSCYmkT4SnqzVvVVYKvf/EXje/xAA/v8X5AAXdnSWpaprwM5uUhwGnyX0Cdm35hBsHs/1Qq7QpmvCePtbqKzFZC9RWrxz77HqdfB2YSmgbd6MaCk0Q6EdSopuCzVGp7x+ltwJoHX5InauKc7Wh4ORi+2xtsXfdh7N1AYW9Ildv5+DMl4OxOdd7Ows6mVRtXaXU5/a/9u1C2iqq3sdpUFuKnAJ4jkRyn/6UYjEYPKQbE1q70DYN2Xl5lCtG7p6ENfNTI8ZMX0w3klhsS8ONBnKsob2vzj/8DSPPd7r6cCrDawIxEEj+4/EMYZsXA4xOyaPun6pf3JdMgitesTF8qM1sLKxCi98MMS7oHthDxopV2ou7hDirF9m6LxnQHmx/Ip0RuCbDHn+KqB5fJRmzIhNW8DoM8pLtwkL4b2IXshwQ6wcUOkxukXXb4bwcKIPecCobsAAAAB6s3DuVf6KpQ8wKPCxXEhypRadoyFmD78iE8OUUp2S753zN8ShsarYKTfP4DhTeNFYDL6PvMSoi1NMy0nAK3rGecNwHIonDO9atYGalgbIBnl0DHEfVdEiMxFm94eoO+cJNiNK0YpYucl4N2leE3A2e2k6Xo87chFd59NI0Njyl0/vjyX105xBJLBpiMky0nsykAPAqr75OozWFsXUVPTS6VKxqLeRsI5mNWVgPFub0UDKpd7dNGQZq8RO5eqOMmIJvRSc2hI3DSB3PWr+A7h9FyahxroqvMt78lP9tJZrx3d9sjP9QIYArWXUjltnVTbVE4+6N9OlAdvjG9nQvCdiBBKUsN6GSIE/vwaMoLcp77xqZXF2YEW3LBacyb8bcRFHFGZ1SIYLzAfCs6MktKjlt4gAY0RwprkUX3GZaby0B1k3HnUwR00VYRLEDUAg5TG7TwhSH67kr8YgXRC7xWH72GuVKt21vg30aECQvvYj6TzgthRfdHln7H3piDLdNxvRveQHPkZSNwmQ4HV8miMsduZmnb5w9HTbZSZdY4++AAAAXdyTgSG7piG6hViTQIxKaKG0/Xn0Xq7K2lKphPkCOf7qUT9e0dqC0nO+yo+xTJRMu7bncCNhrc20vqsXwiXf8PUcJsW/Gf3oke4FZaa7BFMg0PP7tOvsbCT5CGlbwCD0jyrdMZyi4R62S4IV+LNtmyeYYnaiDjeOWAuCDekWnWWc4c8PsdQWndkRr/c5D5pcCER9yUwCNlZAeQhrT+3RtApGmfTp99iyMs7NiD3R7SCd7xgMLpMDh2UjNHI8D07FADzE2XrDeHdTaE29z7Ha3X4gYxXAPapsSdJmJ8aXD+RZVcziD4Bt6Epv1ubEpbYS5L9Y5yZybvfhynYC/8ro0aP0fwkSFbDUdRKeF/0NJAp0wgAB+Kwh0E/C5FTOjqSwGtLVMg0QvXfJSLObbkrYeXzjbZCeSAwsAT+vv1/wo3t9x9bRqnGUWS8tFkkdG/nclEdmk/i70Dnj39JSZ4OZmVGtFRg/k5ISWvZWKeiKN4yezBr1E40jEfRsl3snhGdox2fwEhEmbHaBhN4i9MI+f29AAAAA+FfOYbT30H025d1ciBCwgn9/u7bhGtBYLyoMjJXxKcjYfI2HWPuv2Nwlxzl5KN+3Jn4t+k/5cWgQKmWLRIrgLjfS0kpbw2Xj38wAYh3Ee3rDWk5oQKAiDpMxKaYpDjWslBD5Vvf/VZkb2vy23gilPptZFlcUTGEwjADV6Oznq4ool8Ogu1+mMBNqT7w82wefdDe+NtX23Q7cpjsC6CgeaS0jgvPRiG3YnOIGlJRY4A9trGkgS2Ueg4rcSXDLnjgnOGDoWCHyPm1VNTNnh2GxjabeFlnktHw1sX83qDNqvIppxv5KOE4noR3HIO/b9Qf9SoPHnIa1K+OrxcFcX2/RurqYBbZHCfMGflutvZylDfJgJDBSwwhGMMWObTIAmkYdGKl5v4xt59pTzH14is4NuJxMyJpXId9iexCBlkAme4MoTzuh+IXxn2vUe9VBQPAO31pV/Vyf1+EAdXAU96XU77Y1UcOj++kxnIPwz1ILujwN1553xURsVWfo8BN7Ru5UkiEZmFV//6L0Bj++z2buZTg+90lE99PNXbM3kpW/UUW2n8MPCaURvWSpyJhjK4QHooRemTq9ONd/eSY6FXI2qvmS/KWZ68wJfYYmiozqDoA2DrpyZISH5R0D30OylpSDpy0zz/Ss+2+irEXbCKT3w9Xz0SshezLi/Qj5R5PDgybwSX+8aYenK4ZC+c3vE1IvNXU+/Wf98jj7jteKVqOiOHQYT4/iV1ihnOn7riCVTrGAPYEC5GjC4pqfCqqaO/EpuUxnA5DLgJIDFTjak3pUTXpuNRKaqdMrYAQ7rtpYSzdw77orL0xnDMAnmURC42MiUxqKuP9bIhnk51YRUxYYcsAWbf+RONtzq+aRse1Ejd17BcRe5fvGc273L2JQE2xp/YRUtuIQze0ksYEs6lO9EoXq/NF/iZa8TNg24jnw/J3dGrfGivI1/QE++iIMdNQyw4q91kpEpdzo7sUKGVik4NeutCaI6k++X6dLvHm7kglO+wfFBsdAxib9Bado/H0rUYGeG/aBFHaM96tH6fep6fGkYaBA6XdRzKj5g7dPQMW3VX9my2bxo4xx+FL4lLZwEfaFoNyMtWnNX/Wr47LbMSZGLIfKm3UhpuYVvL9qDRT3XRviq2V9Ay5o2y3LV4yiFB3vBG+KBflNK402OxGzgmzKE480Bcrn8umWCi4zh+JdNGrLk+6TfHUxzLCEL1lbkVTiP+2f8eGN6zYm+qWA6vN/ofEmWnUBx5Ym2VpMcgk2oMZnDTE4ZGfk8DS16Bg6OTSbgAAAAQ/3XmimuCpCZ+WHpNYhdfp8x2CfYEqk1gSEdmNzmifo4bj2UqmQjjdXWN0o/sndrqKYS8zxeLLf8VAU/N8pwLnQzeCaPaCFSNWGrWkxgZ/k7BNGDOE9FwgGXCHvRBsbHvA9qALazuMC/IxHf/gpOH9Wi+D4i3jJ8NFwdvt2xFRa0lNPmkUiSD0vJreyEOg33ZaB8Ohm1VKPHrqULD2nTjEm/w2tCs+pejfrtgPYJS/i9Z53VDMGZzIh6PaBSM+nz839MZFcvl3z3YAhlR8MT6TOTdq8XJJLVNIFooDr6Y2IGlvfJpUVvElFYHFnB7AOVe9/7K5/IZw5MOIioSNWouWo5TXQNNNYd7H8WQt4Y2zcAiS2yi6cCbmn8qMkysFGTken3w8+PTkygRDSN2eQwSlJQOmQ69i3CxfQjd1wZYm2P2F4CMqFcLfecNPyMq1KPb6jmN8NBnoMnCcES/bTXFVw5BUTWoQDLIla0kjcIUAKL4H6DqmM8l0Dg0+aiJoGxoE665M3EMHN22Ygc2H+GSEwjPkHtAHW/ran3D0dFW6O/4icu5su5YuDUinp2R55ppfsawvzqr1KR6pJtY71Z/iV2emQP0vBdI4hh6z3crsEQTrbq4dgZ5HRubj2EWwzoEKN11OIeuYeXYOIZbHq72ppPe7WCKdE7lH1Xp2p4s7/3n8oB2omWE6Ct6ddmGBsaJQI7D2WEvNR1fbHeGO5T8BBAy5bQljG64JjJpFlBxFnLw1lRTUy/+JVTiPz5FgR5qrg3u1/5O0SmRa9ybQ00jtO89gZorp/Wq3EENre4uef5prVF5IiXtwAZrS9fqmkJty5t3J+T1PLc6uQNOxGetZ2chKuFK5VztDlyT/uupsCZZrtGq3KmX2AMhiajSN2b6HJ1PUbCYIZlmK8hSnN5GwzKTUQgJsYYjCOWOHuK++V2GXVpWk4d+34kNaUSt79yt7j8O15nf6kRfi0lYeKEPpTwNPCMpYQVU2neQDzKMRXFhPBgbiR+EW6438OvaUZHzYeWLquM+7VLgfMeD7SQdTPqQzhs9XzJzlOvSVUVJE++YKOKcj6PlrNbkf9uQP8tOveaw9tdzMAD6VLCV5uXdM0Faw45Kh7CsEJ/hojXYAAAHHU+KZf6X1U9InDVkR/yniVHFc3L4sVXL0PmX2E5NIQ6pVaS6ivibVUOc11fY2DkDSZ/HdQa4JCeoga23tuCYCHpDnVEFFcOiigigBPp6aXGQ8e6r5RFSSYmNTGczM+q663a7ZHVruIExi6tVtZgQjITHV2v9hcp8BVDQcQe5d3stUtmN3Bhc4DfpwnoV0Zd1Pk9zv/VBJGpDUHpixsktnVn/90kn7HY3PJh/M66qUVdYrHgHU0oTM/ONHa9PaGi1q/8cNRNn1rUPNlYmZIcflkEGpIuMpKw48VTNPJSnpdn8iBlBb6E2+ZNjbfjuX+meCmhSJOd6nLPS15tusE/u7Zcw28u/jQzgxXJc02hXyLjcrxxiwW3vWCJBEW3+UwQNnBa7lKyn8bkaRnQs59+M5vQB2G4maYLI5aYGOW+PsIYQ9iQGioOJqMUPWnay/6gWcyvw6sZPo8FUjUUWifvt9ciMOSfdLCZM+AxCdYgKeNE/me+UWBUz4qXhVdvDSXZxfB8VVDms7jZWry8YG1zbmF6CXC9MMd/Tf299eja1IFjfdVmO9U1QsYnEeMqGF1vfjKEToR0d5Q4yY6P+houLDgVwkqgf0qg8IyM3/sCCsv4WPzj1AdRfe6OXGdaJ28P+VFJF/2f2NKkDWsdjsQFd/I+BYE3p+dR4S43iXeb8xR8bWuXQLR9e9q0R1jwBSNbaZMbrlf/6yNzZH/BGxTJlDELc/Ha5S93lHBCBrqUKA64H/chCO3eMSKdzdqbX3Mw+o5wjbdb2ET0tXCtXu1XymEsyM64jtEp5LPGx8ghXB+l8smgwrHag83a/tffb8lkEGTm476KhuyQFDeb5nNGPIdi06f7yCXSlUCB2TPp+MHdxkyNQDbZs53mroqlysjBnz+NFzOo8OQzp0CSukCad9ineYsjmK4Yv16t8lD5t3Zl/WtbmfNjxEtWR8vJZnx8QnE/9iGCn1IzbalWg2iay1yrbOLmklCVTsSuMGwMDhfQWu+DAR/3wEecS8OLfcQa11f48IPqPdSdWHWYC7/Y9DQQrg669qwgh51lDEsyu7qEVXzB4z+jZHBF6WooaD9nJjPsVo5Zp81apHG3eCHk9BShzzQ9K90hHFzrZBBm3PBl2uJ72jTzcnK/7nExu1vrAEqARf1+/sJJrF7JKciuMZsK6YI7bSi0XTawgs/+IBdusUx/KyjPyw0MUyxG+CbxXF16A0hhWEFIXIi7s0YuKZp4ECIur+ZNM0BQuleZ7TEGYBv8LI9fzKTIIuAb7rA2YOeYjkZ15lX3WBjbOGlOyDAXwnIl9zcgmwzOSYY3QOgliqfvVE98NHG2OS/NGBYApwUoVyT2jdGlsUyb9C3Em9gee/f4HcN/wKiDkO3IvAMC4ZV336dEcodAvzqyihj0pEEc7yP7pm78DZEct+SptM9aa26I49grueGAAAjVqGSypCiw96kWDehdpUqInCqVJRIUAT5b3Xlr+wC+gfuxsMskVxbEgDbK+RIiFq79FBLi4BKhedsPlH+VyjVtJHl1ffZ2P8KTKofdDE1pAuHawrmEzX0BUmeMQftghKK0fS4XZsUe4BIHNNtJRaOKZoU2PY+krhVmmytbD22HPsl3SaEGk3ICn2+WcAwIgqvULVtstPG4o3VWF/XwB0V2MZqtSSh88BU55mmCPz0k9UNYBGcrgfhXdBv8anRjXyuPD754NvfmU3wF9lEqxOgK0Pc4wqNmKRYwXy0LbIGsYY+doMtD8k3JHLk/KNeiC3eJqIa/CVWbEuifb3Q298ShPNgpAtHlceLsUSDZUGbvRVKfRW8EHR9OYNSyD6tm+9f5zDYuemQ6P3B6ldH2TXTZ+bcLPwDgEiGBiwTMU/BewAKh421dKFyPFFVOWVOR+9yrrYpA5TZpu5/gkFhgRA0gtqpgxoeMjtcP2sbDICh/PHgBjSkGLsnRqTsigxrnh7vvNSqApTTmuFd7FOzryPWon4Al8W5MBr0sQ4kKA5xDcSyWXcwxkXRPVngjPl7ujfWvOT7ZtwhRATsXTh7trO/vZzfqnQCXCz3oxueWwqcj5FKgRkQeqQGx73243CaReOX5fJhJhHX/rRiNQ+xrvB5MqEoduVgVaW9DPR2pp1FRULDiEVfhOqqIhyhHoLHT8JhO7Li/3wD+EFb87hRoIxhRk1noo3CABJNCPHcAAtEcWmLqkBw7A/E3bRV2BVRUflU5nU8GBCIMY1o/5/jMzTDwGi+HQNJVyf7Qj38Hf6NEirryJU+WND1Bh6NJeEV7fVyUIkaQJszsaAgUGR/70S4S7cUovP6WVVVgNT5X8RIU+eYbrU66D+Z6sMqVdYgDE5BofN31wAABIO3pp21sYoqKGY4cF2zNKtTN3HtbYYkvjpub0A3ZhBuwca+hhm8lg3FV0KnBDBqwuF5EfaBCu14aT0K8iZ+R4YKUdlvnOu/bmUPzvTb0yKfu95ehmW1HDiBj8Ox4V4Emjm6A3uhosSy+3RKJHgD4Ke/0USjnK4J5vIK/sm8dmjGAERrO1Q5LkI7RNIjn4O4FsHtgAACHCAXHknwqCCz9MYlXtDlwcLzuPWcfQLTgloObsdKwwYmB7v4cLb4z+6C/kFFvUa4SonG/BT0S0AfHfDa0TNIRAHEiFY4462GVIxJxOR/sK6r3E6fBCzCIqj2FUnlYv90yBMsmca4Lhet2ZSmV6pnzhX+61edbY3uN+wXpUrYgPeGbQHgX4VM06AArNiPZSm9Q0e89IJERSIVpsR+dlt++SnMX1cHVBMyRIwj19V0fZd4ZCwrN6JRoIg2gGOlBQdpG66udS6O+Ullm2BjHB0Z2HjOio/dWq9sNMPv/MjNA9jccnLFm7xoXXuJq4Ecyky4YqEQqfE2/T5Eyruih8KUssNMYkG8PJ9Anlp2CvZ58goih+Nmb4mhuNxE1uULJULd1orEHrkWECKkb37MAHk4RT0OG3E5edCh78QY6ygq8lJXxHdMPpnpmYifTS4tcNjVcuF/gI5dtyQwT0VrR3FcYt3hKa+hLe1s4bQuyfipbJcY1z/Wvb9W6khgpYPDh/44NlG514uYU1dHiOpQ4UA9PLueQnl1/keqefbsTvQx4tEO7EdF1sRpj66Hhlvtb/x7x5F0RFxyh/0CTmMYZrMHm6jYsCOiuYBvyk4sfjFMLXapKh4O4/J1JQlkYly/Zy7cQAKVVrFuhahQiZ6IeUfOhT3d2Tjm142lGYJ2UWO3BMp0aXhUfO12RJU0cOdy0BfQ3a9zm6E+gGDOcS/ewAvHznyZIh8lHgM+RTvIow0fbwOeGVgU2S0z426oDSgNhIhTKyTnPzTuviYKu54wdgfGF8AFuBjEeM+WfMw+lCEi/oCLlo7As4S5cqT5l7A5sxr5gly8CTFCWRnUpo4gGWjqBhoxap7vTqls+RWUpP2ST925s4LJFJP8/KBI+hy5OqCIkOcYPbH/V4+6rOwjZSO+8M8Ah2M2xyBnBNacyGO30BIiu2mb3Mry1BSh4456SJLrTknpfkKl9E5GBh4sePrl2xAwEhmN2hbUOLQe4Fn0z4T9o+Z+/6u1FM0WA0JyIVRgwWwMSNjrXrtgCwFg/zc8ZjQafkF+KnRrV9oL5RDLq7GzeUpxQRS8NzWGQQqSOUZyQARCT76FD8f07q+UPDxNLK9n4gseMkbz4P7uSCe9sj4N2yvPcap+MT47WfE98bXrIuqsnAl1iCnO3ti4fMSbZiFHCRLgEdzNsVcaNtRuDbXpXRjRkre1BL7O3sVEojTqdjLuhmuI/BYYc86BeQ/bgJik0ABmreCFZvWS5d0EER8lBjNSiqurHaJbs9s4S3XZcsxCIOwxY2BOokOFJDZuvwBhCs17lZh3JOcZz3qyKttlcv4TuPn/2uB3aH2VA8DeVSxBqCigJNpu4utMqncGomYNztLROtf/J9SX4dbH/jD8sJ8/bc5XsDkrDwXWQ4VJyLkEUOzW7tywIY7ECSx6mVycorRpkPK9c+clZy6pz0X1G7NbNcSXmUvm3UwEQvUk/FSpqraRpfpwBvTv5/giluZC+Ob67aEEvjlRX9VYg3RGyRgiBJ0R7VOvM+BBMQqXfsRfz+J9JHownRID6DJgK5Wl5jVJ+A/kyATIoBzDFwHl3atmLgPihLh1TOIvn/NhSQ83C3xJxhsZL4wQOR9hJUEYiT/xWmFMrGX05ysGbCnLUb6FAh3qN3oz3gyTbZ4OoO5QIf7/d0K8axuApdRCJDa2Lm3QTtWHKRhCt+JSq61Xj/A2vDwXSs4AjIQCyCyiowAMLTzkDHM+mnzH9j7MXUoF5rY3KuKRADrxqTYxiX2tnEJNzzcCy8cfCDI+7vE++eNg53n6maC5+VxJYqtffIjtm3AjFsMXR9AuKcw7pQAhgUoo2mKy7CgoEBdtHP5RQOqEegWD0bvWjz2iRfbRVFKVIFld3L0zkY2RQikXWdczyU7iv2hyLTV8exEveTIOLVxrYTsNAONEMQxBdadOxMuPAwD21ckLZ9lfDjfpfGC5js8vZPpww5YNsXXqO2ro9JMADr0FfozgJ/nsVCkhFkWraTplKQhq6Kn3vqN80sRaMa7dqenRPAAa5aK4uv+kRVMkQH2zFytO2HAJ+YVAHIZpL+I6S5NSyu+IRs21v0jxDTye7Mj2jNoNYvwXlhHXHdOe3I8PmZSTrx6QfP60TmSApNGqODRZkAnKG8lxUfZ3WoJI7RqY0iWUdYoIxenjVVxClqixUAsio3y9LD79U6YjQW1oOVsoBr3PtaJPVhc93x0on5aRXIXCyeZvSPRugPZuyLoGWvHraNMTYvMDE6+UCSC0W/HYWqcshhKACoeEyUUMmY3Sljv2uWNnQZyQ/u0wjRGoVMIlXVNXKtaXNaR/9s0QMptOApjXOwHjh2Bkx1IS8iNt78xXqaOStc25+uVUWQ3Qr89SN9KeE3bzc3jbgr8FNEFEn3DTixSMrWRGECDfe1tCwAuNQ/rybISt/QZIM3DRL3HGneW1Gx5pfNK/4seqPBQ9Ixw4DOTayX8ECoKyAEDSskaNXfuMS727VGOAc2cV7QBLQ3DAOwoyoQla+DhHPld8fwtBMxnU9WiUeLT5rzUd9hZ5kZmhA5uIruVEIKGJF1fxqUswwW7ALyL8ppBwTLIPWZCQn5SMP+ujvm7GBuQPnmvcwPSxgKVqiBUAQzBpE0PLFGfzrCqvLG2id6oY7WciguVwvmQkkjLHsmP0eZCktgABLMogYski7QgUPo324VJvJJM0+dODdxpXAxTuvE/YMctR944TsffU4jRsdvr9RFegZeU9OWE9wHLpYNtyA3l+2tCggMTMRlYqd7eTEALOHBCDNoGY157JMp6E5/bWa3b4Wwg2ktLEc76V0AH6So19QhA6gbifTjLbW1veQ64wTwV6Lxi7syScTv+oxm4MpKuJXgP3Znye9xW6hjeummoITEuK5F4YcG6Vlbl6PE8oKI9s5m8zN4JaMqXnLgZ/hsYcVzDJ8hueVxekpz5tji23sj6Zcxo94B79yg1daqBwCBm+YaCulctOb731ahTi/qat/ReUlS6Np6FkINH3X9oNi49Rj8oJEQkZyQwWOyGC7dR5/fvfo4SrNe3R7NNFlbgrhemWUht10WepQKXaqcXOmSe8IhSRAsrsflSVZ7aKjfKrlpC6Ur37fvMbuCOZ99SsG5Zub3LkffcUlrYc05KG4np+lzew7iSkFWvaAYJkdBnMGR0YllXHE1k2nDOnCSvQ06n82gAOjO8Xx9pIV0zosrc6qpZJN6fTQBxODVxhbE9aq+HiklkvvuBDCnU/nlMYNiVpu8nrIT5alllnXnZbyxrYf/x9oCuDQDGG53Q2kQjGOd9+TsB46uR16lYUWOs9L2DQCsjTrrSAisAA0tqjeaEbRdQfaqm79ihPtRBdPRkKDlkjTgyroQDaIuAkB2WEBc7ybOIrYrShXYG3M+zrfC9Qsa/7q2DRDug8diW469FIjNaPbCvrl3bvpARVcqd9F74dZDlqri5BZ49cJ2f43O/Ke7/MsCJwMEv+m8jAjceaNArS1fz7LOowjzRIMOPlU7+VmHgmRnRpd4foA2lGj3YsLkXKCGYF3sBc+d2NJGfX+W3SOeEqkkst/LfJAXQ6fDKRBqx2t8JppaeviTEjruqRPA1HZhDm+fcnc0OomsyhkEEEAfinAkkXDNhi8gDULb0yhOegY1Bq6RXWvEpkEfqrMz7jWNHSK55ZrIREreOHYKcXeZTuJEQOOSa86/Z9+DkzQ7t0eleLR1z8tflskSxpCmQD23flRJkIT3P2uc6e8oXa/iAz8xuROuT3Oh7wtBvEzDyuC766OtOTFdzheFGLDquLP5kbU+YGCG/Yy3wabqxFHQyYcpr36DSoNBcSuDvBu34T1D04ArPZdfs8qmoJChhsRHAKYYVMIF4y/U9EmCF1KpJMJW9z74CU2z4UpyglZWgsypYtqEefxvUmIoym4Fw+CNYWzAqe2ObcVvlP7Tn6kgxJnAg939WwX+3YRUmsDphgaNg8e4zLwCIkOdx9Kqolm8a7MPCbWajSzmx/mwuJ+LIf0v1QybzLDHbNPANzhdwF89krS+Zlmnis0QP+M4QTjfpSU2/pvAH3GKLqph5NQ2nYVk/WYhCb1TIthDrUBMqDhiyFX7EbRTTVpmuTmbdgAuxy+mgP1ro0knjYXFIQ50dmEGWy8BZ0Pu48bKOYneY8uluOhAr9nmu+YfGpiMfn778vunKJAT0KvH6ehcRaSp1XxDZJ3yxe9EjsLo88wvb+z1/3jWlvXiJw2aozdhGbtOdhJEEKn0QcQiZcEGtvVjpHm8ZfjPMITvNEiYXJJw9e8Y8uyREXLmSnjhMv5Bw2/qn+e+JqutVI0NbPuXCc/pxvNMkOUKnCInc9SQtMBYWhFDtaaI6Nqe7FEFftMZdEZvG0Vu6AYUsLOA3oNdCqge2SY8kKIPIWA6Pk/uo0eC4mDwnewr2v9s9tMdLYU6a+6jHWtDr3dm6dnLYdxOC2hDoZzGJ4Kq9r7hcJc9y7Lx1ErKmuhYoZt0OdJhxeKAovNpxSNsLDOCKQK8UD/XznMgFfZX3FVoccTShPz2zeX1RnJaZ9zqYPOT1mjRu96RwL4giWlzhVMcx8fgWmHm7LbCZRCfpteOfBGmxJIw0bZUrSz3i9k8jdiMczXRtOMEKTRJAPp0fKlBOzJnOS3cOlf50NBDQcNjMpAKD12d/4ZWTG0jDofaO2Gfe45U/qEjkR3rfVpmUErlKrPAVzxoA+ww0/HrWs2tY1oaGjwC8BJL+fwQqD/ggypLaQ9YAr7UJcHoczAOijbPF5uqdg//3fJEY9CHEgZuUr6n9jCvN+m5orRvbyFO6UlPFENuvMPHH3Jypk/kmUF5vkX/bHT3D9nEihGUGu9LzTEdCH6ytQC5y+LRqsKW99lM8g7yvsktgxAAJxKD9cNhGfzI1ZAkn6vuNnFC/fC30r55d7RT++1tQA+y9jRyl2m7FYFxvasI82MWVwi0g4lYYYUqX8SC1AHiRXvPl/sSainA/N4NcAqgM72PIa1EXUF0CucrWWvdRrnLgTg+i+cTrGl4q8IRwS0sLN2CiplGPOpeY/evr4wCgWCgHLF5F1cH1SahCCaW3VwrNDCtCi446oSo5B41THeH9kIwLCft1I7jazkVYuQyyVDkxN/3vF9137pj7xokfH1G+vxzVK9UsVIShFaoIWtc33k9qzzuoxQgjYDMz71gS3OCxWqRQLJ59S1hxW+IqenzpW+tNYzlBAbhWdTl+bVjnySdOggurHkF4EN0C13AZiarkwA61QRQyg2ByxkGzNaTwAIUHLTJFDNLF9frOvL3Rq86i51fFPgjqDagH8BYepTBklp750rq4iOWo2b3chAe4QFBsmpALf/6VgzA/oGb5aGcdVVJOzp2BgXEyNzZCqHRWlnzm2Pmryv3tAFrWxID8EIHmUQPNAVGIqG6mDdeLCjeaVq4IYAjuS1aI0ihQ672L25J9oJWQuE8zZoNmC52kbY+k+qYqONffIJ8SMalOemAUWmIdOaRGXauiTzXh10ZFZgInCSnGk6ny9ySBR3xm60cYLoBIfmSJ0Zu7zktkEMWO2BHqavf9+G3UcWkhiR+gn9OuAUEBer5NayOVUV7O9ovQzqNkgo6vegvY/JSOmxI56mw8wFVXdRzabEQFH2RY4lbmvbNcBwrkJffbRNSbZs8yNzlBpb85qg/Qxv4Th6cZi94eNhogo2S/ZzgdTiOpPTcKhcEUgjXbF2MofgPVzznp8iKD70/IlDOutU7nT6d1fNNx0GkYZC5vaa4m5gScDlA9uPAva53Qd2Ws2L+I/6w1Z3dOjUDoM0vc4cpc72SQZ3CV4Yr9CQi6IBhyymlRjKqTRBqlDbhz6Hk1HGFd+Z/YcRYb3fG3ZueHKDuxqK5+TgYrmpRq9XXw3Uxp29QUZsJvTC4L8uNFyjwBm62RKD+2NHpoYRpZ2hl7h15n2aZPP/w2MroWqgWTlmPhe8ZN7ZFbbK4D2+plue08/DITpv8ZGafSTx3UgNjxAZbwVEXbGfcc+kwgvpjahkFZG7p6oBcgvVgtFmrHsONh4ajaQnCIWFt4o7J4xKjAteng4hvmsDfTn7kdud70cCqAK9zj/1anWY4E/9oCW34zjZSSAtV+DQdlhFVzIVJeAGQysYj4kbqDBSdcF2PUKH8XZDTIvNJ05W65UeOkhlAhxjman8mfKcoOfLtGwfwBTsKCfsqZ0XO+hQIsHpvf46gDS3fXLZj7LSL6GP3YpOZeC3Fi3as+OmIBHI1zJMqjLvouehxCm08gtixZGGNfO6i7aa/NOsLtNShg+XOIKgTLyh1yzaw/tBlQV52sZNj4QjmMBRAvTvXU6j2fjzTkZMBNZEtJspyIUsFe+WfgzomtUIRe8LHzUKhOC4ta0aTdB0fmTk0zv9QnKKb5ovR6kbyZ6JyAd5ZyvgbNLihEkxpLe3ItWT4hkzweKv2Zm7JtB8+trCN75LbL4pYDXwvMJIlPolM4XB1KR95ZG+KULj9+t/F/X5FkYmp6FsgiOrvSXwgf+gnkrmyqB5+HT4ZGb82ew0y9WuFt4ZC03tVpdbJnxLtFDA6WxHqci/62EzifSl7bUVqLYNsK3NVjsMGYvyDux3eYNGG9UzsrD8gsWKLkdnErwfTFzupOMRQryldSQnk7i7O1cid6VzSUJtnJFOigv5lHcmAdZmrRkwPclR7jqQPxtidyObp0lD/J76QHJv+cQ6HAwFPa6Lw1Kf1E9730qrFqlpFw6uHCAP+YX13vENGe5p2DtDKEbIVxgjuOf3+2/bhDtik7WL96Q2hpuLAEcsa69E0gRUUkap7khyKKQFLiyyCP5XHvRlwVuGQza5JRdY5S/raAOsVBn86XqKr5vgcDF1+L7tbDfHZlmJerNfpP7chmh8zEN7f8bs6bkF5JLN/XGSKpvQcsCTV6mnpEk7VE+QKtz3EfphKywes2GK1974vBDhSpFtuBVuPhft3/zhTOoFprIML/EgYhTmz02nUC+Zcg225b+9RCZ93cVtTlS1d646Uwivq/voOUCkxETsbj7eNnhrdQXFmkLfRU7E7e30G785QYg1GqxIkaYiW07M3SPlACImhA1QmB6VA1HdzKHTDkdi+rqLAemHT0akh+s2tDDrlx96nSGs/1Uy9m22E00IZHkCef7gdHvJYHFuKGNI9J5N8QylhW159urVliBJFEnHOGm0o8z+WjgheK4RnbRFF4N4a9kuFZh8HBgdIecGHRbEneoKIx8wvuHKDDEHfvRDADmbPs2Ld72WXEsrqgbJeghOpsoJANdIrHs1pRJPJU9ffxK336NCm7Cko7CDaV0shuAQm5h+MHQ8yJVhpdnkRLF+tYU6apFMRz2YxLQh8IPoeqIHVsa/JxjhblruoOKPGlQQYMhR+NWd1UVp1OiKmNn30LuGRCXBt5BQEW9gWjKBCVRPmb+5U2LQGyNURHLvlbxd4ZAGEqAIUyh3yWSPpISgUQRjOPF/64daUYPYX/Y8dkW51aP5t6rVeBXNt7pkaROhglQPeLM6Ipe1yUnim0rIDMkbL8fUdmW3PlpgA9YBGOYewDFA0pEpIJQzQtxLva6eQuDxskslLwL8cTmpYZTwZW5LtpZkQPo0sr51uMSnGFZZ9SwuLBhzD5FFGr171bbF1nAtEXKV+7GSI9wB/4qeBl1Ru8a5qzNkNair6GikkjWzddLfnFrIFk1BgD3M7VwRMQgZgTFQHzzvKIajCVU4ey+oAjyEhiAtHud0sYz8QbLmdUJBU+pDXM5Ip8lpKH1Z21DVrgqQkVjQh74hMRj27konVQ44a7MDtWy4BaIIoqVDnuN0VfEAPIL2pKSMHR2TCNRsjYgIWB2ZoMLamGywzkezSRuF1HGg9u0GZE3TEOb7+nAovDPM7/T2k950iJHFpZzSwo5Jy4cl6b4jG3OPu66zzSmAfrfb2Dl4DCimSyGX70BB6OnfPqiWiST3Xy2h4f2GCZZMUSINvRwU955/9HKI8iOIH1PDnW276QHV6tMvV0B1q7AnLx9H8OWccfq4fzOq7f2jF8wT10TW9BUZT2fXT6tQbXYZHez3GK+VJRUqk9sVB5OI4zIIsLADVcifU5jlm9P8XINrLJ5aDYOeqCDJZYYrOsxcTQHkNezPV0u5I9YO4fTWwbva02blfdHjn78YvKJHEUH6M66RaAd9CHwB2ojdfeyaYPhYUs5bU7HN6XD/l4QEuX3t64iWYqTx+FNFfaI64rU0KOKZ0RnTtfYDwF0UPlFKUKYTGisdj0irl3Asi85WMzFbUYW9SqJRPLOiOb+Ji75BJDLpQZA8WaoaE546Zv7Yjjsnp5fwwdjtPsVvcOzF6sfrG+zoSeVTBAMqW2XbacoleCC/LiiiTC+HwZOgaLvzCa3/awvH4+ZMfqQBUNqx6SUaMDCmXbrpwHXlX507Ebh4x3nXQthiEJpdfZ0kx7A5sxdHNKFZiYCNDcQjzlCMj0S0NuOxXaC5b5IAe7ehjUlEQy+Erek3H6cUDxfoHR3uvo4aEDKcfBrE6eggFJgfd/fXsB3j62S0I4BYvgUmzCWdGuACuJAVdudtB1yoTDw4iAasTrCDLN0nTm4QuV3G13AkYeBLTB2Tzgb+06KanJS89EPvWeWy7e40kutk6QYFRuFEsb5uRhRVhZD3s3FDZ7E3pPckoE6cLsR37xeA2DEOoNBDFwyQJp6R9nF0bdMIAFqiwrm/Uo85qdMhnYupV/p/cbEJhUtfU4ZQoTbWpOQlUoFMHSdtUAlLV36KFXtXU7YBp9s0//EzXh/bKqzTEa7eZLcPP2GnpFe1iVfvc+WMg6VfTIr23kSwfvhtG0lLEGnoQe/KPjA+Aph4poUdDzuXKjoq4L1BmiZ5jwgzHHp9y1KBCA6u1iwMRgFuFz2pWLJXTjDfh9kHZIrUp/JkzAnkgoAVbWoAH8BNOtX0GCW6M52qcLLzJDYndHmofEiqq9nTL5TPKL3IX68nNqG/+UDdcYbudppC8MIfTln3uSAXewSsbYDQqN3XWlwhp0pyHreIeWDmRHu7wrYzSiznhyS8rE2phD52ywlvBDvoSiSjezFUsgsPBwwHq2yJ3A7urUtQN/6DsXBxdARDMi6tmXxsrAKIIVyffFdCHiFQutlDzetwwZMjubB9Xvs/9jynehlu0OJ5qYF7pRzcyq3HEbig0ItXlESLBtwt41J66vNyM9fvhLY1ccCoV1AjNfxn41shfeE9ffQoD3rSLgWsLz50yGxRzbAxBDMUoM4Oaj1bV89TqSjVLyqaSVc22vh50z1UASmnxp143P2uXDHdtMWHerxPsy5OOmaOFdxZVp/DvxPrC+/sRkVkvJfFW8HM3jXNvN+6qstNzT0S6AkrT9/EWEMd7j8E1PszIqWtMUwLHSNJ/9qv5ouw6thTKnEnbANYBw3Tx3+l7HOHJHMFpUHxNWMGSBuokvRwlms5W37soyEqJCSmlg9U/B+Mt32yJUJRhxTlWu7JQ3w5OxFZQbvrEVfHY9PxaCdKuBYEkzZpvaFDfejeWz25CmsRgzrwIQve2/dPtTf5xZnM4TWWtxkx/jZHEGwGdeU/TBMaVz7/3EnEthImgs8Vwm6w4wgxSFHRGDQ2T6409La57T57s97XfCdqgGtw5o9X9/quhnsEEhXfXvwkO3kOimWNFaEaCrJVPrrytCmqbSn3kq8KX0By0MjGPfsF7mql3ddzCB3r4WALbJs7tvfbeEtyCU8ZibJExV+jWZueijVa8SviNcn4VHfDnR3eWQ2djlGY8JnlgIUadukbWNeIVIJIa0fPVnxMrRUmPhqCXlcC0wolZgsArCHKBN8DNdMlVRplgdpXr5n/iiJmzcAb9LcF1SRqHNrteyd/JP9pLsZ9n9/A9vzfjISEanVKn+MsoQiuvVY9wuojcaZVL7kIX5ISdK6Fw4pqYLkCeX44hX3kCnC/uERaVEUZrbthW1AHCk3/mAV+9w5v5Ngg7+GJ3lvbM28snyKsKH4bmmD+DpAbtMzdnJrfmIKMXb83b0FSET7/uC1xD8cIZM2gn9LSKANsMwUaedwlhUAtVjYeCtNspywT/lq8nrjbGiBI+MOowGBMNW26W4PK/nRQUEc8DEF48pAsHGFTaSuUMcOPJrfoxn1Tyu4JG/tsGSLgcgZn+KBx74GgLsxl2Q8hZk4a0IMm3s1sXuSGYgnXVL+PX2zitQdwyV1SAKvzbgShKfGEdcywr+numX171qMAYswdhnrIZEZXQ5PLTc+wJPPBD6K/n6LAqn+sokqMpxli4vQLrdXvHOUNQYtTZ5fIEXKoqkaiUbmKTJfhYvnCNZBMC2cgKimG2xabxhjiqB2oAgMzhidCl+QcVVv6JBpk40niAgDnb7HSmHB2W7y5l60BR1hRrkBNGMCpFBr6o8KcTruEV3cC1TDORUvn0kN8ul+QFW9DA9y7hKHRMaI2L38P6qBGTaP8XMpDT9yDeJWl7VFnamyEf4pcSmD2q4rVE4PesNoCsCcnvcfwGxYAoagiN+G/r52bbvjkeOY8Ztu3vv0ZiZV9cslrng8c6jWahLS1+JVo7O42eoU5+mcGFRTaGUK2DaHGSsk3MNqTDzJsrHhuiRhicA2tvy2Dr++UccDcsJ7g1gCo3IxAvavbx6dsp3W6DG/XVcZIbUvUUzSexVeap0/ZRp+7pTS+sn/xNRPIsPVkWvT0t3IfQ+qAXgf7XHYwESoLpgYPGtWKIQTJBnuJCDj3evoKUL4EnpMPs+ArnSs0D1Fdty/dasBKgJ/k3cFuUnTJD3BL7DkD5ME+eYZzz9D03T+HpGNiBJSENYF+ZwqzrJzFJKUI+dcKidPOyRK4IGZfk9nP4fZYzPsJGDCdUn/RAVZoQd/3q9ec2H5EV5xSP+obATmr9nAzS2y6AU6gl+87oxr3+lEd3dfsK6ejv7Q+Oy3BV/uMzODMEDH0asmorI+5Kh296qz9e9wrblvovtBmmoZjjr1veNeGL6GpMcdXhRwpiltCkm/XZTt1F0gc/URnnSZuwfQPmOsWXM6j6MFdRUjG8HPdZQ7fiEzra8lNX6QSsEuW12vFE6N1sVCtnN+xaD2begjIzhjBGfO8SO3XFhCyAsI/uoa9fiUI7bMrkHMTF2Z5kbMOf9IcdZBrUtil4sEDIipHGhKhDTxW3NnYt1yIoBKsy0zg3NQ0ZDl69cn3mMhYuJYZBK5v0cJMR9I69vA9YoBfeeQF5lX0hulMnmHi9Z1zJ7lQ9wAtSBXou0e2z7kl9uId37rj4SlauM26Wb3MMrgUW7DNnDf/RB5THhd6TTeXud8rccIlI3Bptn3csUbYkYEwYjVdmkYdabeCygfWgDF5TPxRz9gtDR7IkxERqw+rs/1JLeznXIobtVgHDBc6PtYBPV3/NMtPRcAGTkmZf0UaPkZe7p5K0cuAOSK7KSb3SyIlPEfNYQDCAgiiJs//kth4/bnDgi3lS2ebmRBWQJmDbrS2Wa3HWCBuoDrVYAFULJeFY5/o+roOyRlKPD784SdMTa3c5ANZGsQ0XCaFMeDJbZWQ1PFwWwciZvHXVBhzLxTfAjJ90PbN1VKpNyimPnhmzjFZGM1ZRtCuAwcFkfXOyjtlUQkGN9nA+d3gc4bGntwvsQgQcnuhH9si6en2fQCje9osxPBtvKwESJTVI8bYJY/tcV9Mv4OsI5QCuHPCjVfXhmsO9mObsuyJpLFhAEGJ+r02HKpO1jCIL90OxPEs1dpdG99G02dXL+ss1m0adinanNXedY8H6Z9/S2B0pN3opLrsdT+jcOKW3s09OYyKfq1rrQDX6S9GUKKwqQnzJTdhsJs3T7nMH+K2y/gXo2shpBBXfZGDQYw6ymmXgBOvQhOZz+ptuz+IzqDS5OiPcMBE2YciSHWauvFJ090QA9gdkZLQpqVKjlqLJtEVLIKeVwQfBWb7wnpgjnCQ9oDp7xHUi4nWAl0gAlDjXBFePcoe0LySEBM2LprnnmuzIzODm6DNxJN7zQM3lMLJWnTwSLRKEnZQYn/Ra287uwfHChcRFMeXmimtqftcZ8YtHoekPQpMhqwR9lSWdMhMUz18I00jIHcjmjUmSj0eCn9h0XXyTmT+Z0S8wg74lvPi4Cvdh9SFky0lnGS7/fn3q69XItYMeYz0Aq7h7fCZQRHRR+EtyZrqcWEZ+1BnCQfdiHo/FisUK1mAYl/UOXFOb9xckwvD4417Yjz5QZJSqkA+uSbX2IVUnydmm/TT8Roz343OA4iEtCCQWCJlATUapCR6k+6NYa1DBjbFAY0J6Olh9U6lUJqSKiC3rRZpW3KmyOP4lJqcqwhtrh9SoakpBPd/1kWq5HXA9xmk82GT4VtOGZ47lycz0Qt7/G+n9hQJpqIq8I7p0bq59+0nqs1FYpXrude4ZA+HKEdv+/+WK6wriwbXnjWYmx8iWjV4p24V7EHPX4/8i7EVmZkhZsG30A+gpX/KQuQobOJhoY9+GtQcl+udz9fmsivN72Moglzp58JUAKGlgrESOPD0XO0ZCvgY84lHW05/Pd1Ek6f9kRunAkWQDNYvbmvRrN67nZgM5is5bePsjCRSaDUnxqxPmOrL+PLSPfpwJrZbgCJAYM8VvAMkhhWfEmV1Qv4ygoUPtQ9+ACqik0lFX+NvNiFRCSmW9G3F+3GW3unl4mVpI6wt7d4SMhe5aO1b+CKq34zeCbS5jP7OABCZuPUn/5SqCkxJXPh+Z2Cx0NLW5usBHlhVZrLgJ52aRaSMlPbi/Z5uvcHFm65QEX6qU5GoduBSrKRCPsrA0JEyfuoktjTXLbJqrGdV2l8ZRrGOFNHX8YqbUuUXf2xwQCB20jOrrPPDh3X7FZNut0BYQa0D61LMNPxNwMzSC5TD9D5StCizocyzcDeH++MXFR1LU8mYIY41KoXr4O5sVK7dk35MRgIEsPjcdD6meLLdDYb2DOII013I/NTmSu80fObGPNmP4rVfuIFfVHjeZ12upl499FVBwucZLlxMNOJ8mWm62fOXiDb/i3OCksCBxkwJr3IFslROUlViEaU0qmv2fXtWB+9QUcbDV3IP4uMWDNOZI4qpQd0s/pqMSPLqBJntAMM9tnkkkyBurhMR+CFkeMKgB/sBi1XhwX7XK6sfuXZ9dvn8iSY4USy1YXBj/yq+YgB1TSo1ots30L8TsUJUlpB1jK0ezLWPO3iYcWBWBt0FNu61Up/ky9JUkNqHwovVaWezY5AuiiEGCX/mDBiZYmMWm4IBFowMvSxJ7jUE5AlJ4BemINPyAcOIR+fDgM3oi7VhXWuqqAInW/DfnH/HL3puqvQIDp1SEab+SwnWtaKta2ykaBCrTJecFmpt7GSi1SPo5KezIp7ZcJUxu00Niu2tN2kyiDxbFEI957rvLEBKicR7UvfJFe9LnmBTWSUg8x0KPgMJUbPmcc37HeLAEfi3hj9otjmwBwoF5O7Lnev0kUH6UWmdBSkcrzL4Je3SnsowX6WPJytbWV+BRmVdcOOeDR3Sh84yFnkxjYiUkxXNL3kbgMvPZ1hU2ivH0vFapn23hOsDhPhQY/Y3k8sEAfAIAA/Izy7BxDMI58GeHof/COELdhzC9nSn5Mmd0SjfYR6XdWmJuY9YuZbjJenlqk+fJAR1bsbIX961qA0tl4wWcF96UVVlIrW9pi2Cero32eeOLDHDzlmZahq/VKEO2squ1MWfDvyMllwD15/HEsQIz5ZlsDt3vz81yUzOGuRNQR2arsRbJRGBr0OhI9R6Qo5ebp2zaVV0yo3VYqfnrFaXVIpEzZonBNrncBY61RQxN1FZKoV+Xi8FzEUDkl+9hha1SXjsYIHE/3SEzylZCSn8DlUTxcIWNta/pUG/i+DjQFTrxsEkcKm/Kl+ipU9Jum5IdbbQIdjXaKXgho8mYIVGna7EBr5SxXZwhOyMjyq5pQYl3+3PbB2auKAcAMONqPPZgpQg0Q3h01rQ+W3fnUofG86x/9rP8TDEOIsarv32PUfRTAon/xCZPbx7ARr3pcT5v62SdjYm1SN57Dnce0u4GHY3qVmzwwQLCPklMdnhPGX9pEprbqBRGu6bOuZvyCLrLMb2ZFY48Qh2JHBycWDEz0bJLu9y+QkIWBn87aj0Q9nEd7wionmMvkDM+ebhmRC7hUyZMjdzvYPyGIMd9kQgv1YoPfkdjV25JiuZrgDGPFy3ZRR8kii0TQFGXughBs3vqlaqv8Jnuw+yysQLMofU5ZL+/W4tTDQnwsfqfVNHBQ6CnKSFCLVS5DkOjWlsLIREJJlFJU+suQTb8nQzUdpffwgeF+LPwN4xlW5a3EPkY3coyO3nRizPLmGjBonojQDiSufKwRrsbW7IB2VAJdJ4jf+b8ZZPuWRiSeCVO+i1tfNC9wzwZ3zIntNlxuh8hNmF/kyBsetpK4G1fTKIZZnOy+glzivKVuYqvXNPekBiOf4Ig+Fvzt6tYQcpyN3qe1iz8qveyIk9EDn6ZWqZECPoy2F0oX5uHiBg9SUZKFuONP682ZVLOCoa+Jq7m+9DZKfdzSAi5A5CQFcKvl+IRG+1amRDSq1rDIXL9CQVDHZWySryYl65A8ibGQqoWX0zbu4hCnq4FlVs985kYeOdos5DSt173PLUa6HUvkS4BP3RFul3Ca9/DmaVlJqf2YJUtVY79zT9f3ZGTkDwK3727atgfjoOj7EJ/o2KciZO+pBOpLMJ8eUysaB4aKuqLnuk4eSARAV2wPdRRkV5IEeTNIK3THmxO8/Fw5e7gkEE0dM2p4V8j43/N+YATEcOAtlvy1lR3kVYrRPWidDtVzlXsQfiOkm7mHKL+WEDlojqUVlguPABulWzQXkDbVFVHfpGLBjg50sNYc/z1RPYEcyXbn/rj7fc81ypbuRRleG+ZbMlh6bNiMp1Oj6ySjIue7MSPT0D3i4oocEs/Yr9e+5Pq2xpxhK/lvBHg6YfZbLbjdSnwcTsJwPfnv47+ZHX41Lo6xgLoU3rRyVTuaIfLeGzQ8hNsyznVLDA18SnBzIoRLfV9RLcsc+t2lTRjzAsRdNepZ3347JIFJrgQ5GIYhlnlr0LFWaMrtbM6DpkxbbKiNlg05Gsjm10uZFoUD+fFtfls+bOtigVFc0Nih/vwu8q0stG8WiSYnkLLdYImaXVA7oCDkAcXg1EDXfsQx82R9fbUJeMTdpEyrR69pLQrkyLrP2PQMyZwZLjz5gLNxtCmRGAfJ63j/n+V+ySzAG59zGp7vJt/3yKhM2l87zgKSgMp5fd5WYvVq/tKz02MTxlNPiPAGB1hx8LKqvY+UZymTC7nx+yyavaZfZrkyVxbf+uUftMTRuMuAIZmWYnr9aLv267e/Nryi/4ufPixTDiC07B4SWkvYUxUjqKSGDbVh/VK4DD8TYecn6LmF2x6fTnf6NcQRECB1tovkl9Lh2dnKNbcTi0858z5PNZpOK7M/1lPRBm0vPXg3etvtp165HWjwktgvajEwBz4RyFABSa70aFTvk9J2M0Ud5majHmpqzsXnvLUvn7naKuaz4pweYjPxaJCJyXlybLO69hirUSZkcbP8OJiGisRCFoGQXXqIHyM/FsVJ9BupB8Zn+YbES0fe5B4TcvLTAElO70SYus5GNUsYiNi3oHloKB+GwiCqcpIcoT3wa6s29WyLlc9X/pkEit2wEyEdm5PVZj/kzklDMEptihlGjIxFqiVroNIecYICP9tyNqZAuRoWGxsDV+zebyuvJ2HnvAK/Ba7bpyF0KAZT9eXKTc3qg+SJpQm2VTbCHw84veTg7MgmM4ookmGuBatwzSsGels6v2lbdP5ga9RAbLLxL2n+vn8MPa5zAjRvAo4UpdVw5SfGrvifj0CPQO7ZoOLbJzdEZ1AjG1oBXnwntafuNJu6lfbFav8LqAhhYNNAbPySyqNFck5uYLgC7tpHqnRFUf0GapaFicEHBWYbtWG3+IgmeUolFVyXPu46UNVldUANAvOWaL6vWwerSw1/l4d27bqsg6z/VskbHvjiN1nhA0/tcAkcedzwaJnd5Kz4+pgzV2o5c42gFDsRn5N2T/f+YByZvTBZ30GVtDU1djnwUQjbDgoD8VwTqan1k7qW6FqN3FoU/x1/Y0NRqLYtfT1wYhbSsedzIwVwpAlFUUT5/VFpJottNF5fvcGWaksm5uTrdIIOBS4dG+Wp47uh7hAFAJlBlx/yCpAkoAdryM8zzRYGkQCElLEPOZj3EVk79RtSlZVJ5KvVHxZX0Ow9Ny7Q+o0fBM9IuzY0M4vy+gO2pYaK9/n32t9Mijz2Jbyw8gVEzmrUuHorW7Oe4bwi0zLMfVM09S37/St/pxiqWK39ZwBexEEDetd20aF2nsDD+OL42fP1i7tkECoAmcwQ47ijMtCDKEcOrDMSsczKvXW7gNao/Y7ucYyHOjHMT6IoLad9rfqy5FxkL1GlfvYyTcQPtrGIaDaTyMVciALWypVJTQwSws06d/PleyXvAB9/6JEelW+qESFT8rImR+zDOt7z6xmWYTz7Iyd/J8h045YhtzvTIeXHWgmPDRi1R1DEYhGaO2d0ZxyckUVf3nfZKnfS4qGDraqSPKP5+4A+ECovfv25iqR/Lb631VrUYH1VZgUHakxmugIFmnNqBzKeIIJEALRGezALiUXvXkHoB9Mwc97i8LOeCHliRkUf0ADJiCSWYUyQxecWUUnozKLzSIjRr6zN8ul60JICKwj0+l7UoeCyqbc6pyNTT3a/W57fmTq63F6CTFff4gTM+zbws2qnPJKpIscWo5xLM+lgZ5I179TFQfjSmyAjyycG/QlSK+wva59G6TSwhw1DTs/lg5c9a581Zp7Gry5vNAgZ9BrHUh9d9axdwDrv/8HOzMHs/63QfSoXGxBl2bnrBM0cKcoJmuE+BEj/yyWn4wdchkA7IGVI3S87VRq9mS95z+BsughEE3N1USYK32zoyynY1jfq5oCo2Drkv5X/9tRz76uybxTQiqGgBggAYQhr7HvFUnOGC5J0gV+WDNvQWeRkSOXxzfc5kV8ShXEa4rHppjwJvsPd2r5ikq7g052y0rm7J43DTo463YSvkfr4rLyvxO6KSLRLutWSIJn6wnoFH8aj9aNDM1Zy8WiTgvOke1yffhzn9qa2rDMWmkLzFDg1pYDdFam4x9nZNTLNV+4kUIWBFkxLfa8QM2khDlD9bOlg++iKzJ8j2LWBwRRaHhUF6UAJWUBwTj5RLyc4HO8/cw9pTS2/ZQ9hQaRRdHUdQrV0DW6VvX+0hezvZVl5iig+upHgbjYN15xu8eX+3ao4WPeEAYEPCFiy4IzZrC8rBSlEa+61lo8CddqoTJ16v5ExizRhb5pU43oJGrZHKoWrpwivTrtsHkVFLc0HDbwe5yhvZOnIueBktjYaRxXbGC3Me3eTtFY3T7OVk7OQrqCrur2Jp7Fy6WXPUgNAZ88fHlD811EYq7KXGf3SwAflCdIn0K7g/zXmhINcE8bBDF0KKzH5rK+wBKiLGu3riKIjPz14nHJjWVKxFUkPfmfnUc20VY7/zkH6Dc6pM6Z4KAkDWa1/IZplyY7dsX0h/JmwbADANdJkrFba6qxiUAWVxrdGLxxXoc6m2R7ILNQz4mIaI+M3zhYoRfC0qZFEi+KEIAQC2sjZHhG0593ncE9vwZHhx2UGWdo0km90AUHNx2UMedfa0KcvdWUuqGFeN1n2MB8ofyTEz8Y/fUbxzniGQm0zUmWbUs3y+LoFuC8GCqYCeQXTjeQvCuL4ghNxfmqvEuQGeJWxv/NzqPPB3hvuJOUaci7xRyIzPsCBi57Y4qgNfLWa9yjxPy/i54/H1NIxNGQkY0YxGCRyfI4kbsqBINb/kYLVw+TkOSQ6ET0oEYyQZZ3vVy+MBHHVyqu2Hen5COtKoxLBe8HwwCPVcy8bp6u13OZg1faEIMvLSE352Iilhs0tZwnSTYCfOe+jnnBGigu9DKg/3EgG4Pu2HM5FECkd89ierlfyFIch42jMEVZbH0n6N1WRM9hT6A1WkD+wOPCr631DH6uELARdOii3OG3hjaaDOHOEmHEBjaFyRHOPRdb3effLQy0wJM9hYOIVW+iO+KJAW6MWCzJQgRicptHlw1O3JIFWg3r6AqGp9ZYRNKx4RJ7DL92f5ATuKBKxeAzQQqhWF+3db2k4VDTYKrXzSNamnXmrAfGOtBzPnozvUINXyaytyxow9M0FsaMn0lad5IaxExNN7+i7o7mUMlMMnupoEdLp6F1qgY+tnzTG8jHthzc9ELwbH3mGLZMnSIPIW41mGDWDVD/ApoaXfBLzHCjscLDcj+/ZmOJha29uZUwXuDw6fYOf156DyzyA4YZUjLhQ+WybMXuR0tZnS25q02sVZdjuKaqClLd/n+OTyIZueS2RKJ4gzmb0I52Dn0MaZxzlei0MFjQNsnHbkesRc/hItpm/3AkunvG/BxsSJ56MjnItVm14w/00YKitWmCJ/EU6xFlBgEB52I/w77fs0B8RfGJUa0y2SM1xZ5sy2z/RlA7n9WSVjD41HEl0xmreJ+iU0FMR31XcuIqyiWQyLCMQws/xdh1JUY3tlgqU45UPWvHDaS577iwF6Se979kNYUmphxQUHkrxw+2PaYVzx/kWNZ/fLdPJpZBB14gF9phcSZ/nbs3EvqfR2xphX1a+ZsjmYewpAvcwIKGLXYwakVJiUM3qIRGoaoePLypLhgyo4DVOTElKYzx/eGFD7TNw+JEJEy3lXSXiQJY0x50nMU4ZPGeDHr8xOgDtRVpHZewSvOq06+DOrdCjLdtYOB4PWoq/+XA546SPPRRzz2vxoRipa08HP7iWH1Ypwc3KBbTLeRzwDmPYe9VrFfOLOucQ8LA3k9xz2p1YhMOX0zVtJHB26aROSyZCxcrnm3L2UZ76zRDL+NCuotXLdzGbYuxriiHrSNrVHldsUvWy9lwXwHO/pkxj8nZMDU2oSR8RHKxg77Wgy7R1+pXYRKg8mxj3C6lMct9ies1nZOjqoLUM7pS6/CAqWXc8skerAFn3hBKGaAbqP6X+wV8YDWWHb18dNynkpbAtxOh7mUKj+OSXpx8T8lFJA0oLJmJ/2oj07K3jB/oQeWfqb76GzuwaPEi/6xOFqXdt5D9lXctrzybl9tpMTXkqlnfiLn2RHYxBRHJ2bS9hjjbeZMWv78CH6rgwAQd8eQRltGu/ejE2PjSz2sAAeW+EyyP4Fs/AnSHwu0rNmara0R7HTv6bkgQyAyutz43tY4uz1jfbwmn5VeA+T4xk2/W0H/RXo4lynLcL+oK0nzreloZjT7li5CgCovzFLrlIwggnkduLvFSV5seTK3zpbIubJxlERHbbRG+9vEsBv4j18ewae66gS+denjRg0jxRDw52E4me6WLi0ZLQBiAEGrHUyNDM/AA+kACUMavdxF/OUwDEAhU7UPF3ji0Okde9IV4rsOzqmSG/uAABJkU5kgBSYo9ZuNoUA3RBbvDTKhzdMzbb4TYaHhfFzYXX9euZxD5XESWwVgaaXGnHnSOKMeGUqpB6ddw85Dk5iHn/N2NcuuMfFJJp4Vd8wZAgTDdAQj2XOjAojOS7jj1pMMJyPEHmwgYh3aQ+11lBU/nY9j8NtseWiyL5BjFNvVeCeWY8Ul+mmBzyfoCeyDYU8yV8l61nprap2L6LsgmklVrqZXP9suAGSWg2ATPb8VoDgaMEMRfFUEgSH1v26cT6/PLRWFf9MLNAfvIFzq3j0FWK0QXAcQ8vg5P5zJnc/O3Z28CiDk7UfQxFtpUZKuYeqTbBq1q8SwEpoBvcGR6X4eKPo1ozqd60w3t93mpgTeN0ENUt0w9fsXpulLu7vsJ5GGC+GTY1okFDPx7dAwuN8mYGhVpNjU4SyZg643dvoTJbThDX6jldJNWZUVGUbVldi2XO4AwAop2cvlfDQRShN5MRKhs1PdpMPZa1XpkITHp7RCMmEyX0XMB/uHH6woNiTI8f5kg6oew6+sxZAf6nO+VNooP1xy+b0Ngih1+1/NKkSzHhWkX6ZtzpJW12Qs4uR//6oGLnAAzMv02kMr53DcYcVUpFd5rHOZr6JPzEo4o6dZqdso6T1A/k4ri5jvEfkusCa9mgga9/7jIeXguRKXoFk50xwZFGebQ5MXjhwjE+tAvFzuH6hqfDOcAJ1kWTw8KWbjHbmr/N2VsZN6uLZGoJ9WFFAnzDAyEJpKfdl9D3heWHKtkS5NsgL2mGwfld0tfyD+msRSbUtTt5N9Pu4YDrimnijSuZgJPtA4C9wVx9UMrkf6ZGIv1FHNSS3oCgZR246QKAjO9AAVfso8wIRsaQ0swElIX6ZykDg+6beI927expP7Jk/caP2qtMmG64u9F5pKR8j2dFo9W20ytdmKXcMnD1Jb2gj9slTLfx7NxtbPNqrhXFgjquWA8GYyyTFEu4P10f4Xn599Ddt7h/LYugX5nWVdY5vRygRBBLWEL/7+15a0AlZ/+jlIi2QOXoTd1FSSio3+STIqXAHpy0FBq4xW93YyYhBlWYgxwoULMGmN4U1+8R5PxHSm4trQc0lYfZaTknUjSPR3Zv1TdMPgqRkSbtDZyziTbzz+QzwMwZ6Z7eLpc6ThHPm6XrsFPiVzgcC7sANg462FRaPIkVR2KMlw+F94IC84yI2znNQTqtmhwu4Pk/lFjqx9WOQtGmtFPjAoSk3cq+xAUo+0PhC36+1lbT25FxRU9FlI0J3UER5gcmNH1pFUzkA3vGxE8Ic6xs79ImMtMEXDePJxB9O0LcXb0ZTztE4wXQaS78mGD4tXFqK6nrN1REv8LIFHhUpdxQ+ztOgGnvlwVpz3ZQ/8+V90/So/9L1oSiTgaI+ZZ0xpguTWBdK9MjGZ1UYcqQCFgpDcIUR3uXnVzcrlCCLQZQc7SWihgMaizmyGRIEjOdNHH9dasbFaKXOrJi7Ejmot7qcIHPOCbu7NTzDubF/nWaDtplNOr295b7egAE/uYcpbYLvFSIJDynvZZkuOzdCAUoi400HorCTP88TweEBfpv9r4HitsRt2aN6084zORdFkXReZJ0hq272PuuQsnbsD8qlAiuBqbY4ISmJoYPF9e74SlM2Mqum3ADoBvDGlzxQIEcQrKooo/YQvp+SB+PihdWKD1fNDj9AlMCFkd+nKhF/BO2ngqUDfHjCAH1e2XunwoR4l4XAAK/xahlR4CGqbdn/mx5owr5NS4oTZvqHQ4gEwR3P4pdQ6SwkXQ7BzdVpSHGuuBBHXjye0d/aw+nuCuIpZnLOgkkc/afYHbNxzl2bUo+DeRts3pFo/49OxDhZmUiC9Q8FeLXVsWYXh0rpHngievK978mYAysImac5g7VRQXk7fp53DI+cRQlTJq68GaJhIbI6TEiTa/VZpqrXEWc/A8hSwXdVSe66hunFEV4tioeEacGPUBNeT2OgDI76fnssxK6CeSG8qlKuTxTMmA/wbUZSy/+4Yu+olOhVtFAzhfT4imkdQjoZZkGg6NTFLbVUGAa4ii8y+SO+BbmFmPBfHKehTet+4lBO+2bq2JBo/BH1kC9yAZmF+TGfEJ6dvXBY/hAbHtWiy7dSWAAQxG88xoXaLS2ev3WpgVH1VOpL4TTk1baB8G41JBl9dzYkBNZ4/v77Vh/j4hMQR36O2L4wBOEnQ3d2cIs91mFIpqlIrL+84kkbc1ZpmAjnk19r/ISeHF+v44VMz4G+KyF+FD+BRhZiv+P6JdeFC9rkNdJmB98MhOLS7nOJPiiWsRTacOze/JeVoRTGQAojCiJwfaC2K8dMw0qhUDCnC7aCLhxQCDxPx+snbqhXRls/oqOqffRZDXt6efNq8R3zXXy6z5mJEjcAbEhXaAsfSW+H0Tl1nmbZjMNoWrJpt4HR3dwzADMnFYWV9Dp1FLtw63raWF+bIjqsFVdW8pASRTuBFyHzXrbHiNrEDkQbIXQhpPPjaXfAZi750smcUm01rvuQQMUoFwyGqn/5XCf83vC429yagUIXj0o3ilELFIwD6DN7/EB54N6X8Kkxq8m07Rq/SN2AS9QHyd3QxEZKbtGD1Fh4AUZVpHqMWns6Xp6llvkPxdfHYHFDLptDBjNrlrY9fpIwczOmWi6cDTQgXUwf92QIyxsnMSwqlb23yRu2/x9r3e/fjgkwjW0FNHxjkQh7e2cBJeYgzziDB8TFkGzALF6/jnVIV1i5aTemd2GMjcjlR+uGWT+xw1duWFe8rV9vc0bLj7YFlcQ2ESSbP4/ia2T89srXJK7jpxcpPsvx/tJW3u9O3VP9ZMines6JjbMGNdopxB978zL2+9VFhTEEswpNsEP2ED8f9uW44EARcO1Ret7kqOzZMFEcFrc3+kWxDW9Hsa+zM5uCyQdQ6uTxDpcM/3fb9bhGOLl3V5/E45490Pp+SEPiW3u2iuQmMI6c6XoT46twpE38n6+OadCMuYi6mlVC3X5kLr8B4GAchosdD+eh1iAfJQMDlMXquOcM8F0sJdSs2SYPQ8z8WvF/Zu927A+s7N1WDVJD4G7GKjxS+X829/P4vaIYU8NT7HydU992otR6K0H2Z0TGQELIOZ6gH48JJuMQMlqhZdrybFLu+5IrMXYFSkfeiRmPTqdHYfwZzlVETC8/4r1+WQqI97huI6ZahMHSRVPQmgeRBgI//FaGmJwzLiSP0t2ESZCAAFEv45zgpwln7GbF1bsHPb2WFnTekiUvYVYO05ZzyBSJacsboRVdZG27N+ZL8pYQZPL+TLN69mXTPbRN3Wutw4AdJaAylNiBGUoI+NStwPKChAGDecD4R/9TRznx2uYhT/XALN0l1dAhCJZ8zO8K7mTQLzotISz7/67Bb5sSmE3SfgEvnEPTJF5K1BCJ9YWadZHp03i0lceSTa05cVzw6BkXar9rTFzId079EoxZne1fJ2/M2+/GCnlRvbsi4A+Bwa8/eo+grDezfHl76hPcL7o7jH+hJfwywV1qb7GgTjJ+q1jXFKdt6hFKK2ln1Fd9QCF/2oEk8YHgDTgTKaH/eBalvJ6iTREZWWLRdXsGp2VBDZPhItTZ7qLyQB+JtstSmrtfDlvCADvO5vaqddUM/lS0LA9XRuBfDw9fA9y0BaojICwPYo3xeA4B+sXQRru0AyzOZd+6WwBgSRjMO3dHEQJeTgcp9s5i8W+Jpd5kvMGjHmqTUMuhuP6Z4hia1isPV9cyNQI1mFpB/Bav1EmXRNFMqB2ckqlCutjOzEh0LvfUcKs6YGucGCUQse1gSeTPcXfmcjtf9o0Vm6xP9fGogMJbMsR+ZlffsrntoGeAc/BdlXHjDPQLp9LtPJQQ3VjEStfdTA6DS1ePWtUsXhvuu20QSzvZuTGzAdTaAoeWpxRbAo2uvTFALhMixldykyRFX9eJJndjhzgUBkCahV4p63NIZkT2dGkHM8D/X5V0Sf3lex0TAu6LQclwZbLIUSzYygNDpx9cCdzsBQNbpInQS07+tpsmdU1bXthTSGEWZlcfu4qD0sC/KGyN3RB4tST2tv5Ub06aol+U/Sr93bBfm7EDTvVnr0KShCeWAqG6d7IzeHAZ75S458z7WPvb7A24OxwSyEDG1ONFOcuQTzn6NQjDYqpdmYaPIch/zrU+kCErxN5xblXufxcgB3yThLpfeXRuh5h3Kds47G6iN4aE/EsUHn637fTI91EbboaucN10jN+nWfUphh7BEnP1fD67cRv0LVYVWMkmOnNBHeb5Ibiu0SU8HgL/uq2Spiqacsy0g13SqhIp0diligw9gd/gPz0GvCxVoIZ+1MKQkX2Ft6htfdEYTOE+jBOQYtzHKHW/ce2vZZCOuzwSBO1DDFmlnCbACY6vHh13ySXgQxrsNJM8dSFyWK+Exa7kjF4pqYMB/lwgDeAQ7R8akdkyb0iFHCijptxjlNAPauSmRoJee5QOJTXYHwN2K9fZkcpJ5XHE8nMbX9F4HdD377cv4dco89a6D+oLKOcNTfOsa5MWcsc6KpOMS4pMjM7lMMxcj3YSn7uYB+3kfuiV4jIsU6XonriHKo+2ufNHckFI5t1rZjdwmr6BEuNA9oyhGj+dkVYBaI5INCaJTJkp5Ksf5qUU8fOwmkGqemkbAsfPTyJRkLGandtC1NfIpi70lAPpyAkx1ktQtyh1Xb8x9Snm2dE+nO7ShwXqaSoWGhmnqDD+Sp3TFAN9gCIFb1yof9SeuJd17xmdOJXrO+AUEI3cOz9fanLcnJbvXOuV1h0Fwir3wd3H/vfJU5+tLPCW6Z8Lqtb4KQZEiLBB6pgzFAG/1dXnRPcV4b7Tr28xLoeZZ769w/f6kwiOYsspjwDz8bGSEFxfzRNYtslkq0SLhZ1+ZeQ/kuaWZiu9BGXfaRPbNxDn2D/gmT/FeuA/J6mXMILxPT1a1Jtjg0LsowxXlL+Jmu3fH3Li6DfEJMmbFwKxyxtxFJko4B2FEGRRuTyQOTSCwACJozdqIXewx/ms/CwP3ypz7+l5CTImCwTMSjlQbviS8YYq9NLl5Z0vajlI5SXfgMOf8pzWmfC6K7+eo+F3r6XfdPfnySWBvTcMUWpY+adJJQUHY+MiP9/3N0cNQD0V7YVfbogEbz7BRR50qQkge4nPeF0Jen8d5waZrOV+zrifO2fj3MUW7dL7P91XajeWKA6cAZgqhSaLdhALbrzJ4A9SfDFrG/N6uHtlB3C6S5B73j6RDy01n+wNkmlJ6Y36SlJtuoM+UjuVn4joxAfIdnNLP3WTglj8E/hKWz5zlAHcYXDw6Xtg50T4/doSX4gIYcEDccGiqYEj7HzvUHqCZQjo4MOl7CC2OT85+V7Cu3NM6Q/3rzjBKURLQWiaGx1aMueg4FEjTiwHfll4+/3p2TTXRGUJSKVX/F/8VpmC13zPcbzRH+bp6zs73ZpEKeo9HH6I6K46mSHfYtxMu99K64ewVvJOWqub+PD7gmpBh9u/nK0Cg3/i5ascFN6ylkhKZ794nNiP9XmKdTaAbXzCIinzTalabIQ3NbMdxrqPfBy1RhL2rlw09EL2YHu8vFF1f70vjAK+tkS2INKE1v7k5Wb5xsAaOVQxE1qZY9aTq9pe4lbTxmVozijCD84btsdnWvlj0rPeQbibd+PtG/+JtPmh/qalXIMTc3sRuAV1kUl6I00CUBi7sXAqzfsedWk/swa7UVvnC5rnL3Opzawww844A3Rlx9as4Mqt7Z95rzGBfZREi4NHPzKnLBv2RJ2uNVn2F5smDKbazD6i9viczRZNr8uSAQyECcMFm63XXkNKUfJIt2av3xObNVeDVaFxLVj7d2U4kLv+avoeBU/zf+VFgJcx8w1YxmCG00itJRyOATfFHwqYip4av97Q6UFBFp7hGxrrvYw5jUBnFTVc8t9JrLbeF4K6cXQVEHpH27oGLvVR8bcUqDzxgvJAMlcI7hHRS1pZ4t/eiymw5Y1GHwH+hnHXkw/Q3Q/RmtYYVuBd7GOCIwEx7EiFy2JbgMcHiRr06myJIOokOKK09DN+WjcDuDle+P1mT/XhEJ7IUp6mdCV5lTcASASHNWTfRiJ9R9At8GNNyH2aTEk+610CiKhatwLDukHjzj9lOhqRge6Ab5vNYVRiEj1HpyIR455k5bje8KTPyXWYAqSSW+mXosko/lWhDcO8N+UAoe+dPafF0jiiSd0mlr60Du5GU+NK3c5UZAR2jZMQ+ULypdfY9ESV066TUsBEZSm4ib3RGZRyRKnlLDIai/7quO6dddI2uNYmuSrvcRsl8AvnuvlMIoRAS5W+IpBgLxrVJGKLIx9Xlvv7+F0GOBW32q5cF2SA0dg8UlMNAR8VTMzBL3DmJ8A9mR3iruw1JrWMqBd9P84Tep5RSq+1kUy4F98ESHYMWx65KXDT1UL5eKQ+dUBXFdOgHHgrlDLaOFfxvoTWnHOPtYeNWi1uEBjjD1Bc+8Z+H1YU8a5pBbNRo6DFLfsXFwRMS6PlfJPFwCDiHdLAxO/vsG1sCCj04nJxlrMmq31BZQbwq71PmG/9PfyhsI5IGD0sveeQHCa1T+S2vuVC9qDCJqqj96gU7aMqztTqyGal49dHP3UXV+aytT4iD+7KsSDT08FAQyRZPjnRytN3Naot8CPXRfe+fKDzzEPoyR1r+NvYfJX5MUkURMD0PlsYxOF1BCI++9pHT4J7bwsj81YX9ulxSGSdub0CI+trc/Lw9BY5jNeTYUmImY6wAaJ1mp5o1NfpROjjeWoSuuxcDxeBpmR/WlspjiY4rvFSupIHIxqFyMlQFGZD2QpUHJLdaZULM/cDxSFC+cet7hdaQYmBz6mh5RWvmJrRpD6DYr2btrgyzhpJbsOKEjIpX6s8km00ogmN4Za4xGKYSUSscDq7+E85JWtM9di30oXR96pDMK7phTW28Is8yyB1/P3hHwKesrgNa3VCZj0DnpzuPpYGiWzsJH8QV72mbAg5BVXOnDAzzzLqIYRs93MSEgaE8DaxuIdv9XklpEJGM1zwqHUS84YXUmvT8khPW8oWo5jVKP8HZsICaUVE6IjImNs7vFFiekMXEVh5053DbHweUAeVpwjAiYYu2ERM9LpFNclkRX9kwxdJdcyd53pyE52z/SeiCH7wGIas+/oWPzhxLnjiXOik3xNWPwaz5iu37seY95vbnC2z26j/SiORApXAawL5gEEdJg7PSp+5VRUzvAAHd/rv9PC1dg25ZofMFBDP0K5vCl9hKdMlcHQXHxEaerKQTUCzBNfBqOKbc3tjke30lXFsoPuJQmtEToeXxBeOza/sekp8hH/c/8b4KsuOwI+QpiYlVuotoF1vAfugToFMeDgJBtBHcYYwvGHG6ZA+mD1SigOClQboT55UJZM7qCVWGIm+ZEbZh2H/jFPugXiypYNeghTDUKXWrVmMjvAeeyObDnjffpq7g0tVq0ocwh3tigCCEjZRW4HRobjlkm+c0lq9lDlhR4ZNMLItXX/K6xgO39TA+QUzJcFy4lGHj8SiV9XKNH1E4kr0/jQUbiLlmgN6tH5Q3OLSRLQYdL/RTNwEoFauKJFDhQwEiRFRKPRcAJVmUKG1H1mIKgNOu0yPcJE/WtATr3GtGUCGXUhq5xeT6mXvgLV6qj/ifQpvglMrHmIYBoQqsdJEWrs4yG5pCS/e/VzSua+R8xBbulwrLDB+kHNE6bOVn/evOQoTmlHmIWMFQssnx8YYT+TDU/bE0E3YYoxfU5qE7sq+XFssxL8QNkDsSkHlsLtu5Bq2zto2/IyJwlrrIRW9xgvKT/K9KbfZadp5D5r2uhL2Hiwx7bWUUPNamlW5jL1e877RpH0HT4AsyN2noY/ls8h1ROOh/GEdA5FcRkXyHMRGirU7udXUsTUeGOez37wQaEFrol+H+Kvw2dSYJK/uKQW49eZ2SAzJLKWKyoJFsE6SLvqoi5X4+SmXY74qRYdHAJ5r7SQpoWOybYBWiwgZDT7B4w8Z46cCFbFeyWA45GAZmn5aaascJZiY/WVwvEGipUH2fbc1CyVXef56gAcLrQ/+cynEFWlYmiDHOsZFtgaZPfIcFyi8ORpTBHynkwZdqB3bDGVlwg6swIRvjJw31RMk7QNxEa7d4s2m+BYAVqoyn/6LD+rGbUm41FjVcfz5blcfGf55LfVKx6BBNpl7xYv57HZdli/eWRdZwRJTXSHEPke1V0CjYix+8X94yyvllY7iuEco1fkePihF585I5SST8bnXJ9//XgFISPILUZd0mwlm0CvrTFw0xzR7iDuqTFSpiWWRicqnPcPuMHN0KMh7MwI9Fo5C4qslKi44ylLfbDkyNVif2Y/yH2lSRnaY7lVBZzBOvUKHZpyPw9mPbJElgmQLGC2S/tfH1d4WwgbS+3+7JiyOzN+m8795afs6OW9AG4hbCkzS4huJ3lhrkAi64901wRS7JyDEj2GbtM5rtzk0zh/tw5Kl2zrddOYqrQmmlaO65nqN13NQZ4hUpZqQemnk1mJ1+jNQJkVNTjdDwBXpdMZBfOkkbC92l92tRafVx8BTIFXLPg4eUIiKthKVtz9nQrrRL5UpTVWePkQX8Ti2VV+Wk/jabqUNf01XlMpWc+IH86G0dDdFs694k0cTsiV3FAz85+EoIDVhElT0zdFrqOZtnq4j0SefhzwBYDgbWe5BMAy2MIG+PpXWJ/qrrLHtYiW+a1G0WjDvR/Bg+MfT5Fh2oxeNulO7HUQzs8FnPuS7Q68bkkOtI5Ada+w86S5nvqtxqE4a4FFuJ0PlCBrC8ThbZPDMjvMgtv5QfKW8WkQDxH1Mx84ZWElAD+UBRclemJe6yKuUXoMep/1+L0Nyv+4bCbL3BP8J95kXMFFR1pKpsmAECA6jtdTEjKJLcaAki2BKtLc9BkXfcAAjMdWpGKfA0mFyGTywlzpRFD68I9OD3Gsb3nnKjz+9DnrPONHB8WDbYog7wK8lakxNM1gFdRZsTY3em6BM/wE5wrs+8YI/hZUNnPb5xiRA1qGg5PbSfKH3PS/wNOraUBw1AMeqGowvuPplTaAHcz+O9ESavqG2soN66zBXksixxLyXHyRLO0Lc+YuEa/pY9FD7UaGRFyYaV2o6iw/yQLKwu11BmHbrjtl9cEgDN+e6K+84YSqt+7ZQ1OmGbjWrChsdpgGWTuxOkyH46qE+YKkA74yJN96npx5y6gj2TKg0F904VPAoGkrKflYdQ6e9CY4dXCCWZqtPBlnzudMYVGNG/DM0odPyBDXiENQWID33JwUh6G7ym4SzVPvmxvjd3xvOAIEPXX8L/rm3Tv7prlaP0CieGhJmrTEhY6ygzNgXRZF6CODPS5I5JIx9ygDMFe7L2jBXRgRBgGWgEG7RvEaiwF8+b7JzbCmNIWyF96x8yJnxx8iMRq6EYtsCjPtoLqhwiJw+rZJ0DRIfAiFm0ZTHiA9ndL+2UM25n5jBjUoMf62c49x829vjkCkZqnC1sINnDu8CF2K07mI3JLMO9ITxJYSozWyCf81YOPMLI3XS2+8aFgZPEYqJMYDjhQspCdCnMQ6ljrT04kKbOr9ej2O7dnsX6kz1O4G2I/HDvzNp1SPMIdAUdWzlFv2EYrKPWX5KhrxHUOKi9PgOOlyKGTSYH64pl4hOFhp8BtFQzePxqtlkPmVcjbTd0HRwVS7xaGXUZ1uF0VOSnyues/md3Zpz3Toaoe+Yzf4zJrrbJEKB1pU4wXznC/8IHawUf7sB/vvQ5v359kGSrbv2EUAxHU4X4Lmylyp2JYNcu8Q0qMxSlbj0dLKS/LTBLZHPNzPDqDg/XdnT7Fa6YhS3ytRbhH+FI+P4nEiBNTq7Nz2d+vqsHS58mpIEkznrv/8jQOr6ZT7h6dhm2LUFqsvoh5dxnHrokwekXhzoFtN2TwN5xcF1Lm5I2YhIoUb2v7HfVWl77rcPtMMQSmnppu9JgmfBEQb1tIigXq1aYBYa0h5CgE9bqmoRWXqLf1ySbX1zxouNFoWJsmxK0IKyimcvyY9M0PNdHjmDGZdIWueLPoyrwRecI5GhoHnxX4CJ/l7u/4cMH25Frvb8+JIgjz0BkxTmthi9vpGm9aQVdo6dYk8yI4KmIp6v1oU3cQKV5ebVZpdpXueW4si8Yun3SoYuZxff9rorV4Wq18eSMi8U+31hyrpYHjaFrDSTCzXaqLNSqUYFEvPqLCkijDDf06bY5DVPe6ltlp7lqi0KIG1R2sTHvVpTlG6us+CRy4e6XQmbItj80Zme6jXgefhjmPk5FvI8PePCGRmOvcaOTHkRVPJPsGp/jtdxSJEzszNG9akFAqZ5cLec6PArBmUU9oxYGpCv0RWdyJaJTAG0DxkmLlEsoJBI33LzuJV/0m8v+y4A3biVo8sSIeN0HuRUp99IVnSmab9yUdXrnQsi47AagmuJA6MtWU7tFvZjzOx6IMbiAmSlsjhaW1pnaykS4k8JCaDGS+RC6KhRbVNnWM7QrS1YbwkEW1y7bzRlxRyWZZI9N9iqLmr7g520Pjk3vZy4eQ0NVyZztxXVeHUcKYvM7WRNivIVTaAtwsbzItYYFyzM7mal+VDPHXCv7cutlBn9TzSdRcBu+zx6SpDprIuNvnwSuL7/TP9Ns0ujJwq/lja4/AE806xJCGtKWUdqUWVXxO2nkM1BTiuKNStz6VASKAKjTFtYMKcYrHrO+lyIo0Gi15WqNb9JprzD4L6Bwen3AfAFIBF1tYPU2S3KDNLFKVU7q2UXCDEe4j/FS8GXI5FHc6LfUoRElYkfgyJ+WQedqSAgx2uxJtNiKhGfesorhvfJzsEH7IXSb4QKKpUuh5Bd7ZqAAnOguIYv9eXBnbBMtzkA6x1uGYodB83nrUSldLvFxbZBQ21db7D5W0e8S2rb6IN9gUylhlmxaRK4KMxSQiVNNwLXaghS2UqxC134r0eTbfRUtcJNtfJ2bwgxZWUW2gjQdeRQ736WdwqWVK7kiZ/cH+M6Rzbcv9TKGUHvt3BaqbIJUVXoYr6l0g5f/3lnpFBN6OotAZxkaNQFlsUpXWlPPp646fNd90IKBnkyDgfVG1grtwVMbcUwvkz6kNLqpC1IEOfWIT03p1ipEGhUNXE1WQSPyUnLkbA3/t0h9lhJMGd/y8gjwVKSPCBHvlPyAJjoy08c1TNH2wAJLCBdRobFa2TqTCpXDBm0pVrXGv9RBp7DvCwTBK81DTbSEgKgwAP3ykdUXgRoKjU7S1D1LqphiPoHnMcq30zFHKcwGmJRtm8Ubs1c15rnC3nTXXm218vlWcXlkpkRssgHRZ1AeTpi0hKjzD2GeSsw+I5CaRlsuYS2kVor9g1mk9ta7uWBWSSWIzbEkbrJx9fBvx0t9Zoel0PDhcVmpwIsg2WT/06kkfZ1EWelEW1j2I73gCFKBS8KlpVPgvRL3jgZTGoMDflkrdKN+nDF7jo6hyusm2WymGb4S3vK5rG94oEjVEzrPau59FrBtUnWHcLESwHc+OBTb4/dNOQFZSkp4tIqxdV5SsM3vczmuAjeBWcNa+8yLK4TO8JhL/i3ArJncdQcQDeSiPnSoLOoD99YWQwe4iZeAX9Fi0Q6aF7Tsfnm/R5FGo+ZalJKTcV7Lx/EPxCj1HVScvmo9eb7tqdKXa3kkbLwIQ9kumEuNerZxOPE6dZ2wVAzK3F8zMxkuX+Teu88nf3NpstZqUcX1DPXrxGzEA2qmUrPzoKjKezjbx3MLUjzKJeuUnpD4EfafmatPOiwzZPfnIAuesnGwO/jLVA9+MsrtMdNxQGJd2AVnVt6nEUikhJgunznbmhXon0D6QIHUvtH1jrlAcJG5DZLNGY0Xf3NUa9hLMK67pLRf52EAorbb4T8azi6yOZDblV4MJHalGPDN4cLCNUZIIoufhpU4uI+jwLnEAdavoiivQQDX0+OBexEYhHWQ2a9slcq0oKL8XlBEBBMEMJEmtYlYCwIi9QugoPahHcwa5D7mfETVXZQk5bQl1BsU8JSvKfVVUm39kvJpSas/kgxOavt03+j+F+n+8rtRl2D+mkiqZ4TFQgt7wSV5pAbjWanydEo4srpp2kJ6YMmritZO2VFhbHpSE515gTQz8gz7GAryMWKg9tBR/p1lW3CRvy76K/7AtH7DNXd1lVfxpQSQ/uxK6Dm2HiZl1bw8g+AucfKsollOxW02Z4DHXacPJgccYmjzduOFVpJUqbH57+6yr1VOIUV3EsY2b/G3ufJP5uTieheDtYe60J2wzjNs2Hdk/3mX8CGuoNCF4iNFJWPzvs9VVQJ2Tc/wLVMtx7vPplkx6M5Eu9RKHgA5JaRRqZdTTIl9OBasd0Ax9HRdu5hW8F3KEIPqiuqZLvEX2/1R0MUU243G/EpxF7CqglBXPdVIxXUXf3QIBQ1jYrTWw8z5M+p1sHJD7Kc9ef9AtSZB2Lqi/EbUTG8mgFzARZsnMFQ2c3GnTQJeygcVV/hq3bqPFjRPjb/aIzfPZ+WwClNyJEEm/eQI+Imi26ACusEStV18jZyFLs8jOIgBZY5Hz2TsKkSszNTXjx0aG6Wjj9vLeHiPjPEDcmDj5HiWADKh7KHMjR9qk7o6+MatsvEG831dj/c2G5hU7U7K3aRxCKBLMbBFInfICvhU+7j4Yfcw3CLuy0wYELU/xmVzh4msTvp49fzOi9taY/ClM0+jWboGNtlbHflH9OkNcVqNIBuFEo1bGgydgWaBpCZLjVDCGMtdmE3JEUZTA5UGcFrKVC2NXiSWsQaWaxOj42L1bYyDyfSAJ0YVW2OBkSGsny6kV74INfkS8QTBQ//J7SQrH8clqcWSsre0uCrAQ35Ca/j6nPCl0NtZ5E1KaC+2oB5pYQesEyi9RAe94IWG+rTO15WZKn7YskHyxU9y55jfY95ya4Yd/h62AVQaDSllCCACvESoc9rurqS9QJhBbE2isLiDcPE9YBtdt6bkqj6ABWGjBcp4i/V9LPksBB28cA7SEE/DnEInTum6wWjXgxbkP8xLwA8T+sTKdAMBtDmIoiw99ATnoVEGertqprOTHRiEwpUTp8Xm74jWLXrpsDHLT9k8AK2n96B15jHuC1ejcs/OuP49Anqn96c3HsmntYu9R5Cf7wkZ/JEttDOv51GHSjYQh4f0oJrIqKuBmXBMHexEM30uOL6ft+Vg6M0yx4pciDMXQmHw5D/J08uVLt2r0O5YJ+eaksRnXTbSChAKMXJEfKKp/j92GGFy9WWAB7oa29uaLiELaZjec+BXq+hdsEGp/NNvdo2SZ9Qucij05pH7/wJvKhnxn6EjkVF5GGKi5bEfvu6U4GhCf64/81LglaC2Xm66XwJU0iCNHNspWbA0PZ+UV2QjdDOqR+CElIZhKCBl/tsIz1Bui2A1n/QUo5WxWnza5XCrq6ckrWElpDmSRBogFbHMLhuIwu+olFOa2jmfFwNcD8Zw+QKpIGsLbQo4CXMQQdpTwZIj3PLRWlBaEXtg87b+WSL9kb6efWC6N28stgzlh3HgwfbY9BJzIDg0C5uyelVo6h2AC3SmBhanB+kq5/hI4SU/q7RWtc9fTKHl1PkanLckqiuOaIwcXgqr2GcWYDVC/KfWUoCQHUQ+xXrandzx/GDobEJWY0qEwnLYrXdgceF9W7J86S40/8skWqlh4XlQ7AUgndj1ZjE5/lJjRyUdNIWedVRro07fBW2MPJ0K/4hP+h0JOG4Jx43cVDWHcvPUUVP4ELAK+rZ7qkEQ6d3nbBYFSHQQT2XgP6lOysHbewwvQ+HWdDHBvGDqOvvaw8WlXIPVvRBy2yJUPYAoCPVEM9ZorNh1KrvYZN/irqbDm7w8KAWevp5dMXZLoaEuFG+z/pqe3uavK6lZlMOCOFKRQjZxQE5cbAu/T1QwV5PWjutwUvgYPPhihmD3Zbq61/b4Jen9H1wnO/NUvwyVvf05wLDV2mYqtc1IRUCfyrGVDr/EI+8LgW8QUPWdyOFxjG1Stn3CGXkzwAEFotB5CreIoxTtMGmJEg12DO1P1/cu6jxENVIjNTEu46uVzizqXpgrcB6aWsevtbZ16GyDC/qxEXf2C7311osS4QS2GOzIhnk7GZ19b8GY8GFsGJGB+3qiQRmnQoDNmojq30XSS5qaPVGIJHcWzjIOzHQZ6nU6r8VJSIlIv9qGToiG0+2uM7K3YckcPWjPz2RaAhJsSTkRpfcHlJuNzOoKxsgzWVcHqGpSozkqfEHUm45XlZXSkiTQqQjuZrmgYWiT2Mftnvah3Ccc+FBMAnKdPyRtdk9siwwhxyTDesi0EFE/zCM/PLIcUJJ+bq1zzPGLf5bRGXoAmnSMFnGjcENN8+MOqcZVDjQcA1+usARz/lGtwuTk4d5rOCc0ZdHAoFKYxn6kEFJuaodEa8JwcMui23Eh3tGMpbdIh75oZJMyMqEUYq+zE4ZKaEsMyu3CwKLoBq5AnCfPpI5HSfXWw6GJtfcnoXMwnk/Khq09lm4T9cakLjWVsZhPgwe4i2A6BW3gsWa7gMOVmhAsROjSqfzD3VUe1vfb6q7hDZHYgkuXAKXLxr0iyFvVvvPcs89cDUn7rjXqAHNj/FL8EOt6tLOaQeN1Jqkrpwn8fDtr3903PNgL/3PpuUJ7BcQQvCKqM2FhejgzMatvexLEtVaq0kl2AhNlNUl3v4Cqrt2tYKdyB5zvfNsspzCDEUnfeGEVnVex2FkBvpq9VLCnhgUGGdyp7m4xZawm55yoCt3RqrhA1m//Toh3yTseaK0EaSNPr4hZ0ajE90nvsJZN89Scj5b16gXMLm5gvGUFxXxVWY6eiUzjnSyjJx4VcpiOLtj22Yfa6POLhIA+ZvXJNgNBzKy+bOJFUGxywLJqN6B+GazvO4N50Mas3ZWXbLxi6GnXyhccfpamfOnXRG5RpSz1XEcCRMMuzMR+A7SI3nTwtQ/qxq6nFJ4JCDf5H0Zo0/YBq83DWzT/uvTF0SWBrwvy9FBEvSgxdlAQVanZFump8ff6DD1aCc/DF/s1WF4ASVFOVOqGNOukJf8MYRcELP9ZcGnk9tPp9tQOM+ja/gAxc5HlPkGt/1r5KJ1l8fFClTWwhGcbjT6tiAqnzheavO/F+gnrO45aBsxcS0pwL2ymaNnEyfoonxM9Pji3tCk+NJupRo+SVehtSPEJtp4+2A94C+nGWCe0pGMevkmWqufx4gOQoqEWjj9xWW4B0KcNgrj048y4zbeyZnAu2fPurcpOCfpKWNLix5Et4i9NDLJ+nZIzKOMTo5faNjpuzqpF91J+Z1G2SmAnuemcZyk1EwJQOE7bMdY1+1ZXG/YTLt1Jbgs17O6FpTcaRTZw/V8RJxDJc8YylvcbsB743TcPs4PTdK0/vmVzHiT9X5ZVJw9JEpCUEK0YzkrJGsU8aYLc//s8gzXpptCX82X59ZCILS+gAtNEa+jPvth8+TTxClGYjZvtgMZBciZdsSzW0Lqy5yf4wxmPxanystUXOsrP4yWBh5acr+oZZ0glNS020RN1UFEvKfKZTYP+w+6uXEduH2ho8bhs9qlSyEiDymdW9+ZTzfQiiqIpzE0Gd2d/N30ot+B6YAZu2GrdKjWSU2EJdI1dkm5SgoSaeA9633/wLgJBi9FcFBMDSx5r+dq+4+Jw56KOBN6xfkLKLevlXxcVxC8eZPZVmw4nDaFbL8jJlcMs3pgaBTxf10IVwAjxiTYWH219agGmBGEqzc02dTt0EnRz/rc4MJHFc4gVjAZLf7fzIfnfDo93HXryES1fs5jVZNiIdnXWuJlCL/fjwkhcf/LNHIhMCY+qJx8/cTQpI73sUeaYtQbHSkOxyol4Z1UbreUoMvAP+ytK3SbU5EvxREAev2KmE6poHKT92xNw1DiTDAuCUCalgm0YFcnPb70Hyjt6zQAD+GQox45rC20H7JCANw22lNnvkSJHw/oPN3ZjtQaFU3AyEpcmWU/gHrTXhcTw1rOeoAp8relsR2bDbLqnDlz+nomZx74oGH/JJViDhtXFvlZ5i3WGkQUJW1pYZ0+Q+JDdmajviXlKOyBFKvm5d4rk5TA1X9AYTjqFG2PXpa0c5d3cJQRldV0xsW5DoRmuPfNay+ZL8PqkSrLx4Oyi/H/JxZCdkXk22BJ8vxIqNMSIqYV2EqK7tLF74ATdX3VxU/LrowHm3s2BaX6fObkYrmblsfEbW1kHr+YNdO9RJqFzV2M+9GbvzlagtlPcgpYScX+DyWZhGOu/nS4FHeyIzyOih+vfAl08W+1jdvWmvWB3fr2nipbAE88wxiPSwTBPkjntSMKx1Fe7bVBo8rtueZ7GBc5xopHyZV8LjEKF7VlLW0pjMo2TOel8g1/JEQYnioRE2HC7KfKdj1cJIqZld9+08CbZcHNw1Nfer4cPLt61bHrNMd5I+cHJzFV85glZfQiJNm7R3BKNf9pFjl54EIXCOEEkyiqBflI4AQNrXH9gFRoKhPq8wabjFWyin4c26z0LjKMtXrMemQCdrV6dmBOG7OrN4UqD5JdEp3c5H7KSY37U+buDxzhPXDY9dd83g9oNNkrrtfV7V8iNNK7aV4VJVIJaP/ykWAGcoQrEwW+tsJJdtelQwRPMdwzFzrcFOhzh2nRhf0z9IL2YKrO3KCtpvyVdDVBXFy98bVgG2qQOseO8k7nDji+4OgKO+fXcGXaS2KDlswKSHOKhZC76m5Y70Tahn+otBBVpTPgrDSVlc4BGakqeK42oJlyXNdhjp5SwO/k4iSlO2MT/zFLbdUNTJZNyD/VLL7+NpPo6MktzPWwq/F4QuEXR5Jgo0j+MktCg8cO8H/tVcm/K2T9TSOGYnYuY0yEBrXPMdzoLtTfKdiPd0nyAwuEQXKqaRNys7zAcQZDJmGC1+6XarEKEe/rMJns+cab7ZIjuci+FmUd3mkTZXU73nHogB+mEd6BncIR9jpxv52pVj3qlojhq3f1A5j7gq+NGOwd/HN+Ze56pE4/+8Maq/l9UUTR3kLURbPE1Q75GkSxtWh+CjH3Eh/MTjuyuuIAVtIV70O3IqDQalghqj4BobumUznLLxQk2cfYi+3JjdiAKDFvGEwTg/0fuqZ3uNxZem7R/DkES1eUhetEl/umM1gidqNo48jDer4Yt0dNgDIyVL9s7HqSlnbbpTFxB1KEUxR2pZdzDbFPHd1QKstGLsx1gcE/XTpze9XGMlpGX6/+6rDIVAJljdI5Q9eDNhHeMPVtZxWkMEVmJQNX9p+IaZxJmNCGWrxnDtNTN4ufXj/gg4T8Xyt89tTZ9rYjuhtRsnfdqcAvStDPez7MOr2Guclxam5zfUWK0ZhVwf5oJHo6Wlur5GouPxmh1N8MHJCnyOtBbHzwD3xjYMg/65Yii2EoFH1x4vL3yFakVbCXz7dh7kLkBkfuXmWMMIKA8absTO91IbDrgF2PfYuHfsBKu52A1wx1HqPsF6LExRGa689fg+qcsJQ1aUiMD4B+M+WyOhBbmVStVJuqfnWjpnW2IrMMpJ5IJDC81stpmlCfIz66rNaKtUwIk45JWBFI4Wo1eMxBPuD45+ZRpnDN0Upj95M119yxyd+NiUn2dRG4B5kvL2j6GZIqt9arvOdaQlcbIBZ6YUrrjBgTTJPPA/Zh1tTw2fwlvfrIKFV6AkBjV8NZVeXUB4fFWToxYlFV1lqeB7hqdlV926OvnAob3y6+INYpBOX7ipyMSAxG/Bg676ZoyMCzgKp0M5ob55YMkiPjzjpuLqYeKyW3j7fY0sG6zKbHR+zqhtDh2c8oU/lH+IjJjQO2BvKatQOdxDQMZu480Rodt8WZ4fZyjCYIYWqWdGmEH/WeexAz4BGvjzmrlzPqlDo1R4aMEetd7mfyXHqD357FcH/9HlUwghHElhnGlZnFhF4/C/oxIbP6V1sXWKT5HRofXbJ6Hx6wR8gAp2+Pat0sXVMhIUzbCim+ZLxpD+oJmTPVUDG2y1T3OFwCddbhNxMCUI1Ly5WDVfURp5r/EHdgbgcmKJ0Bo08RqIi3V2VPlW1ihAejGdvOtj71hjq6eCwPSV5Zqb1CtFbCBcgM/OgC7EezopWif7xv6qf2N9WcjpmbQnLtVZQB63xrkDQEFZqM/+ANacotRMousfjteRwXOUH7sPs0Djbikwh2eBSkwJJq6Bo0TRYlQ5t86JJAYh6BhXvJ/Ah2mAQv0Ozxiqj07fwyTAel1IXeR5f6WAc7jZqJKFxsBypddlEYLz5P2q9m54GbntJyv8QZDjwSFLhEq4n/PUcZ9dvjgdgMrxWNDnykapFVOaK1WHQF6gzTvLijdzmlGRBq9U1H+bIU1VkIDv/wEod2tJXonUrPOQ7/qJ12oO0PwYEgTI0YX4Mr5sQuHwj27v7VwOg+Q/5LC3rODJvRv2oNpRDEWOEudqVjFICCng0YOXDqbLZlrSYkRTkTziGCYfFh3mmYcWHd8ijDTIfujvieHMxVeqgANmuxSClKMgb9hK91zhviYI4yfZlYwv/cgujfU+kOHCH/ewgVOkABua2qjiseImtotzXabuisKTf59tZksTZK3rvUwyp0H2AhciCS+qJnLBo+XgTX1nAfrQOjlZTsgRolEJQlZKAYLycYav/Fg9upgJAABvXv4dr2reXi+2PgeA6Zyph2+YZm8cN8QSXr+pxLFwURVls2q1zdwT5rTyu6HPEcamhQ1eDNFPFXcCAdbmPBKKYNh4N/LuSMY8YQAmqP8xLCLtNiFa3fxW4hJG2Q8acW35jmMYKQF9iGr0jujyXaqWdzi+ueZH3IciWhjk31VJpp6bsuZ47bYDhJPTNSxKpJkCZ5L1cBOMk9ETUhRynpbr7DDCWzq9ppduoTs+OL8QkUhaqyn8l4th8qt4AOcYCzkxb9O1UEoQc996I4cqwGLRRByBBUWgd/A1pWjTgQREjqfPXjQwnTQgMXTBm/yAsGw1b98a4NVEJLg1UAyC8Zj2T2idE/s3JG+IdV3t/cBOIOO2NXYmehiTtVSUFqMVanlwE8djAYpZnvun6/ZR1the5t2l06t1ZH1MCbiRP99wT5dXaSP73jeZ5Z2t+JDErxniQGzvy/w6iLr0kmd9pzs7OOzYGk14/TopQW/7uu5PSKHUjnFglCuuXxho1E+O2uoIWaNEixFZJ4xW7G73RIciAa54oT68YjrbuHjiFuJumoEJ1eYKvlUIHnvl7YWASFHxVpOTyiWbFLtMgmj4R+pZPpZX9H9HT9SJas95lCYlcQ5lfkRMSOvttrc768HpXcQcIDQboNol117vNfcpGTnFehdlEHbfmt8NiCOlwrCBE5IakPv1KpxGqNyFZpCP/H01618i8bUXvMGU42akfeMPM7YmSwj9DcxdwZPv7ZAjTi+UpWeWN5X1HkbTWwgKmyH9VXB8dvi8i9zB9DXUv2xQVmtgJz3/hV/KJOmhtyEKvtbotWPxserWpGs0o6g1VeZlFzOTrz0wncbBQaqeLhkijfyI8G6fWqvmOxRNErQFAFZlX154F63Dlo/GGYiNmr4suDFEHC8JyEA9IEoy2f7C8XVZ7o2BcmbYi8YNKpjVPRtZqoR3AdMXzLihL2JokYS2wqg+pAyhOLFG+nkNFO2lkLYTNg2YrBnAtXDC+rl4HJv6ii7rrYnuWprsTloh4W5JZcy311WNWGGlErE/pYrd7Ug7gUNVBPMPMxGN/NcUUXMyERkC7il923SbVmNb/Rcma9Y+9Lh/gB3sQFVM5qtIdPKk2+hH6PbUkSmEVLt3mONp36P+5SGV43JvyNfz9hck8rPvBabO/0yIScHa4NDDNQ6YfKoAYgA0eB2tB5dyYWViwx0PdOQxEzbbOmQ7fhK5BlvzmCJsdYOzSEJPvHfq4+AI8gCL4HIOc923VbdFNdWL2ffbFmjeu6HxhXBggAfXlS1g/rwBcO6nzcO8Ulr4ZxPK5lZF6LuXJwrrmp/ysOgQ1KNqr1UKaYxKfVXI3cCkGuHr0ylTNhfxKoAbemn0H7PpsIHPy0dBhjLAS77udg4MmOFKzY32v/FB5rvb88TifNkJQ+cNHLi4xae2e5X9lAutNSFvpXuSifWCrXR8PWlUFK/vaoBzXMr3Ebjj+Y0PgyREHEYwv1Nr2wH9+CpQoITU3HNSDgiGjSPUK7FkWRHwNx5/k+00ygscmy1UxIcp30GMkeLDz1Ca6627PIILTdYj/mFpR38ajfnM5fFrMIhR+xzUSKLXWJYREBdFqWHcRRX8PkYmxbF5XwA2T5QdHX/RN6O06T5Fe77K29ZtfTHhYx/7hEWsIE28fr4krahxBBC5Xz9wMm3oWWFTqis09uBypVLmu2/SF6LV+AAXOVlkqKFaRfZb3Bh+AfScupcLSYTcKUPFPS8KB8cKfHRfMidcDXJSPR5vqaoBgilJYzWy16ZdvqLItE673+9eQL2qiujq+ytkQilPGX+GDI3E7l8jYj7Z4JvlS1ZpHIrclDSAqBXeiHZb7f2ZbTEbNIBApuA1EKY/W4z0MTBQ9jKMTKz2gmN6EiAzB0XzmRnnGpCs26jw/IZzhSTNBI3MOEH4t/GVdYCRUlQ/bQFUeoAVFdH+IclXt2OVm8e1H3tG2E2Bzhvvj714E2vszmSS2ifiGgg5uKh7F7q0Mq+xnWk2+b8OskBHdAtLWd3umbCZ6W+wHvkcHxpFzQnsuHeQ5eG5Z/X/E8NV3G5wpdII1kCgOfyY90ezBPcq7lUiXO+8r3hTxz/6ZKKK6//lgAuoC79Gc5J8FHboy46ywRHwCB60aUIVxaxqE9wx4aM88OtHkisymS3PyWoEr1zkZi9XVivm8Mi9PgGFTsLGUHitspilLSbcOqd2Rb/rV4iQfPJU+Y13zuzW/uRmCEe6qA1FnfxcfgSiunvwooneqFlEf+GNHnsUNA8Uf2vAf9gM92Cih1Qwq23rSqXAA7w9S6wrBrQdOUcEWfd3TtdZSdh3LSQBe3OHyznZxgVOc7EHJi27mzgm3magAQwPzjEnxDSyiYY83E0dloyssVOIn5PL84l88U8eHIwHJmn8keKFVL59ntNKgsQTakRlNloj3/58XkOZWp9Tub40hfVmW4c5G79jD/pHqQxXhGCNsPo1LsXFW7R6kmLa7GMByj5ylXlrRgSbO6WEUEMFSPfiiuHs7uZs5uBchFhLPWWWKgwTxvvlge9+MSmbBsEs5oRzKyHajgiX87g6tvUwprdfw0pwti0xk7ddt27Op5zG3dKArrPKF1JU7zeTYhfApfUSTapSf94EPCmKSMBeZIOjNP17/KPyEKCGl7oZsvb76GIQ84w8UER05lkEGVpu2RrMLV6KDBki8CWFxqC0Dvt105Q+itoIHnRm8O1eQEeXMtrprnVjXpAGMcwsT3LIVCXUkwVDOmvg+bUKsFyXZqLiFtWvNh1ioY44HZRVPYbVhNLEmbmOpS8kT/sEvk254bsoLoXiDmM66G0LeLtN0U53FKycmhTjguQocqCxxp0Nn0UYWO2qADqh3dbGdH0slJnN9EmA7jKKnCunBcqO+H+XCHK6bLYhwN93lhYUovB4NoEHXd03U+dnatKLrWG52Hwv0wWTkMVheVDdcUwxOIffpiSKP9X1mcUr42oCcAxKCR0gKion8DKkoz/pnNZPhl1BEeoHC4rheEJK6CgRkV3bUQYhTxl4a5uLjOz2Sf+Z/mxlcPiWHmdkOJ0w0AJW/pEKgVJsoUAJYSieY6asokPZilnJwkZyldpMcHIS5cNoOjQFtRaN02sbjCM2L8aHvPnPhScUDJMGRSQKO5LULBNa4lEocvl9oKQ6lrEaVXaCpzB9ijdygEtz/kLKYZQbM2B68qWzNr2qCMQev0stdDrJUS15M562+txjYuDrfhIlJynYD2HrgIBsrE7xiyaTQ4wkwM8s1UFqUF9pVuBAa0ROS38HgG+EXh0OWGDZlfbJv73CyM315ddVPR6z57+bqKEtbgbIu15tOq0i2eXsYOoevj1i2v02RdXhBcbIkImTrmBYAESfx5Tm1vdgvCKnzyHIncuKjox1KMeYjUEZoXzEYey6baXTj2u7D44ABJvDDcWyeh1e6J8Edq0QrXrbh3E07vFCx81fCwfUtxRIg2Iw7bRWMBRvhb+L/1D1hFon2iSSAE5N9Ttw2x6RDEIV/ieEnIctcpfvT8zdA/lVpgIR0O3y0iGrzph0QD2I7Tk2d4LzZ9WatRDacuHu8QICrn+elFlzW2gKyR8WM1zP8Xr0fE7T+j5uskHqvcYRnX8PUE2lpcp6OYeNyAggJ1lnL0iC8OM+4RYlg7uCrtQkW336TaUrpsFTVCPrxmcetR3xHUIi/D7PO6xrSk/4VosbwlZF49fNUcBvZKTRUNXAC3aBOtt0Py5x/enKn+oatZ8DC1vcRaKrU4OBC7RbJHJi9VUvlT0qSg6Lgp/cvEEel6sdotC0KIuvn/DdQgyBjLCvHHVryugM/9NcMwyC8j/z9JNhc0ZYSAnbaiW5mD087Q75CwGpe4+CL8ZqNFLCH1RIpXjDjLSmsnhl8OrWpzYtONK5y5Tl9dwClSgGG31pe7XCO/1EnC3XwVMwOug0vez8yybLSCMF8NGH3p1BWxOXq9oL7rU5ZQQZRAR0zwClGHHepEsUmSzmyzwR8NlbzdAW6qu2dGp+Tr7zx1LC55rYiDR3Hcosduz8SZf6Bp/DRCFhfCkPbFBvzJW2QjCixqibviTv/gnkOY3JwZDDetlbfBHBuJ5Oa2jxyCu5e1JMXH27D0ykA0/Nj5mQmOfTjTJKnR9ATDYycuW4vo8Q/lzHMzBU8iROYpngSoCPGu1hMmuoCFFwGSx6XVsqJJPfHqJAopb0285O5jWHk9QyBLrbGSL4Qq/jD8MPJ1bU8H/JP61r3ErWd+lE0qCuC2lRAGIG9h/zZp2kG2501BgoPYfjSgPvxcUlfDMdeYRObzvDUoMM83myA96cw1DhgkIas/ecHOkltLxwjag9o+9ImIoHB35gzyZfzuew22IN3f8NSCihdRsTn5nXbTSQQMgN1dcHj2xn3BPVcVXAh23vrYBpozpUX0i7nmPiozzQsMadeK7TgFdT6bRfx/yKt8+pR8gFiWkbEt63WlZPEVICeLb1wATgzTgit2air59KF+xQal9R2agNA4rp7Rku5Qo1E7uel60EUROChKq9FNiePKO1KesHjvUSFpvHYyN2dQNLQV6bWO0kYxM9v07RK2P8d9jyG17EAm2SH6wmykaUw2ZVV0fRNMUKqMvwAh66UZDVhdGO0rg6HqcBxaa8bIeO+D/LrxKOBX+RkENFa70J+qcOEo4ru42Qj0GeqU1K9Zsv/zpjI5RQWO+z/X4+iDfNGVmOWrBzj7t6lv7PUAH2/m8QXuEQibZ2esdfkp/dchPeCASRk2NBPUC7Lz6E21czTaW0/+ImQU/eyZDe2i4OC/gtfw9/OgFG53jgX7NHCIJOEBb4rxPPoHLchASkUxRb7Kg/0GdhszR9HcRqPW8V3+uCxNuglHxY3LLDrLOZfuyYIy0EhjKetPd/FZt2RpxMXlMXZB0Mn1Sg1e0oE+WUbU47oaJgXBtSI1qbybPSu5W2OAuZV9v9i293O187lpsA+AM7cfdRoFREvJEDKBrl9Ijks1kUkdFQXjRNmdR4BVo3wHaDUumi63L76EXr6RwfdIGiukJSK6c9RC7qzt5gMm8+AYaGAGEyiAhpjY/CK0usOIDVIg0atGhr8lPVMmYbvA3zM5znbCfLPER+FM5L0CPKoSjrc3njF1XLgGnQ9O1bSZ+Cgml4FIMNLBT7d1olDHePAyOI5owrBoW+isLG1TfgLi6UW+b2JzRS7KQF4LSkqqgwZjvlIPRMO0bE4hQHk+uKy/cICRu449YwNsV9AAl2Qyf6jEjrf9Q57Rq/XgoSdbC6Z82LrIR02i9t0Kzi3xNlAAOBppJJWviARuUeoFIabvLRykUJppsVqnmm2UJJbFXlhwDjKHHRJmG8rtCPWmxpSsqFicJOEYQEaMwK/dMXpX9ZxBLvEq4HKC4OSgrqIOQUKZgs00P+LQ3s5UnikNQulIhu1/PIK+Oe5/zbzMAeMkPrsj7kBPiteBX2Gw4qTPvUGGR8147PlenguS6dpOX3PLMpQxlH74TEheNFYuFcUiK8rY4teASPRom3U3RqkJoJuZCnTPCLLjdOiwkRW2MoYr7UnkrodndFi3VzZ7iMC+RZmq1r9nv5pWbZfzNkc9VtfAfTx646/fAe5m/f1ymuKFImG0HxMwEBtJ/Fr6byBeM4tJ8/7Es6T6ZMl7g/aBrSzticuIsrAeglMSvSXHw0mfXQti/4JJdsu8bBHG8MaljBngzxcZnD86abJ01ElLIkFkceLqGXGYsz2W53JTJiu5xmACD5EGRuHcMCsyqDWi13JMysWO61X0VljjQvTgH+q0mvpqVVi04W/QaRv8s1/HccoQqBUBO9nRyGTcKTLHVIhLFxAdOwj0V7di/Qi85j6gCFiHU44CFa1VODlakMAziqj9dTPberBspLaAZBfZ8WZkA5GAyGGFuFplYB1fZ7uj02FDpAJsCSu3i5UBVNMtBRMwb0Rn0N8yqHCPJpfli0l784bcCdG4Lju0QTkXgCeuKtypRQv7HbZ17+Mk9oThpZriZC3/oCwqmFpo+K40xX+j3Z0T+9zbfng2awSi3XWYUanHpJFEuziGWHSa1HHBvI5PR6TdGcQdMInHGaEGz6B9OQcQnzL28iOz4XUBVYMnqpr8d2GoT1kcUV2NYKuAPsHZcI4iKnkgf4BN180gehnUjUTrSuzn+Ubo9Sb8AJBLuMPcjiYRRuaXKNwsYVsSr/R2xpzzu2TgomKmShlBRsAjKZf6DTuYbTYNn7CUfXuFKANgiG9RUzzwNELDTmoo89wRNzClzqlejEI396WShJEQKRsNDFqaeiPUXaELqwYmuHkZeVvQqTyJJRlarHnZTWoUp6BOrVygfqofyylBMVAPDGq0Tgts33kYaBf7/o/nb3KVKQwdmX5XbV0HAD1fDfOYB6KYKTuQhKiew9h34DfcJSLTprPUIwNb7mnM3gTjRxFoqEpuCSB5mLybamxmGWxhhYXxcHPBNM8TSAp65J0RyY0sufsI9+yObN4fDZv5IWxfVPwbBCALcrvMeTqYnGgRA06xcbxz4Pkcb+/AlEqbmUeouR5mzOldSxtdi46ODK14YK7acaNjaXPflq+kbn6qGjI76OqC2VfTUfW2+i9K4Yie5P2n2YtvXYk3aLC/f5jVsVABKWIkZRf9IBffr0o7PtIGVBSt8yJ/j+ffJYVrUt7ekr8HaQJaIYfpaEbtiKxenLjBeR/LuEpIk45Newk7LvmrmWxefUO68wUR2hg/0zJuAEVIyBm9G4MyFVm+TPxB0tzn+vaUW7m50hBqRlBD3ZS8jLA9WrcjWDW8kJ95NM6KiRTDAcndJOhpfsInEKLsx2jD+a1yohw/yOhLgmkI1JHgwGo+CYgOIfYFdk04SkfQ/9w/1MWjrMmiwlDKXM2uUP7U5yWIuSl46EAOkOTDEJNpq2ESqYMYHAuDY6XZJ+9lNXiZC4Ex1GQL1ZUOfQIPEfj/yv/eGs8oT3VzZKOQf4Sy3udddmskEWjgzC+bfyNbZ0K0evgS2h/9bc9NNxVi/drXJqnPg4yaA5+toMou9VNVZJWozJoXGPt4S27e0Y/0tEiRnKk3TE2Yq4SKsY8a2FhfI5SW5jHUeCxfUdHtMBoLWXYcjZgiNm7Wo5TVY6Q+O/Bny8b0KaQQcMx0uZgGiTKft+FnOIztnufDdKl18vyOf0kFfalFjEdlAhEM76gYlwDXU6xI5/aFGhuWWd/gtGVrWCOw2J7QZrC3fQGF1/TvEUfB3mVt9wGTdrUvULEJSFQXYHUtq3WVK+5TP2V3aR5EyNtHN8/830B4buARn7yPjXQBwCwLa3j9q1VbkKc70bEtF8HATkjAMmU4vYMKRXfvKHB/A4kL3evsIRyGB518iHuApzZiJh/2PcUVDlL4XA/nDxKE2fSCXLo3x2xN0U7j7FwqIZRwnGbpwLME4SLEDvp4j3wH/EjA7fjJjxCgC1YptR7k/s4PnFXJu+ysrJOC5Wl3p2CUg/w/QcIP/vP+7Sz5Sqbs5OsY6MEmLkYXlj0s/tGq3QgqhNuiRkakHkjEJlvBb5+mM/zhbd4z6CA+G/0OOHaIpdnjkJOIrz9CUtKHJvZwXZXuFgWE+m3DrxY66Cavfy5jtCN80g1QKuY/GDblI4x2vtQ4opiIsfT/z39m1umgbhBOwrzkBxZyoxHDNwET6gCb6WxRWbu1zsQNyw0u+ieOyXYnbtxtmAAbCkPya6TBdLLhvtu78vaypPUAIByxVMMcCtNchhbvjkMH8JhVUTdCfOI3Bh9TLp/+3K69fkf7ZDEEzPM8+a7JW1IIvWDEwxUHz14mSfkLEI+SJJ/kpEk75mx+XUJODNSOL/3SApTd/ouh7dmg0EcUsCIvsyyjXS/259578d6BvWnVh6/1ULuRXgx/+NJ52YD09eF+rv80aFT3+9f77N3zoTIvlzricAsH62slpBKBBrroyoDsCST0ewqxKkfBIdZ4zgooTyrWDTLJL+rwpyasgYyHT5UA3Ri7OhnPAJdd/Y77+a/BTV6xX96b2Q2add91w4DpwdRL2/3Z0ZyUpvnJYHxPjUzyPNftiUEq4+AxHuShx5LQOUSRhQTpffT1dqdSmsKXS5G03/W1BYielpXEDtKU2RC5/gtox+D4rZvM2FlVgLC2BGQUfEk0/V/bpZQpjIPZOPUAomnMI+Y9hVKUIgrh+d8qVs0sN19wF5XeeAfzjWZmqZEYdXZ+wktKak/ESVN77sp6T+5xiOKCC1/r2xWr2itUnOy+mPiqaBpFJdqSLho0Uwh+XJI8tBbDt1slZTesvj2/S6C1fK+XFvDOX8jGpeE7NW3u3J6wmx9wS/C3zesLU24W1A7BDxNilZ1MwT7niuD7b2OtZr3KEi3oZFElIIs627pd6lduKf/l3mICMA9A9kZIgPMXJSMxABOmrOf4YwJZwwRFcGcFIlxe1Ju7m7nz8NvsJHgs6hukwVJ1puUTt/Ccqa2qtSjeB9utX6Y4tpn2yp+KA3S0JOVB7nxhjtMcR/eC+AmK7A7BzVAbyh8UEFZPs7T27iUOUhW3FxG7WFIdoeeXz+pNcSwZRkrGOvHQ4KounuOwiGEzOj9Dkyh2FxwGOirsiiF2UOtdwj/y+a2+2u9uNcL75hOnRf6XgvBTSW2a+J9PID6nuuR7VbbBOyDFk8gK7ve3n4o0F7lajB2iko4bCJZ6KaV0mM0me5/SRxurVVbjjpQfkwCTmM367DjKvYdWNwfIS9/pzWVCWSPtxSHhGkZF7tpyCCQhfSds4sNQPfbDjM3FpjkD51Tp2f4zIgZC3LqiG+qDXy66xapZlaEcLRhDh966yt28HMdlg+/xDJ6KdtJxEkjNpOWQ0GLwaxxTJVq+BAYRIdFf9Cc0HR+e1oL66RqzJocRV5LE+bQDEaEIpOPZ5pb3zrMGOM1nZ72w1zSOBo+f930QjKvQEnSqE5ILmJD3b+E354oteKln5Dgodi1rnHXGPoiLch9bM1mEjlmvQQnHN6wxgGgdjkkVNF2mUOKOku6JKou9IUGsWQ3xRQN7dZrcyRqMAJxBFPQBs5ENQn98tEJr29NUMZZL9lN8HjiiQCn18eing1vNIyg9cFeRQXEYnjJPdr9oKMH/V8g08NX4eO1lwgdH1gMTMZYDaMO1oQnnfytvf7hC6qoKJbXJAlOut3/CkxUV2cw3COLmuPB3kA5B7HUizk1dxP9mujovnaNWt9mcJaLg6/PTuDz5P3nkQdsP6/gogTsSyAfTCTSekAY3mEgXnQxK5WHsEhYcNpqGQQXYdeK5gVBqf7miEbonnWf+RKaRfLEy+llmyFbo+PctJG4fxZl5FWRjgSaAVQjvIv/+X3i6vEisbKRs2tEFIYqZ3RML8BtUyKBlB2tcWxV0Lkyi06RvKTT/acyNddXrH3fwMuOowGEoT1QbYA4GTcRcQzJctDwrAjfKB6RZtiiDgV8dYGf4iSn4kd4SEEOwFSS4r8wB6bNys1L+iPAFuanZAvKtyA+EgFC95TXxET10KL7AIU1XprUiN2bjiCMVGMC3mZV0500nGNVeVKhw+DBJ9sbAFvH5OAesxHPQoGMAU6tvpunIanfHZGRa/0vW0oFpaExTMC5fMtBtSAL8lDdeGze1cUxwEYTw6yRsK7UKPIEK5aQkIB5bch/+loxRkeXAHNJAsKb8AqbAkFn3LlKAidYGgTmT9SEOmrIWCiDdjqv1Php73oU45bxOchY0It0ETICYLMNw+uPQn7FcSu9yrf2b66SxXKwWW1LDGdVHojeHjNGmaPcZxn19gvZewyU19oM2qdN7+vjyE7hALAKm5sGmgmf98dMZkJOX0NMABFVgHoKKYabj9ADpObd2BqkiuKd85KQ3B5iNP9wVGAZnZQmNY9sdp72OCwUfkIzTyfHx31bi5KKnl0RIpf43tddqzYNKCuvNoftrhl7qK4p7SZD/uWr/jZ8gf+Y2EYHtBFp9+Un0BDXayFoKpa3kyZVGkNVe4RZlx1GAwlCkq9rD6Vv+CVxp5AakWCRC+rBIT/IPtx592szWj1oo0wrbxI04N+DwYVgK7VgW+3MLAyGh1Vq333gCk31BCAAIQjlzaHVcszKXschiH6ZX8ta2RxKaW2GAz+4xJn4yobJZbwS0B/xjxY806gpL1fdVuOqTFtr2cwo+jUQ/pdocysB8dwGeANfiYmGh9EdRQrIm+6j1roSn+JqP5gxAUucBMsrik7OkqLYUXC+uhXhCfa6p1mRS7zN/qTNT4V+tpMu3iTLpFH7F0y1ICoD6ttL/CWUv3EE+28eWIBra54M/BU75htDp+vlBSsM6yHFySv15JkOKfU5fjUtryPTeNIlRtr+fibpmnPb4/pQCgkbmN52ItxRrZP1/Mj73NtZa3OI+jDQnDwl5NnXmJfcaL5PjoXoggh+TGjLFt6TD6gmU49wx3VVvl4k9QyQiv8x7HeCckjfTc3WGpaXyc9VAE0AxpaKLUTaqnjFmQ7cna/E+vy1RUYUbqxUnH9jr4vpPtYTFtFsfq925FLIfExQu1DBCkdFwAGzlqKpSnB2oo57pkjvT5VFIWIkc3M9pZ4iIWEm5osUnm/vUfP2riuWMl0QAx3AOTHmTKP4kqkBUwDjqQtMEZeFxrtXR2MtCCll56iLaPfypetZieodqhm+AwN1MXZWBPpataLb3HSSM9GjcnV0+CsIU9TVdEI+miqBzhOMdI3UM2gSzLirUzGlRIcsxfuds/eY6P2L49b7DaESARvt2GtbfhcB3ncAAAAAAAAAG4hgoQDQG+lQO8b/jUoJKjqpqbT2xmA9h8PSc9GCFGUt4aD/HOOmVVgynaHXug3u2meya7t1yUWIuGYK36GOnBmtuqRz82u7vhqWWFfEIZqWmW79Z3paqsrqif2tY7cFP4cCXO+TERauIKO3kqnJqMb1VL6AXfePh8RrJdK4q07+DSj9Rhc2TsIiz4t+sJGnEHmIYOECgg7FF+NLGp8MqUDn8LcAN9WkZ8CwtjyoTAt0IdBesY1p3+WFoIP4+rth39a/VHh8H8vxhBRQ+echc4k78hL4R7ZrFkU4zX33f0p/TLvmPQD8zjdf0s1ubbJkNkKDuhkmunte5f/72cDi8sCTy5VNLjWBAwCvEqslJJvkUgQXK0hSDUTelKro60s53vi2bVXvo5uxK7h3iqcwCWS7hgi2vmeUNq2tX9XADhR6EwIRs7TQ58nfZOO0BLPTjLv2KlnDAsErW4txvlfzZNYe75+u3/Vci/6vf3me5q2yB11Vz8B4GHNZsGNRLMliwCRP6ATPLrz+L0bjdPdB7BYTAS241IWAWT5hCSTQ+0IO/Pch6gOZeQPkggPWis4KBHSlfcgythxKkwIYnHTa/GlbN/YS0jFtPgx3p3h35dlLDK3lNnwCcfq2QXKF571tyKdr1lMSfo9Jg49xxtwjLM6zvBd9nVJO7dbyprvsrDfxmh0wbdY1FevrvLIuiel3X79WRoksTGh1JXPtVetySy2vrL4FWrAOQpQcvK/+VLjeh1K5J/0kEJijrr8UWIi+cRiVvDoCyNEQUyBP7c31hqJSnnndS0FbQNQj0vhT26mAKGABb+8dUpT+LBTyjz7WuLeC7mzFo1FHStINbnFtm30NoVD1Oz4ehXmyo+HmrNn1qs65yseL7BxoRHYcOesJPey1+Ouq1ph3HyRk1vgrcdtTf7cblsS5lMH23cPmeusCy/xTo/HgIvBAd29iBpsVwUNH9hP2wmrAtXBJCHeOsnWsa4CY9NGH1iwcKAUuXNFCSQogX3LlfhiXr3JSaK8xCgIp5zLAvBUJftkesjuRfm8KmPuK98aJG+5jVoEvEifxKUIrTYDfTVWO/CjrSZIKZ+Axzl0kPEf+nbBzfKK22dQykysl1eF2vuo+ZQxatxkGJs41gbSWHW9K51AcLc+NVxIF2KCflzj2kEP/mHdIEmZwx++hSmPDL/1LHXePJFBAdVr4kBiDjF72r2X5hAJTm6gEkwzRWV+xpZ0aQVVKnzVYNJ0f6I63AdpZt99sMiXWV2+H5YjEByCKHLd8JIlOi+qHPtPKIHabLIdjDOsqiaBGlTOWvhPf4HtpJ1DCgiRCwMITow5YpPn2Ro4F4BNXd/TZEIZESwEcoWrv4dkRPf4LDG5MVx9MZIc3IF/VC949palCds6xw14kP23sMYrXWiN6VlwaWzLSWLbJCXUWpCploXi6uuVmDVK+7vufDRU1YfaYj7StyQfBWb7xk7VO8SeF/gqDfgew2Ig2q4DABzlP8NFx7Rwvho1HE/SIfL/sy/EqnY7n4ITaYM7EaIlfEQnDQdq4sKAn7q1BSKECleXELevhNnnP9ItN6J2xk8gcxUOS44oc1QAyJy7pRvPw+PRBjpHyQzVRLrZHazsCsuUVEUDgPSBIegBdWvpK5EphD9eRmsAcc+PeucpZR6jemd2BKOGrX5+QXZusQn4/gMg/fsxe7R2Z3eHpzcJF1JdnsBdCP9bX54dTTHC5bag+J8LlbvE1U0O6yIb8t9jGvRgJYkTKBabZNdBA79WyaZjMdBfjoSHnjYFRu2r0p9t89EMGsuqoamLZbo490P/w25xCjLnuETN5mNFUsgMo6ygsj2Tb+r9yXhOrBTDAF/3I5J3EFtQlh5+FnckUwNrqxIqxzR0ykth0ZXGPDSHiOSQrKuagtAaoqQPks9w4A1f7POvYGT5q8k2pMYlwjY/pdBipkvaMu3EUSgJtk7zyrB9yfTfow5HgXkEJKAxx9EMdGZJ9Vl7TjMR1Z5dBNl/Tnmg27Z3mA1s4ESUK4QbBwWmI4d4xUfQviqEOJchMUgJjquM0jweJviVsdkAEhHuJL+D6awj6sro34QZdWQil2svW5i+9by/GW1Em7xp09C2ie6B5R3/OiYPRZn+Jq6jCMgGsxj4gnmjljS8C0qZpvxOt8r/SyrLQPgo+lOlmLrV0OETGOor5GKRzPTMg7ndn8saW17LzUc1F8srhwoiQqy0ff3oxFFNBmh6Byn/hF9WybCa4iGmigJGHCOiXeDbH6YZsjyEyLVok6k/m7B/DRUD2FuUySq7Wn37ZfdRTrL/V544DzxxVkABlNV0Jm6hFyThFiSUi1O8Lp1wjnjvbkaoMw1Vhe+OpI1IvqDTydZ7LOtlu44rX4wCpnUvYUzRcLlhIxq+v2nFVcy92+rU2QHyB0HKmCO85VNiUWFEqWPhTJzlJTsljcmTeTRYitnRyrFxpyG/Udnadi3AcjBDtSQ6/2gCZEm8W+PDnaDr+COdkoXesUbL9JNMtinr22krhB8UMY3OqhO+pzbi3wGzZAvgpUw7qtItF7+lokxYyaqqxFoKtYJOxg+cU9PvNEIZPcbExWSLf8TzUNAbIfv8vLho9QG3yKIRVR8h3lDt+BhtHtMC8ZMN9z8XQJK/qkJ8Uu/nmYKm1v2Igva77NN/bRsEMUpmVLExA8+XRxTsoKbETXyOrIh20gjgUiMk2K85ukgDhpwj8hq6eAGFCR2ti2E8YnDTl3uEbXTyZ30p1Z99S6mEgaTaTzPXnjzhmBQAyy51iJ01achVrFzN7S997rhGC7uaVUK0ANvmt0qXDq2Ovutf8r4Vr1c+J4QCfDLaHAKX7MX1Otjfql0byaMAAkxhRYf0IlxCHurh0z1/ZLuYZSG/LjhFvqydMcka5Lz1OUuZpqMXaY1DVm7WPtDj2w0AvzQ1/HNHhIHRAWe+WtbBQSiJc4V3DBDSH26fZ7fUo+zuzGvNsZ5BP+ixS3yUI7k33ANPHYtq/hJ+zWyDozr1eHovk6F7GId+dZ/zxDwmOFCUSGO5NGgBJfQw5EXZnMbGYobKR2y2fN8KYw4RdXUpmTzxx1DlEOqirqbM/Y2q8ma60f6rieNibQwqHlmR1LOxksAy4k8bqJV+j/7Pz12Rb7dm4I+1XgIHwDok3M81lICWSOvHVULKRX9jOttOYUODDDawq61GC00E/mB/VM+x6HSgD3xK+zJLvS7144fah5Dn2jG0c+oaOLJbMIdHBrivc6BcoSYLIH8xRC1tFCWVtX9gMh4O6w2GMeP3+OQ7FW39/78F8OncvZ19bnt0DPLTlpCgckfRWYANA0pyLtlpazkzWShtjPVuBj7zjqzL153WqH3m4Zu4BHQiRD/MFAjtZZGItdW4+B+FpzyaHkCwiM2oLjzFRKzj6wf8Gj+D2IRMETKREMEQ1zdbDl63kKsij72Yni0AzoPMAcfLLsBq6lisjP/RcPHrB1Ieonp+rGVI1ZmrNWz6pvSARCmXkpyl3uJypBWJEDbMlHrYGPdi1muN7UZ0BS5Wy+gURoB4P2IrELGfY4kmk5lfoDwdKwwmqqpbYHclrWnbZZyFPM3ddgDl3Xeq77dWunTb2U4eJr+wp0BbdQg/Sh5+nw+meBg9VLdrAg2SPlUMD/ZGj8C/IMPM+lopjUQatCX3NTQSQmUhv2scc5Y9Sb9OBy9Blv9XP3h7yt0v5sAwpRXAGxho6L6P7iv99ZQbNSXPAvWdzEpAwZ3CdYt1sK/oQPj9W4Mbye6FXCqV40X0V9oOOds6TIUV84nCOP4sdLXY0Ucbp10QBIsl+8rTYQ2h0oP6BfZQXML6Hmjsco5wPuYCGMYl7rw1SC4fAELu7PAWJKrFZbbnQu52eijKjDktXNmaG84XDNlXembB5T3hGj8WSsP4CT+dE3bcDahdihGd01M2fpc5KCxfAGcJgDLrRTCUdh+AX2FmVlxCUbUqKbDSBMzn96lfJHirqBgtmImHg9DqdKAqk07Iqx1MMlSXeK9rORDkOCM1TDZstreRxpGK0EDnGouJjqYpvvFaq9FXJd7f+e7eEbp5c1HqAHw+lWqDAKU1reIUrlbMXQvilxuYLZXAhl2ifYlLGYr4xtrBV/IIFzTw2ofot4+oEPeBBRifM9hrfjHSj2+/k3VXob56GunuyM3XAlSG32Y+7C4orLfY9Hb2G+mPJ4HRGdKnUJueN67wdBdQUqWuQmFu8GujBZE6fd2+D8e88ZL96ljIG3sMsTGAy5mi1Ig95hZVXir1YZwaaQpWAXHmHp9QKgaA6UasuDL6M/cwD+pZfFKYr623+IwYibflnNnTkFg30QrirUesvWh2iOugx40TUBuavAcD0MLtSugshMVKwmDzkVWKa/WC70xiS15rLx7Uayq8TpiKSnkrhnepMYPZM66ylxlGBIqjanFJQR/QJEd/FWfcfYnr5VsJsFMnUcgoongma2QGGH1W4qN9H9HzcLAWXJ7m8wDiqUOA8u+mwghxyb5ne9doC/MZHlt0g1ZxGS8VnMl5O9kXFURu4m4DqnCSkIeHJactx8g9/113KT2zOPCaKfzkfFbUHktEO14EZa12fKw6tJ6Lae79oemdwRHgCxEe8es3K0xr3BVeWe8k1QJq95zTRwCRHkh92wjw+OD2+8E98M25iZ6YfL839RTnx6sV3oAL9vUtNOg+ibl+oJpMUBA1FtWdRwMswp8PSuaFb6gEaFeQvQfnRJOrQ03a7rJG62bcp8QiiQr14maH6SE7MTu6BefLD2RrS+qV7Idkr2Qe4+ko1haMgf1JrKrW0AfLkOdnrurnrZUO23n+Qxhr1bg6rwBaMMd3AXN2zdivkJPLZV1xnSfSHSxsqoleQ/F4DbsZbRelApzjmErlfZKVizYvHhenGf7y9gFewzbc6fB6pUyeOJsfzbSlEPwgUJ0nHpIsvOEwnE5T0ungdQxZaaO5yIs0xvfg97MANaAcnK1ZzwIlPKZEYDpQOY2Rell587tlDGXMYXlE0TlPf0VyCWlebbstKhqruOXNjHofxXI9b1kvPGkeXMWJ983ASqksyObeDe16OHpmP6Yy+/OZ4bNR8SI8lTIAgvKulxrSnJZFMuhJqu7BqY9WCa4bFMOO0Ag0BqVF6vqydND2H2z76VK4RskipFNJJGTOlw5+3vnVVbdgCBwG4AAADNHtbocb0XItvxXI5FUPi35NCVf0QXA3F6e+9e9wO5Mavp7tQULI7L626ttmtRLselpC1+LTlurjgs2CLxL0NvFm417QX9N+1yvQU7pCIi2nlzie57M/uCsy33KhL2gs3nNlfHp1J7ed4+PDyIGzgHkHAtist8yCsnS8tscdLuCNFRVl+L6Rg1t4vDqnfSH5s4NMq/KCxV1kQZ4TRS/nfbfYuXr/h/4OMj5GZw/32bGFm+XSyQU+JRgkl7n27NymB8FPPGNzvICKSCJOauGBFU8dJztPgWg9EgYEwNO58DIpDyX0YA3rGbL9NJPsFkLfIXby3kUdiD0x5NCjSVoTK3eAW7c6GYzOoUzScfuZYRR+pOGD6wAZfwx04Xd7oj2aKpUMSlrTl07v/W3RvWraA4CBRcgbKYRxO+554U54bvzRdUKBEFe7dRSwnWOJLKiWmlUJJMK2eGmGwv3RtggkQrOKuvRRflULt4CX1E0Qg3dkGUc9d7LqoiCZCdm4DgSrXyEf97n+OXTX30RwRjWU304hstBS2TYTCk0DMOuz1bIsApCIJJKIQgP73qJVK4G7QEpuXGZV6pRbWSNa8MAutDokzZdx+3ggk0ydaOUqMY6vjVPr/h9Wp2Dw47iXGlDk+Iw03nZwksPK2C6beYSUWWCmeEKkN+OUK/8+cUTnOkmoFE8ZvbcDPLh5YRTQW3rOdYkjVY3ywC6gdAMzsJUiXTpQ6I8slFczPSsBIJZrtR7z3QI1fYKOqnoO87BzxyA1Vtsy54o7568AnQdIUcaRoSG1/X8EcJDqaLl+L0wkrtv5MKjAm76YHZ+kB/uTjK1g08SsXgO5y0/+8UTxl1b2DO7J6Mx3y3dQzXaTFMcAscou1RyDQrEVmfKCSRg0Xc2Xq64OuIt+VibbNVZXePQ3SqLNYkA2x7jPnc2c7BZQDsnY1/nDfNCzwrveHkK0aO2olvm5aKeclJo4u9orCeHraIQoh7Mg4qqAqUn+yEKwkT2rcw8ZagIsn1pxT49v/Hh/mS9BpPjXw20SXSp19QsOmQc4MDApPBTp1RqOB7HObl6RhbKPAMX8PfGQWeBmz+hQ200Td3Dl/4M3BrRtx2PVgJMHvGB5AYeNOy5U+G3+L8RbOu2HHJruty5WIAR6dow1RO6j97eKVBrM08ahWqDwoxO4fNhMxF/Xtlo8SrHz9tRP40bJ1g0CiaB5udlMRfccawv5bhUS4uY8Q1cqNA097F+bxAQUEgFGiAS65wuEDdHsbauehVPfPsZCPj9f28YNZyMciuvG1Nfnzq7vQmMlloOthKaXG5ZhQCTRS/fYtDT57/Am5v1kQHtvUPe2bIy44Ci43b7lAHeOloqm0aBbHkM+eZTRdZgPBhdjNvv4qKTS3bXtzKlWnxgRP8gXNHMtJaOnugg+BKnDkV40tSnYztC8g7n7lFvzLYXNthPAIKpBjZoyVnvYUf5rZiSJEvLibR9ys0Gy/lZqfO74Jmq2xCFE8WQ48G2ueRzFQZRProHvmuODo/lXOp6hkMp6YItSv4wYu8Kli5atRgXsVbevzzUs++GOFDAcj0NSiMrED3OCoOxvLPevg8ADnTjDCEg71fwVfASSgQaojBXv4XRRsEJEExbHIuZM7KUf6sbSt52UbtIjcHcj5GqoLQ9wJ7hiIHbYCv78MSgUNYY5GAfVHJJEH4dbh3z96sLiIUNbTca/Elq97Z7YCR2LvHLQmnw7um4aDQt1fwxMoCOA/88nTvLuJrWuNzgAy/by2MYnU40NfYrz/w0CTtiHzzCk8zZC4r7TZTRbhSRuL8tDBlskpsDGkvWoUFyRSqxjxasY+K06YfbbBj7q3BnE1Pd8f085aJ/Gw9jGRpwzsZac71iB7dNwBeYknPrpvtvxYVqPuqV2hMPmPu8bZtpeu0LruwI39me3PcEvGrkT5U/hZXTIjNrCVlFuMzY6y0uZTahdMZ+Ho2fCiKdI0a8uuQKkPNpWtgeIlWS5jxk4j5y1XjczbfbcOLEpTyVID15LR16E5LeJBhsV0vn9d55QkyrueJO/jOITSI3NnPIPgj2wC2HA9u9+WEDSoqRjXeqIgLTDRn2c9W++Qei2qjRnSE9pzT5Ny7UlSIAvtkmRPKSBm0+BCalEuJvpbSLOq5yMdwRzdMmxFuIFAH0inX7DA3Wdm3c75Jqzm7Zt7szLK6Q4KZY6Ta/ZvP4fux4ZTzrrCEysTcLjQhHx5PQZj8O2KpFuZDhBj8DUGISMsRAScIeSr72RZ9cSexM5RgAtDdFhTM/nuJh/Te9fbOePw/AFe8cLkDJ0rzmFjs8/r+lx+5vxEba500HRF9ymkhRZ+tEjjod6QvMeUUsKS8TPFescwomDTjrRBjhuueKSor7NnepKOF3LBv2bge7mz1k8kGA7sfunH7UrrphG6q5+xnAJtnpbzfdgDMpKOP7vNtZWydrVBYaXrawc++Edtwjcdq514Jy/HIlqOBLgfOY/tKuV9cs1iyX34Y0D5hEZ9QHu11NZRxmtUeBI2V51BiT2Mq2neCTpMggeYWFphuWUH5upXrtZlk2E1DSGdBEKGjGyTq/2CBASNWQgfVgj2viKw4MPJAPH6DoXOJtRYvRxAqYkXorvsWQqNJ9rSVjWXAIGhFb/hUr/jGR8xN1ABnnQT+KbtFrSPcgpA5GOnjAxBCiR231gy2VYWkHeUEdajmv+UV+sV3G94QDK2kPDa1WbjaR+oFGK+9pHu/1mYLsq9nXTWt0m+26TLb4eWOBvt+NMMfaI/ROgkEUveJzSMT9mMIdQ89w/HB9LIAyuXuO17YslCLMKjxD+ZKHXK7AR1SC5/Jzia2URELM5D9aAXj3dL53V+MEULauC9htkJReS0wZmO7hCIXhBD45uJAtvcMdApfWMW7adFX4HLcvSkGQOlEMtvsqksAqrDhT4xZZVNSAr1zNj9DdIxCV94MVOIaPiSOtq0ngM54v/EyhWHtDaoL9EOYkG8igELxO/Dgf+reUX5V/nKUY9pSTqZomZM+KCRd9UZLN8DJwD30cs4KqIX2PWuPPEo3pWVPoiVhcmvKeaflsgeT9KrPqRoCByXxd9hsKnLVmm5r8jZHT2583e3ep1YzY6TPN7+J2ss5fT/KehlUPPWEs5HQZ3BSY0d6eD9mKdafeYcqQN8gS7cFZCu9sCUb1fnerH253afLM2Pr/ztSeBITZe9axirRDk4p1Ee0Woq+9hkJ/dx1ecRiOMOfLiuqNclqG+3w81OWTkyK6unD1u3mNPlFHDbARzsZKfpUFipUTR0mZ7AHQmkSKJThXqI9v1DoSVizDhPmFWWk9zC+oSc+ynLsW0u7JyeCd99ME63pfNx4j8dh839ab/el4IKzk1b0f0VF7WETyaH08Veheyypme4YRf2lwrESqYma6eQwNRRccv4xMXAhKQ7HG+70wW17E4nFIzenVF28BjBnmdoyJUYJ6qbTQICIU4xhVzJva4WvezNVy58OgOm2HUQms7elOrOOx0823dMEJG1q6zPaWRMycOE9HBY62hRu6KUeMKWhZ7sEe7ycsgVJmtuFVLqYc/CxBZjkdTqOcdF+inWuSg7/mPKPig4C1elGzLICq1QpFucZs7OHvg2Z84I9MFZERPvh/rzA6S1Qdmevf33Gf+U2Pb/tqe6CUy3BdVjXqWPWraox5xFKDpdlhL4HcI7/WcB/M08xqsBH2HFwrRc7v9JbEwfSdkjdWXQRsPGKLnfMgGWk0naZKFQE5ueajzZQJyZMl/t5XWV7a8mnXz9bifc794ff9z8madt+lUt/rkSaweU0tONO3sNmQlhGCoOS8MRvX9twZ4AS0OHdc+vA0WQfXzsaDaBTm4uTbRpxt99n+3AW3WBJOso7EfQPJh0Bc1ZKaLKg/DWkpDZB+cQ+qenbWf99M6fkj2EHDV/FxQR0jpmBb9D4eb7sYu/VUrp4uH+k1tYHY7fbmUg0V11ENUOUZzvgDhbFk2D1W6zlYRzTN/PJdaujhCzuAxTcziBW69wstJYlzmhqzTRUs5/YCG12HOqY4s6UnOoPBUKiFmM+iaCDTLFZzsYBtL/c+glwa22bg65x4t/94/vN3vUupahEdheY+6Iidtv2zPZNGHcBYQahoIxucMNsoxSXW8CFgiUOVG+KTwUF62f/ke3pdyuULFxRwOJT9MN43HdQeVTfc2ummz+4tzldohcdOfe33jKvksv7HqbqZ3vR1ZO8c3rg1TTU403QrCOLKFiEzKHkCm+AWKeU4mSg8dt3gkIO1pOdhg5c7+EhgoG+HLBV+bTPGM14iTlwk/9+ilcvXGDXSVf146/7zn37fZO/gYyL9fn+TUdpARUNNO31cuRU/GaVaN0mXTmDt55nMSXctC1AFOUmJHpAoU7ZtjPOyW8OjkkXZeHDRz8YLWrOTP8picaGox53jcPjbip2+YZMn6lORqDU6VOFODWlcB8tQi+Abj/JcitbZpy6EL0bNxCFp0KOWEHqHuqX1LJx0ij47OxAuvF8slTT8RxG33WcSLY4pVUHAwvr+BrDf3UHz88+UN2Xf5NVZl2PvJ/oNnuimEnQmcUurEeUYIgXWni+sy6o2oj2GgWnrEVzy/nUSI5A7jL3IRU4jbzOI4vNJJqCxQAOBHP517ubt3hvnGM+kGst36FbeIQoUSCOmcrVG07CnE4Jajyx1Qzk18OXOlN+bZiaskZ5CEVffFal+IJg8FYrZjY2Yp0zC1XH6/43R91MOqfOu+GFuFTgDZ2X1hZ+HuxubyU1Ua/pDHA3NwAJqTUnTkAS6+Wmc/nygHjiw5gX/ToE1GWm2kBp+2VDspkb18ceEJNFbvjMm7u9E0lZUhjeeWCg17LUeq10hgMO36c4hqjKCyqnX79rrLBLUx8Nk7uNgwUVYJUtU6H0FbFwU3p8BEpmJINx1OQPzdlVkAghlSN9Iq5qNnxL9cILH1GmJVO9ZgYu7bRXFhs/hnsOZbl3lacx/Ure3BL5f3RH9bP/axa+jkKB5ECRZI0y25L7QKdkqxtbmZsRtBsWsRn+ggLHrirLUkLqMgUNGqIRGTIpalcatt2wty+0M9CzvA3BoKoK/mkOzhec/A7fTQCs7IX0qifWlQMKd3isLine/2qKv4+esvPdxG6v4HNA1jdoJ8FCyNXTHCH7EEiIO8o9we2aj5WZKLZ/Imoaila0JdBrZ6mc3JeGrOshuFS/bbzHo8VYBmaQOGgMqV3/eYb9VY6AKLtyYVJXONam0FEJgaaQ5SUyGbdgAuiJPq7blsR7hcXMnbyZRRMvLsx7zMgj5A9IWMJnYa3+ZbxWOkhpjLB+hXoPU85XNBmr06XmQbsZ0OjuvA/7G+WpfzgqnYZivls4zSrUh6W8i0YyM3xrCz3NH84KisbLxOoBa3QACr2kiij8siiLOsYD07bFe8d0Lz7Dl/Thow54f4hcEeE1ZVZAkKF9UlMTbFOB3l7OWGN9wKQYYtZRV9LsqN5C/hKxoN6RI0CWb8CaKOTuLTRkV9W+awwfL8MeoSz0GQbaPZa0Z8373nhDTUkL0L9ASKcAWlw8LKIyaPuTr8pf87ND1SSYB0oKCeyvEd36vk+sSl0/WkGsboHBrN0kY6jmi8mI+MnJnl9Q9MBMzEvqF69mYADAl7INtR0mo3kIFr2Y2dE7m5BDI1NYcsPmkS0E6OLcnrv/7/q/n6pPRasKttph2DHCNWu5mJp4vZv25C/AK/UzDbWIj2133zBS2FxrSQSKM6uzhmTJv2uqm++N1ZbmAou0Yn20443fqugXigfgziFu4MCP+sYot7fzJ+uAJoFVwDKDBbrLNSXCd/HwT3FWJlKNdrWWRFLRji4c5y/a5YNlJeGSCexY84Ndm7Y49RGBhKMu60vogNXZw/CHiWBEthMJAI2x9UpGbtgblLhKtZuXYFNAHZtT79hmq/Ef6p81RWMkRuEfITTh9LfcjH9O6Re7dX8LFYjWD9xGjZ0LxcxsFOXSDZliXsLf40Rgn0/TnrdcYtHxIvAvZXI/4U3fEBV+cR+aPk1DCCwPRxHbdODgIBMDElwTsQc7gNHHmFOc4qVyBtgl/Sz8OCd3Nr/6WVEtCGMk9H1+Mqn3K/KRnld/u8TYMSCiFr/omeQPDNHHFO5f7E4eK5KsL2fSCzd10nzjr4imlVglm61I19p1pzLVF7RuBtKisVFKjRkvADhg900iDegmxiWptuwwSFdti3VFzb4EEAo8Sq/SC9BID6olgLcMRW4jMJjlYr4Fgqxh30zMxXhM4UY5cxLvh+jWHfPVmp12uNQ0LKT5p7T09J15afkLYqbAal03Akr+E1g8PkoaohH0jtCr8Ldgosx9Zar26QYwPUoaxMvkk15xaotiKI57DRZbiFoeCTUzVQl2QAND79nb3DIIsb3oBr9LqQUq8BVHesH3hyg/LyX5UiyfF16IWOPprnhJmmN9eFkpN5cqbvHsSKtWwPWyQ4rg07/1HpYEkAYsxS05fARTcDfLOBPJP9Ro6QVbqyfVtEowJvqrzxIjeyZqN2pKKfRzsX2ogMKndBRLOHm+2guorDh/zmca01wsLBe+JAvW6h/c3HVB/IJSzLs7pz2KGEzOjsvYlrwfSf7q4/X0RUhrsQtqfDH4t2rhROgZayXKiFUc0VFwCJybkjRYHPRJivr+tspTuDQhYFj/VomCjlhNFZY4014izgHiz/8S1LnXJ3ZOkKjjj3Z+1pZF9JJ9rOlE41tAuDF8yS5/CatpdbNbuL34z/VLjSQPiUGhKxrogQPViJB3txrJJ4RQe5/ja71P2G1YXvVcHE1jy9omGNah9t9sQkKM/T+eorK95nCeGDZHMwsqFrA3Rln/zWetAcEtPW4Yo/2ADJ4s+y1fe3nQWGemROMbdhnz1C5MPQsFrPZFhE07MxedDoaA4W4mEy6ArRJDkMv6rNTvsEita5+IRvW3uqtZ2di/NpjO45u/wzTLI6MQQFgGWZQH/l4SFAqm3byX0NTsszAW++QBOiNaIJhuTWw8Tlct4Mk0aoNTRP+EL/KvqseLYiwqT0oakHPTUHRA7wBqO2dhMZZzWSLlqDwq6ynhDGw4S+acca5RriO6VIZRw6qytPU7uV4E2gZPNe5hh/6vXuge67hx2SfHF4P2CYBMAhzFdqzsTySDBOKZOzh8AWDn4MvXlMASOTwMv93JUUb1pPJFdmzw1F+7ji8we7W3ilrjC5Z5WOBkNDrMchO2nY8BO+tKgsNhoZDIOfVU3GuzvcBFf8Xj3vvCBiPaZpYMSWWLnqLQtig8kFg/t9wsvDgruN242aUlyIgPX3yMQprh0nU2Du90qpUwqoXdayrbLiR6fgJijJD+SIth7qK4723FDarfCoFyur3RsSdzy65k8eTQEiOTAByUj0oOx7tCUDoo2nRQivHDj33nhmG8U6+tzqE7c5EbXtHpH7QFkVzPSAb0f4lpVfBSWYxhbVj3kjSQnBSZk8Yg64j3J0A00xwBJDYQZ2sywKThO+qOdvNTY8OGI/1P1rEk/eHR/Di/k/16VILRcB3OTYYyvvCOcnoKmi4jgZXGJKgP58/NtxuNGDJbTpRIzIVeJ7n4lEKNVgPIaBR3Ev53lIwkjhlKJG1eNyuapvytKFWiHuIrOVBWcYDN+NhUyAvY1fAvHQVh5YjWyO6h5RP+PBpPTJIss9e9AHzqPSU6Lov6tvuCHS4gRwEYw6ftsyUiW2KfGGznhvgK9Yd0jjOYBhpQEQ4JG/B/ynTZXistfk+3GrE/olknfbSVgHunR/Suua5NeOS5ydHSuvK3zDZ1U2ITuNBH8CHJpERMrBO8jcFlmDM1HapHKhRPga9McUqDTPxilb911Lxgzyc3RRbHMophRdhnCiY61hV08fMvTvpNlyXzuEFXy5eaVPlUmluMWIbBUAIT0oRBSqMARdV6FX0vmZQe04+eo+39a3VVd6Y6Zn1w67hu66edg14C4LWY2jySL77DZWRPBHIkvP+fib45NBIGsCmBKNJjYQGJRSh0rFsSfVOHH/9elt1JprHu6jnj8FnWYN91zi4nhdngI3Pz7NgwM+0l/kZOUzWagWEgF0zT66uP2XCcRvcxH5CmLzfg1i8aQW15oTu7oAkaQakUY4JeMf7JhnTCtOmT6UBOrwLVWTgBldwCpsy3Wu/k/5zmxe9oewwS+Q4T4o0XNlR4T5mtewd4mAwUwH+bxi0DUFOax1GiM505oQsHUp+7W9ySEYX18O6g3QG7RSGd3WdofXYz+aWxdVilUWKTsIUAdwbPwHa2si2Ck6mcSmGGiMvZUu+I2zfPcjazkCQ7SPn/IcBf4sUKEbsREaw8smyMIvyyvrbYjo/jXrsWZocSeNI5+sGiR+lnnzwN+DgbnCr/cCtbROv5kw63tQkhu74xhcUI8qFdWYlo6uogcVc4httUCRfVGKFxmlKXi3kfzeApQYN/5MVQXvbywPJ5dA36lq4Dh6aBlJ/MZix/DRCnsRRY4fPx7iEQDRlVIaPH2GboXIEfnORO0poY9TLJ8/EXEcnI3f0DO0rMjj8gxFkRcRDenddlPQ+MyLwXRxMXhGUlnFrdniMVpYaGl2AMIKl53D+rK/BnRwKk7CsqeiS9VotzNzLfHW/Guz8bboIbj2Td7JQiz4+xrrOIsRrssC89nSmAbGxL+1ydTsQ5kJ+yRdDX3XUmCo7PYS19A2s+qGKWF6pE0V5liVqWQelARgfnZyCxiveLsrIJXIyQaGxVwCsyyg11tSsqblZbNFAzUb+wUPrxov9u0tx2mrF2Q0CfbmIljZZVX+ZYj+nngvjf9QYrXfW4jLOlfG0sCHrnLNcUj/8FPDsxgXWamRtMQAFrV4n/FrfmsG5tXxlg+vwH67HHSdNGvSi2jLrGKA4tlChkzj7IBowsiAIOc6c/Pbwt54C4b4bFYxyEl8PajrA57d+Mi3fkGdiwSlyMqM82B1bvJIVbBGVAJ7rsoGBiRj1fhCyV29jVm3NLbIUDqhZ5N6nMVsqlgx0nI+/e5894I00G6uJpSTUVvSf40A1cKOgIaidHepCySoxKJ4wY3pOufBMcj4y9cMzlFPzMF2DKAYssfb0urZ9RjGBI6Bir+d+yovAdExQ+9aiXe6vcNVipuhjjwbD2RZbYtFqHb7LAufOHDDSYZyBufW89gj4x7bHZsRd6yN6RE9xrdEpxl2apCXr+h2obVkFaTVNuntlbYf6rAfGCKpe+dCiHA/AIyfN1Oj0smS1ax8hViF0/Iy4SlAnw0KRjQ2j6iGxgFnKPgHCBH2CkWtTuErhFodKqoNci4GquhK01kurS2g7/sn6Cu+cw8WmvQjCD1Rfai1ZjfEEuyNwpDCQRZzoC99qUanLo3zHhkKwfHh5saWic16aANIHDWSm9wxthYWurB5pyj4sBlyBw4PtvdIWsQC9HPdZlvxHrMbVSPXxarOqqlCLed3iFOK3IE3NVqWUDaLxw1xZ5ta6qQUF1nuAGCR3gUSb4XwLLjFt+cDODhrXEcGPeBmFLWxX4176tqsKSmZGXhod8n0A3LBgexRByIBJu08hJ5sOEvFz72rwBBuhU7vNqLNMUPy45iqOpRByX0cEZrQqRnwUk7MlCFBwWWv8nz6B7hhle/tfiXmL0AQZK6Zq4QpyjJOdNfDD8jQmKUv+g7+6jtMEYZdor8aNVlKzx1W0yq6LGp2LoKEztkJ8cU5dGBqXrcHpnOs0NVBQE4u00GOKr2vaEzXdwM5YTxAPCoUzjiFMrqa1kWrM516ARV5yC0XdIdVAGKYs2qhPqdAGmr0JqvNhMLtNqOWjpM+0PWvzJO9nN4uxKYAo/IF3vcYT9mivcqgZ8dZ4uYZGPWCggo1s3sBb1KGsnHvcGriZCTvRJ1IPbYw3Qg5Z8pE6qTKCmAnx3eAgKCs53wEGnYMnz6Hontvt8/p0jL7Q2YjacGWKgaAQ7UCUAU5nwenHzbk2VDbol9tGsJf7kl7jokikvM6/UOkul4jMgikwgL2+P+4xslyGSILYUPd6ZtwjQyumV84O4IfJ51M6oqekT97h3vAGia3vASbp/LOwm5aew7syLWW9sSEIolkkdZLmD4MOWSf9VYTCIyV1UCTp/4el4sbWhA0dRqdQkWtFY8eayDNsyDd8I4qnBa3b+vlhPevN0K56CPD+9pBbQz7d7QnsgDm6eI2Hf7dtmBAB2lFrjc0jlbemVC78Lxda7kGybDk9nz2q7wx6Js9uBaeAVOSdXOl9Me6orPrBow+m3XMtNyo3T0j3DcBGzFkT4Fp4lVXm0DVoNBaEU6VOBOqzQrz7ly/ibYHwalSnWB/a6ffzf79CC+siVkHP3gRIOssCaDXPQ7J0ZuHgq6fRAMG6E8JHOOqVJcdHxcAAArVLv7nMjj/DxvnyCCwYNf1OSxN4AMw9998HmDpou9A+T//A6fbuB+cs9A60b86Ync6jd5oSP8dxpk1+IU/vEPuDF05huQrQV0cVS1GivwCf4phWd6zAZoec8ElSu07qSsbCkh6T8amSUh2iauk/kLZmDenQUx/iTk8e6XgRBa0NcRi2t0Jq1E0iyUKosQbMGqVc4HIbWUdwYDjHjvA4JLQwnV37qMTUMDQi5eIWPhb0YpR1IG+ZYd9KMXz9VjuRk8BvkxmulNBYG6oi/xXvFgOfiHDny+KbzYRmP+L51850KsGkzjc/uYL+yz97gqWKws1ZK/AefTyZrQJUH3RnKDCnOk1uhjyHUBgEGlnDHmVy06z4Mi/NR+F2O3DVib98qTTPaGK/l3cZo59jN+JrRn8+tPjwEmgQMzDBn7DQt9ZyCXimFEl3xwLMcBbdBohbS99LDjV5CbILJxRMO2s9/KA+Htu70y3UOE+FOSKdOfAMlYqyZJPsrLHBq0U9OVu8ZwbIl2ZXQxcPD3DoaDsKebuvuYQ+iljFf5bW13lOGSz5qnNR2NtMnirZxy9IAmQDxzg5DthukG11gvMiOT0Q8pzWOeT+t6+DTU0w579DbAu9saScElLrAR8ZQy/j7I8vBN4OJYJGk+WXmQdFscykBbMGcsD+RAinqaD4JQG+0v7IGCSuXwRBbFfnYhiLwu+D+lrUAEVGQpgX7IjZJmju3jHxGCY6cWMzHIyI33LQvmKR35BMFJiVNrMGpB379dAbdjQkxIbMpYiPkiacvoTiiNZjEBrCawn2K4GhBllJQ4sfPQpFGgMogXYhLM2GhqHIZvVxuIu+N16YTwAreZ6zxU3XRQYhJid0M1OLQSnvtKeEyOs0C5f8KiOTBdQoVTEYsGSdwMsFR/HNoi184AAvibYbYUBz8rcqPbV760GydOkWwtHBVvfm7RID6Prmdo13Fe80JEcMX5A8AlfrnIz3uVLf0e6tke8kEAiSmTvh4iRtvoIgS7bQEp+sGQvlemDPw1CQE8Hpjq7KoDcS561mTcjP7UwWgMSCiQTkzWOviMo/Ec3Mce93x0leVso+rCNg8lsCdHHKHhtP6yfE8ySjfiUVGeoovZe0Cclwz4hRua7Na1/cDwx27MXsvf1yg2C0+7T8ikje/i5QEPg2f4LrqlpZ8NvWmHJ5DuG2JRPuFG+qgaa+cYVxjAjD7UJJ0pqC7+Yzv7fDPawxgZ2R4upDQ9/7WevrtwOdZ39i05oaORp1n4hWUfcyYJAa2qHK+sKV3BDBxqe/Pbd0m8NiX4nUeRKzVIpXnQJ7p/WF6whR4GxUWTJIXLKLqWPGrVIe8X8H6/6KISUG5PajMpYwerk1b2kQoZaX3ufJUY5fFlIGwgngC959FqwfQAl2HWJF2BBJAGnYKW1NMkaSthbDuVlWcwJ3Zkmw0XsWwdQBgqdB/t7nG6aqKoS1Q1CPEVnCAWYkRx599BPKXmkHpJeGFgNxg2bvyjBb7649VZObn4wu/khcOvfWzkHnGQzaB9NPiHZ9wMbJprp9P8So8MU5As9jssPdB2oBVH7H/jo/uW/StJfd69CIVvJBuSZQc9BhrLe5BB5PrsCiOtAIzomPQmnF6qZFpcBpUwdaJTwLwO8R5ze3E3GL96mKUNuOrNM2qGLeF/JJTMhxEvQUNiuRs8faSY1cQfx1pp3jna0CSuS2PzQqSBpPJotGaGrzpvsx5VPOmkZw2QLm1cYCNcAIUPWZLUWeKXAePXegYeMAXGddYN//ETps5AqcHK/b9/nbW2p0H5n1aKF+NJuwAs6SLP13/wl67c+T8v5aFn7sLWAXCjQb+y0VSRwI2l76swL/UL1dsAQik62BSJ2V3V5Bm4IK6p5/zjOk9NX0utYRb6fKL8VC1z3ihC5G+lrObCRLMPMedwTZ+8/0FHceDZB3FZN3/cMzsVA/BoCQ/O1F8kIb0PR/Wp0UFTwog8bcyUgy58DouiH5hUMBabJDHGmAvRtcYfsl0UOYGrDjcucWlLVQLHta/8QUS62SYk5//TZss8ILmdYNnB3C2EkY8Dhhj27xWQ3xIIcuBhsSNVvEo2MLUMgion9kpmJ/rS+8aONGQfLXzddnwoZZjR3rU8XGy3f6zWlYb+debgxXIw0K4kLroFLKoseITxIJMhGCGwe0g/MptPCRpGB6QoPWk984GgsTjfPjsI68w+CAOGZuSnK/olbnV8jAPwlGctf+EYK759w+VwxvYK6DnT8N+C6sECXJkMnUMupP4/Y/6//fX+B5HYTX1tV15NVJ5xt9qsAD8aNJWD/XPNv+tnhOGZnRQKTFyP88EDlZ5HEEJ1DM80enKHPBsCSN7BQeSxrIn6Schj/mPXvBWgBO13iWalSFR43q9lWsPWR/fJTrKfa3sePGEF9Hv1IaKzqwCBoH+PS9usV3qhvGrewNc740N1RBUaQscYxNCi6GOC8Lwv8yRF/8pJpA1V0ZHa+fI40RhUcksFQCqZl6e8bp7ZygFJlgCSZIRFetDbaNq57iRlXbe+g1wnvesTrvRRFLZKptiTToN2VTMLlsi5/Jj0rXlpXLRALuMEhVvU0Hmv/u7RZn9c+XYYvPYpl8c5V0b9XPkPgFlgX/eAkD0wcZfht6syScJuNPmuo9xSh/oa7mBSGR3r6NIoAFxzdziqZXM7oY9HYGdSJeOYZe6quSb5ghltRPnO4cOFPYNuInycqiZkRdFZ9KtfvwJ84zrp6qxXbaGrLcc4FJq3BMxnfZcoxu7p9bj7CzDWw2oHFP8Wjpu7Kjo+Avvyh3lFiw3S3JebERhMdqxR+GYl6W7OOLxs+twgpSgCqcZ/qt6vruNpI8fhzclxjedWxH6rVbpNHUYBPCIZxfxyd1BRYCJAo9yOsuCzvzckKM7HOI/5uuj9o85aVm/Okhtngb/C1lYIJKTh1pD1A5Z3RxCMgr/BhWxUzUTOCD/PpO6ALZuT+CzGCM6n1UxtQ0grykM3tcGSCohwOcWh6YsK97kLNYoBAQUwUf2ghCoRJpNiuAqwsq0VJzisUWiGGnzbOfPLscuPIqvFA9HFb55w/Pp1Q1uCqnraOs9KYZp2GQnOmTNLzmkOiRWbgW957g2LZFTRAYZRxDzIk1ngH7UGLIL+XAFU/3B6GEgNN2EHIiTkYMOF/TZASuuSFWCc407dR4bEd1U8ghmjc+EoHygy2Ve3azdJSNVAUXXng9dWjFYw4O+ABsHvizsQxZLHzhfW/ifZfvBDM24KQgluHcqQ5LCNcC9j4ZvMlSGQqScmH97kAi+zWUPKF4lLcW2zs4IQj71Gnk8xsnm9e6GLkkBy++CDOPwf0SaXR9zztOIAExsIAMK1XCBDtZ99Elz/d1kBOA0RXkHrbzVL6/4ZZYd95jyiSFutKou7MaWH4JHA2SAyjoT2uIr2DGCVbgpSNpaaEQ0uqGIDxEhAFX9JTKINIKLFMqYgUOi7ukR+graA7cfAmCUbqIx/f10+a+0m6P5ELDT0b/XwLB4tFMTZNt+D1nrH+i20K37dG1a6mnWfnN6bUwAVaCPCqUuPP0Zq35NMZYMsey1V2+ik2o07OeBrv7xXoc7txRYD9DYhYz6i4siHEJt8WzipRfrx3nNDtO3mN5JzTTdEK3WFbbAC5Tjf3z5kdaXTTVGZE6y0IWAcTy4LPf2YpEa016qBTLJJS2e2ka67OYVTjRmUkWqEtLOsI7q7UKj5ZOxefx8j785z2MOhQtzLKTwjo8DDLNI1LiPrWTHye+KXMAZiZTkIM1yWn8PX/yAaD4q1Hmgo2MbYYgF6vzcsyziuqQ+BOeeXZDGniMWbJPtOgNSYGVphY2IogCmMVtSnsa8h+dT9rjyCXTlrntyTzvxtBuYS7whI9YNMNl9iWwWl157yEtH5KeOiN/nYzzDsjAt7dyEakFRzjKfilZl6fmB4MmDgvwqG3DB7qoIifTYqf6z1/f7FL1fA9vQVR/fimdxnzhLrIEe7VQ3EHL7uIjpgCeAQrYCkmrhxDFsxjFGrJHlL+ZBa0wivs/fWTjVyilmDU9T/byGvozXE6qxRdpNkwyl6QqySQWdhPX1VwOg/3rtI+ZGmR7HwicXks0CBn8K+YKs1N6LueG9itofp4onyY5maEgn6aTNvZm6kxVTZXxPHiT2ZnphUmSloGTnWXRVzDTEJy6A0Syov+MOxYBC0p96UaD4bdH4JZFi9L9Q/Q7J3oUJUQVKemebuiRkAkqd0IJXfdjEgCxzbeip7Q7EBKS3xQ1uF1G+gNL1ZeSfw7H+WeSpoD4EvgRjEqh+cen7O8LeFWp/BtHXSw+7riKy/cQnqRlD6SNZZbgWhXEmaB4fu9wQ+Mo3Af4BimdLdQykvBU+OQEJrSo7Ap7nq5JC8XMjT4ArLuoKQKobyke6kHG0IDwuGjetQ35iIUnZAg67P0FZi+3bIUFfVSzS4c0XwwrCAeJj/xFrIlp5uAJS7nmnDUxsua2wDHmMyReW/cJZvgrvbVJ4I6WZAmX5MTapkXgW7qMUXkdhXDRH5hIA/Q5BDlu9v7e8SHxfAZdROqK//lwdjoUNhSYDkh3AV3nARCbHgVNRbWyBPnpWVqvzDnBYTzqBtjQ23IQwO5qCln0EM/luy2UTkZYyIEbHUIhrkniU7njM6uMfi41OR/ICPmyrzU/pUBfR0G6xrRLbbkSAKp6mY15DoWqr6/VXBioLQX+hXMeuRDOQy4UwN2zSpW664Jf9y1lvxHc5rgNhWYf8j6Pq+JfU/WrvIzWblgcSox1Da6U1ItBTbLjfNwZmdvGW85Egp3YjsVGJvioNbCokf0cQgZJO8wtU10wZsFSD18KK2BBk0wH0NQnscKicYSmt7hsAMwXMfX/LXfbZQUy928MoKbOBvxvrfiOPcKGoxcIMBQKBZufvQ022HiTq43i+gXEAqJOp2h/ddsazl8mTKf28tfsKv5DnaGL/frpagGuHsYUTsHuOyt+cf4y48DhhsAoO9dVqUAb+1WMVV6EVAaDtCejyV32MYx4Z4O36ZDCsHmULFMQmmpZmHO29M0LuBfsVihC+34UZtS7KaaZrlWeqCeNx6vmTDI8lK+UG0kcbCxHmb6LNpaI+S9OvCvtP0P5vImpfaHgcka5es6tkMnW17K2xE4yJ1j67oceMgohoZ/pb4WdvfxCAhkjB/SNHUwzHTXxCeKVQxbxFqUeV+Z/Jt45g2/neidB3xX7qa4EOdP7AVFD78zQJc86ThE87xLhhUJsZQxnZKMNA7LVl96gSeIKDEAgD4/1XSZO2VpmRJQBQU1j0vNRicNmuBKATilgkv4pLsYFQPM+MT2rYRnugL/ctokygVOVOtiIURk9/kJ5GHoJO8mXQfrlveaYrjUTYXiRmhSSFEJbehnYvNW7fWHpg/LNDZkmCHnQX9lCRAfakPOHBWyNkTmUP7Zh+wx4Uasr21/1UmDb/U1M9vo2Ar/DVGpUvrOP9Hz9wJU1DrLUzDZyoAhaKcLBJ/YwiZuk2x3wkOnh29+gtklI/7iNdFhqLEyy9kC15zqF3YPqkz2tl7GkHmByGGthrkpCXMz1ZKa5paCtNYIcgXIrXMjCCa8UMuf+ZG4NPOyeU842aq2UbqQtDAk56WJ6QGA7P+BjJXT0yUujKAwJ4DJQ4A/cNdgSSndghc7i9hNkye+CnFTzCc4+gf4NBoaUo7xV1dmT3PDdzyLiFqx7Sk+OHvZo2GEYfuDivXwObq9rQtyAwtzfRLgmxoYs725GMrvnNnoKsunMLryWHw8mfwGReRdSUhpX5ECdUvmmFw1h4Kp4igg3BkYpJfnu7lSzDpckSPqT8fuCx2qfjkXwyJIl/qci7UqDlpQ4Os/jQQcA/hx6e41/Am6zRyK5gl4SmdMnzypsiakNjJUqPRxhNKUUlB55d9JZpxHCBQfvXbJlNHVcPdtNN9PYgfsdAILCdtTF1bYExZEashGUPa9wMwC8wNnWVbanCllZBFlDLhuZeSclyRFZWssjIJrBnwwdPpD13P91Ucl0o7smmzQHXjee7v8YpSJwyXkwqDRxgw6rNvef+84yu5ydiqJX8cNR7r2rNCEOWdBQiCNwV4UeIDDTmkQ9FM5vsMs5NCdRq4/cSXtOC89YTCNE9Qm2AUU0Sl6x7iqnK2h5D/2b4eh86YKOBAYBftOQI2FLZsIUrnPo9oNkvvKxedfEt0lSDGIz3I6mqLAssaDHwb/pNLk9G4J8XwOEZ1NhEglfjI40Zc8Xjh8BPZMBb0gCelaK6WOUinm/FnYFHjpAkrkzRolyS9y2KcS/Uek064i5PyONTTheY/nAQFjkCdrni4WEi8/VKjl8K/uDFCp/J/KzRKe0mC1nyhZpP6crfufzYLHMQBNJwLYXbZ6pVWAv9SugMtGQXNZ1jy8ZdNgFWN0UtVzgUsGfsvapdoQ03TXvTfMufkE6uCyNSWxNAAoUJJa5bR3zsoiGNdipIZvDSh7oR1zRd+s+dqNfrnMQJdrYrc0g3D2JS4bZT2/K6XFnX5lK9jDmRz4Ud/wLlLyaIgf4wfUd1FuojeGYQsMqNXAJdUPWMoR6q2OEO6CA+pqHTvN8HC53ICm12ibtcovQk3uJ7cqbvIW078Sta2jhBKjP0vPIoAPnkdZCrsDR0vFyPe1gb1eicDNOuzemqe3kYX29+yXBcOXoAc5zAkDcL/e8ZK1RWtXn+SZsatcgkME/IAQOgMhRInrBhzJELTgLzP/g7HNeIBdQrfPHhmB2+ZVtnLI5IVzAWpsAY9jPT21oi9FhOXX/D/C8c4Yo1h0BPxMhDvNWkfWSNISK48mtwfnqO1JPXLApWL7jcVLTHkDnTCv/AtKQmwplNMVXMoopvk6ry9cnrrWoqbPVtAmbjvHzwOt+9BSjuHq+a/UlQI2yyAruSIItZ1jVpRx7p21/IIC69OjRYvANGVlT36LeWgDTpuBM2IXJkYfeaRURcnp6gVYv7SXeYfske0DQ01pVSA6xHj4YO2qQ+tFje92/mKOvYOown+OJJxRvAh6KnD9NDcW/enILvpcD7xAzZNOmWuMDwD5e6Dol6wLbciha3iePFrlogzEcNI4frROGcD6tthV9wh9G9q4MPX/mNlwg+JlPBln0LBKuiMHOWiNIDSs7/NEFYwq9BjMRDSTMdAwiJTzQtVy3dbwJRqffyBGB5EwP7muKz6Mtc7NOlWw4/hMpcW+h2sOYZlblnrG0cl2zNpevMF1NRuBsC8mNntQruIlPwRPNzaM/wiA+me9VOntSMguHVGEv5JMF7NFM7xYlIeh/LVH2wwY/3PvgQwz3GvsRga3VSwCzOJjR3GomYwQHNoyuQOHKlM1IKf/G9toQ0H2R/rSn7W0TGTKI4IstPsmMnDIyGVMoDOai9t6LcnEs+cW/FFlZrw5Cya+YQ7zb1GcvvbCfUhanJWvQGKM1C4wJEoj63m69YOXrijdTW9MRo3huc+7Q9R6co2Ua9KWT9Gh/YBWLX3/soHEHXO4zs7CJXIGknePJEWttGx0mTttcbe9MESD5Zo0cgSrptrxgCvgz5/1nac235/zIdh5SMal/2kzPqfa66wjBrk1OnoNFoTkJ4wwV9zRZfb08KdH6tGoMZHI5XzUpkcloPilxMbbk+oNKoRlUHD8uqVa7suieoeyd2AQl7GQtx48p/liLJBj4Vw95ZlbbnG/qnM3XUhEY+4Gu2NxqVhZcPq9w8jCHrKKjFIs/hnmPTLnPBVjibeM7aDKCHrqdWa+j9FDeHDwoQ8MUp8JYHAHtQy1cNYZqbrAvGfmdBtuWYJFV0V0AMHszBEok2Ze6ZAu70K8SbrZkj3UErduhGAGO07HrrP9KzeniJfdeSGizr5HsjNbRFAE/jDgM5+8kugT8u8cM+Z4DBUbKsDnBOgwbJHC2R+VfyfIxGFfagIXVdtn+NYZzupBx8oEXU266a+gK37MCelY/ZIC8kxJ6/oIz0mjhkuTHPKCifE6QEdCUfR9tGd4vwVhVMQIea6ox1rftl829ug5twoxUU1/Hg13uLesfdyMcH+CnYR56Vg1ZU2e7uQY/1XoqCCiggxo7wqoAij7UGKLMLaFmuqDCiayz1xCa8UPRLymmTNcqTUcJ0h6Lsus7UwVBm0pDaSqca47J+my6K8tNkhVIFNgOaaInT+4IKfCp4o0OyUWcxNVBX9PVEjJeAA5NjY2xNTOixq1umkCXpuBlIsbphSXEGnawPKyi0QwGM5+wcAJoUtVQFIzTQK3Uoed1+CewwcMYyK32GS+8hMiBzRWum+Ar6yZKSSOptkajSq0TnzxJPFghvoiwCC3SWpNwn/4UoM8BJghOoDpRz/01q4mHpxcPe/jgZHk40Seqyh4L61/Xo+3RWr2EypfcyQYVeTvTDEBWHnCZfLKXSkFKS3jLEOXSeapLILwfvyyWrre0tYQ9x1W8EMzYKA/c7bKlwM/fZLKBhmlpJ2aSYP0tt7PNsGylr8ZMtDGXqYgvK8MqOE9xS2xisWykE6FvhP8uCLCklQvEa2nUoK3sioLzxOkqcpOT209/prtkyQB11h6fOP1aQf1C+mWr9jNelcZ5crAI7Q4ZH5pj+AuXveDrhX0BmwKFgg57CMLhCa6xovHz43kJ8/O249C1xshAkYq4MW4X5vQcIVHwTeLnH9e1WiXKJv+0GZzCaHRb70dOx19KhYHtoZKPPmjfsdRtFrM4sPQoY9r9gZnFcVGj3FROV0lwWeXO4u8hZ20KxxLiAruhb6wUoDi2z9DQMPI890W6+wb0UZ7J81OZ/FhcmapSFbqWdspCJL26St4jL8DPdsyB3meJxRYVmtK35S1URB3tptxmvWTPa32CVZAVEAuczu1nFyQiKvydTXG4L2oUUTUQX/YHnCdUjD1fdUbQxVZKMRyEmuzPAxOSpp7t8oFkXvxHJzVwQ+Hqf69aQ/9nmZ+mFgkLegs7Ce5yqLbaAw8el3nOeY5FqJpyqZNoAe5Xhh/g0TuflS+cwiw7aTAmy7I1ZxsS2pCZiM/qYzx5u6ZEPfw09hu5kD5VVligtPbstkfYzmUim4TLrSaR9qxoCWYLNeRN14DPVVDdd9pdnm/m+FpDlazL7FDOv5fexTKfSYy1LPE7jwHz6zu+5N6+NsB88YVNFxybtn7Hv4AFyve2CFePOLiiKvAB2KsMNwqjFENHtimKoeDZ6xA9tEYrUtFE17Bn81RqxcdJLHkzT8mXuH8GN7JOPZ0kr39OsbKhhFvJYh7uEqphipL9RV8XsQxZd7188xAWmbDgm02JiUVfSH/lg4+AfBAsbxH3vbabIIcHtJNf21xZwofhkrVwfkuLaGCi9uNhmv1APv0VJjCRpDlp7+yU0Y80ypRTgbhdmhGu6gJ/2gioudtV34sLzIDGB2TBkaR/vXrU6Yl/e7X9in8z3x+v9Oz3K8ZGSObEufWD12jpZwhmfYd8351HGxBUF398qvg9U1QQDU4oOSSXV3Etk57uTwGFwRytdJbt0m9xwmdbzrz5GJWL+JFdRSdzgvD7vLbb7o51F18bPkyU1etbG8vKlxx9Ed2Lnr9A0kelJ+H0F5MIN1TxTVkuWLFdVPmXGki2o2gv4FEevRD6UeC2fLqRQDDMLK0PIN9ZXjMKc6xTHgjUIse2rqlmpk3WQ3mDKjcVVks3uqOGi5eptto5AvMc6XqDih8U01UVuqAEPGCBzI0RQpbWxGU9xPwCFQMQzO1Ii1gVvGEXZlTWuGi4L92CHBAs5rQv1z+nzlsZ5psUCVvJa6RlyeSebDm4VG8TUurwtF950p0Od6tJu2kqHFn8GW7Ggm8QcNQCE8rfsu4eFOD7clsbI8soAVAsr3zWUsO+xl59BqJfRqN6i0mguVCrQM+D4oZmW6gcEmpxTxA22v03+JLvjR/wo4NbOOyR4ea/ODGZalr1ukTp4oXW7rqhrZAl8voiBReAZSmnhaYWBA0GHKaEITe+aoDdWTHzCIzpcxW08HIefSb6yBvCrHuKqVZHvtj3j5RYJgmFVwKdJMz5vrKVp71h+lDHEKOsjqr2zuUNNYHiZKCvt/TtOexHMQ2iTFEuvotKHl7tngyoAX09Hm1Yz3w6nsKD745C1pYMKxhGhpAyzzucVdmzYJ71lD/2X6NuidslvV37NHYeYdawDn2mCOrMAM51dQVQAS8MDQi5fNNc/lhc/mgKQkvUI3u2OQtxQsaraXyw0oZtYbN2Q7mV5YJWj55Vs7rV519o4tKVXM2M63nNEhbtFGSdA1IPxqlgAEvSyL7xM6YBJKTkv5MsOvDazdAWcRZ5mp0WAUBzunqJ/HYckJ4BNhPEL3BQ9RGrkUDXvrLkEAVitzuG9GxE37d4EGL2DJcKTOvH6YnlKoueEwSk1lS6HP7bsMUuh0gKogW6CRNb6qMOxRVxCw1Os42Qi+QwlOgUu0cV+7t7M/SWXEoaXhB6XRUMYXjDmVjm1afm2XQfxsR93pheoEB9phgICcgAGW5aOCnt4S/q80AvdDyS0Cpmcf+pVqNsvzACtdBWKBgweNCfcNw6X38JX+YaIWeVtvDhYiUmMhRH5ILE6oBM65rR+zH/4Z06K31gqEgLkTOeGb1MxfWSW+G1bQBrmVAKfcPFv9WIYCb4A38KeTPO+kHiW6uqeReJxM96Oa4MiiWne9ztQ8ikItsru1FAVqKEXBRAHPwnx2ExVRaBEKuCETCl+PnAyOsYHeIqNMMRxMkTs7yucp4jkYt/5NRGDDMr/cxxip5U7Gz3hKmMwranxMFcvtMNjuRYrGSIc0JOEoghssRDadi2gH/JGu/t8pS6lHIOcrGp/1xmhbiwzPH5oEoxexY+oXz7anf6UMv2L/TyPlIFD6UBWqHdilFpm15IWMS42fdMX4uBysvOdaFCmFuOUIBauhRe64t+PiVZZgL/MNBnlpZwkprkIgyLfNWgMdwaYM96iIFtguHBBqr6c9c0F4cmVuE+dNW3AEv7De+fTQ/vhEIhkNtoKUjkYbFPq15MkBrecWAD/RINz2NDDCuWB98IKmVAOGa3W7BjQKT/5ZuyHc0pFmVT2ZGSqRoqtCY28oA9usYkD1Fsb6omD6xlnVwZLLvRXSvdMUV4//oQ+CdbrcoRkO6hzNYc8FchZ5aX2FtM+F6CdQdvxUQNEu4hSiIlojyxt3GbG3nfi9GQzKPzUSEMKvhMwjxtZ1lLwmKq8Lez6x9mpKvyhOGmuqmsAb78oWLIC1lLPhuWrwC+u7NexXqbm4K0OeHPa3gdT5zUZ+gJ4OyhhWWu9aPVkqipWsEs0n4PIgGKC81YkIeoLfAIJqOtj2f2zdcsoGSW+adqMSYcKImJSQ3uYjtt44yfGEYLUuD+0PELdshCxZmvdUljZhZxMQKW4bUfEZkUWfIr6lSilS/pW531jAeY2TegRGn3S50xFBTHvorVkjhCZEWl+Ugr77EaACkscDg3ZFEwaHUSRCy2JjCSE83lvih8530SuwwpODWQJ+2tdCJqH9vmazY7InSwYq6PIajFShp2URzqZLPZvN8Wn7q//J+hwqJPLr+1oGwFoE1zs1rlzv93/OJwp7JTI/9s/2U10+3aF8Q91c+TERpvHgDcwKi7vvlR2qeqhAxpFG8GjEDOzcOqlp1/8Qf4WeIbtcF2Sq0n8tHyxQk4mxIfS7Xdlyox2VXUzHMCqDVvZwPUHDj4TKLsH9XScXx5meudzz7AEjnVQeNmaUgRsd7IVTcIf/S0tg8OkDuegkcCB7snASK6NXSv7RZjRHvU+QW2cllcAYh7Ty+8EIdYVOQdO05TnpdYS34PQuHcNx7X1hDuKP6iABa/oY+df5UjruYmMEJ6t7N651GArTszWJ8ctui/Hif7y20Z/jdqU2E43R76MNUTLxzB3Uj6kjJweQ7H6jaTOC/WN3NagPkqxwKe40GdV2xXU6Mze3Fpe/T/1IvzFceaVcllDrpFzdNthaYiIWIU/kBqzDM5PcSw8QhRGJ7re9RzKb36wkoeEzvsIHeTUuik9cu/0xsgdtWKLJXCzefOAcSLO5psSq/elbAnT2GPyKbXptmy3V6eJ1GYRa9SsFGyNGoAReHAt58PLsHEMy9OmmnvKMPfkklwy5MEujj5EuDxrr5dvncL4+5TJ6ooCYwaT0R55YlrOcqfG4R31OF7SSZPALCIWdtFWdxynDEu6BKFOYrYAbNn2OPFhp/md6ycSzJx43udCbrUeUojdY22erBSpGwv5bqW7QUyL6bYPhqvXh+HNSztRAac2K1G4grm8oqoiAkmgx4SfOiR5Ul0p66P2OVnFkus5w59wzMA1Kamt507MmRSNDUgjy9wq5T2pYX1DgJ5kttsew6IZglbEBTmxNt7b4fudNY62oHM2mYY9N9LeTcn7YOjnH/olFKKf2oQAnuox77PW/TDSi2pXibYlneEMHaC9irZz/t+Ir5eUwSJ2tHrSlVPS/8oTF9wr6OOW6u+f+TMx0h2tcdt6ySsbaZwQiVSWWlvtGlnaNlB4arPC3NNluKDlmNNMgkS8NiAERzVsl9rjwfzluyagFA1OUEAZ5iUk4pW30TyuNw9Srs6hlQ+94j7UJXWQCiXuuXL4iT/hhkBdzH//ToTyJ7kkJi/FSdcTgtwCU+mD10piXfTWsPKaSTaNgOENQW33e/YWhB3YxtZQL7UTUKc1sUrEMH6DNXpAtgxCX4M5jpqzuC6dkZGCO7cmUkBJMPYbittOqoSGISlOlndf10Vv+5HUhaYCJYlIBKsQm5BXHSX6qJbenNnaGzP21ECjvVfuxHi2asRSpcCaHflYURZiq9b2cTILZtIpSDYYk9G9aIy5eQOEoHdUTvqm1ADySbkSct8jpPXsBQmKdMjeI8qe3aaLs+ruvpMKwiRzJ7qjTcGC4uljkjHhLVUz2Wn06XMf5O8icDEAR3Tkx3R3d/BCy8wN2e3OCWwJRKM7VC3RtPAs0ascyUx6lDBo7D7BAx4tMDiflA+9g+iyYjBz/TY/Fsd52ST5FNN5m3iXxs3V0mlAqotGoQkGLGBa90hHHufKcfWOEVUf2/S/GFzmWKjtNoDRvhKFIpWIoxKnOXleL99Z8fAsmdiRXjcbKm2k7CeAZHgfAlhlV5cFNqL4pC25t9BL6Fwe3YzEapJMiTQe9gWXNmT5IR6cvh1jv+L12eJHHCkTznWG/dgamJj2mU5EldNA9gNtICEJ3wlhAhjaqQjm2kDW20dKSxhK8jETFDHbc5f6y0mCAHnITEl7aDoZZuxhQGxinfhstqc/X12fmMvc+ZViOZEBIUBIFxPYMTGaxMvhytAbbVlRqiTD70+NEQwIbr67qmSLWCE50hm8I1OhhM+lVdDduOUKwUYPsP7WkAu5hzA4zlBqXYvSwqfiOV+M9VVbjCC/pctgIyHFAqgWHzrYWHCnZ9POCxOh9n7eSnhFbahmQnCa0EvcW7vHJZlQ3V4q7kDT/TSb3uXt9BJSS8Huk722qbrl3x/CNkPtTdLz2LMvOx8DGNclUE4qdL08dd5v/9Sk/jPganFLu9vcRzcK5GNt83fTtDx+/nFIEk/6+bnpM+WBt1Ge++raMiCNRVuXIWTudkvFuhdoCAo4wB4e/XOZK1OGQmmb6BJ5CfyQZQZR7k+WkW3ih4LHpLS1o0REhpVNC+uhjY9DVmcwjrsoJWMelZ6JYg4DRi2Yl1v+NZ2AdFKkmm0rRSHc+sj9o6GElO6XQCwWxwNXqYMPztuy89Eg9ISKneQ2WjeTNUUBo4ceO79JLTnYyi0WkKrY5mNDsDz5vAtW6iFbdGzEfEZPdoVqGAkS/6OuBaB3D7XjcxLsJ5pol/Qhzm51eisDf7f+QMxiD8yokhqgyJzzcMOeKvhsWIrRxoCPpjnoW0BgwMWyD6fykXHgPds7ftJfPnLT9xImw98MSNMRSLVuQYuww8iJjUCwVQGKhU+1oTHEonAOWjCJt7F2N+BCeLua2i1RzZBqDdgIXrV7wZx4mIerFVNXgX3lu50x35k2lT/kegOOErosAPJdzCknInFRDoMV8rQTl3p1ax9Npctx4MZqtNP9Si4eAqpuo3XQZ7gCoxa9AxdPWgxJ2pMtQ8eEL3RmyDV6aAk2CtPazQNG5c6rtTQkmRE0eRp78dUgYBVXiU8MXxWHjzx8WSbrBycjW5gIjkfYU16FbwvLerRjc3d+X0stePqNPiZvJllhPIS3KGpuKiNZcRQVhVqQlVEkxmnBXLCCqExnN3aUEgWWDXQFq4JrwJeJSGpDCu3mPGMzLLqxcZPvmyoz6eVeCL1cVUaNO7UFghldnhDbCrrpEI9aEBMwiTXuQF28q+G3nUZNAALgDyehJzCPPpxR7dY+6zIDgAJKhb1LXFG5FQPddYKBJ+6WJ8zX2QO7lQG5Klc590OFy/ln0EljOltGmbedK8m0vuJKGNouX1oyHUsrLrADdQjljMR6vklwxP9ChbcLsHaiXsKc6MLzb/vmw8A+oYkoxLbxDVJ1PyVpQBE9HwPMBuPLLT4jxopSPr+mxt3LWCiyFnx18JwRAGYlSDPwSUK4DKd+5n5pRSDw3esxJyQ4JraGcZryQgubdK/9kkE8yE6NohpI8HSpp2JNA42MztAxdNXMvTOhseMdUMfMzMOhOV/gwT9DSL1UNkRBzIBf7MP+6tdUup3TZWctimSgFYDnd1A9X0jnlR7nXokXPzehe2e/Bqtht2a4hVnxZjKGiSRLeua5VgNp1Dwlhai+F7vkDv9eoXQ3O8UURlP7fBVzSSAd+FH8aj0sDcz5IHFWkE43Pcp2M2ySoMwxlHe10lMITT3EaNDU4nN4bHakGJnQ36ZrZGuGtvNfV/vKxPVGZMoU60MQg5UtfLcmIZWeEv9KnxW/ixQrrQSbvHfFDL9geEi4ra/bBz0zbxUN5vhocJvBhD0uhhVUEE6KcL5fL0i+/qKLJasME9knJzQCqpB84NFmElYD8OF1glOck7Ag40PCEB8VSs8zTCmB6Jb4S/hX3zeC/5rBZc/+QMd/HGjmgA/hTu91pdi0u0PjUQjFkc5BlYHvcs3Y1RRyAAfp0X7fbLblbqEM4B3kiUL9z7Eb+dCR0ij7qMSHMwOnnDVAvrW9H/V1D7kir9I4R6CEsf3Jq+B6+pnP0LIY7hUdJES3SK1m7lzoEDHw8oGystxglIPJCDjuABH9z8gmUsFfR4xQ4fTI55TO0GcwNiDhdHrv7VcdzNrDAi5MrUfA0uSCrjSLmM8/oaQkLewoTLqfHbWCzBsOGp0y4UvSy3z76NZ6OjodN9gfRyRIrWadwbcKi/3hrsD1vevh6k7sKZW7quMTe9C+Jw47RAgFu6AQtpon+K7bJnReopjVFGCReiz7FO9dL+mDE6lumcW074/m3XmFv0VA6UweOEvOCLCq/o1ul8G6ksSUVcr1Af2knIXsAwLxp9Pq7Dn1AFRoGkbaqfWJ5Srxa7gUVvcc81VDA6KcaaPk4ORiAWwSc7F9+XADhUbAaz+e+eQS8INDBTV3SvUxrOnstoLwe5s0qE50igKilDFNAFGqDipZZfniG4wAEAruSDBHkAFey9ee6SxqOAfWoCFu7EhPkME8KtB9WoLWzgrRJ0oL2ALFz+uDyQGBQEAvlp93/TntVK2Tf8+1jvpvVl+1LeunZrNng0VSJ/smsW+IjsEGOvkwPa/M/Rj4FHpPQAAAJzbG+K6V3x8fx9eE/aDokLtEP12kCb5mS39dzurNHsmacMqN8I8ak/CWsPeW7OlqPlRaO7CeQGpx4KUjKGr5UpOcEIfILAmEEPomw+5QW09sqrRlp1kzPCppjbNJ4XY5ccmUEVGYtS6u6rxcEsUuFLoTBRIDDNgLRT8t4GpOwyyU1hiTAhzPjOEZZZNVTweZGIyTqk12n8H2uVkUgfmO0SOE2zgCamzVJQeUk4EN0za8E3SiAWNlnzRt/a3QF2Qi5yKCD5NbGPbgt2iVQpUriwJToGhPTjEwEce+WJGJIJp0jOcw1L7uVTNomeouL62WXATkbMPWN+i5u5av1iowzYiAbzbN1Cio97JWpY7Kk+PrxOQzEb6q8LJeBe1qdc2ofSBcBwALXtvUeqNHqoaZl/rnOCwMp1GsSVzhFs15TvSWkWZ8Q8qJepqZPcDXeSiS2yAbh5NlzDoP6IfvgzdunhHwvybtutv6T/P5yio93mmVMS6/d4E8VgXtrUf7RrmnGC6+AR2TrgOzkI/6YZAUa7lDxHzwEJquQwxDfVjop0kA5J9A3NulmDNnZRXEpt0f/eDlfFxK12EXFzyGtOvGYSOYzomeSAS7eenT3FvqwO7wwiqXbmr94qnxHx0TAskXtT1HM4JvB2eM0jRUPf39WBasigucaNEXm62FGwDmPP5zdYFWVx61+47/ia5NxFRqkSXEnOhty+8sabxK1a2gcxFlx/s792n/jmFnpwPdhxV7bwIjWAZPnyeRy+auavE2RVha0S8czNFnPfjDvU9Cv3j7s7r+QGqvde491rd34mSO0qijJFdT+6twynJACbUCK1E1vohS6zHzqzS8jFbHL7hjdl2jN4Z8aXsfHdsOK8PaTDiDdJFJs99P8gY4bu63TlUosrAOkBqYOl3hAirPb6NgZc0prtK8Pk7Wey4Xb2XBqkuc3cPZUPZ7a7bieSxJgcUm/1uebaxCW9IX1hAvPsCgZSIRYVh7+vGRKRzCMqGrDCmdNkyM6gmwvPRGydeZt+nWpfQHIUx/QP1HereLELgmr+ffIU6lgfeF/p42plSdhkzO4HGLWJr+V5w77kgqcACYFbVZeo8o4KIBK3q6eW9QmR+5apk/hVpWot8cvsEnNkID3QGBCTu1cD/iSTQd+BV8ekpa84eaaZvGWj4eppwPoi7Y4oM2G24g3F4K6Js3N98FIGbcwR6L0eyYb0gmcjagAioIy9DiBmcyGHIx0aPM0tcj7auTuwmvxYNHMDkO5bMuCXnArtwBGmuWGbt0Tw2MDtUB6bczmQDCN4ZbkJbBonSmZeXsYwg+xMDdn0VMUJwIqFbuQ7O+iVl4CWHvp+SUSekZGULH2oHQ9OeOKA+suyhGgINkv19mcDgbh7PwJOxNWoYI3rfhOg1lpAOefShNZCYphnJrz+FGWGv1W8bbs2uaTaQCvK0BKs+WFNsAcXPHX3DRwTbdSuZvfWBu+aY3zrduR5rSziz3M2heXL+jmS4jGoE7jspkKJvNQErPAj3Bm592+75CAX8KYtSfV5XkF1ll2b3xHAhA+u6FQUNmayXsNcvVg6e0ssAiYsSwyTvGZv/tauWPDgPk7BP44j50pGmDkr4Hv1jS5x5IWOK8LIY3cyvf+HIxoENbhGYCzeG8gZPEHjG2S+/A9XXEdovVLcVHoCiXxJ3ukiD3fTTXQsf4jChr83CUFBif0uqS/gqrCpB5bKFJHQ2N7Hm/Tv0pr4oX+y0vOezTvO3TxjhQXLOV40NuJxMrzr9XsUdb1zWA2h3DtzGRQ7INzfW5aOAti3IPHOzcskNYvJg/V5Oen9wvoZVBdDMLy6zDJS17RNOXvHiaEXelWuY9xlCzC90ZYQdwZ7Ukasex2l5XqnxLd+A6z9V2aRcGINNm90MLGHLn534o3VeJb9nHVRE24xa8y+8mqudfc5JL5glronr30nFRM5twPDPer9/2p/5L9LzgFihfUYCslPbBXZzew0STElNfavHtrTgjiczg1dXhfuDJIzW/J6v/UVCatp3FdGE2agSZYUnJuZeJdHvpMCzHpqO3Xj65pWGy8QckfR5XQWgHaqi0S4qaWJNaOayXKX1kKmhfEBVTRCoWZq+cFY09tusOMSWm3qgV6Ksd09RGXvRoYTnRz2depAcMurQYj85zn5lE0KmFKm4jFeiKF2Mwu3gJpnquIgZLvpfeN1E85KVgWaoEo1MW0wRO2Nt0/o6PqHMJZkor+y+4Njv3rywnYimZoKHqAwlLbTb/c4d+yuuCpdyPYJJwB9xbf54FuH+yVc9ziMpsO93SihKe3ZxesdyCTOzZgjY91U4ETv/okZPuMEuNORHeqS7frAulSvYv17KY3dBdi1Hi+1S5DmRRHhVrWSl79RiuwPEnPmia9IFrWQGnHAHXQL8RuUuHZNqFXb46MmA6gABTBeI2Li8yAl/dQ5sTIh5uwOawpmgF0eHA1ztcwYcFB87YF4C1QwukuT+SrjmU2rARU/IJAKay4G/35TKl2cmnqtLd8AQYbT7CYyOlPbbioISIXFpaJnyiG/I1HdP59TPyYZh2IEOHODAwPgAuYSDzBBELO5R6ROAZM3bhZehEgbo+VVi6oOZNTU4awgh7kK/WAp9QCPAoZ0IVtOVJlhSUiWdQQIQcpzGNrGitatw9umW4c8BguWVuVgj70Eze7LDPZ4p4o04mXUaWnReIBnV3RYKCiK3r0swBdZLjjicj6kws8Ll/evZAvYflAPZ/7Ln1X2UUquZtg5MbioUbAsQpX0XaySQJwExDXmu3FN/uilf82d/Pd8g4WfwL+wPfE0OWPa+KRIQCuS6QmGX2pAw/t+T2dmAVJhJwRUu3XwkwpZu47KxF8TPWPz6o1HZ+Ts4G9pFy+cv6c4q/ZsmeaJu3icII91MhaV3ufBsus83st8jvAaZSl4pTarlGGZSFcXkfw/5+oY0ZriI05Ch1gyFKx7+tz3G+/iHNQjD5TUJmAeTZfCxTZb22tyV8O54zGiNp01uTG+4xijFgeX2qvh+AVowmnJ4IlI4sldzXLk2UziZltrjkDlP9AMOH+S9KaqvbpFO+9PoJA3WVsMrsjQoEQmREi2qJ5Y3OWJXPEUO36cLiKscavoLVFvxPXRpH81sPiJp6OpEW5hj0P7gF4Zu/vhHYhUXpZQ640k0MjLQZdec7jdwKz+IQj+0NZyC08l9ZWJpb9MxV9vK4FOr1UzAnzIOViJdOg/N3fcu6OdOcQvv6ujWpSGj9btf+piJ3teAfoyn2RRPCmNZSjhfT7sYWejZeuAqzqNris3Iaoh2E8Y55u5WK7ds2SKu5c3uzI2LVJ59NTXIiQ+R3vwOgGHwFfYYamMA5QTTeRJTGn4ClVaxYSei2DxZ+hiap2C9h+0SOvVsWskgV4I147LIdh0+lhJjk+FfpZhCDIZLdegJJww9G9lkMdA4RKVbFa5staVZu4RgD9cN/GOSi3qJLRdCDpL4DI+JsG2KgWFZcUaYm3ZBRupPAgSz7PEPg+bKRp10X9X4m0IlVzLX2yVp0s5F1WZOHvA5zDzYmZyfE03/+eAVAiJWeR1Czm7Gh9Psi5LSGw97tSsvrV4VXmFf+mb6XfsGhD4Y4sdJRRjzjuJAId15+P4Mj0LeOdtXAqb4bQTf68/jQSB0ZKLQM3bC7KVM1T1KiS6ZMVWeNBgYHi3jcRhZBow/TKVGiTJBdbQca/oQh71nfnUHlw1EuouRYyL0Ieus2l/8obPlEsCNHsK+DtWTQnoIBYNI0PtLDGwWks8jTKUt8hQElOruVaHQGTP1grjM7s0Du4Rd/DqUZ481dGMYW972h8xHVsCrIAWVY4CpfY1gNKAc6w/jzIsbMMWR1Kv9P2BPw+0QcLXa2C7apf4vxkZJjZshQehn5vsQj4oLFf+ZPXAxADDCK0aeBt923rB0a060OtmNh3L39b1LnlYlz0y2pr/FcHnXD3ygFbGl1eJnN7yEZeD2pc9PqByyU9TOpM0LyJZRxCHrtOEWUiWBQX/1Gh8TOvdfFtgRvY4TPYtyquYyeJnCWhXjmYITAUw7QbwwSit+wpTQJw27E0DQYcUfIkkhfqQ9LXAAAOB0lE70cO0JzwdO2gw3Jp7n0HAu9ygYFTzjx1YmqnX5gdfdGOWo25DeZgjkGfBRXEoNJc1JIbr9JdeTSdsWVjNkPgn45bGjNFRJg3XR5isPsZjS4sJtHYKT64cEtUjnP0NzDCAHbPJIcsDHGul9gX7GnwqgwqLsh3xfP/KLXpb0X2fUJjSk5OrBOaPDwLvRpZZr/wicNg9uh/1VzAx57TQCywYnxiqUmgXJKe5ZCZUdXb57ooFZoCz6rKYLYEFIk/iHRZ7j/9jN4qr/tp1E7iLBiR14sQr0veTKOdC+LUlSBXdjoQMU5ptN6C0WVsOrA/B81wa8M3RKsWmCD1clXP2YNvbZMBvIAggLgWjxGRhe01usYcv+F6LqbLJeaQ+OS0896nI+WhSNZqRFCX78XkQDZhDsxyvrENNa+xEIx59uvQahS03Yzc65Ark9FS7Xcwg8+YOx4P3RNu4cJbggG7Z3PGqsc60LOcp3cgsB0kjY3ywJqGEFDh7JufmFQrrz/Bsg+ePN0YTSl6HozFXOKsDcCpkRtkade2/C006FuFcgqqcTBR4wqrMGhDgrUyME+p2i1yuHCIIz07fnYxDPoz+how+A7ro0dhKYDzYDqJ5vcRAvnpOhAzn6jcrKCR+BhegoKnVZ7P0vd2NCinSpWwX/mxzKcl0rTtAN/944637AxGxlk8ldlwbWBdPnItB0dumKNG29QTRC7tFH4UCvpVK1D6Yvbww0wpH7P970ml1iAUU2hwmeBreO1hh84oftNYRdggsIshfsD6PZhwABFwZJiOzH+mLOAlas4ouAyGZqMrhrBlP+dOW8TB8Mr/VQKLtAgvRnrLkI1Ys2LSnDmMmlv00aBin+P+wYhgBJpq/H6lW6KNvFUMoCyJPNY5Bh/BHIpoa53NqjZt7VDwk+S8Rz6RHp1O9DC+xtVVyAw2OykU4w94zkbDFpAxevph0uQhjes/4IrHQ1WaELDQLl5HwN1akACyM3lBW2oPeIUx+Fbtl1oKnQBhdNmnUnVd+LmcrrgTsT9k5K/RVNuHBdD1S/gHSJlkK2GAo+AO5nvBqS6lOdAv6rZl1m/dh5gqTsqCX5cAjSlyx4gcCD6NHKxxXPUQafikvV1/D8zOaCf4g4WgsHM1nnsJrOIylmEdThJ3ibfdaX2CfUvYFpQjmVajaEO8rztVRswMAae3QAhewk0BCWMs89/wCyNbw/EyhqmOd4HxXFUr6PQbn4EOJp9axSkE4lnnHm35h2Jl/uSLeLp+CYNpEDPwMYrNqdpyy3E4TePYRY/aboD4jOrhI6cQTEbFXCejn1eHHrzJcLMvuO/gJrjXmwE54UBEVNI9kHMlHKUiLGd4/pvx4lig/UC504Tcv0uEvF+/9N11N+pwL7CCYiwxn9UPGpypbQ6c0BeToursaUG2drMiAtDRtaU5xhtg7JTZvScHT0bGxEYxcKHEFcQe/EdGyr9KG+dpEtIzP4nYYkmsRnsQI6/zg0NVEOPAA9PzxREt6gD5Xv+qbLcPSIdKYpEAnqlhErei5pxp6t3RzBqpnASSv3I8Gm8i9aLUYbSSB+66aefmByIHyZ4+eTr6qncYWp8YiTeJ4l7uKC07Lf7Qtz5igheAhoxLCR0UOe3GvdOGb6Onm37/lHUJxU37nFI2q2iBUARCpcsxN79/LIfFUtVu4fER62x7+4gmGKAq+L998KP7kH0c9Moo9cAFy8xnZ2cvVebXMh0sO78KLf0eKxf4Wzh89YapsWqwTsfjZb7TC+aCvbXS0bAj5O2FCzDUdJfKpy5mgfFtM7Dhlve8kbCzYsX53djmo7ExSIhoN1eeYm3HzGC5QEA5SyRc8KwurKm5EDfscrkNnja4lxn2OJykhS+VPegWM1BDQj0LROFFxeaG43jUJXwc3YUJHpWi9bpiBdCB5ZE86CHrWWuybn34zQKqe+l5wOZ5U0iXQVrAL7YwRgoHCVWZqnDi1vHcVDiZpGRIFWiwzv6yRjK3oPFmckhuA/iUuqAZkI5Fvq5VIT5kauexEW99O3N6qsKRU1WHvOV3E/KVEcjE1aBmIwAJsAjiF7p6g+F14DDWoWAAAE5WmzWVfVnenw+3HXrRgJsRhuWRqagRuyFJLyszGuVLvwXRsqHOB13x5iHPSxU+CgnMvlDcvM+fW4ubuFFT0Xs4ISnGt2wFUe4Uww5KTvXpv45HGV3P6+qpUvL+fyhSb5GhSlsnALtkAxi5VIssVsitdyaYpl2FRFAWyQskBVKXOSB35GU24ag5LcYyCNt2GHQtOUq1VUmwnUE4C9JeCEoCjMJ9ls6Z9EYF+BW67D2tSp2hQjc7Tjl4qT7I+Vz2+nGMmy5usJT/0elEtY+6Nn0BOxtDwXLMRFOVp6gUJu/R+Oj37J/YSQhab5BKieevMBKGXnPgF6ljYeOlCfbHlOzoijRcMXVveB8jf0bWhHGK3FdJ59X2nGZQQLveMrvqp45Kgr07DrIaVp9r2rdlpk+J0BVQbOROJAA282tUh9BWOCVYNHidExaSSdOv9TEP9cdP9W8lRqc2AvfUgLraXmP3R8AGtk11OtcGw2Do/9G8armiyiUybhrSaXNi9bIbjFYI8tb5CglQNKie2tsxw8w/ei0COBjlwVr2eIMiG/td3IGV6KmvfRW1kqA2DamaKzQxIkQpNC3T+hSbhHSsDjUJQzqMXNMmCdWcJ8sJlkoZSOSthc4r2EZbA8HRUR6d9omJYFmvceDccKO14MakMAWruNrbuhwnTIMhCENuo8ptAUoRmtmAACIWPv0or8W4ESm9wSlIBhjLVCs79KK/Gs/zkEGvtUeoydeQUWkBnpCnZ5/99YbxQwKo0cG2lH1keHEaHq36WK7jy31hDq5ExI8VLws31hg4vNI9oaUvbqMnVVxt1NCqKEHGTSwGxyB8WlKPfL3uvCEZOXbyiwxa0WEJIvDxSzU1x5nGhk+nuVCYOPVQMdMcyNzkC3siZwFYUYfVzO1Ud8gUkfRuRVkqHmDRaaPCGfQrlZmd08jXekZYZAyMvDdCfvT9FxRgEicAvrZP059SqTkc+6VqMAdUVKr52Wgs91degZ2ZEMSVWDckSG6/89evz7Z+UUMZs+rDlePVoswhhBgAgYAAAAAAEg1Ii13y2gPMjOmibxk3ajbeRVgZzKAidFsNCiyMN/ICI2A8aVn0NFp5yRg8xkEQgRlX7VUN5pFQ/CwVrJ2aCcIQLEpYFXmzZzBI030T/Ph1f4FCRvOMI1qTm8npEn5OTTzBXO+rAxw3Oo01IaD1mzoSoKDSzijYtS64WIp7lvvq9TqEU/O/mQHaRw4XL+YOi3eDScdUw/rNuIc+Dp7dc5C5vA6T+wxKC5uiDrjAezsm4KiXsMPiAAAAAAAAA==" alt loading=lazy srcset sizes width=685 height=762></picture></div></div></div></figure>
 </div></div></section>
 <noscript class=sf-hidden>
                
            </noscript>
 
 
 <section data-title=Facts><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Facts</h2><div class=c-article-section__content id=Sec1-content>
 <ol class=u-list-style-none>
 <li>
 <span class=u-custom-list-number>1.</span>
 
 <p>SARS-CoV-2 infection-associated immune responses are central to the pathogenesis of COVID-19.</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>2.</span>
 
 <p>Innate immune systems sense viral RNA through TLR3, TLR7, and RIG-1 and hyperactivate innate immune responses.</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>3.</span>
 
 <p>Dysregulated neutrophil extracellular traps (NET) formations induce immune-thrombosis and exacerbate inflammation in the lungs of patients with COVID-19.</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>4.</span>
 
 <p>Lymphocytopenia induced by apoptosis and syncytia formation promotes the COVID-19 progression.</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>5.</span>
 
 <p>SARS-CoV-2 vaccines often could not block infection but provide immunity to reduce disease severity.</p>
 
 </li>
 </ol>
 </div></div></section><section data-title="Open Questions"><div class=c-article-section id=Sec2-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec2>Open Questions</h2><div class=c-article-section__content id=Sec2-content>
 <ol class=u-list-style-none>
 <li>
 <span class=u-custom-list-number>1.</span>
 
 <p>How to determine the importance of specific CD8<sup>+</sup> T cells in the immunity to SARS-CoV-2?</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>2.</span>
 
 <p>How will the COVID-19 pandemic end? Will COVID-19 become endemic?</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>3.</span>
 
 <p>How will the Omicron variant evolve? What immune properties will the next variant have?</p>
 
 </li>
 <li>
 <span class=u-custom-list-number>4.</span>
 
 <p>Will herd immunity built up by vaccination and natural infections end the transmission of SARS-CoV-2 virus?</p>
 
 </li>
 </ol>
 <p>Pandemic infectious diseases have wreaked havoc on human society multiple times, including the times of the “Plague of Athens” (over 100,000 deaths in 430 BC), Yersinia pestis (50 million deaths in 1340) or “Spanish influenza” (50 million deaths in 1918). These also include several viral diseases like HIV (40 million deaths in 1980–2000), H1N1 “Swine flu” (300,000 deaths in 2009), yellow fever, Zika, Ebola, SARS, MERS, and the current coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Despite that more than two years have passed since the first appearance of COVID-19, the lifestyle, economic activities, and social behaviors of our world are still being impacted by this pandemic [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Chen J, Lu H, Melino G, Boccia S, Piacentini M, Ricciardi W, et al. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020;11:438." href=#ref-CR1 id=ref-link-section-d261924e1117>1</a>]. With over 500 million confirmed COVID-19 cases (over 6% of the world population) and circa 6.5 million deaths worldwide, the causing virus, SARS-CoV-2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28:3125–39." href=#ref-CR2 id=ref-link-section-d261924e1120>2</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Goubet AG, Dubuisson A, Geraud A, Danlos FX, Terrisse S, Silva CAC, et al. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021;28:3297–315." href=#ref-CR3 id=ref-link-section-d261924e1120_1>3</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K, Mak TW. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020;27:3209–25." href=#ref-CR4 id=ref-link-section-d261924e1120_2>4</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Matsuyama T, Yoshinaga SK, Shibue K, Mak TW. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 2021;28:3199–213." href=#ref-CR5 id=ref-link-section-d261924e1120_3>5</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 6" title="Verkhratsky A, Li Q, Melino S, Melino G, Shi Y. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct. 2020;15:28." href=#ref-CR6 id=ref-link-section-d261924e1123>6</a>], shows a rapidly expanding genealogy to now warranting a classification for at least 13 variants and appears to become endemic, with mutations at the N-terminus and the receptor-binding region, including p.Glu484Lys found in the most dangerous variants [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Murray CJL, Piot P. The potential future of the COVID-19 pandemic: will SARS-CoV-2 become a recurrent seasonal infection? JAMA. 2021;325:1249–50." href=#ref-CR7 id=ref-link-section-d261924e1126>7</a>], Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>. The variants of concern (VoC) have been Alpha, Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529), with Delta and Omicron being the most alarming ones [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Buonvino S, Melino S. New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion. Cell Death Disco. 2020;6:134." href=#ref-CR8 id=ref-link-section-d261924e1133>8</a>]. Dreadfully, a new variant with the Delta backbone and Omicron spike has emerged [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title='Colson P, Fournier PE, Delerce J, Million M, Bedotto M, Houhamdi L, et al. Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France. J Med Virol. 2022. Online ahead of print.' href=#ref-CR9 id=ref-link-section-d261924e1136>9</a>]. Great progress has been made in controlling the COVID-19 pandemic, however, much of the efforts still focus on reducing infection and disease severity by vaccination (more than 11 billion vaccine doses administered) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Forni G, Mantovani A. Covid-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28:626–39." href=#ref-CR10 id=ref-link-section-d261924e1139>10</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Lin L, Wang Y, Li Q, Hu M, Shi Y. Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence. Cell Death Differ. 2022;29:263–5." href=#ref-CR11 id=ref-link-section-d261924e1139_1>11</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–4." href=#ref-CR12 id=ref-link-section-d261924e1142>12</a>], which occasionally caused some adverse effects [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Mauriello A, Scimeca M, Amelio I, Massoud R, Novelli A, Di Lorenzo F, et al. Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia. Cell Death Dis. 2021;12:762." href=#ref-CR13 id=ref-link-section-d261924e1145>13</a>]. In the meantime, the virus tends to evolve into variants with high transmission and low pathogenicity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Telenti A, Arvin A, Corey L, Corti D, Diamond MS, Garcia-Sastre A, et al. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021;596:495–504." href=#ref-CR14 id=ref-link-section-d261924e1148>14</a>]. Unfortunately, it is almost certain that the virus will gain new mutations, possibly with higher pathogenicity.<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-1 data-title="The mutation landscape of the spike proteins of selected SARS-CoV-2 variants."><figure><figcaption><b id=Fig1 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 1: The mutation landscape of the spike proteins of selected SARS-CoV-2 variants.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/1 rel=nofollow><picture><img aria-describedby=Fig1 src=data:image/webp;base64,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 alt="figure 1" loading=lazy srcset sizes width=685 height=354></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-1-desc><p>The top panel shows the mutation profiling and prevalence of spike proteins across 13 SARS-CoV-2 lineages that received a Greek designation and 7 recently emerged SARS-CoV-2 variants with public attention. The parent lineages of the new SARS-CoV-2 variants were depicted in the table. The bottom images show the side and top view of the 3-dimension structure for the Omicron spike protein with mutation amino acids mapped [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 170" title="Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. GISAID’s role in pandemic response. China CDC Wkly. 2021;3:1049–51." href=#ref-CR170 id=ref-link-section-d261924e1164>170</a>]. Note: the insertion mutations are not profiled.</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/1 data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>Here, we review the yin and yang of innate and adaptive immunity of acute SARS-CoV-2 infection and emphasize open outstanding questions.</p></div></div></section><section data-title="Underlying inflammatory conditions and infection severity"><div class=c-article-section id=Sec3-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec3>Underlying inflammatory conditions and infection severity</h2><div class=c-article-section__content id=Sec3-content><p>The majority of people infected with SARS-CoV-2 experience mild to moderate respiratory illness, including fever, cough, shortness of breath, muscle aches, headache, loss of taste and smell, sore throat, congestion, or runny nose; while some become seriously ill and require medical attention, especially the elderly and those with underlying medical conditions such as cardiovascular disease, diabetes, chronic respiratory disease, or cancer [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Sacco G, Briere O, Asfar M, Guerin O, Berrut G, Annweiler C. Symptoms of COVID-19 among older adults: a systematic review of biomedical literature. Geriatr. Psychol Neuropsychiatr Vieil. 2020;18:135–9." href=#ref-CR15 id=ref-link-section-d261924e1186>15</a>]. Clearly, the inflammatory conditions, as well as the immune status of patients, are critical in determining the course of the disease progression [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–4." href=#ref-CR12 id=ref-link-section-d261924e1189>12</a>].<p>The deceased among COVID-19 patients exhibited a strong association with age [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Chen J, Lu H, Melino G, Boccia S, Piacentini M, Ricciardi W, et al. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020;11:438." href=#ref-CR1 id=ref-link-section-d261924e1195>1</a>]. The group at 30 or younger had fewer mortalities, while the group at 65 or older showed dramatically high mortality (Data.CDC.gov). In most countries, more death was observed in infected men than in infected women [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Dehingia N, Raj A. Sex differences in COVID-19 case fatality: do we know enough? Lancet. Glob Health. 2021;9:e14–e5." href=#ref-CR16 id=ref-link-section-d261924e1198>16</a>]. A higher COVID-19 death rate was also observed in smokers, obese individuals, and patients suffering from chronic kidney disease, cardiovascular disease, or cancer [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16." href=#ref-CR17 id=ref-link-section-d261924e1201>17</a>]. The biggest change in the death rate is associated with the recent appearance of the Omicron variant, which is highly transmissible with a death rate lower than other VoC [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126–8." href=#ref-CR18 id=ref-link-section-d261924e1204>18</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Kozlov M. Omicron’s feeble attack on the lungs could make it less dangerous. Nature. 2022;601:177." href=#ref-CR19 id=ref-link-section-d261924e1207>19</a>]. Of course, this alteration in the death rate could be due to the success of vaccination. Indeed, it has been reported that among the unvaccinated, especially those over 75-year-old, the mortality is still very significant [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46." href=#ref-CR20 id=ref-link-section-d261924e1211>20</a>].<p>As flying mammals, bats are a super zodiac reservoir of viruses, especially coronaviruses. However, bats have a unique immune system that is well balanced between defense and immune tolerance, which prevents them from developing pathological changes after viral infection. They have enhanced constitutive expression of Interferons (IFNs), interferon-stimulated genes, and several heat-shock proteins. On the other hand, bats have reduced stimulator of interferon genes (STING) and suppressed NLR family pyrin domain containing 3 (NLRP3) inflammasome [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Irving AT, Ahn M, Goh G, Anderson DE, Wang LF. Lessons from the host defences of bats, a unique viral reservoir. Nature. 2021;589:363–70." href=#ref-CR21 id=ref-link-section-d261924e1217>21</a>]. On contrary to bats, humans are not completely resistant to some coronavirus infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Irving AT, Ahn M, Goh G, Anderson DE, Wang LF. Lessons from the host defences of bats, a unique viral reservoir. Nature. 2021;589:363–70." href=#ref-CR21 id=ref-link-section-d261924e1220>21</a>]. It is interesting to note that unlike infections with other viruses such as smallpox, measle, or rabies, exposure to SARS-CoV-2, especially with the Omicron variant, of individuals who received a vaccine or recovered from a prior infection with other variants, could result in disease, yet with milder or no symptoms [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10:e17." href=#ref-CR22 id=ref-link-section-d261924e1223>22</a>]. Such evasion of the immune system makes the elimination of the virus more difficult. Genetic variation in the SARS-CoV-2 virus is certainly a major contributing factor to incomplete immune protection. Most work until now strongly supported the notion that SARS-CoV-2 does not infect circulating blood leukocytes, since they do not express the SARS-CoV-2 receptor, the angiotensin-converting enzyme 2 (ACE2). A very recent study [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 23" title="Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022. Online ahead of print." href=#ref-CR23 id=ref-link-section-d261924e1226>23</a>] suggested that up to 6% of blood monocytes can be infected with the virus, however, this requires further confirmation. Another important factor is that the mucosal SARS-CoV-2 specific IgM and IgA decay very fast [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Moncunill G, Mayor A, Santano R, Jimenez A, Vidal M, Tortajada M, et al. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a spanish hospital after 3 months of follow-up. J Infect Dis. 2021;223:62–71." href=#ref-CR24 id=ref-link-section-d261924e1229>24</a>]. It is also possible that virus neutralization could only be achieved by the receptor-binding domain (RBD)-specific antibodies and that the RBD is hidden by protein folding until right before binding to ACE2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 25" title="Zipeto D, Palmeira JDF, Arganaraz GA, Arganaraz ER. ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19. Front Immunol. 2020;11:576745." href=#ref-CR25 id=ref-link-section-d261924e1233>25</a>].</p></div></div></section><section data-title="Innate immunity"><div class=c-article-section id=Sec4-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec4>Innate immunity</h2><div class=c-article-section__content id=Sec4-content><p>Numerous studies throughout the last two years have established the innate immune system as a critical defender against SARS-CoV-2. In the best cases, innate immunity eliminates SARS-CoV-2 without activation of the adaptive immune system, thus creating a so-called “never-COVID” cohort. This notion is strongly supported by a recently launched human SARS-CoV-2 challenge study (NCT04865237), in which 36 young health volunteers were intranasally administrated with 10 TCID50 of SARS-CoV-2/human/GBR/484861/2020 (a D614G containing pre-alpha wild-type virus; Genbank accession number OM294022). Surprisingly, 16 volunteers (~44.4%) remained uninfected upon the deliberate SARS-CoV-2 exposure. Their C-reactive protein (CRP), SARS-CoV-2 neutralizing antibody, and spike-specific IgG remain negative, excluding the contributions of adaptive immune cells in such protections [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 26" title="Callaway E. Scientists deliberately gave people COVID - here’s what they learnt. Nature. 2022;602:191–2." href=#ref-CR26 id=ref-link-section-d261924e1244>26</a>]. However, the innate immune defenders can also become deleterious when inappropriately activated during SARS-CoV-2 infections [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419–40 e23." href=#ref-CR27 id=ref-link-section-d261924e1247>27</a>].</p></div></div></section><section data-title="Cellular innate immunity"><div class=c-article-section id=Sec5-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec5>Cellular innate immunity</h2><div class=c-article-section__content id=Sec5-content><p>Genetic evidence indicates that cell-mediated innate immunity plays a key role in resistance to COVID-19 and in the pathogenesis of severe disease [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570." href=#ref-CR28 id=ref-link-section-d261924e1258>28</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522–34." href=#ref-CR29 id=ref-link-section-d261924e1258_1>29</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107–13." href=#ref-CR30 id=ref-link-section-d261924e1261>30</a>]. Genes emerging as playing a key role include chemokines and their cognate receptors and members of the IFN pathway. Cellular and innate immune receptors recognizing SARS-CoV-2 belong to different classes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671–92." href=#ref-CR31 id=ref-link-section-d261924e1264>31</a>]. Mouse and human genetic data unequivocally prove that GU-rich RNA sequences are recognized by Toll-like receptor 7 (TLR7) in plasmacytoid dendritic cells (pDC) and TLR8 in conventional DC and myeloid cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 32" title="Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M, et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight. 2021;6:e150542." href=#ref-CR32 id=ref-link-section-d261924e1267>32</a>]. These TLR receptors are located in the endosomal compartment and trigger IFN production (pDC), antigen presentation and uncontrolled inflammation at later stages. Consistent with these in vitro and in vivo mouse data, TLR7 genetic deficiency was associated with severe disease [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 33" title="van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663–73." href=#ref-CR33 id=ref-link-section-d261924e1270>33</a>]. Cytosolic receptors including the retinoic acid-inducible gene-1 (RIG-1) complex have also been suggested to sense SARS-CoV-2 nucleic acids [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671–92." href=#ref-CR31 id=ref-link-section-d261924e1274>31</a>]. Finally, recent evidence suggests that surface C-type lectins interact with the glycosidic components of spike and play an important role in viral entry [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Lu Q, Liu J, Zhao S, Gomez Castro MF, Laurent-Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304–19 e9." href=#ref-CR34 id=ref-link-section-d261924e1277>34</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Lempp FA, Soriaga LB, Montiel-Ruiz M, Benigni F, Noack J, Park YJ, et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021;598:342–7." href=#ref-CR35 id=ref-link-section-d261924e1277_1>35</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275–86." href=#ref-CR36 id=ref-link-section-d261924e1277_2>36</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 37" title="Chiodo F, Bruijns S, Rodriguez E, Eveline Li RJ, Molinaro A, Silipo A, et al. Novel ACE2-independent carbohydrate-binding of SARS-CoV-2 spike protein to host lectins and lung microbiota. Preprint at 
                https://www.biorxiv.org/content/10.1101/2020.05.13.092478v1
                
              . 2020." href=#ref-CR37 id=ref-link-section-d261924e1280>37</a>].<p>Pro-inflammatory macrophages are the major immune cell type that expresses high levels of ACE2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Muus C, Luecken MD, Eraslan G, Sikkema L, Waghray A, Heimberg G, et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med. 2021;27:546–59." href=#ref-CR38 id=ref-link-section-d261924e1286>38</a>]. Upon SARS-CoV-2 infection, these macrophages release inflammatory cytokines and chemokines including C-C motif chemokine ligand 7 (CCL7), CCL8 and CCL13 to recruit and activate T cells. In turn, T cells produce IFN-γ and other cytokines to further activate macrophages [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635–41." href=#ref-CR39 id=ref-link-section-d261924e1289>39</a>]. This positive feedback loop drives the elevation and continuation of the pathological inflammation. Epidemiological data show that older adults and people with underlying health conditions exhibited a dramatically high rate of severe disease and mortality [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16." href=#ref-CR17 id=ref-link-section-d261924e1292>17</a>]. Along with aging, there is a tendency of increasing inflammatory macrophages [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 40" title="van Beek AA, Van den Bossche J, Mastroberardino PG, de Winther MPJ, Leenen PJM. Metabolic alterations in aging macrophages: ingredients for inflammaging? Trends Immunol. 2019;40:113–27." href=#ref-CR40 id=ref-link-section-d261924e1295>40</a>]. This not only explains why chronic inflammatory disease occurrence is more prevalent but also provides a possibility accounting for the high incidence of severe COVID-19 cases in older people. Along with this scenario, it is reasonable to comprehend why SARS-CoV-2 infection in those with underlying medical conditions also exhibited a higher prevalence in severe disease and mortality [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–4." href=#ref-CR12 id=ref-link-section-d261924e1298>12</a>].<p>Single-cell sequencing in combination with cytometry by time of flight (CyTOF), Cite-Sequencing, or multi-color flow cytometry has been particularly informative to describe the deviations of innate immune cells in COVID-19 patients. Early on it was demonstrated that granulocytes and monocytes were dramatically altered in patients with severe disease courses, while moderate and mild disease courses showed rather regular inflammatory cell activation programs with high level human leukocyte antigen-DR (HLA-DR) and CD11c expression [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419–40 e23." href=#ref-CR27 id=ref-link-section-d261924e1304>27</a>]. In severe COVID-19, monocytes are characterized by high level expression of alarmins and CD163, while major histocompatibility complex (MHC) molecules are reduced. Within the neutrophil compartment, cell states reminiscent of myeloid-derived suppressor like cells are observed in severe COVID-19 and at the same time cellular programs necessary for neutrophil extracellular traps (NET)-formation are overexpressed. Further, the appearance of neutrophil precursors in the blood is evident for emergency myelopoiesis in patients with severe COVID-19. Mononuclear phagocytes are extremely plastic and diverse and undergo different forms of activation and tolerance [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 41" title="Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123–47." href=#ref-CR41 id=ref-link-section-d261924e1307>41</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 42" title="Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40:274–88." href=#ref-CR42 id=ref-link-section-d261924e1310>42</a>]. Macrophages’ function has an adaptive component which has been referred to as “training”. Trained innate immunity underlies pathogen agnostic protection associated with selected vaccines, infections and cytokines such as interleukin-1 (IL-1) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 43" title="Mantovani A, Netea MG. Trained innate immunity, epigenetics, and Covid-19. N Engl J Med. 2020;383:1078–80." href=#ref-CR43 id=ref-link-section-d261924e1313>43</a>]. There is evidence that trained innate immunity can contribute to resistance against COVID-19. For instance, if mothers were indirectly exposed to live polio vaccine because of vaccination, their babies were found to have decreased symptomatic infection with COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 44" title="Habibzadeh F, Sajadi MM, Chumakov K, Yadollahie M, Kottilil S, Simi A, et al. COVID-19 infection among women in iran exposed vs unexposed to children who received attenuated poliovirus used in oral polio vaccine. JAMA Netw Open. 2021;4:e2135044." href=#ref-CR44 id=ref-link-section-d261924e1316>44</a>]. The relevance of trained innate immunity to COVID-19 and to vaccines in current use remains to be defined.<p>A major clinical problem of severe COVID-19 is the development of an “acute respiratory distress syndrome” (ARDS) associated with prolonged respiratory failure and high mortality. Also, here innate immune cells are related to this pathophysiological reaction in severe COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 45" title="Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243–61 e27." href=#ref-CR45 id=ref-link-section-d261924e1322>45</a>]. In ARDS patients, CD163-expressing monocyte-derived macrophages that acquired a profibrotic transcriptional phenotype accumulate [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 45" title="Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243–61 e27." href=#ref-CR45 id=ref-link-section-d261924e1325>45</a>]. The profibrotic programs of lung macrophages in COVID-19 are reminiscent of cellular reprogramming previously identified in idiopathic pulmonary fibrosis. Strikingly, the in vitro exposure of monocytes to SARS-CoV-2 sufficiently induced such a profibrotic phenotype [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 45" title="Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243–61 e27." href=#ref-CR45 id=ref-link-section-d261924e1328>45</a>].<p>Other innate immune cells are also altered in COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 46" title="Kramer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-Garcia R, et al. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–69 e14." href=#ref-CR46 id=ref-link-section-d261924e1335>46</a>]. For example, in severe COVID-19 patients, Nature killer (NK) cells showed a prolonged expression of IFN-stimulated genes (ISGs), while tumor necrosis factor (TNF)-induced genes were observed in mild and moderate disease. Further, NK cells in severe COVID-19 showed impaired function against SARS-CoV-2 infected cells and impaired anti-fibrotic activity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 46" title="Kramer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-Garcia R, et al. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–69 e14." href=#ref-CR46 id=ref-link-section-d261924e1338>46</a>]. Other studies suggested that untimely transforming growth factor β (TFGβ) responses limit the antiviral functions of NK cells in severe disease [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 47" title="Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295–301." href=#ref-CR47 id=ref-link-section-d261924e1341>47</a>]. Surprisingly, other blood-derived cells including megakaryocytes, and erythroid cells were also characterized by an increased expression of ISGs in severe but not mild COVID-19 further supporting prolonged IFN response being directly related to disease severity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 48" title="Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity. 2020;53:1296–314 e9." href=#ref-CR48 id=ref-link-section-d261924e1344>48</a>].<p>Further, SARS-CoV-2 seems to trigger an innate functionality in a subset of T cells, namely highly activated CD16<sup>+</sup> T cells, which occur mainly in severe COVID-19 in the CD4, CD8 and γδ T cell compartments [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185:493–512 e25." href=#ref-CR49 id=ref-link-section-d261924e1352>49</a>]. It was demonstrated that increased generation of C3a in severe COVID-19 induced this peculiar T cell phenotype. Functionally, CD16 enabled immune-complex-mediated, T cell receptor (TCR)-independent degranulation and cytotoxicity, which so far, seems to be specific to SARS-CoV-2. These functions were further linked to the release of neutrophil and monocyte chemoattractants and microvascular endothelial cell injury, the latter being made responsible for the heterogeneous and manifold clinical symptoms involving many different organs in severe COVID-19. Worrisome is the persistence of the cytotoxic phenotype of CD16<sup>+</sup> T cell clones beyond acute disease which might also be involved in pathophysiological mechanisms associated with long COVID. However, this clearly requires further investigation. Innate functionality of CD16<sup>+</sup> T cells not only seems to play an important pathophysiological role, but the proportion of these cells together with plasma levels of complement proteins upstream of C3a were shown to be associated with fatal outcomes.</p></div></div></section><section data-title="Humoral innate immune response to SARS-CoV-2 infection"><div class=c-article-section id=Sec6-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec6>Humoral innate immune response to SARS-CoV-2 infection</h2><div class=c-article-section__content id=Sec6-content><p>Innate immunity consists of a cellular and a humoral arm [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–83." href=#ref-CR50 id=ref-link-section-d261924e1368>50</a>]. Components of the humoral arm of innate immunity are a diverse set of molecules, such as Complement components, collectins (e.g., Mannose-binding lectin, MBL), ficolins, and pentraxins (e.g., C reactive protein, CRP, and PTX3) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–83." href=#ref-CR50 id=ref-link-section-d261924e1371>50</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 51" title="Garlanda C, Bottazzi B, Magrini E, Inforzato A, Mantovani A. PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiol Rev. 2018;98:623–39." href=#ref-CR51 id=ref-link-section-d261924e1374>51</a>]. These fluid phase pattern recognition molecules have functions similar to antibodies (ante-antibodies). Among these ante-antibodies, MBL was found to bind spike by recognizing its glycosidic moieties and to inhibit SARS-CoV-2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275–86." href=#ref-CR36 id=ref-link-section-d261924e1377>36</a>]. All VoCs including Omicron were recognized by MBL. MBL haplotypes were found to be associated with disease severity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275–86." href=#ref-CR36 id=ref-link-section-d261924e1380>36</a>]. Pentraxin 3 (PTX3), but not its distant relative CRP bound the SARS-CoV-2 nucleoprotein, but it remains to be elucidated whether its recognition amplifies inflammation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275–86." href=#ref-CR36 id=ref-link-section-d261924e1384>36</a>]. Indeed, PTX3 has emerged as an important biomarker of disease severity with for instance death as the endpoint [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021;22:19–24." href=#ref-CR52 id=ref-link-section-d261924e1387>52</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Gritti G, Raimondi F, Bottazzi B, Ripamonti D, Riva I, Landi F, et al. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021;35:2710–4." href=#ref-CR53 id=ref-link-section-d261924e1387_1>53</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Gutmann C, Takov K, Burnap SA, Singh B, Ali H, Theofilatos K, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021;12:3406." href=#ref-CR54 id=ref-link-section-d261924e1387_2>54</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Hansen FC, Nadeem A, Browning KL, Campana M, Schmidtchen A, van der Plas MJA. Differential internalization of thrombin-derived host defense peptides into monocytes and macrophages. J Innate Immun. 2021:1–15." href=#ref-CR55 id=ref-link-section-d261924e1387_3>55</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 56" title="Schirinzi A, Pesce F, Laterza R, D’Alise MG, Lovero R, Fontana A, et al. Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department. J Infect. 2021;82:84–123." href=#ref-CR56 id=ref-link-section-d261924e1390>56</a>]. The results have been extended to long COVID [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 57" title="Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210–6." href=#ref-CR57 id=ref-link-section-d261924e1393>57</a>] with PTX3 being part of a disease severity signature.<p>Complement has emerged as a pathway of amplification of inflammation and tissue damage [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 58" title="Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, et al. Complement as a target in COVID-19? Nat Rev Immunol. 2020;20:343–4." href=#ref-CR58 id=ref-link-section-d261924e1399>58</a>]. The lectin pathway may play a role in complement activation. Small pilot studies suggest that targeting complement by inhibiting the C3 convertase or by blocking mannose-associated serine protease (MASP) and the lectin pathway may be beneficial in COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185:493–512 e25." href=#ref-CR49 id=ref-link-section-d261924e1402>49</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clin Immunol. 2020;220:108598." href=#ref-CR59 id=ref-link-section-d261924e1405>59</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, et al. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020;215:108450." href=#ref-CR60 id=ref-link-section-d261924e1405_1>60</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Rambaldi A, Gritti G, Mico MC, Frigeni M, Borleri G, Salvi A, et al. Endothelial injury and thrombotic microangiopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020;225:152001." href=#ref-CR61 id=ref-link-section-d261924e1405_2>61</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Bumiller-Bini V, de Freitas Oliveira-Tore C, Carvalho TM, Kretzschmar GC, Goncalves LB, Alencar NM, et al. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol. 2021;44:e20200199." href=#ref-CR62 id=ref-link-section-d261924e1405_3>62</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 63" title="Flude BM, Nannetti G, Mitchell P, Compton N, Richards C, Heurich M, et al. Targeting the complement serine protease MASP-2 as a therapeutic strategy for coronavirus infections. Viruses. 2021;13:312." href=#ref-CR63 id=ref-link-section-d261924e1408>63</a>]. Whether these therapeutic approaches might also impact the functionality of the highly activated CD16<sup>+</sup> T cells with innate immune function requires further investigation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185:493–512 e25." href=#ref-CR49 id=ref-link-section-d261924e1414>49</a>].<p>Thus, humoral innate immunity (ante-antibodies) plays an important role in COVID-19. MBL represents a non-redundant pathway of resistance against SARS-CoV-2 VoC. The pentraxins CRP and PTX3 provide important prognostic indicators, with PTX3 integrating myeloid cell and endothelial cell activation. It will be important to further explore the value and significance of ante-antibodies as biomarkers (PTX3), candidate therapeutics (MBL) and therapeutic targets (complement).<p>Macrophages and monocytes express a variety of pattern recognition receptors (PRRs), including TLRs, (NOD)-like receptor family proteins (NLRs), absent in melanoma 2 (AIM2) and the cyclic GMP-AMP synthase (cGAS)-STING pathway. These can trigger innate immune responses to viral infection through direct infection and sensing of SARS-CoV-2 or by detecting damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs) released by infected cells that act as a feedforward mechanism propagating the systemic inflammatory response.<p>Single-cell sequencing and flow cytometric analyses have established the presence of SARS-CoV-2 RNA in human lung macrophages [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107–13." href=#ref-CR30 id=ref-link-section-d261924e1427>30</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635–41." href=#ref-CR39 id=ref-link-section-d261924e1430>39</a>] and blood monocytes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 64" title="Junqueira C, Crespo A, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq. 2021." href=#ref-CR64 id=ref-link-section-d261924e1433>64</a>]. Neither human lung macrophages nor monocytes express the primary SARS-CoV-2 internalization receptor ACE2, and as such alternative mechanisms for viral internalization have been proposed, including Fc-receptor mediated uptake [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 23" title="Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022. Online ahead of print." href=#ref-CR23 id=ref-link-section-d261924e1436>23</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 65" title="Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022. Online ahead of print." href=#ref-CR65 id=ref-link-section-d261924e1439>65</a>]. Lung myeloid cells infected with SARS-CoV-2 induce the transcriptional programs and signaling cascades of innate immune response. SARS-CoV-2-infected cells upregulate chemokines, cytokines, IFN pathway and TNF associated genes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107–13." href=#ref-CR30 id=ref-link-section-d261924e1443>30</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635–41." href=#ref-CR39 id=ref-link-section-d261924e1446>39</a>]. These act to inhibit viral expansion and recruit monocytes and T cells to the site of infection. However, excessive release of pro-inflammatory cytokines was early identified in severe COVID-19 patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 66" title="Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–9." href=#ref-CR66 id=ref-link-section-d261924e1449>66</a>]. The detection of viral RNA potentially drives activation of this transcriptional response by endosomal TLR3 and TLR7, as well as SARS-CoV-2 E protein detection on the cell membrane by TLR2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 67" title="Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–38." href=#ref-CR67 id=ref-link-section-d261924e1452>67</a>].<p>Recent reports have shown the presence of an oligomerized apoptosis-associated speck-like protein containing a caspase-activating and recruitment domain (CARD) alongside NLRP3 in monocytes and lung macrophages from COVID-19 patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 68" title="Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707." href=#ref-CR68 id=ref-link-section-d261924e1458>68</a>]. The monocytes displayed a concomitant activation of caspase-1, and cleavage and translocation of the gasdermin D pore complex to the plasma membrane, a downstream event of inflammasome activation that facilitates cytokine release and precedes the inflammatory lytic cell death process known as pyroptosis. Indeed, sera from COVID-19 patients are enriched for IL-1β, IL-18 and lactate dehydrogenase (LDH), indicative of ongoing pyroptosis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 68" title="Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707." href=#ref-CR68 id=ref-link-section-d261924e1461>68</a>]. In the lungs of COVID-19 individuals, inflammasome activation is not exclusive to SARS-CoV-2-infected cells, suggesting that paracrine signals caused by SARS-CoV-2 infection can induce pyroptosis in neighboring cells, potentiating the inflammatory response and disease severity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 64" title="Junqueira C, Crespo A, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq. 2021." href=#ref-CR64 id=ref-link-section-d261924e1464>64</a>].<p>Inhibitors targeting inflammasome pathway components, including caspase-1 and NLRP3 reduced pathology in a humanized mouse model of SARS-CoV-2 infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 65" title="Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022. Online ahead of print." href=#ref-CR65 id=ref-link-section-d261924e1470>65</a>], suggesting therapeutic targeting of the NLRP3 inflammasome may provide translational benefit as society proceeds to live alongside SARS-CoV-2. However, it is important to bear in mind that most studies on human patients rely on post-mortem tissues and therefore represent the most severe form of the disease. Consequently, it remains to be seen whether inflammasome inhibition can yield effective results in mild forms of COVID-19.<p>The innate immune response to SARS-CoV-2 infection is not limited to macrophages and monocytes, and is frequently associated with abnormal activation and recruitment of neutrophils. It has been reported that there is a dramatic increase in myeloid-derived suppressor-like cells (MDSC-like) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 69" title="Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, et al. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020;27:3196–207." href=#ref-CR69 id=ref-link-section-d261924e1476>69</a>], particularly in those at severe stages of COVID-19, contributing to the pathogenesis of SARS-CoV-2 infection. MDSCs may delay the clearance of the SARS-CoV-2 virus and inhibit T cell proliferation and functions. Neutrophils are known to release NET and the imbalance between NET formation and degradation plays a central role in the pathophysiology through trapping inflammatory cells and preventing the recruitment of tissue repairing cells. Strategies that dysregulate the formation of NET or destruct NET with agents such as DNase could represent new therapies for COVID-19 patients, especially those suffering from severe illness [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28:3125–39." href=#ref-CR2 id=ref-link-section-d261924e1479>2</a>], see below.</p></div></div></section><section data-title="NET-driven vascular occlusions drive pathology in severe COVID-19"><div class=c-article-section id=Sec7-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec7>NET-driven vascular occlusions drive pathology in severe COVID-19</h2><div class=c-article-section__content id=Sec7-content><p>During the membrane rupture of granulocytes in the process of NET formation the preformed pro-inflammatory cytokines (e.g., IL-6) and chemokines (e.g., IL-8, CCL3) as well as antimicrobial peptides (e.g., bactericidal/permeability-increasing protein and histones), serine proteases (e.g., neutrophil elastase and proteinase 3), other enzymes (e.g., myeloperoxidase, lactoferrin, lysozyme and phospholipase A2), and reactive oxygen species (ROS) are released into the vicinity of NET. The activity of the soluble mediators fades as NET formed in high neutrophil densities tends to aggregate. These aggregates act anti-inflammatorily as NET-borne proteases proteolytically degrade inflammatory mediators and toxic histones [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 70" title="Knopf J, Leppkes M, Schett G, Herrmann M, Muñoz LE. Aggregated NETs sequester and detoxify extracellular histones. Front Immunol. 2019;10:2176." href=#ref-CR70 id=ref-link-section-d261924e1490>70</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 71" title="Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20:511–7." href=#ref-CR71 id=ref-link-section-d261924e1493>71</a>]. Importantly, DNA-bound proteases are not antagonized by anti-proteases [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 72" title="Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925." href=#ref-CR72 id=ref-link-section-d261924e1496>72</a>]. Thus, the formation of NET is considered a double-edged sword that initially initiates inflammation and later helps to orchestrate its resolution.<p>The imbalance between NET formation and degradation can also drive inflammation, e.g., by occluding vessels and ducts [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 73" title="Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, et al. Neutrophil extracellular trap-driven occlusive diseases. Cells. 2021;10:2201." href=#ref-CR73 id=ref-link-section-d261924e1502>73</a>]. First reports about the role of NET in patients with COVID-19 were already published soon after the onset of the pandemic describing elevated levels of NET markers such as cell-free DNA, citrullinated Histone H3 (citH3), and myeloperoxidase-DNA (MPO-DNA) complexes in the sera of these patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 74" title="Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI insight. 2020;5:e138999." href=#ref-CR74 id=ref-link-section-d261924e1505>74</a>]. Single cell sequencing of blood-derived neutrophils from peripheral blood supported a reprogramming of a subset of neutrophils towards NET formation-related transcriptional programs especially in severe COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419–40 e23." href=#ref-CR27 id=ref-link-section-d261924e1508>27</a>]. Serum from patients with COVID-19 as well as the virus itself were reportedly able to trigger NET formation accompanied by increasing levels of intracellular ROS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI insight. 2020;5:e138999." href=#ref-CR74 id=ref-link-section-d261924e1511>74</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Arcanjo A, Logullo J, Menezes CCB, de Souza Carvalho Giangiarulo TC, Dos Reis MC, de Castro GMM, et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020;10:19630." href=#ref-CR75 id=ref-link-section-d261924e1511_1>75</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 76" title="Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169–79." href=#ref-CR76 id=ref-link-section-d261924e1514>76</a>]. This ROS-NET pathway together with the activation of neutrophils, the formation of neutrophil-platelet aggregates, and intravascular aggregation of NET enriched with complement and tissue factors form occlusive NET-derived immunothromboses, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig2>2</a>. This is particularly dangerous in the microvasculature, where severe organ damage occurs due to disrupted microcirculation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 72" title="Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925." href=#ref-CR72 id=ref-link-section-d261924e1521>72</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129." href=#ref-CR77 id=ref-link-section-d261924e1524>77</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, et al. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis. 2021;223:933–44." href=#ref-CR78 id=ref-link-section-d261924e1524_1>78</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 79" title="Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130:6151–7." href=#ref-CR79 id=ref-link-section-d261924e1527>79</a>]. Because of their central role in the pathophysiology of COVID-19, NET is a prime target for therapeutical intervention. Therapeutic doses of heparin were shown to prevent the aggregation of NET by nano- and microparticles and the efficiency of this therapy in COVID-19 patients was shown recently [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 80" title="Bilyy R, Bila G, Vishchur O, Vovk V, Herrmann M. Neutrophils as main players of immune response towards nondegradable nanoparticles. Nanomaterials. 2020;10:1273." href=#ref-CR80 id=ref-link-section-d261924e1530>80</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 81" title="Liu J, Li J, Arnold K, Pawlinski R, Key NS. Using heparin molecules to manage COVID-2019. Res Pract thrombosis Haemost. 2020;4:518–23." href=#ref-CR81 id=ref-link-section-d261924e1533>81</a>]. Furthermore, Heparin is known to accelerate the DNase I-mediated degradation of NET and first trials with Dornase Alfa, a recombinant DNase, have been undertaken [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 82" title="Weber AG, Chau AS, Egeblad M, Barnes BJ, Janowitz T. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series. Mol Med. 2020;26:91." href=#ref-CR82 id=ref-link-section-d261924e1537>82</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 83" title="Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, et al. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:548." href=#ref-CR83 id=ref-link-section-d261924e1540>83</a>]. Disulfiram was also reportedly successful in the reduction of NET, increase of survival, and improvement of blood oxygenation in animal models, which makes it a new promising candidate for the treatment of NET-related pathologies in patients with COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 84" title="Adrover JM, Carrau L, Daßler-Plenker J, Bram Y, Chandar V, Houghton S, et al. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection. JCI insight. 2022;7:e157342." href=#ref-CR84 id=ref-link-section-d261924e1543>84</a>]. Lastly, inhibitors of peptidyl-arginine deiminases (PADs) are discussed as therapies to treat NET-related thrombotic complications in patients with COVID-19, however, no clinical trial has been conducted yet [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 85" title="Elliott W, Jr., Guda MR, Asuthkar S, Teluguakula N, Prasad DVR, Tsung AJ, et al. PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis. Biomedicines. 2021;9:1867." href=#ref-CR85 id=ref-link-section-d261924e1546>85</a>].<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-2 data-title=NETosis.><figure><figcaption><b id=Fig2 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 2: NETosis.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/2 rel=nofollow><picture><img aria-describedby=Fig2 src=data:image/webp;base64,UklGRkpSAQBXRUJQVlA4ID5SAQCQYwKdASqtAhwBPi0ShkKhoQ1mu1wMAWJbG7hd2D+gq9C1OXr/9i/ZX+9fuH8h3GPRn5h+0/47/W/4H9yvlJ+z/OX03/6P9b6GPoP7z/2P8j/o/28+d3+4/7f+u9xf9l/0X/i/0H79fQF/Qv7v/2v8b/rvhJ/1P279xv+J/5X5ffAP+vf5z/2f7b3a/9x/8/9t7jf61/p//l/q/9j///oC/n396/8n55fMp/z//f/xPgV/wX/H/8v+w/f/6A/6Z/mP+1+enzB/9v9zf+N/8/or/uH/K/cf/j//j6Cf6f/mf/j/pf9x/+//D9AH/w////5+J7+Af+r///+b3AP+D///dv6Mfyv8PvbZ3c/VP7T+vn4/+w/5H82/iv7l/mP+X/iPjR+Yf8X/T98X0L94/3P+S9Qv5P93f1H96/dT80fuR/I/sv4j/IX/N/zf7nfAL+T/03/U/4n90v8r+9P0afUft73Cutf5/9p/YF9m/sX/D/yP7p/6n93fad/2v9N6hfpP99/7P+e/eX9//wB/lv9P/2v+L/eT/M////rfVf+v/bPyMPt/+u/bP4Af5x/dP+x/k/9X+0P0wf2P/w/2f/I/bL2a/Uf/u/13+3/+P++////3/Qb+ef3b/q/5T96v9F////t97P/+/4f/T+P/7lf/3/n/8L5Vf2d//H+j/3rsM8cp00a3nH7X1zfYscIc28Uvu93Ykwpinr1cs9q5Z7Vyz2reZ+bxAoV8SMCyabPdYue5yz2rlntXLPauWVyBW17ttU6TkzYNitQabxaUMKzmR9bLVE0qxBOz/q/sU+CXkcyzrLsDeagX3AF9wBfWo3Bef0v9qa8+TNwCGzyYM8mDPJgzv3qyPD/NCeQVUDW+LgC+4wzRi2TsihIollmcul7dblVbprCAULRZ8O5o/5Xro7zMc2r/+i1JPvKtRWI3mpAmmv89jfcirztp+bepcNczZIU/hn8DCd5QO5NPV4SIFfr+mwH/7oi+AvncGfbs68LUnKifBoyg3Dg4jCEKY4GUvKurogmbuZqdDGTz/ArI+zY+36dbklwhBfxd5gpiMs8R0qGHUpk02GWNJvkP1I+rMPoV4o/LSWd356OtD1PdDe5MUPI+XOBpDfT1wabxUxnf3qBVqJ3iQneAP9ylhsrsL/mUYA+riMNTHrerf/uTfd2Yv+tuLF4jaUXIaiHqltjMaizwuZzZbV1jb3cN2UCryW/ZaST9Azzu4CmXpEL3YslWFWTq8gFl9tXDLru+9TLFom6X5xn5/tKOS2M/HYv0JGtxkN54jf65SIiSNOvFziSRMSNtZQpl+Zm8XfYbXahd/SOYPoZXPl3gMJci1v2Inrs+SbMyekbG4cCG+wi0mDfAibPA+Zfh80SohFSr3/JnENdwvVLTtVF6gQtefHYxkrDbI2bhyDxpMiQYpCHOHUIalVYLTv+ghmgwZ4rPy9gkq0lPEPax2dRIrFsOr4Bo35dpyLijx3BeQQZSttVI67VgH/aJ7jSEzKsycBwdEfithApMAQVffhVp9k1GlCMTIehpfdEU2Ev1TIlmyOvilyRij6I1iSecpsgyM3steI8s0BvgTh2xPOs/HzigpvTk21FyMHlMcen1trJ49pPaBsIEGNAuADI2Pw3arFMKjZJmm/SKuvhaaNfavZuz0St4iegNYgX+ypVeh7cjeX0382N+vihAt29HD0kAM4bAuh2sDYkH9zN0BX5wPkNL80A7WK5m/lz/ArieI9G2l4hIkM3eK9RRH1iEn3xMv4jqIdkSwZWz3k3WWwPTJBQst2GUjomyXp41166Z4cZHwe45nV0bDdx2rIBChjgorkr6zODf4Qj0jEblcur9xHkdvGK84ryNOh3LVNV3EtOpf3zD+iBBUHAAsydLBzfY8cg3V4PloYNhWscmvxsy2nA1+BUS530B/BTDdWyPGfHQmbJ8/Rk/J3efrmgNoH5Gsp2ZA+9Rs1Bh2Biw/KLDB0LmorWvSWhrrFd6+OBipk/dKUult2zQ5qiNSvdwX7sXULAnAFFwPfE16PeesTpr2TtUW1IzYHoz3YZ2utjFjtjdLGmbqL28/rQ+6VX88y58GzFjuk1/zW49RggnIZj8oaaoDY5iRU1Pwn4EbYc0MoJ+6fiqktHQFVVcjtHgcXwSEqPD9YzAdBMYXXmTabsdWsCzxFRknHTZIrSyAtT1wAJXIwZGcT77fTOHqlLbCcXjKweJqYLqXpWg/EKw0swpBBqCRr84ErKrOfJ8e8pLVE9bQOS4qBRTCiwBLpmJfulM62sTKKW80HETKsz/OE3Wfjz5ZGn+rOKiAwRcZd0n5t6zAWlErX1RuYfIzLajTGuKk9FOk8lcTeXfYPtfsjmHeRIiER2F2cbAZemWDbDoeEea99q0/Q28vnXZP+IRyvO48tuhKONNAnRkjysJTXHBr3pgL5TRpdZBGm19EmTOndiZh6IUcYNWU0kNVJ5lelZ7qt/w59kiCdlGgTXo2jF25WXcoD+XvKxLFezUdHABhNqshJklYfD8UYoTJoiaZHcWCvZE8411zKvchJS0DwXumGpLNKjRflpGZDGEnwcWtNEAjOMoOjoLzYozV4CDOVTdWrrkc9GZfzx0M8r3tOZhQDuYPjmdSE4/leyhFsP1aMWQvEKicjFQTmRB/OuGTLJSkJRdPdfNKz21VSTrX4Bse3uSK/ylJqqAgoadK3vunSGHx8W5JuyZnw11oJaS1gigyx5RTtGl+fFXiXDzizzyZau1IFQRA0DAz2odfKg6KQWniTga0lxbDcXrRELq9ghiBlDOBl/xaM8SIgHBLWQNTb9Ia5KJ13MFXqcZ32+RsA5pn5iAf2o8dYYLKhWBBd1nFVrg+BIAombjM/bjgORV6fEkNcQ3zJpRGZTMwh41aLyGQw9Jf3ht7qZHzv2iQApnBKDFxB5oNuw751HfCOWIKwOXTkQb0Tx27oXtgJrqaLqVtjQ4mDKsf5IQlv5e4Nnx2f3ca1+bqsb82hHJYI3K0uqJpPBNJzjHyP7+k/AA4aegyDLH3dgXNAnN5vT4AycJrlIIyZyXZDkQLwdHVJRfuhIltlbn5vRX3LniIo/j28MUHFl4942D1ZG4X6ffdZ0e/82f/ghBUX6/2nOr0ljfTA084i+4NfP7PJQE439P3bvMDMekGo/cMUIbk20Fn4GJtQSMYh7lEAo0xSZSRL7DxNYDejtxeXSnSW9uCaDmn5Y0SEmbDCo887mCAn16VRt2wfnztJnxCxmI5OgAXLpTxCdsdmpxnX7p3Otf6qW5MOCCUZb7LhBHyWux8vZR98sU2q1LVqguNh7F4VCy6+fS1jtam5zwsAhG8QTpXreXDj5feYBTPPc1fuw006scUESgYrllbs0SBOpbwaVoB8MyvNJvIW6UFNB19yR1BFpKpTVNCtNE8S3voIF9nJGMHO/KczmZNs43r+cabARmrr+HM6KbiBiFbUIVxGLmU/3eWQHHFOzl521EaAO5C9MZEfo/yOJRAIJcT8uo6lsts7th7RAtj5vTR4TMOPn1cI6tl9b4vH/mTyw82dSnbbkXXqYeyh/C//d62cOL/lET5uLMqGlsetT/gujGAdm6iKYsksI4FUVlASLctjoKbO8nA8irI25Rj7YP185ROVNQ32McRI7MzfZvZtKusQREjLb8i/MddpsyUyQm2QI0L9feNCrHnQnWQmb9TfmsJZY7+Jp+24Oee+FZgE78R+2zg3uD9rxhik+6n7PAndb1dYR5Qo6CzzaYJ7gT53M7HmouTM/NkPs17NdippnCsqmDF6SqcGrREfD3VM5jWPXFN1XMIdB51cdZfD209sdYNrWILCElN8rn5FVemT+n6O6BZBwMJhldypcG+3KQFhVWWwaJyJ3SBrNw/VLcuNJQx46Nk6TfCWHS7LYx7Yw2Xf3SWRRfJMCCH+SkzK3Hkzmnnf93pJo/eFMm6xTq81jUwy1dm0wQH/byb0zpJF48cXe7Ok+Nuh8fM9Fl5ewbdl8CUzwd2BN/OWLPZ/tOeZQoXutHw5+QNV1UBA0NHqsh7r1WmLPYCjPK4PcJ0eT3Lf7O1K7OteEeBuGptcRuzi/d+td6F749/MWd452nCcz49KdBy/Cv+j1AiXB08KdWkBuabMEc8/4APkfRHuXenuLGKHVF/sczofiA7Lng60JYtA1B/rDePPSzJ07nCKGDZ71c5scE1opx6EIyD7zhijP2XoWyE1tCVezlqDdR/v1/mRttPLYUxE0g1iNX7mroxAPvRFuY8mthdTmTJePZcHglfXDYpvsHbDr9/t8BGNfqNIcZpei+P7EQwTUavDs/16BCNT71a+Wwn4vbuMPr3N7MKSbJxQSLPw3ipayE8YlwlCXluSw3i5vAGDp8g+kzfaMdmsppWWmam7IkALm8iZyw2xBxCWkETLTk/Gg5qPwrp+mLA9nKVwC5J3+1Dna+tK5gQjDBLVji5OTW1zNq3M8De43G+vu4VcpqtKlLey0WY+BgOOLs+rqF8ozSYwkoI8tXj+g+z+JMJ7qN0FK5Fy56yojWGrMXrY4mwP1SiGb9FmvQZtt/d5GgqAEKP7urBkpsPpBP6cgiR0ofm/Am4vXmfKJGn755mixlTaBcVqLMJx96VC9ShCZYWKAvRv+4q8M66CZRc0YalaBT9wJsMiu2JigqcMWjfWH/XuSH7aBE8L5CapS2rgGi+nloLDi549fHYJ6wdWlPe2I+0NUMl9xOgyM74bzTRzfTr5PXWOTilvmQ9UJzaGz+v5G7zMt8SDPIf58kFJqEY7wVtSCOB5KsdpVxl/Udo1jvvA/Kgle02E9EUKmT+NMuvvfrQJLfOZktAr7hF3T1yy5JmLy+6T7RXPKzpBSYQ9KlATL2NC+L0O8bJrquUAEcHEFCWO/osuztH7qLuRdbmwyGrD5BEGo8/04KSHK2Vo1ZO8xPBxz2Ieqj1C/hDma740HFRc63r8aJIN+8lP8ZKO/TtYqyrMHAS5R9kO1gtx4JU0oiOJaOvcihz0zLCW6NjU1OsxUqgzV0vd8mXxnTTPE+6G+vCprseZfwnOm4eHarzv45vu13cIiLFHwiohPt2D/2h46a85oELEKqVJniKmWh4huTt29sgwEhvGGkkx/FDozQls7ThdHeg7SItIieQfHSjzio2pJJLncaP8nsPCIrtoBDUVSeVvJqteU3Tp59bcFXTyFtsAUmw15i9yDZKzU2LSe/8GzF4fMWpI3DH5AMi9Kg6j8Aee8s0PXDp7Cy/YpK4JJWYsdLoFUTbn6UNbQRllpdMo+WxQE58nqT0ga8Jua4QJrG4+3TIXE3QkD7RamrStqy9b2tDFgr2Nm5axHkLP4OcGTK+LD9YzLdVVA/whcusFxQ9PEt2flb91+P+gJV4b7/HTzZBvxog0CMPKmyhbLKoJij2Q5j0J313RFZrPzbZA5saukd87TR4TLKXJLelyrjMHUDIi9k+Uc4sFJLRHdlfLUS4KdeGu5FvQN/vTx04HFdjYi4ljN5g16QrZWGkPshANhnTDI1RTv3Cf+2Sp1AKNpC5zdLsfyzDkRr2MqXGidrwgraoyA8jjKCVrcpeWYD6c3Aa3b+7o1dD9W+WIjLwbIAdtuX65A6lH64++SAp+9ucoRDpSuNEP6fJzSRV6g6E1oS0mt3NQA4SkMcjYjiw1Xr32OW56DnokXSIvpEBnpzyLvJeVq8sxk0Gh9GmPYZ0etzV2khNzHRekpC8p2WZa+tnyAE4USsHMwjKIZacymQ1XX3bP4fQldddZZ7XksSBrJAuFIrQBoXX5ScwL+ZoFgiSJiAnO3L+TEl5GuV/O3OXB4nddSASe3twjEzs5I033c0pkIK9DWanproDEpXY3cDNm/1I9hYqzUOwBmEByFYq6p4qOCzc10TlnIKZF3GMRWJAvSETN8Ju0PpORuvJ0y93Kdo6U5mnOnIF8/fFBxUvxAFx5o8M93hCDmDRNctYgqv/qs/eHocbqjEbT/P7zhhcF2AeLV812aV2QvcUm+xc0OuEy7HxqDwfscRNoeFxeQuxXM9mpVLr5BUQ1IfmP+WxeqFREqEfEwVAZV/7E0Hb60zy9rv7+EPFJTFpt9PZkAz0lnRMVeWj/+Fs3sLUQc1r/CqOtWnzI/ajImXN4bCToMUosFtgGwrwnD8zbycUcfhcUFm14LeucLbhGr0EmYIV6Zz+/7WUpAIiZ8/KtVTre/OLJOd+XWVh6sFgXM8tRESEE2nCcgGNgPAX+bZk/ixK1mGRrcTftA3ifhm1DzqJMAv7lJJH3ac+OTr/q3DZscq+h2kAeS/pZXAOMvgLK/8Nr4hzKu8j7Fj3kHkE7ijtlmZxUEAeBhcJ/LXlRztJ7coWjnPFPJv2hLbHyKQUIdeMseqaCjfGnwI49vG68LnIHQE46iOqftc5YSY62w97IyEvQi7M3dylWGjSsP28fKFZ/AnVrmauxDu6TxThpIRT2TF6VOiK74uHhx6xLR6l0evo4v0IzB0gv1RpnvKD9AVi3VXbQDqME8YL9sQ41Qy7szua8vXLYCRAuQeW0IgAAD+/3AJkL2RUAFK1pzZWIB1P/Hx5SuyXYDznFvq0uiNUTbOVMbLC0xI39bykLbZKtJhEY2kjMBcYQFDQqBA25sXVvhAVUHz+BSp46dHEKLqfg1/Ew5/+ZQMeHaR4cDx7rD426R6b8FeZXNcc5F9Kkb4j9MTvDEJzKYSkezzXwF8u37pv0najVcHUJaCwamD3DAeJxRwpI8Hw4mHTXClabvq/GSTRWbRX/mgX6EX0hGKF2Pvdx3LELsn4ueFxd+GwJ+nR7LBfRTXvSmELEnniXKXWbm85sGjKqZ/iTlCL2PK71caAADPPnWStgfl/72+tyXCVoHGurkK/bh3ADaIou2+CTzEcEI4FfyoqPWJ4WitwtE1TXIy+h2TztrmIoq9UQwi/D06c81HYvRcNj0rOhz6lX69nf+cIrn5/tJv1T/H2w7NC8RDQ8s4SRg48xHj/I8m7n44nx7m1MfNPtjPMYqknT8GzG7DrKG1JqAPnq/o/Jpvgjao9/fY4QX27cYa52OxffBcj3zIuoICmVKmBa+cOWOF/9BWJse53y7FaFkYncoqBQZD3Prb8WG/58dqwTiH0+5M6s7qgCTK47/Mypnm6fbl1zlCUUZ/ioKuubufKazx4gA/NoqH4DM13bJ8/7JRPrp9Yh/jVYL47X3xV7I4B+f7XJwQ8yhP7qH+DQmbq53SEE4cRlYhofC8+QpSviZAihrJizraQVc8hX8TmH6JGLMWxUq8bPpF7s0CCh5INEeQc5+qFRe/mWhbuqnqc8fLi/yq9+kG5EEzuoyJwmt5CuGrNyKDsmtfzeDmvgdooykPYAY/SwBJ+O4TZNHN1CIz6WwaOwsMC0DzqXAF3e3HOaP/g/TEbYuW5F9Fn3I+C91QGrpb1qUARvABCJzqUuCmpnpuqZj6PVPXmavL9myB5eR5FYpdVyn8gZAN0hXrlIOowZhoT96IdzgxGfY+9fa+Cf4Swjsfd7xPKkM6tBYg+SzW5yVGhP/I8pGctDi1orK7PsHUacsys0zxPcT/j230SAh5RVMMaWbxyFCzY7cWw9FLgqGSbhdD8qjr0dJB/YretvZ8A9gRXPM5W2LgQmSUVhqjf+UWAeNhun2qpd2/4P0uZESWNsZnzb4knjTCbi47Ynd0qpkHRjjCVCfQtYD4CtwyEClNXuqjU9VqsIScpED8dP+fYmj8l334V0AyS8AAeyEqCt37mElWHD9fNDt44lVPZtPDAj+uCwyy+zOeBviG438YRUrbrgE3B8v28VrbmPg12SfAKtPdqOSs51KzXa5l+1OuDCN7hsHyC7SltXVM3Wz/H/TgUNUnubeJx4+FplmnuQGeqbJCJvlQcfeu4OPbdreolFS6jxces3Ph5cLjMj4yCHY07+GyZhlnIWA9eC2A7OFr9KUYwj4GzLEGdnGP69EtqnZbTUu1ohFxoF+qxx+9ZpX666U8gIAO5zUTTg1JHe5dP6NbIL5jZRnU8RBNi9+soKNs7UV/a3mI6N3j1JZ0/McDpk87hHY6kR7Qyv5JpHZGvYJwTUjDNDAQvnstJ0AzK5eMUzzI7Mnwb9cOZppYV8pE9PH3mc9/GFGNcH/wLIcFly6fBpIimhG9kDaSXRa5Z129XWXyh8cobXafIPn7bbFzPESHRFi4V3rH+aYbIeeS7krkE/IhIZRyvemW2e9VC6yPf4a82UjWVjPW29Qh9tOsFrjBgJ6K2oK/6LCrNg8+VigiITHZ6qO5ygkEwz2hy42rqWZA8w1+rjYMPehUPaOQuQup4SoS/qL4QMDyiu1nD27X7RvTBskb6g99fqxPGrxvyS818jGHsikwun41/WQAFK+uHgvq+Ce5wMt9uNkd2cgqq3HhHDH+MuNXIzxc1BiBgJH2LWdqunZwQcR7N6/A8wo9bhJTj2vZ8Bz+7tbD+1Yiyo+Dd28xo2xaSzcL6QyV6DmcQ6QRKj/1Tj0PyV8ikhOZb3lFp2Y4aNP6Qz2UOThmihwSi54e7WGaHdxqo13dW+95YCyF3qbwTy2p0aAJGX+nXSPgnLutHZDT7Pb6tpw5Mh0JfxX1ovHV159MDu3pbSgbw/KSbnhBdj565ILd3fRZUo7TwjZ+mYYeIHXCdwfwFjELq731e6lFrkXTpK5HOThGm2AvQM/Cz3z4gIq+jL9euQV3/vDia6+t5OE6mXx37dMeHG50x3tiUaj46q5JY0wfF1wKabm/w6zEQfrXrWjhoN6CqAdvSYZ0I1MmPg5o2J3TWPazDrLDy+a2erYf79MOEzc+khWG2+wsJIgYxmnBZ4M59KvTrORakCtObreFQst7KEhixIoMpdqBQEaWJufTpBCsBTMYxqeto1lZv2Vvs73ey+Fy4kzqnjEvV903OtZc3FGbX0tbdERa+85Cl1OfM3kx35CmmNOU7gmRPo915ZP49Sn4hkk1s2UZ7i/xR4wPe0Q1Ub0mmoR0IMwXltsjsslMHVSUs0uryFih1TMv8LdPPPe+XWFUT90kJergvVHwhiVMOTYN/EkeECHXfSoa3bwki8aBtZXDsmmWLN6QECjq5062CS67KR8ZX0LpFeKKI5ETV00fcEXJxbwnw8k99OEK1B1O/0MLlolh98cD1IZsP0lcLHpUYCy6qf03vAUO0XDBqQuFxWamPEXtDgV0NtpQpFKbU4v7xVTCIROuQrpmRlxg6Q1MPk3CQkJiv6bf4gR8P3l0LUoGNy7x8O69iP362AxgbjVxld7/HBQvp10fRNWPNwp1sf1W5ogiaYhT/CzBIT/rhvXll6kVvwUB56EBf7TihGeOoiKGWBP3liC6zpeN6hABben++bn6GnyzbhNCXqkOxk3NuYLfN4sKnYyWS4Sm6l+L3qiT1riJohuy1anrHVa7ihkMFrutx1vdbwAuwPvmxkroJj43pvJCVvfqhEdpD/XI57IuKC2Nb6iglmiiCCfSYj06Y+QQn4G5ByPUiMchUzQqIJbEDRrJrRZLRJtJXuH3Bv00/0gLr/76RyyhR5vdMjlAz9kzWU4u3t2Xdv6L0/LqSvnZrjzOrSZVVJnYfAG61j/2kv85XHe0EsvjJ+bWG1SuHVkyNVcF8VwanmySrrgNKKtBbPSaRIINByyRPFbfp2j3Zntpb9AH+DWuzOK26XffauYbPR0Lk6y0Hr9eOywpY/YPRmiJq00LinXTURwF1yPIJkbgtuZWxfFxeqpChuAj8617gfEaGYh3Kxe2HKG8JJtaOHmB6ejpNYsQ/2xm7rpdDnmj9JZUQCd+vwL8eTEuMqiCcQRTR1bvYZvZIUlXNOuBUg1PaQEjXOKqCAIb9zPr3m496u5gaXk/bVylkKfV2Xwspvlb4ex2MaW9ca43Pwg/X5sGgJxW0gjcJuO12EL+fYjF5KkY8AF965SMoXJT/AuL7H+Pnne8BaO8ovoXhFlcKJRbuoDvuQRZkOGpZ7jb4z7KaBVVHDkDI/YYoWZmieGvZt2v3NuvZm2d0nWH9BAOjMhslkrQdydOsAqfDcpRFx3HBH9L7UwnDHddgtUY65NjEtoV+SxNwup6pAK5fOHWR5/4FNTCvI1rS9XdxhrSrf7NBKInlHOM4wXcAJeI8sngbNqVF9NRnrAVK812tUK5sOvjG4WboCb30rT9/o56HMAfCJBHMaMKxGKzTL0Hgv0NoE9oMrj8abnaJpUBjuvYKFXIEVKMtMZs6z3Rw1BcqMAD8ONyw6EN5AA5YVuT78u1JeiHup61zv/VP0aAUUDQ15k2OW3JJXYFt25I/s9QOVwnJms05E48J9mjhoJOM3B5LV0kemZ1nQZBl/SaNTJ/MKVhVT7RrU+oBLoLSp/hLU3Nzw3S/EiaX+2G3XlvmpSLyXyFQKuPJ9UpCvMhuSXw0NuRR6r5Yk0SWuypNU5UYHXoPPwq8+9Zp9q1Ex/Ssdxjnqur6iDLOIH3DN1qI1dd2TYB9oyFJbVY21O/xwb/5weqT0je32vayjvh5EwoVEyMa7m+0Tno9ci0P3kWrSkOlXOf8doxqPMy8cmq2kB7qWfRdL1MsPNAqO+9qavO/StdQ2Ksy2Pzz2XnxOELrO5Zj4gDR/Am6NeRzvP2dHVUbdGZ3eAOLMAbQhAnlL7B5A6+je9gkard//dUG0OF962z/5TmZ+67+pp5ZiW1JlEe70hrZL/87oCL2XCTOr9f/ik8+J2awE/0vWQTFylZ37UepHNVRsyZ/UQJBUro7VN2+306FkWviZx5h9I5Ys7s0uZDsqCefkYfaQ6WH9DmkR6wX9+o8zwM3lJ2zYfq+IXwgONFLxo2DXcHqXfLng3nEEbMk+xPjQltTz2xCA2eE7WjJgdtwYXZmTKUDz3mEBY8hUkSlLObbgsByoG5tN5OEhxv45w5ooET5NjZCAmyrM/QX52Pc+Z0II8JenwWO2keTLun7EnVZ9IhG4CAQXXPeKIH9Tf0KjQhVAzvaR8JFvZTbFc/myGMMkaC7c7KzSMc6S3GreGiu8jG0nWttMzHFJtXMzOss2L5pbToAo1WS/NhUnqn87bedfO71iW6seipfhkOT9Jq2A6uBdFMVxC9dpxaLIRetWYNKZARYFhVbXFjXCfH2G229zcN9C0CF4YfZMA8Mo4wB6JIwsrsQCOltgVZLNxWfwap0Ljl1fASmwxXACnMretJ3o8d5/WHOtZMwIO8aphSiWKx0Zpt4iox8GogGU8IWwQGRymXohKgrfSAqw0bdgV3CPmf/B2wvSm3LM+F+31gI8+GXMvrftnuOkYsBFqfH4OsYttjEHDWcdyEHYslpmcrcU3qc1dgHZGleRLhJDLvihHm70+8PA8d7MJuJ0qx4n9BaUGjmy1rvPBbkpF/Ic8I9Tc1PZOjS0xej1IBEfZ5VfP1yI3uHPL6f/cFSyHY6qUwLb9A2Q15dEar0vLito1uQR63sWyk6GHr2vmS+r0IxL7iB6vBRmMMPtkVS4AouF+wwpz96PhAu7xK5fJKqwNkyMNkge3vyqi4ZtKsUEpZy23tLKqjU656ItzK5E7e49NnzqnRuH541YzouVUCezgQJtJlpjEkyP8PipautmwxiaZbsySPeYLFcapwT/6zUwHOmtZi9Y6XjCPdhWk+vb0lCpKm7W63c6KpUxYtwDtlWpMnwR8NTjRpVUptiZpK6qrk2LlaRJx8FfhHBfvrxVKt/rNRKi0I5BrkHcg5AcKHB6VJZ8y5yRbVwpL8+pcmAYMO+ITvVMEvRK6J7EQkcfGA+R91nRkfWHH6aivf6AOylCvQE3vvwKtEnEnQqsfDxO40OykzFn5EDThG6Hd39Mb3nsLHnm3rYxVBKcpAS9AT5Sub2NXvvZ2XYY/tGJi1bwyCaEBxjn+JKD8+JTqkjx7IQPJAFVnwHVgIZqeFrQnuSZ8r7dSPRluDFzjS6JCv4KxORbesejBRnF1dT+6IYCsTNIec0YKwVjNVF3RSFfgGYfn9b/RiSN1SWvF/xHPsH6NljODjD/WOa0s1zdkk1Jcv+riXV+ECqQPcL86JINDE3UkAh9RcpznZNPHxlyiY+P6t9EmHab9ZSt3VhPo3z1WRAfOH/xL64x9OXPs/hwGWYqnmKq6H8eUJTYaXtzQSFuV8qefvm7BuJ3P0i7Shv1dlXPeeL+ovUGgnPwp8S3X9q2BMLAdhlRNKe/obdaq67kAsh/iWqzxdFsi+R5UXYVjqZqRgZ56aVM/ogU9XrLUkC50OY4v1nwlsE88qcxxlQ4OdjIBK2wQLRMxlz5n7GX9joSuUJFk7sA+E/cjINYLxdL+zk+yABON00/AGm9teORZJt1BJ6/QlQWlJY6efZaBKy7zNWKfunF/W3PzW6pDJUuGioz3P657zOn1IxbOc+MJHuUeMRfF+6Z1WbFtQu0TVOAbkQUaToTYB7QbZeZL9xp6jgSWZmYe/gpTVyNNu0Az2Q2+XWC72o4Bxgu1E7H+uOdKxT/WFLVoH8MDxzS6ef2PLuUb+SecFvpycrxK5ZF7fTGGzUDouBWwZK9bS8uzXgPSOchygN2Lhf4UlYt2zVQGhs1MVnKWjSznogWJqYnPSvq4mY8pJ3pHZr+E478VqPAclVIEodohKW+oh9FRyBwi+Jr56mrCkSw/de8eu1oTM6GCbTEBBLLf/z8TXNrBKIVcbqselrYVK9yaBh8+cqpUpR1pgaFU8oWtg3ySZ7mgVLsLDmWyie3AV2Hw5QjKQFnH8uIEyJIqFJPA7Mm5wRmlawbnKmz28wqlPXoA77NJ/nzclun/ViIqnYLFSTkt3S8VnNDCFDeTbhSiDtOtjd2YA4EnKkIAGJleQIfX189vkUpnYYmT4MR27N8QBpc9bMjObXlRuVNGWnBj5g+O0dCeP33Vf+hJYptqvOLsBUWIsr8ECaMtk2ujf0888p5fD7o8tQLyONQy3+xrPTV8uiMlIFKfTbvP2mX4VP2Lb+N+AdUfgNr2Nc40QCIaND7W9cQL73dTisgFLCZz/Fu721cJTul4swtXv8UtRQHcma05dIn+gF3vlBN//cDhD1BlMZFxXCb+JrnUxoLK7q+DKZSQ0eqvj7ICoaB2FJPDzqjEBvAnkrlHZ5/g6M5FH0H87Dhr7XCte9K9M9F8QK6brAK6vlEbY88sCadZYb8VOpLV4Aqppe3+qsuQuim567r77viN2WkNf27UEPgpLD2WugzQ/77enzngkgVvcfw+HzdXtBYyKT0nX4q1CcwUS6F9KlBSkkN7U5oeZwW6AbMZrJ4I6xXKr/qydSj+Dz++KnjoZPUQXC9n9ShaeYyVRf/tja33VscNGxA8FZTdWEc+j8vHS2XPky6NRsfD2UjhAwHL/VJzrLlnVBbV8kKizH3EaVgV7cI8j1tmB2iAFhmHlxnefh6MtSk1LB3p5rUNKEXPoTQBM6WsAy1bzlgs7d4fzePc8Y8pDJY7ef6k4NZhtfDirF3D3/kRZsyxn6OYQm3LSFEVlktPuxMRfnoUdDbQciyjWmUGxqXQra+/GsERGkiK8ZEDgqT/vjSxp5fsvKxBNCou63u9ps492WnMR5nRDg9d9/O04IFdGE/866EGbse3KlA6AcEFyocWkbkEi7q18EPh/WcqiKavc2rfUmx/aH7zI/uPdxCDmtR7NjAEvQepx0vUDBpT2+kjXNTWeYQfrYcEG+22r7uTHvPpfZ5MT+nFXE6mSJPm5pFckSLeshjj4k9mNes0W6mGUVIZv9mXt2kSDuhmnqcGY6MFnhWfZQtuXAQ//fwcNXHTkehrOdYhASv5YdZW3KeaOFGKd7bAXUhkaoFYqn9GZy5ItZswmkRKctTdSC4c3dkB/JuNEoOv/Rhcf0G9VOIIYWWt4UvbAuGmxqcFht2PXQeI72mIrap95LfwFyLO5Oq915VyVIX9xTU4GFsTiMorZBKbysfMgXLYE0NZE4XE024hiJODuOo0B/knQBIqOKYGXdYHQhGJqaJFobBgRAtVd+JzcY8eURzjjIZVm+m5N9eadl4zGUxykfbmaUHaRPF4Xd9U+SnmUcvai2fuvnXK7v76ngUoMK48T/DXr4esECv/W0Ev79PwaDTJOf/O9/s63Ae0NcLWjBIBilu5YJQhPmzbl/paMNwmXb06uHwHxco1OFbrfkrQz2FfIh8luFbH0u82OHfowZFEOB+AU5m2/EeHpVRxI/DlJMXZAJwiXOvo8pKVS2m24JI8upx3ZgDwu5v5JOm2mkmPOMjzCocX6LjlFRB7v5WO0o4JEUGhkC/X23I/09T58+MPjXwchPS+95i5Dt65BYjxlqxn7u9eLisVg6yH8fzlSL3HCw2fCA/zf6k4Gc+nCtTs7UcJEwunSjLHQAuQjFS7qfokdWVuPd6wP+kDFn1N1HGd89SmlmnCUxXXkqo5rJeSwJ6Wl8rPGNNvtFMT7nqlGbK/lnYcEzkbsV7voawS7Iu8femw9d21FawYfk8oFUPlQ9KhA2vQOQvUirVT7OoKt46in5ZiemYSic7l8jrTIXI3T8x1vonJWPuWslFiuRGNRcdqcooyE8L/tcdXQa+DZpXSsOOsa8x5ORVw618MKBdUWodxELmRzE/hNH88zyDG/iVzmX6DCgtPYx3LTJ83j/iNnLM5VEI+tIo3Qu8LO34dKpVec+dKbhbdhZQKV8DTM5PLm82jaHRKvFW+purbLvCFZUy+qdqfK7i5l5hRyeSkf5BNoyJmhXLCTFscyGanINUxOAVBZL0bpDnWi3EXDFwG2eMEgA+aUhdF2TwS/Gal1hEo80KP9sVaN1gm7V8UfFdZd6qj8iK3pGuuvaInNHQZGMOtWC9iz21iS9mIAf3HUyRdW602fHwLzRaC+f6EfazTabAgTaRraGNq41WuCkUbn3QyK8FYgrYx+3IUeg0aHZdFVrNP2fGL9hqtJc4fY0agXGA3lnQMEQFRcirQl47fIxL/ArnTFxUps9VEqmu4WQ1+7E+kBQyR1wS0YfbqcAgTqH3aQMDA0sfkLRZsUTsYMHcgFzUdZZEuLMRAjy3vJYGTBCwQfIivOPjMllvgoVr9lDFJ5zdhNWRrwitlsYHy2O1xHn33h+XmKE1tk46o5XpCBSWlqABMG9DpI8AhYKVypQDvgSUeYYFLicye8atNvCJrGbcE4uZkyttgYGiiimzjHaqUFJrLVGWJE5YWChrQ5ZNrIf+uTiRquKxevXsJTsdoNfo6dad/jaNxuAUB4emCnevOVC8AlR+QptZY4E3fnOMgzzPmnxhoYsG9hJraNTw9AHm9lwfrMZQXZyiuKcst+0nPYsS7ffCvKAzi4xm5CAdOx9A/Wmhi29aKY3Ir+4EekEk3kNXsyGv66pd+h4yqdmF2cb/6+ADlZQKK4ccHyNlz+eT+QaVKWubJBiGF9Sti2vXXSiHE8IEm4RaY1JR5qsfujI0XvjQon5sDRlrOSxj/xTZf6SdzZIsQt+Ni/wqBlfcFYAZZNp2gOI2ZOLIebxkYhAnsHf98PpKySl42MlI1ccWLmwDOv+nAO9NGMZ4CeKvoolu/95kH2zzJp5Lt43YgcfvVpOf3Yc7TdCi4Hviff8bdIvwrFGOg43QbmQI11h/8YEphBpzQ2p8wHXk1gfK4ubf+7IG0ELhAy15KdyZM20X4IcN0xeEiNyS1GOmBVFtN0zhKkL34RuyhULxLiFoNdvWBc8l5JmPN231sR8s7WeAstZeCXtzu9/kNfrp/F1Lv0FkCIe81llNvYAJ00d3QK4zyIuLfCaDtBdRI4AEZaUU69cvya/NsBkywWlqn/Wql0kSb9Tli/6Ud04LVkP6Q9uVXCMtEZVknVW81RthiIQ26rviLLOK8veizt5/SV+ORZqLR4AVhAr4/EDsknBy3YFLJLuKeO+NkLF43ElOE0ENGoWsNyZI3GD+aqW9VYXO2zMt5xmUjg0VcWRY1CGffxmCMNGSBo8/n+aVjaVdq8a3hCMJJ7UBfaYBZCOJqN+KxK/pYa3PCHwd//++wPN6WWOwaMrRVoHUKs1Wb7DU7oFQ2L+vMVH8AGKBSVXf+ja0mtwHK4VbSzSr8FOlAI5ywv+VwAZGFuj9OQjsq7PgBH/uISDZa4vJqNQNZQUFYUkTIMfadLPulKCMdaS88PJL5D3IF9umMWOaXN3HZGrrey5AN9StsrS6J86lFwLYmgulEmTOuN63I1pPByIvJdZ7ZtiwL2NqwTq+uNDNEM2fmSusoca2pa3FLo2+M3py/VhXqM7F07TKRQ6U2vB34mO/MN4FxNtkpMkwP98X3deZSlygmsLd2Bgfd+p3gIqnZ4B257FWipe16juSRpD5aHvJbli175K/0NT1CQuQMLRvu/ItgjGlIoOytfvOpwLI1XYx9f8zCTyJjDytsFC/80fZSfnrWWka8CuIekOK5HlysAGRP7IlCSsZO1G9a8MCQx9SWK6MnwLAtUanCJ64PchfuuMYM5xPOz4MtYswxpKOJz1iG6alhYa2YEXR6b36NwVG0UrgINLetnpkyVlMDlOrEdhGjus2OKC7DYaiAaH3u+vNBsLee/SOzAFXKoAnx38Wet1MXLlEpsg+SPO/V08WE+zp6r5I7iMeYPAn2eDZDxhOK9QDt7/4Eod2wZMNt+s3XDPtDYqkkDspciJk2NLIoLKC/7GTRpB/mSOl/xvB+FARD9iWmH5RSEUXaIidPwWI4+3pHu1mLP5zzsXAGNroOr6KZB0jj0KoXCKtdkFtRDqkkTjxV5URn0naUVxIaoMx+bfJQJFsPQU1fz6mYh81qYX4Zx/XkSuSF8qaQEtLsHtc8GVrZwD7pHwpza5EULeKtsG1JIpuz4rlYR1VrGRes8LB7/Nm3nWxwuGE/fpUfZhODehU2EjEwm96tusNE4fXo+WFddkDFVOJgDnbv7ZeWD14LmAQZ08ibfpf0aglOWkrzXO/aHJpKN4ihhSHKk7NHyPkwDGBCmpXwtYXMOgIn6RZJebTaoTQ03I/nKA0BJbOJqd4tdjqXATZwVs97EcgAJcEB/l8RIC7byd+bVcLVgNv94v9+UIFZMFksz0X6gV20PhX2SGEm1L2m4KR7OuwEEMZYCgMvtrSuznRycIJ7dVWuU7y3Anj/uv6ZuzAtsZK7EzBID2fA5HsZkrWY8GdzKCtWMYAWmUhzYZF8UwIrErg86WOO6bOimCTKNUjorO+FO3R1MReNI9BR8595E/ZFIbsIZ9WALw97Lcg0gRXjhaAQHJc6nedKMHOdsgAiQAg/cl3SmGgGDq3ayp1oTMfoWv7l7amWDMM7E4gvf2VEt9oqb3u4aQrtJdosikApj3xIjX/WZDL0N8xJkhml1SvEavup8d6ZCG1kI5qD4C5koGJJLS/tXHIcI9O8ADJrFjiuQKn6F5knxdoDbHPwTM4SgwROh16e0O21fuqYaJ6dMSE3oDTm5pxvI3wvi7eGZT/DEbhUC/F4wUFqorA3iNWnuFnI2O2C63/WHPe1qZ6r5Qjw5DR/Cd9PSyfuMj4FrL7/pk8HOWWgY3dUZbcV9VBAAjmzrAs6JhB4Ls7JXTvc6HJleD4x+9KogYXmEc+KsuEGtcZmyTXmzHStGxgl1FzhLBQzYy8A5hLewowYQoN41+/BcshhJoZOfGgvYi+mqRIF2itATPLoAY7/swlP3dIwF+bkxegkydjZIgzMX29bBR+N7oAoXjfw/hz+remXeOh6SQlfC1wPEanDwqqSUzCGVFMMUJRlJ0vwCgHFXxjprQc/DLUpglFKnk0hxj+Vui9EqrGf2HAFrCBI9mCQakWWNBS2KqRnCoIpRfp48U5/B6kq2GeMBONrc8HZfVHvantpT8Gyv8YNgMjoUJLLkHORfLbgIIzmiqU6Qz/SRv8YBW0LhZO3lAcjyePSP/KHjDNkYA/Q2esOpuAWuh8N2cMD1XggZhPhDsX9tMzJbqO37rqnyD64bqHxVvfA8lqAX05U8yzBm9PI29J29wnsTcOMrElVxbNrzNrKaWFpbUOsJlCxDaytD7OQAKZVbQMRFkV2zeOlOH7zDMIkPpOmVPfk1zIc72S6eDSr7UKYyZLJCf07Jp9zG767F0w/XEVvyG8KMcox/fF0EE8/cMljx0VLyWDFWB2nplkuu8wvQeCGHIBfI6WcYTs8sXGysUW1qByBDGHT54tdCFeSRFJR7t0APWlx1tnziEyTQEQqSpS099V+0QWIzAFRwDuy3NbKBPz/BYzsQE0nNsuR+pGp0H6tDk8dNqL+dMI/O7H+lVqkxqxuyC7N8U+v4bnNW2tp3iY93EvtcA8ZGVvNVdOqckzmFl2hZ5fGNXE/7UOopG14MHf+yiajJDMrK22tKgNJj+6e+UA7Bcheq84nUs/ZHZu1lOhtb6R2Qy0MNpiF7zBuzDC5O70SLh1KXMdrfpLHWiuA57b9faaG5MCBZSJUAmJBIKJjtVzWCl6X2eBPFr5IujVDaEx3FeizCQP7hib8Ri9V9/Raq1/DCJT/K4IYaQhgpEj1XE+u+gPWmVL64xyzynMu7r1JMShNMGKZ8kJdkZu7YycmoaBiMxkhqiJseYmR7gSwBJg0U1H4MvONgHehXxUQOpfNrMN36MBCJXVKkmXZuFR9QznE1cIsNM6Hi/pxRX7r9AKZu5yIZyicBiH/mvLGdLiSpsXN5L73UP0vp68aQxV6LejbBxiEPfGD2jLOLy4A9S8K64rD1toKQ9GxFQj69TQdoHdO7Kr7DutMO1sgYfTuHug+H1NmVQ+XOvevVnRs3EgPmbN/dBkrofLZUEy/4ZIpCF8jqwVVMxoJhqh+SFY80SiI9BvPjfuQHsAQIcIuZxo91HNFqdvqSJsZ+ghxULeIypxgRnHs60YtPjzBbknVijLsVh8n2khtt5zOIjkfG3puaO0B2b5K2vZSuQXPmg6gg/1Q5788My+5cvxpzGCsXdHlVQWQBSePrR9uuXjgoiJekCQncgN9ZtHSVKhdV/bITHyGHF7AOF8pod1RA+fe4LnNvIXcgNMnizM44cBylnlnTvKGYpvoGTMD507moaXtRle734nkR/VlV3AKkqJln5AY1Ox6pFJ3/rQH6v1wW2paQYBVBvT3F9U7oVyfFnNfMdMG7krkmZxonYea52tJ85zVGV23N9sJ44BqgOy5OA/ksqOVoANBIYJPw1F+w+T2pH7l/Pze344MUf/OtkI1nIRoV6tz7eE6xbIPt0Fcz57V840RkVHegNswBxh77tI09RQCleSE9tRhPofqHlqY3XeiOtGQ8wV3hrVGQoeM2JC+pCSV5bjODjGMX5QmVYWcrClV3KtwBt6MdWD923uETJ/37SWKkADWevyRMnsXT4/SdCidlMfG3+z6ijPp/LouKXIDJ9b2pOZFXgbvJNE6e19BHYBJUvGho497a45cEyJk3xwQYQluSGfuV22X3N90iYyHVNYx2gKskUW47wLM/h6Q1sR7TzboAeXpfQk23tvum8FYfK4vPbr3bhLLUrvzqMMxz9lS+ZX5gHUEwpAIQyVqo4V+oMMRBIohnGLHcoBz4zodnlLVDGZg+DmehRr6eBsqmQTg3MAFZOxsDspSjXpS0Xsdvg8EfwQ+2iM2DRyaZmc5Q2Vz4mpmUlGO3pjIq9q+Tyl99Qxmjl0lZRbvDkM0ZY1ihxzlFRijCXFgPhsxASfk7hf80TEEQLk5hjYiZT9jzM7aCR/dcIKSfxhDKPDG5/8k/hZ/6kGR57+iPEK8LjtnTRsmxnOeqsu2moYbRxocvbvGiZO5N4amGbiwbnSIb2dSQfONvWvwAKzXvgBrAYfWc1wTlvXheqGRQNfzzKQeRdJWE0q0v2Za7614fO1S4AJoUp8NSgaqCiAUMqH9WTOHB7Yi+218T7sHg+IxHAL8c8105tth1t2bNnhqBZyJdeKTWzFVO4d/xCOTLUuYNrpuQoYmOXy2OfkO6iMdtY3cMVzWIozsu6a0D0ox+itimlgZYtpR2XOir5XrhMyNU9sL6AoRdHF9dO5t2xbFGgwyhuGGFt1UZzdSgDEbdGpVSHWv7YPwX0lcTKLFRPKTbgxGaPtF4wrt66pmIor1cPRjemxayKw3p3xfqpATMotVN/AC6ftVoL9pGVTkFEwALieWZOME66EfQ8JkOFqFRiiFd5Wa+4Ah6Jj+gAdtqRIOxeCVG7UbMZ+6VWwb7JPlj5C7EGVoJcsfy/FSiik0LEwCVUYnDozWiyEHKVZn3Dlhm8NVy25ntEMISAHYVr4Osf4GXGsSzuxWUWog+jsir9vQAGaKmH/vzjljkLcw86I0Q3cf2rTDU7pQlftIQZR/9ikytUto7XHD3hOro3R9QwsnfhXVCoB7RUVDXD6Js9fj7gm0F0H8Lz/Xbhzz5PlEieyxRWqALDellSqst6Jh1AGFF9u6aAVgmQcIcLx/k2mZJ13N7dIFKqEbmWIILEwLScF3KsE2eq+q9YAzuN4GbILpjat2exr1oIav81plpGhqCYb+eR4s30MPUtYKxSJt7L40dMqk3DIUZZwvUYt8Smdweavh1wKvgOKT3yyjgjsZlO6SJmfEKySCcAlFGD2Bzye8+bS1K2vYWA+hUJwUR8BWTqNiKu9wRHzPvyWi831mkrUUdxYzaIToKHQHMNwoeI1V9/y1N3oHdgg2HVKqAbAawAdBp07Uz08qm2tUUFuqi63cxCoYRBwDqgFipmJLiwoACfflo0ioafOYv3rGIhfEVbVglhj41xIprg5XRBbfETAyxFFHnAMIDu1WVBLNIISdmKB9hAHHQxD26YHPFDDyvpwkcVBbQSkr7bDe8pX+21vL1GAOEDs5Frs1b2pfYDb2qN05xBIdmL6+FW2aReEeeikYCmG26CE5mLvIWis9wBfUUH3UxaC7yaT7sVYfFdhc5EG8p8HH5hA622F0Oc6fAufqHjugrtF7lBd5Cl/EfAHt6jA0sTwvsdaxqnzntHN41Ygxgk4D/tRL7pI3f9PugNtF4kaaOFnYTSBuwVjyP2+04A94hbMxu5eW6kqLjWCKU3twILvGYXuuxB60gZJDLNaYfa3CB1TqheBmnSWerODvqf1g6HVHdZUGIs886/ibW+k4oHuGybLaxxdHb9dmAnxu9Dsv1BYDhZX1465I3fnRp84oNKqJZEdDfMdbrx6EpSxnb9pfYav8nX5aRbDdYq2f6dLHqOIwKAle/nohNpFr6O1dIXiiUYWC60vaFejBpqFPhhbW6FboaUNxYX+JZZrZFxWU7iZyZwnV8K47j6xvmjL7k89LOC8o8tYi624wSNzcX7G+gvzH89nXqaQkvdhDA+B9SYyvqCxN9LFZHOMyNBrZiECUvtVxHDINUxX1tBmsjX2U4T43tNte/qMJoh16lQSiSKYAfzGaqFM74OQxE27hNxIyc/j7CA4jfrsmmkkH54Zdg67oGRCTeCErX8+qENdf/58A0vRn+fq6UyfVVOCdoS/GKWG1DSgfsK0KpYdh3ZTanJHL8YxxFJJVus1Oi53eigZj6BNkuLf/jLdrSi8ofntWfXXaHud8hVb64R07NbjVR4UlFOagYWc3JmVStg9bVWkNaYqwyr3Wq+dVb0V+HiTmkL8FAfc8En/W99E41TyKyXHvOvgyNF/Bl/LNHFSfZkUj3PuLKM3nSKx0Rfk/A4dYYwXIj5o8juuKXnnVgyZbC5OhJOwfqBF2gqHHl8pecGB2TW9V6SNhXGbsLQ7u0SZ0Q5GGHG+cbojp06ndfYgi/2R4u9QlY47i53RMdrO4FBAB84QmBAGtLnTRsQCYiawSz85rkJ8ccqaNOlrQh6X8PRmpppOWUeC9TjeBBTAih1+eZVhATYV5Oypfz3rz/fbaNH3rA9FoewuN71UPO9a/eC3PrUTlHurCxF94fupPanVFC2UGDhX6raE3piNu4WIE9bzva3XxPoTmq9xiaH59gqnwimgxVKlmicUIv9syuNYGaZBiIcx9D6bd811spl2TfXZhWsuwWxITbiFS1X9MOpQ71LQbsoqi1OcOlpyyVRtm/cFPZN88ABcqSKlk2+m12tolDr7R3PFiBznZ7UY+t39yQFoeQjsQY8A9TVaoKS3naxDVLH89qYJKpF9FO79azQ1XbuSd0AyyFSCxs+eSST025h1R/MITZtH8f/KcRglaVPf2LnAh9Erv/wyXyx7PBp659LkVigPm1+AqXRuRrcfOBzt6AG/7or2cKwcmshvYo6oXThWX7bMeU6UCXmJhY+J80v/NBwil/WieznVZrj0ivqik1WIxvbvI67kOAcIJg9DuBPxdGNjfVb9huyPHsQWNrvDce6TTlkdTCt1xpA4asYCEcdMgoJ3q+evEGQEPAAsHXsgyA6pV2DXD6785fXZ2KECOqROf+pjw64PLYwSd+Inl9ZuF+nSNxbONo3WJVKhJWdhZKoegxSTQnRiWjk84pS3jktZuGc+L6Rfte0nebc1PO/amZRSTkUT7JUFdFOljI2a2Zx7xYedSd4ztvSPK9N5r2QoriTB7Ghmq2PVaxKxbro25Uy3mghcSRwr7Kly+KDFkJCax2sYWSPyU5ZrS2RzLzjZItM0mjB1UzpgBwENRYsq/47D0+rC2xiY6ffU+TcbFxkQNS2QHe0tymwb63Vt8Gn1BpB8N4Gd2w6BtaP69+t4E5I0ctdlosMwj6Hk4FIvmxcxZ2V5SEuEvEGL4wLbKWcKCcN4NwRXvHXF/3qWa79HujR8WJxLGz1GLULZ9TdsBnrkX/8MfE83x5BbUKSpxysAlklsuszM1CYAyt4a0n5bUoQjdw0ky4hiqHH2/JfG8fHlL99Y0abVliEEygt2j0pW1xHP8UPVYnx05PDzXc8VMzUjrerytlaSZwwjMJey9lJn6XEVhnF/wP2yqnVxnPJwRyVXIemNTZM86LystuzqNwOlE8eSeXm2OWL7Z3hKezoR+9M9OaaDU4jOC15Sai9ut0BYYZSFnIqFWM8NU61cWbaTvywkAYInQbLnTt9LNfkpaBJzQnpTHKp02V6X4795Q3sSOTBpaa3KBofMHCwOwrsY4PVh+35X7CGnpflms0lLFubEWMBTFATefe7kNKfOJspm7JLnZ4ZbQSJPOJSbEB8G/fHf6UtlALCkTpLXfVjQd14QEGBx95aQ48e8jY5jxNN0Le49gTNz7PZbhjpUxIM87vElFV72IBU+C9y3g4ThDV5qZPADx8+H3I9jteWt2towz91tsLdTUPMhkP4awrMHMKP6C9z/i++U/mR/Faazx53WxCSjGpKzce881pRDR3hOe6XLFLoMI7VYrZS/pfUi996bMuBaikEp4zM22cXHcBjbFboTjWG1EFyLfgUVjc7ZY8huQ7Vkye0YvzmIMrBnJRiOh4qL5DHpuNASnhXuDLAiarJjAS0i0EHSHs5tx1OmxqUCFhO8ay1Ve/RVFOquB2h3OqAs6uF72NVWsVmnkWXeiXUr2takEVre+fHptcazYErlzx1/BwTO42iIS1mhOltMMPuME6Itj1sHAdpIOUTdMDUi6b/RC9bQ7kfzQG9wJTOmABXTfDrymDSxVxG/ouvrZFYXNKVTJ/oYadCa0a6H/8CI7poWqLQDDG0iEHW+3tit51Yqazsh2izeOnRJvHpVUDwH/B5/LDlYh1G/AXlFnDcQjPiSV+hVw1Oh/dJ6/wnocmtF1cpLfIVghAnidO9F1TQKtR85umNVEZIzBJj5uAhy0Be5corZh0itRugP9B0F6B/5heC0C/mxlf5aW5MumSvU3+9pU7kmT1KItXBuuyfHWF4si+EmOP230lBH9pBNAQamznswDJNiG5C71vavrcZa+gTS2sgqz+XdyKlojdjP31Z1oq0DIoh2l5jpheu3JAxlhTqLax2w2a7S+gzpmO6nNQifMMDwvmkw6acJhkdPzo6VO/PUFOw/JrZH258HpWhJwW84N0GP8qlxuHHGNmTwjgiwwo56yLe0jOcJuyKIRfOmXiuf4r1W8HbpqMJ0vNTTcyfsLCw2HKRUmlntijEhqtdHh4DuE2sr/qicL5eWXIVCj+lXEDdX/Ccnav2G4WrWMQQ38BVI85JLo61EMeIGGLX1ksr5Kikrg5UpjZAd0ZoSi4g//V70FN10nx/aE5QloyqGWuforB6cLqae8zGwTAi+0IRU25BLFdHgkTDClty2GSyjIpd7euLBHuy0V0A0nHlnblCQnlw/CTaXBR5fDEUJElpu8FAMVyVFVLchMb2bqw0Tnqey+A7M5rrphV16LEnfCWjdqCA8n+o4jNjXn4nYoEZEEeRflOVyse6VpKoWsQ2dkc9gU79sMV8iSfbskUcJC0U7UDGIPBiOvnM/TBNldWXVDt6ZC46+9rl3vl+9VcR8B2qe6itXS5iyjqB40t+paMflqwKtxBruONScCVD5IAvfwsUzovQLJeYUSmc3+vs4fxpL+MZSFmuMdVVl7e6nT/5eFvpyMNCtziqD0icv5Tu+5q9e9JF7BXBcYbE/SJDzMTYhmg9b3EkPfCQJrrD0Wge246qPptCm+uUqy3C9rBDhPy/dNKXO86S983v2RhvU5varVc4xeUPPbiTlNNiRvZfAWyT+1g+tRbAl1y2Ruryyfi4AiYk++ikvpSX84nHQRhBgkKuhyqow1AfQAJr/6kQSEWwoijc+zat7ODhcdelA3SWA6oOzph/yNYaFyk0cAxjBRsYWJCnmYPrNLHcxhfN01XKVfkwddaB/6zbJzwH7g6TvjYj1CIwgCpqpFD7fQUES/Iw25ZgrWh0EHxdzReLbUlIhaEM6OmKkZkNv+1XAlvQB5cpZrRAKGEVH1pWSFcD1Qs9WfAIfYKJaKVxR3LAzcO/DJR1aHKdE4xa9rWlbMhL3FqLWyOr1Qcu+zOEF79Wkp+UyS431dkTWwNmdpuuQCVpNMTaqb0F9eFZRedpKsOEBx21QXoHejCIg5gztA2F0C/2LlSArODW2UwtMeRCwDXc5xTsK8mFXEGkYYc8hxpzDmdWhEnn1FD+v718Sn4pyIZqzm9kP7vafahizbx1dQsshXjU7pOpudlD+xXFUH0MQdl2uKDEAkVDQ/pJ1EVztf6dOeSTNCoDY7VuXyeHMRotPitgdUA/IMd1AMR5GB0kLc2qy0zn2OEjhBAf6VRo1AUX8IcEYh5gdmYJDYgmO4YVDwAgkjYK+HgvHzG5lDNa5+bhkP3+kaKlM3+b+lDwQ8AN3i61glAlZJoqPcMwlUpOSsZrtGXMIoA1gsd6duFkuHtUfPatx94jiWUv6vu4GLeK2hoB829qnjZadFAwQoAgp/cHINnK9hPEIgu/jy1gFUH5DO4b8yBcUh2O/6mYviosmEtsMGlXKP95s+Ibw+HZ9pheKJ7/a7EmoXAwZkiDxuZ13rk4uNsyVw1JcVrlUDw9AhgHSNB7ZXhbyTVkaGIRE+/2h8ZB/gyykB6gbPHf0eIiq+//PjDcUED6+IaqsS/nfiztkQGhr7q8vkNHeCy9ATwd0EHL1Nmio6GRj+PSmCkPD7aUX6ruaYF0vVjm06+X0bO1edo3uMFxSfkop23Wm2a+Ot1zjziPZDpNUMqJbQ0C6bSpeCOlN3SZLvad0nSLZXYfdyQFJqy74qTbYUDgVk8P4jZ6bbfFSJY03bTkC/TeTLssFzujQyVRd2WzEokh7sBTInQWuvuo9K5UPE5ST29BNOAC8YogxHGZzRI16F8zvd57u88urzRacWl/ITdwvvBheKS2SO/FkWA6D6K/Avf7/XM7HUxUIG9WG8e2pHOQOdviuylpZqSSRCYm750Xjvn3TBnCdYdD3HbnMgDKXLi/PBiONDgPDxXaj6etwh/FAxZP6QtSzadC/HnYUbJ815iNMYHR9QT1kuT0Y7jmEP7FGBugTifEwTyS5LC2L7kuzR2xW8u1T5P4dh7aq5mFcavmbHFnOaUo6DqNSLDodZOgtAFVtCeH+pdW7RHLZvLS2FiecEKp/siYH0ZHWoaGJEHfBchHCPsOicu+xURsXFudQodmQ+UgqMlk4EbTnJKFz4xzt59xvHUgnWjI4c04M2jofn6gP0N+i8fVgxp/RhAFPfrjJNeaSN2dJd4K9zAvpqRu/OS4e1QWfY8pH+5ZDlhZmYJeNi2tmcS8ig01MJ3vjRAUuC6Vi3SVWRYW5uRAt/eohqaH5NHymmzA00j58wFeccEnt70XiZrR63uwPhsc46QCDmFPBF1PkiCqGROIy11PgYYdH6eTQhLnWoNZmmoV9uB90F0LRtRcx268gpTJ0U8a6y7KgTxtBBJGqa/UzLv9RAqMDLvLUlVwt5PndZDqQnYXTHlX+7eHMPnK7yOrKSN9Gq01LXS21kwwhG29TzvNdi6c/v2RIR5FYz0wpxncdb/pNl+5B8nILBAZ5SmWQYmxJyPYUbjHlLgteacY/fD5l+zrPEZzNCamKUGo5cQ9vhf12hCEFebwtVO8QqeaRj1yH9S/VcoqOSftgoQA2VzGjzpabR22lPCVImyaopvZg4d8fofORUz9LkcdZSZpx+RgcESTWHb0H+3Uf/bgQXpE6cKykpy0mDzDKgdqPDpFJyi03Wp4TQFNAxgqbk2yP6eW6W7EVjoZAbDzuYCDfFkCsysPfsPuKHZ71zdDdeRVEj5hirs6xQPWPV3TYCPiWWvDsL+9TW2Yj9A+HrE6YH5J2fDvaipLoBQ4McgUCNIHlZOeNsz0V5d9RiuioSh3Q25R6JOZ2E843rSBAI0Whg7qwcGqNuh16WYjlZYXGXXkRi8gIZs9aCB76LLzyiuirL04OHYqxRKWBchzCLbkdfT53iVELC4BHPCB9u2C/iaJvoJ8DMqhwdGbE3awZxIiZvFWXajzmfWWtmP3NIV8Hg9ilqXnnf+emEM0zzKWCBzVE5WKURwHklNA5dkWmLwMAX+CCy0kpKWUG1EJkyYmPjOxhF3hZbZoWztBMJ6a3mER1I66nhbLMxFfOBsI7puopma8U2g9aDHeNHOBDx6AvB+fqtZw/kycsVfQnmPpWKJK+yWznB27kz4k+6EoLUayvD8/2OMZ6+C0xljJV+zaD7BWoXcw/ChH8Z2H1N4/1J0RTKOHsTLFhuY5ndlldN4adlsGY/ko8jIEsdep2RF7DGuD/QJwo4rUpSw/Q+Qo+73CZ9Ge7ZqbvQ/dPg/6crGSKHx2nadOJAj6M6n1iBA+795Ugkl3NQql/+FuqmPH0XQktlLuvtgOFW9kdf/tQqSBkTFG8mdFWaG4AmI9P/2P7XkjKYeXjlqKAXyNsTo8EO9Fkf+dMS02YlEkrDKgJ8O7lP+TsGSZxfeB/8rZUKm2dPDzJsikyZVC5RESUHwGk26uA5nWQBIXYttbde2eYpOmUmsh8PMlTT3CF6K+1y3PLuFMwEFcOTFNWH4yBitWwy5FmT7roV0iPHfP1rAaT3VPudGFVXTwodFO2yRSuNxrElQ9AFx2OB84SZDGF+SbESI5qWdBPHZlDQFPULztkUKSMuYnibHCa1/oF0f1DRfqtKdQLIRDYzHoPVNf50M+mHnzLlIyVxzXQ1hYeSCO3hE8Vj9Srbr+QZH52w1R7IYDPRalHYduRm0dikhuLN7AXDI/MiJmfvKp5ooITUkd4rKHuBcx/ntbQz8jUA/M0ip8OtEykcogI4D01kzOKpvSEqeRsxhHit79Q7jR+Jinsfi/r0OCqX8/oLI8hC7KaWn8wnN2zs7O6Q0VDzaOrbfxZZTOlQ7ouBUGt7oRXalN2Pk2mJM1x4hWK7N91l/8OpJa3z041rVN4Er/WYr/7woSsq4LIuWhJOdMRQHTgt2QNxjAIRv3QTMN4ICRy+MWv7ZD409kj71VvQdNjEXCqyiIO0cd6N2XJEOvnBrArnDLSSLerv+kGiAOD0vXN4YeNQyCGhbuK5wGFuPZ0xQL3oerQpAKGmE4eccS4c4HXCDRnuZPaVXFdXESntucF80v4U3VTV91V2SpPS78DaAi6onKqoXqe5A+HE4Fiyp/VUrPdBCtbrVSP60l06lP1AkDubpv+8ogtDPkNLpK96qmN2/bS1I0Stc3s9us5gwNroN0c7ycQf9yFBJjd55rkSF0q3hths/U6xqxAZ/yAJb7ztxKeNfG1Grek4DOyiMcuKe5x6H+qNHguaMizdMuKY9RQk8feho4UJu8nMctLDmy43ousXGoEVs6vgcTnv8WyPsWuopdhR3Yf4rBEkM7qErdhl8AY2PmMr9lrb1MR+rY4DgiHncqoR4oc6EdqCnMBrBJBW/ZzSAoSSlzcrjNamTxhbMuFxHFv7uBp7zcj/a46suZd/lNki8ELX5ipIgnj9A5I05U3L+7aWCarz0Dz7gGPym9a3XQP6W8ugjWCyWbjiRiLGl9gM0r1hv2W6XoNyx+oySr9VBWuYbR5SK2Xo+6ddVCGUFePeWSqI4JNYQ6NHzgVne+gYcAVcmCR1FX8rRqnUJeo8xhR0lBYzai8ejPNcUricHaPQBZuUzR1SuyRWPZeaWDCEN9+YKZzxsZwFPx8g4veqAC2WcAhdkzbjXs2FSjtdVdFamkIL5rwR6xtOJ+0hi5iAEzKq/siGqhj3V9FqYVdV1heZVdKumjdxTQR5a3/vOdvE+FTLbc4JdirLxL9vuzk7LXCMp3EfdlqelqbmoIaXtIzBUKIA0V4vNhKsoCujX6eQ5wdookLyUa0wrPLIgR2w8NBcPL5pxDy9WShR4rAkn9mmPln2VjU9m2r7SgWX8PfMLWpJNEDGL89mFBrITsddEWdkGdQ78x5iLnHO1hy+JKFg2/aG3LM+kcAF8eDXmMGufZowNO7L6+SZnsFSb/bQ2LcfrEc2UHHDItqmEDWbU1uffIittZ/x3D4sEG0js7+bgi2uO7AR0eKVkbwPgzo8HsgtLC5oJZX9i7zJhsxK3IxaLgQd9mneouLZSsEgVKyVV5d3qnydrIKvR5rwYGySpvdHZHqjnniG2RuUscmE6ZOHysRWv4BfInfUMfbDz4uF+YltO+Wk1Uj+o7YhhwlApjM4avzxfc9dkA3EshrnJI5vmmOji839QCF86XCNhlHiFq6VuSjK/18YCgTqs1maQmi7546+3RO2YYFacNg4U0SlswfbAp9OCCRAiW6kBS8pH21+woRpEu3+qGuOJQc7B+0YLkr+HgR2zB18HD31FfS8vS86FWtxIp/kPRaTZehUAsfZjzXcjO9tXeFqX52av49S8pH4kJ4TmM17ABKk5rjYxXfCeeP/wTB+N9iDn/16oBfk5g72mUz8tI4rOdL7iQ6Dg725n5hcBCt4hPi/KpyjJ6t26GLpHpeYSP+/9ACVkgOklHAd/UdCusitB0v6PzEscoiaKMKLM5Pnd8/nGnlfYmbCITsEzh3NvKhxDeqYpZP24XzsWDJd4Q1C1fu9VXCpiKjMGrTySq15S4ux3J7ytkS7SDZ/zWGHwNS991U9xbaJmKG3Dd5YtSNemDe2DUTto2z1H/bpbVmKcoABoOVAEfPyVVc9cpGcwER78atLMaSQtF8Br9f12MmWihqyuAVaN6id7deJMBTNyKf5gOG6weimut/SOZOZbem2WpQagMHIgSWC1wNi2qomcAyQmYlojxPKYAaSBGn2o036GY4WzHtSRdyJEhH3NalvqB3RDrOvCKcEZHm0J/C8yBOqxnjXqLinimnBkhe9RSxd38v/uFnum2soW00tQUThVoxBo8Rp3pgbV64+Ik8a1uEeL92IyipXEyEQm8UNTTUt2T/ZejHyVEwYXHxOJrouABqqlhuZ0Hks6V+kVyT1JMaGgDrybEh03/mBQGuX6kPVeCGNvly8Z7sg9ApYQjtjQmtZh9UgcsJNaeSUJPzmPHV2lK7KZvTnrZXd++6Mu1J6W4FXbzsDC8gNXkQdifdkwtsESjme5kRNCJaYJWdC/tWvByL+8FlkwQvn3AgXyo+kOrY/iNVT4taSjcSE+z/a07W6P711jjBbgE1oqFhkbCNbBS/6YDLB84RqQlbVEdkSE0DufwO6n4U/aJivHX6GoucFLxzU2hH9BHFAN0VL7OM4A2vS35XfYHQbe9Ili/ZexGC6eRgGm4vG9B9+wuhA/J7R/kFgswqo1+VdINLESIqFA3d86avk9voNpeSAVDoEDW13pl9Dzmq0FeMQjrssXLtz3aUpgEecgG5goCKbWQ6pewK5tOb/0Mesgv3zmovuFDquJYZUqb1b26/WT8eAzO32vTI5wL07xxtCj0DAM1PBfqMTmfYuFsrEe4BHl0LnCkWSXL6DXD2p9neD0eWMC/iaYOetNvEPaztukUi5JqgbtWhSoVDOGIjNF302ojH6PE+bKFPT51eeus76Tg32wLuro2bn+rRsZKlgTG0+WmRdF9Jh54Mp/3Uw28YSORt0v+BXKCrlmuVX+QoeAvCbnHPWWiGCtG+jlXkYZIBDTmHYj2eyGQDCoAx26KnSNDEScPGCdUaGmLxkI2h2dyCAJmcGdBt1L4sVKeTQvAzZCU7wzzeTysgeojZqIn/zIrOboPkrPHOJiFMqqbYsRZggafj5W7yIxscC3T6ZHvG21lD8IPP0db6ZdMEGRJB+qh7I3TeDrur73wWp4/kxjSjQNOQhajMt1SPHXJRwRyjEyhZhi69Z4SWTDDlDbTGzOPNdlsQgQ7L51U94hYlLSEoIMRKZRH1Bg9WsKW/IvLxd1GYy9UQUCmAb754BxcNzFZjmc/u4FV3W+Hh0sA/Fgvhw+BdQ9OX26WsSjMRnAiqBaR5+JXzVgq8LzgTvmHFxPzSQXMmsvxdTxBdjM57+nANsFES1pxYN+TsiissoTxnm+PS4+BuuMbiUvJAlD9yT1N7Wt2ODsdH9Xnn+/RfjOZ/Ml9SlX6rVpURBa+U87viTSgsWZJM9rdIIEM77uqRfS/itLsM10vulfwzLmsB0js5Vtyom/jSB0Ox3h0ztEvou8V9bfldznnFX8Bxu5Rha6AEmSCiuEiK77Wk1PpypXanzHyyLgBI+r7H0Tad3h2fizWt/Z6sGkzLjBYivDMncuSzqHEaQqOOuyC1yuxfBp70IIBfZnpo119gZz6SAW2JFk/y40JXoPfVo0HtovX9GXZDTh2gDtnOn+R0D2GWH8V7cMOPd4JhFT0VOq2wS7BrcU1SHJZu9uCNIQQZkovDtc/uQvc8AduTX/0pc6fosxfEddLC2ACFe7wWQ2qhRfQos0H0vCbmGYbf9BeAkxRTVyg1+tY3qgGMQ1Ef3ZiKDKxIPH9bRlccLxFUJRAe2OBzxffzvbQvwVkjkJrwgGUuTwXISJE8FcD7C3i5UiBrHv3JqhrMI8yuNJSS/GDDbyrilFtBJtKj/IOyXnik4f1mRSvTWYTish9zxlv3NZk+UsTIwfCDsykDLGOzqM9Q9jkBo+YP/n6RQ9CNaL9TUFpmvIIdBQQxoB0ICIZHHC/EUtxDM628Zz3Jtqtal+liFluojIK9j+SF+PYvDGqBNr1sjGqT36/oD8JT3dUxS3l62GQHPWkBDgB3frGCRHD5fTtHK41TQO5z4AYwQYsOZwWJclfpvgFuDF1KLw+6kQSJ9rmZq3Z/3OK9nYh0NdQwQPnhThjmZg484b6evZ5Xx3PsaS+LI1+d9OMC7m2pNSwsRD/yWbr/0Fv9AGQyxSanZ3enOWfpUJpcp5xlPTGh+ZI7FNZs/+cITBUsqa2ASpUxT/qfLqvWFnxZqZ38E1CuXQZFoN0nWG9PmHt+rsJdNyaTF7HpqKm6dGosMdSidX5kkU71nXLT66DScIpe7QYTvluAQCa5pil0i7Ou3vi6JVW431Xhm+tDdk2su3laK/2L5wljO1qPHSNbbfeAkONzFz9PWNVJxXWrM5Ioe5MdtAJv+qvyqyY4hnPAn2d4HtfuINJcFH3eUYdH6fNl3UXLI9h4OQxcKyR1WXjBrFQil4/WoiPCp8zcN8sQrhG3uh12EvsBwWlShBxvG+YS4etIx27mMNLmA9j2l137Yuj4/JyMQTfxZAesxZmr7ATWNfLg6aXAjagWt8WlfYC1oA+D4EP8hkM1NktwecSFr4MybKEeca/VYM6dIKn9gzIe6+k/3ZoC5r4upT2ZYdBZIFMuAZbvmciKNp/vRVieJi6pdrcbSONhXjfU6svjl9suHcik/sp1Rlkeqv0nZdU+MpTYzfv08FJ/V/n5ElmcZPU5kAtIoSebWaESHHea4YljB9waqjRo0NZg8r6JK1yyxCAc3BqaMogyxzGIK0IwN2EsFGQH/n+rlSjOuBFEpbsMAbCtANo0blBwnn5n7yCFwAAx59cRjzHkcCWh3w9sjKdyPZ0AAFeDqO3RQOaS87upVLPTGTzKGgFro9Nd7mkzQom5nwLIe6Aik0ZBCHjYmEohG4Wgpm+jm4aMMFYSNOBydba/HeNHbfa3ws1dn46wAmkrnSec4rE1TtJmNGy7mhzFlz4rhvHZ7DQhpv4tyGTQ+y8ak0Prrh43FPLChVIHm5szlaRr7nFLeuaDW6Q4opmMJZVF8lNRkGhnp1XM6IkqSr/qR8Z/y7LYnKnyL3c2FEzbiGRddqQ8aS/VOgxGB+QB+pvvzKkfyn4c2jEYp7zslf7fA0nVVH7SYyu7bnb9pBnng3azOdCIBUZIN9Cv/auH3ORHxqaP7cy+LH/DBJFi64oFYjBCLvxYZ+5d17FF5gpv0I0pbVuj8OZgpxRHlxJRpB7mxpxTwD0MMRxpjZexwRw5FtUNSjE+vR+CxF8C49luSDW8XMlriC7NAr1iNbhgA11AuwV4CEgpSEOACuCtF3uzfXckgBM6XoNQQ5luNtl6d5bjK6wnI4cLLtZ7dct1IQME5eiJT8Eo8nsM9jw9ko3Aiiu3ZnFjh+Nrt3BD2b+ejxB8QXdo9n8TNWAshZp5bGthPaf0sA5vc55+Y2n+LQ4HKRzJ75mefJbc39lj292sAML1X9NKiE9BEjd4f3O1jimiK6DHKAgT7zCpfVOSw1SMnGqxENsNKIZ+DSUfE1IwMR6DAFIp2FVT7Dr54XeMmc4iwM10l6SzAi0EkDM2+QZiUilZDM+cbJehMSC8di8c+3GyN41jRsNT4+Xq8xKD1A9uj0I9CgFWbOulNXnTfsoPKavhorbMe1HMPeK+ufuRPp4FdvsqieBBaaqY4y6tUkVCZ4+WqrQKHQloecInB/sOiLLDH80PuEwkKv5Eo+VQiuxVEd18RpN9dkSYtrxPiDhtLoTVi9q8L4V6IPzStodE4L44aKlwuYTRf57eBioNLSAsq5yrArdGaiOlbziQAhHSDYr9c8xPe7hv3vm9mkSdXh5njex1xHMGUuttZcpGuBaq5lCD1oRlBLbfnllGLe8oaCZuDefEgNil3yWz7JJ46TwXzS53bo/2UDCSJ8+vySzOEcBmeAQs2lC1W7TJtLiSUp+SvmcuTjrSiP80NLNyaTgxMvjNVyy0NQStGgcEWtuNWtfRZxHrBDQjZbXrAN19ZrT/z6oUNlVnrWFr7i9RuZi0NwwdTFjxquGnKxt7C+vMqumMCWsgsDHB5yIUaqttdMDsFjObloPRjlPZxrjvE99Sl1hViO2HUBzCTdBAs+4ZqtZYbuQR+9O420Jo5wKxjDSsVh1Ku4NBcOylPWCT/TCgyLAPKr1EX9o8+7SzIFIrJV6M/N1CDGTzwl8lCD6UcqyLcoJZjPaiTaR5kSqDTMqeecoaULasohcj8ZhsPDk4uU16V31Zb3najkoq/paqtp0EDq7YTXleX0v6pdPT2Ty+2NPS36V/VsatuFApejEuKq0bbO2vqvcBzZo10MaL5YaBun9SyfmNLOsvLVsqpN25GVkLF04Pousl123hY2cH7j6LUVCGOABpWhvVRjdHx8BMjR5WZwUvC0FrpunvhsLr9dvb3BowokwmDR58c+6I5723y1AQqh5dLmNHcAgE6QKHuH9YE4fXWAIYmOZLfUghN4GcoUvtx6jxYgZIjn3PH1e4U8CNuPidWC/4QWpcc2iR0EB6AtxNtldZVz4LqdaOw3M9wO6JrK2AsJZalIS+yXiF8SKheO/kLiFrWBR6HtndF2TW+ReKP1vHweexjIxbm5UoVXVNLwVpnIQmx9gpZou/uPbvbX+fF5uLapgOhyIZyip6zL+v9si8hwq5KW6ZcvgL7hAPkz8kTi93ntaOcnN31yqoUbcJGKcs5GEBQafOyVGhjLj/rUGCPt7fLsEfIgd24Wm+IyoXVQ2tOg1iIY/Hu0Et8QnhvsuiS5calB6oprlsKDEf68yn/lp4X64Q2Vcnh7YjLVQOn19doxN7DjY3Dblxd0Vijc3+yxkkouDcklLf5xM9E9D6i5A1OGEAjMUYeAQdDeLE4JTMe+riQOqeQg5K1ljumUbZz/dHgAFU+K2tnyxJFwKdnRm9pbrgmhgPap/53Gv3exzBcEJjMA/NiLMDRfkshC0S6yjNk31Jno3XRP2VrY9ZFYlZX6mHH4pEEcmPF/CKk19vdm5QPk2UeZBazgpVY8d/4JY3X1+x8daVDQ7B4AbU2OmgVm2q6IsEfpcT5ZoB73cXIfAD4HnPkng2fPPxn+ITSobMayV2IhXjpbSKIHgoBGsEGnVHxFG8g0ma7lMdbt6dNOcSD5u6OOz5w1izcrwww7M2uU7bNiztPvyMGzQ2hfoGU1Q1L8V/uZ+8+Aji9Fp62T7BSgPPbA6DHKTDmZNKVTUaoNcfQkDms5ja4gAPvB96kA3Pk+UVsd6bVuvz9oaGNu9EDXb9JB3Z/xO1a059xBZEBfUxPQ/y60Hb/UTaPcvz8sqCo5YdtLZltT0m98uRfLcalDLH7posIYORhd6K6xYUEqWuLqX0KZe7OS7as4rurYEknBXCvGKGjF8M1dGBGF84KLdE3YRwAoOax50rnomsF8UAOdZUYIEs+3lCOX10NUd5Vwed0hzKbOYytJu5vnQny0SqESMhnf0LWGeqz9OQLzp2/FJZHzNVB00wtDGxnbE1463c+W/F1nQblIu7f1Q8pblAY9DdtGz9ltkIVRLRm6G/6EkPZErNn+QkVbmOj7UnF9XszZZ6zOrZSMtDSdAgIluwhF0M37AG5zKjp4ZAZ8nOkyLTz/eoHFqxYuhhv5PYjUFbs5Oax8msQzV0zau6zQSLt+2vKdGecNY2Em5yV+6vkk54FLLOuHficczEBvlm9BYpSGP7JbfJKMNoJ7GgTP+QlGX1iHtIH024KgoHG5JFa5EQqZvB7NtFxBWt3ckQkc6c0hstQCqnRGZ3gRl9g9oadZwyD8wmnJsATOZeF9GIXb5evfNlc6klbVPqgbt7RFkjRp2+SfTX7GRkKgl9qlwIdDWQSbSu0LAfyIJxiPiGWVeQI7WwR0goi99L6p319bCnenyA9ORWyzpcRng4DdtJn0gZnFEYgoldQZH9fL7e52VtXyAnNNT0fL51m6b4gBgH+hSlK7uDFvicdJi4fWRvVN340K+rng17fhfFfSJlVGDEnHDbNGkpFOKV1/mP/aTjslVcpxu7lUxhwPswfcyBKjEht5hr3hBj3fIGv/9y+fWeminyNJChL6xmpCKO/A/hsOTKvooabc1GpqBv/+DP6+gIJ/qI/zfrNnj7HAg4Y0sUP4Yzqd+4P7Pi/Ozy5JOyBDQY9ixdpwdCx199oijLwvgcai+5IKA3a85cyXY2w3U5kUZ1ikAZzzrJS8c8svehwFxOXjiGmaqCJv/9fnofNDj3Bkq3zAfV+Kb2+ZtwTF1dXw330+ENADEElvsm4Kusu+8YavyoIN4RDboFY6M5F+eJWk6HqEwSOwR0QJ1R4VOnijzj3kJD+3ay91Wz3vWEDbANo4w9zhIEdZ+7h+4XZzsMfgNvDQj1JMjxNYo+UF1N3A8EPfIfFyjX3gZYhYCceDg6y2Ok2p0S4Ogc3XvRHY1fPSsNBGq7vi0lXTCMDMc/A0Oddrmn3bakX9AMBifSesLjHl+RCVnnWQmqb1NcwsjR3ohinZmufpfIeCDpB8aD4xfnx7GGVaXireR0+xsa1+WsoPglWl4txYCKOBae/QJx+pADC63v9W+b0I9dobpvU/nGvKlo7/V4KRGeit1C+TPAec4YR45vHkhqXq+rNdWqIFh2+Q3hMvcWi+SVN5gshvpTpOxwZHZacsTepuRjN31SkpqVjIr99918MOBmt/JCjb+aXSLfdDGMICTAQuNhIpe4rmfGD0S83d1vGhF22T5PuM+zrpONtXQOQOT1o1359twOG+/nAhks1VZmkl4Cv24ssiehKIyh8Q0LhC5z2SC2NDfJM0lVL1acmPmYelr2r+quE1++RCFBSr5t5Sj0mWBUKyHbHSDpboTgzrBwjXSb52drrOT0EbPbvliGqO+SucqKSGWZyduWpFRc4k/i1ES+g3uxl/3ttM8w5ChwfhJdTeO+r4O6wajvvz81pdPMpGF9mc5ayR3jC5Jjezq7ulmsg9I5g+H7LSqo3itg273KU9s2BchOhy5mjuf3N+9wYkgD4Mp+U4THu5NmRQCZBHKZ56fJxKyp3SEzU9wqkY8K8+NxH8mMB2K56o5VB90QHRX8IDOYoA0XlIMU0yRyQmyheX7okjagcRJOFVob8rDK4QW4rI2DMK8y3wYKfMiZhh4ImXWRqTD6EijWJOwrNbpcJTvdL+B5w4BhzZpW8xtAfBO7zQ6aCTDWEkPXk2Dip6KhOoYpLCLwYfTPQzfvXcS6w4cmMpONkW1+ZlaT00FxjM8qAVe6fZNdDQL3EOueAtpMRHg8Lx/bZHiC5tpr3+FEuXZeOIzfTftb1wB5AasrSCNej/e84Lw4RSudEZBeVYN3JqRwbn8uP+xNmm9TCkFIN43CV6oBjKDLgqXRcMPpHalqQTNu9fU85mfz3TJF991jYCs6i5IUpCHEgFda40YESMSBBzAE7hAFEWdBZZlVOcK4vElz76agNwrueTpUTC80k4Aln6o2EqXzeGrZGOru+knDCLVY6vCT2nGEwMUHtzCZqugkb83QqLAA7IMJrZrqhvZVZHb6UUAXfsxu0cTL1LHB8LqKh/z4X/6WKkxWMyTffeeoW0LPh8WH/Q6tjZuPyqGa/Z9Oyd8vzVeUB1lFFdzVq6J9Pi50+4nxyCzPI+1sRCJT+prRrmOj0/phbL/mRoDSyxQTZoHtMrx47dLSFRFiaNgbiMkfLY0mEHSx5sTUEjnDoRRQnuar0+bdkXm5VyksrqK2kJe5PVptzIg69RmF/qp6DeI0sF9tjk/ScbwEkzK5PoK1y1mbIwU8h3MbVVt0lp+JKdOSEKTrACyiLBKD5xvCYfD7RwB9MS+GV2dqqDST8oCE+W6xU1bJqUyJpOd7GjpD+wG6z2d1dX5QOmFjOm5xz3nqmJIpNy+ojIRrq9r/HrdouA9b2cn+IoBBpV83JEQiWzVm3gjNOXrlOlhX9S3LJImPAt8Oo4sHfMJg1FKDsGxW0kAgaFZIEIhjQ5l8My49xDI6Cd/W+mRGTnkB1TiWGitUtbqOmiGTcalvqUHRcNYzArBU/uQhs99IKrfL28YwAhtFZVrNxboSaGVg5k6AJw0mNesiRxxkFleGlZIfFYRj2nALPuiVhKRUb7+2jY1HSF460pX56alPiRaO9nAcrwZkec4sMUc+FixuLnS4auwNCbP+44x/j0VKUZVxXV1as7gAeJcRsLUJb0PiX0zpX26i43xX24TdCl4d4ScgbJbPfbfM+7HiFu8mo9N9bs65O63CvteuRsyB6kEja5QxZjHAWDe8nVjJu0x9/68uZZBZNm+AXPyDw2130Es8/LSlg7m8U+2OmEfmBEDoT/N1SpJpDy3IDG8nM70UXteHAUNcCXWzP3sthwRM6v9Po2OaKwe04Xz5LVLQXPaKSFcG7JAhWwcpj/48aauM5nh/JsMG+NgadGhlFi83+FG8STx4FTUtTlNJUmgFvAAP11RbjSiYaqsrCZjX1+nYf++NiZW6i+dJPoQcNMgfDWM7J6XjzqLeixBtxqKO7uJpoG5imK+3gyVJwYjux9EZC1grCjM8pZgGiNgfSdBu6Bx61CBHkZJFDtaRXfugP7bUabQx1ySS1BfUZqZKXM2bo1Ne4rBqbLYKphS0s6InHlrdeQNw3mIwYiJCDqoG0nR9Fs9YbfqnucOimGm+oMG7ud387PBWH7X3/nHAIPKff3TlW+Cwat1IwNsRPP6DaksZE+4M6UFZpzwUqEf57oE+/XvMC68sEeVjZDjocR2M02ixUoPt6FIfHd3pqFwmlevQIwRafmqBk9/U8wgPsnCMMgnUkGRBquk8oNAmflZ0BrPt5kFgxwf6JA60PpVFnaAoUa8HeLzlzw1X74aljZmzlR+MITAbjcts8sLrJ70Fi4YTMrCpRz4L+xJNCvpnNZ7bgy6zSd85uWQ7yQbTGpEf7aN941/jLnCFBcbnWB+ZpMVUkAhPTN88Z7dJchNYCw9mRtu34tMmMRMRovcjh0IfJ0tCxXA0m5WNxl+yOtvft1v6GD4y3b5QR0XtfIcE3fLy6wHNCjUrYnNBW0ySKSWcfhNmlcYuOrAxUXWy8R9p3g+J6SRTjWC+DHL8nZdgYSJf9ocsocz/uGChx56/DUn36yZz3vigrn9u1ns3ObTO1fZRXuiwjviPlFtJ5C2cDGzE1UJ2WnRF55G/NhIIdeMKAFQP4p13GIQncMQBV6IJuCfS2rjS/LydAfWY6UkmYGLya7hdR99V2+BcEJ2uCkuHtCbdZvcAiKmdzPsiakSobTDKxGNf3DteYXDEGKuQH5TZMJZAo7Ap7v6rkQRHUnJYuc1XaZ9BxHdMlhJXBOFsP8nZej69f4eN/+FpNYBoWv1hQQo+fp9FbZDsWeCaC0IHc4MubkS5y3l2DsGJ/ysIO7FJs8E9n6ugz6u/xZIjV45R38UOt8TNkXuG37FwrfMIHfMh7Ml9kN8F9G/Xmx1katNLD2HOOX94PgfFDq2T+qFe25DWi9HUwSw8cSrd1LopToJobkQ1bTKfusLWI/EnqU6xTgpxcv9WuqdJpXe2Y0WdOTb9khWI/h+8lh3xg/tGQ2YOURKm36PUrH8fHlK05K48h5i/EWVetU9VRlAVLkPiou1OVTpV2ogtvkD/cKpJQspBanmF152Vmg5NQ46KLHVSzM3Lk/H5Q3RKmInXIuWS3FR1IXvY4DRd6lkUAHQS+mqa6T3bszttNPRy5N2Z7olUro8Dg/Loa9B11kVGg1ZOtRLBKpHY7rrFdTwuZAJrYTUMYpd0DAXeUFXl16MKAR5euWy1bF9bmJFRhzv+qmk5cP8yN4JOvQ+VSZTzTZgacCV5qEnU3UQylJzBNC/rWp4grAWjJx7I8QPf9uhD2kMVjnJwpZwISlt2iNFUd3V2DtsZToscdKo11boSyLXoolsvnqLsWD2NEUtiH6pKBpmISUf5zXPuAGmTDjEiW9A+t/oeSoMcO7dbv0YY74Yd/WNsreC8jWAfPNudvWVESpQVFCp9kQ+aDl2whb9m7AFaGU8pn5tnv3GQ+fTL3Cw+GHTEcbz1OxdiYYT4IRHkL9dPXE2S+93D/SZxE/NIF3dSL9NL6xrRNyaOGeRDm7qcUwnU+0eHPXAwQXH5NPw1S/dsr3udpEga7Uh6ddO/5LpJYlrU1hmRoFVIvliUOnET+v5Ghk7b4kj/LSTcvq+Nsv0itUBHaiwBf338nWv4MMm5G9kbAVEAYW4uY0yFRoSOnxNVTvSP/x+H9qWsc+fvZMNqIJC00mRs+ROGFGJGXBSWyng5D1n0UeWe8GNYuf+N2SvQ0xOObqC7C+TUPbYsaoiDWv8CwLO0XNVZy8u2kjgX7KFj5W+5pJ36bxRpuVqv3qN6jVJd3Y1bAzcOEckT7eU3IJBF9c/Q+u5fU8rJvgTAs9u+UHHR8D/t+hCoGaY6QWT8yveLTYII8Aos/NKJ4Q76x/M8aQCoFShmHNRX4wyM9SSSLZWtAlYBl5rmfrkaCf+IaWNEGq0V+tFvonisET/TVJniG6eoJchhcYhLreDkCZUN2tMQmTLNYptzHsGIh3QVes8KqShI/SoVnjZHndM3Oga+XTmX/K6WbsLH4SY6YW4N7tbFj2Zf2cl5wSmKqJ6H+OnCOfC3PBLklsNR5xnE3LrQWjwUtUiF7cYi35liSd402EfMlDccRfUgoDb2UMTYf8vlKSlzsoWLXpIHCp7FtihklB0h8iwJT+D+Trh0JQJmIN9SH2d556F+Ec3ggDcbv84gL8L318Iix7UlORwkuXiu90KfxHT7m95yqd+1qs1c42ZzQGSjW6sCzEB0qPu7O6HuC1stA5Dr60AXrPcIgAu1TSwRaQvaxsgJGlwUTujy+oCjw+7FUUQgJ2srck2NV0XzgOc+dXEKRy7uZN0z2K5qQly1ewPfmpfS3HooQeMrF58Dg3EcPhu9/bE9v9DtIUAbi4EVH6y21DhUCDAhM/ourb81Ch4b5ukMHOPLPZkqvcpAhwz4dtKL6ftcjM0jlGscbyaQMz3zGtYlsrUkta8CP7KDeDxZDkcLymaWuOLaaFCjsvZRvoNvI+bRA3SMH4oY71oiTsbn5APdEKsANS6o2qMiGSlL7V/WiH7XFh56CUx6x+e05PpVMJ880yxrhExmloQQKV8qR99Uqbfk1COK680cKmhzR8Ap+F25zQ5wihWBq5b7tYZ9MS2t3QPwZ4yzKX2BR5tGppPNAP/jmPYm29CmqMH5+3iFYDhIUFrwO3K4YOFN5/jVlWYtChLg0uUl1Ge+yd6Xe5yalUTDbzSYuRaGf5qwzEomP5ay4oYGl1t4Ahb2y6ymGdFPi8ysX0an/+aJ4d2DA5XhFlDv5sjZak63s6+KDDd0zOdD+drJqq9tFfVUxBKVuocYLmjgw1aK3WaO6tb2xxgi94KUCsIQMzhKGdHzUZ/cBwEMl6jUB0vnDttuS1kmHhYAlbTvxOmWv+pM/1eIV/mLg7olwYzJyJvWGUgcgZLBWzGCoTm+K8NRjN6c+NHSUQ//XsVpCN3iK9jKCcOKijmoi/T/sFJ33Zgwud7g5Q47Pum6BnIyyz25S7iGG/OdYC2TMBSoFJwnQJEzEjjPs9bregZUX+27d+OOTRoZTb0pzE24Ewhavsh6V/Kk0InmP1hDKYpw6S3LIiDQJRqB3gKbyuJ+pkoib5mad19vqFZz82v4QE8DuJ1kvt8wYwHGgVQbxLy9tjw1QG+QbeDYYUXtqJDDJ2bMeiaN+8FZ3QBGuqC8GOV4h1AkqcSQmEEprAh7QHc30Wn/G9QugmZ77naNNPcd7iB2ADz2kOihav7mmHKdMhNSXhw5DMWrXKaQKeNCsDhtQ9qx7AbYAdRo873Py6n9Xe045EbAmTIMqyEzhgKty7gepYb4pUdn+xT4CR4eFjbN/v3nL3VZk1kIvNLrSXVss3r24nEz8YCGyienYeGCMxCN2aH6YS4ubNUrkGV6tV2HeNt8+oI3L5KY+9cWwvb37lTWsBMCObAFAo+hKQ2Qhg74r3y9kUwikWg6ClayhRxSn9WanFCZiCQwK9Oll1c65awdrm8ZEiLyjux92hVJKsTZIApqCxveCF03EWKkWu1z6n6KsljpRhdtHlcMwLlSQC1WYgqJ6IlRxrY8vQ71H+al4hd4iWDwZ97WUJo5RJEcXa28/yW2ZklRj9uMs6O5te0sOiHbFXaeRlneQEBmTk0ZBjkhwMhpqXxOC3AM2ehKuP79GMs6giHO2HGP2zFM0kV/hUVNu+a8XLEele0Ca0eb3DIRhXeR1PgwSM/fu39WSWGIpRQ8EaH4T46WkA+ONNyQHHaO2T6hAmhvNKz6zWMWxEcM+Pbguu6Ru9zisfkvoZWM6sw8auUEtPz/lUAy6WwcZnPIlxSoujn3A3XObZyutLCE33eCgAMsnFCwZJ3RQjRDRkngg0HEDexAnjzyuMkhqLiHBDwuHNvB+lRH0MXSSBvhdgappJxnfAlULMnGA+jmJka5/8UC6QWPVZUBLsCJGyh7Lrmhkx6p9zzIEX1z6SFT/NPrkqM8fQbuFRhQUkaPDy7EQUdWTWgUzLjf4qdBOj00/EX+yZwiMDcu1SqTsRm3V3Q8PwCkHqDKhnoomQ4LZyq0Gexpg0D4DkjS9qldToDUiyON5y1zxuvg6/on3lEm7DEXAHBhz+0BVx2+v0+Nj7zOJt3coWiYo8SOo27UkMjz0+pNnaMgC0a3ho9KbDBzW7LHRIynFFHlTbEKTT5o28goJFfqy39+9GoNTHRuiXgdZynx+KH8D9kfE+VgBSdzz4DHQfhwDDdL4ZfCCm6L8n/G22a6lHYIJkKQ7bXDwfCgnowgyjWWoIrHEe6p3jUW3mz1N+qarRHr32bAC2ptYhOySDa3CXrh1uLOz2ACZUy67d2vErzuyrPt5fhJ6H8sGa+OqgcyWU1IbwKZM7PB01ANBFfkta4jEPogKnw2I6jHFR8ZOcF2vvxyDnt2WQxHjbNnG5NH7TQMNj/p7HNPUOe6VMg40G5pG+14sqAFg8Q/B18JqUpKRmOOpO0xMggwo3fDjdCV3I/mGpQdGlA8vP20G5EEN8mz2tdQT9NZHBCYESLXU+Qu4OcTVdV/iqvO3WqUNejS6r+DUUWwz2ueZFeTM44DUBFfeWxhGpC/CK8++YSs9oVu2eYKbYyGLg1iSGacoTKT1GpX0VTRppQTM7hszSL/4LoQAUYDdQ3/5lC/zKJrz5jSPwrrBWzcdGe2YDtrHZKSxMjxKpQmmc72A/bmc40c8/ySQoCba3a7hNf4m4xXtvRNIEtgnA6RaiR+H34fUKeF3GxVu7jS8bWiC/R0O0II6uQdFxyE2oowftvD56eu7IvqDqNMis5sgPPlB1PfpUuTW3R+ZKa2wNAjXB6oNtdukl8OJG2TxMuGlrNQXdNGij4627hJWtpiZsNd9Z5PeEC7PbmIZATZlwcYTIvArJiGx8WUP1LlJ6LNXbSHePRVNwRkW7PfvIylSkNKI4lOIcVxxSZjX0T8c3jzf/fYfBN9nuHWgfUpa5y3m4rmkJP+kBylPvzbgW9jfwWErcCeZ7biiH4/6qJWjv+p2ZXZ7tXRIgEKZNZSI5bW338/OnEkPEInG3uQ9aNSFPhS1gpdGvzpby4WoVLg49y/vLxHMhu8pFJ0Qe+qRf0ZYfDHqD5mMKqOA2XVcjV80nYQlIVY5T6N9YbnBxpxxwvkKlxHqJmJAuhk/g6mt93pUISZkQZW4DVSEjfQ7KdhdWpxqAL5q3/lFsWIMGA1BtcHAeD3q0BtaEMhQsJU7hNOkprZr6XneLbSxbLFM29Iprw2LJMDRo69gWlRD7AUZmTU1d3Uh1aWbGdlqxQlHIYEhJrXrIMFEiEhVTK9YeooJB2ODdz9ET4oZw9hJd9hXBhypbL97rqP6iFugzOVWE2xsYyKOZWRj6lYwlAX12YGPxiw7GACuKqUy3foboCJgxDTQs3roPFyp9UlWs6fIyJDKPlAfVcEWYnJM+2sl97thdWNZYUC6RE+iRRvQolNqeVBFwTF7RKhQH5ttbEZNMtJfV2qivC+YDeTEZcUNUCQ0XcDY3/q+fO4WmEauWD431+3tM1MyYTXnujVig0QMRAbWU59sY0UjowqysyKyWrGuyUIpXsMo/caPKqp6qmgEwYEpUehHN+FH0wGRoOqw5GLll9cbzSnwdWUbAoZ6qyS8lOZk4DahZLaGbfWy9mJ99oTGAowUUZkS5WB8gIOfgFElM/UcENCZ+/sNIYylZbdjAQ8E6PEVe/Qpr5DSwol7gldyPR8i3fpr/pWW/JbThASinPyIb2XCuDcUuAHv7XEE6P3mSLMvy/ZxKp7RwNKfzQD1yI/ukX3qeW7ff9WHzqUa659+aVbJ01YRcKn0IgCJ/Ru93nl8+Hv2OZdB50wqKQKZXdhD8rvInvOXLst5zulLJQMI36WpREhxtgFaiptfJCRUiBDcSsOYzazU/bQ8PloC00JCY5c+dL79yTWUVgCXmYZwgRCosAAllCIErQ/803pb57qzaNLeOlf1x9lpL5d9s4hD8x7fmDpediGldPzRAfdaASv3GY9OZL7flhRmlALmpC89GYr65iuIGS4qYxH+OWkdeTl2UuvrcL05cGNUORr6RYjpwY+CiZ8CyRLstCxoStWPn6Htnv0tvq4rT5HN97VEwXmtt9PORZQf0IQDtSnCUAJDAzLTR8sCxRoIxZV8TBW4xYVQ1rmtr7+hu94jvCd5V+4Xm0ejWPFBiIAJO5UJlxRvBXbbEv6lpGla/T633KOTrZFsZuixI+ta/cdXNahFKpQz4jMobc+0WDgEaZ91JZYDhLkOd5ovpfGH6AZ1ZhxNbsForWfEsST2fxl4D6d1dzJY+mY1xLeXAtH1RIBUSX6e0GxDWqvgZymgtSqm0tJO7w0QfetJi+1JcJPQXjreLjoMIteL8/e9PsQ5tb6T1PVs2joq2YXfOxlTqgSt+nqIIyBGyEurxEnhI8W29PxAJe9IjjRniBDBk8Y7IOgfDloOQ2SzlJ7St/MqJUlTX6+/wzE2owrUcnLNxFZBbuFx84PJKiTEqrJH6V7zS1e2hTd68+Qbl1bSAlvxz9M6DOwcdy+0lQZe/Zoflhq9z/CpHN09gtLhFdda2KXd5d6vh3/cnVyisyr8aKxipny9PbAY8F2l6MsSCDk6iydZ3zihpRueY4l37LW+B//NhxVPrQV1QItIud5RLpEu4cfJaG31lMo16xWqewgIGICgu0sSzMWjkVtSxvD4ar9ko2QgmN2u/2UkOr6fh7Q/Kl/7NTOH9e/SDPRLnnW1XfVoqbYq5Y9gLIO0VTEVB0AR01krPJFL71/8V+ohCXUuhExdUTjR9CWciRM/bWirtZn/qQ0OIt92CzRrrKuYurkiLGDiE+pllApnY5tPZzKuHRcc68j+QS2ND20NtDyASxNdC5aoi03T9A9hQsQK0AHLafRRds/Iht0vOxBKhKOK/AdIcb/Gz2cPmx7y0DSvh/5ahipsSk+0Wcb0DIjLNghuYNH/AtC8SYBiluz5youwv24eKPg1wXd24N13o0BS2rqZMV14/OYLOvR3B88E5/rygqrx9vFncPVaHgyGw9+ouJ0ykX8YkzMOUOpKGKK/lrX5bMezM6Pn2KXNxLCXKYAAQY92WgXe1ntiLC+7tnDa50ofbwVJ5jQN/CK5XC9B3HKN1lapd8kAP8TGff59neN16XgEja1VHJIZAburzWxKgelrGKvsDVF/BQhYV6R4j7zv1LcufwEHOCSkT4B4avuYVptKF6RKw4ylZiHW11At0N0GtWRI/NqbDlld3ov+Q257cE/WSjRevacCw4QM6mjZ/vyGLCcFyvso49B9k+0+62CJSv7k6DbIvJMv8hD/P0K05XhJbJYMUmRE5u8B3ZSnn7roacyUlzwaZtzXg+WFwrp+avSYLSFxWDFtZ8KChZcoc8Z0PVrDM67W3JK1acV3eqBB6PCANdpFovl6qKMsOT8aVs8UyW0aHDswsbb5XdAUSP13DMk8xM1DZiKR1Uf7+uLZOXUwPUYQ8yj/Uv7bbHFDzaroIwKXdobrMxHALA2YCpUIhsPMhix9WX2/vXzvsfg5f6TuNVGRl/aAqSYTp3ogLXp/kVPeGH2iLOKAIhY7n8gaSnPb1hgrtIspeq9epPwQfIdyif+zn6hBbrZUWMSZ4dK1gTen/CsePsmtlgb+uYcU8FgQagYxACY7bYDxhczXViDdPijxo8NL7gt25ddgZ+Iy2aslQd/0DfCue8EVd+A2+h0utJuE4zYZ/iiKeW++W5I3cIBIhOVEmICw7jdarTUUU1sWJu33g9F2bFqWFXRZdtGhq3J26uumzxNkHp0PWDY1sXrUipfWP0msJPe4LjThwiWwF02hueQM/oyKSHoGNm74YY05bgd2ErnsjaN5fS3ZQOc9Vesm/XOpdG9VIfoF9KXEQPA+EsPKLj6TCSz97DG6i/NBhIqrojjzwo7l1GcsuieZIfECRFeR1Ngrmd9+1gMBierM2GH0zmq9Qu2cgfMIPQZ9b0JxIrBu/VvSBBPyOnlp/bdZmfYhizmWnt8GkbvnzmLbTnTTDMOOzWenZZ/AwYVzS4eHcfnP4D6aHJo/WoOMAVUGgxy+X7aJkV6LoPisv09zsXJdVPmT0ZkpOruaGO1X8ujZWRCl7q0TtEQA8BxT3Pv47O88Qpnfa+iay+eWmTVZDvbSCaEBHKMC3nX1DF5VpxxwhGkWeiOi/O4teFrUF0jt9jDd8pNHKsBxg2uzbSIIMMLy6ID/S5mLh5CINDNhRWrwuP4jzH20TFmVGUmsIAe9L2ir63eLExOf03+YWNOzIqxIXxtkewaPdgSYZrSC0nqMK0xDUUSV9Ub9Sm0SefVdSynxNZqhxpfBi2nDTo/HWNo1XbS+prWUw4YIZSJqjRcoiDIsJty/DXkmfeh7/wTnqi9/FywTVfzFWAYLEFEjm37KvnGDUBEhAk3BhK6m2HcUv/YxF9aVP8d5n5a01AXnrgnH8Wz8NQUTWdPe3NSyDK31C5ASpDuHhA7Ea7wn55NsaFGOlfMTxhMWfjlxyAgFHYUtQuMpTFZBkdaOJ3AlWYQkLQJjKhxe2i/GR8ZyfzrfdJY9gbdlmCk59KJg96kiBTut0zMhBBKcXpvccmujuU1Bc0Umij2WGRz2AKrLtdxbvHf8UKBwkUzwKWgkft2KX+HSr3b/j5xou/OdKOQ+4Rr8Mi99WjregKPTYUCQ139l1tLK1nuUjCNUm17Ma5JdIUqCuF707cbxhM5IY7RmBkbQTVzXZ7PtVYqwgFNcC0SmXL+ghA7P0nfhCW+NslvxaaorlMgCeXo4tuQ5xIqQVsmr+EvzDuMUtc9NEQFWg4kXrgDtsSPrZ/caZ/nDLR6FTvoO9k5AAiqiFBbKJa0V1neDgPtcH09FmMSWVlK59YzRJGlyVQOzAUC/EBBMiS5EmMNWj9LSIjOBvnmCRLfZgpv29PFNh09iqbbQnCrBNYO/kcqZR11d2dHwtdKwEPI/9A/lI97oICfM9qmb94E1/zkkdjmrhYd/OC8YaO0adhJqpUQi8DhgXpWI9Z7xfCjVw003n1LH9cdiBDiOLknYiaMA9Ez3zSWq9f+sZlLfI1lHuLqFzf1ht+/Um4UPvfqEj4LddhHqezL/PVGvyiONh9F4Zyvgbbcxg8iTAdD0+nPWPgzfP9iYPL7jmME1phRjQ8ns3echJla/1qH+ODsI2J2JEOW9jDR3lGHR7KUVTbbqENnTzhfqW/5Ktj2aygtJTLtLff6b221XUqEiSotUcVfplA1uau/NsFHKqiWyWq5U6y/B+cecHPs9jcfsSoPpG8eYNV9t0k7nHpuWHrdZXT7rjb/kJML35z6ccU/SZjSgAqJBsJ6e0X391e7390ZHwVbxgWek3Ay6FrVlUsrTQtxNaQlJQy9YSH8zT7kdI90ljAncdGiMebeNUogCmO7/KV7VLuj6JFYiwbBXinI/Tef5GhSo01aYiUPI08hoW/E19xOwGQVAe7T7aJboiXlSnIRDLB++rGMabba4KzdfQexZ11vTNIqNZE4BIs0gLsg3YdaodXqSpMSLC/xEovVRss7xk9gF59gkQ3QLQV16u3udcYPz2Na9M5uy+lqUN1A+VGgXLrjZSSGwmpXsz4fcRgLP59VNSDMiWZ7EqTWRIEhbrdWMpxSw0yBoF/XudBBBUjgEwgKNRfr2YJLrOpYXueDbm09puVjZdUGdjQPN7nfAQD7LNIHoD9sp6vZ5ffSvYLfomAaMzToGEUf0YRiNP2FsMs87I0uAihg2dSIJsVQgxhKnXkz6vvk641DYGN9HYbjASasLz0Dbyt8SAUC/eKapGFwrehGUCzQdrGHG7dWq3FwK91j90oiE7P7HdJvxCs7j5ZrA4U9XdNnL/4fg0CNSeo/OVhqjam6/oMhJOKzIiGeor1sSogTb8uzE1KRJ+AII9lx32G4l0JcBlBdzimozn46ySwT5MGCgaU2d5EoTw7cvXj9AOCNZMngn6+s81uvnXqPdYpGFGrjI1v2ZdVLvdyLc8S+rfq4dccTImz/rHS35tovkeOOiyItHkVSrMWySceU3HCnkkNVl2zZmIFbyQ7bEkkr1PGbk2ub2pK6cE3e1fVez4L3sHL8HsFeGge8/QnAwX1D4xcs2evK2JlA88hLArHyVaJqAzZRg0Y0J9bRuNwyq0gfmaUp8zFb6/PWL5AYTSIqecuKxBi1OKCYegr0ERZbmrzKQlAUnLWWXyqAlMlGeXKi5xGTFntKRyaR2J/lZmN2AI5od2lZHUgCgnIe/oI/tYltzH4PyM26uCKCqzTZyoIa4o04H0he7uKgYHhwh0u3xdxRo2x+43CBBdmjWoWPEM3FWVclJZ8lJ/X/xcmEZpLkg4dBUxQwkJMY86qSgFe/bpPG0s3jDE77FWCxLcl9fBfIGIvNXaTvgE+mmp0iIP1x0urveikG2NBcujTyE4WyAFeZaQOMyUVcb/gt3W+lzu3B1DZ02gkK1YNjpQgc9MJ0wopcFbZiadzh+1rYTXlJ28XUVeHeqB1PfV7n8JMfJWg7PsAeYWJgCq2RI0JQXSC9/aGRxfLQPivUjEyASh1T0vYIvBs/89YOGwsbJ1K+hAzOJDe4SbnnHLzwSDT2XGIpUil8chDgtTfBx5frHOWWD7/94yjOISJ55cXGXTgNr8LpBG2Piv2yT23zhgzhM2rVHyJJj9Z02Or/abkxAnyGOnrvKLt+39jyJV/ke/V9rf5L9yFWdVzsC/pKdqcMynez5rnTiouyVolCspkzrOxo3Y5v16AKoaqCs0tfPzTRbDVEHE+lfLGRd4mZZdwFRmibImpHl1ZKMcShfL1tWqHhQpjoVPoxIrMMkp9HRIJ/cDln4o/weuMLojkt+/gAag6RKHizKjnnJZlgEuS4WpN/EM/VG0U5sOmqBYrfZlX+h1B6Tv79L4/LxVzF+sxDZyxJZLFSC1hPdBWF2j/K0I6jF5et93ps1hUHcLdBPtrsnZhI7Xwy0KVEj9tKkMw41HU5fTJX8OkNTbJXXk8qANtljDKnsjn0GR8x0X/xnw9jbhiQrxcDp4k/WSKjTPHkbxWKt/tmlSq37+VluRy1gLnWH34YdYgawOF4BN2Syiw9SLI3HB5TNn5xzHOx2eu9xm82DNpCsgEPForE4hpzHmywmgno91DKLxQLM5ihF2SVeIoI9yKNhvwEnqGcb2nqsaQqC7QeDrOJI+50XhZ5I1Xz7dt/YfjcmYjbcbeS4k5lj1dXhXLAnq8uZvgzRm2AbdfotAEVvs9e9XpRrpee5enlzt5qCwuY/7D87l7u4cddUkMXMVAOz2QpfvFMJjqRlgg9b+80S00rdsYCbGix0isKdLi8Hteti3f2z99SRS5+ATGzaaY/vxnc9qbpneXoCbHBYvPSMKK7RxjkZCWkjAro50yjwa7HntqkkHwYOXPEeMnjWBMVyt7vIhZDLUnGGGGEJCA0dV4XZTQ7TlWa8FaJti/RoAOXYmuLPDqmuZl0tKXU7BXylscC7Aa3mRnVsBsZpwAbHs2Jw9uynT9LSvUQqIBRd1NOfRuhO8sG0aBr86Hol2JFDcbO+hV4RHYs8Qg1Sy6Ws4onjDzAiVX7IrJ+qzVhZzsisJ9bovGzV8aNnUvIJ1JD/+2LCgh2hy3/iXfRwcE+BNK3XEnVK98FPym02NqZenYQkmUZyCgXEwNzaNrtMbVwJEB0JPCkyVcADWtO4BG3KlMkPU0aUABavPJeGfbbVPi9yyQbchC1K99E+zgyZqnDYX+Do9AoiNnrTJdyzq56WVj7BCVwFNs47QK6yXSgiItjGFoFRNPfOa82qsDFKL+YrKwNJyPSogQRnlM/RzxuqNHwRkzXRz5IPEOMM4YFT+/treTI8zksZvryZ4zyEKzJEW8vpohklgfnkHESdzOrqwm7ztnmx9nkAhXr1egu5G/IUDC2h2T9gAGQ/h//KFhH6czfguRzHyxALosrzwdOVXyoJp5G9NVLeVHDMheWPZjzmDdmNBDoCNBAFGsq2qk0QIMbeSqI6u7U/JbyFTlQKghoD+L8h7GnMTKyIitgeQ/XvRfvQWgzikMbhZAfIc8Skr2Vvv1zt6UflrHdsjFTGp65DKaxUWQ9Kq+zDggm86ZIpAy7QZBkeGt7Yk/nptlt/aW20p4r+zOC7wwp2VSq/68al3ei5qXarH5L/ACa5oBHrDtZJ5fDgf9cpVFkuFxN6lnOhilBMzFvyKTXLrehbZuiKo715rFoDxeJ1ZVZVcAASlrOvO2OjKd36ajuelB6NkujKmfvPErvwvDF7KqXInhWUkiLLFHpGJKf8R06CB39vn9YmdU1WX4Vw1vrFiEafRaEDDShMS8qKArj0kYWNFb2Wjaiw3eFuCNlwcRB44lPWjogvwqBi3tAv7fZOF9NCAmZ3PtYBeNGKEnIMs2RNFtmrSdn/BXpO6ErVAjJPKp+kIHYXXF8WP4y+YBW9P0erROj96NKyqR+5YCuODt/bO1JMNVmJ3a7rsbosQn4VgUBbIsZMuRHYobKN7647Sg5886g5lePcnizWJJlPiPgzQm3iRzNl8OJ3SGSyGXaBqFkSOMazHT6ysNN+zCQXg2CFxVnFFwNSusKVwlsecUNuK77UTjULw4hsJON7wfgoWWdgzLYqejLkg/99cEctW7p9+ic5WrM4hl/ZxA4wcpdG562KX5nPbZ37AOBciDswo+C5kTRZJOf1tfsRv+4RHvp3KSiqBsKqiWxDSOBc36/hleCXfBwK1Xxf6cr22pgEHwHeWZ4hpLN7am1bdCjt37EQftn1tHpCXMrvgB/EW2MT787Tgi6NF+lUPbuQwWhSkrL3TBUg6DMSEkPsYLjUDrFmjidEtZqzQEjrMnAtQdk6EEbDKHpGn1AYX2On53MxHDmqPfHSfJJKvs6sLUWk/AHXufu5nVk6N6v7NGjNpQyDhxHVeveYXE98cRoWx2UzqMhTTniR2JWAd9+GyZ6ctcDLbnFOM71MK0mSiGGwlfjDgDrvDDRRbPLgTZkB4mN9zJUr84zzd2bN1yifgmng7kPYCHL7pLzwSE7MV5AqwIYFxcvAMoihrHaLohbW3znfFzHf39sH2gNVqjgOqlJhLqvtPa2LYkel9OrzD25GVRF1rRZAWQMAICfhRJzpR42WBr2uWlYw4CKz2UKAi9Y3zbEuz4BrYm3Tsez23QLHTAN+kmp9hszwTTrd63tlSBj2AmKCTZ0SsAQJIw3cniRffTNyBip2hAjX+O/vWWRpk9zm7qBNJ2AA9lj9q6yhUUJJ7Ry3j03ksxgovLxnIC9nccNoz+8Z3CaLt65ouQtRj/6Z/cA3Gat9OAdwG8zhje2XbnA67HfdAuYJEWHIPsrIEyLSyCvWL0FDYYF783RrIvbNUpqq6LdI0DaL0LwlCzILuL979tfI0+QV4we+V61gNV6zzxPyLdqpWudlKcuIGb3tm0u69CxkMBSTj1DiQJASKScha8LbFBBY0ppfOHkTV7TqBmScY/qTbabJuqIrfDaYFWtfm+FcZuZsZZ+K0AiPfvD30yxyuyLLyZSchhKJQPfFxDJ7sMlctrkE5tzoH58XqnCZWUW3HPL/6vT4iypl3PEE10bJb9JmW9NAr7iKbS7A77+3Z3X0Ha8L897ej/bsw1dyQ9aqVkd2WyjyZwdt6d0nRwep+SrIv2kq23BOYsWOc7jUqHnv9qWCWlwThE0TS4sVk6/0pNckXqeKp9TgkuO4yLjFPrslUMYJoMIZOYFS1tlJMttFI5H8mxm8nmEZfNYEnvWaojIQ51i9fd0K2cFZ71Pon6s/g32G6Ee/zkwjs7ao0DN7oJDPzh3QGwQXfkb30XOn/GR1Yt9l0HLnYbeyqJq8JUduEF3fk3h5kear4iVr3AohzQb+XQEIdmDQ97J79vuu7g1MBDDcE97XNDxvKMajC5hLkRyMjDixe/UBJiZ4QTcwGJdrUhn5VEHTgh7Rpe6KcX8x5H+L9RqpT44grJGQFuNZphvHMIsHVzxMIEllGFFAOrhZcNDU+4FQMBZ4/pUMTyxyW8E0aA0bKYDPWFSHVKS2NZ2sPifMS6GK+FrTWajV+H6fdO9xtKR20rLac30LdmDsb0SZH/a1VyeSPZaI2GMqnCAoTheB39S2kR8nT10EHXaavEGomi+RnZDcEO7XehoiWpQWZ6AY/w0yfOucUZiVvAphkoqMjsfDMtmROUdPVnylDivtz9RNTx0c6jnWrONhKUg/fqIfpGhtB1nzLGDpUZPoHbl06uzhCXt7usL1ysNsBFlIc233bVsYmk0xkRnUZZVKhXDBQhdxqqujevyl0N2E95bVizyxYE6IDsLvdJkZE4IN7z5pn3VAQQ5nNtsy2WqA8qx2dhHg9YdT0cWNvYz4Pq7/eZhq0jJO+I93AFdEfs9WYYDwuwaBpO6RLVJfK5KQl29kIak68b03bZI5pxueMpSGNVrPmq08PrkoaANvTsUWZ4ajYQ1kcq9cGB1UIR4ewej9hYy1aQ+WGcdunkb37PEBWIy9EkgOUfhacugmkKX50Fq36P2z1rpIBpYXWSg75Qxn0ABo4y8U2FaiTQ7LEVH5TubJu6zreyzI/Hh1l4h+FF+RieA4Vl0keY6TsfxT8V2zKoQ6WPNZWAUSlTOL1E44c8R2NoJjlLkXNppMUX7mNpZe0K7d9gzfqg11yT1AF9coku9Ml0WxHLagm/Po3EbDi8ACqLWYoHgSlnO3lXpymO2n1/i6LsdaQl/bXHXkLHqm9VIOyVJtHy+IATuLOwg1/A7cHmccGgCoHtYqZEhsyCJ5lWvaXYdImvlUPs8tTdI7NVVA1bMHp/bb80qSrSjny1uyj9xs1PInZiOmWIwfTy1Mq7jGpiDOKCEAUJN0mZXcZ03ebMnaAQGRsfZzQfduiQYv8WuqLhDI+CLv55Zymteedkx74kjfR09PFvNyO+FOqBsUeyoptO+ED32vJ+MsrR0XmRZiYpNlIUjmTquHtoqau/A+vfTdAu6LCoD+TxBxvfijSUJJoCskF32XonrFMGhpBpZ9TorR4c5IAMGsEgGcbJhHY5L42An49IJL49n+7bF5ZAKwGAHqMOio4jiAcCNzANYyLKFuMJziiq6OpSg4aFlZ4qyQlbRRtFwDwkw9lAnUMW/mCNmn25omRpk3Liw/wdgIw9BdhEcEptM9Af6iZb8PTNd4HoxsqHwTVjzfcgN3oUztVnKXsWxNLxMkpsbDgz73H08bdyWA+7BXbAT32kWeXrcwe0zk8+vTehiWSPHDPVEpOrp3vTugEvRYhjkJY25UWgSz7TuWYk6fhgVGZIx2Xw4guKNvZ3AudhZG4yNIJ8iRmSw3hq81uNJv1zYY1q/3hodUgMkh8b1Tfe/uv9AkXhy7Wdkw+HZZPNeluXTQ4m+eKJ3UjY6ePinU7MzCr9fTW0nyZfgTAAC2+tITOeNT+ysPW3wugFe8BNIDz/5Sggfa+jWsPHyj74StFm/IzW4i5jN4vjH8T3LeNeTTe35Xp4cpyvM2XQ2QNapD6Eiw3zL7mosGJXWw/c3k237/fZX8kDuHedMk40Jix7YDAjeahuPTAevpCfKSIECORYAz90yID0dgpAijtUEyZixg9FPjUlsMdoMAnUsyoyZTXqmp9/n++ayjcOp7Tq8u9f+gvFn4hAAl6SVIzPqdwU2NmYpzYx9I9k/q9rcquqW8iqVeVHIOa+A0wcUnRhwpQGUw+oEfdCr7FW/z/wpd7MVKrfpYEDTLHi1pvzXdMn9JNSnchsBi5ueEthRSTysvlNzCJNhoYv3qDpVS8ClObkkg0aMzWgYMTtUZdhfRpdA2FaqadhDmbs16PzKHqITxaOTtNpwICxDhDjh65E88Z5ckCrhAjfTVpTNox9bnnPSaG0MhBFitT4yu7obQXeYU0n4wkWnbYym6V/BYap1NWJbFl9799ks2rvNb7BDz4WWQlj3QpO4wNOa1NyTWVTS5MB4iJi2LKiOSMyThiw+NZy4wcQiLBuJVmVE5otJoWLfjAFxA2yW4i/yRZMCCLTCq5zEIv0IDvu4lZvk2wBAZDuzRcT9Cr2juONdJ5/9FBn348/98+/vPd5VfWoIlTdKUtAd4vdVeOzEYVKb8FP1vx4bXlGptw3gZFE96qz7F29k+DXF7gIKqjm28H7zrPb+gidF/Baeo15wPEtejoNNTJOcfhjZIG+zRNRuE4V7PAJyf8E0O3OWkLNap357W+u2NjmpABt5pWlEu5CvjB2H6wGIpp3ZJmBMyYZRZdsWixMUBXtqP1f/zyNJPoqv1eOXvnX39GDz+VRQw0f4dkoRTm0VpPS2yLgVHzFm0VbCz4sEktGCSOmCIi22GLaYX+IY4ZzyHkFf0k7GnExPkhTyRlwFiKRNS+JinWcnpkoUSf96OftcWf1SDvWQeQFWJZp1r8xS5uZ7rsWHUhWjcUYAgArLBRQnDN89M7Jj5vu7zffWLaVe2/CinBYWO5Wzap4O6wOiOwxykJsechUiv19pZgzV/Adt8iVX2LrpFbugablTlG08ntV1DPPCIYlirMjvbw+QzKItoq4NsVvrJyIyl4zb+EIuNkFYKievKm+/Fe9WYOrxwbJlWGnQZohu3wXjPaMNHkgqVgvPfDZUPA2GUWeV5tMqGc8IKZuY9rcT8hQx+PT4S/IQsHYzWNlVr5lK8fGAFNdwipsUny/wC0hcw5ikozGp4rBC8m+qViET0W/ln1ZzsIzNxcj5lNEZ+F50zRsaU25D+z+6cXN1m2VJOcPNgnPqWX3rATqUp2sQRjxTGA4W+0m3/OyC0OIwquwwZbDztvdlyvcrlvbFdOnuT6s5fCg/6hYisD7b5vElbnzG2zVVcg5uL3/tgLGqfX+upfe5cuZs/RQ3CJyg4FPakx4CsTz5XDhDDDqdTE3AJ/nZ4IqMe/WK0ebLGGFtmYhEyzbinnzEQ8F+i0GLeXgm37195YqgYfk+6X9Izln+ihiKU5FvVTFVMwiDoOK/jsYqGX4VWcY89YT6Nvmp+eqZLXvD02JFZ9eVZTq3phRNLDL65A31rBxbSyb4l6wxnU9VpA0ErYUabjkexk6o9hzdOooShnacqvqWhNg80MqPhjweJ7nJFFXRujAFUX6h2u/2s6qUdHMyqzokrF7tfal3FNj0VBrKrfWsUtJe6CvEiIYvE8lLlDm+Rw9TFq1cKJ2bImAxYF8TW1CRB8JRGNar6GT77DoOKTWUq9hg1SCnexjxC+6DONjDFWct8lFk5lerwaLPUURdrOAkGcLLwPTBz+Lfm/OqqtW4gi/Mq4c+vLRxdXceovaH+x+2+x6xMCaMpeejd5QnsgrVXypL9GNfCwn+OL493N0Rz9cNIet1FVgevO3akoYkiJ1bJvBu+/DPtPYxSL1GXbN+BlLwBOJK0v3uT4aOLuNdzjIJtNze6jKAkkqSEx+QSwwNQDqK2KWbovaZyiUzC8pwnNWldthZU/er8QM8dg9zYB93LGAb+AC5MQQpcghIZX3zhxk/uELAK8unOWWcEp2VAHxPVaRgfSBj2nkcoMv/7ltX3ulK67q2KSYnr3MhuRKhrcD6X18LD2H7O2q7+H9t5NocZVwz1vZ8aecHWXJBy2lF8hBVNhRR/PKilOHa0d6GVcb7GUPqlJFSOCheK0vIKxTeWfuyV9eMxq7exwTHB0l/kQ+Mj8m5Aq/LMZZhHmirp+J5QrPCb61ogq6RzCiVHmdGtJC4Np3zCsf8Fc8XBMu20qdxBOZ2rehDk1QXza/hYB6tFD0tcdOhrQ8hXhoc27aAPIibq27dU+aWPFaQNBkYBxlvUElAMTM+Eht/y7E3Io4X51oqC6W1qNA9fvwBSh1ohH7JOvgawCjlVqBBAahKfPGTaTRtPXsu3wbgqvQYyb6UN2hhWPKvxoh7DDPkJ1B2jswXv4ev7TQe8A6CJATSDnGT7Hx+My8DTh3w91BEWVbjSAFpJJtKNw3OIe1KoBWtF/LlxmaHtPl7kmvFwhlvEynQUfbJL2puiNBKyppzB4Fsurz0k9ITz2Jz2rpChBKMAs45cnoE0q0FUWcHNhfYWbI6fH1zjbNTj5bsAcccywHGvpTKZXnQp5NrUD3cuN2+eDGgY3k8mnhgKRgdOmyu1nlfjHQIPHoS6vnnSSxa/I88lCrin7M0uyJlw5N77RWPbqUahDHTCZNfadSHLNAIbXJkEpcJKPr++PKDEpqyzFi8/9DdytjpGxRIcmQWCoE9T0C3Nqn+SDHxIqiSoIGWh6IOx3yNgpm/RJ2mgsOQT2kJOpJ8/xE9WfZp/TPjxsij+es8/b4VGs8DUwoO5xsHXlEdDPbjbNJW85rjDQN0QNRq25muw5uxgPfT6zZ+jNtwS86Tfl5JF+gBPd9SmhoQJsnGx9SHg8019/ddeDfieiKxPUqjqtjdoScXNza7otfkUespHO07Cc4c77SVVWFdu3NtkEfTcBUBCRerF9/9k29BZQVVtAyV0heVwG5kIUIKn0HD62ayFX6vEdCzbv4iVdiOfBQM0s1KgMIAoFe2vzCjMLQEjcbYYk/JEJzw4+TTPWRo+XkVP5gUxhg4BsCP1Ipvlxj7ZpTJo3fTJT/hmEtj5N9VD4QZwUhtAJ8NCegIgtTYlypPrA/ZtpH9LnwnzDy6SgrdYFhzPdRmDukujP7JwGYiDguvgDUdSAAYDQM1qj9Ku6WXaSg+jvK7E/1iRW+90A9dK7hGJgmmkTevNf4Bkh1aKTWBdYleRFpVKJ5uBrsOcz854GdsTXWrlESSY0hiqZVFBL0SJsvwamjXu6hTszxfcsbiMFeUWw1Umd4bPORLbPFhTs7DIzk9KHVAaCPsEza3dXBL8nS296ku9saHRNe7HWdEiXuzNbQYe2Kxuc5mnsuHfSgh8P0aGktbiHJKYdO/qwYQBQYyieml8D/Irr8RJsOKJ+BYZzJY9yUgHDTvWrAdLZJ9rgqHTkz8LBCrc10IrKeOECqVLmKxn69uVsOsqWutJZ9l4FD4rCpqGGqkUBnGlUceqhvpcv2Wq6P3ciK9WrlBdISdov74WGH+VbszpBeV8Lkm2W8ExXaLjUoCQkZ5jhsmGEqT9NiCwXaSvkzKu1F8tVZAikGgYiWYfrbsmyS0dz3DhkkVPfQ4pLHycsaPb4/YvevV3m4pSp6V6P/X/68hEEvNjPbQMcT9KAnsUE1O7yxAT2wDv/oUScwF8oitYkRUUOEeVMrYy+egEiTZMfLpy4MTpaMYhBrY+8JvvSiNvQw8563AfKMqkOsajlkih8IwBnNROjmFucBzHFEAuv5mFXvqdXqqnxzwin1LFyrX5QtmJtTF9GZi5U6pxQIzVIpCELdbIEDnYkHWtvn4Wu+b8PjOMX28j3TZViJOmtfWXErpiHAZ0RNPCpHL+ePa3F6y/Czz7rvdygC/VtlvZ5k/MFhzEGYsVSB9DvBNKmzX5SWc6trWe4rkLnxRqmuCi956Uf+s9UIGLvqtIBjmropisxHAXFw9OcSFwi7JMjZ+d6tc4Yt3HXjdD02Pyn2Ibw/TULfAeuqfq8aI1tbMHft3OheStZF3ZiA6xpLCtFAUchPDbbmoFytWicN1QNuF3uvfY5oFxIqisHi6dN7IZmh7LTwyBFbS9G/R2ke2UPgIImHDu2hOUFZ8pHG3mUKNr6yPAZ8Szi5tbwIYGdC02vX2znevMQNaNWm7vTF0nLM8+bAZ1t1H/32VPFIhZbNHL+Q7R8ahwdt7GBrkKgUAZoiZZmTkmg51IMQNN00dsii+ebYbjmKeGw4guNajJ7SRQ22ThpZiMqa7xqy8vgSmDfxUT5EMCjDic4T7zKysiMaBI+ijxR/ZptY0in9EK1382dYWLNPrER1kqKDVfym7SaMN6n975ViFEVFDLyvAfp9O5FJ9GDeFjel9kqgpotMrJy+FLWmwLDU1aKYwdrz84eWp8aWW2DLnY8LI34J/hN4pPZnpmWHNeGZAnJHXyen+O2Btu4B+xLrYWlUBc5pjANmHrYb/shaFgSvT1W3XBXLyg9UPr4p0ZLzCUAhU2qkLkniivjw4gS3DRz3XzSILSADHGzK5wiWxzPkwivKtwU080eTNC5bGKkOACNUr8hiMdS4ZFjk+esio/EXGDi+oGHRx+JLwfvl40a7FbCIHQU5UcebFsedoVy2D1XowQAs9l/5Xik3bc6OGnNAD8W6LPT4EE0ExB6f/peA/bIhPvJednWrRB7CY0yROs2Ken3foYMtWiyMBV8ZBAwN7fobVr34MPKkjeyZCRdzXT3AFYjuMu5YBeKJOnzqBvZgsu5z5BHpRdw5S6ypPi8/aU6F6eQ9CVzkzuPoNSbOSWOXbw3Hm6aKzDsuac74iGxTafSbG79dC5uIrCxoaDYJWcUY3Kh91vQMV5mXF5zD6QU2dsB+fzeXHr3l5xj8KF+pjbzpOVg2FRi5zvd1Th/ZQqzKEBT07jHjqdP4RnyZR4YyhcZXKAxw6PpEjVkl35HR+HKN+WabJwAJ3rQY1dLDuI6118/wnBdqn4InmLjpDqWyVcUZvfyttTgnWgY2Ezt+rdYRVprDx5UKq6o4xDVaisn9iWV+1xBVhEOhDLx2E7IFuDP5uQ84GVQPvheUwK/1XPj0iyZCykg4KWbJHCH2k6QObw6SU7K5WbUpl8qWAQlUjodqAAueRyMF63UynPhWO4P2amsQKCbiCjhAiyZewhO0hsubxJ+xQOZ3C9vOpVoQ9aUBBuoRd7aZjcIKpyKWWOQXfZOSgBlQakYtdv/v27Je7zwBSXKrQWT3v/5QTyzkcuhlKsvSIt6lLWXPtIJYVS72EdPuohBB3qOayIg5AkIrtOPdPBvN2ZP/rsmwBs8evhPBRba2K+EpC33RgYnIGZ1M+dW76aSyRWKZAW6Cv/BSdk5rOK2rCNBxvp7CGGihg2EidNaK6BEovl1HF/iESPkjkjPQXoKefolGJqLrfU0V2pubnWaB3+ADLQOY2m/u+lacBH1Xq+DxzvFvaRy2MFzJCKFSq4toF+kuI9N61LcTDYzU+gDiIfnp4dk2SYDaLtcAG3yuIECMiFQhtIoa2m/A8qc2gtZ7yoEiWIUsx7d4g4SVoCZLEZj/1QA+X7/MU3TVZXENdcw9vtDkyJm8tCsmZ8+FevjtnwbXPTlLuDQbZgX8W1cCZdLyFF2gZVhkO6idnAt4D/lgXwg2Iv3HOooWbP6/6yJ/n7MNM3sbdN1rbnHb9ESWtC7s+xLWjUuUpGg+cMpZhTuvEkcKfBGIEK+/vFjD8XhEQj1n1/ytwiifcpa1lxEiky1Otw2SAzoyCSnKeSSk2Qh+NIuNrlnpIrhGFPEGJRuG0SWBu4OOiVldRmbN5kfzhkLnHQ6sByHCD7lSzePkpQqeael2dv/HaTE9ACPaRYYdPT4q1Yh0Ao49D8tsv5UZ0VTsh1b/9iaZtMb4gKqSOW1SmlLDV3U8Zc9bGOYF50lS6X/7serF2alkHRES7nxnhgPGBgxi+6vpuuHvxsHiJ0ZOIHwUxZetipb8JyFFmwZgRRNyr4CMDpMaeZu2CsZZQsl9Q9nQWE75dQ0pXLH74d7UeE7NSvcWlFS7WnrqGI7d47SK32i6oau48prp6OhpKQpX0aegEZ7Q73BaJd+4IRUWq0ivbdy45RR+HSsdqXba7G5d+mPaVOaujia4IfnxbUzvj4izsvGB4KV2k9Fq3jVppqMlaAOPylFkXOcZ1bZa/UnrVBmfAq+VBMI2qEva++PKRG3sOeYbF/v3Lc4yrOrsCUA3t1XF7fru5Nj2rlGOMpzdaW4PTsybEbfp5b78Sb/wnnNgGdzDbNY2c+ytStSv5VzOoof+U8zC894E2GiwHyev+CF2AovRt6fdAFldCrsLPCRHP9qLNOKwCXHa6pmt3FZ2M01WEPi26N2w0jCr4pSCQa1NmaBzAXf2NfwJyeoodpvw/n73tiAFCnt/drBk+8m8+pnL5d5KH5wJzLNjhqdo1fQc+zIRk/jEa3GhfaLqUOX+QnBy13Uw00xbkzzWyNMXqDRl4jQpiu1Rb0WaehnBuUD14KDvb3ZRgM4pdxTtoLrgsafrsB5wZJP9j+gkqRqox7HKSGzIm4CfGbUrmhvWu8v6BPkftkbBqXdkGczXUk85rpadr5Wwt09t57iu5SCiqjN/OJ75K2RkPH6o+wcpDEsg/v+SQOhV6LsGe342HRdhdYozUtcwTkbtrDkAga6F9KJ9f8G7Ca+fAHGmGnauTcUCjRzmUIX3dq1zD56e7nZ06/EnTyxV+Ug4JXkliuprhCB2uWuoGIiIoP22V6wOpWLR2ADeJ6/35ivgz5C/goDvlnZnwYELDnw/gr68HCQzoa0A1WysKDooHyAFpAUTV6tO2/E87iyM07Z3HikKSyShA86E5bqAgql1Qx9eFuIv2v1W+FQaW/dfquoCA+FwUalusC14BQsmMHR7gf0XLjk+uZ0+HVrhea1TUTAqY6bVARZFbI0U6XK7SMuf08Ftoua3hAtqarnUC4AN34kCY/jyUKDBdYBJKAd+b2BhqChOA6PY/dCTuu4e9soG6dQQdSpUX1RyPaVrxHeE2miB6jtQxhW3WpfJOw+7I/4oXQoWESvYpR9yfN6M2uSlblH6Y0eCWtBsq07e0/CHYIwbN7pi+/spFP0jaqJltyMvC9zEAEpap0O4GCnlBKJsQawd8rAOeDBV5alSeQKK4GmVn9LRqCfPfGQVcVjDkwzEB/hvrKZaFdDR41jOk/zho/K65ZFThwg5jmyVkVh9XZuoiPk+n9x7U6ErERajKj+XZkZlNjrjO9ocqHoiNYrygNyMwCsbU5Z09q2XXtYSOzhDuGm81o8aq9eBE65DJqLNLJmgRhaHEUMH2P3abHOPXd8hGA5z12yN0wIwZQ5HEet+YfnnYijHWWauynU6lS2jGHGkIgqJwcSiaZHIwjdUJE3PGl+C7K0KOAtynvbovjcPvYiszvuxP1Xim/nYsnvL4wouoGZHG+FmNn22fnz/vJEJKwhEa956TeDAyxcs4lrvxL62wp12qxHotdCERk8aKn+zXAifgx/DIIfS+XHKKd9Clnd0rCqzmj0YnkhnNLkMlwLnTjpRFTQuQ2H5uFrz/vTlQ/LOtxqJH1W4fVYD6mfilkE5/Xvr4XkJaTXzVU2aF0HCWTcAt/BnB1Oz1h6M24bhWwel1+2ebcNhyIQxnJBZuxa/PP5LoU5EetuBPcfXmXdHcQjKtUz4G++iMG61RgTXbwx5bSh/xrqYSEHoTaGIqPBIefXVe3OEu3Rg7LbD/uf95zg3IOQ29zOVWeZoTkL+OtvjXIcXgjJ93DwNNPysZ4qi0jrN1v33whXhThziZZ0GdHb2foQVgy0QC/v9bDWm+yQZ1ZjzXRZSxMetSNOB4whBoo4eAjTteA7uUxMphFeG8TaKcxHXXgMOQnm3+AUU1Y1GjZ+FB86okkwsF+ZugLHagY+cGZQ4KT9985nyU3JL4GYMCX7orA/PYkWSX2P9i5WSRCpXCkGfz0k4WbkygAoQyofpppPfJQwcOw6AUrDOmuG0qza6kW05DCgrGYEjZoxhsm76UrLeKzTw8+LGvUu5hSVkVAvABYyMXT7EP3X8uA1ztCJg1Yd/aoRhRDVagPUXtfTO7uiZBXnFfLpiIwn9zEjNlVSZO3vdHMMHjVCeAwcGkZ7IJ2XrZA12lRtS42+Ki7/b/Hx9fNXgUlOMMMVZT+Dn9McYSELlOHy9Ghdy9jrYrAjmGW9WlgdGgPz7JKUhwyhXsXYoE7y25Ai/DreNYDizWd6bUBH7wzh0XOHRMqFgXVdJqCor+GuR3Cw2ECngkw69TRVQSFtV6jzjIb3Eys0F9C92hfxQDodIOeqLcb6hhoNfGzdajD3raPYey6ACZUJAY782nwdzQWPRSLoHbs/seyfGLNEm6GAAcS05xjVesOvvKIPK7Pqb8+ZiwlEjCkFZ3fr+ycoKlSl2HvNIKdxEP1k8zbckhnBn/w6qAcI+PLYTGybxJvEeRfSquHir+v0Qx5tpV+QJdzEousdFT5Cc826QDDY0WNzd8wZzlWsTeUfpYfjYtClu8ix5Lr6CH52Gx+Ml9Nl/Q6sqlGm/bvw5PflbGYxNoWxn7tgjoIBEjnAjT7P4VGgfahXMA+/XhI45t8spRrQYvXfzICLmIc/zj2ZgybOJSRE6ivLx9fAyOdaEoNAcO3nVKh9YD2qbyhPaZovqou9/6B3NfDlICRl7lqeb1JiNg1Cq66BZmzWumJ5BFriZWb0z6vwC89LNVLMrT5+2UhH5e3okKB971FQRVkk/VC0xXCpoTwVuRluSYgKhOy3JrYavovrjdzmlvXd7xZgq1WRSaDCsiSVRY5t5wdVZl5z48YS3aKP8Y56XGvBIl5pr2Lm8AkSWM/fGptOPtxUs5h2nHi2F9nI4tUhVk26NT9Xr80A9YFvxJVYV1QOqjVUTuasgXJrEFXoj0tMHfu2GVESxkbegXQoWR47kP/gOhcDqJPQygUpoH77Txx75lhhfE0wp1wIEEGzj+mPAyHeS9cHcgHnawoyVAdr0B1z3RRnW4bA6/kLh7OhDERO9HbEj6O7kRsZG3oyqbD0si6JxYbd56ZsG9hIzmq+GhR4FFhiyEJLjtdk+6UOecfqiKRFITlfBNafyoTWyR2n8CdsyAqlH5yr1p887USE6aK/Ys76FyTcAQER/4ps3CHKjuedDbFwuAFN6o3aufJ57ZofmV4lnNS7YGsUlJPllPj2mqPTRn4qCZcD8HbGvjKM4s/5xU1UJGycBE3U9ZxykNnJcGHUomBnLyfSI3CfS29BKoRFrRXEwAlkJQ6Jufu02IXDx6zeYA0IIkOx00OL6yiK4FHWfDhLBq/QXJB+v4ej+FjU32xYn+seVK/E6ALcftWPTqBDzW7Wz3oZ/bVHMFNkEWWaeQAblRUhPS6rHr9PwgUEgn6EqkTYUcO8jHcWD4oeAWjVozEkBB+x9vzdl9ZNP/LX1OhNiJEEOsQp0pJiyxfc2KX6WI4tje8LqvigtseGMe5sSb7lCJRoaNBJYUyc1ZkT2LIE5JtK+NWMHDelVjLOE3ANMxsPx9vy4V1dXh+TINHEkiPJt33zhVdY8IlmwzXnxazOTOE/Gn6agYxYzUQPu/ikmsPUS0wEQ8L5ZnG3qCO83MRECoWXvBddS0QDkW3do+IC+BBxX1ugIncGKfdh5Vxuz28YBI6JXWBtTvde2rQKak7jE7flxWgizbHu4F90RrM4v99QaUFRbvm8sIe6/fvZOlb8QB63eyo8r3xMInxgCnIjbwHAzjtZmzpZTKDwH4Dubxf8wFmBPPsFSd/idgUyk4diOcssbZ55/ZzhI79EBNFArHqq+pIS82kV4eYOcGC1hE0k0yIkUDukUvBjpe1tsybqpC6Z4L9Lo+YXTDoHIrdDn44vQEpN5byybbmIkNORfXrQ9aFcMGOIkhA9dddQJlD7EhFYWYXveUpME8FQMe1aJvtP/4RxuhsD6YZSpJbySdgaE6TeuBtSRBgS0yJ0kuLS7J2yrPygpQLqWiemDzepMQjRQVHlg20W4Eh7mpcFNN7Q6gVguqROIaGwoIs2SLhLRL2MrWo9felc83sxJ0z9U0Z7dhfjKGTg6ZmBnBAfq77S/6Ha3dE3aMspBVi/PbhM95jucypffBx5Jkb4LRJ8YWTgk6pVTJKOXYWu+qbR4pwRJGutTeTFCq7vBQU7gBGYHu11sGe4iOGg3Yu6Q3UJk6mMoWsFdmZk5kS2SFoePULymfU8hEz5uQXkSzIwqeBTr2IgZD4TXKx2+YAqpC7cMlv6r/rEB+qsBsC9V3XxtH1EDbgK15AgNJRJJZdeI72J98kza37le5PqqSXGcAcu0aORzEafyt1mNIHfrdi0GNqMOld1VBKBUkDevlTlS8yfK7SlrLGWKHu3h3hoCTqkZlIpk7TncoFNC/4WYDrw5jLSwvr35POZr7mc+gagYuPuH0TUdSwTQaLbBjCW0Md9Hx9jUcjGVRxGAzZn/ojOziESPNvBKH88OYkOA0TVPbAo1Vq8Z3El5D8eGB8SZa+qkkjnuO0Ipn8tnVVs4+VLrgfrFlygZR4gEDHAwP/y48KGYfQwkmNp2NLLP1mOe/K1KVIiDaEh1+Y5Ypt13qFKC2bVk0qEbCL+0D21UPY0LeWUnK0crbo5b9vBOX2gfM2Uo8KJ39NWbTLgCteeYLm0NGF+hB/nilxFrov8H3FSSubbb7uoXbjgvRK1l19pAPA+S4ryFisbkTUkvt85j/AJeVjGWKKahWCGr6fD6++PMht4SI4+g46PipuHedCpmN0NA82ly1awsUWJP4WfM0yWJXe2j/vR8j3ALH2jWsnx7uLwu630rJIm7eej9hdB8LbEoxNeg7c2u2HV7YKnmlUkk8kaRSIMJ1x89EyC7XL6pvx531wjEI/mjebDOgyb8ZswKtuoI+/UyT8KNqJKR+2PJ7pwyUEqpNShJut6T35RtTfcNNHGbkWrP4BOpSIBbF/Mlql/BnVIPz22juQkMwe6U7T3iUyb6c04JKNZ31DzOg1c43xTKREp6qxm25BjNBQdKlsHlFkNca3ZLuH6IrtIJrYGNR2XihAObS6/fziA64tpqfvoYTU8IsRsKBvVAgpoLW6zcx0+IOL1smPfZS38v9YT5acMZokJnWxWYSWxeuOKF4vlpsFr7VOyr8Lk68z5RUw10Glxy149lu06AQMXp+37g1t35S8mnLhbAOx4iYe9R6OU+TfHMRmzeDmjAXC6OCzolGmZijbhZx/47zvmVjrXi0zTIRbuF/2YtXfwuayv/kNuio7OgC2cE/pSYpt92IK2CSk2Mk6M076CloY15g8T/I9C4kIqSizvYE7GyQhzP/wAQELnBnF1qC5ozXMsRQtTI/wvKLTIgmelOZtNMgjOjWGpcYv5Z5bObmJj2vjNKYDnMgKcnAXTFOzIKVaW/m5+U7WHMwghoWKCkIH3ucHmG9fNTAv+MlBGpGNMjIna6tDBPvrNrTV9W3CMjsgY54ejqQF9ZNPtJoUVGFpLDqNOQBeZc47GzW0TqCJIiuS1pspukRnExRXI9XiMg1YpXS9+nMBSfqiR7os1f4DVgmhrKIzU1VNIuQzwz6LlbLdr+ChdDTviNeCxptT3Rny4dUoUabH+ZyBE7s0asjObDCpPHyc6/6chfQqvcpVA2YdIzHYsUamTfbUxL+7/qgC3iSKO8UKQhNM1B+nU/RQngwREGJJQ2dGAnLErhaGk2CyoSOCbrWr2/u5hP8eAKmXsO+F7Bpu+TtkLRrG1kD6CWfpkh62pnvLlxI3CqkZdpOPzaBZBuIlXmNkxZGCvO6GQYcjFefRn4Bov9nkyni0668d4x7nQQdLjJb+OK5IK9iRx+JV9/KRsYPS7g2aHTlSe5XUteA9tjjEjGSU3jc+B5YJTZHtrD/S716DWo8F+y+0oJZxdTUod+y/Trzig//3GqXekcv2uAkXm1NTXCiBHElZXr9jhYqkeK7639/Cmb2D/SCuLpnLSKshd0hVV83vpulkDqH+60elvG5yP6HgjIZnSO7ZdRQ1RYTb86gGGnYZtAESTOYh+y5hcA6UTa2+yziv0Woh6j5gJH6ingG1ZM1mBiy2k0sBzLIhUEL2rwkPagBsdAUsosiTF9JsccJSBhR0O+CQvMr0mMgHNW+lATYWoxdTsl0LwXRqclgwAQnmO44i1Yr7+woyqUNQlSsgdurYVS7YGhHfGiPxgpAfV4y556Vtc28qCDQVB7CEdC+fWN8QDheBLjjFI7HfSyJCG5HuOIPpITtuYgtLab8+T/ZaaFZN5FnpPYDA9juS2cue3sDAY8Bi751oegSXh2ORWn+j4yh3o2jYnfHCH1Yj+WO5kLCkJBQeZQmFMO7UJQOITRbj2BwIqnXcERtpC0d2P/by/czzCupLInkdLM3MYeVcw9c/r0+aLi1gaEIhBqm96IAZslECwPA/ZQhvWUUJmuFbmlYcGj4beGY6KAw9nLwvZbgyqoTH2DA+r22yqpXXaMrq3xZklKENP095RMH/nWVJjSf4GigHT3UY5sbp7V6ashRgGhUKLCRr2piCBHGkZD7aNTAT5ypqMElFSf7kd0p1yfQIgLAArF1W/DdIhJcBoQBUo24g0n8ljaOXLYpoZT2GBv0RMFPN4KboBuMAVDG59ZclIWqyCTRMUDNMKRGLACKXqFcBI5gVirXDy/dy+9qldeAe1pMyBbR8tDIehnldGHqkFSahsZIgI5IKqfmbJt1uPD/xPRK+Beyrq1NwW72J8hrt1INBAlvgqDC3nKg1k1hrBeHCzlAdE9TGwEaxwm6mJPST4q0XUK/td29xXTn7lkyV8mxgH8wHRENjgNi0I9kena9cBCtzzz4PactRZ38jFauVCG3erq+bHIqFg9MAZ8beq3mMC2eM6lRxhykql0A8FdeFZY7ol9OLRkhRAFdgbkS18ETh+E3/zl/gIbdF7A5Nj3xrmyqe9k0xy0yU3ADDQPKkP4VGlVQRK4N7Vhzy9LbHd8B7JWOTBTHFNqYwPTZHnzcImLTJ7d+Atcd+B1dD8J/th9iSC415DDA4J2Lt9gLqAXKUh6Uqd8Ps5bx4DrtZrCGJU1SrR5HrLSojT3uYjhHR52PUgH4I0SPfviJOolsV5zjc96YI3Dpxs1veB+GfZe0CGmvq9u26z6nIvbGQ9TD4/bHtZ60wi766pEfmUSiyaeqhUi3+BzVDeR002PaI53wAuf3JIic44xH9plVnFirURHzUnrPB9MXYA471uSVqmMVZdPg+2EPlThbj8616ekj78U0s1CfaLxbw0n6rvK0mKRgGmAN8s7NeKO/qoHUjT6pGOW1Q1UKyb6y76rPCwwAyqfs5vWcxsi6zP/yVT4iG4BWacT+zCmtfwOySTtqr2SSi/Tjg4X620zhyLV3cIt15BDwCpkBwfpQF9TksocK7R9/azu8jZ82YbiV4VUb4949vxn2HyinV1kGd5kIK8qKeoHNoq7tsniLRAgRlF1f1WSGyDtNH2vyne/l0lIKr+Bw56j50/XN7+czEja/2pEnSC3s1Ez7qV6OpPLJY53VeziS05JhaBp/Q8DowWofYsQ53SOViUUL8uRXJhFO8tC4nqg8oIhQg7U64z1oW0P3CaM4pIucSZhh8iQqlaExO52jsDj4KjigxB0MwCwZOluqrsE6G2hFNzg+3xTgQ5zDivzzCy+JeXDhHzlI9+4IsZY4qRDO/vX8aX82jGSu0p8kaYjmS05+NkTaJN7v/iM71NG+XQ0rs7f242uMR7KljzpoNmR0qUbv4hCB2Lpekr/ff6qxHuDbWQibeq0lswhs5EM4cQDiwrmJ/mMboM07eSX/uEhXm/Hczu0tEs56EzZD5VnwIfQUhRJIldRLDbTCtHXqJXb2SJaWKTrfQnFngqCsxnTggB/f+O+Gl5TKaHZ0jH9z/yDjzhcPxlvcitlVZIH/glpXWr0Rd64fCCvIrsJTgYr09V1pQw9uH82y8RNCGLB2kWR8ulC+8wOetw5vHdBeujihopYZqsTxVooUdRgVJYAbZ9/xTOYsidJhViI+lIIreQggKrpcbvgcpH6epN3BGf6yTckn71ouTkBiBkNVr8C24qkG93sAMEX1wHzoFg9pdsEJ40vregJHLkPA6MK3CnQI3RlLjhA+drhLsrt0JjiyPxqafmYrzxf9iW3b/GOKLztB3lsZo0//ZKqrGi3+QQI4OtQ2OXYCjQ1HjhC9t7BQPTF36aR9vldW0MLOmEv4c3zBfDs/DQbZFyjFt+1+7HUfMt99aJNJsLia2y+3F6HY/BmzGCNxpTBONeezCAf9ZlSzoc8AqQqHkbkzAWMEKNJKH+iiCowIf/kwAKVScjQdOdQllz5zygexEcTxEfIkunnUee9VB6lp+z1JGoiS6/nZcSvXrBIilJRgL+5vMAuhX5ty5fVuBa2eA2QykPXcxMKXl5jKMkPiz/wbCLYes4Ols50pQlrkD85p4iWcIGi40m+Ykhda+4ROonRmS8samQsMvQyCryF6DYRd/T/vaxLDjcIoLKyC054RxhsGd/qKlVb1TPbehNp5A19IwmcqpJhNf8HtPE5baQEg4cWN4cEfjVS92XOkjp7hO7ga71rP00RBFZSCJEcLcImaD/s4S4F3flQc8x66UM1gTLtE1tOeyzBEDRwRZ6MuuErxVpeRXtrS+7M9tmUZECVti6YAjAjXiEyDMya00bJvhShTauvfbLsmw5HgpfgI3/AUmG774z8DT1e+89Q0qYcfZLxuLST88pywJnB+E73q1cRTWbqv+V0F7QyYuNGzwCQgEHkgQsw2I8B9LQQbNyBPUvwVYjqF32yA3aEV0K/3Ez7jmwpW1jf6JgQHFQZmRF+e02BhJ2daOryjbaog+sG2dRmxkgTHYx8SpVK3dkZXkx2+87hxDXK1yVCMbixeoVDAPghITrM0oCTY9Z6o/oJXfnWlwgK9K0kxbbISWxmecS7PPP8sZUbd1bgS+BAOfGwdlM/RGJBRo9S7WPyI/2siGuTcOpaCTiFEwbNQf3x5e4f8GWeO38k19HAa6/gsoJYKef29qpOuez5SjPO4E4u20VRIQ9jhAxFpwjRpFMxAkzJrZQNdhnCzbaWE+AChlBt0YLenPwlWg/0p83GIac/x/nTVFFG3toFc85kjcfYmHgbEABv7ivXLdtz7gptSXLt0+tjlnrPK7lfr4qikZefP/geLC6ZMw7YdeBk2kAMycKew101ZB7Z/UMr2NxfpX+je9xCFJGYaTURkltz0v9BUoJQOSTQecLJZv5FcPZRgYwHAcLdQl3LTmR5ruFXJY5NShujWnz+hz1zrwS0Rx9rMYR9ylu8sDx3Y9F24/JLyxtZ6ARAuM3J9f3Hj8kwGhpnj9xBbOJ7Dkf1+ZICy5cB9jh2EXsqFLOVBIsaOlFt0xLA3w8CRnvE/SM9gzMaQZ7um+QmkgtywZ7FiwkK4a0l4ZVpE0kJp0+PbS5zZg4HXk4A24DKrz3/VLtZKcSz70iZQ3A5iN/sswejvsBH+La3N9SvtKJqDfPvbKPcaHW/ub1NXOXSRTwXe6BkQBZr246HcRGZc3UaOLsqAz1a0mJ7cVCoRqzHdXLxgAsItS31gF6ObBW8xIwTu5WqFAZcPPsofddNN1ZVg3DDXyxymQtZj0JYMePIbge97sKdQ4oVsw5oO9hLPXLmH35JvtGj3D0lgq38v6LsvNwErzc8TqAgcpJWYtiBKrvMHE85TVT8QHm15BHsfvrjmZ976A93+bgMe4IBuAFTmt4FSYqsT1kJ8MM7aJW9wpbt12QXlt/qEWOcyz2xCiE03JRc239vx7nrCHYgWUnybjCwRVhzm2uvpL4TbGnIKGIYYmXWbWlsPYFWIwZJLEkct6af7Iqnhrl+8sBCTjhiwuUSYPU4VMAw92ScT1jgK9yEA1XfAdDXQu1d/LwSYcayQ1F+9T7YgvliaQtbUgPd7BuPpNQE1iZqCI1nxo7n1tBOyBOF/ijdGgWx7PBlDBrNGEHXOBwFQ7ofefoFBYSRhWuNotug21CsWOB3T86dSMlzs+gbWHvfpHlI1eiRKoW053TSkRY9zKNeGvwqSLh1/Uvi4e9ZFsUHt0CNlAgVr92Yo4EgSpELxPLb4pFzpALFXWiEyzt25WQ4Z5ebBq9khp1unjP9m6M3sIyvPqAHGxfb5AYE0/js8d4C6EkYN0u/l6GUVzg4LQevsgE9cTH+JioeK6/c9+yC6VIx5torCos1Q3NVIjJnyBDMi5Vkg0+aGnLSBJbtZccc70wln+byZ/q3B5p0tw8IZS8DYl34kUcFHVM9kJZPx5hduKlEW/TAgo1YcFss2PWXcoTDPcgw3q0xVmrIG/CSDZ02muSmxIMDc0y+KMpkQX+RD53bWr8sHQ8PYZMXeXMuwx7s/F5VWjtmMusSI9rNfr5kRt1dGPb2R/NL6CZHDpUlhyANcSJiRQAzzqELmA1c3ClE/fEtGnaSO6t4B8IKYzsj4S94cGRVb3vrJT8+Upa72/0SgCIKnq2cG9jmEOFqUg5DFMEWWvj1mcWJlRI+KtOgh3jkRPFrshyWNFay7O/zeQkS8RbXhCPCv9+xncBBv1x3E+3mBUHHPgG/4LuCcQkLnKt8U6sKsVlU/vnnLYCA6Cw6YuH6ZbvTHlgyhseFyN+iwzGGmh4Aw3IiROWulh8j1UWfnHrCegeppvOAsarkeZQh5Tvg8g05GBJFmD+AOL+neuWXBlV8Kvf0Dxi6CDmczlEn8cKc/+KR8qoyutHe+UiQuQDItzGWajz52wqkgpaG9crQhFbZpmGaCnd45S2dXksG8rSNr++qYawyk4KC8ICt5B2PhCmGxZhq/gATfiLsHC3RzUAfszBjrTcc2+SUgtKB9/LdK4iAOemCH/o8nlMJb9sMaG5hxdyjgQBfEYFkH/qqN8yrqVaHaa69fwes4NtrugOMVjPlRgcFxyS/NfQe037u3QoBLhkTltYGGzLnqqVCYHi+2oJkWBSSKwch4y5AGGVzLjK5rFZFhNU37jJCZJaCAFUGwYsHX1W2/IRpqsSkMclOVgWJRxkrkpL4ZMesqDuiZKkaMnZqLHEKy2FDbD0d9clQqq3ME8o8ocET3kUoNStrQkwMQT2sFRKUE3Ryq1dj1mG9YgUMeEYLGgh6tlKuITv5CGHyZAx6eZGup4/j+wRS0ZA58PDHiIsW+Plmnq858IMbP0vZUPplRm0QyY5GkYSioYwoQabj8MAn1zh+LX07BhTCpEY3ZoVXLPjOuwU3mPxHCb9pJDtsS4grUjE3WGvBgSynt6MZtB3bD6Bi2BNYL52JKNQM4QYoPlxBEALqMAyChV5knRumGG6zyGVnI3lDdZS7CY9g2pLSvOHYkmkYOODSo0iGGgdhH7ejdlcfot5lEH/t3OLsXpwMCxtITDfDMmtF0XPsR6tSO+PpRIfW3HKBi8cUmnUu5rBUXeOGgPUdFOrSmJQW1hKu8qnI0tGMLnGxJ6PZMyhU6QzX2QQN0qkcFR2iX1QJbsW+xFOPVjlVC0Gw5vTl6rkcYWu4vDKPKFygVHahL+TKSiF4VQH57TZomJQMYWwJoIh5hOCjxI7lFGwo47HVs5nd7hxKCnTFsenZPWvdxQtOK5aVe817x7OPoTPTpQ19mZJIHEtLbFLEczy/E00V0ER0TftNeDVvdksZZaSRTMWinTNcpEtV8gRv8LMicnzI4I+0D0L/tt50I9ScQvViCHfQXI9Fro3BFi6opKSD66w4I36vN8dNCjaN5PCG/7Z918n2kP09HhSsvdx5RgHsWdP8n/KjIKZzQyIrEYpYMyNTJqrEJquWTHyWyYGZ7l3PWI/WgxcP0J3uOgrKy4DLBBnigJ3MMH2qnYWgBENXZylIiF+a7qDaJk5Kf8YEf7tytYtszlZpedU1K3XR49zHBtPJVJtqRnvp+eNITZy37cjTXPMHb5srAzKNW6BOW7IkmDL7woxUOj5cTS37P6ZAOyFKeqRA24GZMr8jEcEthaIy1g1p/fRZ5e8Q6voC9PJ+jkiE1ktJZVrcVSjqYmCwAYbjzuOxPbscJG1zd7d4Zuf/71b2M5k1Nx2qGvVLHABOJ8vr7ZQz/7CnyuYyBudGBoV3xt+XguQJBddrmTeOFFi/GKW5zevNsGBsk/BNUkZkYKcUsHXh7PGCIjsL7ZeB9Xpiu5TKQpVR5i1VRdvHrofMqTsss6ll2v6ax2NENa66WQ0KZ43LYsXvIId1MrduU32+Toi0dG4qzxmd6FdfxURgJiVKEaS0UpsmP7OSpaKQRA06ZEt155EBw6TyF+iMeYlu1nkQK2FuM6KtN1GQ7Mehzv4FjrMU8AjRqk+MtWCvcUo7LmxGUgzcRE6RxWiNsWpWpRW8M+9qOyJfnXxnJLHh//gPjPzycNHOyKMzfMTlanDgg/wiZVV8XAQwpdMuf8mD6N+mHYSnJsAkVAmiS4grryN+f/9FtXIP8TEaVyI1BgHdjnCPWw/MqoLkI/xfZWgMn4NBB0TWMRDa8eT71RTlNq6LbkELiX9yjPVnkEB4DvIzb7MWxpnUWXKSovpxI5ydLBvBQUKbYwgWUYKgfkIX10fCqxsD8y/Np9fqAiY1ZmWWFmHBZFL76aUvDMyve+5UYlugeJ/kyOOSu3n/wbAC4FEK6qUCS36NyZ6hLYkJ46yw8IvpY/mSWmKjvQ2XeAXaWffxhz82+wVblwh3Abs5hmmk98wiQ821wL55CFsVFRiAUObbn2avcri1cDLjVGP5Twt5wI1UmThvrTE42SzKKwhG0L1LBB7kvh0C7qjkreQWZ//vUAcSCztEYCoJLIzFOVq1OHiue6q70sy+voqrUOPzO+/j5MmYwsKDfy2Z3KE18ECenw6gibsnEcedj5pV8bQrVKA6r1EDPnKtmzut5kbV2A2SLKTyGKf9MOWlhW14Y3plwkc4fezSNRcF0UtRmp+qjJ9gqxqh/bdccePdrCtBWJs7uNgqVz/wgm8rapbhXkwIhKD2MMkHMchlH6jMfWw7pqz+07a2lpMxx6MZJiU7ooksIx3MtOAL4VXGvL+XM42xRRgHDeLIR2tfp9X6qUH8UQHRJi/9CuxYG6plr26OLMYeGhvnYoW7fgJXIFLJ9/8Iss2dFUmXfwGELnG4qNLZOW2bTnh9BqWY8FfxtWsYJhDykvF3WlkJWVpMq7RBHWEoL+r8LY9NaaJ7zTuSM08u5mubKk8yJTNxF8NcFcztNeFp8dFgwTcPY98Wx4sGdovPaMz2hFMNso/WwYKh8W7q3txJFgkg6CnLsOD4V0fegDocaKoG5mt5Ound4U3Qv6MPuOyMQ3ss7QAqWC9iic1jVhxS9pOmZRQDEzjPPgne+kbQq9YUvzWr4425SU35rn7Ye2/TWAvsBsCUyKfD2TtFpqIwxylFb4Spj2wFV8FkhrjortKuqy8KfhqdMmIu1GvXBmx67r11OMd0KEJsyKno1I0yYfOw8LItMOtJRqktayga6FBoqF3OtzaHmeNuye4joCAJiFRZFfKB/uMUd/Ik+mWO5GbbTD02kZnKainuXcdcY+qbb51IkRXtqTA73WjsgLgKiZ99W1zFd0cO82Y67kS0vvH43fJzboNo7GHaIRBZB6mfjUsrUsMmVDGS9HeD8hMHXWrOz75J0OtLZkG+pDcAqN5F3rRLy2EzzzXroaKN5JJ/NXChDpDrMqL7yUXpcy8XjyrPAlCBmSaEQSc0LdHA8iSXwtVjEw8nprp9Y+N81tS3j5uFg4WpcGM9bHEDLUf8lX3QRxZSVH+/WpukLQnwRd2RJWCqWJv7XgVVzFDcr5vIp/8NBZk7x1zEMMqsyxS1OgqLe5wd+whHpUymKCS8DWy4lYnn05JJQl2J5MNRzaNjqw74APUcvNKF08voOqyFJgrlXhgokU1OmtXTM77oimwvIAlH4J/j9pGvGV6x+9ZXpt5VbOScYEJOj7QUPwr3oYqI3kBxSdRRIX1yWt8+GnKUD5p05VAxxXFplNLOabqbpiIym6iNGU1YMZol3lG2AFRRzj+o4+Bunh6biEk4UdUhdElrptOT5uMMXWjShB3b/anJ0zFcvkKuZe8RoJ/ZywGFASfdriEWEvutnSah2O5MjBdaHuf9dCP5fOt0fHEgsHUOV8vAZ+Nbm5xTc4yS9jt5LWwDL0DG8QlFuVZKsEum57CYZ5SrJ6pHOtB2NIHzauxCVU2CgSiTajh18e0j/8bMi2Ub38twBVZ5upov3h0A3cGxmnlfkYecmz1RLaeE/e2R1ec9lr06MTNnkdA2uf3RhvhVPQq75tWbu/qZjN8tQbhkHt+CLAYm++v21c4QgnnWjfuksx4jVQFbW2HAJhSHyn6KR4T3Bj6YpSHAmYo3bPWgQVL+E1X6SR0j7YZ3EEMrVlP0ma1TKuGiJ4DQEIKxPEwaSi0whFE/SJ9LZHpiQEBQ01GgnVUGv3Dnk0LJTi0yXvEjrhU67qipreEwBkEnQp711vnV+K4Dvh7V4ifpcgoDLDEj9G460gm1yjJqX3JoR8ph//bdxV4AazNaxdA41SgGxK5/bBeJckl36F2AvL1BpCu3Pi1jsrjBhZ2f7A5WdnRQ9PFSMCVQ8iYc7FsPNWF86xabE4l/feO1S6L+uAl9rJY5Gtp9TPPPg5f+2YigwbFqJgeA1WgQCMc0+X0W9FCp72Tsvji+dfJwrJPcZjWPSnuPH/DPRm4wzj2VWTxUdFd1rdP6sG3ISI83zFo17ql6xI+fAyMI8DYq2YGug2Cyb1TJlDMeQ7BITOjID8DVeNSd5q+1nvT1ETlE75lav78fNuRwrhOQx5TtI2y8n5eLBme41UE1RYDBeL1Cr8LPVnDnwUEVHfI5MTXjPGtwFWPArPts8b7OmsTs1i4tcWZ/bGy1eRnieiXVW/v5794wHV6Ldj/ow2LFQw3L237O9bXzYSJO/ElsLloRteItdhX9YIvPujFuyEDB8RlpNi9nOfsqaGE85SEmbQmv8/5zei2KnA2TN+AtNK/9YGiml/j/LtSPWpZW3c8izWOVCWk3WioJh0jJvVBBL9AL7P8jQC2q7c9XMDcxtWvCbv+QAMzE5KInEYtsz7/JK5/4NZQhUdD42nfyYCoMl/2tBjOfICws+U2OR5ahDtudvqeZ6OMtWM/J2JH/goekcZ18Hmx6iTw2WXWsBHFcdvmPWiF3D5hTgq4Y+cmPwXLlEiV08+ZE/aeQDtJE7Qj6SwIReDm5E4lImYpR847w1ezd3PoWwwmb738bThzQYkDmGJMqGUbZ/x7QRgjYVSKNnRWrK01wZgs3OcZ2fmfFivKbinc7+GlLo5cmPttrKnuUSG9vuU2J85z/DIAhyQ9KOF54FgYbo90Xu0j4A6565Et/drOUqGMw2rIRaSNaljXPgLN7QFq4l66JHYgNR29SQ770Y6bBJ0Vk7105BH/cHoY6gxbAO4BL+Lfq3qN6st/ycHpamM3vPKpI95/J+tgspKfshYbc3xv4dt4DOU/iDDErWhi7VeYZdr7mXMnQBlKL50JyGT9Ek6FW57StUdeOMmry17KY7l4NyozbOhuNhwzs8NIiu2mH4PRDhos2NeFnYo69jgjaNBYkvg46q1CN2bjmo4kPT4wHvriBHvuiNT7TbcmN4vwfGJ8Q58Bh+aB4C3jlnF6RyRt+8gjouRpvZe51Cmixn9IIguCmGYPHMHJhAXqZAzNvbTy9Smk3l5482XgH+OdYm9LJsPT8bHM4hAqmtkd6+1qluOtqrRw3ZKJbasmBJ6uWlgPq+L7HydXmSxC2RWCeywcbTX74FyG8kPl1x3uZLvFRXZotj5J7akCr9dk9YmTNBEI+bluIT1v4BUJggsrTV4P07UJNoIRA2NM9XTYhBPifbtqJ1Wp5bMOgg51nD1RuBCqqWBPf3mOwKSUXLLYfpntFmu4y3lMXa4Bj7+/jsXQfm09Lwx8OjRl0fBCjSb2cymg20r0ehDoAVhVl64fYL4A5nGCKCnTVBqKyOcuU6FuLAenYbLPczpuYeghSeeKihq70l5IZkpRzTUCJ3MlVzbhION1PIPr5ycJXsAwCHR4jOhBBf7tm80M6otdfX8UP+iCCL1/klWv+9sPIorZlQUWo1uUUDwT0Q0wLq/ebsVQtNLcBYCdylmfKm7EY8gFF4LyF5hPC9T3p2gVXhVZllhYGP7f55AIbHJjtkqWmSDfnz186KvVa0Iogtbg0mlBna2jYtq5OKOmc8qhfravDx86y48UCqgpEvPDibFJZxRUBAOI/UKTUNSyKuQPswFejCp4ODO4r75ghi+Vexk4/KMOUNlnJjC6VzFadfmeSFHOp7ZDZIhozi21JdgQcv0tb010yXxw6pWLajdD2PUxWW2/qbSvN3GC1uxmGxUpQNEucNHxLzAw8QAAG2pplC1UVJD8JC2dZ1JEBGtWl2LeFscw9Kdd+38p8nbktgGvYh/wC6OYO21rCApGcEQgZAQ2dRqABe3t6a5fgMRzUQYchPYhJNa+IPq/qErhCZ6Igd4wmRs7HcBL8tw6XnJ+OMHKcq/lSwAX2Kfsqevuv1IMi7KQiipf29kPQizqYwV2ROiktGM3KvM2a/6GkuIbd6TxhPpf21zbIYFnOxrW4TBN5+BooYaobL+X+nqD4v23QA/rxhBWgjr4hnBr1AgmfTbkwOeAZpOvN59PxwLs266F4/+LCCnef9gzn18aHU0nWaQDEUyhuFW1tl+VbGoC/cgi+WIZCnObxHB0v2tpSRKCQ+SNBB4oP/E6TgVrcAJjuUSxYMU8SRIluQkHGEmMOBvGfu1LVfq3MEnUFDIGCz0hYPPeNAEAPBo7q5uMqqLjQlxixqeDVq2DjuIMuEy89CGbS8DXwf5I6hHseyFZ38yAyhPV01NALhN5Kefd7AGcAsdfWW68wITl2bg0/MGt7qS+XFLaGg9qFjOFOIssDNZ3acw7eNB64nes2IcfINQcZKqX72MauN3rpi7/pjzHxViKQ82LKz82q9tCqQ80+5NI2Zbj7BcNG0MrnmusJ1jM0JJnFX86QFoOywBoVZpsIcjg2uxZ5OTfmogshImzivJaXaAjuyYBV8V4Ytfi+MmFkAYtB+kyrryHuLkMikNYiQirIYIHCtqwSyil2h87aWx+UXhNeYGg9dW97idxKmFwNzQDNuBcna4hYOvwx52+TRzpLRYG7cbTPfI+7P/R4yRIrzXpVjwgCk9Vh6w4gRHVyIdxxeVpxeACXhBTXISlR6YKrW6CUcTtaoOVjqbbLgFWDKgI63yGu8gcJMmV++H6cljxYd3EDUFTbcDe98cND0sOKgOwfvyKb11vwrBXc9wJb3EubffosCJoU23OkzFYb5hqsvrznt6BYfYLeoOULuNPAT8spMp5uK8XqhBVaBwcTsVchOVTeKJ9gSXvJa09fOYGxK4rRcMtXzG7ASTq/7gC7tCcftv0Jmepi4ucSOMxQZe5RzQwdcT7VyF640Oef0S6cXuLDu3XHaPvBHTpTiQjym1qBOTuNab/slfxoQ9cTs3wbh+k0IJCTfsI7ElGqu5v5Yz4aU7/QYYC8v1gX10RtMzhd6mnpu3RXGmAHFrNNx/h9atJk6yV4Mwe45xgsVo9VIOOEdYm/ch1QRh1pbXyd8BE/zfJOt4yGJXGpS+dp+TAlr2rD/31r7VmmCH3+WvRgCsAj9ZAhk44wI/I1CJRoX25TzSVpvOu8JelHjvNlnd7usfhPtsdcdsf8mpipPZH9dLYDdKI0tXQoIcVcFr2KVx6ExuYyk2HGbsHOOe9TZ/puV0ax3CIpcwXgIKEB5meCVr6phQQ/0ly/JPEMqVOdGZrPBE+uy5W38A26fE9G8qat5qF4kP/dmhCG6ExpzaVMiBztw6fVjrahG/Mur3QXd/AmofWps+7RCfsGgMjM14UNXmPtlRAap5/V3hPug42CwkHpi4STfopdSPlXiG4SOpIvTou0P5omMYILPbSkp+EzULSWCHge6UpJlvbywtrWq9WBzuUmGWwYySxhQ7Ear99kH2mbYIrgzpApYPhW5Wh3myVkzLaWGhTWKG95lIY3xDZX2ryAX6vpcdON3x9N88pJ0sIjoyMzeW6B54Z5BeqzRnU7yUs56jBtWsUx4HAwYmmRAH2b1HWvvDoq7vRTi87mkRVcjkHHkwJp1dHYNYkrXnX6CSvy72GxN+fvZN5P032Tf+oMyodGaJATkqBPwjxLhvJtEEdhIkgrZAtkgcqxnV0Y1wBQqcFLrDWKgqybMng6XXdhfmu3fO/Y0/z/FSKGl4xI1GR3wGOgJmGKZiSJYzMqwEay75DhW08y/PbEV1tUU3n/ylJFLAeS96WEZKYQIHJ3FdwCkcm8VfUvqzCVHCnKt+Ir6BDHYTfQeSaHW3RTQekIF/NDWeUxL4gEAYPQlNBEw6WDp+wonqW5ZnbwEMyEp46myUKYslgdz+dzXIKCa0AXv8uFnKmjSumjkr3w8jHW8fYY3nwqzi20ZPvd1zKcJTXOgg29eAXpqVSson+YabYu2N3eLmFzOdcnaHAYMsv/duaiGRqJlctWH/taiyBmMlWd1tGF1cSrJqqrZ1g8o6CacnrCsp3F1GPLjqpayFyGtQNUilacEoPcblMClVB0ZqeobC8/XDB8nyprsJNh1N1Gh17kctKGpgJiEayRdbh6dI1L8qk6w+JQACWUnmKp+d/FUSQ5yhMholwl5OV3NUQ0ckE4M+fd7RJBdhwEItasBPF7gRa//5FnJpg1AGaJQ2zalcjB0r5kjzFz4jA5hKtM2yYYUTIWaOoL2m9+oR2azIJlrzjdQIgSfqSveiypYrA9zv2MS4NgJO8a94LNZ+EGmKyVAgcHoWHRajY60OXC0cBTSERpeE2iRu7rKfYDDMHe7k3MgnsJlxFTXqDb8jkEJuVDBJ9uNpgwMcAxPBVvVLV5WrwcasSFtOuOiDi8cR3pOGQCMfFP16Ac8oJ738zt1H+DsneTTPmaZsP683ptlkKzkuWsVWPjmsYAfRenkP1mFu6RfExFSVzp6NxhjitX28X/IjskjrYJzSrmHDMS0ru2WycPLBEz7iT+vnnmtwXherkQrRqLqQEpDGp5u05A0jIuHgoDX1EVNoLIsHzZ0OFYUcZLOjNJ4xLOepn0dk1cAe3p/iWtFT/hNhV2xbaVM7roYWfy+nvLqlRItY84MhsxHslyT2y1z6OBKEFnAn17Bdy1HMKA/Pss9aRMqS/Jl0Nb/LiirZgdPTtAvc9f8Lzw8U8ZD3Nb09FpWWx3FnWMf2Z34eqFAfzXyxsCEeJjngZmJRDYzR+Z4lxo3cvQXQZ+U70UJOpKrwa+0Jk5+GE2XLeGnWGqk83IuJ3YT4c5H1LSZuXL86DA+nRS+pmi2OB+fjbxflAnKDMWUaekhllT4KN5sQIeYWjmQN3u/xGTyCQTFjS4AzPyaBTJHHrPI7SM1PGAIZ0M4YUK73dN+rfduQgndL3vCXlfiZb8vQdGDHqHjw5IqA1e1fHLQL+9yMyDoyPx3XKYv8RuMtunYWjdcH6eEUj8FMcejtM9DVuY5LEXUBmp2WfczK03AtyWGUiyZb1gyh6ML4ldNjcmsH3PcfxM3BBjvmXdip0krf4HNtZicGjPg63DNaiui6MWv99zhBA4TCTOFzwVX0esxqZQhDkBBrxVYCSRPmoDUYRfszPmfQyd2lM5YQ/aGli894mIH0Ewlf++Vzo3epMogzD8W00t+QhUnigkICr+TkFUzGjE3tFf5m0Uz17cBU83d4CgANVN0dieeH4beYJzQeaIhkiYLRplujWrCbRUE3t31wH8bslHAldZ2/wvVK12tOilJ3MSjTyAO1vmteHlc6MtTI/Tv/lvgBbG+iCrlA5XTFHhwiGuM9pdAY1NS4LZJ0WKNK1PUTNaQbeRCQU1eVj31FU70xv4RB9bb/FeYS6NuN5f/Czoew/JKh5DNCxps4cHHZcjW+6FV9O4VBiNRYmCTL+P5hCYZ9/ghiv6xA/peqHjkqlBKPDrLhF8sHerx6/ZbJcqZeGJsOd7OxEc1c3tYF/OSqwbGDZTPhuJVYBSQ6zYEDmpqXKsBA712v575y0Cy3NKSg0FzLGqkn5BpzASI/zGLGLftOS2ZJLuULrU7Jw5rIVtRz8nGR5AMfa7pYbikOQXyYLV7k7JnKzolsTrfEaVBOTecy67ABzuDO5eIbL3ygT34PAfreecZBunsO11KOyUM0/0e221uzjiXMQbnRhxUqvkSN1rnGAog0euPZlyEhooxvqK+Bv1GxDPPRSRuEwfLED/IWuOF5lX0gAwyFdcIy4SMA7hC6oTisrmLdzKVoHe7n3JbisoG2UKCCzXbcSMskeE7MxiQy4712nZIkRZpupvJ3hhvVoSoWT77OWdpV3fqnscHedHmb+MP/4gNXvlsg1+OdMPu359aCM8ef1bNTjJzgnet42/L8qZdTXT2zU/RaacxrGKV3ZZ20p08bC5q8Q4UOXdTiy51AwhX10wB8RzAtgcZrPn0ivquqRsDBTtfCne1VSgBO+ueqHzeFTNlEDMhCzXcVvu6jPaYsj50myxboOUalu5sJCSEB/+bi7ZF6b6pm9scxfDhEY118qjfVw7igxtwUQ0Ia8A2/zphka0MscI6ikuZwltgry22050J4lV6sv71oORFi2f7LiuqafRe8vfjlhZIBTVa2gAp5/5u9u3gBihRz3KxAThPWHgKfMDthpOEo//Mjn2Az24kNrJ6dXDqPMCFtEYQgDHTrvAE3pNxsK695NEk6YEMhqGWVwnpMnVTS7XuZ3Pkz0K8YUZN3EMCta+TF5gXrsd+D+99mtByWgmtjnJSQqyq8E3u5090McMCwRpjAbxW3z7heOP1h2XE1SswpBiPvnSi6/WAar0iXq+NW1AexV3wJ1jAQ4CqlrAAvofWMgqmQM0tzECEr/9n0SGwgjmaGaRPo+jKFTW+USkFNamzf2LVLvDAkeMja3hnD/W6qPwbJpoiaCj4O/ZALpDzA6qzpP/y5jkqHb12/NQqLIdHoOPZVjm74v0lxxBe02F8FR634MVWQi5JkLgkWq1TlwyPQBeSR4dcOLAYLlQh5tXfQwmsz+nfZAtV3iiBmZ2SrSfo7ZfyYAo1Ty6u57UgPCALcFO99YbUJBQTZX7EaEZOk/ATt0zqt0WX9KubTKbnFx73JJEDeeYVL3rBncQh4P8U4vJdtAXuhoZ/Y0MxxJQN2uMytxzTYejK0Oq+oqfghvQ7+q8iR1PnxmWpiaS9qqKHnf5o+FnkInz7Rs9lzptgHraBKb+zVjQ/37vEPEZaXXRLUxOar4c/Vu9mKFhyWURya6NVCURl2Q5QnxopXbApiMWeU+TgXX0a4+dleQbj6SkBk10EqDT2/d3iFpMOxuhUp8av36EoEE3pzCz6g59J2DCnji/0E5n7fCEzfHQ1oAQHNCTQXhPynxaErDWviBnPTkeeijVr2HANd8CKZKBJEUTivtQbKedxswlCPZFYXGM/cfxpLOEIPqeEOpqxavuKLZDefrzJuqZZsMTEe0pbsSKbwSsGVtN4E9ZHXABY8iYi6ZJSi1LlrDsObyMq2g9qFBbKGXfFsZNUM3CVauTv80MIdYvxoCV81gfUAInNizGLc5K5zCPrcVTws0Lu3etwaEgEg+Ytcr2L3JSD+UnX3QA2o51U5hmT0h9lfNVqqTzY2S1ZByEfb7wwecVTt87LOayxzYFVDA3YBCwWqkTCxKI0HIRmddWMmpFB4pqNyiIsHTQoPKwRYHPYbjmaFh1RwWDyfAzmlXiIELR4gBuvHKaK0PCjwJlCjprF8X5lUO0IjELmxSRiBiyJ1TBuLFmRNaCS4G9excItFNoQo5De+SyakrRcaCyVwd3gMIzA57u74qYxTLD6pWHk4xDrZzOs5uqeGFYaw0LTXpEZyEON35xeFHt+UJKKXmOpXRAR4LdKFjTcA/lOAzIMmZBC9NHy/79jR+v+Y+R+se4Nh5p2QuyY3gxduInOHP4EujudilZYTharYzi1USFgE6ipa67PQgQXRIc6rMg+/7Z6jZjSOF0PfXNCvNvfl0Ymi2MWisS8qOHgfjz31bqD9S7kHKUMbzWV8xFMiVJ6l54HG/xhGKSqV3rVeZX/EUayBUlHKDB9S2sM1SH+zK8uWvsaRjIJp9k2sMwb1uaGxztE5NtF/DMdtHGIDmCDa+o2c3tBtEpoOHnIoAMuHwd46ZfDocUfftllWNWMUgRrKiX50WXn58HwV8bbZthJ+9QRiOHUU/AH49lEOArZQnbVk69javQ2fVTeUyv66uehZiRG/pRiJtZDxiLRGJwujBS3nYKlhC0hypx/g9ivS1eoDWAYbH54gA5qG+Gf3jvBIRnMmFCM+s2LbU1vwEKfyWGSkarJw6AEhOsMMdA38W2dyntecVg3qBenzWvI0ymMVuGc4j9zFTow90ES48CYNl7ibxeGTIFuHNmlgfdVHxj0e4rAAcIeC5uesnaKNfcW/trG51pXHr1U/GC11lIjkVeBXyy1pFOHt17F8aWK/t2o64qObIT1c2Vw5bCCNrPhqWXjvnafUy3adT6fi9e2z3kBd28/sExuhQS5nuil0gUO5+8QPQgctj4eE4niB4QUoYOS8R9MUp3g8WnrXUhhz/ACS0CVSziE4VT9I86LICUMg4fY6I4VS4vO7I6/K/mU2CJPfnOpPU87kMtyof0ob9rCIVmshmJqa5OXphTjJUb/rEUqJn+fRk0HmcUeUa5Of7SI8BurkPCuLOOK93/6fkU7ruXqgUUvDpqzH2MHwcsLGmbrm6hXfMBDqceDio5v77xERhLgJZEOailrjTbNgUC7i/c6TjgNonE+axDigKYX6Z6C98+a5tiUG6MZRZR1c0XFs6UKSYGc5bPghwYIsVC22Y0lqBnhQk7A5Qx4m2sdumpExeSmCgRjnzr1DvcuSEdzok7SG5x5Kqcf3e7J7tj/mpLCwQXr4J6VSQFD8gAQLNgwcFXsogNx/6ln9e4OPgPHUrxyE+raeE25K27JqT5lT2aWkenXvYBWCgu9r33krDCfJmYcfMEcXovaYTbM1UhDv6QyvlXStZBw/rKcRGOOxuKz8ycHpxIE7hik+zvKGRSep2tDS6jbT6K3eGT8FEbWgKA9jxN9Rb6RhM2Dt1EP+Il28ypiCpqC6f0IwnRqUFos64RETyUBwUr9kdzG6L71g/ToOpx+7IjUUAZ9Njc/WBdrPRtniww1rkvGKZsJSD7OwFm7y4Z5L3DW0JF6Qb/TUvBo/q3rKy1quE0iplIfHFfeNpc9WGiN+fA7855FHJkfHa448Lh2IFSIfsPcGKetl3OeGxubpKQBwf53o1XWy8hHH5nI5wIbUm8NsjgzLFv9/eV7CdZDMxQOrqjtjSpaTMavdAXgoAzXngLAFV+sbYcn3q1DtARhaOFnxF9BOe4quXn4n4hvWLCXVVGAHZY1d/cIEEFc1LzfaeRxZVpuUVZyJUaxDRCizxRpUcvCpw2k6wEl1b/lsK5SgXeOIjqY7n6G3j48IOKvaB9ympgVMR4UE9TuGM4tJWbvoDsoK/tJ8UDhD/YJc2WFn5858i7EgwpcbGvMqdutizLAaOEfNt4kMr11TTjw38xUujzxiyF6c6SG2k5PDF4Tr8mIq+onvvjGMEFAfDjkr0RtYZ4JLyBNAqih+BS3G4W4oYg59Bk1FZnKr1+xenHXou5w254ZXoFAuKuof5aRbBUqNxOCtFWDKllVvIRp7esEqg1q6droYaWCbesi+WK9PjrncDbufgvh62n52W0HYxUMGp10wGTPxlxD9CU+5l82T1Yrm9h+BmVr3sqkWy0mXO4Ky/Zp/sgx7aQLiSreBW/JmgbwBPrFoLe4P7cVRMpMYzUTJmbYV22LGn/t3QwRx9e1/wmbTbiMIf6zVlz4j2MtBhT8/tgiEmFuPYDEHJ4kNA+iDXWVfIZZrJrhftcC+SghrJbQwI6sEgTZYIhjpNRa5R/LnP87QjVfpkhTRNePkgAgNjAINwnOZvkfAr4cukbSNltffw7tr4hk7xhxD/FKuR5dZxF+DA4adSUuVZxNmO7kq7jlPURNqu8scI8M9MjCJs6y3nXALRHjcnlOcmj3jYonZ7FQVaaH91o6iIASIQQT7XHkVM6hmupWEZuG6BN0L6TBKskRJWdYKYTPEDkJAuTV1xKuBc/mfbKAdVjzXweFVmXiSRDah+n6bXo7RzCMY4VchM5B8qnMJPxmGS09JNkZPkELi82M/x/AaRjBHdtw6vMVWrGQ1gvHorUXyCHOyhabbK2t3ky/YKRxGML1+K3xxVMIo+a6N17Xngl9a1eQ9XIIm9QDWS/1nbBdJodZ/KGppharJeiW5MujB0A5KD5HjxGT2dNZB4oU7hS3apdXoNdqcble9dnhn5w0xJ0w1G9Vw3YtegKk9RTuEY6E6hME6KmuBmrbLj3kGaTaRkeck1RhDyjwBMqWcm0AOEi96TcrpLMg4fFORbPKOtNFLyvqR4GOClqzjyvIxyD/UVfqWwjDiHkiKy+uXB9+9OD0mXNqWl1o2hef0xwxW5Wbuo6FiIy3a2Nuqat2OUAM3XxSJ8Y2HcA/Iryx3la61SBDj+nvdhSOC8g64p/QzNWvpMeW6Q5vJPZkTpCe4b1XWOHdeTzYFJn4kr5KwcvUPXb9M46TEmAyLbdiAbF7loVZGj4bkuocCOChRJCgcF/8AE7zJgYog0lqvDg3pZ4vVr6wxPXYUMe4ENHvqdbuyMQe3mUYXHjLoL+HiZNESTOMtJ8P3+0N3iJOeCCQm77p+SvLYisdo2n909P1JCVOBWT2zB2dLK3v/R0+8Kvi/IOsCQ2RZ5ZvBnmOSl+kWXiYxiulIwI6nzBdbiFF+PHzWVMyoWJ8OnC+h6vqS95DXUbtWImM99PDGokYxbE6XVJTH1rzjUKV3czQ1Tg7xZRSifEFL3puVrHPeeup2/IYcq9E2p6Av33oZB/uUe4rkKGhNXYtHYnighXRrwGa1mDxKGlXKm2IXUS/5lMnFIinQkNK3FgSNPuvCmNG7+oAAixiu5OF/aN9ZVlfACacrCE17cDMGLfNVvbtx1phuzfSIJgIzZW+SzXbdlbnTxh7oce5KfA6jWG0OW0b9H+pCLI2B+QES0HR8DpcdL0jiAd5VzV+ov/SCNPthad5NUqJT6S5qwyg/1sFxmzpICdVlv5vExwMumMimwkIaMQDw6VGQdi6g0eri56bB2vG03jg7TCrwjhRy0fbkzT33GUiWi4fTVf57QyZJKigS+ds+HLHypG1F1H2dtfC4TptHl3C5p9ee7kcAPK8HLA2pe378PbWFhrxW/D/74Lzuqcd1nj+YW1naJNzqENv81Rmr7P65kbbQzdPKrNdQGizGL2/RFXe8PtzR1UkawK9nI4V7m3Rp+bVdRPy0E8Ybknb+L87z8uUEVQbth6H0S1BevLPgh1ghdV16V5gZRj5alRW8Cexte3BFyNCUdY/BNTz17PWNOOZtCEUC886EFHeSgxMydnMhXGC21XHFD856bFIw7xMTX7c+55zs8aQxvXrpzc9EsdFnxNq+8cxHQ2avflK1i132SdSQ7ZBAK+//D42e172mZmxkc+V20KDbtdPMrTyWh7edTgbjE10BMaWE7gxV0rLaLldpm8NXL70u3dF3yHsCxchuHcxBUIga16sAlvYBRjgOW+tJsVae7iMd0a7GHD/i5QEdFqmRrzDT0UmiQOBCK7ttrMKCED/lXCkt7q7pckOcs69F8u+BXUvIBKwM+DeN0ng1P5nSFQ62KS0FBBHZVcWUvJdM8SIH0pIqNcqGEp5VpopqkWzSoL2Q03/1Hf2GT9EsEoA6EY6oKvTwmrEKMzM47+ZTYT78rnY6h/3NifeI0ts2FX4WN2p/dzneTNh5EAA/55yCpE55UtOYUPlgRzV1bva/p8263fU7oKm2t6uIMXMsfn0uz7j+h648rEufRAYnbdEsB2hjf+k3E8qgZxDRbS3jMobrGwMcyDAO+fJOGFH8FfQbrS3jg5Z9MWjIlCrmmw/vLIdp2B6jB37dylh9Yq+c76PnlHKLBCnFbg6bP3BnTw+QygO7I08yjopJ6WpRO0SQ/ME+GUaSSbmva22DcXVdjogBRBMspjRN+GvLiiGsd+PfyEF4EkWppU7fhhpFRpnVuE54OpirYnLv8v4UBzRX/ydCFYTium8/EeNVJ28ReLsoWwIKOjYwmxo1+HkLS6nHz2h0uSi7lmPRJKRcBXZu9SgMtI/yflAKN0egGw82+/XFCL+ChXYwUhYPiz+Md61SXe8Pzj8mnBZrl314xp+2MpnaIHu3xk4VRcMpExvmsuiQZYtUIu7ntq+0e/4as+wbgX8oOEiUikzBgDuA2eP8amazAYYjjx1XO53xHW/Pi/q35GoQyt4wTSgXCjsDZ2h5EWr4f+Z6RmMqTR9b1boHf+V7hrNEQbFMydLjXtETGlykwPCKBCSQHlhSk9UXqOqoaR/4jrzolIJ5keph1FOg4qTM+C3ZEOwW8Nuti4JGm7RhLKNH8gqrIQf3fSpErw7Kltb9OsVlYO0tX2KvuNqUQBJSvxchUD8Gh/vb0WBtt8XyhvjYZ5KxzhUpwoB0TVS8KrqXgAYszyeqSgw2pjg32FVIL56GFHhG9YrO06lEzLvkKD2YNCt2Li8Bu/XOQZqN7/S08pLt2gfdCFX9BQuKOMp6BPztZsienGNll8E9oT4lLovOMa8TNTGBaNmKj1Y10Ul+UYZlWH8mw5kfulkKofd9oF73VyZFyu02sUgF8zy6g9ark9hjMx5e9Ng1+v99q2/iAXyRylV/h6inNwHQWbrQPbTg3B7CKlqdXpdLLGrMl6DGBS8vGcdbvoxcj6Rghww5ivDAAwUo/ObsyS9ZJW8LBeyWS8IIXwJVedNaW/4vYpCjG+rKnZTF4ya2AhdeCwLKi7CqdeOq2OY6m/F47wPcdukqVPL4ccpYn2Z36pwPDaLgj2VSfIPks4EYab8LwWJG1EIc4sWc3rsOc3Y6ybjPYEuMUkVl2YX+jiIOIyODQsS07pWBJkUKq/bbMNHWG5MmSUQI4Eik9QnNFZqoPgb+QPXCNSc40mY0Ap6bEay8pad0Wfs8j7fG4yvlMMWLlLGyGwenYXeKmecOnFeGkN0itdD8aEk4uJnp9CY0x/g9cUFBAl2FZfUha+yg7TUEBkOBEiXIH/ef416kMfhO96VtBNnTd5Bx2k8Bgufzr3hBPWQZPBdKRV4gFcCVt/ols+cqEDSmwCj6SJ3MFpD4y0vnfX0JZvy7eKtG/44dKrh6BdAL+ReFPT2uAmPKWhZnsEjPhlo+vTOEokokjWxCBjzLTkn/gR0g9B9ubt+Y15tgg1nldc46efG0ARWIvymG4zaHcrEne7DazuN3InQkTiuBYiHJ4q6x4PXEP5s7qkmuqaQ210CrDd+YBerxSAgIad7P0cmOBbt+6Ype0Lyu6RjXMTuCxmpyvBOGPEhUKqg823A2SVSL4mzyy4zW88rvXIz3c8lUWgOyIHSE8Mzf4I9F9osNHn5XNvjgAqctfOhrM/JaFw5jVZNdByl98691U6To/QRV+VPrW41uXkZlVGDQNY8f03Tn+EZ8GRzu8wbh8NNJVcJUf25iA8xbSG2EZEuEh86VMutlS7iLjHCqOQBgC3pthZ5e9sLH7MQArHokz4K0tFPH9OKJwYxRR6bq/daU27G+AZOC5bLBtmWfFymWpID5TvnRjxt4havKHtbCcLhRo/RGey8eKBEMtVDnEgw3X8Vwe9WAQAwhUAsv65CrUbYFtSXK6L+otZnzWyPkYmmx5JTtO5tZ3dJ5d1AHYE0wq0pSiwt1mcUhol4pdqLkwJTBxXRI6ShRbKMPf4SpvI1oxXZ6bbyCMZhIXTqxyaj/+gEOlalMKI8+EFTO36vFXftTdjlZxPQkWeAOTjiDc6IJUaAkkKjp98XTQlE8lzpLwkglwVBG9FhN5Zyvu8/BoGhKl4GYntrivtYpfnI5UiSSIHXGIIzpLQgaSlqOP0XPp/xu29C5CB6ZEqMgtM2DMlj2dupH9TvVMJAD2MP5AvDn54I4wlvbQzHbK71J6OBuCQmvSkehRKxh6BPtlvH0urQSCEdWgjCWBQ+1JCkMMMsoJk238xpzJWhBtCDu5YSZx6DlbVL8KolIrNg5kc8DahOvjPRHfsZJX7iJF22t9kzYfexIEJ+4KS/lsNvp1gRVQrP3Mu3TBtiwnl/xE0/g18WDT6rJkEckh8px6LKvcb//HD8IzmzxiBRQ+bLhJHIY+xk4XHnTufLU4VyM3zluegBvJcwxIj9QEq5zJTlgwHC+5fEA7bu/621og0cSNqeYSgo0vmO2Tp9Qa1/TbzDhYrhwDVxS4WAk45YEUBDb3GHx3nRojJk/A3x4+MAXGGzGpxRM8bguJ8bSivco6MhsOQtbXjELbeqOu+PrzgquL6TEUIxIwIH8+geO0haXT/qShFwGB4pkB7HsmTCWSmSlA7tvHeFVc5dSiL+utZbYb10TJqwc9+Vqkjc3DH6MmwYUWRoi/JOYuyRDQFiworqZZF5648iBLPUukY97MvNByUXB0XgMRlBCnn2iVOWy5eBd8fgf5raJPWvOZgxoS0BHNVffvagL6uW3YXS9wFPEspwj8FslR+2VMyfZVZ8IAQxZGgMc1iLNYaepUZGMKagIRkMxDbKtXwKFTeYRKW+C7oIje0VJTuHwp2zaW4DG1lWPQKfXEe/Dod1ZnRpg297OrppNSbO2saQU7f9VWIqfrVFwJ2tnJu8M31kQSfvXnoZf6a+kH/P0DTtKgEberCl6VTW1SPRu7YZ/UKzG/Rk6Uk+gcUklSnxAAKPbe0836ZRmuCxQkkHLmQX3MEQ1ByNmr2F7qMI3oTbNHHExm4w+ELOmb/mmyQz/24xQnJImAJYXN6PMrw7vqZztlOdVZPWNpCTdolxV6amejiHv2f/OY/msZKdXLbt/gL33/4embzFHwsqCe1CTB3nmRRc7WVL4fZaZCjGFzhrfWm72zbKJLfUCpxdSfd6kwZJ8ktQRuOXbR/t7V+/ZoRzBwWa5eZEha5nXUMqfVvq8fBG9hjGVekh66tDL6obgQc4Krp9hcMZ4awFf7xQu/LQvR2tqfb72AJHgUm14fb0yLr9Ml5FegeaIKrC1XgkC59Qw74RRghjlfbx5QgbSxDAWUDKzI3ELIXzotghsbgSh4p5+c1WD/z5LP0HZ7G7jFK64NWay+N6aGaHuUavKdAxzdZ+7SaoyEnyUbDYWGEvkbU1XSJNaLV8yLOvSCxyMx7L+tr45If/5Dv79xwrWwOlFk8laQ3vkTHDIITcObP8lPEQ/NSxQne5kGHF0jxRhuyx3G/4jlU1JNRla5rEx/equb/Yrxf8tWXSmWZo4PF+/xcgQzvme2HAgrm5xmPEUilhyoTymC+HH1VAomZHRLbWPFL2iR+afGgUQcnlHnatwwdxpmv2sdUlDqSzxyf6jQVeVk0Q8T7T5A25TJUCNGo4//kjrmG7wlAKg+XCabbzszhuYsgCWT84rKj5fUbvt//u/t/xetYjltc0Xnl9zy3fum+6DoeCp09FM4QyBUapI5kff6nbo1yAjVyndg/YfDtanYXD90wgR+feCq8fB3WM7a+rJNJrPxYjBfjCGvn4dauVrPD8N3zyLlvLoNJql+3qcmFgMRxr3qoSrihKWfDoTWTrQKofGxNQYkVU8h44XASgKLiFAlOPOqnOf+Y9iI9EyQPGrEH0a2aAxCfVjf5sKcSdhl5VbKTt4nxIVcNGemwWtMf7TII6GS4CBwUH8jt2HSMNghPiQ96UrRsk0TbdZ8KMh8CQUWI72qMZEh9Fo+GMgH81aG9qC0zPIPMKzojG7SQ7m9Oj8YvHfmDQ5o+RSORFTgVlcGVXjWuJ2xaERyXDGVwK7xK9dV7qtXVRS8t4hy3qg9AMJ0evD3kN9C5fM0nB0JByK+EA3Rp53L76GV8E4n+EFLm0vxWx5CK9bUu/EqRLdTB7x2Odz57f90oAu20/SKAsSPTXCX4NRCkGNeSZX3YlloaI9O6X/eRRPrMd7A1x2Ai+B3WGC5psILyzT1nLGdxev/Zu9PDpwvGKu3W24db8/mgqU+qwOcardyEaRldx2f7CjUJwTxpk1zoa6a3SogdVnlcwYLMD1j2+PxoYz5xh0atLI3ztknZxn16mAEebWJNylpa+MFjpY0cFuDSJNQ8KQP8tCg/VRtsReAFfyC3iUsWJBDR9WyAfVie6Mb9il3qvMwZMxFWlyimrp2FOrZ1GrbKK3ED3waHzr4E05JxYAXxverwBTH5Zkkwo/W28AushDKUsHWZj/VJqhXH2Byomx6WMnXCo3W27bH4G3boraxO/7pXQBvbjqr4w9GgufO08Izk3CQ/CJE6vFFMbJpmrSg/W0x7BWjEbYxH3D4tKWK2SlO1I7JeS2I9cxXEt4ZZDiGcPZ6s6bYfZ5Y6mubzRabB/gLHibLAfswd5iu+ss4wEOWJVXLSmo8BmRZ9KDKWleII4R+YgPQAcTdo9dUCbRzMgaMTTK6PVNdovRRNIKL8UAtDJlaZ/AXf/x6fnT5qOYuSWIaYJPQpxf7Gg+nHgQtgTqYwJ0zul5+HDbZj1BJ9MMQRjgoqbIoO8VwidjamwSzjudfHGG7VaL6cNnU0AY6e9p7ui7fwhKfRdauQaKs3XcDYGoflLPkh1ZhsJ/OqaXmP60WoqrMzeouDch2cOgN3a4+LwN6TKVh+GG+U8pyVShhsudZTfMAiweacKncVVDGFR7uNBNbqUEN/oxkQjCPAnYvX8ZKDjDOFfPJ7s98Vz6HhlW2/T+fdalwFAklHd995n6Yg893FdIrLf5w9sq7IE8ay+WNOO1ZyYLMY4LhgwaGLYH0OHPrKjkszecjvrurwwgcCwYV9B95/h3/wZ9HuvIqE1y1eQlm5R9dB+rPPPUKidWSYi+r5lWIAWXSLEX7tvUbEQH1HAlnj9Ur5BkaQpm7ilXJz/ljP8q+5wHYnH2R9ESjK4aRHMwvdvFPAXELBIHLp3ofHZ08/VkPH7a2bmOok7z55JABGuEaEMk5Nz8Yp4JYluzGKHBcivJhiGFXIZGmGZ4rqx8vekPu4zYaHPvCXA4ii4MCJlyc9czvAkjvuxmM/l9h3vgeRMs8KjSLlZx3NmkUuc4TOlqEHWaABM1O0JVMoTWBebwQMsW2TNDRtfoqTjKLDEPnQW11kyqzfeMCnNg/NVUR9fId2P/OqlbFkbFfh2JMmpcc/cV4dhlDGP77l+dsGmU3H9DHXvTFrdwAyf9dDlyrYtQDnaQCKqVfs+6nw4GHZzUZKrYgYQzeq0grfUIc/lv2LZr4LDhVMSPoci+WKeok1rGs9+feJSHDzry0r3u4duZjvI3ZhSEW33bIScjW2h5mGB/o66MwRXuVi1RlEG2zubY6mhncBoFc3+BQ8UCmp3S8qgOgLmaM20nB/xHu89Qbx/eVYZahLEUOr2t8/42syJALENj2SGdR0NyQz4yvNQAZeTlLL4dszoIeAtPu5r6lr2jbUOEWuQZu7M1nXACGIkx6trqiM2a2puK2pSArbJiHIAwdv42YchqEuRkWyWqUsbw6m5bOeodwDJsJ1U9+N9+ZGpv7c+pNJ2YHeS+rMyGwuaSGap7G6+ECoMd9R4OdtawFr8vMCqwU0ETTEqz7dP4X4TxTg+pLM9XzDNjzB1FaZBUUg07IITqrESpdXT5wyzpSlOb6bv0lJN77Vhysvd+BCtcLNmKmHes2eiL9wI4oO3jwvRgqq5SXqzaZxAN17VY0+6GB5YAvhUsSxeIZB65HSPvCnvnh3QcEQOHbGQ9edIoJXmRVa2b550BzB4eH+yXBGg4I0gkyS0NV+3JCppB/NW/B/26EIQ1UkKlzgOfxQdxR2ieiuiZMb4YaQpgR7QnKUEOX/JH3+jLbJHjErS+2vUgQWW5ENbh1xC3uud6T4JIOfy237gUcllPoSK4nJCKh6dzeaRbrd1jujAcLJNoVvoJz8noUjAdEFBRly22JyvoBVN4hm5TAp8HB9r9ysCnakxL86nZWj96wROioiQfFEyTq3NZcvLU5mGZKf4ktCSL0YOsisPqLO8iYSE1nsEtKQjVQmqWE+aKaQ/CoAEVOF0QYiww3FeSg5DcOyCZsV7CIGsmq6iKKZTVQL7K9JrRTfn+0edHQibtANnRAfNrbbGaVGqOQNSCmMVGNKaBVOAQgQ6ld+WXPzLHUQ0zSOCDFNpVIeG0+D1Hc67K9PPEUaC9bjvHfc5X4N+HXXDf4keKac/sh5Dt3oBsL4FXFi3u7PSKL5VydQ7tn6YkRADfeRLYfLLZLIMxa6meWWBmdduDYVKud1uFwmnP1MMofcBU+PVoB6ApnypokN9mF7dha/BryxTCaHgICfTwaXv6pRgvlfvs3KgLzsw7UlOVPP6shd8Uk2WDVW2gXcDSTcG7mIGzEMxmwBWBh2fQcc6y9nP6xBaiRJRtjF+whUOgudXutjlhi8LDLy6jbVKOK2rHHld5nLjrvRDEW9CkMbEqEVbDziFaG3AL2wRLhpXU2o5fWfejHZFWIOTU4986wFjdJfMSKLT52hecspoi+FzafYMccZtIUbmM7K8F6Jin49ZA+VWzMZPJ8RtgqUlfAe4I+JDkfVcRJ7Hnduq/yDJSg5nEGqHWixuoyVQSw70mdig4acD06vgJPv7mN6Bs7fJ3bEVYNjSKzVt4QiQXXHRFSWzq3PbxB6njWFaNythFnjAexZrNnIifzB011Tix3IgLCfe5HhMWcGY+eoakChWYgmCVUVUbrtftdmP/BM1xe17kI6Dwg/jh7HX4hXh2j9Xm1Knxu7bVO6XeJYEm1GODMzItQt0OdEiH0pwdmAUHlJleyzp39s70I4dlIi21rIn/Q4437c0nPjiMciXzmM3PGsCgJvX72+gTyzUG6E5cnHvIcXLJ1qnC3orCAVwoL1oavHq4WQ0gBsx12Ktl0qN86elkDPa+l5e6EuHXzalovR/rlKTamQ9xw3h3fY35vbPvjCo88vBJkjrrlZEUNAAivlZv75HchRopQUszdnqT5ci9UEwGiPSf4bHmSdNn4/HaLSQl7zWnnlkCSfQ6sJEsZo5zSGEy63mjHY4RmLtKFLeCnMmQ6lc/kclGYV0zEgQQvvNRigC/LWiT83V0Ft51qrBO4sF2jhSN8i8ne2mU2AfCbW1++3SgUkEDDsiAUoTAojEK0lwge8/EcsMcyveIM76pnl3SHbaUUKILIczc3sO6rl+7IjSkE/LIbiOOJwb89dC8BK26O33O8zDZNMKTbIvGSmAdeZ6BW/oZNl6nQogkQ3DfMrqX6FFJKf42Dyznay/It7di6YJmKRul9AlWkZe04szLBa1D2HMcVIloQ4bwjIcMHoa+QLJq34zcXldU9cNcHpZGdssOKLUetWbrLbq8/E29tkETGhVLg5eHazKyFwg/fjt3PHSlKGFm1rFPgttiPUsZBuhVR+HUeblk1Qvs8mz/mf38EnrFGPSUGvKPJG9G0P4cqL2dRzjGwS98U2NNapmVvaGj44zDWA7R9CmCGIgSYBAy875HejzwoFhhyVoIw0H8uNaOlsxD5mAURnVzRlJ+5xF7n79Z6hHDYrfSWibBOH7+cYS9w9abLoMFbSFtCYZaS1qvX9AMiWgcy0nzXETudgMEosGSnyjuR5DOiIPv3Sn5gCYRWkyn7aSO3RkgGpbsz/1qa5NT0MZkc4CuomksVCcemyWi6xy2pvNbE63aYgDkwmVkQdnll9IHlz4mNJLwHen1rIY7sXYNMhM6fsBgQXYjIhCz6W/antfI8AyCFbNZdTDEdjg/JFZqDe2wGhpjRd+m3/xckxRYBXHqUbwf+QF+mjjxNpb1DT18DXghfaVbAql5olWZBOXzdzynQarnkN+SwuBh7y7tVG8f0FOPvAx/fvvs2uP4IoexgoAwYietd0+ZEUPGrCE6+t4IGiVqVkA3TH2o5FM7OWN88JRpOF7HaqWlwOQv/4IMh9KgTJJ7MtNG3t/6Nmf4uz6gtmh2nUA02qkLEhmZXBdW6Sd5hgodZo9OFS1RoaQSCaDBhjQsRJcfhh5gZnc0Xza6VX9EL8UofBx/eCk8v0BNecQjIOPg/bX1LkgxUqS/A6wIK6G9QQbtmMnopEHBsCBdAad+aPafF4F8UJy58Z1bXq1sfHBBnLmQmPt+Lvcc3WbYjp9H+DDXJNNZBYhYpvkjLm/kMtGIYc0YutTxVEOGH+P0k4JOGVe9mardb6ebhubJXB4h2WSY2zwqOoyIzpWj9Jb067EJi87co8hOKF1pTwlyFbzosw9YP4SQjmPIxDp7yqZwdz27roxXNqLgy9LO/XehYVn9Jg3Q4TmUYCTuLbTorM6y62GXFneB4HUgJKCRJgK2mizmIDgB9+xrYMQ37M42vaCk3LHhUUoxa7e3zoNwXQXlLwifuhAnnrSk6PW9Dm/oXN+MXYzt/YH78VlQFt/RSZ0Nxe+02RY3Y91b0LqsCVRm31zaAjJd9tZxIt3ylZfHw6okcdQYy7OKBYUbGh0qFCxZnyiBmWXM0dJIgNO1A5J/UYqvDazqAkP7nl/lGTXEKghVMWDlsGgsFmH3BShK21BTP831vS6WMZBvIYfEGZk+cCCU/MSlrCHJ5XRRY3oBYh/YwJD++RuZcnlRl7APJlc5/ADfMBcKQ2G3FalnUya/fmXADjlvMwWB8w0+jDRQKHlB4yHQpn9HhaqXuttaFGReNjYdBf9wGy/L+Zi3TizJXq8tEng9+KydygdHHS0+tmqLpoqBW//XoT7JODozWGDFLQPC5FLiNxj8drUDZnB7kZUbANHtbDoQFuLe9pgOHPayMM8sgI/z/upxfvTnci3tQ5gBAkeIfyvuApu71PvqGnWpKeVm+Kl0109U7YaIGHNk/Geop7Gk3c9WpsEKaCL1nhKTLYtWHoDGG2Zv0KEhAYCNEYZZygv3b4Ku2qTz20NwShPmdQ0EKw5qtzuuFq+Vb6wnNheEoGmbf2pmWnnkafNRUDXvVwpv2DYmLRG/JWID9qAcfDuPWsuzlNqXITyFCagueiJMA/Wkz37NaqZsnEy+nXeUrWS3szOP6tBNvnURjOd8JIMNkiTShyILIG2L0NyIcbIFK1NVvV3AOsNHjhl4LlGhB7IOZEn267+0/SAWUe2RD0iPyspvbccWe/BZC13AMcjuFeUlZbc3Z6hoYtVjLpOtoEvC0Dv98arsJSc1OVowm77g2W6nnO8EewDvB81JsTSKU/03M0n2lC7emWbAAZLOZanW605IeJgmgvjiXPBbBEBRyCD0Ns195Q4Vsr2ViYfVXeHEeZjT7efGcA/7AM5ChTokNEvDgr0T2GQke6vO5okCUiMuYJeNf5g73zTC2M7hSOOD1j9cVjaScRVM/Js0F798nKLr7YyPTiUM/2oc6ltkUEXOqfq8utWULGrWydW2HyiMOuGT77ss54ikaw3aNzl51uPeHxooMkkaMMrLk/uJQ6P6ZLcybZne0jrviiPEfeboqDxyctj0IAiZs+QgQdVer8yzB2wUnks91CpjMKeWWrsFVT575q2bmMgRTAaTBQz6SRRQfGwgkXZHM/oL+1WCmLDbO+IBNCSMsPvbycNOiMWxzIi3z1pIKAtCHrjo4lFafiF4LstorxRF+drMFVMKlW3vikRFL1jnjK38j1Gh4/w7KRixsRCWyD4fhf39xPv7rZT9Oww5ppa2W6ErO0VKOhhZRD7eTxkyHCwL2Sub7J36AsMF7c7u0bPIEZAGNReZF7IB1CjqBwX7uGRJwX9KYRa9TEFwtD+AZUmjSkvaCgsW8XD8SRWU96FPOeuoSs6ZqzyqoMAWASDb1SYDlgxC7e+rlKxpGIiSZYvQM1LSU4PtFvnayI3vEVa13kspKylOySu+SS1JSVc/MRlXysUEn49B11u9/Nb6YhplsOn5YOkWAxPfoQ9uIT2RB7KTErObCnilz8HTzugFt0izUbisIPAp7lcPOFdeajq/pvbIdlf7x1TqeRsGlJbPgkq7V8DRgCOAUsZvXh5TpqkAmJddfV7DYERex7Anow/9MLtR0QQZCWa1gdJ6RKqkqSQHRCxwrZBFfN5NVKl/iyjwc4N6ZCeQoblIBg73wbqBwDD8//oAXY40bbfObFKNn31ryHnkSufQy1XJQqUceD2MzHwQHmmV+5sVzILF0WFFwdqu4JYLXcDmqG1PdMnwDU3csTBKCwIZzz94l/SGiJG7PS1qgx0qRheSrmqOtlWebLtQUjweAi0GEs9oIZH8g8ai8jH5kdsc12f5INRDhjpSAB2oFDmYN9lRJIB1lnNbCHAQbgQ6/WLepKCkglul0uz66/deqdBiVoYbD+dO4TOxJFMMKXZQL4/O7vPNc5JEOKoHyUg7mSIjsE4Zm41A77DnDT+RDh7vOyoH+YE+giKqIFz/LHcMrm+R+bagVD6XIxSgZCCe8mRSfMxYq5OkaH1J3Tr0N+nkTZeKm3Ejft+57eG6S2/tBwaz3t6lF2PWzUoEYfkg6Y2uVoqklL2XJsP75vUOZ+NzHzxg0zUy9wmd4PlfpTBHY/LpK1pdfEfI8/ym6vK7UBss++HuLdsF2iuZXhI8lx6inmkiNls/hGkZ2HexQyXF54sRUCNyg2xkyiTwfUGQzTDG39ZJ7JRbXJWT+ZJyAsC7l/LE27Fwngz3eoA3fsyHI/iaVRD8GIvmfJsSxBMruD8gVT8jpVbtA8CoZceCGCKwNun9n37ki3uHsETrJrmnvOKZV5fkVnLTc9eAjvndf/s6HmvzqBswRGpAuezwQRwuUe5vq2MXpUO/x/ETfQY91qh+U1DbsIHiyZZ8xUhSQ2OG5mWLFVYiHAggt1L4gbOeDEZCozLgG/yu0bnZFlXGn2KVzS/5RNmuNMx/4PLzQffFohJzpSGfTYnJSlXJ+sMCL5uaLtLnXQY4YMxfhCB8ivfsL8SK6s5Rwq6ieILd46rOnYl6E/zv/d8LqTJo1enelibHaOl534eKQGR3g/N9vIFcRkdAlgOv6TddSbbnlcBZaATVcE+Kg5o/cz+sbO+JB0HPAkOUPEtDWrHS15Q9Evf3v++kQspLzHwAS/427/nMjnZnfMkVtmRiZM4M3dDFZjRr06dP5XIsgh7txKVzf6D3T8ddJsROdNBwgtLIkDcz4OfhThvVdwoaa3VYKF7x8DwRru7gIMpz1fgKXEaPofcxyxRIXma8/HkgAJCHltHrAgc7rfgkARWNe29gV0C7maNjy77MHWS2Rj47ryxXoQE+FqvdYlQTW4iBWeKEo8EvJFfn/waejNsT8N2UiTLy7uAtWoOr401Dp4vgxHBzwVk4jC3oyDrPEXDggyuWwjJWNxuKL2pvUv/q14bewoRcf7RgAYECwvUmRXFjhAY5in/6i8GLhBMp9jQjfucMTg0txC2rhzLCCiRein/RP513WebF7E42OM0WYQeN6V9a8zVoMdmLc84TOInqSwCK0WZn8OnL9sd6xZqAqOtD9bEudXSf6MtARXLXuyh4s4J7AprouBm+8UdU56Jlsv4u4kxNdBV5/4Jov8dg96mLkO8FgPP4Nlzaim6spWhXyuntOrZbRkc+uB+ynoPZvboNPjhAMjms7NPliGqpqj24QHyFkFzYwZUSHjOn+GGDrGVYg2sATn092/8HkpCgH2Fbobtouzj5cuIzIbhxvAl+N9yySx63pXmPiotRW3ZYTXJ2oqIE3CxRB6xwvq5wICJkO1TnQCFKgqWNIfzk+bWAYYnH2qHpEIKIVsljW12V8smCsOqIfbh/4iAyXOfvEMDdZAYP7oFszwdsmPZVukIJHSSux30x20b8yg4qMYdYsNNxeWdYHwN6/ld6fKSravNiiCmj0LENPlxl5CM6nURS25lzR87l0rmvT7Ze+pOvZ8w9jUKEqXId6SVvCOwtSp3xWQYnqIiaLHKSLi4KrRZMQDQZC6PS3Y+fBXViR4u4L2vjMlX0OkOQ0PrDbi58iuLx7a3pODntXhJXgfjEje/c6nTWydxXUKuE1FZoD3sko4wtQ6Grjq59VZCeFHcN2Vo5LAqwiOnmrumDSaDDaH5KDg/vvnwwRAqE5Z+6w43scQI0wRpwm6Ajv1AkK+K3yO1H8hoYELrc1DpHpirVLzwMU7dPig8QvExVBgqCVG1pKlxTCwb3CRdAKM9ZErTBbYEuBgKnYDlO7M2gtsLqpMN0wewA/+Er7ZjVSNkO0uIpORk6Ny5zpQNN3/IDT+7zb0qyD4bBFNN9mqUzDZEnZLYBhdlxhZMc/fGONWiW0SNDEYRrhvMYvyJHqzOKsM/wpDaYf6xQGzN/EjYT77LimBuzK1RfseVScxpTjNYsDgwjsZ8YZyw5maPmlP6YxT+luJSCcBaJqYizTQOae7zBpaClxxXTdnPjA4V2+htvOosGksldn6M/KLy5DgO2FboverFG0cgLGV6t5s0W7X3+WVtOWCVtsEWI/PyS8GIu4e6OBc4OChzR4XAEILXRA5Llrdf1F1XEu1m5VDDzlNY5wsII+IjubaF7cEWiV5P1lr6KqFZn+Jjonha8Ba9Ti3LEpfraCrQJIx3MwSF9+2XwYuLvPQkI7leB8xf6Gp6VAWvECEARiyHSneDA0Fb6vv1q6w/NjKakaL5rW+rxui+lS3UJdlPBZ3Ijucd99Oed4BM5P4hLmsTjjf2dH29UO4xvc6lvvVmMXO/RwT0CDo+YkLip+etIzals+mxZP08j+sXWHpaxySMsQr486I8loDsy7iwQFP4WYj6L94Oh/xAR6t02aPbcofjl0MV3/VnV3IgpIstpVKVAAxzqQzu6Jp4uD2eGkpqR0aori75A5XVwpFy/cWolmF33tvrpeQFsEqgi/7bbTdbEAw5VXaiCmyAgxuQynDbay0OMZwkqLX8nh9xVazijFT3b3Yw0GaZBehj7aF82f3zQAG5mzAbQAW2ziJut481cjyaup/sSpb9sZ/kg+xgQMd64iP1dfsisPEc03VeFaCkgY/jdbfpOW60BDuYzHlN+XhuZtzQ3E4XhohRgNbNOh7suPKlGChBEdCdURVtVUL3Z/8/23ayRjehObAUrfGILY4kMK0WzRW1h1tZrpkss4Mt4d5r3xuRNk1m6m8xQM6tHn+86e8I87x88SjLGq8dIxYl+N2bJTe7HijWXUt9Cl8WCSopL8NOvxNB6piyN1YRNcr/g/weON/Trr8Wij6hsknDejTmaTvWJcdHE6zf9HSa4YTohGgs9/3X1BbU8zZcXfBo5F+ACqNm/tVgYWbrwBicC2nT0W/0TK2NQdH+hJYC34oCG/BQW+K0hJBcWKHjl64q7Ltx29fOPSXAhvmLmR4oUa1x2F2PIXp6Mf0D+fMBgEXuOWkz3TGI0cIvyBtbjKbZwcciXu9TmAXmFoy99MYmY3Eu4MYJd+KNacWwbEQyXLHNuZrgcLqhDw4QTnykMqeKlZj60BMBYCxlsQJcimTuup1FjarOlD70ZEOI3wBYQU+74mfRFl0Njonf3Mf2K2EsgM9EH+BV3eJU6Dsk1YsItHD9u+rJ1HXidF7tXWoy9pLTA/5j30qyMJbSiq4bfy723Mm71IZHWn86OVgTlOdFvfSs8S3mLABu1VEMZv+eKoF7xqUWR/sjAPgcCLdlRViYMhjOYa/c/I2Ou/1jVnfeAhx2r4WpeNk5cp0sRTPD3WvCPOXXJslNQCKHhAXIdskk99I+JRWx2VYhhfHQfSGIbV/7bvafsFktAFF19WCdHfLPMktJ5Z7cKE/nhBl8MNjtqbAt2jc1yKaXuEJW0xhjaVv8M27LbHyVe9eiFHQym0hr0YGLIxh2HpUTTKjc4zwCCvA1DBRrChZ+54VhkswpRmMoeL39GSFpraEtpB0l2k/vq6rqiK60YJ+3IQMIM4TG6s3F94TQmHTIU6z486+L7+U2K6NCpCF9NcmIFELrNIlWTJKcnZUh1CjMp50qgyVdbaKrfIizPeBdwlTyA4R+h/y2txLi8yqHA2Ve7hL7+Z95F5Bm+oQ9ozpSahuUqjNEpPX8vxwFhQc/Wl52jGwPSDaucU0QfP9YMczJwQmPTg1Q11XhCRqeziNe4NtLDnGO4YkKauJI++cELO4UuuMDv0HN00SVwrENpTLwZ57qtyuUoBpUBYCXLqPeykVzNYuUheXnz+vXQH90EIzZpbWLi13FIb7HpO7oYRoQX5S8RNaFM6QBKmY0AkxsE4NAHTYsVpp82Y3/zwkuFIUxViKcONTHstCNcGS+wLUrl2y1mPWtnkhgYEI0nj8XZZbkIBTG8IjGaMFxrJbca1tlaXxcQgv+nRe8meE0+MdxSoHMr7Won6Koe/H+8nkjLJWe/MR2hlHMnNeWqQ38KjQMTIsiMgiH2tfWZP1TlfMYh7hw/CsiyU1lBXPWuYBDDSIYkplvYPTuQx6ROQ3Au6ki7XNVMdF329+83dIt1LYJAanf6VkEYTLRznxsYifRELLl4csonjR67STSKKXfKyaXpj7E1YXalu1OuUwgWAbtW3jqXSYUGsA1puIYOTAVqCBdjNDv+R5NMgT1XknvG5cMuDDJ/9rCLE1OiVJrtE9pQGZxeqzJ/J/Kn00mMXnnP9534DLc/agd9KkLO+pcAczq8O17mTTFx0+Owf8RAUtoDwOFqF5Oz31hHn5xH1m5dpQuPQ68R8Iqk7uaGXAGIqsVMr/dbL040JsbTyCeoXEYhV/kqulYXv3OHK7igTvd5fGfIn6cEBdo7nGg2tx5EHAUjhyQQ7AIXEXKsyEdLqVu4PAkl5+m5MPUAurTcCULQHQqNTVDUUScWz5qjHkK+JdAfCH4mB9psTkIFVDDXnY3EnbAFW6IIvCUhDQmYDs0mQmFGrRiu6LaOf7OSwle3h6F5x50f8X22pLvr/5XRHP9rsg1QYyvOgARV1HLT8s76ZhgE03QlH5hiKpd443tHwOAoDG1Qst9gtnd467ahO/9Jaa279w8aEdREBMtBswclN5n1LEQI2ksRVqHLmIdsD0KNHGYDwMXcOuSk/EqbsdnwcAsUmyblBXEtO9pQF17sjfjXo/+Kkh1ujJ0rSctrGUAZQAItPWJmhUpqLUgGcM0znl7Cisl2+vCVzLNielyzqaQsG9gaB+qaBp9tg57zR19jciRxEdo+WmPsFn2NCLK73u/fblSf9Jv4VCazRMFkeiYADEq4q0CapO4nxHdktH+8eMmwTaT7Rhr3zmNI6jkDYWMxzSxhESU5McpSoF/xO4OvZHInPu4AGr48kcAi8Rx3nosbSpDBgpwTPHcirmcy4awpiHtGnodMhM+wMjuv+RAmUd1Qv0TRKlYkyAOT3OgAiOBEQ3kmawGoyLthsS042qVOTsAEz/cvXtR9OEqHZ05riNKX/VXkStq39uWrGLui2dltLOaIpX+pee8hqXgMDB1xBaEt/H0gkePOZrg4yueCcdETHQ0C22XbrLE3+dlF2+hPpLFQL3yfuygd2xOiyLbw2JSkobR0JJ/KskWYvvwyKSiJ3pAAVqYcGl/Lj9ZRuSPyZLgsxGRD0qY4VstuzkpzbhF7HFjTlZQjWqxn/BH4qtYJJR2H/wCa0Og5FuWk0Mu9nm3cX/n6jYZ4lwPh3EY3ZbjfM8NX8o4XgKXqYTeDlOhNlmKV0gNrmyDwiPHA5IHWmqXOicvypWW2iKBpqCOgY1C73LLv1jxUhd8DOpLra5IFoCS5GJzTK6i7VqAeVBQPVu1I4ZwUSGrM5VY79ECIb0y5m/3ENIfc8kipLVKI2SNPbwdmARKjLD7dqIczDGgCp1/nLjixAvx4e+4WMg0VA8s4tvkRWb3JxMZRVOODkIe25qsUFzl7uChG8bcfMmAFo7YR6cxwQQmITZxAwO9mfwBULI6jpjvDIJ3njYUxFnprmQAjkABBWOEXy+0OqQQignqcMzs7bbtitI2V8bLqvXGSvkYbODWqLmMMaoHroJbBy1hriF/qFeITSWo/b9T0TXCwwU0i0C0Xd7OA3wvuiDltn9YKOt7lLIJdQMcAGlBHf6sr6fd+mQI27liAmGkPkT/PM7x1vDp5MvAOi95R/wFGSGY0A0iNjYtpA2ObfAiCfEbrd63JjFUT5cyJVejrqHFSj/6JD4Wo1hzmKtS82zcOtfBXFUBzKH19ltTcPIuWf5zghVzLkVai8N/gFa2aJC/CiC23Evx+SR+iQllJSvJ90WvQkVLeBXskKOe+sQgZ5qmZmP64Ddc74Q+4+NnNkKuIUByJVWZ/C/U88eHDx+3yB8y+2ga/TC07VXh8qIdfH1gWeNRqswGIAslQHHFAf8anXVsKzK5Ur7y0ijmhSXx3g2dtwGs05oNSQdMqmHyPTklqxcqUm7A7gIOiG9QFEqxRQvpSP1k1PLbm3Sylhjio5kBr8Ae17aYS5U1Z6YmDPm8XSlD2GeWl6jsdOSCllqaGZ//Yauesf+Apij3OnVJhe50Nez7/9PJd500BtTg6Sa+LtbV1yjoPjpF31S3gf/WQ02Hq8TV033/H/eaav+cpZ2TlpVcVaRAkZnlEo/RSUPw5/RPx8xEBgpljLoFznS6Wp5VJiaMitL0Lzvkqw/niqQaWKw4zOas3oEpyuqEVyO6gd+/0M+K36Vt04yXarJNg2aODZMPNqJ6737BA36yg0QCL/tW22xJD/Mt/35580Bgn1+JwH8/YUi38xPR+PcB6ohq6QbwiVh7sWeNYIMv0rlnIm/tF7tqdlu9wOgIweG17zHTN5bMZvmLMv6eN/1Tc6n/GKmoKLGUUAHXoco4WeIBOQT2v/NufvkvL04PBtwKoYHgqJBEyD5b9Vk9NfQMOHcF0HtsjfPn+px3vyoi4mqnkr+hepXJRRHfGujEn5S3Z8kfOTmoZ5rw6vzdZlrAwI5FbB7eJkxMNIcHo/dSMa2V1y+BvwiUOndx5xY/Sc7yWJNwOr+1y5ElgL7ukXlPrOFzp+qv/33BGXUCIvhR+KbC6xH/Q22bww/4WxtsHOV3VvkUvgtQedE/iasHfQkixMb0ZBX7SD54u+LeYfP0/qY/9IWO6MhY0e97sHZILwJkhICfrRY2bDsLzm7q9T48o4Zy/FDW+k6H+tP027DXkZu7BvISjVfjNs540p6JncbztmVuoBvpbDet7oy6QF/mb/wG7P3+uhqeee0/nMP4L0cead21EVn7gdq4/+5/pYVZfIHTIRnJoAEL9eZ/Xd9ClYSkf1Y+Tl7YXk0+YEddzx4cTHwqXoZgP/Soj05YZVy9gZBb6Oq7QLJkeOC/hSARq3b7Bc2pT6+oi1D1P++MMkMa+a/R8SaehDDPFHIsvurdlVt1sYjDp+EMD6DjN6fCAydl/7VBHfzbpDP0z74LiMXRmqS2Dupx/R09yf3V6Sxd/d7sWfvengnO/wj9VR5KmupQKOz2QDK4+L6BsxPSsO5NOm3cEGaDGdCI9tHlMEX0E+7pueHh8FbaSl6582Ctr3Pc47MsKlNtxUmpC75LHA9YJ/3ic2C23LmmbY5FZ9XvS+7qVTTNdND/3wQNWXxENUZvxKQNsLqYWpE91jHQCAp0vxm6E7+xoC4NwfbU5w4GXmBfGqf1/CT57VUTf1tQxSs5PF3WvnCl0IIVQuX5MrN8CGeEe05nfmgvEZuJxbechanAvVlWKp7Ap4KYmoA1Idg4e8R/J5XAHjvc0udTo+Ef5chBJMoYBZRp3wxibm1fqfhUOmURF7T4X25/V3FAgaTXoKo2l7wBp35Dsdnp0CS1HMg4MqQ0m17QKd0C/jEC4VzKO2HrFv4Y8yJFg2deW+vSnSgdJAJ+Dr+kc0wamAzUIHv6BMCFQ7vNz7h0DCN6kM10pEU0CiBse6n8ceJ8q+/NGn912qfIhrxtkwsvDw9RO4woDrOChOaMAmp5R2VwIbDduuKBrgYDoC1rEShKK6YV6g2toDQqHjNGIVluzR/iE7WXKXR5T9uv4iChsaqA7qdzB3VMRgFoRHMKrxIFs9Ep06JXN6TSdhmSpebPskufo70/eP3SWlbxkp8Em6MLaOSKF2kmo0SuYl5jPxUjeqZSiE21FZGsuijCHIiVe6B+ZPEs6ateoIiyP9AaSfiEg5W++NkQ6oV1ql0DCzzjWsdcPhO6EutFq1WSBwdEpnLtpLmccneiP0DAWsbQMuvumPHlwQm6SK4Or+F3y1/j95YlnLyXwvmrLfQdhntPsdEjbOALY0+favaISlhf/S8WINHd/nGfCbsnAzu9QVDO+gHC6z9xChRT467fXIq2pAbP9yJFfGzNiovdBxP5trQgv0JUDN84b7MbXynbQ623ADhkbQ8tAouzyQqQPEBIO8oE4Ln3zePnx1fsqD7sPGwsRA1QY/qt9p2VPDKY0QJJqxPGMR3z22kNJFtcck0HiMOhz6o5UOmVACAIkUwljPueE1Ht2PwDWYrgC93XNiweWphXBboh+w+CUFlN96w9NqmFYigC3SQI0GYzIVVtYWWXn9zO+1kuYYx2y/UfNpMqRQgqV0QveakekE8tHpMTTrWpTkMVzyVKfdLDjeNUrSI/cXl8hG1qtlvYBQ7UFc5PxtiWgLILkzJBiUTRiC/g3EQr6om428BIl4TJb2MHLO/F2ORt7NEYxeCKYvYD6mWIlxIO7klAFbnKubphKgh9DLeAsd+puf4Wy/xcNTHV+jV5yOuZgGpad31ygRR+yDC1ruvUaG5SPgk2V3MiG4K3yhLp/FVr3eVHU3JN3ojNFoBGbv9up5EBaqCgf91aWTmM4PW8CHhcaJTwrvT3O5axrPLtG55R3Sv3+mpsGi+YZVsx4EajMo9OzK66PZoEmp+NrAYVBlXXASfsQ9C+0PvpAc4mDGetfxRErspTDLOXW7s8IZhYhSLRaIH8ScPuzz93Nc2lw5qE+41D+2/YKrgv/eZWzzzFlH44/brs1oTCN2j+HiZBNIDkhbGzcnvXgtc72tu5A/2dZ549B6rbgEuKb3AXk9rOQjdS5/klwrkIa25WFDPUKQWTY134WHpnaBHFHNWaYwPE5M1T8tpqm+ZqWebNsKOnTZ10Z8D7YntZQFMAZWkBG1sYo6O+QA/UymU8mSjxmREr7BKQ9UTk7hPmSMQdAp68v+C/jji1tjPRc4F6F8tltZKR+XqiFPAOktwacYZu8lBadC/XNEQ8W+J8hg43dLo49wzE+xOixMBjN/R20hoa04PSClzBx3nSOI5aVORVk6JqJiMJ80naPdJWb1fbpMvueUIscJrrM6Aab+oYN+KCmMrTy0zSip6BA7BedpMyyjAmfBqX43hl3HJCgvgwrRuEGaZEMLqCqcwWh9jAdSuH/Sq2paQY/7PcIvDzL56ruHi+R8vg2pD35l5VME2HiVtvdmaYjrWTfiUzGOWFc3JCY/kaVHRALQgqksO3MLaABvvEHQYl5eFmYj43Lt2EqTueUq2mq61s6j6XQKIuqjKBiZaR8bp3p1IFa18Zf1iFJcf0+RGYijxV0qVRaHw5bzFjaBSV8jFImT5eoGZLxXkhzek9LvRWU53Cw9P+CgRyJ3dxsNkLoRh77GdzqIHQXobMCoUjzKUHgjii1Tn1AsdE7nU9lX1UTzssYQR8nQn0N9EGNwpXRHl+sQM+MaNZKhAKAzirjmEPTBQKz2y8lgpVa27WZs7Dlz0jRRSXeymyhhGrLMkhF8sqERL548Kc00p2KxzurmBPVE9p8TJ239ND6a+iC7ifUSPvWl3OkHxjdHD5xGyXvuBtN9MRiOUYL2eVyNnhkIjteNPBM8/m8HM5uGMzpfyz5odT5FRhvJMI95zBWbO3+puBPjHdTTNbP628HbnB/jI5PGFG0wytOSPcJP8nj8wGKNELmNkDsn5kqc6iNxTfWzZ7p6euGPMprzehdlvaEVKmAPLd9ODUOl2yueDLPHgAo6nN3gPi7bqVWn1KSsqmytp+UX5cOaEhR6q+FisDGv1BwW7S+N8fpRSRu21hevBuDXndUNb5xd/6fh83qgaYmvNX9UC8w2EpsH0xo4WODfcpYexPSrQyj/L75o462ifOGLRnIf2BXemrLdBEt9yHxy8qS0+brnbOjtLfqKXSXCqkQ4mM3EO2LhF+gGflg+yxJDNm9BT+ZbbKDcupeB6fQolwXdXMDgguZE4nTGK4WAVQL4hzKOCcPbl3ZBlXEYjkB0kTDkRwqItjt0anr9pccu+Qb/kwadwVdy1CtMl36MayYRpqJSZzy4GLnXrZ0vMu6U6vBr1DSaSmraL/zuXG1B5jjfog8EKxInBwQ2QUr6xpRyhC1+exNpONtT7E88DdHVx9OZMbYyjz6WIA6ecZE8k/kA1vpht7rDCqMpWsa277CCeYifq16uWS0IHWr+0/yrU6FEahkfo0XecY9xkZz5+t0x6L5v8ou8sw5TljZsc/uKlJfN8F8y3niGI9+0roxXYbko18AijTK9W+9zjZ5QP1FBoqxN3hKl1xQB8OzfOZTMGYvd/Zxf/l78op1IkLrMz8N5stXro9Iiq1oT1dfL/BDdSj+W2OMO4zuQssLQOfk0mEFmSXXNJelz2Ezk2WpzjcoKbfCDQj09+iilNwBSEQtQZ8aI9pY1pTkZD97olw45ychbcgJ4UiHhkLe+4zFnPd1ff6/g15Y9VV/CucYb0clboZQg9WlSp11KQDX3r8pi6Mm1e0K5cbznXwVVQHnoXiz/LG5G1yPZrN+GpxwesD67nILgoD61G8MovqukhkyARyiJ6KAwc8hKKXY0N8D3MBNzazb5+9rtnccMPvJR14SQomT8bjIkwiBSrUJlZtgrdMy+s623TpuBnGf5t3zxEwFnu+3OiPMOUNFM3ynpCwbznbfMH9/ALwJ/7AxorwEqCBy9fqIAdwa/mXM5jkgC4op0Fb6pmEFXP2JldpVNiHFwKX3Zd1SqWqCKRHXNYcRIovBsW2cFPEzID3ddF60XGvPl4MyDk1W6J1gM5F1twoBKaKoxCxT7lP5fQ1BentT7ZIzcewezirFrXF/L9YWRMXzN/Wruxky9E0vdymv2nIwCbHmdFPJBg6cl1zfNtEvI3kx3mAhyP1elrftA6lFZKW+ggvs79Pht8VycA6ngIllehQHZhT1EatSjsZLtUKSB9EfX3g82jHh5qwraKM95HHQi2htPXXicI3PLnRwu2WyvMGlc243Juhak0y6akpTwclgdH77sUkGbmtJUcfxdSVMDgXKuRo/7flqCb/Vz6KEvpgDVG7PJZ5YiWpzs93g/Iz6FSqvzWTYbVJy22uj75WVSxY14PePmpsjbDWOM/T63qhc8sfQhJ+KebzAz/ImcBcXZ1lSbll6UdJSO8S/Yxe8AaA5phtkLzx3sMm5GNiNjoGNL0uckmq56zAi94C9y/5xfQStPgJwVjdiESxDcw4cE4IGkn56v+kNLmMbAtbVOWTeWJHUMvNysfx0wx7SfpSDcWGzZ+6ZvZAtZ+VZ7LNo8QYUWUZz5+Od2Ka5pY02dfC0vp/PB8nsL+Jg8ZyN+W+qbWSMoJLvmP0nfn3rwOdNigcUKO7Sfnbict2PwIlSzjBJ9VMq2bQGIU4JKZEQRGjo9K86T3yHfnRTQGZpEW5MpuF4dnI0NRrg0Ds1thSIZDp1tZluN4gmgUF9A5W5Ra8PGpyeBWLYBiy+ZrSZghoBDGJEZi9leeYuSi9cU8kDgovffrWH03Z4hwK8SJs1beZqEeSkyQDxr2TC+iwJXZ3CbfoKwSDM/o0/BTtO/xUwc8llt5L7ccwhfPmElbf0Vv3fROQoe1JVgpjGqo2mKQRHHWXlytsxNgTDf8+PL/svb8jV4e2i7yNvW8acSD4P5/LGDNK4wmOCJ7BdjWhQJPkrPjeXgeH2IroZYilstn4l1qd8bbuk6e08A8CWnYlndvRCKpw4K09K2wUNMsc3M1emeMZ6TXDzF2W1zXcokAiQ6UmDWC47ikNHfaYYV79OVnV8tcsXXllsW+Xe0Q2H1o+nHhWZFuQ/kuo4RFTuzIvYQGEJ/eKOk3zhmw+Zi1RKXC72hcGpgYm124ZRgEJ5F+xDZ1w7glBHkc/lZYJoNVh96va2EBq7tLI78vkkIs7eRZeEkdmuOWGvxN/8nU0XzlNn5+0709gpJVu0qmnmUrKTUhq+kBtaurVHPmlDhFQ3gMabLWVQBeXJfpKPqOWSuiQr2GCuH+7jVtsuaTToAGM8omKr/RDbiJQP9GKs2FBQfOuYkipjB/Et8dhXPcFer/EHXbcGI15n4tYZ1XTF8nVOPX/1PYcx0KnIU2XD8hjIk5JzErEOMJuIT4UcyeM9VjTk9GIDf3SfWOvST0v4YEuEN7kt9B+Md3iANmTsZgBjREp7tvUSJE4monciM78GU3PhTu6yyx07B8B3Ti4u4noiFkPPUsJxpyvpCtNX8n2Carl3sA+X60wKgffw+QemZL6Z2UsNGL6dBTWfb0rkJCEPxIEpA3g6EBQKmAKByLIdBXhK6hqgQQO1M4WKKIkNjy7dHWgbdrZoQCioTTGsIaZKAQ7bw5kRvLZk53UxuRFSBO0CWMatwfwr5FL9Gsk1VGVH3pimZDCFMLibHyv5yxFaS7lU80V/sj8F2tes0qVyX9uYlCrYLOhrD2mSsY6wBKx/h1fUGxcy8pDGJlkGJJQJiDXuRXXEEIvwWN7zUFESXn/sCjE+Sg4ameIzWecnaeTsit4zdnvCEVsVhSZM1t7A6TVuy2r7ooX3ntVynvBELucQ/w/PYq+DcoVKlKK9ODQhfg3jowSb6gsrNCDoUIOyYzyn3fa0cvAWctbIPKOlU0FrYdjU9ojkVbQws7PN/Bxmd0FVA3sLv5nG0mBYvwjTIJ0o6prwhBWNYhmkZ1yMEANZrd7IcOPJe1jtsm435+i35kOUVdzaQGY5m671/qcec6qqffGjXy7TRkW4n9yReF37hAOY807aqy193xQBh2S7dAXt8Hp8EcnbJ0BeOyh9dc4xrM9BhaLzf8wxnRAj9zO67cVjoevTsilNlPi3dS7ICIgQTRPZ2L88B2e79EM959U5ne//wnrZD4hHUljnzb7GEuMaTQSbrtwsK0+g4qU0+AbewtDp3YWOUlvtCbd3qzEZlPXt4wuUwwNO6Nz+j3ry0nnFa1SXoByMh/5tH2+bxZTq8xhgKWTOoSy8sm3f/VN4iW4mV8tie2UAedvqogj+LZ5pi4IGT6OBQgh5BauNf5G+3cw4UNS5izf20hJnQ6+GRROQaYP3UloG7oBc170jhi5RjKyUs9hFBL6SyrVkObUYz5pEqJVCHJrcmd+Ws3XbkMvWdIE9NlGdLKEs6/9/dRz00juwscRjHi/izZbkmZsfR56Zj3kN4lv201RD70uVtk+uGLfZbF3PJ/Lh04JYHCr3HNdRKWrKHxLGotNyPRIPukgHyqsc3OHo0lcUdEPInGLimbboQbE2ADr78BIGLKZtlgy7sRiH+z5+ams2YvLX2yOprEAxkUccghH5BUzxczJ36fp/6vT84EpzzypcUGxHwog7mPkrIUootvX5SonIhxdr/pLAm1/gini3zo/g8flhQGicsKffdkxvhXL1lHsxIRRTBoLwMQEF9TXvTugahCyi2YSdvx7RGTkN804qXqaQck2AatUZGXt219TkqGRq+vbWAr7VwDwhx2g5SgesBIwh8l86fQgXjWOrRl7Sik3y/7fVwBSk2MZ5+jyXrNqoYAKGHTTKeDJOulBnzZZQXVlmlgDFxVkgd7npiHbbj6bywUOQUy+p7nI83b549TuUf3F38GCYPfyqrWpaxCAy4xRs2erdLTm4qN/DzWVwcnTA0ncbNXIZ4DDAFWLZGEsE33eMUMV8+nNeVIOqzYIieNC8e5YYG/gr6mR4BmC7w+wwb96CNY42fLSxRIxN7apYaZcvxLzCGmECkpZH76mmXhnmRs80zpnANlnWMlQnWD8zgA9a9dWb6RukDmxlud3HqQl3lLRoKfGE9kS9mK1KNQTgFGAiiwQ+aYVCMnJsWK/hom+dhX+xoS9J1+x5w5qBOJUTlnkfjRe3tcwlC2dVACCM0TlLW/GF9ZrKQCzoJLEGGkhqVTc1gwtslqY2YA77Q6gc61TBEbnhfCzlwwutcGggMigza/+W4cUf8zJ+GWcCHZv36hqS5Yc5P8ctpVENu2ZSmXrvFUpMWdrrfHyiuzW9kVZD8COTwjlNJrTKFQTEbki9oeOs0ILIq8oxCSYWf8y71K3EC+xZnPEX14nBtGmHkzd1WLkWXLycjzk6mdOqbHHzHWLOqkoGiBMD1F9z/26MCgNoeImvwPCqsRqFb6t7Vft00694cXdaLTKAIIlfrW5KF0WOUl4QGg7hnVubeGkYs5jHfa2+Q9bKav9igHfXKRe/CUdC0HruWh+9m2gRVz2UlJ3/rOGQvMIsODIV2fTnAaSc4cZhU+yPGTndZEF5CS6X+QlAzgal3nxxWMCHMFniiD/t8HCp+rjbe3OVm/rVyldZ2h8HA2CWIZs99rsiPVa8Xzf5tWZMMG2vkH0FYHVxqB3F+LJEIBggAuiFONfYf3ttWLybf4Pun9n0TVAVRBmNb+h/SwAayhLGetLM0wUJR9X+uAy+nzKTXa0Po/dKOQsla60Un/KYKPhA8LizNGdXrfVj3QVM5G5ShvTh8cM9fM0JPnlBP81/PwqJVUPStQdDtRYAo7s1j23x+kaYCHBUUnOY/qL+0FfNSM46AQb6Pfd2x3sujOVgCkFXh0gMakk1lqTdkC/ko21n3a+4baReL9vdxzfH2MlPUSOGWhfQR6r8d8nuTyVYJl7ahEye6XTA6bCUMtLGgrHMUuZ2vWbFEktm/xQqwAFX3PWR8tmSA7nL2bB4pUWI0Dsba6e0CbyYxsobSotrUuzyT0Cck3/4ECzIYS5vQHHT3c3KQSkXcsMcnXBQGOmIdsshnjriRXHxlrWHWVx/XeVEfIjqpAK79hZWLmxhm7kR5UN8xNyW1JUChSb7s/VYQQiG57Ciu5rMfTeqyN/ZC+r8z4z4hUeKqJNAl7Unrkb6QEXiJqnroZKalbybJFs81Jv72qhbQ/DxGR4PridyV5OXudS0Ed7GN76DmDzAR8D9WVn+EPoC+aczmKR3qml2aQgVTG8WTdR0niJWDDwDIXrKNWQeMaTBGP0eTMbK67n9nBOdemgslL54JvjxpIo3XH7rlAEYRIBuLUhZmqY49Mi9p71cmKuMyzFPTxixCCm4xspi/+BoSm8w4b0ICmkIb8MNMjgfx12XiSwVOMmZzsymyEi5U7qRACbdG1wIADC2GlZTua3ApEkjnAcPgHC+xSafcpm2g1pQO1O07oV3i788Xa48/VykQBsu7UVCZvGAn33/TPlNWqDMJ0hdtw45lIIL4+dMBuRkXfoefkmDSKmRPwxuhqGAMOg8Hta9HabCJwAi79LthwpF+hbzVxElu2CCKpx0gM1q2dFKOJpeJgaBocHH9eEMttJmLjUMh4J2IRem3LZcFgopg8zIrGFp5GCHjY8u24Ws5UO2QDlw5Jx+rsGw/yhAsLJf77EYQyBUMm8oLD1Bi6/hz83NKGX+E1zpmxnqzWw4vTcOjOvS3fhv/NBuXugwj/3MAo4W7VnP6WGUgmsbfgR63VTWBQdtW1t+Egc60mmlEDi+DUfJpupP2nxsG6CLFTIX66lDywqOQdvWUoJuTBKsE5pZZuEdlba23ONroxjwT53lSwVJ3uH9tBnyrkew6XA0u8f1fnUc++u88uH2ecj6hIi9gA1a/anaAxH7U2m8I4kNL2nK00Qy4F+KOBwIkC6kMFSLXpjI7xfBm7mbbmf1GnMHO6Iq4djaB0xmOtRjXHztxgCAAH7j7iY2TEDYpDIbNSIECRrwUOkjr/jXkKT8sougdKTI2DRvf/SgNs+T/ouDDalXGWzUwlwuFxUFtas9evbvrXgPWKHagZMxMR8Dvp5pA61TzfE3tIoI3LkQ/oIUCAHC2vxkrohpJqZhJeSvoUnpbRxTD1cRToIqO33lSxxMDYVi7xPC6bfhWOAsPLU6B8mGYEyzMP6CnJf7t4Va+cHF/JJwTi8ljHA9pF0mSXmCIgXMBkiEcpx6LzhTrysVWUAkKQ9Cq6Itl7TwjgGZSo4YZt8jDSlMgNZ3JsGTyvrS/pCzT3sngFVTmLdtwa8ltsLsyBmJCSPhLG0Tu8n0cBVSTKhfM1cp4dTBcSm98ig2EMTGCVh611kpwwi2Z+HjwYba3M7mfPMTyiTVYoCb7lwGJbesuAzufI8AwqCLTLf0yo2T+/kw7nbh8wDD57NOG4cw78ASXtST2X7l/EQPmFfDgT/bWpZexAHLtF4a7PSYMjn/JFsB7xbvM9qrgOK2EtTtsABJv3n1RVmQYRxq43NI6d3OKH6qDuzv1Iz5sSuRnLzj1eIIKrbBUCwKNn6rLJZ9wou/ny3XQCjeS4sf/Q4SWP9nbT+uRLkC9xquACfJpI+B5Mf+WAiGpqwhezPPyEAagAOuHYJMnvQZVC0rfERVFK1ecMRO+m2aexpfj7Zb2EkGUPRgWKBG9Qbp0PY7DVKu4RQVMEBBWkaEBSt+k/x4H95REWSi6VGvbpiz+5pWWZ2L3O3eGMEwBN+drX+/5B3JsFMS3vai/NQrDi72KY9wa+RrCzWYzmSLH2UUfBKpFUi0zCHpbMu6ovzkD0HngdoDDLBCl5Ne5D/+w/H7oZlEylmJiUyjJ7Qy4uXvwW+YXk3oLjK71Exrt5WLqQp455MEeNngDoBumS9K9zRjktuEZ5PULtuQr2Eq13w2ao5sJNiWd9nh4rYGvaO43R1T/IcpVd0FOh9RO54tkdFEC+v0Tc4dKIH7vASVUFoBiBysAQ91F8AQuYZLCuE4MBplkoysSAdZtcKMWfTXfHAXtbVH+jAT8Eusl2E7V69WexFX0mE37sYI1G+KJpIdDTy1S47tiXxjHn1JsiZvnLLpR7tacVpAy0Fec2tXEXwkXzec9uh52OP1fXkp328ggchyiJ8J3tzEENRT5xdX6wy8M51J/qfoISbEIrFFXbmufxGNxB8JKAdhFAtfq5ZhZia1Iapx2fDRtE1KXERTnbfZGNMdAJccMRk1PT9OFU8+7slrO5IX0QulKSgcAu+n76eC4Gyf07sT9E7/6wJZUUM6T3WssE0WQgxUtMVAIzZOv3J9e2nCTW6pk9I1T6/fjxwPlW7bNWVgxhZ65fOkaQo+belcJP8nms38xIFsI5hC35vFp3j/LzBd1xRHPoGCqOb8yj/6K8uOB85oIJI1jsHpP1ECPr3sEmUHHhFQCrURisxYG/v5tef6F/oXnnCbVbbXABYYwQmMpBVjJe+SFyEgU3vqxB6C4+wIVvGOZcMFqmTbexx1Z3OMlxMetYSiYS4HgtQA8EIY+H2bHwCSrxsql/TO/BGDsKP3ST+iCQJ/XIe/X4cvIDooJz/k67IlEgwJcSp1zrddqndodYFo8Uk9uyvzkfrOlzvwOX8/UZrVNNp2iJHNzSsiMfaaaO9VWUeC24daaRF2ZPMF6CneAcTxAq8iHo2E00nRb7s+AwuORdVLkXFMGpwjDGwqDOEwH1vpz6zv/FJlOKZ6zhe+OcGaaUUSm8AY+ACv8XlInbXLlvuvlkCX7JT3MsaUv0hvj0sXoiEvXht8bS25ETN9zg0ZIZiCrC04JoKI5oP0OxBTYjysfHOWOdknSNdZbPC4jbKqAIB3VEHkW3gibwJVoH5h8flz5ht5J7hPhFU8yIhu+Unrah5jPfOb62lE/sNda4H3s2RvG9rVt3wbSw0gS0h3kfEJoN+JRoK/NFBWRusGiJXDjltincuv5wJOVgmVUtjCPOF6Sqow/Tpq+P0t9OIyHOFcfi+ayfiIEWMdx9voouj8ZnzSRmSJBDSbLYnblkqHqUobA2TlxUL0mPZ5W4c7ph5o+K6ZRJuIFKHG5gc6+0XdmSEB8EONwqMqL47eD2snfmMP1gvfldF7BQsnIZctSUobC+Y63/+/D/Xp/xZ3fEXTzZ7LihVQb/mdesldefHwRYRIoQc15cmYcUKwxPa3UdkeblWl3SMsLWFwyI1Qj3f3ZvcaAcCPt2q6+EOqzRtBTlAC3kRhJ1HTrhgXBSXj1A/H8FR7125VY/AqpO+wIngh+8my6OoRu8kIK5pWTpQQXV7xlr1kdgDM8AAxDBa2hZ0lx6+Ikrgzqtr06CBojgXLcosdzjpKIzZCi9fHIYj2TEwJDx34yklZpDjOsJ8Ge0ViPyC1bo2rtMkQwraazvB29AUH4cUAFUkvJqgRkwU3M23jNZkkC9oQDh8NMPrDm+mRH1lv4vWwxeowrQxoPo6+MLA1mslq5s+1ZddGcAU0ObaUmh8k4evXWbPoawvfA3V/PsjK14fNzYrc9aKCxMrBn2PU+op8D61f7pdaPIaQ+GweE+aE5WhSNmgVrTwmeeBoUjLnQh1cqLGppwlXY7kPn1rsM2l/fvyBwJST4Th2WUVGInT1Ntb3E2k0jNNNybSBwlgTzThmWVq4TEXIr91Cf2eBsAkbOE1dsoEHfkewkCU38nSDzuX4lR5ey9FnQ301HeN2InIAJ37GUjMj5EuDKJ0Pmt6QmRFzEVIfovGT5GbqwrcI09iBQkUWgPJRABu1Z3AqM6D63S7srnUZRYqt3ovP/SL3yhycQ+pD/5ihobosF+t9NE4W5TTApzFdvff1P9+DFvRgCcaj1j/KZR4pLxOc2U3loVtDsBbpoSTY3rJmVz2EcUnn5+p3G2tGs0AcDydiDolLobJxt3/nS3iD3sYs3UCVoiBSXFO6D/z2Iv/86NU7dFyFJK2TBg6coxHShiQ45SonTTEGAph+ZKUvD01eeG/v7Rg+Te94DLDEeo1DTIwa2fAUs364K06bij8mNOSLRZ1i3lKwM+CviPHE9KpvfL5+3R8A6eIt5tF1sNsWmtpUu1zc+HlCviZ4yAd/dtrVVVsDheGNDBIUBOKyMnnLtYQF1kA/iOY/gRN7oZc/4kAOdAoWfH/kQRQtw1QjpZ2om4BGqovM73wY3MWTDIGGWvWafD+sl4sYsUW3m2pF3q+Ep5qQ/ToSCtINbKzV5F+CkVCaSYFVVVZcH0HINkyEalvG4AHsi4W6CWYtmguOUcnyO/5pT9WLcrhbhK/UPhvj2Yf//azyRzg2PW6eB8h99XQ+oDrikXcp7CMlohv2yHtah1exbBf4fphBLBPq2qg62I+b9t7GR+i0D5/O+261fBAYvhpYVpSkjKBgyLlVfBSLpV/WnLShtpezfAXL9TKzm0D5NlRGwrTR4HldjyM4LjiZDXYCCUneatj30lliuqoSm5lMavyTMVg/1oohkhDAC4zKpEa2XBLsvJ+GUTZCrtuTafPxLI3OTqURQB96sgiAufPNsB1F5sREd8CSlloHL1R3BCJYROQl+WmGlxIiPEHphhpjNOOmNMbZM8mN0LxIEaNthBDGMoMAhbKnYHTBh5c9r8I3Hbcp/QUgFrwvScB97BdrBy4bXq3C6GhgOBHpj1ycIw8C/nQDWaE+Bm49i5RbQIUzXbXLA6VHngoaVD+I4FnXHO/s0sb/i3xxuC/qkwN0uPYf+/NzT+3K5J+OAAwj1YwZQEHwGZNfSn9ofMXPaWvbnMxxr6QvXOgMyiWqgu1DFkaTDUVh+rcqN22HEAWdgtLr2Ek4D5u6gsHR8dEZCpAZh0qxO5H55CDkBxLr52fiPyt5ffvCH0spl9gisO2daKFpEn8OsDPseyhdkw5bVE04KG86Cjq8ViGJLnd0a/I8EPQzH6nr6+f4mTycfsO4C38az+yMus9uzrDO1IvN0PrZWIi1C77Ew8R2kuPQURl0LAkFMoIL14bvXBtuqlrmYQxXMg/t6UkYLu8oQN4BBhMv3bOx4njohJkVEYnn3mZKvG5Fn2hOmxek11+wAMJKIFXmnmcEAHcojUxZeEvusWGwPvY9oeAqmXIqVjeeQ11mZAV8UmBBBXd7FAXZcbIyVfLEjrdFNMToLG55TDls5i8yLPqtCdCbKgDTovdIGN9FF4cyl2QdTGOx92sE023cvhhqTRxHiIwZpzusWszLP0U7+k8Wfc3E2X1Y8BhJDsUXlk6/+6WN7K0A87LjploseNLGzoqlrz1pjQBUL9gOma3eJ0ZalrsnnfRLntaWHKXCUU+4hlBsA343fAGcUD9TxIqdkPcHOk5kcn1jQXfX9KSWqcZl9i1AwNNpLTuq7vEUYUlv3uTNqJv4YBHEtA6ULXgJFwVBTj7n30RYSXRbmNtaAzpJrQLb0fsCa77qmAAAA alt="figure 2" loading=lazy srcset sizes width=685 height=285></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-2-desc><p>Immune fluorescence detects the NET components citrullinated Histone H3 and neutrophil elastase (both green) as well as extranuclear DNA (DAPI; red) in the vessels of a central human lung. Note, the intravascular DNA-enzyme-histone complexes fill the whole lumen of many vessels (some of the clogged vessels are marked with asterisks).</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/2 data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div></div></div></section><section data-title="Targeting the type I IFN production by SARS-CoV-2"><div class=c-article-section id=Sec8-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec8>Targeting the type I IFN production by SARS-CoV-2</h2><div class=c-article-section__content id=Sec8-content><p>While innate immunity constitutes the first line of host defense against virus infection, the type-I IFN response is the core that endows antiviral activities to host cells, which consists of two major consecutive steps including IFN production and the expression of ISGs [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 86" title="MacMicking JD. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol. 2012;12:367–82." href=#ref-CR86 id=ref-link-section-d261924e1576>86</a>]. Here, we specifically focus on the regulation of type-I IFN production, which is the first and critical step for an effective innate immune response and therefore is primarily targeted by SARS-CoV-2 proteins for suppression.<p>As depicted in Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig3>3</a>, the type-I interferon production is initiated by the recognition of the double-strand RNA (dsRNA) generated during the virus life cycle by the RIG-1-like receptors (RLRs), including the RIG-1 and/or melanoma differentiation gene 5 (MDA5) in the cytoplasm, or the TLRs in the endosome [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 87" title="Tan X, Sun L, Chen J, Chen ZJ. Detection of microbial infections through innate immune sensing of nucleic acids. Annu Rev Microbiol. 2018;72:447–78." href=#ref-CR87 id=ref-link-section-d261924e1585>87</a>]. Upon loading with dsRNA, RIG-1 and MDA5 can interact with the adapter mitochondrial antiviral signaling protein (MAVS), leading to the formation of a signaling complex consisting of TANK-binding kinase 1 (TBK1) and inducible IκB kinase (IKKi). The TBK1/IKKi complex then phosphorylates interferon regulatory factor 3/7 (IRF3/7), promoting their translocation into the nucleus to drive IFN-α/β expression. Meanwhile, the TLRs, such as TLR3, could also recognize PAMPs in the endosome to induce cytokines and chemokines production, enhancing the innate immune response [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 87" title="Tan X, Sun L, Chen J, Chen ZJ. Detection of microbial infections through innate immune sensing of nucleic acids. Annu Rev Microbiol. 2018;72:447–78." href=#ref-CR87 id=ref-link-section-d261924e1588>87</a>].<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-3 data-title="Targeting type I IFN production by SARS-CoV-2."><figure><figcaption><b id=Fig3 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 3: Targeting type I IFN production by SARS-CoV-2.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/3 rel=nofollow><picture><img aria-describedby=Fig3 src=data:image/webp;base64,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 alt="figure 3" loading=lazy srcset sizes width=685 height=636></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-3-desc><p><b>a</b> Schematic demonstration of the viral proteins. Those marked with asterisks were reported to regulate IFN production. <b>b</b> IFN production signaling pathways targeted by SARS-CoV-2 proteins. SARS-CoV-2 infection induces a delayed type-I IFN response, which is underlaid by the inhibited RIG-I/MDAS-MAVS signaling at the early stage and the cytoplasmic-micronuclei-activated cGAS-STING signaling at the late stage.</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/3 data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>During this process, it was reported that SARS-CoV-2 encoded at least 14 proteins, accounting for about half of the total proteins encoded by the virus, to interfere with IFN production [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Xue W, Ding C, Qian K, Liao Y. The interplay between coronavirus and type I IFN response. Front Microbiol. 2021;12:805472." href=#ref-CR88 id=ref-link-section-d261924e1619>88</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11:3810." href=#ref-CR89 id=ref-link-section-d261924e1619_1>89</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 90" title="Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20:585–6." href=#ref-CR90 id=ref-link-section-d261924e1622>90</a>]. These proteins include the structural membrane (M), nucleocapsid (N) proteins, the accessory proteins (3, 6, 8, and 9b), and the nonstructural proteins (NSP1, 3, 5, 6, 12,13, 14, and 15) generated from a large open reading frame (ORF) encoding 1ab by papain-like proteinase (NSP3, NLpro) and 3C-like proteinase (NSP5, 3CLpro) -mediated cleavage. Suppression of IFN production by the SARS-CoV-2 proteins was primarily executed through four types of mechanisms, including escaping viral RNA recognition (by N, ORF9b, NSP1, and NLpro), compromising RIG-1 or TLRs signaling (by M, N, 3CLpro, NSP12, ORF3b, ORF6, ORF7b, and ORF9b), targeting the TBK1 complex (by M, N, NSP13, ORF9b,), and interfering with IRF3 activation (by M, N, NLpro, 3CLpro, NSP1, NSP12–15, ORF3b, ORF6, and ORF8), Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig3>3</a>. Corresponding to the extensive interference of IFN production by SARS-CoV-2-encoded proteins, patients with COVID-19 usually exhibited a delayed type-I IFN response [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 90" title="Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20:585–6." href=#ref-CR90 id=ref-link-section-d261924e1628>90</a>], i.e., IFN production was inhibited at the early stage of SARS-CoV-2 infection, which allows the virus to achieve successful replication in the host cells, undermining the asymptomatic infection. Enhancing IFN response at this stage turned out to help restrict SARS-CoV-2 infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL, et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9002." href=#ref-CR91 id=ref-link-section-d261924e1631>91</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol. 2021;6." href=#ref-CR92 id=ref-link-section-d261924e1631_1>92</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 93" title="Bernard NJ. A STING in the tail for SARS-CoV-2. Nat Immunol. 2021;22:800." href=#ref-CR93 id=ref-link-section-d261924e1635>93</a>].<p>Subsequent to a latent IFN response, the patients with COVID-19, particularly those in severe forms, exhibited a substantially exaggerated IFN response manifested with uncontrolled cytokine storm and inflammation, corresponding to another arm of the delayed type-I IFN response at the late stage [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 90" title="Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20:585–6." href=#ref-CR90 id=ref-link-section-d261924e1641>90</a>], on which recent studies shed lights. Zhao et al. reported that an expression level-based dual-role of the structural N protein may be partially accountable, where the low-dose N protein was suppressive while the high-dose was promotive, for the activation of IFN signaling. This worked out by dually regulating the phosphorylation and nuclear translocation of IRF3 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 94" title="Zhao Y, Sui L, Wu P, Wang W, Wang Z, Yu Y, et al. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021;6:331." href=#ref-CR94 id=ref-link-section-d261924e1644>94</a>]. Alternatively, Ren et al. found that SARS-CoV-2 may activate IFN response unexpectedly via the cGAS-STING signaling pathway, which was induced by the cytoplasmic micronuclei produced in the multinucleate syncytia between cells expressing spike and ACE2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 95" title="Ren H, Ma C, Peng H, Zhang B, Zhou L, Su Y, et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol Direct. 2021;16:20." href=#ref-CR95 id=ref-link-section-d261924e1647>95</a>]. And the results were further confirmed independently by Zhou et al., who demonstrated that cell-cell fusion was sufficient to induce cytoplasmic chromatin, and the cytoplasmic chromatin-cGAS-STING pathway, but not the MAVS-mediated viral RNA sensing pathway, contributes to interferon and pro-inflammatory gene expression upon cell fusion [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 96" title="Zhou Z, Zhang X, Lei X, Xiao X, Jiao T, Ma R, et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct Target Ther. 2021;6:382." href=#ref-CR96 id=ref-link-section-d261924e1650>96</a>]. Interestingly, several SARS-CoV-2 proteins (3CLpro, ORF3a, and ORF9) were also able to target STING to regulate the IFN response [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 97" title="Rui Y, Su J, Shen S, Hu Y, Huang D, Zheng W, et al. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct Target Ther. 2021;6:123." href=#ref-CR97 id=ref-link-section-d261924e1653>97</a>], likely indicating a complex feedback interaction between SARS-CoV-2 and the innate immunity, and therefore a well-balanced immune interference targeting IFN response is required for COVID-19 therapy.</p></div></div></section><section data-title="Adaptive immunity: humoral immunity to SARS-CoV-2"><div class=c-article-section id=Sec9-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec9>Adaptive immunity: humoral immunity to SARS-CoV-2</h2><div class=c-article-section__content id=Sec9-content><p>Adaptive immunity provides pathogen-specific immunity, which eradicates infection and provides long memory and recall of the immune responses, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig4>4</a>. By producing antibodies, B cells play a critical role in anti-viral immunity. Different classes of antibodies such as IgM, IgA, IgG, and IgE, are involved in humoral immune responses to viral infections. These antibody classes are characterized by their intrinsic properties, functions, tissue distributions, and half-lives. Upon SARS-CoV-2 infection or vaccination, IgD and IgM are the first antibody types produced. The positive test of IgM antibody indicates that the virus may be present or a patient recently recovered from the infection and that the virus-specific immune response has begun [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 98" title="Denning DW, Kilcoyne A, Ucer C. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2. Br Dent J. 2020;229:521–4." href=#ref-CR98 id=ref-link-section-d261924e1667>98</a>]. During SARS-CoV-2 infection, symptoms start around day 5 and the body begins to produce IgM antibodies around 7–8 days post-infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 99" title="Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8." href=#ref-CR99 id=ref-link-section-d261924e1670>99</a>]. Due to inadequate affinity maturation, IgM antibodies have a relatively low affinity compared to IgG. On the other hand, due to their pentameric nature, IgM antibodies have high avidity for antigens and play critical roles in opsonization.<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-4 data-title="The SARS-CoV-2 Omicron variant with high mutational burden exhibits increased antibody evasion."><figure><figcaption><b id=Fig4 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 4: The SARS-CoV-2 Omicron variant with high mutational burden exhibits increased antibody evasion.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/4 rel=nofollow><picture><img aria-describedby=Fig4 src="data:image/webp;base64,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" alt="figure 4" loading=lazy srcset sizes width=685 height=483></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-4-desc><p>In a typical SARS-CoV-2 infection, the virus presented in the lymphoid organs evokes T helper cells which facilitate the activation of both humoral and cellular immune responses. Antibodies and effector CD8<sup>+</sup> T cells were then released into circulation. Antibodies neutralize virus and eliminate infected cells through ADCC. CD8<sup>+</sup> T cells kill infected cells through cytotoxicity. However, as for SARS-CoV-2 Omicron, the effects of antibody-mediated protection were dramatically reduced, which is possibly brought about by over 30 mutations in the genes encoding spike proteins. There are 3 possibilities explaining the sudden appearance of Omicron: 1. Omicron may have been transmitted within a neglected population without sufficient medical surveillance; 2. It could be outcompeted in a patient with chronic COVID-19 infections; 3. It may be zoonotic and just spilled back into human.</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/4 data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>IgG antibodies usually appear later during an immune response because of the time needed for their affinity maturation to acquire high avidity and more potent capacity to neutralize pathogens, activate the complement pathway, and kill infected cells through antibody-dependent cellular cytotoxicity (ADCC). IgG antibodies have a relatively long half-life in serum and are associated with B cell memory. IgG antibodies to SARS-CoV-2 do not develop until around 14 days post-infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 100" title="Nakano Y, Kurano M, Morita Y, Shimura T, Yokoyama R, Qian C, et al. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Sci Rep. 2021;11:2776." href=#ref-CR100 id=ref-link-section-d261924e1700>100</a>]. A positive test for IgG is a good indication of having been infected or vaccinated. Interestingly, among those infected by SARS-CoV-2, detectable IgG antibodies are mainly IgG1 &amp; IgG3 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 101" title="Moura AD, da Costa HHM, Correa VA, de SLAK, Lindoso JAL, De Gaspari E, et al. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients. Sci Rep. 2021;11:17642." href=#ref-CR101 id=ref-link-section-d261924e1703>101</a>].<p>IgA antibodies are produced right following IgM with serum levels higher than IgM and are the main antibody class in mucosal surfaces and secretions. It has been reported that the SARS-CoV-2-specific IgA can be detected prior to the appearance of IgM and dominates the early neutralizing responses [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 102" title="Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claer L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13:eabd2223." href=#ref-CR102 id=ref-link-section-d261924e1709>102</a>]. IgA forms dimers upon secretion to increase avidity. IgA antibodies secreted into the respiratory tract play a key role in mucosal immunity to SARS-CoV-2 infection by facilitating aggregation and preventing the initial infection of host cells. It is important to note that detectable levels of neutralizing antibodies against SARS-CoV-2 start declining within three months following mild and asymptomatic infections. This might predict transient immunity and heightened risk of reinfection.<p>Intriguingly, several groups have reported a clear association between the extent of T cell immunity and humoral response in convalescent individuals [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541–3." href=#ref-CR103 id=ref-link-section-d261924e1715>103</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996–1012 e19." href=#ref-CR104 id=ref-link-section-d261924e1715_1>104</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 105" title="Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5:e140329." href=#ref-CR105 id=ref-link-section-d261924e1718>105</a>]. Patients with severe COVID-19 were found harboring low mutation frequencies in their heavy-chain variable region genes in the early weeks after infection, notably in those antibodies against the spike protein [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 106" title="Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Roltgen K, Jean GH, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host Microbe. 2020;28:516–25 e5." href=#ref-CR106 id=ref-link-section-d261924e1721>106</a>], indicating suboptimal immunoglobulin maturation. Furthermore, a delay in the emergence of antibodies, including the anti-SARS-CoV-2 neutralizing antibodies, has also been noted in severe forms compared with milder forms of COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 107" title="Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, et al. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021;27:1178–86." href=#ref-CR107 id=ref-link-section-d261924e1724>107</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 108" title="Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020;11:6044." href=#ref-CR108 id=ref-link-section-d261924e1727>108</a>]. These are in line with the fact that CD4<sup>+</sup> T cells are essential for sustaining germinal center (GC) formation and B cell differentiation leading to isotype switch and immunoglobulin maturation, two features of T cell-dependent humoral response. Consistently, defective GC formation is associated with CD4<sup>+</sup> T cell depletion in the lymph nodes of severe COVID-19 patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 109" title="Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020;183:143–57 e13." href=#ref-CR109 id=ref-link-section-d261924e1735>109</a>]. This defect and delay to develop antibodies against spike protein may contribute to viral dissemination and longer persistence of SARS-CoV-2 in patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 110" title="Van Cleemput J, van Snippenberg W, Lambrechts L, Dendooven A, D’Onofrio V, Couck L, et al. Organ-specific genome diversity of replication-competent SARS-CoV-2. Nat Commun. 2021;12:6612." href=#ref-CR110 id=ref-link-section-d261924e1738>110</a>]. Moreover, premature T cell depletion due to apoptosis was associated with a lower B-cell response in individuals infected with filovirus [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 111" title="Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med. 1999;5:423–6." href=#ref-CR111 id=ref-link-section-d261924e1741>111</a>] or retrovirus [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 112" title="Estaquier J, Idziorek T, de Bels F, Barre-Sinoussi F, Hurtrel B, Aubertin AM, et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994;91:9431–5." href=#ref-CR112 id=ref-link-section-d261924e1744>112</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 113" title="Monceaux V, Estaquier J, Février M, Cumont MC, Rivière Y, Aubertin AM, et al. Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS. Aids. 2003;17:1585–96." href=#ref-CR113 id=ref-link-section-d261924e1748>113</a>]. Therefore, to what extent whereby the death of CD4<sup>+</sup> T cells by apoptosis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1753>114</a>] may correlate with a delay in mounting an efficient humoral response and in developing sequelae merits further investigation.</p></div></div></section><section data-title="Adaptive immunity: cellular immunity and resistance to SARS-CoV-2"><div class=c-article-section id=Sec10-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec10>Adaptive immunity: cellular immunity and resistance to SARS-CoV-2</h2><div class=c-article-section__content id=Sec10-content><p>Specific cellular immunity to SARS-CoV-2 is mediated by T cells. These cells are naïve and circulate in the bloodstream and peripheral lymphoid organs until encountering their specific antigen peptide presented by MHC. The SARS-CoV-2 virus itself or naked viral peptides could not activate T cells. High-affinity interaction between self MHC presented SARS-CoV-2 peptides and TCR induces proliferation and differentiation of T cells into cells capable of contributing to the removal of virus-infected cells or helping the production of antibodies. Class I MHC presented endogenous antigen peptides that activate CD8<sup>+</sup> T cells, while class II MHC presented exogenous antigen peptides that activate CD4<sup>+</sup> T cells. SARS-CoV-2 specific T cells are critical in the immunity to infection and susceptibility to severe disease has been reported to correlate with HLA alleles [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 115" title="Butler D, Mozsary C, Meydan C, Foox J, Rosiene J, Shaiber A, et al. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021;12:1660." href=#ref-CR115 id=ref-link-section-d261924e1768>115</a>]. It is known that inflammatory monocytes and macrophages as well as DC express ACE2 which permits the entry of SARS-CoV-2 into these professional antigen-presenting cells to activate T cells, especially CD8<sup>+</sup> T cells. Although the ACE2 expression on macrophages and DC is only at intermediate levels, the co-expression of CD209 (DC-SIGN) could dramatically facilitate SARS-CoV-2 entry into DC [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 116" title="Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, et al. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci. 2021;7:1156–65." href=#ref-CR116 id=ref-link-section-d261924e1773>116</a>]. It should be pointed out that in most cases, SARS-CoV-2 infections do not elicit a dramatic inflammatory response in macrophages and DC. IL-6 is almost undetectable and other cytokines such as IL-1 are very low [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 117" title="Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–43." href=#ref-CR117 id=ref-link-section-d261924e1777>117</a>]. This may limit their migration to local lymphoid tissue and maturation to cells with the expression of co-stimulation molecules that are highly effective at presenting antigen to recirculating T cells, indicating a robust T cell response to SARS-CoV-2 may be difficult to induce and thus limit the development of immunity. It is important to note that B cells can also serve as SARS-CoV-2 antigen-presenting cells, especially those with surface immunoglobulin specific to SARS-CoV-2 antigens.<p>Patients with COVID-19 at the severe stage were manifested with decreased peripheral lymphocytes, termed lymphopenia or lymphocytopenia, which was believed to promote the disease progression [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 118" title="Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA J Am Med Assoc. 2020;324:782–93." href=#ref-CR118 id=ref-link-section-d261924e1783>118</a>]. Since lymphocytes barely express ACE2, it is unlikely to be a direct target of the SARS-CoV-2 virus [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 119" title="Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z, et al. SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and furin proteases. iScience. 2020;23:101744." href=#ref-CR119 id=ref-link-section-d261924e1786>119</a>]. Two major indirect mechanisms were proposed to account for lymphocyte loss. One is the enhanced cell-autonomous death, primarily by apoptosis. T cells isolated from patients with severe COVID-19 exhibited an increased propensity to die via apoptosis, as evidenced by a higher level of caspase activation and phosphatidylserine exposure, and a high rate of spontaneous apoptosis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1789>114</a>]. This was strongly associated with increased soluble Fas ligand in sera, and with increased expression of Fas/CD95 on T cells, particularly on CD4<sup>+</sup> T cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1794>114</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 120" title="Bellesi S, Metafuni E, Hohaus S, Maiolo E, Marchionni F, D’Innocenzo S. et al. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br J Haematol. 2020;191:207–11." href=#ref-CR120 id=ref-link-section-d261924e1798>120</a>]. While both extrinsic and intrinsic apoptosis, but not necroptosis, were found to be involved, treatment with Q-VD, a pan-caspase inhibitor, protected the isolated T cells from cell death and enhanced the expression of Th1 transcripts [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1801>114</a>]. Consistently, TNF-α and IFN-γ were found prominently upregulated in the sera of patients with severe COVID-19, which was related to a phenomenon called cytokine storm or also viral sepsis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671–92." href=#ref-CR31 id=ref-link-section-d261924e1804>31</a>]. This phenomenon is at least in part induced by an inflammatory cell death PANoptosis, abbreviated for the mixed cell death of pyroptosis, apoptosis, and necroptosis. Importantly, the TNF-α/IFN-γ-induced lethality in animals could be rescued, along with the increased level of T cells, in <i>Ripk3</i><sup><i>‒/‒</i></sup><i>Casp8</i><sup><i>‒/‒</i></sup> mice, in which PANoptosis was suppressed [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 121" title="Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149–68.e17." href=#ref-CR121 id=ref-link-section-d261924e1819>121</a>].<p>Another mechanism responsible for lymphocyte loss is non-autonomously mediated by syncytia, which could be efficiently induced by SARS-CoV-2 via its fusogenic spike protein dictated by an embedded bi-arginine motif [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 122" title="Zhang Z, Zheng Y, Niu Z, Zhang B, Wang C, Yao X, et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021;28:2765–77." href=#ref-CR122 id=ref-link-section-d261924e1825>122</a>]. The multinucleated syncytia were found to be able to internalize infiltrated live lymphocytes, preferentially the CD8<sup>+</sup> T cells, to form cell-in-cell structures, a unique phenomenon that is prevalent in tumor tissues [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 123" title="Huang H, He M, Zhang Y, Zhang B, Niu Z, Zheng Y, et al. Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma. Signal Transduct Target Ther. 2020;5:246–8." href=#ref-CR123 id=ref-link-section-d261924e1830>123</a>] and plays important roles in clonal selection and immune homeostasis and the like [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, et al. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Disco. 2022;8:35." href=#ref-CR124 id=ref-link-section-d261924e1833>124</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Liang J, Niu Z, Zhang B, Yu X, Zheng Y, Wang C, et al. p53-dependent elimination of aneuploid mitotic offspring by entosis. Cell Death Differ. 2021;28:799–813." href=#ref-CR125 id=ref-link-section-d261924e1833_1>125</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 126" title="Sun Q, Luo T, Ren Y, Florey O, Shirasawa S, Sasazuki T, et al. Competition between human cells by entosis. Cell Res. 2014;24:1299–310." href=#ref-CR126 id=ref-link-section-d261924e1836>126</a>]. By defaults, as taking place in cancer cells, the formation of the cell-in-cell structure primarily resulted in the death of the internalized lymphocytes within syncytia, leading to a rapid elimination, which could be rescued by either blocking syncytia formation or cell-in-cell-mediated death, thus providing a novel target for COVID-19 therapy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Sun Q, Chen W. Cell-in-cell: an emerging player in COVID-19 and immune disorders. Natl Sci Open. 2022;1:20220001." href=#ref-CR127 id=ref-link-section-d261924e1840>127</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021;594:88–93." href=#ref-CR128 id=ref-link-section-d261924e1840_1>128</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zheng Y, Zhou LL, Su Y, Sun Q. Cell fusion in the pathogenesis of COVID-19. Mil Med Res. 2021;8:68." href=#ref-CR129 id=ref-link-section-d261924e1840_2>129</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 130" title="Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ. 2021;28:2019–21." href=#ref-CR130 id=ref-link-section-d261924e1843>130</a>]. Interestingly, the two lymphopenia mechanisms seem to exhibit a preference for the targeted lymphocytes, with the autonomous one for CD4<sup>+</sup> T cells while the non-autonomous one for CD8<sup>+</sup> T cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1850>114</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 122" title="Zhang Z, Zheng Y, Niu Z, Zhang B, Wang C, Yao X, et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021;28:2765–77." href=#ref-CR122 id=ref-link-section-d261924e1853>122</a>], whether the preference also applies to other types of lymphocytes and its biological properties and potential implications warrant further investigation. In addition to directly regulating the cellularity of lymphocytes, syncytia were recently shown to be able to activate the cGAS-STING signaling via inducing the naked cytoplasmic micronuclei [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 95" title="Ren H, Ma C, Peng H, Zhang B, Zhou L, Su Y, et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol Direct. 2021;16:20." href=#ref-CR95 id=ref-link-section-d261924e1857>95</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 96" title="Zhou Z, Zhang X, Lei X, Xiao X, Jiao T, Ma R, et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct Target Ther. 2021;6:382." href=#ref-CR96 id=ref-link-section-d261924e1860>96</a>], and to initiate inflammatory cell death [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 131" title="Ma H, Zhu Z, Lin H, Wang S, Zhang P, Li Y, et al. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells. Cell Disco. 2021;7:73." href=#ref-CR131 id=ref-link-section-d261924e1863>131</a>], both of which, though may help mount an anti-infection immunity, would eventually promote inflammation and tissue damages leading to severer clinical conditions. Coincidently, the less pathogenic Omicron variant of SARS-CoV-2 displayed a compromised ability to induce syncytia formation in cells expressing human ACE2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Meng B, Ferreira IATM, Abdullahi A, Saito A, Kimura I, Yamasoba D, et al. SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion. Preprint at 
                https://www.biorxiv.org/content/10.1101/2021.12.17.473248v2
                
              . 2021." href=#ref-CR132 id=ref-link-section-d261924e1866>132</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Willett BJ, Grove J, MacLean OA, Wilkie C, Logan N, Lorenzo GD, et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. Preprint at 
                https://www.medrxiv.org/content/10.1101/2022.01.03.21268111v1
                
              . 2022." href=#ref-CR133 id=ref-link-section-d261924e1866_1>133</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 134" title="Peacock TP, Brown JC, Zhou J, Thakur N, Newman J, Kugathasan R, et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. Preprint at 
                https://www.biorxiv.org/content/10.1101/2021.12.31.474653v1
                
              . 2021." href=#ref-CR134 id=ref-link-section-d261924e1869>134</a>]. Together, syncytia and various types of cell death may serve as an important hub for pathogenesis induced by SARS-CoV-2 infection.<p>Though it is generally recognized that T cell immunity plays a central role in the control of SARS-CoV-2, its importance is still underestimated and mechanistically unclear. A proper T cell response is important to limit infection. Unlike antibodies, which are less sustained and only those specific to RBD can neutralize, T cells react to at least 30 epitopes of viral proteins and exhibit sustained memory. That CD4<sup>+</sup> T cells are more prone to undergo apoptosis may also contribute to the development of “helpless” CD8<sup>+</sup> T cells, which are exhausted and shorter-lived cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 135" title="Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol. 2006;7:475–81." href=#ref-CR135 id=ref-link-section-d261924e1879>135</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 136" title="Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 2005;434:88–93." href=#ref-CR136 id=ref-link-section-d261924e1882>136</a>], leading to defective T cell toxicity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 137" title="Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–703." href=#ref-CR137 id=ref-link-section-d261924e1885>137</a>] and death of CD8<sup>+</sup> T cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 114" title="André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print." href=#ref-CR114 id=ref-link-section-d261924e1891>114</a>] in patients with severe COVID-19. In addition, the aforementioned highly activated CD16<sup>+</sup> T cells also contribute to the pathophysiology of COVID-19 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185:493–512 e25." href=#ref-CR49 id=ref-link-section-d261924e1896>49</a>]. Thus, preventing lymphopenia, the death of T cells, and the inappropriate functionality of CD16<sup>+</sup> T cells could be of interest to limit pathogenicity and probably long-term sequela. Consistently, the use of caspase inhibitor in the early phase of infection has provided protection for monkeys developing acquired immunodeficiency syndrome (AIDS) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 138" title="Laforge M, Silvestre R, Rodrigues V, Garibal J, Campillo-Gimenez L, Mouhamad S, et al. The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques. J Clin Invest. 2018;128:1627–40." href=#ref-CR138 id=ref-link-section-d261924e1901>138</a>]. Therefore, similar strategies might be of interest for SARS-CoV-2 infection. Meanwhile, although COVID-19 in children is rarely severe, a subset of patients developed multisystem inflammatory syndrome in children with robust type II interferon and NF-kB responses, manifested by a transient expansion of TRBV11-2 T cell clonotypes and signs of inflammatory T cell activation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 139" title="Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 2022. Online ahead of print." href=#ref-CR139 id=ref-link-section-d261924e1905>139</a>]. An association with HLA A*02, B*35 and C*04 alleles suggests a genetic predisposition, yet to be validated in larger cohorts [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 139" title="Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 2022. Online ahead of print." href=#ref-CR139 id=ref-link-section-d261924e1908>139</a>].<p>Whilst physical and mental stresses, either acute or chronic, have a dramatic impact on the immune system, both innate and adaptive immune components could be affected. Humans and animals subjected to stress conditions exhibited significant reduction in lymphocytes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 140" title="Shi Y, Devadas S, Greeneltch KM, Yin D, Allan Mufson R, Zhou JN. Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology. Brain Behav Immun. 2003;17:S18–26." href=#ref-CR140 id=ref-link-section-d261924e1915>140</a>], increase in IL-6 production [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 141" title="Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127–37." href=#ref-CR141 id=ref-link-section-d261924e1918>141</a>], decrease in IFN-γ [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 142" title="Hong M, Zheng J, Ding ZY, Chen JH, Yu L, Niu Y, et al. Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice. Neuroimmunomodulation. 2013;20:39–50." href=#ref-CR142 id=ref-link-section-d261924e1921>142</a>], augmentation in regulatory T cells [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 142" title="Hong M, Zheng J, Ding ZY, Chen JH, Yu L, Niu Y, et al. Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice. Neuroimmunomodulation. 2013;20:39–50." href=#ref-CR142 id=ref-link-section-d261924e1924>142</a>], and alteration in gut microbiota [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 143" title="Westfall S, Caracci F, Estill M, Frolinger T, Shen L, Pasinetti GM. Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity. Front Immunol. 2021;12:670500." href=#ref-CR143 id=ref-link-section-d261924e1927>143</a>]. The induction of Fas expression on lymphocytes by chronic stress [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 144" title="Yin D, Tuthill D, Mufson RA, Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med. 2000;191:1423–8." href=#ref-CR144 id=ref-link-section-d261924e1931>144</a>] could account, at least in part, for the lymphopenia development in COVID-19 patients mentioned above. It is imperative to emphasize that the prevalence of stress associated with anxiety, depression, fear, and inadequate social support during the COVID-19 pandemic should not be ignored. There is a strong need to understand the stress impact on COVID-19 experiences and stress management should be included in the care of patients, especially those suffering from mental and psychological disorders.</p></div></div></section><section data-title="Therapeutic antibody against SARS-CoV-2"><div class=c-article-section id=Sec11-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec11>Therapeutic antibody against SARS-CoV-2</h2><div class=c-article-section__content id=Sec11-content><p>Monoclonals, whether of animal or human origin, have been used for the development of most non polymerase chain reaction (PCR)-based diagnostic tests. They usually target the nucleocapsid, which is the most abundant protein of the virus. During the pandemic, they have been used in hundreds of millions of rapid tests. Herein, we will focus our attention on the use of human monoclonal antibodies (hmAbs). Before the SARS-CoV-2 pandemic, hmAbs had been widely used to treat cancer, inflammatory and autoimmune diseases [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 145" title="Rajewsky K. The advent and rise of monoclonal antibodies. Nature. 2019;575:47–9." href=#ref-CR145 id=ref-link-section-d261924e1942>145</a>]. With the exception of an antibody against the respiratory syncytial virus approved for clinical use in 1998 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 146" title="American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:415–20." href=#ref-CR146 id=ref-link-section-d261924e1945>146</a>], hmAbs had not been used for infectious diseases because they require large quantities to be delivered intravenously and were too expensive compared to infectious disease standard of care. The game started to change with a pioneering work done by Antonio Lanzavecchia during the 2002–2003 outbreak of SARS-CoV-1 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 147" title="Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004;10:871–5." href=#ref-CR147 id=ref-link-section-d261924e1948>147</a>]. For the first time, his lab was able to clone from a convalescent patient a B cell producing antibody neutralizing the virus. Since then, many other technologies became available to isolate hmAbs starting from the B cells of convalescent or vaccinated donors. Many antibodies were developed and tested in the clinic for HIV, and the improved technology allowed to isolate antibodies that were more than 1000-fold more potent of the ones initially isolated against this pathogen [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 148" title="Sok D, Burton DR. Recent progress in broadly neutralizing antibodies to HIV. Nat Immunol. 2018;19:1179–88." href=#ref-CR148 id=ref-link-section-d261924e1951>148</a>]. In this environment, the Wellcome Trust published in 2019 a report stating that the time to develop hmAbs for infectious diseases was mature (Wellcome Trust. “Expanding Access to Monoclonal Antibody-Based Products.” (2020)).<p>As soon as the SARS-CoV-2 pandemic started, multiple academic and industrial laboratories isolated B cells from convalescent people and generated numerous publications in prestigious journals showing the identification of hmAbs able to neutralize the virus in vitro, as well as protecting and treating mice, hamsters, and non-human primates in vivo from viral challenge [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 149" title="Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450–6." href=#ref-CR149 id=ref-link-section-d261924e1957>149</a>]. The neutralizing antibodies are usually divided into four classes which bind different regions of the spike, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig5>5</a>. In addition to the pre-clinical evidence, several clinical studies showed that, when used early after infection, hmAbs had very high efficacy in preventing severe disease [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 150" title="Hwang YC, Lu RM, Su SC, Chiang PY, Ko SH, Ke FY, et al. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci. 2022;29:1." href=#ref-CR150 id=ref-link-section-d261924e1963>150</a>]. Given their efficacy, and since these were the first therapeutic molecules developed during the pandemic, numerous hmAbs received emergency use in the US and Europe: REGN COV2 (Casirivimab and Imdevimab), Bamlanivimab (LY-CoV555), Sotrovimab (VIR 7831 or S309), Evusheld (tixagevimab and cilgavimab) and Bebtelovimab (LY-CoV1404) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 150" title="Hwang YC, Lu RM, Su SC, Chiang PY, Ko SH, Ke FY, et al. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci. 2022;29:1." href=#ref-CR150 id=ref-link-section-d261924e1966>150</a>]. For more than one year, hmAbs remained the only real therapeutic tool we had against SARS-CoV-2. Unfortunately, hmAbs did not work in a therapeutic setting during advanced severe disease in hospitalized patients and many of them fell short with the emergence of SARS-CoV-2 variants carrying different mutations on the spike protein, the major target for neutralizing hmAbs. In fact, with the emergence of the SARS-CoV-2 Omicron variant, 85% of hmAbs approved for clinical use lost their potency against this virus [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 151" title="Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553–6." href=#ref-CR151 id=ref-link-section-d261924e1969>151</a>]. Today we still have three approved hmAbs that work reasonably well against Omicron and new potent monoclonals against this variant are described in the literature [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 151" title="Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553–6." href=#ref-CR151 id=ref-link-section-d261924e1973>151</a>]. In conclusion, the COVID-19 pandemic has suggested prevention and therapeutic potential of hmAbs to infectious diseases and that can be developed faster than any other medicine. In addition, it is now possible to develop extremely potent hmAbs that can be administered intramuscularly rather than intravenously, facilitating their administration outside the hospital. Therefore, hmAbs can be considered at the forefront of medical interventions in the field of infectious diseases as their characteristics make them essential tools to tackle emerging pathogens and pandemics.<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-5 data-title="The figure shows the SARS-CoV-2 spike protein receptor-binding domain (RBD) bound by class 1/2 (blue), class 3 (orange) and class 4 (green) neutralizing antibodies."><figure><figcaption><b id=Fig5 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 5: The figure shows the SARS-CoV-2 spike protein receptor-binding domain (RBD) bound by class 1/2 (blue), class 3 (orange) and class 4 (green) neutralizing antibodies.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/5 rel=nofollow><picture><img aria-describedby=Fig5 src=data:image/webp;base64,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 alt="figure 5" loading=lazy srcset sizes width=685 height=556></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-5-desc><p>The potency and breadth of neutralization across SARS-CoV-2 variants are denoted for each antibody class [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Jette CA, Cohen AA, Gnanapragasam PNP, Muecksch F, Lee YE, Huey-Tubman KE, et al. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell Rep. 2021;37:110188." href=#ref-CR171 id=ref-link-section-d261924e1988>171</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Wang Z, et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021;54:1853–68 e7." href=#ref-CR172 id=ref-link-section-d261924e1988_1>172</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 173" title="Rino R, Emanuele A, Ida P, Silvia M, Lorena D, Giulio P et al. Anatomy of Omicron neutralizing antibodies in COVID-19 mRNA vaccinees. PREPRINT (Version 1) available at Research Square. 2022. 
                https://doi.org/10.21203/rs.3.rs-1330153/v1
                
              ." href=#ref-CR173 id=ref-link-section-d261924e1991>173</a>].</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/5 data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div></div></div></section><section data-title="The SARS-CoV-2 vaccination"><div class=c-article-section id=Sec12-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec12>The SARS-CoV-2 vaccination</h2><div class=c-article-section__content id=Sec12-content><p>Exposure to attenuated pathogens or parts of the pathogens to induce specific immunity against a pathogen started with smallpox variolation in China more than 1000 years ago [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 152" title="Cao X. Immunology in China: the past, present and future. Nat Immunol. 2008;9:339–42." href=#ref-CR152 id=ref-link-section-d261924e2011>152</a>]. Edward Jenner employed cowpox to protect humans from smallpox 800 years later. Since in Latin the word Vacca is for cow, the term vaccination is adapted later by Jenner’s friend Richard Dunning in 1800. In the last 200 years, various approaches have been developed to shelter human beings from different infections through vaccination. One of the most impressive results of modern medicine is the development of highly effective vaccines against SARS-CoV-2 in less than one year from the beginning of the pandemic, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig6>6</a>. Since the appearance of SARS-CoV-2, scientists have tried different ways to develop vaccines and the most significant ones include modified mRNA encoding S-protein (Moderna and BioNTech), the replication-defective viral vector containing the S-protein sequence (Ad5-nCov-CanSino, ChAdOx1 based AZD1222-A-AstraZeneca, GRAd-COV2-Reithera), inactivated pathogenic SARS-CoV-2 (SinoVac, SinoPharm), and recombinant viral subunit proteins (entire S-protein or RBD), Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a>. Among the 10 billion doses delivered, so far the mRNA vaccines from BioNTech and Moderna as well as the viral vector-based vaccine from AstraZeneca and the inactivated vaccines from Sinovac and Sinopharm occupy more than 95% of the market.<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-6 data-title="Heterologous prime-boost strategies with inactivated vaccine (1st) and mRNA vaccine (2nd) provide strong protections against SARS-CoV-2."><figure><figcaption><b id=Fig6 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 6: Heterologous prime-boost strategies with inactivated vaccine (1<sup>st</sup>) and mRNA vaccine (2<sup>nd</sup>) provide strong protections against SARS-CoV-2.</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/6 rel=nofollow><picture><img aria-describedby=Fig6 src="data:image/webp;base64,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" alt="figure 6" loading=lazy srcset sizes width=685 height=474></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-6-desc><p>Inactivated SARS-CoV-2 vaccine reserves all viral proteins for immune recognition. Once immunized, these antigens could elicit a T helper pool broadly targeting SARS-CoV-2 proteins. mRNA vaccine, on the other hand, elicits strong humoral and cellular immune responses against the SARS-CoV-2 variants in individuals who previously received the inactivated vaccine. We hypothesized that the T helper pool primed by inactivated vaccine could be activated upon mRNA vaccination, which facilitates the building of stronger immune response and memory.</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://www.nature.com/articles/s41418-022-01015-x/figures/6 data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><div class=c-article-table data-test=inline-table data-container-section=table id=table-1><figure><figcaption class=c-article-table__figcaption><b id=Tab1 data-test=table-caption>Table 1 Top 20 COVID-19 vaccines in use.</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://www.nature.com/articles/s41418-022-01015-x/tables/1 aria-label="Full size table 1"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>Due to the emergency of the COVID-19 pandemic, scientists did have the minimum sufficient time to evaluate the effectiveness of vaccines developed, and there is large scope for improvement. For example, the interval between doses (21 days for Pfizer; 28 days for Moderna) seems too short, and understanding of the short-lived antibody response (6 months) is still elusive. The cross-reactivity with SARS and MERS might suggest the possibility of a universal pan-coronavirus vaccine. More, as in other vaccinations, there is the possibility that specific commensal microbiota, helminths, nutrients (bile acids, butyrates) or antibiotics, not to mention an immune-suppressive status, might impair the immune response. So far, there are two most popular methods, antibody levels and protection from infection in the real world, to evaluate the effectiveness of a vaccine. Clearly, the antibody is a good predictor and there are epidemiological data supporting a good correlation between the antibody level and disease susceptibility [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 153" title="Zhu F, Althaus T, Tan CW, Costantini A, Chia WN, Van Vinh Chau N, et al. WHO international standard for SARS-CoV-2 antibodies to determine markers of protection. Lancet Microbe. 2022;3:e81–e2." href=#ref-CR153 id=ref-link-section-d261924e2917>153</a>], especially considering the complexity of antibody classes and their kinetics. Since the vaccines can only provide a reduction in severity, there is no good model and specifics to quantitatively analyze and accurately determine the protectability.<p>We have previously hypothesized that “there are many types or subtypes of coronavirus” -or variants. Thus, if vaccines directly targeting SARS-CoV-2 prove to be difficult to develop, the Edward Jenner approach should be considered [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 154" title="Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc Bayl Univ Med Cent. 2005;18:21–5." href=#ref-CR154 id=ref-link-section-d261924e2923>154</a>]. It has been noted that a subset of T cells primed against seasonal coronaviruses cross-react with SARS-CoV-2, and this is believed that it may contribute to clinical protection, particularly in early life. The coronaviruses belong to a family of enveloped single-stranded positive-sense RNA viruses. Available information on cellular immunity to other human coronaviruses (HCoVs), especially those causing the common cold, could be valuable for elucidating immunity to SARS-CoV-2. It is estimated that &gt;90% of adults have experienced prior exposure to common cold viruses. Whether the cellular immunity to other coronaviruses such as SARS-CoV-1 last is still a question, though it has been shown that T cell responses can be elicited after 17 years [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 155" title="Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020;584:457–62." href=#ref-CR155 id=ref-link-section-d261924e2926>155</a>]. Sustained T cell responses have been seen in some patients infected with MERS, though remain to be verified with longitudinal studies in more patients. Considering the wide distribution of horseshoe bats in Southeast Asia and the low SARS-CoV-2 infection rate in the area (3.1% in Southeast Asia, 14.9% in the Americas, and 22.5% In Europe according to the data on WHO COVID-19 Dashboard as of February 2022), it is suggestive that some bat coronavirus(es) may provide natural immunity to native residents. As Edward Jenner did with the cowpox virus to protect humans from smallpox, we may try to identify a bat coronavirus to protect humans from SARS-CoV-2.<p>A successful vaccine relies on various factors such as the identification of the effective epitopes or viral components, the delivery vectors, proper adjuvant, administration routes and the physical and medical conditions of the recipients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 156" title="Tomalka JA, Suthar MS, Deeks SG, Sekaly RP. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Nat Immunol. 2022;23:360–70." href=#ref-CR156 id=ref-link-section-d261924e2932>156</a>]. Even if we have effective vaccines, the vaccination rate in a given time, social acceptability/resistance, and inadequate social distance may allow the virus to present in a population for sufficiently long to mutate [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 157" title="Lobinska G, Pauzner A, Traulsen A, Pilpel Y, Nowak MA. Evolution of resistance to COVID-19 vaccination with dynamic social distancing. Nat Hum Behav. 2022;6:193–206." href=#ref-CR157 id=ref-link-section-d261924e2935>157</a>]. As it stands at the moment, none of the available vaccine formulations seem to be capable of completely preventing virus infection, at least when it comes to highly infective variants such as the Omicron variant. What needs to be considered under these circumstances with often only partial immune protective conditions is that the virus is subjected to an unfavorable situation that may force the virus to mutate.</p></div></div></section><section data-title="What will follow Omicron"><div class=c-article-section id=Sec13-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec13>What will follow Omicron</h2><div class=c-article-section__content id=Sec13-content><p>Among all the variants of SARS-CoV-2, Omicron brings the most worries, confusion, and expectations. The fast transmission rate of the Omicron variant has raised serious concerns among epidemiologists, politicians, and disease control experts since it was first reported from South Africa on November 24, 2021 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 158" title="Kupferschmidt K. Where did ‘weird’ Omicron come from? Science 2021;374:1179." href=#ref-CR158 id=ref-link-section-d261924e2946>158</a>]. Many factors contribute to the fast spread. It is possible that the virus begins to spread shortly after the initial infection and long before the appearance of symptoms. Omicron is approximately 10 times more contagious than wild-type SARS-CoV-2 or 2.8 times as infectious as Delta. The newly emerged new Omicron BA.2 is even more contagious [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 159" title="Kupferschmidt K. Where did 'weird' Omicron come from? Science. 2021;374:1179." href=#ref-CR159 id=ref-link-section-d261924e2949>159</a>]. Mutation analysis of Omicron and its BA.2 variants indicates that their spike proteins carry large amounts of mutations far more than the previous VoC, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>. Of the mutations, D614G is a well-known mutation that confers enhanced infectivity by multiple mechanisms including a bi-modular impact on the stability of spike trimer [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 160" title="Wang C, Zheng Y, Niu Z, Jiang X, Sun Q. The virological impacts of SARS-CoV-2 D614G mutation. J Mol Cell Biol. 2021;13:712–20." href=#ref-CR160 id=ref-link-section-d261924e2955>160</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 161" title="Jiang X, Zhang Z, Wang C, Ren H, Gao L, Peng H, et al. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity. Signal Transduct Target Ther. 2020;5:268–71." href=#ref-CR161 id=ref-link-section-d261924e2958>161</a>]; the mutations in K417 and E484 of the RBD region were believed to alter spike affinity to ACE2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 162" title="Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184:2362–71 e9." href=#ref-CR162 id=ref-link-section-d261924e2962>162</a>]; the N501Y mutation had been shown to change virus tropism by endowing cross-species transmission to mice [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 163" title="Niu Z, Zhang Z, Gao X, Du P, Lu J, Yan B, et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct Target Ther. 2021;6:284." href=#ref-CR163 id=ref-link-section-d261924e2965>163</a>], therefore creating a potential intermediate host that helps virus spreading [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 164" title="Huang H, Zhu Y, Niu Z, Zhou L, Sun Q. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse. Cell Death Differ. 2021;28:2840–2." href=#ref-CR164 id=ref-link-section-d261924e2968>164</a>]. Indeed, latest studies identified Omicron infection in rats and mice [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Kok KH, Wong SC, Chan WM, Wen L, Chu AW, Ip JD, et al. Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong. Emerg Microbes Infect. 2022;11:689–98." href=#ref-CR165 id=ref-link-section-d261924e2971>165</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zhang YN, Zhang ZR, Zhang HQ, Li N, Zhang QY, Li XD, et al. Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters. Signal Transduct Target Ther. 2022;7:62." href=#ref-CR166 id=ref-link-section-d261924e2971_1>166</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 167" title="Shuai H, Chan JF, Yuen TT, Yoon C, Hu JC, Wen L, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021;73:103643." href=#ref-CR167 id=ref-link-section-d261924e2974>167</a>], supporting the zoonotic transmission of the new SARS-CoV-2 variant of concerns. It is expected that the mutations in the Omicron RBD together altered the affinity to ACE2, however, protein structural analysis did not find a higher affinity [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 168" title="Han P, Li L, Liu S, Wang Q, Zhang D, Xu Z, et al. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell. 2022;185:630–40 e10." href=#ref-CR168 id=ref-link-section-d261924e2977>168</a>]. The contributing factors to the highly contagious nature remain a mystery. Nevertheless, the high ability to spread and the seemingly less pathogenicity have ignited the hope of herd immunity and the ending of the pandemic. The question is whether Omicron is indeed less pathogenic now but can acquire increased pathogenicity through further mutations. There is no guarantee that the next variant will be milder. The most worrisome is the appearance of Deltacron, which has the backbone of the Delta variant and the spike of Omicron. Information on the transmission speed and pathogenicity of Deltacron is urgently needed.<p>There is a lot of debate regarding the effectiveness of the existing vaccines against Omicron. Almost all vaccine-induced immunity could be invaded by the Omicron variant. Due to their lower ability to induce antibodies, the inactivated vaccines are believed to be not as effective in providing protection against infection. Scientists are waiting for the recent information on the disease severity of patients infected with Omicron from China mainland, where nearly 90% have received inactivated vaccines, and that from Hong Kong, where the majority of people are immunized with the RNA vaccines. It should be noted that a multinational study showed that recipients immunized first with inactivated vaccine followed by an RNA vaccine showed the highest RBD specific antibody and Omicron specific T cells as compared to two immunizations with a single vaccine type. May inactivated vaccine induces more T helper cells due to being presented by MHC class II, Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig6>6</a>? It has been reported that heterologous immunization with inactivated vaccine followed by an mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 169" title="Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-Mata L, et al. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nature Communications. 2022;13:2670." href=#ref-CR169 id=ref-link-section-d261924e2986>169</a>].<p>Finally, how will the COVID-19 pandemic end? Will Omicron be the last variant? If not, what properties will the next variant have? The biggest question is whether COVID-19 will become endemic. We just hope that, with the immunity built up by vaccination and infection in the population, the endemic is not as deadly. Clearly, we have to learn the new routines of SARS-CoV-2.</p></div></div></section>
 
 <div id=MagazineFulltextArticleBodySuffix><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=1.><p class=c-article-references__text id=ref-CR1>Chen J, Lu H, Melino G, Boccia S, Piacentini M, Ricciardi W, et al. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020;11:438.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFemtbvJ aria-label="CAS reference 1">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32513951" aria-label="PubMed reference 1">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278221 aria-label="PubMed Central reference 1">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41419-020-2603-0 aria-label="Article reference 1">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20infection%3A%20the%20China%20and%20Italy%20perspectives&amp;journal=Cell%20Death%20Dis&amp;volume=11&amp;publication_year=2020&amp;author=Chen%2CJ&amp;author=Lu%2CH&amp;author=Melino%2CG&amp;author=Boccia%2CS&amp;author=Piacentini%2CM&amp;author=Ricciardi%2CW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=2.><p class=c-article-references__text id=ref-CR2>Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28:3125–39.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXht1SmtLrM aria-label="CAS reference 2">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34031543" aria-label="PubMed reference 2">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142290 aria-label="PubMed Central reference 2">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00805-z aria-label="Article reference 2">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Patients%20with%20COVID-19%3A%20in%20the%20dark-NETs%20of%20neutrophils&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=3125-39&amp;publication_year=2021&amp;author=Ackermann%2CM&amp;author=Anders%2CHJ&amp;author=Bilyy%2CR&amp;author=Bowlin%2CGL&amp;author=Daniel%2CC&amp;author=Lorenzo%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=3.><p class=c-article-references__text id=ref-CR3>Goubet AG, Dubuisson A, Geraud A, Danlos FX, Terrisse S, Silva CAC, et al. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021;28:3297–315.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsFGht73F aria-label="CAS reference 3">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34230615" aria-label="PubMed reference 3">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259103 aria-label="PubMed Central reference 3">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00817-9 aria-label="Article reference 3">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Prolonged%20SARS-CoV-2%20RNA%20virus%20shedding%20and%20lymphopenia%20are%20hallmarks%20of%20COVID-19%20in%20cancer%20patients%20with%20poor%20prognosis&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=3297-315&amp;publication_year=2021&amp;author=Goubet%2CAG&amp;author=Dubuisson%2CA&amp;author=Geraud%2CA&amp;author=Danlos%2CFX&amp;author=Terrisse%2CS&amp;author=Silva%2CCAC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=4.><p class=c-article-references__text id=ref-CR4>Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K, Mak TW. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020;27:3209–25.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVKhu7jM aria-label="CAS reference 4">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33037393" aria-label="PubMed reference 4">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-020-00633-7 aria-label="Article reference 4">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20aberrant%20STAT%20pathway%20is%20central%20to%20COVID-19&amp;journal=Cell%20Death%20Differ&amp;volume=27&amp;pages=3209-25&amp;publication_year=2020&amp;author=Matsuyama%2CT&amp;author=Kubli%2CSP&amp;author=Yoshinaga%2CSK&amp;author=Pfeffer%2CK&amp;author=Mak%2CTW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=5.><p class=c-article-references__text id=ref-CR5>Matsuyama T, Yoshinaga SK, Shibue K, Mak TW. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 2021;28:3199–213.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXit12mt7fI aria-label="CAS reference 5">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34663907" aria-label="PubMed reference 5">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522258 aria-label="PubMed Central reference 5">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00892-y aria-label="Article reference 5">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Comorbidity-associated%20glutamine%20deficiency%20is%20a%20predisposition%20to%20severe%20COVID-19&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=3199-213&amp;publication_year=2021&amp;author=Matsuyama%2CT&amp;author=Yoshinaga%2CSK&amp;author=Shibue%2CK&amp;author=Mak%2CTW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=6.><p class=c-article-references__text id=ref-CR6>Verkhratsky A, Li Q, Melino S, Melino G, Shi Y. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct. 2020;15:28.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVGks73K aria-label="CAS reference 6">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33246479" aria-label="PubMed reference 6">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691955 aria-label="PubMed Central reference 6">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs13062-020-00282-3 aria-label="Article reference 6">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Can%20COVID-19%20pandemic%20boost%20the%20epidemic%20of%20neurodegenerative%20diseases%3F&amp;journal=Biol%20Direct&amp;volume=15&amp;publication_year=2020&amp;author=Verkhratsky%2CA&amp;author=Li%2CQ&amp;author=Melino%2CS&amp;author=Melino%2CG&amp;author=Shi%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=7.><p class=c-article-references__text id=ref-CR7>Murray CJL, Piot P. The potential future of the COVID-19 pandemic: will SARS-CoV-2 become a recurrent seasonal infection? JAMA. 2021;325:1249–50.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXosVWisrc%3D aria-label="CAS reference 7">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33656519" aria-label="PubMed reference 7">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjama.2021.2828 aria-label="Article reference 7">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20potential%20future%20of%20the%20COVID-19%20pandemic%3A%20will%20SARS-CoV-2%20become%20a%20recurrent%20seasonal%20infection%3F&amp;journal=JAMA.&amp;volume=325&amp;pages=1249-50&amp;publication_year=2021&amp;author=Murray%2CCJL&amp;author=Piot%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=8.><p class=c-article-references__text id=ref-CR8>Buonvino S, Melino S. New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion. Cell Death Disco. 2020;6:134.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFentrrN aria-label="CAS reference 8">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41420-020-00372-1 aria-label="Article reference 8">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=New%20Consensus%20pattern%20in%20Spike%20CoV-2%3A%20potential%20implications%20in%20coagulation%20process%20and%20cell-cell%20fusion&amp;journal=Cell%20Death%20Disco&amp;volume=6&amp;publication_year=2020&amp;author=Buonvino%2CS&amp;author=Melino%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=9.><p class=c-article-references__text id=ref-CR9>Colson P, Fournier PE, Delerce J, Million M, Bedotto M, Houhamdi L, et al. Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France. J Med Virol. 2022. Online ahead of print.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=10.><p class=c-article-references__text id=ref-CR10>Forni G, Mantovani A. Covid-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28:626–39.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXit1yqtLY%3D aria-label="CAS reference 10">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33479399" aria-label="PubMed reference 10">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818063 aria-label="PubMed Central reference 10">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-020-00720-9 aria-label="Article reference 10">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Covid-19%20Commission%20of%20Accademia%20Nazionale%20dei%20Lincei%20R.%20COVID-19%20vaccines%3A%20where%20we%20stand%20and%20challenges%20ahead&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=626-39&amp;publication_year=2021&amp;author=Forni%2CG&amp;author=Mantovani%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=11.><p class=c-article-references__text id=ref-CR11>Lin L, Wang Y, Li Q, Hu M, Shi Y. Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence. Cell Death Differ. 2022;29:263–5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xhs1agsr0%3D aria-label="CAS reference 11">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35039647" aria-label="PubMed reference 11">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761837 aria-label="PubMed Central reference 11">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00909-6 aria-label="Article reference 11">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Novel%20SARS-CoV-2%20therapeutic%20targets%3A%20RNA%20proofreading%20complex%20and%20virus-induced%20senescence&amp;journal=Cell%20Death%20Differ&amp;volume=29&amp;pages=263-5&amp;publication_year=2022&amp;author=Lin%2CL&amp;author=Wang%2CY&amp;author=Li%2CQ&amp;author=Hu%2CM&amp;author=Shi%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=12.><p class=c-article-references__text id=ref-CR12>Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXmvVShurg%3D aria-label="CAS reference 12">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32205856" aria-label="PubMed reference 12">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091918 aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-020-0530-3 aria-label="Article reference 12">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20infection%3A%20the%20perspectives%20on%20immune%20responses&amp;journal=Cell%20Death%20Differ&amp;volume=27&amp;pages=1451-4&amp;publication_year=2020&amp;author=Shi%2CY&amp;author=Wang%2CY&amp;author=Shao%2CC&amp;author=Huang%2CJ&amp;author=Gan%2CJ&amp;author=Huang%2CX">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=13.><p class=c-article-references__text id=ref-CR13>Mauriello A, Scimeca M, Amelio I, Massoud R, Novelli A, Di Lorenzo F, et al. Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia. Cell Death Dis. 2021;12:762.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhslarsLzI aria-label="CAS reference 13">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34344867" aria-label="PubMed reference 13">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328816 aria-label="PubMed Central reference 13">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41419-021-04058-z aria-label="Article reference 13">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Thromboembolism%20after%20COVID-19%20vaccine%20in%20patients%20with%20preexisting%20thrombocytopenia&amp;journal=Cell%20Death%20Dis&amp;volume=12&amp;publication_year=2021&amp;author=Mauriello%2CA&amp;author=Scimeca%2CM&amp;author=Amelio%2CI&amp;author=Massoud%2CR&amp;author=Novelli%2CA&amp;author=Lorenzo%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=14.><p class=c-article-references__text id=ref-CR14>Telenti A, Arvin A, Corey L, Corti D, Diamond MS, Garcia-Sastre A, et al. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021;596:495–504.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvVaktrrP aria-label="CAS reference 14">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34237771" aria-label="PubMed reference 14">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-021-03792-w aria-label="Article reference 14">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=After%20the%20pandemic%3A%20perspectives%20on%20the%20future%20trajectory%20of%20COVID-19&amp;journal=Nature.&amp;volume=596&amp;pages=495-504&amp;publication_year=2021&amp;author=Telenti%2CA&amp;author=Arvin%2CA&amp;author=Corey%2CL&amp;author=Corti%2CD&amp;author=Diamond%2CMS&amp;author=Garcia-Sastre%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=15.><p class=c-article-references__text id=ref-CR15>Sacco G, Briere O, Asfar M, Guerin O, Berrut G, Annweiler C. Symptoms of COVID-19 among older adults: a systematic review of biomedical literature. Geriatr. Psychol Neuropsychiatr Vieil. 2020;18:135–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Symptoms%20of%20COVID-19%20among%20older%20adults%3A%20a%20systematic%20review%20of%20biomedical%20literature.%20Geriatr&amp;journal=Psychol%20Neuropsychiatr%20Vieil&amp;volume=18&amp;pages=135-9&amp;publication_year=2020&amp;author=Sacco%2CG&amp;author=Briere%2CO&amp;author=Asfar%2CM&amp;author=Guerin%2CO&amp;author=Berrut%2CG&amp;author=Annweiler%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=16.><p class=c-article-references__text id=ref-CR16>Dehingia N, Raj A. Sex differences in COVID-19 case fatality: do we know enough? Lancet. Glob Health. 2021;9:e14–e5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Sex%20differences%20in%20COVID-19%20case%20fatality%3A%20do%20we%20know%20enough%3F%20Lancet&amp;journal=Glob%20Health&amp;volume=9&amp;pages=e14-e5.&amp;publication_year=2021&amp;author=Dehingia%2CN&amp;author=Raj%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=17.><p class=c-article-references__text id=ref-CR17>Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32868984" aria-label="PubMed reference 17">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453673 aria-label="PubMed Central reference 17">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs40794-020-00118-y aria-label="Article reference 17">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20in%20adult%20patients%20with%20pre-existing%20chronic%20cardiac%2C%20respiratory%20and%20metabolic%20disease%3A%20a%20critical%20literature%20review%20with%20clinical%20recommendations&amp;journal=Trop%20Dis%20Travel%20Med%20Vaccines&amp;volume=6&amp;publication_year=2020&amp;author=Flaherty%2CGT&amp;author=Hession%2CP&amp;author=Liew%2CCH&amp;author=Lim%2CBCW&amp;author=Leong%2CTK&amp;author=Lim%2CV">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=18.><p class=c-article-references__text id=ref-CR18>Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXis1yhsrfN aria-label="CAS reference 18">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34871545" aria-label="PubMed reference 18">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640673 aria-label="PubMed Central reference 18">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0140-6736%2821%2902758-6 aria-label="Article reference 18">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Omicron%20SARS-CoV-2%20variant%3A%20a%20new%20chapter%20in%20the%20COVID-19%20pandemic&amp;journal=Lancet.&amp;volume=398&amp;pages=2126-8&amp;publication_year=2021&amp;author=Karim%2CSSA&amp;author=Karim%2CQA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=19.><p class=c-article-references__text id=ref-CR19>Kozlov M. Omicron’s feeble attack on the lungs could make it less dangerous. Nature. 2022;601:177.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XpvFarsA%3D%3D aria-label="CAS reference 19">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34987210" aria-label="PubMed reference 19">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fd41586-022-00007-8 aria-label="Article reference 19">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Omicron%E2%80%99s%20feeble%20attack%20on%20the%20lungs%20could%20make%20it%20less%20dangerous&amp;journal=Nature.&amp;volume=601&amp;publication_year=2022&amp;author=Kozlov%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=20.><p class=c-article-references__text id=ref-CR20>Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhvFCru7Y%3D aria-label="CAS reference 20">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35065011" aria-label="PubMed reference 20">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769664 aria-label="PubMed Central reference 20">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0140-6736%2822%2900017-4 aria-label="Article reference 20">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Early%20assessment%20of%20the%20clinical%20severity%20of%20the%20SARS-CoV-2%20omicron%20variant%20in%20South%20Africa%3A%20a%20data%20linkage%20study&amp;journal=Lancet.&amp;volume=399&amp;pages=437-46&amp;publication_year=2022&amp;author=Wolter%2CN&amp;author=Jassat%2CW&amp;author=Walaza%2CS&amp;author=Welch%2CR&amp;author=Moultrie%2CH&amp;author=Groome%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=21.><p class=c-article-references__text id=ref-CR21>Irving AT, Ahn M, Goh G, Anderson DE, Wang LF. Lessons from the host defences of bats, a unique viral reservoir. Nature. 2021;589:363–70.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1yqtLs%3D aria-label="CAS reference 21">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33473223" aria-label="PubMed reference 21">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-020-03128-0 aria-label="Article reference 21">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Lessons%20from%20the%20host%20defences%20of%20bats%2C%20a%20unique%20viral%20reservoir&amp;journal=Nature.&amp;volume=589&amp;pages=363-70&amp;publication_year=2021&amp;author=Irving%2CAT&amp;author=Ahn%2CM&amp;author=Goh%2CG&amp;author=Anderson%2CDE&amp;author=Wang%2CLF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=22.><p class=c-article-references__text id=ref-CR22>Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10:e17.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XislGgtLY%3D aria-label="CAS reference 22">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34929158" aria-label="PubMed reference 22">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS2213-2600%2821%2900559-2 aria-label="Article reference 22">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Omicron%20variant%20and%20booster%20COVID-19%20vaccines&amp;journal=Lancet%20Respir%20Med&amp;volume=10&amp;publication_year=2022&amp;author=Burki%2CTK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=23.><p class=c-article-references__text id=ref-CR23>Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022. Online ahead of print.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=24.><p class=c-article-references__text id=ref-CR24>Moncunill G, Mayor A, Santano R, Jimenez A, Vidal M, Tortajada M, et al. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a spanish hospital after 3 months of follow-up. J Infect Dis. 2021;223:62–71.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXotVejsw%3D%3D aria-label="CAS reference 24">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33175145" aria-label="PubMed reference 24">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1093%2Finfdis%2Fjiaa696 aria-label="Article reference 24">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20seroprevalence%20and%20antibody%20kinetics%20among%20health%20care%20workers%20in%20a%20spanish%20hospital%20after%203%20months%20of%20follow-up&amp;journal=J%20Infect%20Dis&amp;volume=223&amp;pages=62-71&amp;publication_year=2021&amp;author=Moncunill%2CG&amp;author=Mayor%2CA&amp;author=Santano%2CR&amp;author=Jimenez%2CA&amp;author=Vidal%2CM&amp;author=Tortajada%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=25.><p class=c-article-references__text id=ref-CR25>Zipeto D, Palmeira JDF, Arganaraz GA, Arganaraz ER. ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19. Front Immunol. 2020;11:576745.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1CntL7L aria-label="CAS reference 25">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33117379" aria-label="PubMed reference 25">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575774 aria-label="PubMed Central reference 25">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.3389%2Ffimmu.2020.576745 aria-label="Article reference 25">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=ACE2%2FADAM17%2FTMPRSS2%20interplay%20may%20be%20the%20main%20risk%20factor%20for%20COVID-19&amp;journal=Front%20Immunol&amp;volume=11&amp;publication_year=2020&amp;author=Zipeto%2CD&amp;author=Palmeira%2CJDF&amp;author=Arganaraz%2CGA&amp;author=Arganaraz%2CER">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=26.><p class=c-article-references__text id=ref-CR26>Callaway E. Scientists deliberately gave people COVID - here’s what they learnt. Nature. 2022;602:191–2.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XjtFSrsL0%3D aria-label="CAS reference 26">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35110709" aria-label="PubMed reference 26">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fd41586-022-00319-9 aria-label="Article reference 26">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Scientists%20deliberately%20gave%20people%20COVID%20-%20here%E2%80%99s%20what%20they%20learnt&amp;journal=Nature.&amp;volume=602&amp;pages=191-2&amp;publication_year=2022&amp;author=Callaway%2CE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=27.><p class=c-article-references__text id=ref-CR27>Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419–40 e23.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1WqsL7P aria-label="CAS reference 27">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32810438" aria-label="PubMed reference 27">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405822 aria-label="PubMed Central reference 27">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2020.08.001 aria-label="Article reference 27">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Severe%20COVID-19%20is%20marked%20by%20a%20dysregulated%20myeloid%20cell%20compartment&amp;journal=Cell.&amp;volume=182&amp;pages=1419-40%20e23&amp;publication_year=2020&amp;author=Schulte-Schrepping%2CJ&amp;author=Reusch%2CN&amp;author=Paclik%2CD&amp;author=Bassler%2CK&amp;author=Schlickeiser%2CS&amp;author=Zhang%2CB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=28.><p class=c-article-references__text id=ref-CR28>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=29.><p class=c-article-references__text id=ref-CR29>Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522–34.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFWmsLbF aria-label="CAS reference 29">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32558485" aria-label="PubMed reference 29">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1056%2FNEJMoa2020283 aria-label="Article reference 29">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Genomewide%20association%20study%20of%20severe%20Covid-19%20with%20respiratory%20failure&amp;journal=N%20Engl%20J%20Med&amp;volume=383&amp;pages=1522-34&amp;publication_year=2020&amp;author=Ellinghaus%2CD&amp;author=Degenhardt%2CF&amp;author=Bujanda%2CL&amp;author=Buti%2CM&amp;author=Albillos%2CA&amp;author=Invernizzi%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=30.><p class=c-article-references__text id=ref-CR30>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107–13.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtFOltbbL aria-label="CAS reference 30">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33915569" aria-label="PubMed reference 30">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919505 aria-label="PubMed Central reference 30">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-021-03570-8 aria-label="Article reference 30">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20tissue%20atlases%20reveal%20SARS-CoV-2%20pathology%20and%20cellular%20targets&amp;journal=Nature.&amp;volume=595&amp;pages=107-13.&amp;publication_year=2021&amp;author=Delorey%2CTM&amp;author=Ziegler%2CCGK&amp;author=Heimberg%2CG&amp;author=Normand%2CR&amp;author=Yang%2CY&amp;author=Segerstolpe%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=31.><p class=c-article-references__text id=ref-CR31>Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671–92.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXntFOrtrw%3D aria-label="CAS reference 31">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33743212" aria-label="PubMed reference 31">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885626 aria-label="PubMed Central reference 31">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2021.02.029 aria-label="Article reference 31">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20and%20the%20human%20innate%20immune%20system&amp;journal=Cell&amp;volume=184&amp;pages=1671-92&amp;publication_year=2021&amp;author=Schultze%2CJL&amp;author=Aschenbrenner%2CAC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=32.><p class=c-article-references__text id=ref-CR32>Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M, et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight. 2021;6:e150542.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=33.><p class=c-article-references__text id=ref-CR33>van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663–73.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32706371" aria-label="PubMed reference 33">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjama.2020.13719 aria-label="Article reference 33">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1GmtbjJ aria-label="CAS reference 33">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Presence%20of%20genetic%20variants%20among%20young%20men%20with%20severe%20COVID-19&amp;journal=JAMA.&amp;volume=324&amp;pages=663-73&amp;publication_year=2020&amp;author=Made%2CCI&amp;author=Simons%2CA&amp;author=Schuurs-Hoeijmakers%2CJ&amp;author=Heuvel%2CG&amp;author=Mantere%2CT&amp;author=Kersten%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=34.><p class=c-article-references__text id=ref-CR34>Lu Q, Liu J, Zhao S, Gomez Castro MF, Laurent-Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304–19 e9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtFOrsr3K aria-label="CAS reference 34">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34048708" aria-label="PubMed reference 34">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106883 aria-label="PubMed Central reference 34">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.immuni.2021.05.006 aria-label="Article reference 34">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20exacerbates%20proinflammatory%20responses%20in%20myeloid%20cells%20through%20C-type%20lectin%20receptors%20and%20Tweety%20family%20member%202&amp;journal=Immunity.&amp;volume=54&amp;pages=1304-19%20e9&amp;publication_year=2021&amp;author=Lu%2CQ&amp;author=Liu%2CJ&amp;author=Zhao%2CS&amp;author=Gomez%20Castro%2CMF&amp;author=Laurent-Rolle%2CM&amp;author=Dong%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=35.><p class=c-article-references__text id=ref-CR35>Lempp FA, Soriaga LB, Montiel-Ruiz M, Benigni F, Noack J, Park YJ, et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021;598:342–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXit1Whs7vP aria-label="CAS reference 35">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34464958" aria-label="PubMed reference 35">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-021-03925-1 aria-label="Article reference 35">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Lectins%20enhance%20SARS-CoV-2%20infection%20and%20influence%20neutralizing%20antibodies&amp;journal=Nature.&amp;volume=598&amp;pages=342-7&amp;publication_year=2021&amp;author=Lempp%2CFA&amp;author=Soriaga%2CLB&amp;author=Montiel-Ruiz%2CM&amp;author=Benigni%2CF&amp;author=Noack%2CJ&amp;author=Park%2CYJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=36.><p class=c-article-references__text id=ref-CR36>Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23:275–86.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XisVCmsbY%3D aria-label="CAS reference 36">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35102342" aria-label="PubMed reference 36">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-021-01114-w aria-label="Article reference 36">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Recognition%20and%20inhibition%20of%20SARS-CoV-2%20by%20humoral%20innate%20immunity%20pattern%20recognition%20molecules&amp;journal=Nat%20Immunol&amp;volume=23&amp;pages=275-86&amp;publication_year=2022&amp;author=Stravalaci%2CM&amp;author=Pagani%2CI&amp;author=Paraboschi%2CEM&amp;author=Pedotti%2CM&amp;author=Doni%2CA&amp;author=Scavello%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=37.><p class=c-article-references__text id=ref-CR37>Chiodo F, Bruijns S, Rodriguez E, Eveline Li RJ, Molinaro A, Silipo A, et al. Novel ACE2-independent carbohydrate-binding of SARS-CoV-2 spike protein to host lectins and lung microbiota. Preprint at <a href=https://www.biorxiv.org/content/10.1101/2020.05.13.092478v1>https://www.biorxiv.org/content/10.1101/2020.05.13.092478v1</a>. 2020.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=38.><p class=c-article-references__text id=ref-CR38>Muus C, Luecken MD, Eraslan G, Sikkema L, Waghray A, Heimberg G, et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med. 2021;27:546–59.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXlsFehsrw%3D aria-label="CAS reference 38">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33654293" aria-label="PubMed reference 38">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41591-020-01227-z aria-label="Article reference 38">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Single-cell%20meta-analysis%20of%20SARS-CoV-2%20entry%20genes%20across%20tissues%20and%20demographics&amp;journal=Nat%20Med&amp;volume=27&amp;pages=546-59&amp;publication_year=2021&amp;author=Muus%2CC&amp;author=Luecken%2CMD&amp;author=Eraslan%2CG&amp;author=Sikkema%2CL&amp;author=Waghray%2CA&amp;author=Heimberg%2CG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=39.><p class=c-article-references__text id=ref-CR39>Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635–41.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjslKnsLg%3D aria-label="CAS reference 39">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33429418" aria-label="PubMed reference 39">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987233 aria-label="PubMed Central reference 39">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-020-03148-w aria-label="Article reference 39">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Circuits%20between%20infected%20macrophages%20and%20T%20cells%20in%20SARS-CoV-2%20pneumonia&amp;journal=Nature.&amp;volume=590&amp;pages=635-41&amp;publication_year=2021&amp;author=Grant%2CRA&amp;author=Morales-Nebreda%2CL&amp;author=Markov%2CNS&amp;author=Swaminathan%2CS&amp;author=Querrey%2CM&amp;author=Guzman%2CER">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=40.><p class=c-article-references__text id=ref-CR40>van Beek AA, Van den Bossche J, Mastroberardino PG, de Winther MPJ, Leenen PJM. Metabolic alterations in aging macrophages: ingredients for inflammaging? Trends Immunol. 2019;40:113–27.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30626541" aria-label="PubMed reference 40">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.it.2018.12.007 aria-label="Article reference 40">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXnt1I%3D aria-label="CAS reference 40">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Metabolic%20alterations%20in%20aging%20macrophages%3A%20ingredients%20for%20inflammaging%3F&amp;journal=Trends%20Immunol&amp;volume=40&amp;pages=113-27&amp;publication_year=2019&amp;author=Beek%2CAA&amp;author=Bossche%2CJ&amp;author=Mastroberardino%2CPG&amp;author=Winther%2CMPJ&amp;author=Leenen%2CPJM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=41.><p class=c-article-references__text id=ref-CR41>Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123–47.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvVSrtr%2FL aria-label="CAS reference 41">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31530089" aria-label="PubMed reference 41">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1146%2Fannurev-pathmechdis-012418-012718 aria-label="Article reference 41">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Diversity%2C%20mechanisms%2C%20and%20significance%20of%20macrophage%20plasticity&amp;journal=Annu%20Rev%20Pathol&amp;volume=15&amp;pages=123-47&amp;publication_year=2020&amp;author=Locati%2CM&amp;author=Curtale%2CG&amp;author=Mantovani%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=42.><p class=c-article-references__text id=ref-CR42>Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40:274–88.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXisFWjtLc%3D aria-label="CAS reference 42">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24530056" aria-label="PubMed reference 42">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991396 aria-label="PubMed Central reference 42">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.immuni.2014.01.006 aria-label="Article reference 42">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Transcriptome-based%20network%20analysis%20reveals%20a%20spectrum%20model%20of%20human%20macrophage%20activation&amp;journal=Immunity.&amp;volume=40&amp;pages=274-88&amp;publication_year=2014&amp;author=Xue%2CJ&amp;author=Schmidt%2CSV&amp;author=Sander%2CJ&amp;author=Draffehn%2CA&amp;author=Krebs%2CW&amp;author=Quester%2CI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=43.><p class=c-article-references__text id=ref-CR43>Mantovani A, Netea MG. Trained innate immunity, epigenetics, and Covid-19. N Engl J Med. 2020;383:1078–80.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvVejurnL aria-label="CAS reference 43">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32905684" aria-label="PubMed reference 43">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1056%2FNEJMcibr2011679 aria-label="Article reference 43">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Trained%20innate%20immunity%2C%20epigenetics%2C%20and%20Covid-19&amp;journal=N%20Engl%20J%20Med&amp;volume=383&amp;pages=1078-80&amp;publication_year=2020&amp;author=Mantovani%2CA&amp;author=Netea%2CMG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=44.><p class=c-article-references__text id=ref-CR44>Habibzadeh F, Sajadi MM, Chumakov K, Yadollahie M, Kottilil S, Simi A, et al. COVID-19 infection among women in iran exposed vs unexposed to children who received attenuated poliovirus used in oral polio vaccine. JAMA Netw Open. 2021;4:e2135044.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34817583" aria-label="PubMed reference 44">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613592 aria-label="PubMed Central reference 44">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjamanetworkopen.2021.35044 aria-label="Article reference 44">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20infection%20among%20women%20in%20iran%20exposed%20vs%20unexposed%20to%20children%20who%20received%20attenuated%20poliovirus%20used%20in%20oral%20polio%20vaccine&amp;journal=JAMA%20Netw%20Open&amp;volume=4&amp;publication_year=2021&amp;author=Habibzadeh%2CF&amp;author=Sajadi%2CMM&amp;author=Chumakov%2CK&amp;author=Yadollahie%2CM&amp;author=Kottilil%2CS&amp;author=Simi%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=45.><p class=c-article-references__text id=ref-CR45>Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243–61 e27.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXislKhtrvF aria-label="CAS reference 45">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34914922" aria-label="PubMed reference 45">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626230 aria-label="PubMed Central reference 45">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2021.11.033 aria-label="Article reference 45">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20infection%20triggers%20profibrotic%20macrophage%20responses%20and%20lung%20fibrosis&amp;journal=Cell.&amp;volume=184&amp;pages=6243-61%20e27&amp;publication_year=2021&amp;author=Wendisch%2CD&amp;author=Dietrich%2CO&amp;author=Mari%2CT&amp;author=Stillfried%2CS&amp;author=Ibarra%2CIL&amp;author=Mittermaier%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=46.><p class=c-article-references__text id=ref-CR46>Kramer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-Garcia R, et al. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–69 e14.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34592166" aria-label="PubMed reference 46">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416549 aria-label="PubMed Central reference 46">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.immuni.2021.09.002 aria-label="Article reference 46">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXitFCitbzN aria-label="CAS reference 46">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Early%20IFN-alpha%20signatures%20and%20persistent%20dysfunction%20are%20distinguishing%20features%20of%20NK%20cells%20in%20severe%20COVID-19&amp;journal=Immunity.&amp;volume=54&amp;pages=2650-69%20e14&amp;publication_year=2021&amp;author=Kramer%2CB&amp;author=Knoll%2CR&amp;author=Bonaguro%2CL&amp;author=ToVinh%2CM&amp;author=Raabe%2CJ&amp;author=Astaburuaga-Garcia%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=47.><p class=c-article-references__text id=ref-CR47>Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295–301.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFyrt7nN aria-label="CAS reference 47">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34695836" aria-label="PubMed reference 47">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-021-04142-6 aria-label="Article reference 47">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Untimely%20TGFbeta%20responses%20in%20COVID-19%20limit%20antiviral%20functions%20of%20NK%20cells&amp;journal=Nature.&amp;volume=600&amp;pages=295-301&amp;publication_year=2021&amp;author=Witkowski%2CM&amp;author=Tizian%2CC&amp;author=Ferreira-Gomes%2CM&amp;author=Niemeyer%2CD&amp;author=Jones%2CTC&amp;author=Heinrich%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=48.><p class=c-article-references__text id=ref-CR48>Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity. 2020;53:1296–314 e9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFeltL3P aria-label="CAS reference 48">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33296687" aria-label="PubMed reference 48">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689306 aria-label="PubMed Central reference 48">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.immuni.2020.11.017 aria-label="Article reference 48">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Longitudinal%20multi-omics%20analyses%20identify%20responses%20of%20megakaryocytes%2C%20erythroid%20cells%2C%20and%20plasmablasts%20as%20hallmarks%20of%20severe%20COVID-19&amp;journal=Immunity.&amp;volume=53&amp;pages=1296-314%20e9&amp;publication_year=2020&amp;author=Bernardes%2CJP&amp;author=Mishra%2CN&amp;author=Tran%2CF&amp;author=Bahmer%2CT&amp;author=Best%2CL&amp;author=Blase%2CJI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=49.><p class=c-article-references__text id=ref-CR49>Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185:493–512 e25.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFOqu78%3D aria-label="CAS reference 49">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35032429" aria-label="PubMed reference 49">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2021.12.040 aria-label="Article reference 49">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Complement%20activation%20induces%20excessive%20T%20cell%20cytotoxicity%20in%20severe%20COVID-19&amp;journal=Cell.&amp;volume=185&amp;pages=493-512%20e25&amp;publication_year=2022&amp;author=Georg%2CP&amp;author=Astaburuaga-Garcia%2CR&amp;author=Bonaguro%2CL&amp;author=Brumhard%2CS&amp;author=Michalick%2CL&amp;author=Lippert%2CLJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=50.><p class=c-article-references__text id=ref-CR50>Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–83.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXlsVSmsrc%3D aria-label="CAS reference 50">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19968561" aria-label="PubMed reference 50">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1146%2Fannurev-immunol-030409-101305 aria-label="Article reference 50">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20integrated%20view%20of%20humoral%20innate%20immunity%3A%20pentraxins%20as%20a%20paradigm&amp;journal=Annu%20Rev%20Immunol&amp;volume=28&amp;pages=157-83&amp;publication_year=2010&amp;author=Bottazzi%2CB&amp;author=Doni%2CA&amp;author=Garlanda%2CC&amp;author=Mantovani%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=51.><p class=c-article-references__text id=ref-CR51>Garlanda C, Bottazzi B, Magrini E, Inforzato A, Mantovani A. PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiol Rev. 2018;98:623–39.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXjslSmt70%3D aria-label="CAS reference 51">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29412047" aria-label="PubMed reference 51">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1152%2Fphysrev.00016.2017 aria-label="Article reference 51">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=PTX3%2C%20a%20humoral%20pattern%20recognition%20molecule%2C%20in%20innate%20immunity%2C%20tissue%20repair%2C%20and%20cancer&amp;journal=Physiol%20Rev&amp;volume=98&amp;pages=623-39&amp;publication_year=2018&amp;author=Garlanda%2CC&amp;author=Bottazzi%2CB&amp;author=Magrini%2CE&amp;author=Inforzato%2CA&amp;author=Mantovani%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=52.><p class=c-article-references__text id=ref-CR52>Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021;22:19–24.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33208929" aria-label="PubMed reference 52">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-020-00832-x aria-label="Article reference 52">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=Macrophage%20expression%20and%20prognostic%20significance%20of%20the%20long%20pentraxin%20PTX3%20in%20COVID-19&amp;journal=Nat%20Immunol&amp;volume=22&amp;pages=19-24&amp;publication_year=2021&amp;author=Brunetta%2CE&amp;author=Folci%2CM&amp;author=Bottazzi%2CB&amp;author=Santis%2CM&amp;author=Gritti%2CG&amp;author=Protti%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=53.><p class=c-article-references__text id=ref-CR53>Gritti G, Raimondi F, Bottazzi B, Ripamonti D, Riva I, Landi F, et al. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021;35:2710–4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXht1SmtL3L aria-label="CAS reference 53">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34031531" aria-label="PubMed reference 53">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142063 aria-label="PubMed Central reference 53">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41375-021-01299-x aria-label="Article reference 53">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Siltuximab%20downregulates%20interleukin-8%20and%20pentraxin%203%20to%20improve%20ventilatory%20status%20and%20survival%20in%20severe%20COVID-19&amp;journal=Leukemia.&amp;volume=35&amp;pages=2710-4&amp;publication_year=2021&amp;author=Gritti%2CG&amp;author=Raimondi%2CF&amp;author=Bottazzi%2CB&amp;author=Ripamonti%2CD&amp;author=Riva%2CI&amp;author=Landi%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=54.><p class=c-article-references__text id=ref-CR54>Gutmann C, Takov K, Burnap SA, Singh B, Ali H, Theofilatos K, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021;12:3406.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtlegt7zL aria-label="CAS reference 54">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34099652" aria-label="PubMed reference 54">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184784 aria-label="PubMed Central reference 54">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-021-23494-1 aria-label="Article reference 54">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20RNAemia%20and%20proteomic%20trajectories%20inform%20prognostication%20in%20COVID-19%20patients%20admitted%20to%20intensive%20care&amp;journal=Nat%20Commun&amp;volume=12&amp;publication_year=2021&amp;author=Gutmann%2CC&amp;author=Takov%2CK&amp;author=Burnap%2CSA&amp;author=Singh%2CB&amp;author=Ali%2CH&amp;author=Theofilatos%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=55.><p class=c-article-references__text id=ref-CR55>Hansen FC, Nadeem A, Browning KL, Campana M, Schmidtchen A, van der Plas MJA. Differential internalization of thrombin-derived host defense peptides into monocytes and macrophages. J Innate Immun. 2021:1–15.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=56.><p class=c-article-references__text id=ref-CR56>Schirinzi A, Pesce F, Laterza R, D’Alise MG, Lovero R, Fontana A, et al. Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department. J Infect. 2021;82:84–123.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlWgtb3F aria-label="CAS reference 56">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33147434" aria-label="PubMed reference 56">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jinf.2020.10.027 aria-label="Article reference 56">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Pentraxin%203%3A%20potential%20prognostic%20role%20in%20SARS-CoV-2%20patients%20admitted%20to%20the%20emergency%20department&amp;journal=J%20Infect&amp;volume=82&amp;pages=84-123&amp;publication_year=2021&amp;author=Schirinzi%2CA&amp;author=Pesce%2CF&amp;author=Laterza%2CR&amp;author=D%E2%80%99Alise%2CMG&amp;author=Lovero%2CR&amp;author=Fontana%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=57.><p class=c-article-references__text id=ref-CR57>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFSms78%3D aria-label="CAS reference 57">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35027728" aria-label="PubMed reference 57">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-021-01113-x aria-label="Article reference 57">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunological%20dysfunction%20persists%20for%208%20months%20following%20initial%20mild-to-moderate%20SARS-CoV-2%20infection&amp;journal=Nat%20Immunol&amp;volume=23&amp;pages=210-6&amp;publication_year=2022&amp;author=Phetsouphanh%2CC&amp;author=Darley%2CDR&amp;author=Wilson%2CDB&amp;author=Howe%2CA&amp;author=Munier%2CCML&amp;author=Patel%2CSK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=58.><p class=c-article-references__text id=ref-CR58>Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, et al. Complement as a target in COVID-19? Nat Rev Immunol. 2020;20:343–4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVChsLs%3D aria-label="CAS reference 58">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32327719" aria-label="PubMed reference 58">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41577-020-0320-7 aria-label="Article reference 58">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=Complement%20as%20a%20target%20in%20COVID-19%3F&amp;journal=Nat%20Rev%20Immunol&amp;volume=20&amp;pages=343-4&amp;publication_year=2020&amp;author=Risitano%2CAM&amp;author=Mastellos%2CDC&amp;author=Huber-Lang%2CM&amp;author=Yancopoulou%2CD&amp;author=Garlanda%2CC&amp;author=Ciceri%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=59.><p class=c-article-references__text id=ref-CR59>Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clin Immunol. 2020;220:108598.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvV2jsr%2FL aria-label="CAS reference 59">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32961333" aria-label="PubMed reference 59">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501834 aria-label="PubMed Central reference 59">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.clim.2020.108598 aria-label="Article reference 59">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=Complement%20C3%20vs%20C5%20inhibition%20in%20severe%20COVID-19%3A%20early%20clinical%20findings%20reveal%20differential%20biological%20efficacy&amp;journal=Clin%20Immunol&amp;volume=220&amp;publication_year=2020&amp;author=Mastellos%2CDC&amp;author=Pires%20da%20Silva%2CBGP&amp;author=Fonseca%2CBAL&amp;author=Fonseca%2CNP&amp;author=Auxiliadora-Martins%2CM&amp;author=Mastaglio%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=60.><p class=c-article-references__text id=ref-CR60>Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, et al. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020;215:108450.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXoslers78%3D aria-label="CAS reference 60">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32360516" aria-label="PubMed reference 60">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189192 aria-label="PubMed Central reference 60">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.clim.2020.108450 aria-label="Article reference 60">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20first%20case%20of%20COVID-19%20treated%20with%20the%20complement%20C3%20inhibitor%20AMY-101&amp;journal=Clin%20Immunol&amp;volume=215&amp;publication_year=2020&amp;author=Mastaglio%2CS&amp;author=Ruggeri%2CA&amp;author=Risitano%2CAM&amp;author=Angelillo%2CP&amp;author=Yancopoulou%2CD&amp;author=Mastellos%2CDC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=61.><p class=c-article-references__text id=ref-CR61>Rambaldi A, Gritti G, Mico MC, Frigeni M, Borleri G, Salvi A, et al. Endothelial injury and thrombotic microangiopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020;225:152001.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvVynt7vL aria-label="CAS reference 61">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32943233" aria-label="PubMed reference 61">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415163 aria-label="PubMed Central reference 61">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.imbio.2020.152001 aria-label="Article reference 61">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;title=Endothelial%20injury%20and%20thrombotic%20microangiopathy%20in%20COVID-19%3A%20treatment%20with%20the%20lectin-pathway%20inhibitor%20narsoplimab&amp;journal=Immunobiology.&amp;volume=225&amp;publication_year=2020&amp;author=Rambaldi%2CA&amp;author=Gritti%2CG&amp;author=Mico%2CMC&amp;author=Frigeni%2CM&amp;author=Borleri%2CG&amp;author=Salvi%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=62.><p class=c-article-references__text id=ref-CR62>Bumiller-Bini V, de Freitas Oliveira-Tore C, Carvalho TM, Kretzschmar GC, Goncalves LB, Alencar NM, et al. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol. 2021;44:e20200199.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXitVSnurjK aria-label="CAS reference 62">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33729332" aria-label="PubMed reference 62">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982787 aria-label="PubMed Central reference 62">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1590%2F1678-4685-gmb-2020-0199 aria-label="Article reference 62">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;title=MASPs%20at%20the%20crossroad%20between%20the%20complement%20and%20the%20coagulation%20cascades%20-%20the%20case%20for%20COVID-19&amp;journal=Genet%20Mol%20Biol.&amp;volume=44&amp;publication_year=2021&amp;author=Bumiller-Bini%2CV&amp;author=Freitas%20Oliveira-Tore%2CC&amp;author=Carvalho%2CTM&amp;author=Kretzschmar%2CGC&amp;author=Goncalves%2CLB&amp;author=Alencar%2CNM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=63.><p class=c-article-references__text id=ref-CR63>Flude BM, Nannetti G, Mitchell P, Compton N, Richards C, Heurich M, et al. Targeting the complement serine protease MASP-2 as a therapeutic strategy for coronavirus infections. Viruses. 2021;13:312.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=64.><p class=c-article-references__text id=ref-CR64>Junqueira C, Crespo A, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq. 2021.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=65.><p class=c-article-references__text id=ref-CR65>Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022. Online ahead of print.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=66.><p class=c-article-references__text id=ref-CR66>Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2ntL3K aria-label="CAS reference 66">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32717743" aria-label="PubMed reference 66">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477538 aria-label="PubMed Central reference 66">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-020-2588-y aria-label="Article reference 66">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;title=Longitudinal%20analyses%20reveal%20immunological%20misfiring%20in%20severe%20COVID-19&amp;journal=Nature.&amp;volume=584&amp;pages=463-9&amp;publication_year=2020&amp;author=Lucas%2CC&amp;author=Wong%2CP&amp;author=Klein%2CJ&amp;author=Castro%2CTBR&amp;author=Silva%2CJ&amp;author=Sundaram%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=67.><p class=c-article-references__text id=ref-CR67>Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–38.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtVCqtrfF aria-label="CAS reference 67">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33963333" aria-label="PubMed reference 67">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882317 aria-label="PubMed Central reference 67">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-021-00937-x aria-label="Article reference 67">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;title=TLR2%20senses%20the%20SARS-CoV-2%20envelope%20protein%20to%20produce%20inflammatory%20cytokines&amp;journal=Nat%20Immunol&amp;volume=22&amp;pages=829-38&amp;publication_year=2021&amp;author=Zheng%2CM&amp;author=Karki%2CR&amp;author=Williams%2CEP&amp;author=Yang%2CD&amp;author=Fitzpatrick%2CE&amp;author=Vogel%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=68.><p class=c-article-references__text id=ref-CR68>Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=69.><p class=c-article-references__text id=ref-CR69>Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, et al. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020;27:3196–207.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFCnt7nP aria-label="CAS reference 69">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32514047" aria-label="PubMed reference 69">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278239 aria-label="PubMed Central reference 69">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-020-0572-6 aria-label="Article reference 69">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;title=Expansion%20of%20myeloid-derived%20suppressor%20cells%20in%20patients%20with%20severe%20coronavirus%20disease%20%28COVID-19%29&amp;journal=Cell%20Death%20Differ&amp;volume=27&amp;pages=3196-207&amp;publication_year=2020&amp;author=Agrati%2CC&amp;author=Sacchi%2CA&amp;author=Bordoni%2CV&amp;author=Cimini%2CE&amp;author=Notari%2CS&amp;author=Grassi%2CG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=70.><p class=c-article-references__text id=ref-CR70>Knopf J, Leppkes M, Schett G, Herrmann M, Muñoz LE. Aggregated NETs sequester and detoxify extracellular histones. Front Immunol. 2019;10:2176.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsFygt7o%3D aria-label="CAS reference 70">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31572386" aria-label="PubMed reference 70">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749074 aria-label="PubMed Central reference 70">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.3389%2Ffimmu.2019.02176 aria-label="Article reference 70">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;title=Aggregated%20NETs%20sequester%20and%20detoxify%20extracellular%20histones&amp;journal=Front%20Immunol&amp;volume=10&amp;publication_year=2019&amp;author=Knopf%2CJ&amp;author=Leppkes%2CM&amp;author=Schett%2CG&amp;author=Herrmann%2CM&amp;author=Mu%C3%B1oz%2CLE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=71.><p class=c-article-references__text id=ref-CR71>Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20:511–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXntlehs7o%3D aria-label="CAS reference 71">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24784231" aria-label="PubMed reference 71">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fnm.3547 aria-label="Article reference 71">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;title=Aggregated%20neutrophil%20extracellular%20traps%20limit%20inflammation%20by%20degrading%20cytokines%20and%20chemokines&amp;journal=Nat%20Med&amp;volume=20&amp;pages=511-7&amp;publication_year=2014&amp;author=Schauer%2CC&amp;author=Janko%2CC&amp;author=Munoz%2CLE&amp;author=Zhao%2CY&amp;author=Kienh%C3%B6fer%2CD&amp;author=Frey%2CB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=72.><p class=c-article-references__text id=ref-CR72>Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32745993" aria-label="PubMed reference 72">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397705 aria-label="PubMed Central reference 72">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.ebiom.2020.102925 aria-label="Article reference 72">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;title=Vascular%20occlusion%20by%20neutrophil%20extracellular%20traps%20in%20COVID-19&amp;journal=EBioMedicine.&amp;volume=58&amp;publication_year=2020&amp;author=Leppkes%2CM&amp;author=Knopf%2CJ&amp;author=Naschberger%2CE&amp;author=Lindemann%2CA&amp;author=Singh%2CJ&amp;author=Herrmann%2CI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=73.><p class=c-article-references__text id=ref-CR73>Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, et al. Neutrophil extracellular trap-driven occlusive diseases. Cells. 2021;10:2201.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=74.><p class=c-article-references__text id=ref-CR74>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI insight. 2020;5:e138999.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=75.><p class=c-article-references__text id=ref-CR75>Arcanjo A, Logullo J, Menezes CCB, de Souza Carvalho Giangiarulo TC, Dos Reis MC, de Castro GMM, et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020;10:19630.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlGktrfI aria-label="CAS reference 75">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33184506" aria-label="PubMed reference 75">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665044 aria-label="PubMed Central reference 75">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41598-020-76781-0 aria-label="Article reference 75">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20emerging%20role%20of%20neutrophil%20extracellular%20traps%20in%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20%28COVID-19%29&amp;journal=Sci%20Rep&amp;volume=10&amp;publication_year=2020&amp;author=Arcanjo%2CA&amp;author=Logullo%2CJ&amp;author=Menezes%2CCCB&amp;author=Souza%20Carvalho%20Giangiarulo%2CTC&amp;author=Reis%2CMC&amp;author=Castro%2CGMM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=76.><p class=c-article-references__text id=ref-CR76>Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169–79.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFygtr3N aria-label="CAS reference 76">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32597954" aria-label="PubMed reference 76">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1182%2Fblood.2020007008 aria-label="Article reference 76">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;title=Neutrophil%20extracellular%20traps%20contribute%20to%20immunothrombosis%20in%20COVID-19%20acute%20respiratory%20distress%20syndrome&amp;journal=Blood.&amp;volume=136&amp;pages=1169-79&amp;publication_year=2020&amp;author=Middleton%2CEA&amp;author=He%2CXY&amp;author=Denorme%2CF&amp;author=Campbell%2CRA&amp;author=Ng%2CD&amp;author=Salvatore%2CSP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=77.><p class=c-article-references__text id=ref-CR77>Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=78.><p class=c-article-references__text id=ref-CR78>Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, et al. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis. 2021;223:933–44.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXnslyqsbY%3D aria-label="CAS reference 78">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33280009" aria-label="PubMed reference 78">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1093%2Finfdis%2Fjiaa756 aria-label="Article reference 78">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20neutrophil%20activation%2C%20more%20than%20platelet%20activation%2C%20with%20thrombotic%20complications%20in%20coronavirus%20disease%202019&amp;journal=J%20Infect%20Dis&amp;volume=223&amp;pages=933-44&amp;publication_year=2021&amp;author=Petito%2CE&amp;author=Falcinelli%2CE&amp;author=Paliani%2CU&amp;author=Cesari%2CE&amp;author=Vaudo%2CG&amp;author=Sebastiano%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=79.><p class=c-article-references__text id=ref-CR79>Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130:6151–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlSnt7fJ aria-label="CAS reference 79">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32759504" aria-label="PubMed reference 79">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598040 aria-label="PubMed Central reference 79">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1172%2FJCI141374 aria-label="Article reference 79">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;title=Complement%20and%20tissue%20factor-enriched%20neutrophil%20extracellular%20traps%20are%20key%20drivers%20in%20COVID-19%20immunothrombosis&amp;journal=J%20Clin%20Invest&amp;volume=130&amp;pages=6151-7&amp;publication_year=2020&amp;author=Skendros%2CP&amp;author=Mitsios%2CA&amp;author=Chrysanthopoulou%2CA&amp;author=Mastellos%2CDC&amp;author=Metallidis%2CS&amp;author=Rafailidis%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=80.><p class=c-article-references__text id=ref-CR80>Bilyy R, Bila G, Vishchur O, Vovk V, Herrmann M. Neutrophils as main players of immune response towards nondegradable nanoparticles. Nanomaterials. 2020;10:1273.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=81.><p class=c-article-references__text id=ref-CR81>Liu J, Li J, Arnold K, Pawlinski R, Key NS. Using heparin molecules to manage COVID-2019. Res Pract thrombosis Haemost. 2020;4:518–23.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFOjsb7I aria-label="CAS reference 81">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2Frth2.12353 aria-label="Article reference 81">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 81" href="http://scholar.google.com/scholar_lookup?&amp;title=Using%20heparin%20molecules%20to%20manage%20COVID-2019&amp;journal=Res%20Pract%20thrombosis%20Haemost&amp;volume=4&amp;pages=518-23&amp;publication_year=2020&amp;author=Liu%2CJ&amp;author=Li%2CJ&amp;author=Arnold%2CK&amp;author=Pawlinski%2CR&amp;author=Key%2CNS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=82.><p class=c-article-references__text id=ref-CR82>Weber AG, Chau AS, Egeblad M, Barnes BJ, Janowitz T. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series. Mol Med. 2020;26:91.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32993479" aria-label="PubMed reference 82">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522910 aria-label="PubMed Central reference 82">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs10020-020-00215-w aria-label="Article reference 82">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFCrtbrF aria-label="CAS reference 82">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 82" href="http://scholar.google.com/scholar_lookup?&amp;title=Nebulized%20in-line%20endotracheal%20dornase%20alfa%20and%20albuterol%20administered%20to%20mechanically%20ventilated%20COVID-19%20patients%3A%20a%20case%20series&amp;journal=Mol%20Med&amp;volume=26&amp;publication_year=2020&amp;author=Weber%2CAG&amp;author=Chau%2CAS&amp;author=Egeblad%2CM&amp;author=Barnes%2CBJ&amp;author=Janowitz%2CT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=83.><p class=c-article-references__text id=ref-CR83>Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, et al. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:548.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXht1Wls7nL aria-label="CAS reference 83">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32560746" aria-label="PubMed reference 83">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303591 aria-label="PubMed Central reference 83">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs13063-020-04488-8 aria-label="Article reference 83">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 83" href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20and%20safety%20of%20aerosolized%20intra-tracheal%20dornase%20alfa%20administration%20in%20patients%20with%20SARS-CoV-2-induced%20acute%20respiratory%20distress%20syndrome%20%28ARDS%29%3A%20a%20structured%20summary%20of%20a%20study%20protocol%20for%20a%20randomised%20controlled%20trial&amp;journal=Trials.&amp;volume=21&amp;publication_year=2020&amp;author=Desilles%2CJP&amp;author=Gregoire%2CC&amp;author=Cossec%2CC&amp;author=Lambert%2CJ&amp;author=Mophawe%2CO&amp;author=Losser%2CMR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=84.><p class=c-article-references__text id=ref-CR84>Adrover JM, Carrau L, Daßler-Plenker J, Bram Y, Chandar V, Houghton S, et al. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection. JCI insight. 2022;7:e157342.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=85.><p class=c-article-references__text id=ref-CR85>Elliott W, Jr., Guda MR, Asuthkar S, Teluguakula N, Prasad DVR, Tsung AJ, et al. PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis. Biomedicines. 2021;9:1867.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=86.><p class=c-article-references__text id=ref-CR86>MacMicking JD. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol. 2012;12:367–82.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XmtVeku7w%3D aria-label="CAS reference 86">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22531325" aria-label="PubMed reference 86">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150610 aria-label="PubMed Central reference 86">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fnri3210 aria-label="Article reference 86">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 86" href="http://scholar.google.com/scholar_lookup?&amp;title=Interferon-inducible%20effector%20mechanisms%20in%20cell-autonomous%20immunity&amp;journal=Nat%20Rev%20Immunol&amp;volume=12&amp;pages=367-82&amp;publication_year=2012&amp;author=MacMicking%2CJD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=87.><p class=c-article-references__text id=ref-CR87>Tan X, Sun L, Chen J, Chen ZJ. Detection of microbial infections through innate immune sensing of nucleic acids. Annu Rev Microbiol. 2018;72:447–78.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhs1ynt7jE aria-label="CAS reference 87">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30200854" aria-label="PubMed reference 87">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1146%2Fannurev-micro-102215-095605 aria-label="Article reference 87">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 87" href="http://scholar.google.com/scholar_lookup?&amp;title=Detection%20of%20microbial%20infections%20through%20innate%20immune%20sensing%20of%20nucleic%20acids&amp;journal=Annu%20Rev%20Microbiol&amp;volume=72&amp;pages=447-78&amp;publication_year=2018&amp;author=Tan%2CX&amp;author=Sun%2CL&amp;author=Chen%2CJ&amp;author=Chen%2CZJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=88.><p class=c-article-references__text id=ref-CR88>Xue W, Ding C, Qian K, Liao Y. The interplay between coronavirus and type I IFN response. Front Microbiol. 2021;12:805472.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35317429" aria-label="PubMed reference 88">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.3389%2Ffmicb.2021.805472 aria-label="Article reference 88">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 88" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20interplay%20between%20coronavirus%20and%20type%20I%20IFN%20response&amp;journal=Front%20Microbiol&amp;volume=12&amp;publication_year=2021&amp;author=Xue%2CW&amp;author=Ding%2CC&amp;author=Qian%2CK&amp;author=Liao%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=89.><p class=c-article-references__text id=ref-CR89>Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11:3810.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsFajsb%2FL aria-label="CAS reference 89">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32733001" aria-label="PubMed reference 89">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392898 aria-label="PubMed Central reference 89">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-020-17665-9 aria-label="Article reference 89">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 89" href="http://scholar.google.com/scholar_lookup?&amp;title=Activation%20and%20evasion%20of%20type%20I%20interferon%20responses%20by%20SARS-CoV-2&amp;journal=Nat%20Commun&amp;volume=11&amp;publication_year=2020&amp;author=Lei%2CX&amp;author=Dong%2CX&amp;author=Ma%2CR&amp;author=Wang%2CW&amp;author=Xiao%2CX&amp;author=Tian%2CZ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=90.><p class=c-article-references__text id=ref-CR90>Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20:585–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2ntL3N aria-label="CAS reference 90">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32788708" aria-label="PubMed reference 90">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824445 aria-label="PubMed Central reference 90">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41577-020-00429-3 aria-label="Article reference 90">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 90" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20type%20I%20interferon%20response%20in%20COVID-19%3A%20implications%20for%20treatment&amp;journal=Nat%20Rev%20Immunol&amp;volume=20&amp;pages=585-6&amp;publication_year=2020&amp;author=Lee%2CJS&amp;author=Shin%2CEC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=91.><p class=c-article-references__text id=ref-CR91>Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL, et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9002.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=92.><p class=c-article-references__text id=ref-CR92>Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol. 2021;6.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=93.><p class=c-article-references__text id=ref-CR93>Bernard NJ. A STING in the tail for SARS-CoV-2. Nat Immunol. 2021;22:800.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVansbvP aria-label="CAS reference 93">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34183855" aria-label="PubMed reference 93">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-021-00971-9 aria-label="Article reference 93">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 93" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20STING%20in%20the%20tail%20for%20SARS-CoV-2&amp;journal=Nat%20Immunol&amp;volume=22&amp;publication_year=2021&amp;author=Bernard%2CNJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=94.><p class=c-article-references__text id=ref-CR94>Zhao Y, Sui L, Wu P, Wang W, Wang Z, Yu Y, et al. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021;6:331.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFyjsLzM aria-label="CAS reference 94">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34471099" aria-label="PubMed reference 94">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409078 aria-label="PubMed Central reference 94">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-021-00742-w aria-label="Article reference 94">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 94" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20dual-role%20of%20SARS-CoV-2%20nucleocapsid%20protein%20in%20regulating%20innate%20immune%20response&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=6&amp;publication_year=2021&amp;author=Zhao%2CY&amp;author=Sui%2CL&amp;author=Wu%2CP&amp;author=Wang%2CW&amp;author=Wang%2CZ&amp;author=Yu%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=95.><p class=c-article-references__text id=ref-CR95>Ren H, Ma C, Peng H, Zhang B, Zhou L, Su Y, et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol Direct. 2021;16:20.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXitlartbvF aria-label="CAS reference 95">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34674770" aria-label="PubMed reference 95">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530504 aria-label="PubMed Central reference 95">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs13062-021-00305-7 aria-label="Article reference 95">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 95" href="http://scholar.google.com/scholar_lookup?&amp;title=Micronucleus%20production%2C%20activation%20of%20DNA%20damage%20response%20and%20cGAS-STING%20signaling%20in%20syncytia%20induced%20by%20SARS-CoV-2%20infection&amp;journal=Biol%20Direct&amp;volume=16&amp;publication_year=2021&amp;author=Ren%2CH&amp;author=Ma%2CC&amp;author=Peng%2CH&amp;author=Zhang%2CB&amp;author=Zhou%2CL&amp;author=Su%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=96.><p class=c-article-references__text id=ref-CR96>Zhou Z, Zhang X, Lei X, Xiao X, Jiao T, Ma R, et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct Target Ther. 2021;6:382.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXisVGksrrM aria-label="CAS reference 96">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34732709" aria-label="PubMed reference 96">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564796 aria-label="PubMed Central reference 96">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-021-00800-3 aria-label="Article reference 96">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 96" href="http://scholar.google.com/scholar_lookup?&amp;title=Sensing%20of%20cytoplasmic%20chromatin%20by%20cGAS%20activates%20innate%20immune%20response%20in%20SARS-CoV-2%20infection&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=6&amp;publication_year=2021&amp;author=Zhou%2CZ&amp;author=Zhang%2CX&amp;author=Lei%2CX&amp;author=Xiao%2CX&amp;author=Jiao%2CT&amp;author=Ma%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=97.><p class=c-article-references__text id=ref-CR97>Rui Y, Su J, Shen S, Hu Y, Huang D, Zheng W, et al. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct Target Ther. 2021;6:123.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXntFOhs78%3D aria-label="CAS reference 97">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33723219" aria-label="PubMed reference 97">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958565 aria-label="PubMed Central reference 97">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-021-00515-5 aria-label="Article reference 97">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 97" href="http://scholar.google.com/scholar_lookup?&amp;title=Unique%20and%20complementary%20suppression%20of%20cGAS-STING%20and%20RNA%20sensing-%20triggered%20innate%20immune%20responses%20by%20SARS-CoV-2%20proteins&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=6&amp;publication_year=2021&amp;author=Rui%2CY&amp;author=Su%2CJ&amp;author=Shen%2CS&amp;author=Hu%2CY&amp;author=Huang%2CD&amp;author=Zheng%2CW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=98.><p class=c-article-references__text id=ref-CR98>Denning DW, Kilcoyne A, Ucer C. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2. Br Dent J. 2020;229:521–4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33097885" aria-label="PubMed reference 98">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582419 aria-label="PubMed Central reference 98">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41415-020-2228-9 aria-label="Article reference 98">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 98" href="http://scholar.google.com/scholar_lookup?&amp;title=Non-infectious%20status%20indicated%20by%20detectable%20IgG%20antibody%20to%20SARS-CoV-2&amp;journal=Br%20Dent%20J&amp;volume=229&amp;pages=521-4&amp;publication_year=2020&amp;author=Denning%2CDW&amp;author=Kilcoyne%2CA&amp;author=Ucer%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=99.><p class=c-article-references__text id=ref-CR99>Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1aktLk%3D aria-label="CAS reference 99">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32350462" aria-label="PubMed reference 99">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41591-020-0897-1 aria-label="Article reference 99">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 99" href="http://scholar.google.com/scholar_lookup?&amp;title=Antibody%20responses%20to%20SARS-CoV-2%20in%20patients%20with%20COVID-19&amp;journal=Nat%20Med&amp;volume=26&amp;pages=845-8&amp;publication_year=2020&amp;author=Long%2CQX&amp;author=Liu%2CBZ&amp;author=Deng%2CHJ&amp;author=Wu%2CGC&amp;author=Deng%2CK&amp;author=Chen%2CYK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=100.><p class=c-article-references__text id=ref-CR100>Nakano Y, Kurano M, Morita Y, Shimura T, Yokoyama R, Qian C, et al. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Sci Rep. 2021;11:2776.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjtleisLk%3D aria-label="CAS reference 100">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33531605" aria-label="PubMed reference 100">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854735 aria-label="PubMed Central reference 100">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41598-021-82428-5 aria-label="Article reference 100">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 100" href="http://scholar.google.com/scholar_lookup?&amp;title=Time%20course%20of%20the%20sensitivity%20and%20specificity%20of%20anti-SARS-CoV-2%20IgM%20and%20IgG%20antibodies%20for%20symptomatic%20COVID-19%20in%20Japan&amp;journal=Sci%20Rep&amp;volume=11&amp;publication_year=2021&amp;author=Nakano%2CY&amp;author=Kurano%2CM&amp;author=Morita%2CY&amp;author=Shimura%2CT&amp;author=Yokoyama%2CR&amp;author=Qian%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=101.><p class=c-article-references__text id=ref-CR101>Moura AD, da Costa HHM, Correa VA, de SLAK, Lindoso JAL, De Gaspari E, et al. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients. Sci Rep. 2021;11:17642.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFyjtrzK aria-label="CAS reference 101">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34480056" aria-label="PubMed reference 101">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417219 aria-label="PubMed Central reference 101">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41598-021-95045-z aria-label="Article reference 101">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 101" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20avidity%20related%20to%20IgG%20subclasses%20in%20SARS-CoV-2%20Brazilian%20infected%20patients&amp;journal=Sci%20Rep&amp;volume=11&amp;publication_year=2021&amp;author=Moura%2CAD&amp;author=Costa%2CHHM&amp;author=Correa%2CVA&amp;author=de%2CSLAK&amp;author=Lindoso%2CJAL&amp;author=Gaspari%2CE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=102.><p class=c-article-references__text id=ref-CR102>Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claer L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13:eabd2223.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=103.><p class=c-article-references__text id=ref-CR103>Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541–3.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXltFSlsbo%3D aria-label="CAS reference 103">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32203186" aria-label="PubMed reference 103">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091621 aria-label="PubMed Central reference 103">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41423-020-0401-3 aria-label="Article reference 103">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 103" href="http://scholar.google.com/scholar_lookup?&amp;title=Elevated%20exhaustion%20levels%20and%20reduced%20functional%20diversity%20of%20T%20cells%20in%20peripheral%20blood%20may%20predict%20severe%20progression%20in%20COVID-19%20patients&amp;journal=Cell%20Mol%20Immunol&amp;volume=17&amp;pages=541-3&amp;publication_year=2020&amp;author=Zheng%2CHY&amp;author=Zhang%2CM&amp;author=Yang%2CCX&amp;author=Zhang%2CN&amp;author=Wang%2CXC&amp;author=Yang%2CXP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=104.><p class=c-article-references__text id=ref-CR104>Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996–1012 e19.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvF2jsLnL aria-label="CAS reference 104">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33010815" aria-label="PubMed reference 104">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494270 aria-label="PubMed Central reference 104">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2020.09.038 aria-label="Article reference 104">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 104" href="http://scholar.google.com/scholar_lookup?&amp;title=Antigen-specific%20adaptive%20immunity%20to%20SARS-CoV-2%20in%20acute%20COVID-19%20and%20associations%20with%20age%20and%20disease%20severity&amp;journal=Cell.&amp;volume=183&amp;pages=996-1012%20e19&amp;publication_year=2020&amp;author=Rydyznski%20Moderbacher%2CC&amp;author=Ramirez%2CSI&amp;author=Dan%2CJM&amp;author=Grifoni%2CA&amp;author=Hastie%2CKM&amp;author=Weiskopf%2CD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=105.><p class=c-article-references__text id=ref-CR105>Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5:e140329.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=106.><p class=c-article-references__text id=ref-CR106>Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Roltgen K, Jean GH, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host Microbe. 2020;28:516–25 e5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvVeqt7rF aria-label="CAS reference 106">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32941787" aria-label="PubMed reference 106">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470783 aria-label="PubMed Central reference 106">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.chom.2020.09.002 aria-label="Article reference 106">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 106" href="http://scholar.google.com/scholar_lookup?&amp;title=Human%20B%20cell%20clonal%20expansion%20and%20convergent%20antibody%20responses%20to%20SARS-CoV-2&amp;journal=Cell%20Host%20Microbe&amp;volume=28&amp;pages=516-25%20e5&amp;publication_year=2020&amp;author=Nielsen%2CSCA&amp;author=Yang%2CF&amp;author=Jackson%2CKJL&amp;author=Hoh%2CRA&amp;author=Roltgen%2CK&amp;author=Jean%2CGH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=107.><p class=c-article-references__text id=ref-CR107>Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, et al. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021;27:1178–86.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtVCrsbrM aria-label="CAS reference 107">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33953384" aria-label="PubMed reference 107">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785364 aria-label="PubMed Central reference 107">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41591-021-01355-0 aria-label="Article reference 107">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 107" href="http://scholar.google.com/scholar_lookup?&amp;title=Delayed%20production%20of%20neutralizing%20antibodies%20correlates%20with%20fatal%20COVID-19&amp;journal=Nat%20Med&amp;volume=27&amp;pages=1178-86&amp;publication_year=2021&amp;author=Lucas%2CC&amp;author=Klein%2CJ&amp;author=Sundaram%2CME&amp;author=Liu%2CF&amp;author=Wong%2CP&amp;author=Silva%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=108.><p class=c-article-references__text id=ref-CR108>Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020;11:6044.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFWlurzF aria-label="CAS reference 108">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33247152" aria-label="PubMed reference 108">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699636 aria-label="PubMed Central reference 108">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-020-19943-y aria-label="Article reference 108">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 108" href="http://scholar.google.com/scholar_lookup?&amp;title=Dynamic%20changes%20in%20anti-SARS-CoV-2%20antibodies%20during%20SARS-CoV-2%20infection%20and%20recovery%20from%20COVID-19&amp;journal=Nat%20Commun&amp;volume=11&amp;publication_year=2020&amp;author=Li%2CK&amp;author=Huang%2CB&amp;author=Wu%2CM&amp;author=Zhong%2CA&amp;author=Li%2CL&amp;author=Cai%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=109.><p class=c-article-references__text id=ref-CR109>Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020;183:143–57 e13.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslygsLvO aria-label="CAS reference 109">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32877699" aria-label="PubMed reference 109">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437499 aria-label="PubMed Central reference 109">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2020.08.025 aria-label="Article reference 109">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 109" href="http://scholar.google.com/scholar_lookup?&amp;title=Loss%20of%20Bcl-6-expressing%20T%20follicular%20helper%20cells%20and%20germinal%20centers%20in%20COVID-19&amp;journal=Cell&amp;volume=183&amp;pages=143-57%20e13&amp;publication_year=2020&amp;author=Kaneko%2CN&amp;author=Kuo%2CHH&amp;author=Boucau%2CJ&amp;author=Farmer%2CJR&amp;author=Allard-Chamard%2CH&amp;author=Mahajan%2CVS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=110.><p class=c-article-references__text id=ref-CR110>Van Cleemput J, van Snippenberg W, Lambrechts L, Dendooven A, D’Onofrio V, Couck L, et al. Organ-specific genome diversity of replication-competent SARS-CoV-2. Nat Commun. 2021;12:6612.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34785663" aria-label="PubMed reference 110">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595628 aria-label="PubMed Central reference 110">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-021-26884-7 aria-label="Article reference 110">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFSjt7rN aria-label="CAS reference 110">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 110" href="http://scholar.google.com/scholar_lookup?&amp;title=Organ-specific%20genome%20diversity%20of%20replication-competent%20SARS-CoV-2&amp;journal=Nat%20Commun&amp;volume=12&amp;publication_year=2021&amp;author=Cleemput%2CJ&amp;author=Snippenberg%2CW&amp;author=Lambrechts%2CL&amp;author=Dendooven%2CA&amp;author=D%E2%80%99Onofrio%2CV&amp;author=Couck%2CL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=111.><p class=c-article-references__text id=ref-CR111>Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med. 1999;5:423–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK1MXisFOlt7o%3D aria-label="CAS reference 111">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10202932" aria-label="PubMed reference 111">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2F7422 aria-label="Article reference 111">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 111" href="http://scholar.google.com/scholar_lookup?&amp;title=Defective%20humoral%20responses%20and%20extensive%20intravascular%20apoptosis%20are%20associated%20with%20fatal%20outcome%20in%20Ebola%20virus-infected%20patients&amp;journal=Nat%20Med&amp;volume=5&amp;pages=423-6&amp;publication_year=1999&amp;author=Baize%2CS&amp;author=Leroy%2CEM&amp;author=Georges-Courbot%2CMC&amp;author=Capron%2CM&amp;author=Lansoud-Soukate%2CJ&amp;author=Debre%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=112.><p class=c-article-references__text id=ref-CR112>Estaquier J, Idziorek T, de Bels F, Barre-Sinoussi F, Hurtrel B, Aubertin AM, et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994;91:9431–5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:STN:280:DyaK2M%2Fitl2htw%3D%3D aria-label="CAS reference 112">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7937784" aria-label="PubMed reference 112">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC44826 aria-label="PubMed Central reference 112">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1073%2Fpnas.91.20.9431 aria-label="Article reference 112">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 112" href="http://scholar.google.com/scholar_lookup?&amp;title=Programmed%20cell%20death%20and%20AIDS%3A%20significance%20of%20T-cell%20apoptosis%20in%20pathogenic%20and%20nonpathogenic%20primate%20lentiviral%20infections&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=91&amp;pages=9431-5&amp;publication_year=1994&amp;author=Estaquier%2CJ&amp;author=Idziorek%2CT&amp;author=Bels%2CF&amp;author=Barre-Sinoussi%2CF&amp;author=Hurtrel%2CB&amp;author=Aubertin%2CAM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=113.><p class=c-article-references__text id=ref-CR113>Monceaux V, Estaquier J, Février M, Cumont MC, Rivière Y, Aubertin AM, et al. Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS. Aids. 2003;17:1585–96.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12853740" aria-label="PubMed reference 113">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1097%2F00002030-200307250-00002 aria-label="Article reference 113">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 113" href="http://scholar.google.com/scholar_lookup?&amp;title=Extensive%20apoptosis%20in%20lymphoid%20organs%20during%20primary%20SIV%20infection%20predicts%20rapid%20progression%20towards%20AIDS&amp;journal=Aids.&amp;volume=17&amp;pages=1585-96&amp;publication_year=2003&amp;author=Monceaux%2CV&amp;author=Estaquier%2CJ&amp;author=F%C3%A9vrier%2CM&amp;author=Cumont%2CMC&amp;author=Rivi%C3%A8re%2CY&amp;author=Aubertin%2CAM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=114.><p class=c-article-references__text id=ref-CR114>André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022:1–14. Online ahead of print.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=115.><p class=c-article-references__text id=ref-CR115>Butler D, Mozsary C, Meydan C, Foox J, Rosiene J, Shaiber A, et al. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021;12:1660.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXms12hsr4%3D aria-label="CAS reference 115">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33712587" aria-label="PubMed reference 115">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954844 aria-label="PubMed Central reference 115">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-021-21361-7 aria-label="Article reference 115">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 115" href="http://scholar.google.com/scholar_lookup?&amp;title=Shotgun%20transcriptome%2C%20spatial%20omics%2C%20and%20isothermal%20profiling%20of%20SARS-CoV-2%20infection%20reveals%20unique%20host%20responses%2C%20viral%20diversification%2C%20and%20drug%20interactions&amp;journal=Nat%20Commun&amp;volume=12&amp;publication_year=2021&amp;author=Butler%2CD&amp;author=Mozsary%2CC&amp;author=Meydan%2CC&amp;author=Foox%2CJ&amp;author=Rosiene%2CJ&amp;author=Shaiber%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=116.><p class=c-article-references__text id=ref-CR116>Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, et al. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci. 2021;7:1156–65.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34341769" aria-label="PubMed reference 116">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265543 aria-label="PubMed Central reference 116">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1021%2Facscentsci.0c01537 aria-label="Article reference 116">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVaqtr3F aria-label="CAS reference 116">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 116" href="http://scholar.google.com/scholar_lookup?&amp;title=CD209L%2FL-SIGN%20and%20CD209%2FDC-SIGN%20Act%20as%20Receptors%20for%20SARS-CoV-2&amp;journal=ACS%20Cent%20Sci.&amp;volume=7&amp;pages=1156-65&amp;publication_year=2021&amp;author=Yin%2CW&amp;author=Napoleon%2CMA&amp;author=Suder%2CEL&amp;author=Berrigan%2CJ&amp;author=Zhao%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=117.><p class=c-article-references__text id=ref-CR117>Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–43.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32839624" aria-label="PubMed reference 117">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869028 aria-label="PubMed Central reference 117">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41591-020-1051-9 aria-label="Article reference 117">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1KhtLzN aria-label="CAS reference 117">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 117" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20inflammatory%20cytokine%20signature%20predicts%20COVID-19%20severity%20and%20survival&amp;journal=Nat%20Med.&amp;volume=26&amp;pages=1636-43&amp;publication_year=2020&amp;author=Valle%2CDM&amp;author=Kim-Schulze%2CS&amp;author=Huang%2CHH&amp;author=Beckmann%2CND&amp;author=Nirenberg%2CS&amp;author=Wang%2CB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=118.><p class=c-article-references__text id=ref-CR118>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA J Am Med Assoc. 2020;324:782–93.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslamu73N aria-label="CAS reference 118">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjama.2020.12839 aria-label="Article reference 118">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 118" href="http://scholar.google.com/scholar_lookup?&amp;title=Pathophysiology%2C%20transmission%2C%20diagnosis%2C%20and%20treatment%20of%20coronavirus%20disease%202019%20%28COVID-19%29%3A%20a%20review&amp;journal=JAMA%20J%20Am%20Med%20Assoc&amp;volume=324&amp;pages=782-93&amp;publication_year=2020&amp;author=Wiersinga%2CWJ&amp;author=Rhodes%2CA&amp;author=Cheng%2CAC&amp;author=Peacock%2CSJ&amp;author=Prescott%2CHC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=119.><p class=c-article-references__text id=ref-CR119>Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z, et al. SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and furin proteases. iScience. 2020;23:101744.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVersbbO aria-label="CAS reference 119">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33134888" aria-label="PubMed reference 119">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591870 aria-label="PubMed Central reference 119">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.isci.2020.101744 aria-label="Article reference 119">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 119" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20targets%20by%20the%20pscRNA%20profiling%20of%20ACE2%2C%20TMPRSS2%20and%20furin%20proteases&amp;journal=iScience&amp;volume=23&amp;publication_year=2020&amp;author=Zhou%2CL&amp;author=Niu%2CZ&amp;author=Jiang%2CX&amp;author=Zhang%2CZ&amp;author=Zheng%2CY&amp;author=Wang%2CZ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=120.><p class=c-article-references__text id=ref-CR120>Bellesi S, Metafuni E, Hohaus S, Maiolo E, Marchionni F, D’Innocenzo S. et al. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br J Haematol. 2020;191:207–11.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFams7jF aria-label="CAS reference 120">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32679621" aria-label="PubMed reference 120">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1111%2Fbjh.17034 aria-label="Article reference 120">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 120" href="http://scholar.google.com/scholar_lookup?&amp;title=Increased%20CD95%20%28Fas%29%20and%20PD-1%20expression%20in%20peripheral%20blood%20T%20lymphocytes%20in%20COVID-19%20patients&amp;journal=Br%20J%20Haematol&amp;volume=191&amp;pages=207-11&amp;publication_year=2020&amp;author=Bellesi%2CS&amp;author=Metafuni%2CE&amp;author=Hohaus%2CS&amp;author=Maiolo%2CE&amp;author=Marchionni%2CF&amp;author=D%E2%80%99Innocenzo%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=121.><p class=c-article-references__text id=ref-CR121>Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149–68.e17.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisV2ntbvE aria-label="CAS reference 121">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33278357" aria-label="PubMed reference 121">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2020.11.025 aria-label="Article reference 121">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 121" href="http://scholar.google.com/scholar_lookup?&amp;title=Synergism%20of%20TNF-%CE%B1%20and%20IFN-%CE%B3%20triggers%20inflammatory%20cell%20death%2C%20tissue%20damage%2C%20and%20mortality%20in%20SARS-CoV-2%20infection%20and%20cytokine%20shock%20syndromes&amp;journal=Cell.&amp;volume=184&amp;pages=149-68.e17&amp;publication_year=2021&amp;author=Karki%2CR&amp;author=Sharma%2CBR&amp;author=Tuladhar%2CS&amp;author=Williams%2CEP&amp;author=Zalduondo%2CL&amp;author=Samir%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=122.><p class=c-article-references__text id=ref-CR122>Zhang Z, Zheng Y, Niu Z, Zhang B, Wang C, Yao X, et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021;28:2765–77.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXpvVGmtb0%3D aria-label="CAS reference 122">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33879858" aria-label="PubMed reference 122">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056997 aria-label="PubMed Central reference 122">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00782-3 aria-label="Article reference 122">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 122" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20spike%20protein%20dictates%20syncytium-mediated%20lymphocyte%20elimination&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=2765-77&amp;publication_year=2021&amp;author=Zhang%2CZ&amp;author=Zheng%2CY&amp;author=Niu%2CZ&amp;author=Zhang%2CB&amp;author=Wang%2CC&amp;author=Yao%2CX">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=123.><p class=c-article-references__text id=ref-CR123>Huang H, He M, Zhang Y, Zhang B, Niu Z, Zheng Y, et al. Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma. Signal Transduct Target Ther. 2020;5:246–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33082315" aria-label="PubMed reference 123">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576137 aria-label="PubMed Central reference 123">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-020-00346-w aria-label="Article reference 123">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 123" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20and%20validation%20of%20heterotypic%20cell-in-cell%20structure%20as%20an%20adverse%20prognostic%20predictor%20for%20young%20patients%20of%20resectable%20pancreatic%20ductal%20adenocarcinoma&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=5&amp;pages=246-8&amp;publication_year=2020&amp;author=Huang%2CH&amp;author=He%2CM&amp;author=Zhang%2CY&amp;author=Zhang%2CB&amp;author=Niu%2CZ&amp;author=Zheng%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=124.><p class=c-article-references__text id=ref-CR124>Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, et al. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Disco. 2022;8:35.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhtVGhsrfE aria-label="CAS reference 124">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41421-022-00387-1 aria-label="Article reference 124">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 124" href="http://scholar.google.com/scholar_lookup?&amp;title=Cell-in-cell%20structure%20mediates%20in-cell%20killing%20suppressed%20by%20CD44&amp;journal=Cell%20Disco&amp;volume=8&amp;publication_year=2022&amp;author=Su%2CY&amp;author=Huang%2CH&amp;author=Luo%2CT&amp;author=Zheng%2CY&amp;author=Fan%2CJ&amp;author=Ren%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=125.><p class=c-article-references__text id=ref-CR125>Liang J, Niu Z, Zhang B, Yu X, Zheng Y, Wang C, et al. p53-dependent elimination of aneuploid mitotic offspring by entosis. Cell Death Differ. 2021;28:799–813.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlWksLjK aria-label="CAS reference 125">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33110215" aria-label="PubMed reference 125">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-020-00645-3 aria-label="Article reference 125">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 125" href="http://scholar.google.com/scholar_lookup?&amp;title=p53-dependent%20elimination%20of%20aneuploid%20mitotic%20offspring%20by%20entosis&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=799-813&amp;publication_year=2021&amp;author=Liang%2CJ&amp;author=Niu%2CZ&amp;author=Zhang%2CB&amp;author=Yu%2CX&amp;author=Zheng%2CY&amp;author=Wang%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=126.><p class=c-article-references__text id=ref-CR126>Sun Q, Luo T, Ren Y, Florey O, Shirasawa S, Sasazuki T, et al. Competition between human cells by entosis. Cell Res. 2014;24:1299–310.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvVSqtrzE aria-label="CAS reference 126">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25342560" aria-label="PubMed reference 126">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220161 aria-label="PubMed Central reference 126">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fcr.2014.138 aria-label="Article reference 126">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 126" href="http://scholar.google.com/scholar_lookup?&amp;title=Competition%20between%20human%20cells%20by%20entosis&amp;journal=Cell%20Res&amp;volume=24&amp;pages=1299-310&amp;publication_year=2014&amp;author=Sun%2CQ&amp;author=Luo%2CT&amp;author=Ren%2CY&amp;author=Florey%2CO&amp;author=Shirasawa%2CS&amp;author=Sasazuki%2CT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=127.><p class=c-article-references__text id=ref-CR127>Sun Q, Chen W. Cell-in-cell: an emerging player in COVID-19 and immune disorders. Natl Sci Open. 2022;1:20220001.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1360%2Fnso%2F20220001 aria-label="Article reference 127">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 127" href="http://scholar.google.com/scholar_lookup?&amp;title=Cell-in-cell%3A%20an%20emerging%20player%20in%20COVID-19%20and%20immune%20disorders&amp;journal=Natl%20Sci%20Open.&amp;volume=1&amp;publication_year=2022&amp;author=Sun%2CQ&amp;author=Chen%2CW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=128.><p class=c-article-references__text id=ref-CR128>Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021;594:88–93.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtVSrtbnN aria-label="CAS reference 128">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33827113" aria-label="PubMed reference 128">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611055 aria-label="PubMed Central reference 128">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-021-03491-6 aria-label="Article reference 128">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 128" href="http://scholar.google.com/scholar_lookup?&amp;title=Drugs%20that%20inhibit%20TMEM16%20proteins%20block%20SARS-CoV-2%20spike-induced%20syncytia&amp;journal=Nature.&amp;volume=594&amp;pages=88-93&amp;publication_year=2021&amp;author=Braga%2CL&amp;author=Ali%2CH&amp;author=Secco%2CI&amp;author=Chiavacci%2CE&amp;author=Neves%2CG&amp;author=Goldhill%2CD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=129.><p class=c-article-references__text id=ref-CR129>Zheng Y, Zhou LL, Su Y, Sun Q. Cell fusion in the pathogenesis of COVID-19. Mil Med Res. 2021;8:68.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xis12kuw%3D%3D aria-label="CAS reference 129">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34924024" aria-label="PubMed reference 129">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684830 aria-label="PubMed Central reference 129">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 129" href="http://scholar.google.com/scholar_lookup?&amp;title=Cell%20fusion%20in%20the%20pathogenesis%20of%20COVID-19&amp;journal=Mil%20Med%20Res&amp;volume=8&amp;publication_year=2021&amp;author=Zheng%2CY&amp;author=Zhou%2CLL&amp;author=Su%2CY&amp;author=Sun%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=130.><p class=c-article-references__text id=ref-CR130>Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ. 2021;28:2019–21.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtFahsb7F aria-label="CAS reference 130">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33981020" aria-label="PubMed reference 130">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114657 aria-label="PubMed Central reference 130">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00795-y aria-label="Article reference 130">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 130" href="http://scholar.google.com/scholar_lookup?&amp;title=Syncytia%20formation%20during%20SARS-CoV-2%20lung%20infection%3A%20a%20disastrous%20unity%20to%20eliminate%20lymphocytes&amp;journal=Cell%20Death%20Differ.&amp;volume=28&amp;pages=2019-21&amp;publication_year=2021&amp;author=Lin%2CL&amp;author=Li%2CQ&amp;author=Wang%2CY&amp;author=Shi%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=131.><p class=c-article-references__text id=ref-CR131>Ma H, Zhu Z, Lin H, Wang S, Zhang P, Li Y, et al. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells. Cell Disco. 2021;7:73.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvVOrs77I aria-label="CAS reference 131">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41421-021-00310-0 aria-label="Article reference 131">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 131" href="http://scholar.google.com/scholar_lookup?&amp;title=Pyroptosis%20of%20syncytia%20formed%20by%20fusion%20of%20SARS-CoV-2%20spike%20and%20ACE2-expressing%20cells&amp;journal=Cell%20Disco&amp;volume=7&amp;publication_year=2021&amp;author=Ma%2CH&amp;author=Zhu%2CZ&amp;author=Lin%2CH&amp;author=Wang%2CS&amp;author=Zhang%2CP&amp;author=Li%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=132.><p class=c-article-references__text id=ref-CR132>Meng B, Ferreira IATM, Abdullahi A, Saito A, Kimura I, Yamasoba D, et al. SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion. Preprint at <a href=https://www.biorxiv.org/content/10.1101/2021.12.17.473248v2>https://www.biorxiv.org/content/10.1101/2021.12.17.473248v2</a>. 2021.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=133.><p class=c-article-references__text id=ref-CR133>Willett BJ, Grove J, MacLean OA, Wilkie C, Logan N, Lorenzo GD, et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. Preprint at <a href=https://www.medrxiv.org/content/10.1101/2022.01.03.21268111v1>https://www.medrxiv.org/content/10.1101/2022.01.03.21268111v1</a>. 2022.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=134.><p class=c-article-references__text id=ref-CR134>Peacock TP, Brown JC, Zhou J, Thakur N, Newman J, Kugathasan R, et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. Preprint at <a href=https://www.biorxiv.org/content/10.1101/2021.12.31.474653v1>https://www.biorxiv.org/content/10.1101/2021.12.31.474653v1</a>. 2021.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=135.><p class=c-article-references__text id=ref-CR135>Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol. 2006;7:475–81.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XjsFags7g%3D aria-label="CAS reference 135">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16604076" aria-label="PubMed reference 135">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fni1326 aria-label="Article reference 135">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 135" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20generation%20of%20protective%20memory-like%20CD8%2B%20T%20cells%20during%20homeostatic%20proliferation%20requires%20CD4%2B%20T%20cells&amp;journal=Nat%20Immunol&amp;volume=7&amp;pages=475-81&amp;publication_year=2006&amp;author=Hamilton%2CSE&amp;author=Wolkers%2CMC&amp;author=Schoenberger%2CSP&amp;author=Jameson%2CSC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=136.><p class=c-article-references__text id=ref-CR136>Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 2005;434:88–93.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2MXhslClsLc%3D aria-label="CAS reference 136">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15744305" aria-label="PubMed reference 136">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fnature03337 aria-label="Article reference 136">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 136" href="http://scholar.google.com/scholar_lookup?&amp;title=CD4%2B%20T-cell%20help%20controls%20CD8%2B%20T-cell%20memory%20via%20TRAIL-mediated%20activation-induced%20cell%20death&amp;journal=Nature.&amp;volume=434&amp;pages=88-93&amp;publication_year=2005&amp;author=Janssen%2CEM&amp;author=Droin%2CNM&amp;author=Lemmens%2CEE&amp;author=Pinkoski%2CMJ&amp;author=Bensinger%2CSJ&amp;author=Ehst%2CBD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=137.><p class=c-article-references__text id=ref-CR137>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–703.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvVejtrnI aria-label="CAS reference 137">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32463803" aria-label="PubMed reference 137">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456250 aria-label="PubMed Central reference 137">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1172%2FJCI138554 aria-label="Article reference 137">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 137" href="http://scholar.google.com/scholar_lookup?&amp;title=Impaired%20immune%20cell%20cytotoxicity%20in%20severe%20COVID-19%20is%20IL-6%20dependent&amp;journal=J%20Clin%20Invest&amp;volume=130&amp;pages=4694-703&amp;publication_year=2020&amp;author=Mazzoni%2CA&amp;author=Salvati%2CL&amp;author=Maggi%2CL&amp;author=Capone%2CM&amp;author=Vanni%2CA&amp;author=Spinicci%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=138.><p class=c-article-references__text id=ref-CR138>Laforge M, Silvestre R, Rodrigues V, Garibal J, Campillo-Gimenez L, Mouhamad S, et al. The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques. J Clin Invest. 2018;128:1627–40.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29553486" aria-label="PubMed reference 138">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873886 aria-label="PubMed Central reference 138">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1172%2FJCI95127 aria-label="Article reference 138">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 138" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20anti-caspase%20inhibitor%20Q-VD-OPH%20prevents%20AIDS%20disease%20progression%20in%20SIV-infected%20rhesus%20macaques&amp;journal=J%20Clin%20Invest&amp;volume=128&amp;pages=1627-40&amp;publication_year=2018&amp;author=Laforge%2CM&amp;author=Silvestre%2CR&amp;author=Rodrigues%2CV&amp;author=Garibal%2CJ&amp;author=Campillo-Gimenez%2CL&amp;author=Mouhamad%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=139.><p class=c-article-references__text id=ref-CR139>Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 2022. Online ahead of print.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=140.><p class=c-article-references__text id=ref-CR140>Shi Y, Devadas S, Greeneltch KM, Yin D, Allan Mufson R, Zhou JN. Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology. Brain Behav Immun. 2003;17:S18–26.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXhsVCgs7k%3D aria-label="CAS reference 140">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12615182" aria-label="PubMed reference 140">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0889-1591%2802%2900062-4 aria-label="Article reference 140">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 140" href="http://scholar.google.com/scholar_lookup?&amp;title=Stressed%20to%20death%3A%20implication%20of%20lymphocyte%20apoptosis%20for%20psychoneuroimmunology&amp;journal=Brain%20Behav%20Immun&amp;volume=17&amp;pages=S18-26&amp;publication_year=2003&amp;author=Shi%2CY&amp;author=Devadas%2CS&amp;author=Greeneltch%2CKM&amp;author=Yin%2CD&amp;author=Allan%20Mufson%2CR&amp;author=Zhou%2CJN">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=141.><p class=c-article-references__text id=ref-CR141>Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127–37.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK1cXmsFentg%3D%3D aria-label="CAS reference 141">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9441573" aria-label="PubMed reference 141">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.7326%2F0003-4819-128-2-199801150-00009 aria-label="Article reference 141">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 141" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20pathophysiologic%20roles%20of%20interleukin-6%20in%20human%20disease&amp;journal=Ann%20Intern%20Med&amp;volume=128&amp;pages=127-37&amp;publication_year=1998&amp;author=Papanicolaou%2CDA&amp;author=Wilder%2CRL&amp;author=Manolagas%2CSC&amp;author=Chrousos%2CGP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=142.><p class=c-article-references__text id=ref-CR142>Hong M, Zheng J, Ding ZY, Chen JH, Yu L, Niu Y, et al. Imbalance between Th17 and Treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice. Neuroimmunomodulation. 2013;20:39–50.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvVahsb%2FP aria-label="CAS reference 142">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23172104" aria-label="PubMed reference 142">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1159%2F000343100 aria-label="Article reference 142">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 142" href="http://scholar.google.com/scholar_lookup?&amp;title=Imbalance%20between%20Th17%20and%20Treg%20cells%20may%20play%20an%20important%20role%20in%20the%20development%20of%20chronic%20unpredictable%20mild%20stress-induced%20depression%20in%20mice&amp;journal=Neuroimmunomodulation.&amp;volume=20&amp;pages=39-50&amp;publication_year=2013&amp;author=Hong%2CM&amp;author=Zheng%2CJ&amp;author=Ding%2CZY&amp;author=Chen%2CJH&amp;author=Yu%2CL&amp;author=Niu%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=143.><p class=c-article-references__text id=ref-CR143>Westfall S, Caracci F, Estill M, Frolinger T, Shen L, Pasinetti GM. Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity. Front Immunol. 2021;12:670500.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFKjsb%2FI aria-label="CAS reference 143">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34248950" aria-label="PubMed reference 143">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264434 aria-label="PubMed Central reference 143">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.3389%2Ffimmu.2021.670500 aria-label="Article reference 143">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 143" href="http://scholar.google.com/scholar_lookup?&amp;title=Chronic%20stress-induced%20depression%20and%20anxiety%20priming%20modulated%20by%20gut-brain-axis%20immunity&amp;journal=Front%20Immunol&amp;volume=12&amp;publication_year=2021&amp;author=Westfall%2CS&amp;author=Caracci%2CF&amp;author=Estill%2CM&amp;author=Frolinger%2CT&amp;author=Shen%2CL&amp;author=Pasinetti%2CGM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=144.><p class=c-article-references__text id=ref-CR144>Yin D, Tuthill D, Mufson RA, Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med. 2000;191:1423–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXislSitbk%3D aria-label="CAS reference 144">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10770807" aria-label="PubMed reference 144">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193134 aria-label="PubMed Central reference 144">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1084%2Fjem.191.8.1423 aria-label="Article reference 144">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 144" href="http://scholar.google.com/scholar_lookup?&amp;title=Chronic%20restraint%20stress%20promotes%20lymphocyte%20apoptosis%20by%20modulating%20CD95%20expression&amp;journal=J%20Exp%20Med&amp;volume=191&amp;pages=1423-8&amp;publication_year=2000&amp;author=Yin%2CD&amp;author=Tuthill%2CD&amp;author=Mufson%2CRA&amp;author=Shi%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=145.><p class=c-article-references__text id=ref-CR145>Rajewsky K. The advent and rise of monoclonal antibodies. Nature. 2019;575:47–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXitV2gtrnI aria-label="CAS reference 145">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31686050" aria-label="PubMed reference 145">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fd41586-019-02840-w aria-label="Article reference 145">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 145" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20advent%20and%20rise%20of%20monoclonal%20antibodies&amp;journal=Nature.&amp;volume=575&amp;pages=47-9&amp;publication_year=2019&amp;author=Rajewsky%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=146.><p class=c-article-references__text id=ref-CR146>American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:415–20.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1542%2Fpeds.2014-1665 aria-label="Article reference 146">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 146" href="http://scholar.google.com/scholar_lookup?&amp;title=Updated%20guidance%20for%20palivizumab%20prophylaxis%20among%20infants%20and%20young%20children%20at%20increased%20risk%20of%20hospitalization%20for%20respiratory%20syncytial%20virus%20infection&amp;journal=Pediatrics.&amp;volume=134&amp;pages=415-20&amp;publication_year=2014">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=147.><p class=c-article-references__text id=ref-CR147>Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004;10:871–5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXmtFWrtrY%3D aria-label="CAS reference 147">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15247913" aria-label="PubMed reference 147">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095806 aria-label="PubMed Central reference 147">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fnm1080 aria-label="Article reference 147">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 147" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20efficient%20method%20to%20make%20human%20monoclonal%20antibodies%20from%20memory%20B%20cells%3A%20potent%20neutralization%20of%20SARS%20coronavirus&amp;journal=Nat%20Med&amp;volume=10&amp;pages=871-5&amp;publication_year=2004&amp;author=Traggiai%2CE&amp;author=Becker%2CS&amp;author=Subbarao%2CK&amp;author=Kolesnikova%2CL&amp;author=Uematsu%2CY&amp;author=Gismondo%2CMR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=148.><p class=c-article-references__text id=ref-CR148>Sok D, Burton DR. Recent progress in broadly neutralizing antibodies to HIV. Nat Immunol. 2018;19:1179–88.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhvFCrsLvF aria-label="CAS reference 148">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30333615" aria-label="PubMed reference 148">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440471 aria-label="PubMed Central reference 148">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-018-0235-7 aria-label="Article reference 148">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 148" href="http://scholar.google.com/scholar_lookup?&amp;title=Recent%20progress%20in%20broadly%20neutralizing%20antibodies%20to%20HIV&amp;journal=Nat%20Immunol&amp;volume=19&amp;pages=1179-88&amp;publication_year=2018&amp;author=Sok%2CD&amp;author=Burton%2CDR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=149.><p class=c-article-references__text id=ref-CR149>Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2ntL3L aria-label="CAS reference 149">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32698192" aria-label="PubMed reference 149">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-020-2571-7 aria-label="Article reference 149">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 149" href="http://scholar.google.com/scholar_lookup?&amp;title=Potent%20neutralizing%20antibodies%20against%20multiple%20epitopes%20on%20SARS-CoV-2%20spike&amp;journal=Nature.&amp;volume=584&amp;pages=450-6&amp;publication_year=2020&amp;author=Liu%2CL&amp;author=Wang%2CP&amp;author=Nair%2CMS&amp;author=Yu%2CJ&amp;author=Rapp%2CM&amp;author=Wang%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=150.><p class=c-article-references__text id=ref-CR150>Hwang YC, Lu RM, Su SC, Chiang PY, Ko SH, Ke FY, et al. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci. 2022;29:1.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xlt1Cksw%3D%3D aria-label="CAS reference 150">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34983527" aria-label="PubMed reference 150">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751 aria-label="PubMed Central reference 150">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs12929-021-00784-w aria-label="Article reference 150">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 150" href="http://scholar.google.com/scholar_lookup?&amp;title=Monoclonal%20antibodies%20for%20COVID-19%20therapy%20and%20SARS-CoV-2%20detection&amp;journal=J%20Biomed%20Sci&amp;volume=29&amp;publication_year=2022&amp;author=Hwang%2CYC&amp;author=Lu%2CRM&amp;author=Su%2CSC&amp;author=Chiang%2CPY&amp;author=Ko%2CSH&amp;author=Ke%2CFY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=151.><p class=c-article-references__text id=ref-CR151>Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XptF2hsLk%3D aria-label="CAS reference 151">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35240676" aria-label="PubMed reference 151">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021018 aria-label="PubMed Central reference 151">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-022-04594-4 aria-label="Article reference 151">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 151" href="http://scholar.google.com/scholar_lookup?&amp;title=Antibody%20evasion%20properties%20of%20SARS-CoV-2%20Omicron%20sublineages&amp;journal=Nature.&amp;volume=604&amp;pages=553-6&amp;publication_year=2022&amp;author=Iketani%2CS&amp;author=Liu%2CL&amp;author=Guo%2CY&amp;author=Liu%2CL&amp;author=Chan%2CJF&amp;author=Huang%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=152.><p class=c-article-references__text id=ref-CR152>Cao X. Immunology in China: the past, present and future. Nat Immunol. 2008;9:339–42.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXjtlGnu7Y%3D aria-label="CAS reference 152">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18349809" aria-label="PubMed reference 152">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fni0408-339 aria-label="Article reference 152">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 152" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunology%20in%20China%3A%20the%20past%2C%20present%20and%20future&amp;journal=Nat%20Immunol&amp;volume=9&amp;pages=339-42&amp;publication_year=2008&amp;author=Cao%2CX">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=153.><p class=c-article-references__text id=ref-CR153>Zhu F, Althaus T, Tan CW, Costantini A, Chia WN, Van Vinh Chau N, et al. WHO international standard for SARS-CoV-2 antibodies to determine markers of protection. Lancet Microbe. 2022;3:e81–e2.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XlvV2ntr0%3D aria-label="CAS reference 153">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34901897" aria-label="PubMed reference 153">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS2666-5247%2821%2900307-4 aria-label="Article reference 153">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 153" href="http://scholar.google.com/scholar_lookup?&amp;title=WHO%20international%20standard%20for%20SARS-CoV-2%20antibodies%20to%20determine%20markers%20of%20protection&amp;journal=Lancet%20Microbe&amp;volume=3&amp;pages=e81-e2&amp;publication_year=2022&amp;author=Zhu%2CF&amp;author=Althaus%2CT&amp;author=Tan%2CCW&amp;author=Costantini%2CA&amp;author=Chia%2CWN&amp;author=Vinh%20Chau%2CN">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=154.><p class=c-article-references__text id=ref-CR154>Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc Bayl Univ Med Cent. 2005;18:21–5.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16200144" aria-label="PubMed reference 154">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200696 aria-label="PubMed Central reference 154">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1080%2F08998280.2005.11928028 aria-label="Article reference 154">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 154" href="http://scholar.google.com/scholar_lookup?&amp;title=Edward%20Jenner%20and%20the%20history%20of%20smallpox%20and%20vaccination&amp;journal=Proc%20Bayl%20Univ%20Med%20Cent&amp;volume=18&amp;pages=21-5&amp;publication_year=2005&amp;author=Riedel%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=155.><p class=c-article-references__text id=ref-CR155>Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020;584:457–62.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32668444" aria-label="PubMed reference 155">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41586-020-2550-z aria-label="Article reference 155">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2ntL3J aria-label="CAS reference 155">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 155" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2-specific%20T%20cell%20immunity%20in%20cases%20of%20COVID-19%20and%20SARS%2C%20and%20uninfected%20controls&amp;journal=Nature&amp;volume=584&amp;pages=457-62&amp;publication_year=2020&amp;author=Bert%2CN&amp;author=Tan%2CAT&amp;author=Kunasegaran%2CK&amp;author=Tham%2CCYL&amp;author=Hafezi%2CM&amp;author=Chia%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=156.><p class=c-article-references__text id=ref-CR156>Tomalka JA, Suthar MS, Deeks SG, Sekaly RP. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Nat Immunol. 2022;23:360–70.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XkvFWgsrY%3D aria-label="CAS reference 156">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35210622" aria-label="PubMed reference 156">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41590-022-01130-4 aria-label="Article reference 156">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 156" href="http://scholar.google.com/scholar_lookup?&amp;title=Fighting%20the%20SARS-CoV-2%20pandemic%20requires%20a%20global%20approach%20to%20understanding%20the%20heterogeneity%20of%20vaccine%20responses&amp;journal=Nat%20Immunol&amp;volume=23&amp;pages=360-70&amp;publication_year=2022&amp;author=Tomalka%2CJA&amp;author=Suthar%2CMS&amp;author=Deeks%2CSG&amp;author=Sekaly%2CRP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=157.><p class=c-article-references__text id=ref-CR157>Lobinska G, Pauzner A, Traulsen A, Pilpel Y, Nowak MA. Evolution of resistance to COVID-19 vaccination with dynamic social distancing. Nat Hum Behav. 2022;6:193–206.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35210582" aria-label="PubMed reference 157">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41562-021-01281-8 aria-label="Article reference 157">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 157" href="http://scholar.google.com/scholar_lookup?&amp;title=Evolution%20of%20resistance%20to%20COVID-19%20vaccination%20with%20dynamic%20social%20distancing&amp;journal=Nat%20Hum%20Behav&amp;volume=6&amp;pages=193-206&amp;publication_year=2022&amp;author=Lobinska%2CG&amp;author=Pauzner%2CA&amp;author=Traulsen%2CA&amp;author=Pilpel%2CY&amp;author=Nowak%2CMA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=158.><p class=c-article-references__text id=ref-CR158>Kupferschmidt K. Where did ‘weird’ Omicron come from? Science 2021;374:1179.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34855502" aria-label="PubMed reference 158">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1126%2Fscience.acx9738 aria-label="Article reference 158">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 158" href="http://scholar.google.com/scholar_lookup?&amp;title=Where%20did%20%E2%80%98weird%E2%80%99%20Omicron%20come%20from%3F&amp;journal=Science&amp;volume=374&amp;publication_year=2021&amp;author=Kupferschmidt%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=159.><p class=c-article-references__text id=ref-CR159>Kupferschmidt K. Where did 'weird' Omicron come from? Science. 2021;374:1179.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34855502" aria-label="PubMed reference 159">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1126%2Fscience.acx9738 aria-label="Article reference 159">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 159" href="http://scholar.google.com/scholar_lookup?&amp;title=Where%20did%20%27weird%27%20Omicron%20come%20from%3F&amp;journal=Science.&amp;volume=374&amp;publication_year=2021&amp;author=Kupferschmidt%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=160.><p class=c-article-references__text id=ref-CR160>Wang C, Zheng Y, Niu Z, Jiang X, Sun Q. The virological impacts of SARS-CoV-2 D614G mutation. J Mol Cell Biol. 2021;13:712–20.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XislWju7w%3D aria-label="CAS reference 160">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34289053" aria-label="PubMed reference 160">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344946 aria-label="PubMed Central reference 160">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1093%2Fjmcb%2Fmjab045 aria-label="Article reference 160">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 160" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20virological%20impacts%20of%20SARS-CoV-2%20D614G%20mutation&amp;journal=J%20Mol%20Cell%20Biol&amp;volume=13&amp;pages=712-20&amp;publication_year=2021&amp;author=Wang%2CC&amp;author=Zheng%2CY&amp;author=Niu%2CZ&amp;author=Jiang%2CX&amp;author=Sun%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=161.><p class=c-article-references__text id=ref-CR161>Jiang X, Zhang Z, Wang C, Ren H, Gao L, Peng H, et al. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity. Signal Transduct Target Ther. 2020;5:268–71.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33203835" aria-label="PubMed reference 161">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670837 aria-label="PubMed Central reference 161">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-020-00392-4 aria-label="Article reference 161">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVertr%2FK aria-label="CAS reference 161">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 161" href="http://scholar.google.com/scholar_lookup?&amp;title=Bimodular%20effects%20of%20D614G%20mutation%20on%20the%20spike%20glycoprotein%20of%20SARS-CoV-2%20enhance%20protein%20processing%2C%20membrane%20fusion%2C%20and%20viral%20infectivity&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=5&amp;pages=268-71&amp;publication_year=2020&amp;author=Jiang%2CX&amp;author=Zhang%2CZ&amp;author=Wang%2CC&amp;author=Ren%2CH&amp;author=Gao%2CL&amp;author=Peng%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=162.><p class=c-article-references__text id=ref-CR162>Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184:2362–71 e9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2021.02.042 aria-label="Article reference 162">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXmvVygsLc%3D aria-label="CAS reference 162">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 162" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20501Y.V2%20variants%20lack%20higher%20infectivity%20but%20do%20have%20immune%20escape&amp;journal=Cell.&amp;volume=14&amp;pages=2362-71%20e9&amp;publication_year=2021&amp;author=Li%2CQ&amp;author=Nie%2CJ&amp;author=Wu%2CJ&amp;author=Zhang%2CL&amp;author=Ding%2CR&amp;author=Wang%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=163.><p class=c-article-references__text id=ref-CR163>Niu Z, Zhang Z, Gao X, Du P, Lu J, Yan B, et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct Target Ther. 2021;6:284.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1OhtrrN aria-label="CAS reference 163">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34315847" aria-label="PubMed reference 163">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313414 aria-label="PubMed Central reference 163">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-021-00704-2 aria-label="Article reference 163">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 163" href="http://scholar.google.com/scholar_lookup?&amp;title=N501Y%20mutation%20imparts%20cross-species%20transmission%20of%20SARS-CoV-2%20to%20mice%20by%20enhancing%20receptor%20binding&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=6&amp;publication_year=2021&amp;author=Niu%2CZ&amp;author=Zhang%2CZ&amp;author=Gao%2CX&amp;author=Du%2CP&amp;author=Lu%2CJ&amp;author=Yan%2CB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=164.><p class=c-article-references__text id=ref-CR164>Huang H, Zhu Y, Niu Z, Zhou L, Sun Q. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse. Cell Death Differ. 2021;28:2840–2.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvVSltbvM aria-label="CAS reference 164">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34389814" aria-label="PubMed reference 164">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362871 aria-label="PubMed Central reference 164">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41418-021-00846-4 aria-label="Article reference 164">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 164" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV-2%20N501Y%20variants%20of%20concern%20and%20their%20potential%20transmission%20by%20mouse&amp;journal=Cell%20Death%20Differ&amp;volume=28&amp;pages=2840-2&amp;publication_year=2021&amp;author=Huang%2CH&amp;author=Zhu%2CY&amp;author=Niu%2CZ&amp;author=Zhou%2CL&amp;author=Sun%2CQ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=165.><p class=c-article-references__text id=ref-CR165>Kok KH, Wong SC, Chan WM, Wen L, Chu AW, Ip JD, et al. Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong. Emerg Microbes Infect. 2022;11:689–98.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XnvV2kt7s%3D aria-label="CAS reference 165">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35135441" aria-label="PubMed reference 165">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890519 aria-label="PubMed Central reference 165">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1080%2F22221751.2022.2040922 aria-label="Article reference 165">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 165" href="http://scholar.google.com/scholar_lookup?&amp;title=Co-circulation%20of%20two%20SARS-CoV-2%20variant%20strains%20within%20imported%20pet%20hamsters%20in%20Hong%20Kong&amp;journal=Emerg%20Microbes%20Infect&amp;volume=11&amp;pages=689-98&amp;publication_year=2022&amp;author=Kok%2CKH&amp;author=Wong%2CSC&amp;author=Chan%2CWM&amp;author=Wen%2CL&amp;author=Chu%2CAW&amp;author=Ip%2CJD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=166.><p class=c-article-references__text id=ref-CR166>Zhang YN, Zhang ZR, Zhang HQ, Li N, Zhang QY, Li XD, et al. Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters. Signal Transduct Target Ther. 2022;7:62.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XnsFeqtrw%3D aria-label="CAS reference 166">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35217641" aria-label="PubMed reference 166">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873353 aria-label="PubMed Central reference 166">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41392-022-00930-2 aria-label="Article reference 166">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 166" href="http://scholar.google.com/scholar_lookup?&amp;title=Different%20pathogenesis%20of%20SARS-CoV-2%20Omicron%20variant%20in%20wild-type%20laboratory%20mice%20and%20hamsters&amp;journal=Signal%20Transduct%20Target%20Ther&amp;volume=7&amp;publication_year=2022&amp;author=Zhang%2CYN&amp;author=Zhang%2CZR&amp;author=Zhang%2CHQ&amp;author=Li%2CN&amp;author=Zhang%2CQY&amp;author=Li%2CXD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=167.><p class=c-article-references__text id=ref-CR167>Shuai H, Chan JF, Yuen TT, Yoon C, Hu JC, Wen L, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021;73:103643.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXitlartbbN aria-label="CAS reference 167">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34689086" aria-label="PubMed reference 167">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530107 aria-label="PubMed Central reference 167">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.ebiom.2021.103643 aria-label="Article reference 167">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 167" href="http://scholar.google.com/scholar_lookup?&amp;title=Emerging%20SARS-CoV-2%20variants%20expand%20species%20tropism%20to%20murines&amp;journal=EBioMedicine.&amp;volume=73&amp;publication_year=2021&amp;author=Shuai%2CH&amp;author=Chan%2CJF&amp;author=Yuen%2CTT&amp;author=Yoon%2CC&amp;author=Hu%2CJC&amp;author=Wen%2CL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=168.><p class=c-article-references__text id=ref-CR168>Han P, Li L, Liu S, Wang Q, Zhang D, Xu Z, et al. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell. 2022;185:630–40 e10.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XisVCltrw%3D aria-label="CAS reference 168">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35093192" aria-label="PubMed reference 168">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733278 aria-label="PubMed Central reference 168">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.cell.2022.01.001 aria-label="Article reference 168">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 168" href="http://scholar.google.com/scholar_lookup?&amp;title=Receptor%20binding%20and%20complex%20structures%20of%20human%20ACE2%20to%20spike%20RBD%20from%20omicron%20and%20delta%20SARS-CoV-2&amp;journal=Cell.&amp;volume=185&amp;pages=630-40%20e10&amp;publication_year=2022&amp;author=Han%2CP&amp;author=Li%2CL&amp;author=Liu%2CS&amp;author=Wang%2CQ&amp;author=Zhang%2CD&amp;author=Xu%2CZ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=169.><p class=c-article-references__text id=ref-CR169>Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-Mata L, et al. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nature Communications. 2022;13:2670.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35562366" aria-label="PubMed reference 169">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106736 aria-label="PubMed Central reference 169">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1038%2Fs41467-022-30340-5 aria-label="Article reference 169">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 169" href="http://scholar.google.com/scholar_lookup?&amp;title=Heterologous%20immunization%20with%20inactivated%20vaccine%20followed%20by%20mRNA-booster%20elicits%20strong%20immunity%20against%20SARS-CoV-2%20Omicron%20variant&amp;journal=Nature%20Communications.&amp;volume=13&amp;publication_year=2022&amp;author=Zuo%2CF&amp;author=Abolhassani%2CH&amp;author=Du%2CL&amp;author=Piralla%2CA&amp;author=Bertoglio%2CF&amp;author=de%20Campos-Mata%2CL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=170.><p class=c-article-references__text id=ref-CR170>Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. GISAID’s role in pandemic response. China CDC Wkly. 2021;3:1049–51.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34934514" aria-label="PubMed reference 170">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668406 aria-label="PubMed Central reference 170">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.46234%2Fccdcw2021.255 aria-label="Article reference 170">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 170" href="http://scholar.google.com/scholar_lookup?&amp;title=GISAID%E2%80%99s%20role%20in%20pandemic%20response&amp;journal=China%20CDC%20Wkly&amp;volume=3&amp;pages=1049-51&amp;publication_year=2021&amp;author=Khare%2CS&amp;author=Gurry%2CC&amp;author=Freitas%2CL&amp;author=Schultz%2CMB&amp;author=Bach%2CG&amp;author=Diallo%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=171.><p class=c-article-references__text id=ref-CR171>Jette CA, Cohen AA, Gnanapragasam PNP, Muecksch F, Lee YE, Huey-Tubman KE, et al. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell Rep. 2021;37:110188.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XovFCm aria-label="CAS reference 171">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34936878" aria-label="PubMed reference 171">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690285 aria-label="PubMed Central reference 171">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.celrep.2021.110188 aria-label="Article reference 171">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 171" href="http://scholar.google.com/scholar_lookup?&amp;title=Broad%20cross-reactivity%20across%20sarbecoviruses%20exhibited%20by%20a%20subset%20of%20COVID-19%20donor-derived%20neutralizing%20antibodies&amp;journal=Cell%20Rep&amp;volume=37&amp;publication_year=2021&amp;author=Jette%2CCA&amp;author=Cohen%2CAA&amp;author=Gnanapragasam%2CPNP&amp;author=Muecksch%2CF&amp;author=Lee%2CYE&amp;author=Huey-Tubman%2CKE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=172.><p class=c-article-references__text id=ref-CR172>Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Wang Z, et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021;54:1853–68 e7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1yiu7zI aria-label="CAS reference 172">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34331873" aria-label="PubMed reference 172">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323339 aria-label="PubMed Central reference 172">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.immuni.2021.07.008 aria-label="Article reference 172">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 172" href="http://scholar.google.com/scholar_lookup?&amp;title=Affinity%20maturation%20of%20SARS-CoV-2%20neutralizing%20antibodies%20confers%20potency%2C%20breadth%2C%20and%20resilience%20to%20viral%20escape%20mutations&amp;journal=Immunity.&amp;volume=54&amp;pages=1853-68%20e7&amp;publication_year=2021&amp;author=Muecksch%2CF&amp;author=Weisblum%2CY&amp;author=Barnes%2CCO&amp;author=Schmidt%2CF&amp;author=Schaefer-Babajew%2CD&amp;author=Wang%2CZ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=173.><p class=c-article-references__text id=ref-CR173>Rino R, Emanuele A, Ida P, Silvia M, Lorena D, Giulio P et al. Anatomy of Omicron neutralizing antibodies in COVID-19 mRNA vaccinees. PREPRINT (Version 1) available at Research Square. 2022. <a href=https://doi.org/10.21203/rs.3.rs-1330153/v1>https://doi.org/10.21203/rs.3.rs-1330153/v1</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=174.><p class=c-article-references__text id=ref-CR174>Latif AA, Mullen JL, Alkuzweny M, Tsueng G, Cano M, Haag E, the Center for Viral Systems Biology, et al. Lineage comparison. outbreak.info. <a href=https://outbreak.info/compare-lineages>https://outbreak.info/compare-lineages</a>. Accessed 13 April 2022.</p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link href="https://citation-needed.springer.com/v2/references/10.1038/s41418-022-01015-x?format=refman&amp;flavour=references">Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a></p></div></div></div></section></div><section data-title=Acknowledgements><div class=c-article-section id=Ack1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Ack1>Acknowledgements</h2><div class=c-article-section__content id=Ack1-content><p>The authors thank Eleonora Candi and Richard Knight for their helpful and constructive criticisms.</p></div></div></section><section data-title=Funding><div class=c-article-section id=Fun-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Fun>Funding</h2><div class=c-article-section__content id=Fun-content><p>This work has been supported by the Associazione Italiana per la Ricerca contro il Cancro (AIRC) to GM (IG#20473; 2018–2022), to IA (AIRC Start-Up ID 23219; 2020–2024). Work has been also supported by Regione Lazio through LazioInnova Progetto Gruppo di Ricerca n 85-2017-14986; n 33 &amp; 55-2021-T0002E0001, by grants CRC1454 432325352 and CRC1403 414786233 to EL from the Deutsche Forschungsgemeinschaft (DFG) and the grant COVIMMUNE to EL by the Bundesministerium für Bildung und Forschung (BMBF), and by grant CRC1454 432325352 to JLS from the DFG and the grant COVIM to JLS by the BMBF. AM is supported by a grant from the Italian Ministry of Health, to JE from the Fondation Recherche Médicale and the Agence Nationale de la Recherche (COVID-I²A) and from Canada Research Chair program. Work has been supported by grants from the National Key R&amp;D Program of China (2018YFA0107500, 2021YFA1100600 and 2022YFC3600100), the Scientific Innovation Project of the Chinese Academy of Sciences (XDA16020403), the National Natural Science Foundation of China (81861138015, 81530043, 31961133024, 32000626, 81930085 32150710523, and 81571612), Fellowship of China Postdoctoral Science Foundation (2020M671261), Ministry of Health Italy-China cooperation grant &amp; AIRC IG#20473 to GM. Jiangsu Province International Science and Technology Cooperation Program (BZ2019017), National Center for International Research-Cambridge-Su Genomic Research Center (2017B01012) and the State Key Laboratory of Radiation Medicine and Protection, Soochow University (GZN1201903).</p></div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><span class="c-article-author-information__subtitle u-visually-hidden" id=author-notes>Author notes</span><ol class=c-article-author-information__list><li class=c-article-author-information__item id=na1><p>These authors contributed equally: Qing Li, Ying Wang, Qiang Sun.</p></ol><h3 class=c-article__sub-heading id=affiliations>Authors and Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>The Third Affiliated Hospital of Soochow University/The First People’s Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China<p class=c-article-author-affiliation__authors-list>Qing Li,&nbsp;Jingting Jiang,&nbsp;Changshun Shao,&nbsp;Peishan Li,&nbsp;Xiaozhou He,&nbsp;Fei Hua&nbsp;&amp;&nbsp;Yufang Shi</p><li id=Aff2><p class=c-article-author-affiliation__address>CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China<p class=c-article-author-affiliation__authors-list>Ying Wang,&nbsp;Liangyu Lin&nbsp;&amp;&nbsp;Yufang Shi</p><li id=Aff3><p class=c-article-author-affiliation__address>Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2021RU008, 20 Dongda Street, 100071, Beijing, China<p class=c-article-author-affiliation__authors-list>Qiang Sun,&nbsp;Zubiao Niu,&nbsp;Chaobing Ma&nbsp;&amp;&nbsp;Yichao Zhu</p><li id=Aff4><p class=c-article-author-affiliation__address>Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany<p class=c-article-author-affiliation__authors-list>Jasmin Knopf&nbsp;&amp;&nbsp;Martin Herrmann</p><li id=Aff5><p class=c-article-author-affiliation__address>Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany<p class=c-article-author-affiliation__authors-list>Jasmin Knopf&nbsp;&amp;&nbsp;Martin Herrmann</p><li id=Aff6><p class=c-article-author-affiliation__address>Ministry of Health, Rome, Italy<p class=c-article-author-affiliation__authors-list>Giuseppe Ippolito</p><li id=Aff7><p class=c-article-author-affiliation__address>Department of Biology, TOR, University of Rome Tor Vergata, 00133, Rome, Italy<p class=c-article-author-affiliation__authors-list>Mauro Piacentini&nbsp;&amp;&nbsp;Sonia Melino</p><li id=Aff8><p class=c-article-author-affiliation__address>INSERM-U1124, Université Paris, Paris, France<p class=c-article-author-affiliation__authors-list>Jerome Estaquier</p><li id=Aff9><p class=c-article-author-affiliation__address>CHU de Québec - Université Laval Research Center, Québec City, QC, Canada<p class=c-article-author-affiliation__authors-list>Jerome Estaquier</p><li id=Aff10><p class=c-article-author-affiliation__address>Institute of Innate Immunity, University Hospital Bonn, University of Bonn, 53127, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Felix Daniel Weiss&nbsp;&amp;&nbsp;Eicke Latz</p><li id=Aff11><p class=c-article-author-affiliation__address>Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy<p class=c-article-author-affiliation__authors-list>Emanuele Andreano&nbsp;&amp;&nbsp;Rino Rappuoli</p><li id=Aff12><p class=c-article-author-affiliation__address>Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany<p class=c-article-author-affiliation__authors-list>Eicke Latz,&nbsp;Joachim L. Schultze&nbsp;&amp;&nbsp;Gerry Melino</p><li id=Aff13><p class=c-article-author-affiliation__address>Genomics &amp; Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Joachim L. Schultze</p><li id=Aff14><p class=c-article-author-affiliation__address>Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy<p class=c-article-author-affiliation__authors-list>Alberto Mantovani</p><li id=Aff15><p class=c-article-author-affiliation__address>IRCCS Humanitas Clinical Research Hospital, via Manzoni 56, Rozzano, 20089, Milan, Italy<p class=c-article-author-affiliation__authors-list>Alberto Mantovani</p><li id=Aff16><p class=c-article-author-affiliation__address>William Harvey Research Institute, Queen Mary University, London, UK<p class=c-article-author-affiliation__authors-list>Alberto Mantovani</p><li id=Aff17><p class=c-article-author-affiliation__address>Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada<p class=c-article-author-affiliation__authors-list>Tak Wah Mak</p><li id=Aff18><p class=c-article-author-affiliation__address>Department of Pathology, University of Hong Kong, Hong Kong, Pok Fu Lam, 999077, Hong Kong<p class=c-article-author-affiliation__authors-list>Tak Wah Mak</p><li id=Aff19><p class=c-article-author-affiliation__address>Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy<p class=c-article-author-affiliation__authors-list>Gerry Melino&nbsp;&amp;&nbsp;Yufang Shi</p></ol><div class="u-js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=contributions>Contributions</h3><p>GM and YS conceived the project; all authors wrote the manuscript; QS and ZN prepared Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>; JK and MH Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig2>2</a>; QS and CM Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig3>3</a>; QL and YW Figs.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig4>4</a> and <a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig6>6</a>; JS Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig5>5</a>; YW and YS Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a>.<h3 class=c-article__sub-heading id=corresponding-author>Corresponding authors</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 href=mailto:melino@uniroma2.it>Gerry Melino</a> or <a id=corresp-c2 href=mailto:yufangshi@sibs.ac.cn>Yufang Shi</a>.</p></div></div></section><section data-title="Ethics declarations"><div class=c-article-section id=ethics-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=ethics>Ethics declarations</h2><div class=c-article-section__content id=ethics-content>
 
 <h3 class=c-article__sub-heading id=FPar1>Competing interests</h3>
 <p>GM, MP, YS, TWM and QS are members of the Editorial Board of Cell Death Differentiation. Other authors declare no competing interests.</p>
 
 
 <h3 class=c-article__sub-heading id=FPar2>Consent for publication</h3>
 <p>All of the authors have approved this submitted version.</p>
 
 </div></div></section><section data-title="Additional information"><div class=c-article-section id=additional-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=additional-information>Additional information</h2><div class=c-article-section__content id=additional-information-content><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.<p>Edited by B. Zhivotovsky</p></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href=http://creativecommons.org/licenses/by/4.0/ rel=license>http://creativecommons.org/licenses/by/4.0/</a>.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=Immune%20response%20in%20COVID-19%3A%20what%20is%20next%3F&amp;author=Qing%20Li%20et%20al&amp;contentID=10.1038%2Fs41418-022-01015-x&amp;copyright=The%20Author%28s%29&amp;publication=1350-9047&amp;publicationDate=2022-05-17&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1038/s41418-022-01015-x target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41418-022-01015-x" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg> width=57 height=81></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>Li, Q., Wang, Y., Sun, Q. <i>et al.</i> Immune response in COVID-19: what is next?.
 <i>Cell Death Differ</i> (2022). https://doi.org/10.1038/s41418-022-01015-x<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external href="https://citation-needed.springer.com/v2/references/10.1038/s41418-022-01015-x?format=refman&amp;flavour=citation">Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2022-04-11>11 April 2022</time></span></p><li class=c-bibliographic-information__list-item><p>Revised<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2022-04-16>16 April 2022</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2022-04-26>26 April 2022</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2022-05-17>17 May 2022</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value>https://doi.org/10.1038/s41418-022-01015-x</span></p></ul><div data-component=share-box><div class="c-article-share-box u-display-inline"><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
 Provided by the Springer Nature SharedIt content-sharing initiative
 </p></div></div><div data-component=article-info-list>
 <h3 class=c-article__sub-heading>Subjects</h3>
 <ul class=c-article-subject-list>
 <li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/antimicrobial-responses data-track=click data-track-action="view subject" data-track-label=link>Antimicrobial responses</a><li class=c-article-subject-list__subject><a href=https://www.nature.com/subjects/infectious-diseases data-track=click data-track-action="view subject" data-track-label=link>Infectious diseases</a></li>
 </ul>
 </div></div></div></div></div></section>
 
 
 <span data-recommended=jobs></span>
</div>
</article>
</main>
<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion data-container-type=reading-companion data-track-component="reading companion">
 <div class=js-context-bar-sticky-point-desktop>
 
 
 
 
 
 <div class="c-pdf-download u-clear-both js-pdf-download">
 <a href=https://www.nature.com/articles/s41418-022-01015-x.pdf class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf=true data-readcube-pdf-url=true data-test=download-pdf data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=link data-track-external>
 <span class=c-pdf-download__text>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#global-icon-download></use></svg>
 </a>
 </div>
 
 
 
 </div>
 
 
 
 
 
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:40px>
 <ul class=c-reading-companion__tabs role=tablist><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=figures role=tab id=tab-figures aria-controls=tabpanel-figures aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="figures tab" data-track-label=tab>Figures</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections role=tabpanel><div class=c-reading-companion__scroll-pane style=max-height:none><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Facts>Facts</a><li id=rc-sec-Sec2 class=c-reading-companion__section-item><a href=#Sec2 data-track=click data-track-action="section anchor" data-track-label="link:Open Questions">Open Questions</a><li id=rc-sec-Sec3 class=c-reading-companion__section-item><a href=#Sec3 data-track=click data-track-action="section anchor" data-track-label="link:Underlying inflammatory conditions and infection severity">Underlying inflammatory conditions and infection severity</a><li id=rc-sec-Sec4 class=c-reading-companion__section-item><a href=#Sec4 data-track=click data-track-action="section anchor" data-track-label="link:Innate immunity">Innate immunity</a><li id=rc-sec-Sec5 class=c-reading-companion__section-item><a href=#Sec5 data-track=click data-track-action="section anchor" data-track-label="link:Cellular innate immunity">Cellular innate immunity</a><li id=rc-sec-Sec6 class=c-reading-companion__section-item><a href=#Sec6 data-track=click data-track-action="section anchor" data-track-label="link:Humoral innate immune response to SARSCoV2 infection">Humoral innate immune response to SARS-CoV-2 infection</a><li id=rc-sec-Sec7 class=c-reading-companion__section-item><a href=#Sec7 data-track=click data-track-action="section anchor" data-track-label="link:NETdriven vascular occlusions drive pathology in severe COVID19">NET-driven vascular occlusions drive pathology in severe COVID-19</a><li id=rc-sec-Sec8 class=c-reading-companion__section-item><a href=#Sec8 data-track=click data-track-action="section anchor" data-track-label="link:Targeting the type I IFN production by SARSCoV2">Targeting the type I IFN production by SARS-CoV-2</a><li id=rc-sec-Sec9 class=c-reading-companion__section-item><a href=#Sec9 data-track=click data-track-action="section anchor" data-track-label="link:Adaptive immunity humoral immunity to SARSCoV2">Adaptive immunity: humoral immunity to SARS-CoV-2</a><li id=rc-sec-Sec10 class=c-reading-companion__section-item><a href=#Sec10 data-track=click data-track-action="section anchor" data-track-label="link:Adaptive immunity cellular immunity and resistance to SARSCoV2">Adaptive immunity: cellular immunity and resistance to SARS-CoV-2</a><li id=rc-sec-Sec11 class=c-reading-companion__section-item><a href=#Sec11 data-track=click data-track-action="section anchor" data-track-label="link:Therapeutic antibody against SARSCoV2">Therapeutic antibody against SARS-CoV-2</a><li id=rc-sec-Sec12 class=c-reading-companion__section-item><a href=#Sec12 data-track=click data-track-action="section anchor" data-track-label="link:The SARSCoV2 vaccination">The SARS-CoV-2 vaccination</a><li id=rc-sec-Sec13 class=c-reading-companion__section-item><a href=#Sec13 data-track=click data-track-action="section anchor" data-track-label="link:What will follow Omicron">What will follow Omicron</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Ack1 class=c-reading-companion__section-item><a href=#Ack1 data-track=click data-track-action="section anchor" data-track-label=link:Acknowledgements>Acknowledgements</a><li id=rc-sec-Fun class=c-reading-companion__section-item><a href=#Fun data-track=click data-track-action="section anchor" data-track-label=link:Funding>Funding</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-ethics class=c-reading-companion__section-item><a href=#ethics data-track=click data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a><li id=rc-sec-additional-information class=c-reading-companion__section-item><a href=#additional-information data-track=click data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a></ul></div>
 <div class=u-mt-16 data-component-mpu>
 <div class="c-ad c-ad--300x250">
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 
 <div id=div-gpt-ad-right-2 class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type=right data-pa11y-ignore data-gpt data-gpt-unitpath=/285/cdd.nature.com/article data-gpt-sizes=300x250 data-gpt-targeting="type=article;pos=right;artid=s41418-022-01015-x;doi=10.1038/s41418-022-01015-x;subjmeta=2499,250,255,631;kwrd=Antimicrobial+responses,Infectious+diseases">
 <noscript class=sf-hidden>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/cdd.nature.com/article&amp;sz=300x250&amp;c=-192554811&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41418-022-01015-x%26doi%3D10.1038/s41418-022-01015-x%26subjmeta%3D2499,250,255,631%26kwrd%3DAntimicrobial+responses,Infectious+diseases">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/cdd.nature.com/article&amp;sz=300x250&amp;c=-192554811&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41418-022-01015-x%26doi%3D10.1038/s41418-022-01015-x%26subjmeta%3D2499,250,255,631%26kwrd%3DAntimicrobial+responses,Infectious+diseases"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
 </div>
 </div>
 </div>
 </div>
 </div>
 <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width sf-hidden" id=tabpanel-figures aria-labelledby=tab-figures role=tabpanel><div class="c-reading-companion__scroll-pane sf-hidden"><ul class="c-reading-companion__figures-list sf-hidden"><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig1_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig2_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig3_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig4_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig5_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-022-01015-x/MediaObjects/41418_2022_1015_Fig6_HTML.png?as=webp"></picture></figure></ul></div></div>
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references role=tabpanel></div>
 </div>
 </div>
</aside>
</div>
 
 
 
 
 
 
 
 
 
 
 
<footer class=composite-layer itemscope itemtype=http://schema.org/Periodical>
 
 
 <div class="u-mt-16 u-mb-16">
 <div class=u-container>
 <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
 
 <p class="c-meta u-ma-0 u-flex-shrink">
 <span class=c-meta__item>
 Cell Death &amp; Differentiation (<i>Cell Death Differ</i>)
 </span>
 
 
 <span class=c-meta__item>
 <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop=onlineIssn>1476-5403</span> (online)
 </span>
 
 
 
 <span class=c-meta__item>
 <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop=printIssn>1350-9047</span> (print)
 </span>
 
 </p>
 </div>
 </div>
</div>
 <div>
 <div class=c-footer>
 <div class=u-container>
 <div class=u-hide-print data-track-component=footer>
 <h2 class=u-visually-hidden>nature.com sitemap</h2>
 <div class=c-footer__header>
 <div class=c-footer__logo>
 <img alt="Nature portfolio" src="data:image/svg+xml;base64,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" loading=lazy width=200 height=31>
 </div>
 <ul class="c-menu c-menu--inherit u-mr-32">
 <li class=c-menu__item><a class=c-menu__link href=https://www.nature.com/npg_/company_info/index.html data-track=click data-track-action="about us" data-track-label=link>About us</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://www.nature.com/npg_/press_room/press_releases.html data-track=click data-track-action="press releases" data-track-label=link>Press releases</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://press.nature.com/ data-track=click data-track-action="press office" data-track-label=link>Press office</a></li>
 <li class=c-menu__item><a class=c-menu__link href=https://support.nature.com/support/home data-track=click data-track-action="contact us" data-track-label=link>Contact us</a></li>
 </ul>
 <ul class="c-menu c-menu--inherit">
 <li class=c-menu__item>
 <a class=c-menu__link href=https://www.facebook.com/NaturePortfolioJournals/ aria-label=Facebook data-track=click data-track-action=facebook data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=16 height=16 viewBox="0 0 20 20"><path d="M2.5 20C1.1 20 0 18.9 0 17.5v-15C0 1.1 1.1 0 2.5 0h15C18.9 0 20 1.1 20 2.5v15c0 1.4-1.1 2.5-2.5 2.5h-3.7v-7.7h2.6l.4-3h-3v-2c0-.9.2-1.5 1.5-1.5h1.6V3.1c-.3 0-1.2-.1-2.3-.1-2.3 0-3.9 1.4-3.9 4v2.2H8.1v3h2.6V20H2.5z"></path></svg>
 </a>
 </li>
 <li class=c-menu__item>
 <a class=c-menu__link href="https://twitter.com/NaturePortfolio?lang=en" aria-label=Twitter data-track=click data-track-action=twitter data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=20 height=20 viewBox="0 0 20 20"><path d="M17.6 4.1c.8-.5 1.5-1.4 1.8-2.4-.8.5-1.7.9-2.6 1-.7-.8-1.8-1.4-3-1.4-2.3 0-4.1 1.9-4.1 4.3 0 .3 0 .7.1 1-3.4 0-6.4-1.8-8.4-4.4C1 2.9.8 3.6.8 4.4c0 1.5.7 2.8 1.8 3.6C2 8 1.4 7.8.8 7.5v.1c0 2.1 1.4 3.8 3.3 4.2-.3.1-.7.2-1.1.2-.3 0-.5 0-.8-.1.5 1.7 2 3 3.8 3-1.3 1.1-3.1 1.8-5 1.8-.3 0-.7 0-1-.1 1.8 1.2 4 1.9 6.3 1.9C13.8 18.6 18 12 18 6.3v-.6c.8-.6 1.5-1.4 2-2.2-.7.3-1.5.5-2.4.6z"></path></svg>
 </a>
 </li>
 <li class=c-menu__item>
 <a class=c-menu__link href=https://www.youtube.com/channel/UCvCLdSgYdSTpWcOgEJgi-ng aria-label=YouTube data-track=click data-track-action=youtube data-track-label=link>
 <svg class=u-icon role=img aria-hidden=true focusable=false xmlns=http://www.w3.org/2000/svg width=20 height=20 viewBox="0 0 20 20"><path d="M7.9 12.6V6.9l5.4 2.8c0 .1-5.4 2.9-5.4 2.9zM19.8 6s-.2-1.4-.8-2c-.8-.8-1.6-.8-2-.9-2.8-.2-7-.2-7-.2s-4.2 0-7 .2c-.4 0-1.2 0-2 .9-.6.6-.8 2-.8 2S0 7.6 0 9.2v1.5c0 1.7.2 3.3.2 3.3s.2 1.4.8 2c.8.8 1.8.8 2.2.9 1.6.1 6.8.2 6.8.2s4.2 0 7-.2c.4 0 1.2-.1 2-.9.6-.6.8-2 .8-2s.2-1.6.2-3.3V9.2c0-1.6-.2-3.2-.2-3.2z"></path></svg>
 </a>
 </li>
 </ul>
 </div>
 <div class=c-footer__grid>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Discover content</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/siteindex data-track=click data-track-action="journals a-z" data-track-label=link>Journals A-Z</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/subjects/ data-track=click data-track-action="article by subject" data-track-label=link>Articles by subject</a></li>
 <li class=c-footer__item><a href=https://nano.nature.com/ data-track=click data-track-action=nano data-track-label=link>Nano</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/protocolexchange/ data-track=click data-track-action="protocol exchange" data-track-label=link>Protocol Exchange</a></li>
 <li class=c-footer__item><a href=https://www.natureindex.com/ data-track=click data-track-action="nature index" data-track-label=link>Nature Index</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Publishing policies</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/authors/editorial_policies/ data-track=click data-track-action="Nature portfolio policies" data-track-label=link>Nature portfolio policies</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nature-research/open-access data-track=click data-track-action="open access" data-track-label=link>Open access</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Author &amp; Researcher services</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/reprints/ data-track=click data-track-action="reprints and permissions" data-track-label=link>Reprints &amp; permissions</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/authors/research-data data-track=click data-track-action="data research service" data-track-label=link>Research data</a></li>
 <li class=c-footer__item><a href=https://authorservices.springernature.com/go/nr data-track=click data-track-action="language editing" data-track-label=link>Language editing</a></li>
 <li class=c-footer__item><a href=https://authorservices.springernature.com/scientific-editing/ data-track=click data-track-action="scientific editing" data-track-label=link>Scientific editing</a></li>
 <li class=c-footer__item><a href=https://masterclasses.nature.com/ data-track=click data-track-action="nature masterclasses" data-track-label=link>Nature Masterclasses</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/researcher-training/ data-track=click data-track-action="nature research academies" data-track-label=link>Nature Research Academies</a></li>
 <li class=c-footer__item><a href=https://solutions.springernature.com/ data-track=click data-track-action="research solutions" data-track-label=link>Research Solutions</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Libraries &amp; institutions</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/tools-services data-track=click data-track-action="librarian service and tools" data-track-label=link>Librarian service &amp; tools</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/manage-your-account/librarianportal data-track=click data-track-action="librarian portal" data-track-label=link>Librarian portal</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/openresearch/about-open-access/information-for-institutions/ data-track=click data-track-action="open research" data-track-label=link>Open research</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/gp/librarians/recommend-to-your-library data-track=click data-track-action="Recommend to library" data-track-label=link>Recommend to library</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Advertising &amp; partnerships</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/digital-advertising/ data-track=click data-track-action=advertising data-track-label=link>Advertising</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/ data-track=click data-track-action="partnerships and services" data-track-label=link>Partnerships &amp; Services</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/media-kits/ data-track=click data-track-action="media kits" data-track-label=link>Media kits</a></li>
 <li class=c-footer__item><a href=https://partnerships.nature.com/product/branded-content-native-advertising/ data-track-action="branded content" data-track-label=link>Branded content</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Career development</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/naturecareers data-track=click data-track-action="nature careers" data-track-label=link>Nature Careers</a></li>
 <li class=c-footer__item><a href=https://conferences.nature.com/ data-track=click data-track-action="nature conferences" data-track-label=link>Nature<span class=u-visually-hidden> </span> Conferences</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/natureevents/ data-track=click data-track-action="nature events" data-track-label=link>Nature<span class=u-visually-hidden> </span> events</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Regional websites</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/natafrica data-track=click data-track-action="nature africa" data-track-label=link>Nature Africa</a></li>
 <li class=c-footer__item><a href=http://www.naturechina.com/ data-track=click data-track-action="nature china" data-track-label=link>Nature China</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nindia data-track=click data-track-action="nature india" data-track-label=link>Nature India</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/natitaly data-track=click data-track-action="nature Italy" data-track-label=link>Nature Italy</a></li>
 <li class=c-footer__item><a href=https://www.natureasia.com/ja-jp/ data-track=click data-track-action="nature japan" data-track-label=link>Nature Japan</a></li>
 <li class=c-footer__item><a href=https://www.natureasia.com/ko-kr/ data-track=click data-track-action="nature korea" data-track-label=link>Nature Korea</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/nmiddleeast/ data-track=click data-track-action="nature middle east" data-track-label=link>Nature Middle East</a></li>
 </ul>
 </div>
 <div class=c-footer__group>
 <h3 class=c-footer__heading>Legal &amp; Privacy</h3>
 <ul class=c-footer__list>
 <li class=c-footer__item><a href=https://www.nature.com/info/privacy data-track=click data-track-action="privacy policy" data-track-label=link>Privacy Policy</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/cookies data-track=click data-track-action="use of cookies" data-track-label=link>Use of cookies</a></li>
 <li class=c-footer__item><a class=optanon-toggle-display href=https://www.nature.com/articles/s41418-022-01015-x data-cc-action=preferences data-track=click data-track-action="manage cookies" data-track-label=link>Manage cookies/Do not sell my data</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/legal-notice data-track=click data-track-action="legal notice" data-track-label=link>Legal notice</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/accessibility-statement data-track=click data-track-action="accessibility statement" data-track-label=link>Accessibility statement</a></li>
 <li class=c-footer__item><a href=https://www.nature.com/info/terms-and-conditions data-track=click data-track-action="terms and conditions" data-track-label=link>Terms &amp; Conditions</a></li>
 <li class=c-footer__item><a href=https://www.springernature.com/ccpa data-track=click data-track-action="california privacy statement" data-track-label=link>California Privacy Statement</a></li>
 
 <li class=c-footer__item><a href=https://support.nature.com/de/support/solutions/articles/6000255911-k%C3%BCndigungsformular>Cancel contracts here</a></li>
 
 </ul>
 </div>
 </div>
</div>
 </div>
 </div>
 </div>
 <div class=c-corporate-footer>
 <div class=u-container>
 <img src="data:image/svg+xml;base64,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" alt="Springer Nature" loading=lazy width=140 height=14>
 <p class=c-corporate-footer__legal data-test=copyright>© 2022 Springer Nature Limited</p>
 </div>
</div>
 
 <svg class="u-hide hide">
 <symbol id=global-icon-chevron-right viewBox="0 0 16 16">
 <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-download viewBox="0 0 16 16">
 <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-email viewBox="0 0 18 18">
 <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-institution viewBox="0 0 18 18">
 <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-search viewBox="0 0 22 22">
 <path fill-rule=evenodd d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"></path>
 </symbol>
 <symbol id=icon-info viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-success viewBox="0 0 18 18">
 <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-down viewBox="0 0 16 16">
 <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path>
 </symbol>
 <symbol id=icon-warning viewBox="0 0 18 18">
 <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-plus viewBox="0 0 16 16">
 <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-minus viewBox="0 0 16 16">
 <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-error viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-springer-arrow-left>
 <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path>
 </symbol>
 <symbol id=icon-springer-arrow-right>
 <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path>
 </symbol>
 <symbol id=icon-arrow-up viewBox="0 0 16 16">
 <path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-tick viewBox="0 0 24 24">
 <path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z"></path>
 </symbol>
 </svg>
</footer>
 
 <noscript class=sf-hidden>
        <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
    </noscript>
 
<img src="data:*/*;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR4nGP6zwAAAgcBApocMXEAAAAASUVORK5CYII=" alt class=u-visually-hidden width=1 height=1>
<img src="data:image/gif;base64,R0lGODlhAQABAJAAAP8AAAAAACH5BAUQAAAALAAAAAABAAEAAAICBAEAOw==">